SubjectNum,VisitNum,VisitCode,Testname,Value
1,1,1,Occurrence #,1st primary
1,1,1,Tumor Site,oropharynx
1,1,1,Radiation Dosage,70.2
1,1,1,Research lab HPV,HPV unknown
1,1,1,1st Failure Type,no known failure
1,1,1,Clinical lab p16,p16 unkown
1,1,1,Research lab p16,p16 unknown
1,1,1,Treatment Modality,CTX-RT
1,1,1,Overall Stage,III
1,1,1,Initial Chemotherapy Agent,carbo/doce
1,1,1,Metastasis,M0
1,1,1,Tumor Stage,T3
1,1,1,Nodal Stage,N1
1,1,1,2nd Failure Type,no known failure
2,1,1,Treatment Modality,CTX-RT
2,1,1,Radiation Dosage,45
2,1,1,Initial Chemotherapy Agent,unknown
2,1,1,Clinical lab p16,p16 unkown
2,1,1,Tumor Site,oropharynx
2,1,1,Research lab HPV,HPV unknown
2,1,1,Research lab p16,p16 unknown
2,1,1,Overall Stage,IVb
2,1,1,Metastasis,M0
2,1,1,Tumor Stage,T3
2,1,1,Nodal Stage,N3
2,1,1,2nd Failure Type,no known failure
2,1,1,1st Failure Type,no known failure
2,1,1,Occurrence #,1st primary
3,1,1,Nodal Stage,N0
3,1,1,Clinical lab p16,p16 unkown
3,1,1,Occurrence #,1st primary
3,1,1,2nd Failure Type,no known failure
3,1,1,Tumor Stage,T1
3,1,1,Research lab HPV,HPV negative
3,1,1,Tumor Site,oropharynx
3,1,1,Treatment Modality,Sx
3,1,1,Overall Stage,I
3,1,1,Metastasis,M0
3,1,1,1st Failure Type,no known failure
3,1,1,Research lab p16,p16 unknown
4,1,1,Overall Stage,IVa
4,1,1,Metastasis,M0
4,1,1,Research lab HPV,HPV unknown
4,1,1,Tumor Site,oropharynx
4,1,1,1st Failure Type,no known failure
4,1,1,Treatment Modality,CTX-RT
4,1,1,Initial Chemotherapy Agent,carbo/doce
4,1,1,Research lab p16,p16 unknown
4,1,1,Tumor Stage,T2
4,1,1,Clinical lab p16,p16 unkown
4,1,1,2nd Failure Type,no known failure
4,1,1,Occurrence #,1st primary
4,1,1,Nodal Stage,N2
5,1,1,Metastasis,M0
5,1,1,Tumor Site,oral cavity
5,1,1,2nd Failure Type,no known failure
5,1,1,Occurrence #,1st primary
5,1,1,Research lab p16,p16 unknown
5,1,1,Overall Stage,IVa
5,1,1,Nodal Stage,N2
5,1,1,Radiation Dosage,72
5,1,1,1st Failure Type,no known failure
5,1,1,Treatment Modality,Sx & RT
5,1,1,Tumor Stage,T4a
5,1,1,Clinical lab p16,p16 unkown
5,1,1,Research lab HPV,HPV unknown
6,1,1,Tumor Stage,T3
6,1,1,Research lab HPV,HPV unknown
6,1,1,Research lab p16,p16 unknown
6,1,1,Overall Stage,III
6,1,1,1st Failure Type,distant
6,1,1,2nd Failure Type,no known failure
6,1,1,Nodal Stage,N0
6,1,1,Radiation Dosage,59.4
6,1,1,Occurrence #,1st primary
6,1,1,Treatment Modality,RT
6,1,1,Tumor Site,oropharynx
6,1,1,Clinical lab p16,p16 unkown
6,1,1,Metastasis,M0
7,1,1,Tumor Site,oropharynx
7,1,1,1st Failure Type,no known failure
7,1,1,Research lab p16,p16 unknown
7,1,1,Tumor Stage,T4a
7,1,1,Nodal Stage,N2
7,1,1,Treatment Modality,Sx
7,1,1,Overall Stage,IVa
7,1,1,2nd Failure Type,no known failure
7,1,1,Clinical lab p16,p16 unkown
7,1,1,Occurrence #,recurrence
7,1,1,Metastasis,M0
7,1,1,Research lab HPV,HPV unknown
8,1,1,Radiation Dosage,70.2
8,1,1,Metastasis,M0
8,1,1,Clinical lab p16,p16 unkown
8,1,1,Tumor Site,oropharynx
8,1,1,Occurrence #,1st primary
8,1,1,Treatment Modality,RT
8,1,1,Nodal Stage,N0
8,1,1,Tumor Stage,T4a
8,1,1,1st Failure Type,no known failure
8,1,1,2nd Failure Type,no known failure
8,1,1,Research lab HPV,HPV positive
8,1,1,Overall Stage,IVa
8,1,1,Research lab p16,p16 negative
9,1,1,Tumor Site,Unknown
9,1,1,Occurrence #,1st primary
9,1,1,Research lab HPV,HPV unknown
9,1,1,Tumor Stage,Unknown
9,1,1,Treatment Modality,Unknown
9,1,1,Nodal Stage,Unknown
9,1,1,Clinical lab p16,p16 unkown
9,1,1,1st Failure Type,no known failure
9,1,1,Research lab p16,p16 unknown
9,1,1,Metastasis,Unknown
9,1,1,Overall Stage,Unknown
9,1,1,2nd Failure Type,no known failure
10,1,1,Clinical lab p16,p16 unkown
10,1,1,Treatment Modality,Unknown
10,1,1,Research lab p16,p16 unknown
10,1,1,1st Failure Type,no known failure
10,1,1,Tumor Site,Unknown
10,1,1,2nd Failure Type,no known failure
10,1,1,Research lab HPV,HPV unknown
10,1,1,Occurrence #,1st primary
10,1,1,Overall Stage,Unknown
10,1,1,Metastasis,Unknown
10,1,1,Nodal Stage,Unknown
10,1,1,Tumor Stage,Unknown
11,1,1,2nd Failure Type,no known failure
11,1,1,Initial Chemotherapy Agent,carbo/PTX
11,1,1,1st Failure Treatment Modality,CTX
11,1,1,Clinical lab p16,p16 unkown
11,1,1,Treatment Modality,CTX-RT
11,1,1,Radiation Dosage,70.2
11,1,1,1st Failure Type,locoregional
11,1,1,Research lab p16,p16 unknown
11,1,1,Overall Stage,III
11,1,1,Occurrence #,1st primary
11,1,1,1st Failure Site,oropharynx
11,1,1,Tumor Site,oropharynx
11,1,1,Research lab HPV,HPV unknown
11,1,1,1st Failure Initial Chemotherapy Agent,Cis/doce
11,1,1,Tumor Stage,T3
11,1,1,Nodal Stage,N1
11,1,1,Metastasis,M0
12,1,1,Clinical lab p16,p16 unkown
12,1,1,Tumor Site,oropharynx
12,1,1,Metastasis,M0
12,1,1,Research lab HPV,HPV positive
12,1,1,Research lab p16,p16 positive
12,1,1,1st Failure Type,no known failure
12,1,1,Tumor Stage,T2
12,1,1,Occurrence #,1st primary
12,1,1,Treatment Modality,CTX-RT
12,1,1,Radiation Dosage,70.2
12,1,1,Initial Chemotherapy Agent,carbo/doce
12,1,1,Overall Stage,IVa
12,1,1,Nodal Stage,N2
12,1,1,2nd Failure Type,no known failure
13,1,1,2nd Failure Type,no known failure
13,1,1,Treatment Modality,CTX-RT
13,1,1,Metastasis,M0
13,1,1,Clinical lab p16,p16 unkown
13,1,1,Initial Chemotherapy Agent,carbo/doce
13,1,1,Radiation Dosage,70.2
13,1,1,Tumor Stage,T1
13,1,1,Nodal Stage,N2
13,1,1,Overall Stage,IVa
13,1,1,Research lab p16,p16 positive
13,1,1,Research lab HPV,HPV positive
13,1,1,Tumor Site,oropharynx
13,1,1,Occurrence #,1st primary
13,1,1,1st Failure Type,no known failure
14,1,1,Tumor Site,oropharynx
14,1,1,Treatment Modality,Unknown
14,1,1,Tumor Stage,Unknown
14,1,1,Metastasis,Unknown
14,1,1,Research lab HPV,HPV unknown
14,1,1,Occurrence #,1st primary
14,1,1,2nd Failure Type,no known failure
14,1,1,Clinical lab p16,p16 unkown
14,1,1,1st Failure Type,no known failure
14,1,1,Overall Stage,Unknown
14,1,1,Nodal Stage,Unknown
14,1,1,Research lab p16,p16 unknown
15,1,1,Research lab HPV,HPV negative
15,1,1,1st Failure Type,locoregional
15,1,1,Nodal Stage,N0
15,1,1,Tumor Site,oropharynx
15,1,1,Occurrence #,1st primary
15,1,1,Research lab p16,p16 unknown
15,1,1,Tumor Stage,T1
15,1,1,Overall Stage,I
15,1,1,Initial Chemotherapy Agent,cis/5FU
15,1,1,Treatment Modality,CTX
15,1,1,Clinical lab p16,p16 unkown
15,1,1,2nd Failure Type,no known failure
15,1,1,Metastasis,M0
16,1,1,1st Failure Type,no known failure
16,1,1,2nd Failure Type,no known failure
16,1,1,Treatment Modality,Unknown
16,1,1,Tumor Site,oropharynx
16,1,1,Clinical lab p16,p16 unkown
16,1,1,Nodal Stage,Unknown
16,1,1,Overall Stage,Unknown
16,1,1,Research lab HPV,HPV negative
16,1,1,Metastasis,Unknown
16,1,1,Occurrence #,Unknown
16,1,1,Research lab p16,p16 negative
16,1,1,Tumor Stage,Unknown
17,1,1,Occurrence #,1st primary
17,1,1,Treatment Modality,Unknown
17,1,1,Overall Stage,Unknown
17,1,1,2nd Failure Type,no known failure
17,1,1,1st Failure Type,no known failure
17,1,1,Clinical lab p16,p16 unkown
17,1,1,Research lab p16,p16 unknown
17,1,1,Nodal Stage,Unknown
17,1,1,Research lab HPV,HPV unknown
17,1,1,Metastasis,Unknown
17,1,1,Tumor Site,Unknown
17,1,1,Tumor Stage,Unknown
18,1,1,Occurrence #,1st primary
18,1,1,Nodal Stage,N3
18,1,1,Metastasis,M0
18,1,1,Treatment Modality,Unknown
18,1,1,2nd Failure Type,no known failure
18,1,1,Overall Stage,IVb
18,1,1,Tumor Stage,T4a
18,1,1,Clinical lab p16,p16 unkown
18,1,1,Tumor Site,oropharynx
18,1,1,1st Failure Type,no known failure
18,1,1,Research lab HPV,HPV negative
18,1,1,Research lab p16,p16 negative
19,1,1,2nd Failure Type,no known failure
19,1,1,Overall Stage,III
19,1,1,Research lab p16,p16 negative
19,1,1,Treatment Modality,CTX-RT
19,1,1,Metastasis,M0
19,1,1,Research lab HPV,HPV negative
19,1,1,Nodal Stage,N0
19,1,1,Initial Chemotherapy Agent,cis
19,1,1,Tumor Site,oropharynx
19,1,1,Tumor Stage,T3
19,1,1,Radiation Dosage,72
19,1,1,Occurrence #,1st primary
19,1,1,Clinical lab p16,p16 unkown
19,1,1,1st Failure Type,no known failure
20,1,1,2nd Failure Type,no known failure
20,1,1,Research lab HPV,HPV unknown
20,1,1,1st Failure Type,no known failure
20,1,1,Metastasis,Unknown
20,1,1,Occurrence #,1st primary
20,1,1,Clinical lab p16,p16 unkown
20,1,1,Tumor Stage,Unknown
20,1,1,Overall Stage,Unknown
20,1,1,Nodal Stage,Unknown
20,1,1,Treatment Modality,Unknown
20,1,1,Tumor Site,Unknown
20,1,1,Research lab p16,p16 unknown
21,1,1,Tumor Site,oropharynx
21,1,1,Second Line Chemotherapy Agent,cis/5FU
21,1,1,Occurrence #,1st primary
21,1,1,2nd Failure Type,no known failure
21,1,1,Tumor Stage,T3
21,1,1,Research lab p16,p16 negative
21,1,1,Metastasis,M0
21,1,1,Research lab HPV,HPV negative
21,1,1,Initial Chemotherapy Agent,carbo
21,1,1,Nodal Stage,N1
21,1,1,1st Failure Type,locoregional
21,1,1,Radiation Dosage,72.2
21,1,1,Treatment Modality,CTX-RT
21,1,1,Overall Stage,III
21,1,1,Clinical lab p16,p16 unkown
22,1,1,Clinical lab p16,p16 unkown
22,1,1,Tumor Site,oropharynx
22,1,1,Occurrence #,1st primary
22,1,1,Nodal Stage,N0
22,1,1,Overall Stage,IVa
22,1,1,Treatment Modality,CTX-RT
22,1,1,1st Failure Type,no known failure
22,1,1,Initial Chemotherapy Agent,carbo/doce
22,1,1,Research lab p16,p16 unknown
22,1,1,2nd Failure Type,no known failure
22,1,1,Radiation Dosage,70.2
22,1,1,Research lab HPV,HPV unknown
22,1,1,Metastasis,M0
22,1,1,Tumor Stage,T4a
23,1,1,2nd Failure Type,no known failure
23,1,1,Nodal Stage,N1
23,1,1,Tumor Stage,T3
23,1,1,Metastasis,M0
23,1,1,Overall Stage,III
23,1,1,Research lab p16,p16 negative
23,1,1,Occurrence #,1st primary
23,1,1,Clinical lab p16,p16 unkown
23,1,1,Research lab HPV,HPV negative
23,1,1,Tumor Site,oropharynx
23,1,1,1st Failure Type,no known failure
23,1,1,Treatment Modality,RT
24,1,1,Research lab p16,p16 positive
24,1,1,Clinical lab p16,p16 unkown
24,1,1,Overall Stage,IVa
24,1,1,Occurrence #,1st primary
24,1,1,Research lab HPV,HPV positive
24,1,1,Metastasis,M0
24,1,1,Tumor Site,oropharynx
24,1,1,Tumor Stage,T3
24,1,1,1st Failure Type,no known failure
24,1,1,Treatment Modality,Unknown
24,1,1,Nodal Stage,N2
24,1,1,2nd Failure Type,no known failure
25,1,1,Metastasis,M0
25,1,1,Nodal Stage,N0
25,1,1,Overall Stage,I
25,1,1,2nd Failure Type,no known failure
25,1,1,Tumor Stage,T1
25,1,1,Research lab p16,p16 unknown
25,1,1,Clinical lab p16,p16 unkown
25,1,1,Occurrence #,1st primary
25,1,1,Research lab HPV,HPV negative
25,1,1,Tumor Site,oral cavity
25,1,1,Treatment Modality,Sx
25,1,1,1st Failure Type,locoregional
26,1,1,2nd Failure Type,no known failure
26,1,1,Nodal Stage,N2
26,1,1,Radiation Dosage,70.2
26,1,1,Tumor Stage,T4a
26,1,1,Metastasis,M0
26,1,1,Treatment Modality,CTX-RT
26,1,1,1st Failure Type,locoregional
26,1,1,1st Failure Treatment Modality,Sx
26,1,1,Overall Stage,IVa
26,1,1,Initial Chemotherapy Agent,carbo/cap
26,1,1,1st Failure Site,oropharynx
26,1,1,Research lab p16,p16 unknown
26,1,1,Occurrence #,1st primary
26,1,1,Clinical lab p16,p16 unkown
26,1,1,Tumor Site,oropharynx
26,1,1,Research lab HPV,HPV unknown
27,1,1,Occurrence #,1st primary
27,1,1,2nd Failure Type,no known failure
27,1,1,Nodal Stage,N1
27,1,1,Tumor Stage,T2
27,1,1,Metastasis,M0
27,1,1,Research lab HPV,HPV unknown
27,1,1,Clinical lab p16,p16 unkown
27,1,1,1st Failure Type,no known failure
27,1,1,Research lab p16,p16 unknown
27,1,1,Tumor Site,oral cavity
27,1,1,Treatment Modality,Sx
27,1,1,Overall Stage,III
28,1,1,Radiation Dosage,unknown
28,1,1,Research lab p16,p16 positive
28,1,1,Tumor Stage,T1
28,1,1,2nd Failure Type,no known failure
28,1,1,Nodal Stage,N3
28,1,1,Metastasis,M0
28,1,1,Treatment Modality,Sx & RT
28,1,1,Clinical lab p16,p16 unkown
28,1,1,1st Failure Type,distant
28,1,1,Tumor Site,oropharynx
28,1,1,Overall Stage,IVb
28,1,1,Research lab HPV,HPV positive
28,1,1,Occurrence #,1st primary
29,1,1,Overall Stage,IVa
29,1,1,Research lab HPV,HPV unknown
29,1,1,2nd Failure Type,no known failure
29,1,1,Tumor Stage,T1
29,1,1,Research lab p16,p16 unknown
29,1,1,Metastasis,M0
29,1,1,Nodal Stage,N2
29,1,1,Tumor Site,oropharynx
29,1,1,Treatment Modality,Sx & RT
29,1,1,Clinical lab p16,p16 unkown
29,1,1,Occurrence #,1st primary
29,1,1,1st Failure Type,no known failure
29,1,1,Radiation Dosage,63
30,1,1,Treatment Modality,Sx
30,1,1,Tumor Stage,T3
30,1,1,Metastasis,M0
30,1,1,Occurrence #,recurrence
30,1,1,1st Failure Type,no known failure
30,1,1,Overall Stage,III
30,1,1,Tumor Site,oropharynx
30,1,1,2nd Failure Type,no known failure
30,1,1,Research lab p16,p16 unknown
30,1,1,Nodal Stage,N1
30,1,1,Clinical lab p16,p16 unkown
30,1,1,Research lab HPV,HPV unknown
31,1,1,1st Failure Type,no known failure
31,1,1,Nodal Stage,Unknown
31,1,1,Research lab p16,p16 unknown
31,1,1,2nd Failure Type,no known failure
31,1,1,Overall Stage,Unknown
31,1,1,Clinical lab p16,p16 unkown
31,1,1,Tumor Site,Unknown
31,1,1,Tumor Stage,Unknown
31,1,1,Occurrence #,1st primary
31,1,1,Treatment Modality,Unknown
31,1,1,Research lab HPV,HPV unknown
31,1,1,Metastasis,Unknown
32,1,1,Treatment Modality,Sx
32,1,1,Metastasis,M0
32,1,1,1st Failure Type,no known failure
32,1,1,2nd Failure Type,no known failure
32,1,1,Research lab p16,p16 unknown
32,1,1,Occurrence #,recurrence
32,1,1,Nodal Stage,N2
32,1,1,Tumor Stage,Unknown
32,1,1,Research lab HPV,HPV unknown
32,1,1,Tumor Site,oropharynx
32,1,1,Clinical lab p16,p16 unkown
32,1,1,Overall Stage,IVa
33,1,1,Treatment Modality,Unknown
33,1,1,Nodal Stage,Unknown
33,1,1,Research lab HPV,HPV unknown
33,1,1,Occurrence #,1st primary
33,1,1,Tumor Site,Unknown
33,1,1,Tumor Stage,Unknown
33,1,1,Clinical lab p16,p16 unkown
33,1,1,Research lab p16,p16 unknown
33,1,1,Overall Stage,Unknown
33,1,1,2nd Failure Type,no known failure
33,1,1,Metastasis,Unknown
33,1,1,1st Failure Type,no known failure
34,1,1,1st Failure Type,locoregional and distant
34,1,1,Research lab HPV,HPV unknown
34,1,1,Initial Chemotherapy Agent,carbo/doce
34,1,1,Tumor Site,oropharynx
34,1,1,Radiation Dosage,70.2
34,1,1,Nodal Stage,N2
34,1,1,Occurrence #,1st primary
34,1,1,Overall Stage,IVa
34,1,1,Clinical lab p16,p16 unkown
34,1,1,Tumor Stage,T4a
34,1,1,Metastasis,M0
34,1,1,Treatment Modality,CTX-RT
34,1,1,2nd Failure Type,no known failure
34,1,1,Research lab p16,p16 unknown
35,1,1,Research lab p16,p16 unknown
35,1,1,Occurrence #,1st primary
35,1,1,Initial Chemotherapy Agent,carbo/doce
35,1,1,Research lab HPV,HPV unknown
35,1,1,Clinical lab p16,p16 unkown
35,1,1,1st Failure Type,locoregional and distant
35,1,1,Tumor Site,oropharynx
35,1,1,Overall Stage,IVa
35,1,1,Radiation Dosage,70.2
35,1,1,Nodal Stage,N0
35,1,1,2nd Failure Type,no known failure
35,1,1,Metastasis,M0
35,1,1,Treatment Modality,CTX-RT
35,1,1,Tumor Stage,T4a
36,1,1,Metastasis,Unknown
36,1,1,Tumor Stage,Unknown
36,1,1,Nodal Stage,Unknown
36,1,1,Overall Stage,Unknown
36,1,1,Tumor Site,Unknown
36,1,1,Research lab p16,p16 unknown
36,1,1,Occurrence #,1st primary
36,1,1,Research lab HPV,HPV unknown
36,1,1,1st Failure Type,no known failure
36,1,1,Treatment Modality,Unknown
36,1,1,Clinical lab p16,p16 unkown
36,1,1,2nd Failure Type,no known failure
37,1,1,Nodal Stage,N2
37,1,1,Occurrence #,recurrence
37,1,1,Research lab p16,p16 unknown
37,1,1,Research lab HPV,HPV positive
37,1,1,Clinical lab p16,p16 unkown
37,1,1,2nd Failure Type,no known failure
37,1,1,Tumor Site,oropharynx
37,1,1,Overall Stage,IVa
37,1,1,1st Failure Type,locoregional
37,1,1,Metastasis,M0
37,1,1,Treatment Modality,Sx
37,1,1,Tumor Stage,T3
38,1,1,1st Failure Type,no known failure
38,1,1,Metastasis,M0
38,1,1,Initial Chemotherapy Agent,carbo/doce
38,1,1,Treatment Modality,CTX-RT
38,1,1,Radiation Dosage,72
38,1,1,Research lab p16,p16 unknown
38,1,1,2nd Failure Type,no known failure
38,1,1,Tumor Stage,T2
38,1,1,Clinical lab p16,p16 unkown
38,1,1,Nodal Stage,N2
38,1,1,Research lab HPV,HPV unknown
38,1,1,Occurrence #,1st primary
38,1,1,Overall Stage,IVa
38,1,1,Tumor Site,oropharynx
39,1,1,Metastasis,M0
39,1,1,Nodal Stage,N3
39,1,1,Initial Chemotherapy Agent,carbo/doce
39,1,1,Treatment Modality,CTX-RT
39,1,1,Research lab p16,p16 unknown
39,1,1,Tumor Site,oropharynx
39,1,1,Occurrence #,1st primary
39,1,1,Clinical lab p16,p16 unkown
39,1,1,Research lab HPV,HPV unknown
39,1,1,Overall Stage,IVb
39,1,1,2nd Failure Type,no known failure
39,1,1,1st Failure Type,locoregional
39,1,1,Tumor Stage,T4a
39,1,1,Radiation Dosage,70.2
40,1,1,Tumor Site,oropharynx
40,1,1,2nd Failure Type,no known failure
40,1,1,1st Failure Type,locoregional
40,1,1,Occurrence #,recurrence
40,1,1,Clinical lab p16,p16 unkown
40,1,1,Tumor Stage,T1
40,1,1,Overall Stage,I
40,1,1,Treatment Modality,Sx
40,1,1,Research lab HPV,HPV unknown
40,1,1,Research lab p16,p16 unknown
40,1,1,Metastasis,M0
40,1,1,Nodal Stage,N0
41,1,1,Clinical lab p16,p16 unkown
41,1,1,Research lab p16,p16 unknown
41,1,1,Tumor Stage,Unknown
41,1,1,Overall Stage,Unknown
41,1,1,Treatment Modality,Unknown
41,1,1,Nodal Stage,Unknown
41,1,1,Metastasis,Unknown
41,1,1,Tumor Site,oropharynx
41,1,1,Occurrence #,1st primary
41,1,1,1st Failure Type,no known failure
41,1,1,Research lab HPV,HPV unknown
41,1,1,2nd Failure Type,no known failure
42,1,1,Overall Stage,IVa
42,1,1,Tumor Site,oropharynx
42,1,1,Treatment Modality,CTX-RT
42,1,1,Initial Chemotherapy Agent,carbo/doce
42,1,1,1st Failure Type,locoregional
42,1,1,Research lab p16,p16 unknown
42,1,1,Radiation Dosage,70.2
42,1,1,Nodal Stage,N1
42,1,1,Research lab HPV,HPV unknown
42,1,1,Clinical lab p16,p16 unkown
42,1,1,Second Line Chemotherapy Agent,doce/cap
42,1,1,2nd Failure Type,no known failure
42,1,1,Metastasis,M0
42,1,1,Tumor Stage,T4a
42,1,1,Occurrence #,recurrence
43,1,1,Research lab HPV,HPV unknown
43,1,1,Occurrence #,1st primary
43,1,1,2nd Failure Type,no known failure
43,1,1,Nodal Stage,N2
43,1,1,Treatment Modality,Unknown
43,1,1,Tumor Stage,T3
43,1,1,Metastasis,M0
43,1,1,Clinical lab p16,p16 unkown
43,1,1,Overall Stage,IVa
43,1,1,1st Failure Type,no known failure
43,1,1,Tumor Site,oral cavity
43,1,1,Research lab p16,p16 unknown
44,1,1,Research lab HPV,HPV unknown
44,1,1,Tumor Site,oropharynx
44,1,1,Radiation Dosage,64.8
44,1,1,Treatment Modality,CTX-RT
44,1,1,1st Failure Type,no known failure
44,1,1,Research lab p16,p16 unknown
44,1,1,Clinical lab p16,p16 unkown
44,1,1,Nodal Stage,N1
44,1,1,Overall Stage,IVc
44,1,1,Metastasis,M1
44,1,1,Initial Chemotherapy Agent,carbo/cetux
44,1,1,2nd Failure Type,no known failure
44,1,1,Occurrence #,1st primary
44,1,1,Tumor Stage,T2
45,1,1,Initial Chemotherapy Agent,sorafinib/17AAG
45,1,1,Research lab HPV,HPV unknown
45,1,1,Overall Stage,Unknown
45,1,1,Tumor Site,oropharynx
45,1,1,1st Failure Type,no known failure
45,1,1,Clinical lab p16,p16 unkown
45,1,1,Occurrence #,other primary
45,1,1,Metastasis,Unknown
45,1,1,Research lab p16,p16 unknown
45,1,1,2nd Failure Type,no known failure
45,1,1,Tumor Stage,Unknown
45,1,1,Treatment Modality,CTX
45,1,1,Nodal Stage,Unknown
46,1,1,1st Failure Type,no known failure
46,1,1,Research lab HPV,HPV unknown
46,1,1,Tumor Stage,T3
46,1,1,2nd Failure Type,no known failure
46,1,1,Overall Stage,IVa
46,1,1,Radiation Dosage,70.2
46,1,1,Nodal Stage,N2
46,1,1,Occurrence #,1st primary
46,1,1,Treatment Modality,CTX-RT
46,1,1,Metastasis,M0
46,1,1,Initial Chemotherapy Agent,carbo/PTX
46,1,1,Tumor Site,oropharynx
46,1,1,Clinical lab p16,p16 unkown
46,1,1,Research lab p16,p16 unknown
47,1,1,Tumor Site,Unknown
47,1,1,Overall Stage,Unknown
47,1,1,Clinical lab p16,p16 unkown
47,1,1,Metastasis,Unknown
47,1,1,Research lab p16,p16 unknown
47,1,1,Nodal Stage,Unknown
47,1,1,Occurrence #,1st primary
47,1,1,2nd Failure Type,no known failure
47,1,1,Research lab HPV,HPV unknown
47,1,1,Treatment Modality,Unknown
47,1,1,Tumor Stage,Unknown
47,1,1,1st Failure Type,no known failure
48,1,1,Occurrence #,1st primary
48,1,1,Overall Stage,IVa
48,1,1,Initial Chemotherapy Agent,carbo
48,1,1,1st Failure Type,no known failure
48,1,1,Tumor Site,oropharynx
48,1,1,Radiation Dosage,12.3
48,1,1,Clinical lab p16,p16 unkown
48,1,1,2nd Failure Type,no known failure
48,1,1,Research lab p16,p16 negative
48,1,1,Nodal Stage,N0
48,1,1,Tumor Stage,T4a
48,1,1,Research lab HPV,HPV negative
48,1,1,Metastasis,M0
48,1,1,Treatment Modality,RT
50,1,1,Overall Stage,Unknown
50,1,1,1st Failure Type,no known failure
50,1,1,Occurrence #,1st primary
50,1,1,2nd Failure Type,no known failure
50,1,1,Metastasis,Unknown
50,1,1,Tumor Stage,Unknown
50,1,1,Clinical lab p16,p16 unkown
50,1,1,Treatment Modality,Unknown
50,1,1,Nodal Stage,Unknown
50,1,1,Tumor Site,oropharynx
50,1,1,Research lab p16,p16 unknown
50,1,1,Research lab HPV,HPV unknown
51,1,1,2nd Failure Type,no known failure
51,1,1,Research lab HPV,HPV negative
51,1,1,Nodal Stage,N3
51,1,1,Research lab p16,p16 negative
51,1,1,Tumor Stage,T1
51,1,1,Occurrence #,1st primary
51,1,1,Clinical lab p16,p16 unkown
51,1,1,Radiation Dosage,28
51,1,1,Treatment Modality,CTX-RT
51,1,1,Metastasis,M1
51,1,1,Tumor Site,oropharynx
51,1,1,Overall Stage,IVc
51,1,1,Initial Chemotherapy Agent,cis
51,1,1,1st Failure Type,no known failure
52,1,1,2nd Failure Type,no known failure
52,1,1,Research lab HPV,HPV unknown
52,1,1,Treatment Modality,CTX-RT
52,1,1,Initial Chemotherapy Agent,carbo/PTX
52,1,1,Overall Stage,IVa
52,1,1,Tumor Stage,T3
52,1,1,Nodal Stage,N2
52,1,1,Research lab p16,p16 unknown
52,1,1,Tumor Site,oropharynx
52,1,1,Clinical lab p16,p16 unkown
52,1,1,1st Failure Type,no known failure
52,1,1,Radiation Dosage,70.2
52,1,1,Metastasis,M0
52,1,1,Occurrence #,1st primary
53,1,1,Nodal Stage,N2
53,1,1,Radiation Dosage,70.2
53,1,1,Occurrence #,1st primary
53,1,1,Research lab HPV,HPV positive
53,1,1,Tumor Site,oropharynx
53,1,1,Initial Chemotherapy Agent,carbo/cetux
53,1,1,Overall Stage,IVa
53,1,1,Research lab p16,p16 positive
53,1,1,Tumor Stage,T3
53,1,1,1st Failure Type,no known failure
53,1,1,Metastasis,M0
53,1,1,Clinical lab p16,p16 unkown
53,1,1,2nd Failure Type,no known failure
53,1,1,Treatment Modality,CTX-RT
54,1,1,2nd Failure Type,no known failure
54,1,1,Overall Stage,IVa
54,1,1,Nodal Stage,N2
54,1,1,1st Failure Type,no known failure
54,1,1,Metastasis,M0
54,1,1,Tumor Site,oropharynx
54,1,1,Research lab HPV,HPV positive
54,1,1,Tumor Stage,T3
54,1,1,Occurrence #,1st primary
54,1,1,Radiation Dosage,70.2
54,1,1,Treatment Modality,CTX-RT
54,1,1,Research lab p16,p16 positive
54,1,1,Clinical lab p16,p16 unkown
54,1,1,Initial Chemotherapy Agent,carbo/PTX
55,1,1,Tumor Site,oral cavity
55,1,1,Metastasis,M0
55,1,1,1st Failure Treatment Modality,CTX
55,1,1,Overall Stage,IVa
55,1,1,Research lab p16,p16 negative
55,1,1,1st Failure Initial Chemotherapy Agent,Cis/5-FU
55,1,1,2nd Failure Type,no known failure
55,1,1,1st Failure Type,locoregional
55,1,1,1st Failure Second Line Chemotherapy Agent,doce
55,1,1,Radiation Dosage,65
55,1,1,Clinical lab p16,p16 unkown
55,1,1,Occurrence #,1st primary
55,1,1,Research lab HPV,HPV negative
55,1,1,Nodal Stage,N1
55,1,1,Tumor Stage,T4a
55,1,1,1st Failure Site,oral cavity
55,1,1,Treatment Modality,Sx & RT
56,1,1,Overall Stage,IVa
56,1,1,Research lab HPV,HPV negative
56,1,1,Research lab p16,p16 negative
56,1,1,Metastasis,M0
56,1,1,2nd Failure Type,no known failure
56,1,1,Clinical lab p16,p16 unkown
56,1,1,1st Failure Type,no known failure
56,1,1,Tumor Stage,T4a
56,1,1,Nodal Stage,N0
56,1,1,Occurrence #,1st primary
56,1,1,Radiation Dosage,unknown
56,1,1,Tumor Site,oropharynx
56,1,1,Treatment Modality,CTX-RT
56,1,1,Initial Chemotherapy Agent,Carbo/PTX
57,1,1,Research lab HPV,HPV unknown
57,1,1,1st Failure Site,oral cavity
57,1,1,1st Failure Type,no known failure
57,1,1,Metastasis,M0
57,1,1,Tumor Site,oral cavity
57,1,1,Research lab p16,p16 unknown
57,1,1,Occurrence #,1st primary
57,1,1,Treatment Modality,CTX-RT
57,1,1,2nd Failure Type,no known failure
57,1,1,Initial Chemotherapy Agent,Doce/cap
57,1,1,Nodal Stage,N3
57,1,1,Radiation Dosage,72
57,1,1,Tumor Stage,T4b
57,1,1,Clinical lab p16,p16 unkown
57,1,1,Overall Stage,IVb
58,1,1,Research lab HPV,HPV unknown
58,1,1,Occurrence #,1st primary
58,1,1,Treatment Modality,Unknown
58,1,1,Clinical lab p16,p16 unkown
58,1,1,Tumor Stage,Unknown
58,1,1,2nd Failure Type,no known failure
58,1,1,1st Failure Type,no known failure
58,1,1,Metastasis,Unknown
58,1,1,Research lab p16,p16 unknown
58,1,1,Tumor Site,oropharynx
58,1,1,Overall Stage,Unknown
58,1,1,Nodal Stage,Unknown
59,1,1,Nodal Stage,N2
59,1,1,Treatment Modality,RT
59,1,1,1st Failure Type,no known failure
59,1,1,Research lab HPV,HPV unknown
59,1,1,Radiation Dosage,70
59,1,1,Clinical lab p16,p16 unkown
59,1,1,Overall Stage,IVb
59,1,1,Tumor Stage,T4b
59,1,1,Research lab p16,p16 unknown
59,1,1,2nd Failure Type,no known failure
59,1,1,Occurrence #,1st primary
59,1,1,Metastasis,M0
59,1,1,Tumor Site,oropharynx
60,1,1,Tumor Stage,Unknown
60,1,1,Occurrence #,1st primary
60,1,1,2nd Failure Type,no known failure
60,1,1,Clinical lab p16,p16 unkown
60,1,1,Research lab HPV,HPV unknown
60,1,1,Nodal Stage,Unknown
60,1,1,Treatment Modality,Unknown
60,1,1,Tumor Site,Unknown
60,1,1,Research lab p16,p16 unknown
60,1,1,Metastasis,Unknown
60,1,1,Overall Stage,Unknown
60,1,1,1st Failure Type,no known failure
61,1,1,Metastasis,M0
61,1,1,Radiation Dosage,70.2
61,1,1,Occurrence #,1st primary
61,1,1,Tumor Site,oropharynx
61,1,1,2nd Failure Type,no known failure
61,1,1,1st Failure Type,distant
61,1,1,Clinical lab p16,p16 unkown
61,1,1,Research lab HPV,HPV unknown
61,1,1,Overall Stage,IVa
61,1,1,Initial Chemotherapy Agent,cis
61,1,1,Tumor Stage,T2
61,1,1,Research lab p16,p16 positive
61,1,1,Nodal Stage,N2
61,1,1,Treatment Modality,CTX-RT
62,1,1,2nd Failure Type,no known failure
62,1,1,Occurrence #,1st primary
62,1,1,Tumor Site,oropharynx
62,1,1,Research lab HPV,HPV unknown
62,1,1,Tumor Stage,T1
62,1,1,Overall Stage,III
62,1,1,Metastasis,M0
62,1,1,Nodal Stage,N1
62,1,1,Research lab p16,p16 unknown
62,1,1,1st Failure Type,locoregional
62,1,1,Radiation Dosage,unknown
62,1,1,Clinical lab p16,p16 unkown
62,1,1,Treatment Modality,RT
63,1,1,1st Failure Type,locoregional
63,1,1,Tumor Site,oropharynx
63,1,1,Research lab HPV,HPV positive
63,1,1,Occurrence #,1st primary
63,1,1,Metastasis,M0
63,1,1,Research lab p16,p16 positive
63,1,1,Nodal Stage,N2
63,1,1,2nd Failure Type,no known failure
63,1,1,Tumor Stage,T1
63,1,1,Radiation Dosage,70.2
63,1,1,Clinical lab p16,p16 unkown
63,1,1,Initial Chemotherapy Agent,carbo/PTX
63,1,1,Overall Stage,IVa
63,1,1,Treatment Modality,CTX-RT
64,1,1,Research lab p16,p16 negative
64,1,1,Tumor Site,oropharynx
64,1,1,Research lab HPV,HPV negative
64,1,1,Occurrence #,1st primary
64,1,1,1st Failure Type,no known failure
64,1,1,Clinical lab p16,p16 unkown
64,1,1,Metastasis,M0
64,1,1,Overall Stage,IVa
64,1,1,Treatment Modality,Unknown
64,1,1,Tumor Stage,T4a
64,1,1,2nd Failure Type,no known failure
64,1,1,Nodal Stage,N1
65,1,1,Nodal Stage,Unknown
65,1,1,Treatment Modality,Unknown
65,1,1,Clinical lab p16,p16 unkown
65,1,1,2nd Failure Type,no known failure
65,1,1,Occurrence #,1st primary
65,1,1,Research lab p16,p16 unknown
65,1,1,Overall Stage,Unknown
65,1,1,Metastasis,Unknown
65,1,1,Tumor Stage,Unknown
65,1,1,Tumor Site,oropharynx
65,1,1,1st Failure Type,no known failure
65,1,1,Research lab HPV,HPV unknown
66,1,1,Nodal Stage,N2
66,1,1,Overall Stage,IVa
66,1,1,Initial Chemotherapy Agent,carbo/PTX
66,1,1,2nd Failure Type,no known failure
66,1,1,Clinical lab p16,p16 unkown
66,1,1,1st Failure Type,no known failure
66,1,1,Research lab p16,p16 unknown
66,1,1,Radiation Dosage,70.2
66,1,1,Metastasis,M0
66,1,1,Research lab HPV,HPV unknown
66,1,1,Occurrence #,1st primary
66,1,1,Treatment Modality,CTX-RT
66,1,1,Tumor Stage,T2
66,1,1,Tumor Site,oropharynx
67,1,1,2nd Failure Type,no known failure
67,1,1,1st Failure Type,no known failure
67,1,1,Research lab p16,p16 positive
67,1,1,Tumor Site,oropharynx
67,1,1,Research lab HPV,HPV unknown
67,1,1,Clinical lab p16,p16 unkown
67,1,1,Occurrence #,1st primary
67,1,1,Radiation Dosage,70
67,1,1,Metastasis,M0
67,1,1,Tumor Stage,T4a
67,1,1,Nodal Stage,N0
67,1,1,Overall Stage,IVa
67,1,1,Treatment Modality,RT
68,1,1,Treatment Modality,Unknown
68,1,1,1st Failure Type,no known failure
68,1,1,Research lab p16,p16 unknown
68,1,1,2nd Failure Type,no known failure
68,1,1,Clinical lab p16,p16 unkown
68,1,1,Tumor Site,oropharynx
68,1,1,Nodal Stage,Unknown
68,1,1,Metastasis,Unknown
68,1,1,Overall Stage,Unknown
68,1,1,Occurrence #,1st primary
68,1,1,Tumor Stage,Unknown
68,1,1,Research lab HPV,HPV unknown
69,1,1,Tumor Stage,T4a
69,1,1,Overall Stage,IVa
69,1,1,1st Failure Type,no known failure
69,1,1,2nd Failure Type,no known failure
69,1,1,Clinical lab p16,p16 unkown
69,1,1,Treatment Modality,Unknown
69,1,1,Research lab p16,p16 negative
69,1,1,Tumor Site,oropharynx
69,1,1,Metastasis,M0
69,1,1,Research lab HPV,HPV negative
69,1,1,Occurrence #,1st primary
69,1,1,Nodal Stage,N0
70,1,1,Research lab p16,p16 positive
70,1,1,Tumor Site,oropharynx
70,1,1,Treatment Modality,CTX-RT
70,1,1,Initial Chemotherapy Agent,PTX/cap
70,1,1,Nodal Stage,N2
70,1,1,Tumor Stage,T2
70,1,1,Clinical lab p16,p16 unkown
70,1,1,2nd Failure Type,no known failure
70,1,1,Overall Stage,IVa
70,1,1,1st Failure Type,no known failure
70,1,1,Research lab HPV,HPV positive
70,1,1,Occurrence #,1st primary
70,1,1,Metastasis,M0
70,1,1,Radiation Dosage,70.2
71,1,1,Radiation Dosage,70.2
71,1,1,Tumor Site,oropharynx
71,1,1,Tumor Stage,T2
71,1,1,Nodal Stage,N2
71,1,1,Research lab p16,p16 negative
71,1,1,Treatment Modality,CTX-RT
71,1,1,Initial Chemotherapy Agent,PTX/carbo
71,1,1,Clinical lab p16,p16 unkown
71,1,1,Research lab HPV,HPV negative
71,1,1,Occurrence #,1st primary
71,1,1,Overall Stage,IVa
71,1,1,1st Failure Type,locoregional
71,1,1,Metastasis,M0
71,1,1,2nd Failure Type,no known failure
72,1,1,Overall Stage,IVa
72,1,1,Nodal Stage,N2
72,1,1,1st Failure Type,no known failure
72,1,1,Research lab p16,p16 unknown
72,1,1,2nd Failure Type,no known failure
72,1,1,Treatment Modality,Unknown
72,1,1,Occurrence #,1st primary
72,1,1,Clinical lab p16,p16 unkown
72,1,1,Tumor Stage,T3
72,1,1,Tumor Site,oropharynx
72,1,1,Research lab HPV,HPV unknown
72,1,1,Metastasis,M0
73,1,1,Research lab HPV,HPV unknown
73,1,1,Occurrence #,1st primary
73,1,1,Treatment Modality,CTX-RT
73,1,1,Nodal Stage,N2
73,1,1,2nd Failure Type,no known failure
73,1,1,Tumor Site,oropharynx
73,1,1,1st Failure Type,no known failure
73,1,1,Tumor Stage,T4a
73,1,1,Clinical lab p16,p16 unkown
73,1,1,Research lab p16,p16 unknown
73,1,1,Initial Chemotherapy Agent,carbo/doce
73,1,1,Metastasis,M0
73,1,1,Radiation Dosage,70.2
73,1,1,Overall Stage,IVa
74,1,1,Treatment Modality,CTX-RT
74,1,1,1st Failure Type,no known failure
74,1,1,Occurrence #,other primary
74,1,1,Research lab HPV,HPV negative
74,1,1,Tumor Stage,T3
74,1,1,Clinical lab p16,p16 unkown
74,1,1,Research lab p16,p16 negative
74,1,1,Nodal Stage,N1
74,1,1,Metastasis,M0
74,1,1,Tumor Site,oropharynx
74,1,1,2nd Failure Type,no known failure
74,1,1,Initial Chemotherapy Agent,carbo/PTX
74,1,1,Radiation Dosage,70.2
74,1,1,Overall Stage,III
75,1,1,2nd Failure Type,no known failure
75,1,1,Research lab p16,p16 positive
75,1,1,1st Failure Type,no known failure
75,1,1,Treatment Modality,CTX-RT
75,1,1,Occurrence #,1st primary
75,1,1,Metastasis,M0
75,1,1,Research lab HPV,HPV positive
75,1,1,Overall Stage,IVa
75,1,1,Radiation Dosage,unknown
75,1,1,Tumor Site,oropharynx
75,1,1,Initial Chemotherapy Agent,unknown
75,1,1,Clinical lab p16,p16 unkown
75,1,1,Tumor Stage,T3
75,1,1,Nodal Stage,N2
76,1,1,1st Failure Site,oropharynx
76,1,1,Occurrence #,1st primary
76,1,1,Treatment Modality,CTX-RT
76,1,1,Clinical lab p16,p16 unkown
76,1,1,Metastasis,M0
76,1,1,1st Failure Treatment Modality,Sx
76,1,1,Research lab HPV,HPV positive
76,1,1,Radiation Dosage,70.2
76,1,1,Overall Stage,IVa
76,1,1,1st Failure Type,locoregional
76,1,1,Initial Chemotherapy Agent,carbo/doce
76,1,1,Tumor Stage,T4a
76,1,1,Research lab p16,p16 positive
76,1,1,Tumor Site,oropharynx
76,1,1,2nd Failure Type,no known failure
76,1,1,Nodal Stage,N2
77,1,1,Nodal Stage,N2
77,1,1,Research lab HPV,HPV unknown
77,1,1,Tumor Stage,T2
77,1,1,Clinical lab p16,p16 unkown
77,1,1,Tumor Site,oropharynx
77,1,1,Overall Stage,IVa
77,1,1,Treatment Modality,Unknown
77,1,1,Metastasis,M0
77,1,1,2nd Failure Type,no known failure
77,1,1,1st Failure Type,no known failure
77,1,1,Occurrence #,1st primary
77,1,1,Research lab p16,p16 unknown
78,1,1,Research lab p16,p16 negative
78,1,1,2nd Failure Type,no known failure
78,1,1,Tumor Site,oropharynx
78,1,1,Clinical lab p16,p16 unkown
78,1,1,Metastasis,M0
78,1,1,Radiation Dosage,38.4
78,1,1,Overall Stage,IVb
78,1,1,Nodal Stage,N3
78,1,1,Tumor Stage,T4a
78,1,1,Research lab HPV,HPV negative
78,1,1,1st Failure Type,no known failure
78,1,1,Occurrence #,1st primary
78,1,1,Treatment Modality,RT
79,1,1,Research lab p16,p16 unknown
79,1,1,Treatment Modality,Unknown
79,1,1,Nodal Stage,Unknown
79,1,1,Metastasis,Unknown
79,1,1,Occurrence #,1st primary
79,1,1,2nd Failure Type,no known failure
79,1,1,Research lab HPV,HPV unknown
79,1,1,Tumor Stage,Unknown
79,1,1,Overall Stage,Unknown
79,1,1,1st Failure Type,no known failure
79,1,1,Tumor Site,Unknown
79,1,1,Clinical lab p16,p16 unkown
80,1,1,Radiation Dosage,unknown
80,1,1,1st Failure Site,oropharynx
80,1,1,Overall Stage,IVa
80,1,1,Initial Chemotherapy Agent,doce/cap
80,1,1,1st Failure Type,locoregional
80,1,1,Research lab p16,p16 negative
80,1,1,2nd Failure Type,no known failure
80,1,1,Metastasis,M0
80,1,1,Tumor Stage,T4a
80,1,1,Tumor Site,oropharynx
80,1,1,Treatment Modality,CTX-RT
80,1,1,Occurrence #,1st primary
80,1,1,Research lab HPV,HPV negative
80,1,1,Nodal Stage,N2
80,1,1,Clinical lab p16,p16 unkown
80,1,1,1st Failure Treatment Modality,Sx
81,1,1,Clinical lab p16,p16 unkown
81,1,1,Tumor Stage,T3
81,1,1,Radiation Dosage,72
81,1,1,Metastasis,M0
81,1,1,Tumor Site,oropharynx
81,1,1,Overall Stage,IVa
81,1,1,Initial Chemotherapy Agent,PTX/cap
81,1,1,Research lab HPV,HPV unknown
81,1,1,Occurrence #,1st primary
81,1,1,Treatment Modality,CTX-RT
81,1,1,2nd Failure Type,no known failure
81,1,1,Nodal Stage,N2
81,1,1,1st Failure Type,distant
81,1,1,Research lab p16,p16 unknown
82,1,1,Research lab HPV,HPV unknown
82,1,1,Occurrence #,1st primary
82,1,1,Nodal Stage,N3
82,1,1,Initial Chemotherapy Agent,carbo/PTX
82,1,1,Tumor Site,oropharynx
82,1,1,Research lab p16,p16 unknown
82,1,1,Tumor Stage,T4a
82,1,1,Clinical lab p16,p16 unkown
82,1,1,Metastasis,M0
82,1,1,Overall Stage,IVb
82,1,1,1st Failure Type,no known failure
82,1,1,2nd Failure Type,no known failure
82,1,1,Treatment Modality,CTX-RT
82,1,1,Radiation Dosage,70.2
83,1,1,Overall Stage,IVa
83,1,1,Treatment Modality,CTX-RT
83,1,1,Nodal Stage,N2
83,1,1,Research lab p16,p16 unknown
83,1,1,Clinical lab p16,p16 unkown
83,1,1,Initial Chemotherapy Agent,PTX/cap
83,1,1,1st Failure Type,no known failure
83,1,1,Metastasis,M0
83,1,1,Research lab HPV,HPV unknown
83,1,1,Tumor Site,oropharynx
83,1,1,Radiation Dosage,7.6
83,1,1,2nd Failure Type,no known failure
83,1,1,Occurrence #,1st primary
83,1,1,Tumor Stage,T4a
84,1,1,Radiation Dosage,70.2
84,1,1,Clinical lab p16,p16 unkown
84,1,1,Metastasis,M0
84,1,1,Nodal Stage,N2
84,1,1,Research lab p16,p16 negative
84,1,1,Tumor Stage,T3
84,1,1,2nd Failure Type,no known failure
84,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
84,1,1,Tumor Site,oropharynx
84,1,1,1st Failure Treatment Modality,Sx
84,1,1,Overall Stage,IVa
84,1,1,1st Failure Type,locoregional
84,1,1,Research lab HPV,HPV negative
84,1,1,Occurrence #,1st primary
84,1,1,1st Failure Site,oropharynx
84,1,1,Treatment Modality,CTX-RT
85,1,1,1st Failure Type,locoregional
85,1,1,Tumor Site,oropharynx
85,1,1,Research lab HPV,HPV negative
85,1,1,Tumor Stage,T4a
85,1,1,Initial Chemotherapy Agent,carbo/PTX
85,1,1,1st Failure Treatment Modality,CTX
85,1,1,Clinical lab p16,p16 unkown
85,1,1,2nd Failure Type,no known failure
85,1,1,1st Failure Site,oropharynx
85,1,1,Overall Stage,IVa
85,1,1,1st Failure Initial Chemotherapy Agent,Cis/5FU
85,1,1,Nodal Stage,N2
85,1,1,Treatment Modality,CTX-RT
85,1,1,Occurrence #,1st primary
85,1,1,Research lab p16,p16 negative
85,1,1,Radiation Dosage,72
85,1,1,Metastasis,M0
86,1,1,Metastasis,Unknown
86,1,1,1st Failure Type,no known failure
86,1,1,2nd Failure Type,no known failure
86,1,1,Occurrence #,1st primary
86,1,1,Research lab p16,p16 unknown
86,1,1,Clinical lab p16,p16 unkown
86,1,1,Overall Stage,Unknown
86,1,1,Tumor Stage,Unknown
86,1,1,Tumor Site,Unknown
86,1,1,Nodal Stage,Unknown
86,1,1,Research lab HPV,HPV unknown
86,1,1,Treatment Modality,Unknown
87,1,1,Overall Stage,IVa
87,1,1,Initial Chemotherapy Agent,cis/carbo
87,1,1,2nd Failure Type,no known failure
87,1,1,1st Failure Site,oropharynx
87,1,1,Nodal Stage,N0
87,1,1,Tumor Stage,T4a
87,1,1,Clinical lab p16,p16 unkown
87,1,1,Occurrence #,1st primary
87,1,1,Treatment Modality,CTX-RT
87,1,1,Research lab HPV,HPV unknown
87,1,1,Tumor Site,oropharynx
87,1,1,Metastasis,M0
87,1,1,Research lab p16,p16 unknown
87,1,1,1st Failure Type,locoregional
87,1,1,Radiation Dosage,70.2
88,1,1,Research lab HPV,HPV unknown
88,1,1,Research lab p16,p16 unknown
88,1,1,Metastasis,Unknown
88,1,1,2nd Failure Type,no known failure
88,1,1,Nodal Stage,Unknown
88,1,1,Clinical lab p16,p16 unkown
88,1,1,Tumor Stage,Unknown
88,1,1,Tumor Site,oropharynx
88,1,1,Treatment Modality,Unknown
88,1,1,1st Failure Type,no known failure
88,1,1,Overall Stage,Unknown
88,1,1,Occurrence #,1st primary
89,1,1,1st Failure Type,no known failure
89,1,1,Research lab p16,p16 unknown
89,1,1,2nd Failure Type,no known failure
89,1,1,Nodal Stage,N2
89,1,1,Metastasis,M0
89,1,1,Clinical lab p16,p16 unkown
89,1,1,Radiation Dosage,70.2
89,1,1,Research lab HPV,HPV unknown
89,1,1,Tumor Stage,T1
89,1,1,Tumor Site,oropharynx
89,1,1,Overall Stage,IVa
89,1,1,Treatment Modality,CTX-RT
89,1,1,Initial Chemotherapy Agent,cis
89,1,1,Occurrence #,1st primary
90,1,1,Metastasis,M0
90,1,1,Tumor Site,oropharynx
90,1,1,Clinical lab p16,p16 unkown
90,1,1,Research lab HPV,HPV negative
90,1,1,1st Failure Type,no known failure
90,1,1,2nd Failure Type,no known failure
90,1,1,Overall Stage,IVa
90,1,1,Tumor Stage,T4a
90,1,1,Research lab p16,p16 negative
90,1,1,Occurrence #,1st primary
90,1,1,Treatment Modality,Sx
90,1,1,Nodal Stage,N0
91,1,1,Treatment Modality,Unknown
91,1,1,Nodal Stage,Unknown
91,1,1,Research lab p16,p16 unknown
91,1,1,Tumor Stage,Unknown
91,1,1,2nd Failure Type,no known failure
91,1,1,Research lab HPV,HPV unknown
91,1,1,Overall Stage,Unknown
91,1,1,1st Failure Type,no known failure
91,1,1,Clinical lab p16,p16 unkown
91,1,1,Tumor Site,oropharynx
91,1,1,Occurrence #,1st primary
91,1,1,Metastasis,Unknown
92,1,1,2nd Failure Type,no known failure
92,1,1,Radiation Dosage,70.2
92,1,1,1st Failure Type,no known failure
92,1,1,Clinical lab p16,p16 unkown
92,1,1,Tumor Stage,T1
92,1,1,Tumor Site,oropharynx
92,1,1,Research lab p16,p16 unknown
92,1,1,Overall Stage,IVb
92,1,1,Metastasis,M0
92,1,1,Research lab HPV,HPV unknown
92,1,1,Treatment Modality,Sx & RT
92,1,1,Occurrence #,1st primary
92,1,1,Nodal Stage,N3
93,1,1,1st Failure Type,no known failure
93,1,1,Tumor Stage,T3
93,1,1,Metastasis,M0
93,1,1,Nodal Stage,N2
93,1,1,Overall Stage,IVa
93,1,1,Tumor Site,oropharynx
93,1,1,Research lab HPV,HPV unknown
93,1,1,2nd Failure Type,no known failure
93,1,1,Radiation Dosage,70.2
93,1,1,Clinical lab p16,p16 unkown
93,1,1,Initial Chemotherapy Agent,carbo/doce
93,1,1,Occurrence #,1st primary
93,1,1,Research lab p16,p16 unknown
93,1,1,Treatment Modality,CTX-RT
94,1,1,Clinical lab p16,p16 unkown
94,1,1,Overall Stage,Unknown
94,1,1,Nodal Stage,Unknown
94,1,1,Metastasis,Unknown
94,1,1,1st Failure Type,no known failure
94,1,1,Tumor Stage,Unknown
94,1,1,Tumor Site,oropharynx
94,1,1,Occurrence #,1st primary
94,1,1,Treatment Modality,Unknown
94,1,1,Research lab p16,p16 unknown
94,1,1,2nd Failure Type,no known failure
94,1,1,Research lab HPV,HPV unknown
95,1,1,2nd Failure Type,no known failure
95,1,1,Tumor Site,oropharynx
95,1,1,Nodal Stage,N2
95,1,1,Radiation Dosage,70.2
95,1,1,Treatment Modality,CTX-RT
95,1,1,Initial Chemotherapy Agent,carbo/PTX
95,1,1,Research lab HPV,HPV positive
95,1,1,Occurrence #,1st primary
95,1,1,Metastasis,M0
95,1,1,Research lab p16,p16 positive
95,1,1,1st Failure Type,no known failure
95,1,1,Tumor Stage,T3
95,1,1,Clinical lab p16,p16 unkown
95,1,1,Overall Stage,IVa
96,1,1,Research lab HPV,HPV unknown
96,1,1,1st Failure Type,no known failure
96,1,1,Tumor Stage,T4a
96,1,1,Clinical lab p16,p16 unkown
96,1,1,Research lab p16,p16 unknown
96,1,1,Radiation Dosage,66.6
96,1,1,Treatment Modality,Sx & RT
96,1,1,Metastasis,M0
96,1,1,Tumor Site,oropharynx
96,1,1,2nd Failure Type,no known failure
96,1,1,Overall Stage,IVa
96,1,1,Nodal Stage,N2
96,1,1,Occurrence #,1st primary
97,1,1,Metastasis,M0
97,1,1,Clinical lab p16,p16 unkown
97,1,1,Overall Stage,IVa
97,1,1,1st Failure Type,no known failure
97,1,1,Tumor Site,oropharynx
97,1,1,Tumor Stage,T4a
97,1,1,2nd Failure Type,no known failure
97,1,1,Nodal Stage,N0
97,1,1,Occurrence #,1st primary
97,1,1,Research lab HPV,HPV unknown
97,1,1,Treatment Modality,Sx
97,1,1,Research lab p16,p16 unknown
98,1,1,Clinical lab p16,p16 unkown
98,1,1,Nodal Stage,N3
98,1,1,Radiation Dosage,72
98,1,1,1st Failure Type,no known failure
98,1,1,Tumor Stage,T1
98,1,1,Tumor Site,oropharynx
98,1,1,Occurrence #,1st primary
98,1,1,Overall Stage,IVb
98,1,1,Research lab HPV,HPV positive
98,1,1,2nd Failure Type,no known failure
98,1,1,Research lab p16,p16 positive
98,1,1,Treatment Modality,Sx & CTX-RT
98,1,1,Metastasis,M0
98,1,1,Initial Chemotherapy Agent,carbo/PTX
99,1,1,Initial Chemotherapy Agent,carbo/doce
99,1,1,Nodal Stage,N2
99,1,1,2nd Failure Type,no known failure
99,1,1,Clinical lab p16,p16 unkown
99,1,1,Research lab HPV,HPV unknown
99,1,1,Occurrence #,1st primary
99,1,1,Research lab p16,p16 unknown
99,1,1,Tumor Stage,T4a
99,1,1,Metastasis,M0
99,1,1,Radiation Dosage,70.2
99,1,1,1st Failure Type,no known failure
99,1,1,Tumor Site,oropharynx
99,1,1,Treatment Modality,CTX-RT
99,1,1,Overall Stage,IVa
100,1,1,Research lab HPV,HPV unknown
100,1,1,Clinical lab p16,p16 unkown
100,1,1,Occurrence #,1st primary
100,1,1,Tumor Stage,T4a
100,1,1,Metastasis,M0
100,1,1,1st Failure Type,no known failure
100,1,1,Overall Stage,IVb
100,1,1,Tumor Site,oropharynx
100,1,1,Research lab p16,p16 unknown
100,1,1,Nodal Stage,N3
100,1,1,2nd Failure Type,no known failure
100,1,1,Treatment Modality,Unknown
101,1,1,Tumor Site,Unknown
101,1,1,Nodal Stage,Unknown
101,1,1,Occurrence #,1st primary
101,1,1,Metastasis,Unknown
101,1,1,1st Failure Type,no known failure
101,1,1,Treatment Modality,Unknown
101,1,1,Overall Stage,Unknown
101,1,1,Research lab p16,p16 unknown
101,1,1,Tumor Stage,Unknown
101,1,1,Research lab HPV,HPV unknown
101,1,1,2nd Failure Type,no known failure
101,1,1,Clinical lab p16,p16 unkown
102,1,1,Radiation Dosage,76.4
102,1,1,Clinical lab p16,p16 unkown
102,1,1,1st Failure Type,no known failure
102,1,1,Metastasis,M0
102,1,1,Occurrence #,1st primary
102,1,1,2nd Failure Type,no known failure
102,1,1,Treatment Modality,RT
102,1,1,Tumor Site,oropharynx
102,1,1,Overall Stage,III
102,1,1,Tumor Stage,T3
102,1,1,Research lab HPV,HPV positive
102,1,1,Research lab p16,p16 positive
102,1,1,Nodal Stage,N0
103,1,1,Nodal Stage,N2
103,1,1,Treatment Modality,CTX-RT
103,1,1,Tumor Site,oropharynx
103,1,1,Research lab p16,p16 unknown
103,1,1,Initial Chemotherapy Agent,unknown
103,1,1,Clinical lab p16,p16 unkown
103,1,1,Research lab HPV,HPV unknown
103,1,1,2nd Failure Type,no known failure
103,1,1,Tumor Stage,T1
103,1,1,1st Failure Type,locoregional and distant
103,1,1,Radiation Dosage,72.6
103,1,1,Metastasis,M0
103,1,1,Overall Stage,IVa
103,1,1,Occurrence #,1st primary
104,1,1,Overall Stage,IVb
104,1,1,Initial Chemotherapy Agent,carbo/PTX
104,1,1,Research lab HPV,HPV positive
104,1,1,Nodal Stage,N3
104,1,1,Research lab p16,p16 positive
104,1,1,Tumor Stage,T3
104,1,1,Occurrence #,1st primary
104,1,1,2nd Failure Type,no known failure
104,1,1,Clinical lab p16,p16 unkown
104,1,1,Treatment Modality,CTX-RT
104,1,1,1st Failure Type,distant
104,1,1,Tumor Site,oropharynx
104,1,1,Metastasis,M0
104,1,1,Radiation Dosage,70.2
105,1,1,Initial Chemotherapy Agent,carbo/doce
105,1,1,Research lab p16,p16 unknown
105,1,1,Tumor Site,oropharynx
105,1,1,Tumor Stage,T3
105,1,1,Radiation Dosage,70.2
105,1,1,Metastasis,M0
105,1,1,1st Failure Type,no known failure
105,1,1,2nd Failure Type,no known failure
105,1,1,Occurrence #,1st primary
105,1,1,Treatment Modality,CTX-RT
105,1,1,Clinical lab p16,p16 unkown
105,1,1,Overall Stage,IVa
105,1,1,Research lab HPV,HPV unknown
105,1,1,Nodal Stage,N2
106,1,1,Metastasis,M0
106,1,1,1st Failure Type,no known failure
106,1,1,Occurrence #,1st primary
106,1,1,Research lab HPV,HPV unknown
106,1,1,Research lab p16,p16 unknown
106,1,1,Nodal Stage,N2
106,1,1,Treatment Modality,Sx & CTX-RT
106,1,1,Clinical lab p16,p16 unkown
106,1,1,Radiation Dosage,70
106,1,1,Tumor Site,oropharynx
106,1,1,2nd Failure Type,no known failure
106,1,1,Overall Stage,IVa
106,1,1,Tumor Stage,T2
106,1,1,Initial Chemotherapy Agent,carbo/doce
107,1,1,Research lab p16,p16 positive
107,1,1,Tumor Stage,T2
107,1,1,Occurrence #,1st primary
107,1,1,Radiation Dosage,unknown
107,1,1,Research lab HPV,HPV positive
107,1,1,1st Failure Type,no known failure
107,1,1,Overall Stage,IVb
107,1,1,Tumor Site,oropharynx
107,1,1,Metastasis,M0
107,1,1,Initial Chemotherapy Agent,unknown
107,1,1,Nodal Stage,N3
107,1,1,Clinical lab p16,p16 unkown
107,1,1,2nd Failure Type,no known failure
107,1,1,Treatment Modality,CTX-RT
108,1,1,Occurrence #,1st primary
108,1,1,Overall Stage,Unknown
108,1,1,Nodal Stage,Unknown
108,1,1,Metastasis,Unknown
108,1,1,Tumor Stage,Unknown
108,1,1,Tumor Site,Unknown
108,1,1,1st Failure Type,no known failure
108,1,1,Research lab HPV,HPV unknown
108,1,1,Research lab p16,p16 unknown
108,1,1,Treatment Modality,Unknown
108,1,1,2nd Failure Type,no known failure
108,1,1,Clinical lab p16,p16 unkown
109,1,1,Initial Chemotherapy Agent,carbo/doce
109,1,1,Treatment Modality,CTX-RT
109,1,1,Research lab p16,p16 unknown
109,1,1,Occurrence #,1st primary
109,1,1,Tumor Stage,T3
109,1,1,Overall Stage,III
109,1,1,Tumor Site,oropharynx
109,1,1,Radiation Dosage,70.2
109,1,1,2nd Failure Type,no known failure
109,1,1,Clinical lab p16,p16 unkown
109,1,1,Nodal Stage,N0
109,1,1,Metastasis,M0
109,1,1,1st Failure Type,no known failure
109,1,1,Research lab HPV,HPV unknown
110,1,1,Tumor Stage,T3
110,1,1,Overall Stage,IVa
110,1,1,Metastasis,M0
110,1,1,Tumor Site,oropharynx
110,1,1,1st Failure Type,no known failure
110,1,1,Research lab HPV,HPV negative
110,1,1,2nd Failure Type,no known failure
110,1,1,Treatment Modality,RT
110,1,1,Occurrence #,1st primary
110,1,1,Clinical lab p16,p16 unkown
110,1,1,Research lab p16,p16 negative
110,1,1,Nodal Stage,N2
111,1,1,Nodal Stage,N0
111,1,1,Initial Chemotherapy Agent,carbo/doce
111,1,1,Overall Stage,III
111,1,1,1st Failure Type,no known failure
111,1,1,Research lab HPV,HPV unknown
111,1,1,Clinical lab p16,p16 unkown
111,1,1,2nd Failure Type,no known failure
111,1,1,Metastasis,M0
111,1,1,Occurrence #,1st primary
111,1,1,Research lab p16,p16 unknown
111,1,1,Tumor Stage,T3
111,1,1,Treatment Modality,CTX-RT
111,1,1,Radiation Dosage,70.2
111,1,1,Tumor Site,oropharynx
112,1,1,Overall Stage,IVa
112,1,1,Tumor Stage,T4a
112,1,1,Clinical lab p16,p16 unkown
112,1,1,Radiation Dosage,10
112,1,1,2nd Failure Type,no known failure
112,1,1,Tumor Site,oropharynx
112,1,1,Research lab HPV,HPV unknown
112,1,1,Research lab p16,p16 unknown
112,1,1,1st Failure Type,no known failure
112,1,1,Metastasis,M0
112,1,1,Occurrence #,1st primary
112,1,1,Nodal Stage,N2
112,1,1,Treatment Modality,RT
113,1,1,1st Failure Site,oropharynx
113,1,1,Initial Chemotherapy Agent,carbo/doce
113,1,1,1st Failure Initial Chemotherapy Agent,gemcitabine/doce/cap
113,1,1,Research lab p16,p16 unknown
113,1,1,Metastasis,M0
113,1,1,Clinical lab p16,p16 unkown
113,1,1,Overall Stage,IVa
113,1,1,Tumor Stage,T4a
113,1,1,2nd Failure Type,no known failure
113,1,1,Research lab HPV,HPV unknown
113,1,1,Radiation Dosage,70.2
113,1,1,Treatment Modality,CTX-RT
113,1,1,1st Failure Type,locoregional
113,1,1,Occurrence #,1st primary
113,1,1,Nodal Stage,N1
113,1,1,Tumor Site,oropharynx
114,1,1,1st Failure Type,no known failure
114,1,1,Research lab p16,p16 unknown
114,1,1,2nd Failure Type,no known failure
114,1,1,Research lab HPV,HPV unknown
114,1,1,Tumor Stage,T3
114,1,1,Radiation Dosage,70.2
114,1,1,Tumor Site,oropharynx
114,1,1,Metastasis,M0
114,1,1,Occurrence #,1st primary
114,1,1,Clinical lab p16,p16 unkown
114,1,1,Treatment Modality,CTX-RT
114,1,1,Nodal Stage,N2
114,1,1,Overall Stage,IVa
114,1,1,Initial Chemotherapy Agent,carbo/PTX
115,1,1,Metastasis,Unknown
115,1,1,Overall Stage,Unknown
115,1,1,Treatment Modality,Unknown
115,1,1,1st Failure Type,no known failure
115,1,1,2nd Failure Type,no known failure
115,1,1,Research lab p16,p16 unknown
115,1,1,Tumor Stage,Unknown
115,1,1,Occurrence #,1st primary
115,1,1,Nodal Stage,Unknown
115,1,1,Tumor Site,oropharynx
115,1,1,Research lab HPV,HPV unknown
115,1,1,Clinical lab p16,p16 unkown
116,1,1,Tumor Site,oropharynx
116,1,1,Initial Chemotherapy Agent,cis
116,1,1,Tumor Stage,T3
116,1,1,Research lab HPV,HPV positive
116,1,1,Overall Stage,IVa
116,1,1,Research lab p16,p16 positive
116,1,1,2nd Failure Type,no known failure
116,1,1,Radiation Dosage,70.2
116,1,1,Treatment Modality,CTX-RT
116,1,1,Nodal Stage,N2
116,1,1,Clinical lab p16,p16 unkown
116,1,1,Metastasis,M0
116,1,1,1st Failure Type,no known failure
116,1,1,Occurrence #,1st primary
117,1,1,Research lab HPV,HPV unknown
117,1,1,Initial Chemotherapy Agent,PTX/cap
117,1,1,2nd Failure Type,no known failure
117,1,1,Nodal Stage,N2
117,1,1,Tumor Site,oropharynx
117,1,1,Metastasis,M0
117,1,1,Occurrence #,Unknown
117,1,1,1st Failure Type,no known failure
117,1,1,Tumor Stage,T4a
117,1,1,Overall Stage,IVa
117,1,1,Radiation Dosage,70.2
117,1,1,Clinical lab p16,p16 unkown
117,1,1,Treatment Modality,CTX-RT
117,1,1,Research lab p16,p16 unknown
118,1,1,Radiation Dosage,70.2
118,1,1,Metastasis,M0
118,1,1,Overall Stage,IVa
118,1,1,Occurrence #,1st primary
118,1,1,Initial Chemotherapy Agent,carbo/PTX
118,1,1,Tumor Site,oropharynx
118,1,1,Nodal Stage,N2
118,1,1,2nd Failure Type,no known failure
118,1,1,Research lab HPV,HPV unknown
118,1,1,Treatment Modality,CTX-RT
118,1,1,Clinical lab p16,p16 unkown
118,1,1,Tumor Stage,T2
118,1,1,1st Failure Type,no known failure
118,1,1,Research lab p16,p16 unknown
119,1,1,1st Failure Type,no known failure
119,1,1,2nd Failure Type,no known failure
119,1,1,Nodal Stage,N2
119,1,1,Treatment Modality,CTX-RT
119,1,1,Overall Stage,IVa
119,1,1,Radiation Dosage,72
119,1,1,Research lab HPV,HPV unknown
119,1,1,Research lab p16,p16 unknown
119,1,1,Clinical lab p16,p16 unkown
119,1,1,Initial Chemotherapy Agent,carbo/doce
119,1,1,Occurrence #,1st primary
119,1,1,Metastasis,M0
119,1,1,Tumor Site,oropharynx
119,1,1,Tumor Stage,T3
120,1,1,Occurrence #,1st primary
120,1,1,Radiation Dosage,72
120,1,1,Tumor Stage,T4a
120,1,1,2nd Failure Type,no known failure
120,1,1,Overall Stage,IVa
120,1,1,Clinical lab p16,p16 unkown
120,1,1,Metastasis,M0
120,1,1,Initial Chemotherapy Agent,PTX/cap
120,1,1,Research lab HPV,HPV positive
120,1,1,Research lab p16,p16 positive
120,1,1,Nodal Stage,N2
120,1,1,1st Failure Type,distant
120,1,1,Tumor Site,oropharynx
120,1,1,Treatment Modality,CTX-RT
121,1,1,Metastasis,M0
121,1,1,Nodal Stage,N2
121,1,1,Clinical lab p16,p16 unkown
121,1,1,Overall Stage,IVb
121,1,1,Treatment Modality,RT
121,1,1,Radiation Dosage,76.8
121,1,1,Tumor Stage,T4b
121,1,1,Research lab p16,p16 unknown
121,1,1,Research lab HPV,HPV unknown
121,1,1,Occurrence #,Unknown
121,1,1,Tumor Site,oropharynx
121,1,1,1st Failure Type,no known failure
121,1,1,2nd Failure Type,no known failure
122,1,1,Tumor Site,Unknown
122,1,1,2nd Failure Type,no known failure
122,1,1,Clinical lab p16,p16 unkown
122,1,1,Tumor Stage,Unknown
122,1,1,Research lab HPV,HPV unknown
122,1,1,1st Failure Type,no known failure
122,1,1,Treatment Modality,Unknown
122,1,1,Research lab p16,p16 unknown
122,1,1,Overall Stage,Unknown
122,1,1,Occurrence #,1st primary
122,1,1,Metastasis,Unknown
122,1,1,Nodal Stage,Unknown
123,1,1,Research lab p16,p16 unknown
123,1,1,Research lab HPV,HPV unknown
123,1,1,Treatment Modality,Unknown
123,1,1,Overall Stage,Unknown
123,1,1,Nodal Stage,Unknown
123,1,1,Tumor Stage,Unknown
123,1,1,Metastasis,Unknown
123,1,1,Occurrence #,1st primary
123,1,1,2nd Failure Type,no known failure
123,1,1,1st Failure Type,no known failure
123,1,1,Clinical lab p16,p16 unkown
123,1,1,Tumor Site,Unknown
124,1,1,Tumor Stage,T2
124,1,1,1st Failure Type,no known failure
124,1,1,Research lab p16,p16 positive
124,1,1,Nodal Stage,N1
124,1,1,Research lab HPV,HPV unknown
124,1,1,Treatment Modality,Sx
124,1,1,Tumor Site,oropharynx
124,1,1,Clinical lab p16,p16 unkown
124,1,1,2nd Failure Type,no known failure
124,1,1,Metastasis,M0
124,1,1,Overall Stage,IVa
124,1,1,Occurrence #,1st primary
125,1,1,Treatment Modality,RT
125,1,1,Clinical lab p16,p16 unkown
125,1,1,Tumor Stage,T3
125,1,1,Research lab p16,p16 unknown
125,1,1,Tumor Site,oropharynx
125,1,1,2nd Failure Type,no known failure
125,1,1,Research lab HPV,HPV unknown
125,1,1,Occurrence #,1st primary
125,1,1,Metastasis,M0
125,1,1,Nodal Stage,N2
125,1,1,Radiation Dosage,70.2
125,1,1,Overall Stage,IVa
125,1,1,1st Failure Type,no known failure
126,1,1,Initial Chemotherapy Agent,unknown
126,1,1,Research lab HPV,HPV unknown
126,1,1,1st Failure Type,locoregional
126,1,1,Research lab p16,p16 unknown
126,1,1,Metastasis,M0
126,1,1,Occurrence #,1st primary
126,1,1,1st Failure Site,oropharynx
126,1,1,Tumor Stage,T4a
126,1,1,Clinical lab p16,p16 unkown
126,1,1,Tumor Site,oropharynx
126,1,1,2nd Failure Type,no known failure
126,1,1,Overall Stage,IVa
126,1,1,Treatment Modality,CTX-RT
126,1,1,Nodal Stage,N2
127,1,1,Initial Chemotherapy Agent,carbo/doce
127,1,1,Nodal Stage,N2
127,1,1,Radiation Dosage,70.2
127,1,1,1st Failure Type,no known failure
127,1,1,Overall Stage,IVa
127,1,1,Clinical lab p16,p16 unkown
127,1,1,Metastasis,M0
127,1,1,Tumor Stage,T4a
127,1,1,Tumor Site,oropharynx
127,1,1,2nd Failure Type,no known failure
127,1,1,Research lab p16,p16 unknown
127,1,1,Research lab HPV,HPV unknown
127,1,1,Treatment Modality,CTX-RT
127,1,1,Occurrence #,1st primary
128,1,1,Initial Chemotherapy Agent,PTX/cap
128,1,1,Overall Stage,IVa
128,1,1,Research lab p16,p16 positive
128,1,1,1st Failure Type,distant
128,1,1,Research lab HPV,HPV positive
128,1,1,2nd Failure Type,no known failure
128,1,1,Tumor Stage,T4a
128,1,1,Nodal Stage,N2
128,1,1,Treatment Modality,CTX-RT
128,1,1,Occurrence #,1st primary
128,1,1,Radiation Dosage,72
128,1,1,Metastasis,M0
128,1,1,Clinical lab p16,p16 unkown
128,1,1,Tumor Site,oropharynx
129,1,1,1st Failure Initial Chemotherapy Agent,doce/PTX/cap
129,1,1,Radiation Dosage,70.2
129,1,1,1st Failure Site,oropharynx
129,1,1,Research lab p16,p16 positive
129,1,1,Nodal Stage,N2
129,1,1,1st Failure Treatment Modality,CTX
129,1,1,Research lab HPV,HPV positive
129,1,1,Metastasis,M0
129,1,1,Occurrence #,1st primary
129,1,1,Tumor Stage,T2
129,1,1,Treatment Modality,CTX-RT
129,1,1,Clinical lab p16,p16 unkown
129,1,1,Tumor Site,oropharynx
129,1,1,1st Failure Type,locoregional
129,1,1,Initial Chemotherapy Agent,PTX/cap
129,1,1,2nd Failure Type,no known failure
129,1,1,Overall Stage,IVa
130,1,1,2nd Failure Type,no known failure
130,1,1,Occurrence #,1st primary
130,1,1,Research lab HPV,HPV positive
130,1,1,Treatment Modality,CTX-RT
130,1,1,Radiation Dosage,unknown
130,1,1,Initial Chemotherapy Agent,unknown
130,1,1,Tumor Site,oropharynx
130,1,1,Clinical lab p16,p16 unkown
130,1,1,Nodal Stage,N2
130,1,1,1st Failure Type,locoregional
130,1,1,Tumor Stage,T3
130,1,1,Overall Stage,IVa
130,1,1,Research lab p16,p16 positive
130,1,1,Metastasis,M0
131,1,1,Tumor Site,Unknown
131,1,1,2nd Failure Type,no known failure
131,1,1,1st Failure Type,no known failure
131,1,1,Treatment Modality,Unknown
131,1,1,Research lab p16,p16 unknown
131,1,1,Occurrence #,1st primary
131,1,1,Overall Stage,Unknown
131,1,1,Tumor Stage,Unknown
131,1,1,Clinical lab p16,p16 unkown
131,1,1,Nodal Stage,Unknown
131,1,1,Research lab HPV,HPV unknown
131,1,1,Metastasis,Unknown
132,1,1,Research lab HPV,HPV unknown
132,1,1,Research lab p16,p16 positive
132,1,1,Tumor Site,oropharynx
132,1,1,Radiation Dosage,68.4
132,1,1,Metastasis,M0
132,1,1,Nodal Stage,N2
132,1,1,Tumor Stage,T4a
132,1,1,Initial Chemotherapy Agent,PTX/carbo
132,1,1,Clinical lab p16,p16 unkown
132,1,1,Occurrence #,1st primary
132,1,1,Overall Stage,IVa
132,1,1,2nd Failure Type,no known failure
132,1,1,Treatment Modality,CTX-RT
132,1,1,1st Failure Type,no known failure
133,1,1,Clinical lab p16,p16 unkown
133,1,1,Nodal Stage,Unknown
133,1,1,Tumor Stage,Unknown
133,1,1,2nd Failure Type,no known failure
133,1,1,Tumor Site,oropharynx
133,1,1,Treatment Modality,Unknown
133,1,1,Overall Stage,Unknown
133,1,1,Research lab p16,p16 unknown
133,1,1,Occurrence #,1st primary
133,1,1,1st Failure Type,no known failure
133,1,1,Metastasis,Unknown
133,1,1,Research lab HPV,HPV unknown
134,1,1,1st Failure Type,no known failure
134,1,1,Occurrence #,1st primary
134,1,1,Research lab p16,p16 negative
134,1,1,Tumor Stage,T3
134,1,1,Nodal Stage,N2
134,1,1,Tumor Site,oropharynx
134,1,1,Metastasis,M0
134,1,1,Radiation Dosage,59.4
134,1,1,Clinical lab p16,p16 unkown
134,1,1,1st Failure Site,oropharynx
134,1,1,2nd Failure Type,no known failure
134,1,1,Treatment Modality,Sx & RT
134,1,1,1st Failure Treatment Modality,Sx
134,1,1,Overall Stage,IVa
134,1,1,Research lab HPV,HPV positive
135,1,1,Occurrence #,1st primary
135,1,1,Radiation Dosage,70.2
135,1,1,2nd Failure Type,no known failure
135,1,1,Initial Chemotherapy Agent,cis
135,1,1,Metastasis,M0
135,1,1,Tumor Site,oropharynx
135,1,1,Research lab p16,p16 unknown
135,1,1,1st Failure Type,no known failure
135,1,1,Research lab HPV,HPV unknown
135,1,1,Overall Stage,IVa
135,1,1,Treatment Modality,CTX-RT
135,1,1,Clinical lab p16,p16 unkown
135,1,1,Nodal Stage,N2
135,1,1,Tumor Stage,T2
136,1,1,Metastasis,Unknown
136,1,1,1st Failure Type,no known failure
136,1,1,Clinical lab p16,p16 unkown
136,1,1,Nodal Stage,Unknown
136,1,1,Overall Stage,Unknown
136,1,1,Tumor Site,Unknown
136,1,1,Treatment Modality,Unknown
136,1,1,Tumor Stage,Unknown
136,1,1,Research lab HPV,HPV unknown
136,1,1,Occurrence #,1st primary
136,1,1,2nd Failure Type,no known failure
136,1,1,Research lab p16,p16 unknown
137,1,1,Radiation Dosage,70.2
137,1,1,Treatment Modality,CTX-RT
137,1,1,Clinical lab p16,p16 unkown
137,1,1,Initial Chemotherapy Agent,Cis
137,1,1,Occurrence #,1st primary
137,1,1,Research lab p16,p16 unknown
137,1,1,Tumor Stage,T2
137,1,1,Nodal Stage,N2
137,1,1,2nd Failure Type,no known failure
137,1,1,Overall Stage,IVa
137,1,1,Research lab HPV,HPV unknown
137,1,1,Tumor Site,oropharynx
137,1,1,1st Failure Type,no known failure
137,1,1,Metastasis,M0
138,1,1,Treatment Modality,Sx
138,1,1,Research lab p16,p16 negative
138,1,1,1st Failure Type,locoregional and distant
138,1,1,Research lab HPV,HPV negative
138,1,1,Occurrence #,other primary
138,1,1,2nd Failure Type,no known failure
138,1,1,Metastasis,M0
138,1,1,Tumor Site,oropharynx
138,1,1,Clinical lab p16,p16 unkown
138,1,1,Tumor Stage,T3
138,1,1,Overall Stage,IVa
138,1,1,Nodal Stage,N2
139,1,1,Overall Stage,IVa
139,1,1,Clinical lab p16,p16 unkown
139,1,1,Tumor Site,oropharynx
139,1,1,Metastasis,M0
139,1,1,Radiation Dosage,70.2
139,1,1,Initial Chemotherapy Agent,carbo/doce
139,1,1,Treatment Modality,CTX-RT
139,1,1,Nodal Stage,N2
139,1,1,2nd Failure Type,no known failure
139,1,1,Occurrence #,Unknown
139,1,1,1st Failure Type,no known failure
139,1,1,Research lab p16,p16 unknown
139,1,1,Research lab HPV,HPV unknown
139,1,1,Tumor Stage,T4a
140,1,1,Research lab p16,p16 unknown
140,1,1,Metastasis,Unknown
140,1,1,Treatment Modality,Unknown
140,1,1,Tumor Site,oropharynx
140,1,1,Nodal Stage,Unknown
140,1,1,Research lab HPV,HPV unknown
140,1,1,1st Failure Type,no known failure
140,1,1,Tumor Stage,Unknown
140,1,1,Clinical lab p16,p16 unkown
140,1,1,2nd Failure Type,no known failure
140,1,1,Overall Stage,Unknown
140,1,1,Occurrence #,1st primary
141,1,1,1st Failure Type,no known failure
141,1,1,Research lab HPV,HPV negative
141,1,1,Tumor Site,oropharynx
141,1,1,Tumor Stage,T4a
141,1,1,Occurrence #,1st primary
141,1,1,2nd Failure Type,no known failure
141,1,1,Clinical lab p16,p16 unkown
141,1,1,Overall Stage,IVb
141,1,1,Nodal Stage,N3
141,1,1,Radiation Dosage,70.2
141,1,1,Treatment Modality,CTX-RT
141,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
141,1,1,Metastasis,M0
141,1,1,Research lab p16,p16 negative
142,1,1,Tumor Site,Unknown
142,1,1,Metastasis,Unknown
142,1,1,Nodal Stage,Unknown
142,1,1,1st Failure Type,no known failure
142,1,1,2nd Failure Type,no known failure
142,1,1,Overall Stage,Unknown
142,1,1,Research lab p16,p16 unknown
142,1,1,Treatment Modality,Unknown
142,1,1,Clinical lab p16,p16 unkown
142,1,1,Occurrence #,1st primary
142,1,1,Tumor Stage,Unknown
142,1,1,Research lab HPV,HPV unknown
143,1,1,Tumor Site,oropharynx
143,1,1,Research lab HPV,HPV negative
143,1,1,Tumor Stage,T4a
143,1,1,Nodal Stage,N2
143,1,1,Treatment Modality,CTX-RT
143,1,1,Radiation Dosage,70.2
143,1,1,Overall Stage,IVa
143,1,1,2nd Failure Type,no known failure
143,1,1,Occurrence #,1st primary
143,1,1,Clinical lab p16,p16 unkown
143,1,1,1st Failure Type,no known failure
143,1,1,Metastasis,M0
143,1,1,Initial Chemotherapy Agent,carbo/tax
143,1,1,Research lab p16,p16 negative
144,1,1,Overall Stage,IVa
144,1,1,Research lab p16,p16 unknown
144,1,1,2nd Failure Type,no known failure
144,1,1,Nodal Stage,Unknown
144,1,1,Metastasis,Unknown
144,1,1,Clinical lab p16,p16 unkown
144,1,1,Tumor Stage,Unknown
144,1,1,Treatment Modality,Unknown
144,1,1,Research lab HPV,HPV unknown
144,1,1,Tumor Site,oropharynx
144,1,1,1st Failure Type,no known failure
144,1,1,Occurrence #,1st primary
145,1,1,Nodal Stage,N2
145,1,1,Metastasis,M0
145,1,1,Occurrence #,1st primary
145,1,1,Clinical lab p16,p16 unkown
145,1,1,Tumor Stage,T2
145,1,1,2nd Failure Type,no known failure
145,1,1,Treatment Modality,Sx
145,1,1,Tumor Site,oropharynx
145,1,1,1st Failure Type,no known failure
145,1,1,Research lab HPV,HPV unknown
145,1,1,Overall Stage,IVa
145,1,1,Research lab p16,p16 unknown
146,1,1,Clinical lab p16,p16 unkown
146,1,1,Research lab HPV,HPV positive
146,1,1,Occurrence #,1st primary
146,1,1,Nodal Stage,N2
146,1,1,Research lab p16,p16 negative
146,1,1,Treatment Modality,CTX
146,1,1,Overall Stage,IVa
146,1,1,2nd Failure Type,no known failure
146,1,1,1st Failure Type,no known failure
146,1,1,Tumor Stage,T4a
146,1,1,Initial Chemotherapy Agent,carbo/doce
146,1,1,Metastasis,M0
146,1,1,Tumor Site,oropharynx
147,1,1,2nd Failure Type,no known failure
147,1,1,Radiation Dosage,63
147,1,1,1st Failure Type,no known failure
147,1,1,Tumor Stage,T3
147,1,1,Occurrence #,1st primary
147,1,1,Clinical lab p16,p16 unkown
147,1,1,Research lab HPV,HPV unknown
147,1,1,Treatment Modality,Sx & RT
147,1,1,Research lab p16,p16 unknown
147,1,1,Metastasis,M0
147,1,1,Tumor Site,oropharynx
147,1,1,Overall Stage,III
147,1,1,Nodal Stage,N0
148,1,1,Nodal Stage,N3
148,1,1,2nd Failure Type,no known failure
148,1,1,Research lab p16,p16 unknown
148,1,1,Tumor Stage,T3
148,1,1,Initial Chemotherapy Agent,unknown
148,1,1,Radiation Dosage,45
148,1,1,Occurrence #,1st primary
148,1,1,Treatment Modality,CTX-RT
148,1,1,1st Failure Type,no known failure
148,1,1,Tumor Site,oropharynx
148,1,1,Metastasis,M0
148,1,1,Research lab HPV,HPV unknown
148,1,1,Clinical lab p16,p16 unkown
148,1,1,Overall Stage,IVb
149,1,1,Overall Stage,IVa
149,1,1,Treatment Modality,RT
149,1,1,Radiation Dosage,70.2
149,1,1,Research lab p16,p16 negative
149,1,1,Metastasis,M0
149,1,1,Occurrence #,1st primary
149,1,1,1st Failure Type,no known failure
149,1,1,Tumor Site,oropharynx
149,1,1,Research lab HPV,HPV negative
149,1,1,Clinical lab p16,p16 unkown
149,1,1,Tumor Stage,T2
149,1,1,2nd Failure Type,no known failure
149,1,1,Nodal Stage,N2
150,1,1,Overall Stage,IVa
150,1,1,1st Failure Type,locoregional
150,1,1,Radiation Dosage,70
150,1,1,Occurrence #,1st primary
150,1,1,2nd Failure Type,no known failure
150,1,1,Treatment Modality,CTX-RT
150,1,1,Research lab HPV,HPV unknown
150,1,1,Nodal Stage,N1
150,1,1,Tumor Stage,T4a
150,1,1,Research lab p16,p16 positive
150,1,1,Tumor Site,oropharynx
150,1,1,Clinical lab p16,p16 unkown
150,1,1,Initial Chemotherapy Agent,carbo/PTX
150,1,1,Metastasis,M0
151,1,1,1st Failure Type,no known failure
151,1,1,Research lab HPV,HPV unknown
151,1,1,Tumor Site,oral cavity
151,1,1,Metastasis,Unknown
151,1,1,Tumor Stage,Unknown
151,1,1,Clinical lab p16,p16 unkown
151,1,1,2nd Failure Type,no known failure
151,1,1,Nodal Stage,Unknown
151,1,1,Overall Stage,Unknown
151,1,1,Treatment Modality,Unknown
151,1,1,Research lab p16,p16 unknown
151,1,1,Occurrence #,Unknown
152,1,1,Tumor Stage,T3
152,1,1,Radiation Dosage,70.2
152,1,1,Metastasis,M0
152,1,1,Overall Stage,IVa
152,1,1,1st Failure Type,locoregional
152,1,1,Clinical lab p16,p16 unkown
152,1,1,Treatment Modality,CTX-RT
152,1,1,2nd Failure Type,no known failure
152,1,1,Nodal Stage,N2
152,1,1,Research lab HPV,HPV positive
152,1,1,Tumor Site,oropharynx
152,1,1,Research lab p16,p16 positive
152,1,1,Occurrence #,1st primary
152,1,1,Initial Chemotherapy Agent,carbo/PTX
153,1,1,1st Failure Type,distant
153,1,1,Clinical lab p16,p16 unkown
153,1,1,Initial Chemotherapy Agent,carbo/PTX
153,1,1,Tumor Site,oropharynx
153,1,1,Research lab HPV,HPV unknown
153,1,1,Tumor Stage,T4a
153,1,1,Research lab p16,p16 positive
153,1,1,Nodal Stage,N2
153,1,1,Treatment Modality,CTX-RT
153,1,1,Radiation Dosage,70.2
153,1,1,Overall Stage,IVa
153,1,1,2nd Failure Type,no known failure
153,1,1,Occurrence #,1st primary
153,1,1,Metastasis,M0
154,1,1,Occurrence #,1st primary
154,1,1,Tumor Stage,T4a
154,1,1,Nodal Stage,N0
154,1,1,2nd Failure Type,no known failure
154,1,1,Metastasis,M0
154,1,1,Treatment Modality,Sx
154,1,1,Overall Stage,IVa
154,1,1,1st Failure Type,locoregional
154,1,1,Research lab p16,p16 negative
154,1,1,Tumor Site,oropharynx
154,1,1,Clinical lab p16,p16 unkown
154,1,1,Research lab HPV,HPV negative
155,1,1,Treatment Modality,Unknown
155,1,1,Nodal Stage,Unknown
155,1,1,Metastasis,Unknown
155,1,1,Overall Stage,Unknown
155,1,1,1st Failure Type,no known failure
155,1,1,Tumor Stage,Unknown
155,1,1,Research lab p16,p16 unknown
155,1,1,Research lab HPV,HPV unknown
155,1,1,Tumor Site,Unknown
155,1,1,Occurrence #,1st primary
155,1,1,Clinical lab p16,p16 unkown
155,1,1,2nd Failure Type,no known failure
156,1,1,1st Failure Type,no known failure
156,1,1,Research lab p16,p16 unknown
156,1,1,Tumor Site,oropharynx
156,1,1,Initial Chemotherapy Agent,carbo/doce
156,1,1,Clinical lab p16,p16 unkown
156,1,1,Research lab HPV,HPV unknown
156,1,1,Tumor Stage,T4a
156,1,1,Radiation Dosage,70.2
156,1,1,Metastasis,M0
156,1,1,Nodal Stage,N2
156,1,1,Overall Stage,IVa
156,1,1,2nd Failure Type,no known failure
156,1,1,Treatment Modality,CTX-RT
156,1,1,Occurrence #,1st primary
157,1,1,1st Failure Type,no known failure
157,1,1,Treatment Modality,CTX-RT
157,1,1,Initial Chemotherapy Agent,carbo/doce
157,1,1,Research lab p16,p16 unknown
157,1,1,Tumor Site,oropharynx
157,1,1,Clinical lab p16,p16 unkown
157,1,1,Tumor Stage,T4a
157,1,1,Radiation Dosage,70.2
157,1,1,Research lab HPV,HPV unknown
157,1,1,2nd Failure Type,no known failure
157,1,1,Metastasis,M0
157,1,1,Overall Stage,IVa
157,1,1,Nodal Stage,N2
157,1,1,Occurrence #,Unknown
158,1,1,2nd Failure Type,no known failure
158,1,1,Initial Chemotherapy Agent,carbo/PTX
158,1,1,1st Failure Site,oropharynx
158,1,1,Tumor Site,oropharynx
158,1,1,Clinical lab p16,p16 unkown
158,1,1,1st Failure Type,locoregional
158,1,1,Metastasis,M0
158,1,1,Occurrence #,1st primary
158,1,1,Overall Stage,III
158,1,1,Radiation Dosage,72
158,1,1,Research lab HPV,HPV unknown
158,1,1,1st Failure Treatment Modality,Sx
158,1,1,Research lab p16,p16 unknown
158,1,1,Treatment Modality,CTX-RT
158,1,1,Nodal Stage,N0
158,1,1,Tumor Stage,T3
159,1,1,Metastasis,M0
159,1,1,Tumor Stage,T3
159,1,1,Radiation Dosage,59.4
159,1,1,2nd Failure Type,no known failure
159,1,1,Treatment Modality,RT
159,1,1,Clinical lab p16,p16 unkown
159,1,1,Research lab HPV,HPV negative
159,1,1,Nodal Stage,N0
159,1,1,Research lab p16,p16 negative
159,1,1,1st Failure Type,no known failure
159,1,1,Tumor Site,oropharynx
159,1,1,Occurrence #,1st primary
159,1,1,Overall Stage,III
160,1,1,Overall Stage,IVb
160,1,1,1st Failure Type,no known failure
160,1,1,Treatment Modality,RT
160,1,1,Occurrence #,1st primary
160,1,1,2nd Failure Type,no known failure
160,1,1,Tumor Stage,T1
160,1,1,Metastasis,M0
160,1,1,Nodal Stage,N3
160,1,1,Radiation Dosage,68
160,1,1,1st Failure Treatment Modality,Sx
160,1,1,Clinical lab p16,p16 unkown
160,1,1,1st Failure Site,oral cavity
160,1,1,Tumor Site,oropharynx
160,1,1,Research lab p16,p16 unknown
160,1,1,Research lab HPV,HPV unknown
161,1,1,Tumor Stage,T3
161,1,1,1st Failure Type,no known failure
161,1,1,2nd Failure Type,no known failure
161,1,1,Metastasis,M0
161,1,1,Research lab HPV,HPV positive
161,1,1,Research lab p16,p16 positive
161,1,1,Treatment Modality,Unknown
161,1,1,Clinical lab p16,p16 unkown
161,1,1,Overall Stage,IVb
161,1,1,Occurrence #,1st primary
161,1,1,Tumor Site,oropharynx
161,1,1,Nodal Stage,N3
162,1,1,Research lab p16,p16 positive
162,1,1,Clinical lab p16,p16 unkown
162,1,1,1st Failure Type,no known failure
162,1,1,Occurrence #,1st primary
162,1,1,Treatment Modality,CTX-RT
162,1,1,Radiation Dosage,70.2
162,1,1,Nodal Stage,N1
162,1,1,Tumor Stage,T4a
162,1,1,Initial Chemotherapy Agent,carbo/PTX
162,1,1,Research lab HPV,HPV positive
162,1,1,2nd Failure Type,no known failure
162,1,1,Metastasis,M0
162,1,1,Overall Stage,IVa
162,1,1,Tumor Site,oropharynx
163,1,1,Tumor Stage,Unknown
163,1,1,Research lab p16,p16 unknown
163,1,1,Clinical lab p16,p16 unkown
163,1,1,Research lab HPV,HPV unknown
163,1,1,1st Failure Type,no known failure
163,1,1,Occurrence #,1st primary
163,1,1,Metastasis,Unknown
163,1,1,Tumor Site,oropharynx
163,1,1,Overall Stage,Unknown
163,1,1,2nd Failure Type,no known failure
163,1,1,Treatment Modality,Unknown
163,1,1,Nodal Stage,Unknown
164,1,1,Tumor Site,oropharynx
164,1,1,Research lab p16,p16 unknown
164,1,1,Overall Stage,IVa
164,1,1,Research lab HPV,HPV unknown
164,1,1,Radiation Dosage,unknown
164,1,1,Occurrence #,1st primary
164,1,1,1st Failure Type,no known failure
164,1,1,2nd Failure Type,no known failure
164,1,1,Tumor Stage,T3
164,1,1,Metastasis,M0
164,1,1,Treatment Modality,RT
164,1,1,Nodal Stage,N2
164,1,1,Clinical lab p16,p16 unkown
165,1,1,Treatment Modality,Unknown
165,1,1,1st Failure Type,no known failure
165,1,1,Occurrence #,1st primary
165,1,1,Overall Stage,IVa
165,1,1,Nodal Stage,N2
165,1,1,Tumor Stage,T2
165,1,1,Research lab HPV,HPV unknown
165,1,1,2nd Failure Type,no known failure
165,1,1,Research lab p16,p16 positive
165,1,1,Metastasis,M0
165,1,1,Clinical lab p16,p16 unkown
165,1,1,Tumor Site,oropharynx
166,1,1,2nd Failure Type,no known failure
166,1,1,Tumor Stage,T4a
166,1,1,Clinical lab p16,p16 unkown
166,1,1,Treatment Modality,CTX-RT
166,1,1,Research lab HPV,HPV unknown
166,1,1,Radiation Dosage,70.2
166,1,1,1st Failure Type,no known failure
166,1,1,Metastasis,M0
166,1,1,Research lab p16,p16 unknown
166,1,1,Nodal Stage,N2
166,1,1,Tumor Site,oropharynx
166,1,1,Overall Stage,IVa
166,1,1,Initial Chemotherapy Agent,carbo/doce
166,1,1,Occurrence #,1st primary
167,1,1,Metastasis,M0
167,1,1,Nodal Stage,N2
167,1,1,Clinical lab p16,p16 unkown
167,1,1,Tumor Stage,T4a
167,1,1,Research lab HPV,HPV negative
167,1,1,Research lab p16,p16 negative
167,1,1,Tumor Site,oropharynx
167,1,1,Initial Chemotherapy Agent,unknown
167,1,1,Occurrence #,1st primary
167,1,1,Treatment Modality,CTX-RT
167,1,1,1st Failure Type,no known failure
167,1,1,2nd Failure Type,no known failure
167,1,1,Radiation Dosage,unknown
167,1,1,Overall Stage,IVa
168,1,1,Research lab p16,p16 negative
168,1,1,Research lab HPV,HPV negative
168,1,1,2nd Failure Type,no known failure
168,1,1,Clinical lab p16,p16 unkown
168,1,1,Tumor Site,oropharynx
168,1,1,1st Failure Type,no known failure
168,1,1,Tumor Stage,T3
168,1,1,Overall Stage,IVb
168,1,1,Metastasis,M0
168,1,1,Treatment Modality,Unknown
168,1,1,Occurrence #,1st primary
168,1,1,Nodal Stage,N3
169,1,1,Research lab HPV,HPV unknown
169,1,1,Nodal Stage,Unknown
169,1,1,Treatment Modality,Unknown
169,1,1,Clinical lab p16,p16 unkown
169,1,1,1st Failure Type,no known failure
169,1,1,Research lab p16,p16 unknown
169,1,1,Overall Stage,Unknown
169,1,1,Occurrence #,1st primary
169,1,1,2nd Failure Type,no known failure
169,1,1,Tumor Stage,Unknown
169,1,1,Metastasis,Unknown
169,1,1,Tumor Site,Unknown
170,1,1,Clinical lab p16,p16 unkown
170,1,1,Nodal Stage,N2
170,1,1,2nd Failure Type,no known failure
170,1,1,Research lab p16,p16 unknown
170,1,1,Radiation Dosage,70.2
170,1,1,Overall Stage,IVa
170,1,1,Metastasis,M0
170,1,1,Tumor Site,oropharynx
170,1,1,Research lab HPV,HPV unknown
170,1,1,Occurrence #,1st primary
170,1,1,Tumor Stage,T2
170,1,1,Treatment Modality,CTX-RT
170,1,1,1st Failure Type,locoregional
170,1,1,Initial Chemotherapy Agent,carbo/ PTX
171,1,1,Tumor Site,oropharynx
171,1,1,Initial Chemotherapy Agent,"carbo, PTX"
171,1,1,Metastasis,M0
171,1,1,Overall Stage,IVa
171,1,1,Research lab p16,p16 negative
171,1,1,Treatment Modality,CTX-RT
171,1,1,Research lab HPV,HPV negative
171,1,1,2nd Failure Type,no known failure
171,1,1,Occurrence #,1st primary
171,1,1,Clinical lab p16,p16 unkown
171,1,1,Radiation Dosage,70.2
171,1,1,Nodal Stage,N2
171,1,1,Tumor Stage,T3
171,1,1,1st Failure Type,locoregional and distant
172,1,1,Radiation Dosage,70.2
172,1,1,Metastasis,M0
172,1,1,Occurrence #,1st primary
172,1,1,Research lab HPV,HPV negative
172,1,1,Tumor Stage,T4a
172,1,1,Tumor Site,oropharynx
172,1,1,Treatment Modality,CTX-RT
172,1,1,Overall Stage,IVb
172,1,1,Clinical lab p16,p16 unkown
172,1,1,Initial Chemotherapy Agent,carbo/doce
172,1,1,2nd Failure Type,no known failure
172,1,1,Research lab p16,p16 negative
172,1,1,Nodal Stage,N3
172,1,1,1st Failure Type,locoregional
173,1,1,Overall Stage,IVa
173,1,1,Treatment Modality,Sx
173,1,1,Occurrence #,recurrence
173,1,1,Clinical lab p16,p16 unkown
173,1,1,1st Failure Type,locoregional
173,1,1,Tumor Stage,T1
173,1,1,Nodal Stage,N2
173,1,1,Research lab p16,p16 unknown
173,1,1,2nd Failure Type,no known failure
173,1,1,Research lab HPV,HPV unknown
173,1,1,Tumor Site,oropharynx
173,1,1,Metastasis,M0
174,1,1,Treatment Modality,Unknown
174,1,1,Tumor Stage,T4b
174,1,1,Metastasis,M0
174,1,1,Nodal Stage,N3
174,1,1,Research lab p16,p16 unknown
174,1,1,2nd Failure Type,no known failure
174,1,1,Overall Stage,IVb
174,1,1,Tumor Site,oropharynx
174,1,1,Research lab HPV,HPV unknown
174,1,1,Clinical lab p16,p16 unkown
174,1,1,Occurrence #,1st primary
174,1,1,1st Failure Type,no known failure
175,1,1,2nd Failure Type,no known failure
175,1,1,Tumor Stage,T3
175,1,1,Research lab HPV,HPV unknown
175,1,1,Metastasis,M0
175,1,1,Clinical lab p16,p16 unkown
175,1,1,Nodal Stage,N3
175,1,1,Treatment Modality,Sx & CTX-RT
175,1,1,Research lab p16,p16 unknown
175,1,1,Tumor Site,oropharynx
175,1,1,Initial Chemotherapy Agent,cis
175,1,1,1st Failure Type,no known failure
175,1,1,Overall Stage,IVb
175,1,1,Radiation Dosage,135
175,1,1,Occurrence #,1st primary
176,1,1,Research lab p16,p16 unknown
176,1,1,2nd Failure Type,no known failure
176,1,1,Treatment Modality,CTX-RT
176,1,1,Occurrence #,1st primary
176,1,1,Research lab HPV,HPV unknown
176,1,1,Clinical lab p16,p16 unkown
176,1,1,1st Failure Type,locoregional
176,1,1,Overall Stage,IVa
176,1,1,Nodal Stage,N2
176,1,1,Metastasis,M0
176,1,1,Tumor Stage,T2
176,1,1,Initial Chemotherapy Agent,carbo/doce
176,1,1,Tumor Site,oropharynx
176,1,1,Radiation Dosage,70.2
177,1,1,Research lab HPV,HPV negative
177,1,1,Clinical lab p16,p16 unkown
177,1,1,Nodal Stage,N2
177,1,1,1st Failure Type,no known failure
177,1,1,Treatment Modality,Unknown
177,1,1,Occurrence #,1st primary
177,1,1,Overall Stage,IVa
177,1,1,Metastasis,M0
177,1,1,Research lab p16,p16 negative
177,1,1,Tumor Site,oropharynx
177,1,1,2nd Failure Type,no known failure
177,1,1,Tumor Stage,T3
178,1,1,Overall Stage,IVa
178,1,1,Tumor Site,oropharynx
178,1,1,Research lab HPV,HPV negative
178,1,1,Clinical lab p16,p16 unkown
178,1,1,Metastasis,M0
178,1,1,Tumor Stage,T4a
178,1,1,Initial Chemotherapy Agent,carbo/PTX
178,1,1,Radiation Dosage,70.2
178,1,1,Nodal Stage,N2
178,1,1,Research lab p16,p16 negative
178,1,1,2nd Failure Type,no known failure
178,1,1,1st Failure Type,distant
178,1,1,Occurrence #,1st primary
178,1,1,Treatment Modality,CTX-RT
179,1,1,Tumor Stage,Unknown
179,1,1,Research lab p16,p16 unknown
179,1,1,Overall Stage,Unknown
179,1,1,2nd Failure Type,no known failure
179,1,1,Clinical lab p16,p16 unkown
179,1,1,Nodal Stage,Unknown
179,1,1,Research lab HPV,HPV unknown
179,1,1,Metastasis,Unknown
179,1,1,Tumor Site,Unknown
179,1,1,Occurrence #,1st primary
179,1,1,1st Failure Type,no known failure
179,1,1,Treatment Modality,Unknown
180,1,1,Tumor Site,oropharynx
180,1,1,Tumor Stage,T3
180,1,1,Overall Stage,IVa
180,1,1,1st Failure Site,oropharynx
180,1,1,Nodal Stage,N2
180,1,1,Initial Chemotherapy Agent,cis
180,1,1,Treatment Modality,CTX-RT
180,1,1,Radiation Dosage,70.2
180,1,1,Research lab p16,p16 unknown
180,1,1,1st Failure Treatment Modality,Sx
180,1,1,1st Failure Type,locoregional
180,1,1,Clinical lab p16,p16 unkown
180,1,1,Metastasis,M0
180,1,1,2nd Failure Type,no known failure
180,1,1,Occurrence #,1st primary
180,1,1,Research lab HPV,HPV unknown
181,1,1,Overall Stage,IVa
181,1,1,Occurrence #,1st primary
181,1,1,Tumor Stage,T4a
181,1,1,1st Failure Type,locoregional
181,1,1,Initial Chemotherapy Agent,carbo
181,1,1,2nd Failure Type,no known failure
181,1,1,Tumor Site,oral cavity
181,1,1,Metastasis,M0
181,1,1,Research lab HPV,HPV unknown
181,1,1,Radiation Dosage,70.2
181,1,1,Treatment Modality,Sx & CTX-RT
181,1,1,Nodal Stage,N2
181,1,1,Clinical lab p16,p16 unkown
181,1,1,Research lab p16,p16 unknown
182,1,1,Occurrence #,1st primary
182,1,1,Tumor Site,oropharynx
182,1,1,Treatment Modality,CTX-RT
182,1,1,1st Failure Type,locoregional
182,1,1,Initial Chemotherapy Agent,carbo/doce
182,1,1,Research lab p16,p16 negative
182,1,1,Overall Stage,IVa
182,1,1,Research lab HPV,HPV negative
182,1,1,Metastasis,M0
182,1,1,Clinical lab p16,p16 unkown
182,1,1,Radiation Dosage,72
182,1,1,Nodal Stage,N2
182,1,1,Tumor Stage,T4a
182,1,1,2nd Failure Type,no known failure
183,1,1,Occurrence #,1st primary
183,1,1,Research lab p16,p16 unknown
183,1,1,Metastasis,Unknown
183,1,1,Tumor Stage,Unknown
183,1,1,Clinical lab p16,p16 unkown
183,1,1,Tumor Site,Unknown
183,1,1,Research lab HPV,HPV unknown
183,1,1,1st Failure Type,no known failure
183,1,1,2nd Failure Type,no known failure
183,1,1,Treatment Modality,Unknown
183,1,1,Nodal Stage,Unknown
183,1,1,Overall Stage,Unknown
184,1,1,Nodal Stage,Unknown
184,1,1,Clinical lab p16,p16 unkown
184,1,1,1st Failure Type,no known failure
184,1,1,Tumor Site,Unknown
184,1,1,Research lab HPV,HPV unknown
184,1,1,Tumor Stage,Unknown
184,1,1,Metastasis,Unknown
184,1,1,Treatment Modality,Unknown
184,1,1,Occurrence #,1st primary
184,1,1,Overall Stage,Unknown
184,1,1,Research lab p16,p16 unknown
184,1,1,2nd Failure Type,no known failure
185,1,1,Overall Stage,IVb
185,1,1,2nd Failure Type,no known failure
185,1,1,1st Failure Type,locoregional
185,1,1,Tumor Stage,T4b
185,1,1,Research lab HPV,HPV negative
185,1,1,1st Failure Initial Chemotherapy Agent,cap
185,1,1,Occurrence #,1st primary
185,1,1,Tumor Site,oropharynx
185,1,1,Metastasis,M0
185,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
185,1,1,Treatment Modality,CTX-RT
185,1,1,1st Failure Treatment Modality,CTX
185,1,1,Nodal Stage,N2
185,1,1,1st Failure Site,oropharynx
185,1,1,Clinical lab p16,p16 unkown
185,1,1,Research lab p16,p16 negative
185,1,1,Radiation Dosage,70.2
186,1,1,Research lab p16,p16 negative
186,1,1,2nd Failure Type,no known failure
186,1,1,Overall Stage,IVa
186,1,1,Initial Chemotherapy Agent,carbo/doce
186,1,1,Tumor Stage,T4a
186,1,1,Occurrence #,1st primary
186,1,1,Radiation Dosage,70.2
186,1,1,Nodal Stage,N2
186,1,1,Clinical lab p16,p16 unkown
186,1,1,1st Failure Type,no known failure
186,1,1,Metastasis,M0
186,1,1,Research lab HPV,HPV negative
186,1,1,Tumor Site,oropharynx
186,1,1,Treatment Modality,CTX-RT
187,1,1,Research lab HPV,HPV unknown
187,1,1,Tumor Stage,Unknown
187,1,1,2nd Failure Type,no known failure
187,1,1,Tumor Site,oropharynx
187,1,1,Treatment Modality,Unknown
187,1,1,Nodal Stage,Unknown
187,1,1,Clinical lab p16,p16 unkown
187,1,1,Metastasis,Unknown
187,1,1,Research lab p16,p16 unknown
187,1,1,1st Failure Type,no known failure
187,1,1,Overall Stage,Unknown
187,1,1,Occurrence #,1st primary
188,1,1,Radiation Dosage,70.2
188,1,1,1st Failure Type,no known failure
188,1,1,Research lab p16,p16 unknown
188,1,1,Occurrence #,1st primary
188,1,1,Initial Chemotherapy Agent,PTX/cap
188,1,1,Metastasis,M0
188,1,1,Nodal Stage,N2
188,1,1,Tumor Site,oropharynx
188,1,1,Treatment Modality,CTX-RT
188,1,1,Research lab HPV,HPV unknown
188,1,1,Overall Stage,IVa
188,1,1,Tumor Stage,T2
188,1,1,Clinical lab p16,p16 unkown
188,1,1,2nd Failure Type,no known failure
189,1,1,2nd Failure Type,no known failure
189,1,1,Research lab p16,p16 unknown
189,1,1,Tumor Stage,Unknown
189,1,1,Clinical lab p16,p16 unkown
189,1,1,1st Failure Type,no known failure
189,1,1,Metastasis,Unknown
189,1,1,Overall Stage,Unknown
189,1,1,Occurrence #,1st primary
189,1,1,Tumor Site,Unknown
189,1,1,Research lab HPV,HPV unknown
189,1,1,Treatment Modality,Unknown
189,1,1,Nodal Stage,Unknown
190,1,1,Nodal Stage,N1
190,1,1,2nd Failure Type,no known failure
190,1,1,Tumor Stage,T3
190,1,1,Research lab HPV,HPV unknown
190,1,1,Treatment Modality,CTX-RT
190,1,1,Tumor Site,oropharynx
190,1,1,Initial Chemotherapy Agent,carbo/doce
190,1,1,Metastasis,M0
190,1,1,1st Failure Type,no known failure
190,1,1,Radiation Dosage,70.2
190,1,1,Clinical lab p16,p16 unkown
190,1,1,Research lab p16,p16 unknown
190,1,1,Occurrence #,1st primary
190,1,1,Overall Stage,III
191,1,1,Occurrence #,1st primary
191,1,1,Clinical lab p16,p16 unkown
191,1,1,Treatment Modality,CTX-RT
191,1,1,2nd Failure Type,no known failure
191,1,1,Metastasis,M0
191,1,1,Radiation Dosage,unknown
191,1,1,Tumor Site,oropharynx
191,1,1,Initial Chemotherapy Agent,unk
191,1,1,Overall Stage,IVa
191,1,1,Research lab p16,p16 unknown
191,1,1,Tumor Stage,T2
191,1,1,Research lab HPV,HPV unknown
191,1,1,Nodal Stage,N2
191,1,1,1st Failure Type,no known failure
192,1,1,Research lab HPV,HPV negative
192,1,1,Nodal Stage,N2
192,1,1,Occurrence #,1st primary
192,1,1,Overall Stage,IVa
192,1,1,Research lab p16,p16 negative
192,1,1,Metastasis,M0
192,1,1,Tumor Site,oropharynx
192,1,1,Radiation Dosage,70.2
192,1,1,Initial Chemotherapy Agent,unknown
192,1,1,2nd Failure Type,no known failure
192,1,1,1st Failure Type,no known failure
192,1,1,Clinical lab p16,p16 unkown
192,1,1,Treatment Modality,CTX-RT
192,1,1,Tumor Stage,T2
193,1,1,Tumor Stage,T2
193,1,1,Overall Stage,II
193,1,1,Nodal Stage,N0
193,1,1,Tumor Site,oral cavity
193,1,1,Treatment Modality,RT
193,1,1,2nd Failure Type,no known failure
193,1,1,1st Failure Type,locoregional
193,1,1,Research lab p16,p16 unknown
193,1,1,Clinical lab p16,p16 unkown
193,1,1,1st Failure Treatment Modality,Sx
193,1,1,Occurrence #,1st primary
193,1,1,Research lab HPV,HPV unknown
193,1,1,1st Failure Site,oral cavity
193,1,1,Metastasis,M0
194,1,1,Metastasis,M1
194,1,1,Tumor Stage,T4a
194,1,1,Clinical lab p16,p16 unkown
194,1,1,Research lab p16,p16 negative
194,1,1,Research lab HPV,HPV negative
194,1,1,2nd Failure Type,no known failure
194,1,1,1st Failure Type,no known failure
194,1,1,Occurrence #,1st primary
194,1,1,Treatment Modality,Unknown
194,1,1,Overall Stage,IVc
194,1,1,Tumor Site,oropharynx
194,1,1,Nodal Stage,N2
195,1,1,Tumor Site,oropharynx
195,1,1,2nd Failure Type,no known failure
195,1,1,Tumor Stage,T4a
195,1,1,Treatment Modality,Unknown
195,1,1,Research lab p16,p16 unknown
195,1,1,Metastasis,M0
195,1,1,Overall Stage,IVa
195,1,1,Research lab HPV,HPV unknown
195,1,1,Nodal Stage,N0
195,1,1,1st Failure Type,no known failure
195,1,1,Occurrence #,1st primary
195,1,1,Clinical lab p16,p16 unkown
196,1,1,Occurrence #,1st primary
196,1,1,2nd Failure Type,no known failure
196,1,1,Radiation Dosage,54
196,1,1,Metastasis,M0
196,1,1,Research lab p16,p16 negative
196,1,1,Overall Stage,IVa
196,1,1,Nodal Stage,N2
196,1,1,Tumor Stage,T4a
196,1,1,1st Failure Type,no known failure
196,1,1,Tumor Site,oropharynx
196,1,1,Research lab HPV,HPV negative
196,1,1,Treatment Modality,RT
196,1,1,Clinical lab p16,p16 unkown
197,1,1,Overall Stage,IVa
197,1,1,Treatment Modality,Sx & CTX-RT
197,1,1,Research lab HPV,HPV positive
197,1,1,Metastasis,M0
197,1,1,Research lab p16,p16 positive
197,1,1,Nodal Stage,N2
197,1,1,Initial Chemotherapy Agent,cis
197,1,1,Occurrence #,1st primary
197,1,1,Tumor Site,oropharynx
197,1,1,Tumor Stage,T3
197,1,1,2nd Failure Type,no known failure
197,1,1,Radiation Dosage,70.2
197,1,1,Clinical lab p16,p16 unkown
197,1,1,1st Failure Type,no known failure
198,1,1,Research lab HPV,HPV unknown
198,1,1,Treatment Modality,Unknown
198,1,1,Occurrence #,1st primary
198,1,1,Research lab p16,p16 unknown
198,1,1,2nd Failure Type,no known failure
198,1,1,Overall Stage,Unknown
198,1,1,1st Failure Type,no known failure
198,1,1,Nodal Stage,Unknown
198,1,1,Tumor Site,Unknown
198,1,1,Tumor Stage,Unknown
198,1,1,Clinical lab p16,p16 unkown
198,1,1,Metastasis,Unknown
199,1,1,Metastasis,M0
199,1,1,Occurrence #,1st primary
199,1,1,Overall Stage,IVa
199,1,1,1st Failure Type,no known failure
199,1,1,Research lab p16,p16 unknown
199,1,1,Tumor Site,oropharynx
199,1,1,Initial Chemotherapy Agent,unknown
199,1,1,Tumor Stage,T4a
199,1,1,Nodal Stage,N1
199,1,1,Research lab HPV,HPV unknown
199,1,1,Radiation Dosage,70.8
199,1,1,Treatment Modality,CTX-RT
199,1,1,Clinical lab p16,p16 unkown
199,1,1,2nd Failure Type,no known failure
200,1,1,Radiation Dosage,72
200,1,1,Tumor Stage,T3
200,1,1,1st Failure Type,no known failure
200,1,1,Treatment Modality,CTX-RT
200,1,1,Metastasis,M0
200,1,1,Initial Chemotherapy Agent,cis
200,1,1,Overall Stage,IVa
200,1,1,Occurrence #,1st primary
200,1,1,Clinical lab p16,p16 unkown
200,1,1,Research lab p16,p16 negative
200,1,1,2nd Failure Type,no known failure
200,1,1,Nodal Stage,N2
200,1,1,Tumor Site,oropharynx
200,1,1,Research lab HPV,HPV negative
201,1,1,Clinical lab p16,p16 unkown
201,1,1,Overall Stage,IVa
201,1,1,2nd Failure Type,no known failure
201,1,1,Radiation Dosage,70.2
201,1,1,Tumor Stage,T4a
201,1,1,Research lab HPV,HPV unknown
201,1,1,Initial Chemotherapy Agent,carbo/doce
201,1,1,Treatment Modality,CTX-RT
201,1,1,Nodal Stage,N2
201,1,1,Occurrence #,1st primary
201,1,1,1st Failure Type,locoregional
201,1,1,Metastasis,M0
201,1,1,Tumor Site,oropharynx
201,1,1,Research lab p16,p16 unknown
202,1,1,Initial Chemotherapy Agent,carbo
202,1,1,Research lab p16,p16 negative
202,1,1,Tumor Site,oropharynx
202,1,1,Research lab HPV,HPV negative
202,1,1,1st Failure Type,no known failure
202,1,1,Tumor Stage,T4a
202,1,1,Treatment Modality,CTX-RT
202,1,1,2nd Failure Type,no known failure
202,1,1,Radiation Dosage,30
202,1,1,Metastasis,M0
202,1,1,Nodal Stage,N2
202,1,1,Overall Stage,IVa
202,1,1,Occurrence #,1st primary
202,1,1,Clinical lab p16,p16 unkown
203,1,1,Nodal Stage,N2
203,1,1,Clinical lab p16,p16 unkown
203,1,1,Initial Chemotherapy Agent,carbo/doce
203,1,1,Overall Stage,IVa
203,1,1,Research lab p16,p16 unknown
203,1,1,Treatment Modality,CTX-RT
203,1,1,Research lab HPV,HPV unknown
203,1,1,Occurrence #,1st primary
203,1,1,Tumor Stage,T2
203,1,1,1st Failure Type,no known failure
203,1,1,2nd Failure Type,no known failure
203,1,1,Metastasis,M0
203,1,1,Tumor Site,oropharynx
203,1,1,Radiation Dosage,70.2
204,1,1,Clinical lab p16,p16 unkown
204,1,1,Nodal Stage,Unknown
204,1,1,Research lab p16,p16 unknown
204,1,1,2nd Failure Type,no known failure
204,1,1,Metastasis,M1
204,1,1,1st Failure Type,no known failure
204,1,1,Occurrence #,Unknown
204,1,1,Treatment Modality,Unknown
204,1,1,Overall Stage,IVc
204,1,1,Research lab HPV,HPV unknown
204,1,1,Tumor Site,oropharynx
204,1,1,Tumor Stage,Unknown
205,1,1,2nd Failure Type,no known failure
205,1,1,Radiation Dosage,unknown
205,1,1,Research lab p16,p16 negative
205,1,1,Nodal Stage,Unknown
205,1,1,Occurrence #,1st primary
205,1,1,Overall Stage,IVa
205,1,1,Treatment Modality,CTX-RT
205,1,1,Tumor Site,oropharynx
205,1,1,Tumor Stage,Unknown
205,1,1,1st Failure Type,no known failure
205,1,1,Research lab HPV,HPV negative
205,1,1,Clinical lab p16,p16 unkown
205,1,1,Metastasis,M0
205,1,1,Initial Chemotherapy Agent,carbo/doce
206,1,1,1st Failure Type,no known failure
206,1,1,Treatment Modality,Sx & RT
206,1,1,Occurrence #,1st primary
206,1,1,Tumor Site,oropharynx
206,1,1,Radiation Dosage,66.6
206,1,1,2nd Failure Type,no known failure
206,1,1,Metastasis,M0
206,1,1,Clinical lab p16,p16 unkown
206,1,1,Tumor Stage,T1
206,1,1,Nodal Stage,N1
206,1,1,Research lab p16,p16 positive
206,1,1,Research lab HPV,HPV positive
206,1,1,Overall Stage,III
207,1,1,1st Failure Initial Chemotherapy Agent,Cis
207,1,1,Occurrence #,1st primary
207,1,1,1st Failure Treatment Modality,CTX
207,1,1,Metastasis,M0
207,1,1,1st Failure Type,locoregional
207,1,1,Research lab p16,p16 unknown
207,1,1,1st Failure Site,oral cavity
207,1,1,Clinical lab p16,p16 unkown
207,1,1,Treatment Modality,RT
207,1,1,Research lab HPV,HPV unknown
207,1,1,Nodal Stage,N3
207,1,1,Overall Stage,IVb
207,1,1,Tumor Stage,T4a
207,1,1,2nd Failure Type,no known failure
207,1,1,Tumor Site,oropharynx
207,1,1,1st Failure Second Line Chemotherapy Agent,unk
207,1,1,Radiation Dosage,70.2
208,1,1,Occurrence #,1st primary
208,1,1,Overall Stage,IVa
208,1,1,2nd Failure Type,no known failure
208,1,1,Tumor Stage,T4a
208,1,1,1st Failure Type,no known failure
208,1,1,Clinical lab p16,p16 unkown
208,1,1,Radiation Dosage,70.2
208,1,1,Treatment Modality,CTX-RT
208,1,1,Metastasis,M0
208,1,1,Research lab HPV,HPV positive
208,1,1,Tumor Site,oropharynx
208,1,1,Nodal Stage,N1
208,1,1,Initial Chemotherapy Agent,cis
208,1,1,Research lab p16,p16 positive
209,1,1,1st Failure Type,no known failure
209,1,1,Radiation Dosage,74.4
209,1,1,Research lab HPV,HPV unknown
209,1,1,Occurrence #,recurrence
209,1,1,Tumor Site,oropharynx
209,1,1,Metastasis,Unknown
209,1,1,2nd Failure Type,no known failure
209,1,1,Treatment Modality,RT
209,1,1,Overall Stage,Unknown
209,1,1,Research lab p16,p16 unknown
209,1,1,Nodal Stage,Unknown
209,1,1,Tumor Stage,Unknown
209,1,1,Clinical lab p16,p16 unkown
210,1,1,1st Failure Type,locoregional
210,1,1,Research lab p16,p16 unknown
210,1,1,Research lab HPV,HPV unknown
210,1,1,Occurrence #,1st primary
210,1,1,2nd Failure Type,no known failure
210,1,1,Metastasis,M0
210,1,1,Tumor Site,oropharynx
210,1,1,Nodal Stage,N2
210,1,1,Tumor Stage,T4a
210,1,1,Clinical lab p16,p16 unkown
210,1,1,Initial Chemotherapy Agent,carbo/doce
210,1,1,Radiation Dosage,70.2
210,1,1,Treatment Modality,CTX-RT
210,1,1,Overall Stage,IVa
211,1,1,1st Failure Type,no known failure
211,1,1,Clinical lab p16,p16 unkown
211,1,1,Treatment Modality,RT
211,1,1,Tumor Site,oropharynx
211,1,1,Overall Stage,IVa
211,1,1,Tumor Stage,T4a
211,1,1,Nodal Stage,N2
211,1,1,Metastasis,M0
211,1,1,Occurrence #,1st primary
211,1,1,Radiation Dosage,23.4
211,1,1,Research lab p16,p16 negative
211,1,1,Research lab HPV,HPV negative
211,1,1,2nd Failure Type,no known failure
212,1,1,Research lab HPV,HPV unknown
212,1,1,Tumor Site,oral cavity
212,1,1,Metastasis,M0
212,1,1,Tumor Stage,T4a
212,1,1,Nodal Stage,N0
212,1,1,Occurrence #,1st primary
212,1,1,Research lab p16,p16 unknown
212,1,1,2nd Failure Type,no known failure
212,1,1,Overall Stage,IVa
212,1,1,Treatment Modality,Sx
212,1,1,Clinical lab p16,p16 unkown
212,1,1,1st Failure Type,no known failure
213,1,1,Overall Stage,III
213,1,1,2nd Failure Type,no known failure
213,1,1,Radiation Dosage,unknown
213,1,1,Tumor Site,oropharynx
213,1,1,Nodal Stage,N0
213,1,1,Metastasis,M0
213,1,1,1st Failure Type,no known failure
213,1,1,Tumor Stage,T3
213,1,1,Occurrence #,1st primary
213,1,1,Clinical lab p16,p16 unkown
213,1,1,Initial Chemotherapy Agent,unknown
213,1,1,Treatment Modality,Sx
213,1,1,Research lab HPV,HPV unknown
213,1,1,Research lab p16,p16 unknown
214,1,1,Clinical lab p16,p16 unkown
214,1,1,Radiation Dosage,70.2
214,1,1,Overall Stage,IVa
214,1,1,Initial Chemotherapy Agent,carbo/doce
214,1,1,Tumor Site,oropharynx
214,1,1,Treatment Modality,CTX-RT
214,1,1,1st Failure Type,distant
214,1,1,Tumor Stage,T4a
214,1,1,Research lab HPV,HPV unknown
214,1,1,2nd Failure Type,no known failure
214,1,1,Research lab p16,p16 unknown
214,1,1,Nodal Stage,N2
214,1,1,Occurrence #,1st primary
214,1,1,Metastasis,M0
215,1,1,Research lab HPV,HPV unknown
215,1,1,Metastasis,Unknown
215,1,1,Tumor Site,oropharynx
215,1,1,Research lab p16,p16 unknown
215,1,1,Nodal Stage,Unknown
215,1,1,Clinical lab p16,p16 unkown
215,1,1,Tumor Stage,Unknown
215,1,1,1st Failure Type,no known failure
215,1,1,Treatment Modality,Unknown
215,1,1,2nd Failure Type,no known failure
215,1,1,Occurrence #,1st primary
215,1,1,Overall Stage,Unknown
216,1,1,Tumor Site,oropharynx
216,1,1,Tumor Stage,T3
216,1,1,Occurrence #,1st primary
216,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
216,1,1,2nd Failure Type,no known failure
216,1,1,Research lab p16,p16 unknown
216,1,1,Metastasis,M0
216,1,1,Research lab HPV,HPV unknown
216,1,1,1st Failure Type,no known failure
216,1,1,Nodal Stage,N2
216,1,1,Clinical lab p16,p16 unkown
216,1,1,Treatment Modality,CTX-RT
216,1,1,Radiation Dosage,70.2
216,1,1,Overall Stage,IVa
217,1,1,1st Failure Treatment Modality,CTX-RT
217,1,1,Overall Stage,IVa
217,1,1,Treatment Modality,CTX-RT
217,1,1,Clinical lab p16,p16 unkown
217,1,1,Occurrence #,1st primary
217,1,1,Tumor Site,oropharynx
217,1,1,Tumor Stage,T3
217,1,1,Research lab p16,p16 unknown
217,1,1,1st Failure Initial Chemotherapy Agent,Carbo/doce
217,1,1,Metastasis,M0
217,1,1,1st Failure Site,oropharynx
217,1,1,2nd Failure Type,no known failure
217,1,1,1st Failure Type,locoregional
217,1,1,Radiation Dosage,70.2
217,1,1,1st Failure Radiation Dosage,60
217,1,1,Research lab HPV,HPV unknown
217,1,1,Initial Chemotherapy Agent,carbo/doce
217,1,1,Nodal Stage,N2
218,1,1,Tumor Stage,Unknown
218,1,1,Clinical lab p16,p16 unkown
218,1,1,Nodal Stage,Unknown
218,1,1,Tumor Site,oropharynx
218,1,1,Overall Stage,IVa
218,1,1,Research lab p16,p16 unknown
218,1,1,Occurrence #,1st primary
218,1,1,2nd Failure Type,no known failure
218,1,1,Metastasis,M0
218,1,1,1st Failure Type,no known failure
218,1,1,Research lab HPV,HPV unknown
218,1,1,Treatment Modality,Unknown
219,1,1,Occurrence #,1st primary
219,1,1,Research lab p16,p16 negative
219,1,1,1st Failure Type,distant
219,1,1,Metastasis,M0
219,1,1,Research lab HPV,HPV negative
219,1,1,Radiation Dosage,72
219,1,1,2nd Failure Type,no known failure
219,1,1,Overall Stage,IVa
219,1,1,Tumor Site,oropharynx
219,1,1,Initial Chemotherapy Agent,unknown
219,1,1,Tumor Stage,T3
219,1,1,Nodal Stage,N2
219,1,1,Treatment Modality,CTX-RT
219,1,1,Clinical lab p16,p16 unkown
220,1,1,Treatment Modality,RT
220,1,1,Overall Stage,IVa
220,1,1,Radiation Dosage,72
220,1,1,Research lab HPV,HPV negative
220,1,1,2nd Failure Type,no known failure
220,1,1,Metastasis,M0
220,1,1,Nodal Stage,N2
220,1,1,Clinical lab p16,p16 unkown
220,1,1,Research lab p16,p16 negative
220,1,1,1st Failure Type,distant
220,1,1,Tumor Site,oropharynx
220,1,1,Occurrence #,1st primary
220,1,1,Tumor Stage,T4a
221,1,1,Treatment Modality,Unknown
221,1,1,1st Failure Type,distant
221,1,1,Clinical lab p16,p16 unkown
221,1,1,Metastasis,M0
221,1,1,Research lab p16,p16 negative
221,1,1,2nd Failure Type,no known failure
221,1,1,Tumor Stage,T3
221,1,1,Nodal Stage,N2
221,1,1,Overall Stage,IVa
221,1,1,Research lab HPV,HPV negative
221,1,1,Occurrence #,1st primary
221,1,1,Tumor Site,oropharynx
222,1,1,Clinical lab p16,p16 unkown
222,1,1,Overall Stage,I
222,1,1,Research lab HPV,HPV unknown
222,1,1,Metastasis,M0
222,1,1,Occurrence #,other primary
222,1,1,Research lab p16,p16 unknown
222,1,1,Tumor Stage,T1
222,1,1,1st Failure Type,no known failure
222,1,1,2nd Failure Type,no known failure
222,1,1,Tumor Site,oropharynx
222,1,1,Radiation Dosage,66.6
222,1,1,Treatment Modality,RT
222,1,1,Nodal Stage,N0
223,1,1,1st Failure Type,no known failure
223,1,1,Overall Stage,IVa
223,1,1,Tumor Stage,T2
223,1,1,Radiation Dosage,70.2
223,1,1,Clinical lab p16,p16 unkown
223,1,1,Research lab HPV,HPV positive
223,1,1,Tumor Site,oropharynx
223,1,1,Initial Chemotherapy Agent,carbo/PTX
223,1,1,2nd Failure Type,no known failure
223,1,1,Treatment Modality,CTX-RT
223,1,1,Occurrence #,1st primary
223,1,1,Research lab p16,p16 unknown
223,1,1,Metastasis,M0
223,1,1,Nodal Stage,N2
224,1,1,2nd Failure Type,no known failure
224,1,1,Clinical lab p16,p16 unkown
224,1,1,Initial Chemotherapy Agent,unknown
224,1,1,Treatment Modality,CTX-RT
224,1,1,Overall Stage,IVa
224,1,1,Metastasis,M0
224,1,1,Research lab HPV,HPV unknown
224,1,1,Tumor Site,oropharynx
224,1,1,1st Failure Site,oropharynx
224,1,1,Nodal Stage,N2
224,1,1,Radiation Dosage,68.4
224,1,1,1st Failure Type,locoregional
224,1,1,1st Failure Treatment Modality,Sx
224,1,1,Research lab p16,p16 unknown
224,1,1,Occurrence #,1st primary
224,1,1,Tumor Stage,T4a
225,1,1,Treatment Modality,Unknown
225,1,1,Clinical lab p16,p16 unkown
225,1,1,Occurrence #,Unknown
225,1,1,Metastasis,Unknown
225,1,1,Research lab p16,p16 positive
225,1,1,Nodal Stage,Unknown
225,1,1,Tumor Stage,Unknown
225,1,1,Tumor Site,oropharynx
225,1,1,Research lab HPV,HPV positive
225,1,1,1st Failure Type,no known failure
225,1,1,2nd Failure Type,no known failure
225,1,1,Overall Stage,Unknown
226,1,1,Occurrence #,1st primary
226,1,1,Overall Stage,I
226,1,1,Research lab p16,p16 unknown
226,1,1,Research lab HPV,HPV unknown
226,1,1,2nd Failure Type,no known failure
226,1,1,Nodal Stage,N0
226,1,1,Treatment Modality,Unknown
226,1,1,Metastasis,M0
226,1,1,Tumor Stage,T1
226,1,1,1st Failure Type,no known failure
226,1,1,Clinical lab p16,p16 unkown
226,1,1,Tumor Site,oropharynx
227,1,1,Tumor Stage,T4a
227,1,1,Occurrence #,1st primary
227,1,1,Research lab HPV,HPV negative
227,1,1,2nd Failure Type,no known failure
227,1,1,Clinical lab p16,p16 unkown
227,1,1,Treatment Modality,CTX-RT
227,1,1,Research lab p16,p16 negative
227,1,1,1st Failure Type,locoregional
227,1,1,Overall Stage,IVa
227,1,1,Radiation Dosage,70.2
227,1,1,Nodal Stage,N2
227,1,1,Initial Chemotherapy Agent,carbo/doce
227,1,1,Tumor Site,oropharynx
227,1,1,Metastasis,M0
228,1,1,1st Failure Type,locoregional and distant
228,1,1,Treatment Modality,RT
228,1,1,2nd Failure Type,no known failure
228,1,1,Radiation Dosage,70.2
228,1,1,Tumor Stage,T2
228,1,1,Overall Stage,III
228,1,1,Research lab HPV,HPV unknown
228,1,1,Tumor Site,oropharynx
228,1,1,Occurrence #,1st primary
228,1,1,Metastasis,M0
228,1,1,Nodal Stage,N1
228,1,1,1st Failure Initial Chemotherapy Agent,cis/doce
228,1,1,1st Failure Treatment Modality,CTX
228,1,1,Clinical lab p16,p16 unkown
228,1,1,Research lab p16,p16 negative
229,1,1,Tumor Site,oropharynx
229,1,1,Research lab p16,p16 unknown
229,1,1,Research lab HPV,HPV unknown
229,1,1,2nd Failure Type,no known failure
229,1,1,Treatment Modality,RT
229,1,1,Occurrence #,1st primary
229,1,1,Metastasis,M0
229,1,1,Clinical lab p16,p16 unkown
229,1,1,Nodal Stage,N1
229,1,1,Overall Stage,III
229,1,1,1st Failure Type,no known failure
229,1,1,Radiation Dosage,76.8
229,1,1,Tumor Stage,T3
230,1,1,Metastasis,M0
230,1,1,2nd Failure Type,no known failure
230,1,1,1st Failure Type,distant
230,1,1,Treatment Modality,Sx & RT
230,1,1,Tumor Site,oropharynx
230,1,1,Tumor Stage,T2
230,1,1,Nodal Stage,N2
230,1,1,Radiation Dosage,70.2
230,1,1,Overall Stage,IVa
230,1,1,Clinical lab p16,p16 unkown
230,1,1,Research lab HPV,HPV unknown
230,1,1,Research lab p16,p16 unknown
230,1,1,Occurrence #,1st primary
231,1,1,Research lab HPV,HPV negative
231,1,1,Radiation Dosage,70.2
231,1,1,Metastasis,M0
231,1,1,Clinical lab p16,p16 unkown
231,1,1,2nd Failure Type,no known failure
231,1,1,Overall Stage,III
231,1,1,1st Failure Type,no known failure
231,1,1,Tumor Stage,T3
231,1,1,Tumor Site,oropharynx
231,1,1,Occurrence #,1st primary
231,1,1,Nodal Stage,N0
231,1,1,Treatment Modality,CTX-RT
231,1,1,Initial Chemotherapy Agent,unknown
231,1,1,Research lab p16,p16 negative
232,1,1,2nd Failure Type,no known failure
232,1,1,Occurrence #,1st primary
232,1,1,Treatment Modality,CTX-RT
232,1,1,Research lab HPV,HPV negative
232,1,1,Clinical lab p16,p16 unkown
232,1,1,1st Failure Type,locoregional
232,1,1,Tumor Site,oropharynx
232,1,1,Overall Stage,IVb
232,1,1,Research lab p16,p16 negative
232,1,1,Radiation Dosage,70.2
232,1,1,Metastasis,M0
232,1,1,Tumor Stage,T3
232,1,1,Nodal Stage,N3
232,1,1,Second Line Chemotherapy Agent,carb
232,1,1,Initial Chemotherapy Agent,cis/doce
233,1,1,Tumor Stage,Unknown
233,1,1,Research lab HPV,HPV unknown
233,1,1,Clinical lab p16,p16 unkown
233,1,1,1st Failure Type,no known failure
233,1,1,Metastasis,Unknown
233,1,1,2nd Failure Type,no known failure
233,1,1,Nodal Stage,Unknown
233,1,1,Occurrence #,1st primary
233,1,1,Treatment Modality,Unknown
233,1,1,Tumor Site,oropharynx
233,1,1,Overall Stage,Unknown
233,1,1,Research lab p16,p16 unknown
234,1,1,Research lab HPV,HPV unknown
234,1,1,Research lab p16,p16 unknown
234,1,1,Overall Stage,III
234,1,1,Metastasis,M0
234,1,1,1st Failure Type,locoregional
234,1,1,Occurrence #,1st primary
234,1,1,Tumor Site,oropharynx
234,1,1,Tumor Stage,T3
234,1,1,Treatment Modality,CTX-RT
234,1,1,Radiation Dosage,70.2
234,1,1,Initial Chemotherapy Agent,carbo/doce
234,1,1,Nodal Stage,N1
234,1,1,Clinical lab p16,p16 unkown
234,1,1,2nd Failure Type,no known failure
235,1,1,Nodal Stage,N3
235,1,1,2nd Failure Type,no known failure
235,1,1,Initial Chemotherapy Agent,carbo/doce
235,1,1,Research lab HPV,HPV unknown
235,1,1,Research lab p16,p16 unknown
235,1,1,Tumor Site,oropharynx
235,1,1,Treatment Modality,Sx & CTX-RT
235,1,1,Occurrence #,1st primary
235,1,1,Radiation Dosage,70.2
235,1,1,1st Failure Type,no known failure
235,1,1,Clinical lab p16,p16 unkown
235,1,1,Tumor Stage,T2
235,1,1,Overall Stage,IVb
235,1,1,Metastasis,M0
236,1,1,Research lab HPV,HPV unknown
236,1,1,Tumor Stage,T3
236,1,1,Research lab p16,p16 unknown
236,1,1,1st Failure Type,no known failure
236,1,1,Initial Chemotherapy Agent,carbo/doce
236,1,1,Tumor Site,oropharynx
236,1,1,Radiation Dosage,72
236,1,1,Nodal Stage,N2
236,1,1,Treatment Modality,CTX-RT
236,1,1,Clinical lab p16,p16 unkown
236,1,1,2nd Failure Type,no known failure
236,1,1,Metastasis,M0
236,1,1,Occurrence #,1st primary
236,1,1,Overall Stage,IVa
237,1,1,Tumor Site,oropharynx
237,1,1,Treatment Modality,Unknown
237,1,1,1st Failure Type,no known failure
237,1,1,Research lab HPV,HPV positive
237,1,1,Research lab p16,p16 positive
237,1,1,Tumor Stage,T3
237,1,1,Nodal Stage,N0
237,1,1,Occurrence #,recurrence
237,1,1,Overall Stage,III
237,1,1,Metastasis,M0
237,1,1,2nd Failure Type,no known failure
237,1,1,Clinical lab p16,p16 unkown
238,1,1,Tumor Stage,T4a
238,1,1,Metastasis,M0
238,1,1,Occurrence #,1st primary
238,1,1,Treatment Modality,Sx & RT
238,1,1,Nodal Stage,N0
238,1,1,1st Failure Site,oropharynx
238,1,1,Clinical lab p16,p16 unkown
238,1,1,2nd Failure Type,no known failure
238,1,1,Overall Stage,IVa
238,1,1,Radiation Dosage,76.8
238,1,1,Research lab p16,p16 negative
238,1,1,Tumor Site,oropharynx
238,1,1,Research lab HPV,HPV negative
238,1,1,1st Failure Type,locoregional
239,1,1,Nodal Stage,N3
239,1,1,Tumor Site,oropharynx
239,1,1,Research lab p16,p16 negative
239,1,1,Radiation Dosage,70.2
239,1,1,Overall Stage,IVb
239,1,1,Clinical lab p16,p16 unkown
239,1,1,2nd Failure Type,no known failure
239,1,1,Metastasis,M0
239,1,1,1st Failure Type,locoregional
239,1,1,Treatment Modality,CTX-RT
239,1,1,Research lab HPV,HPV negative
239,1,1,Tumor Stage,T4a
239,1,1,Occurrence #,1st primary
239,1,1,Initial Chemotherapy Agent,carbo
240,1,1,Overall Stage,IVa
240,1,1,Clinical lab p16,p16 unkown
240,1,1,1st Failure Type,no known failure
240,1,1,Initial Chemotherapy Agent,unknown
240,1,1,Metastasis,M0
240,1,1,Nodal Stage,N2
240,1,1,Tumor Stage,T2
240,1,1,Research lab HPV,HPV positive
240,1,1,2nd Failure Type,no known failure
240,1,1,Radiation Dosage,76.8
240,1,1,Treatment Modality,CTX-RT
240,1,1,Research lab p16,p16 positive
240,1,1,Tumor Site,oropharynx
240,1,1,Occurrence #,1st primary
241,1,1,Research lab HPV,HPV unknown
241,1,1,Tumor Stage,T3
241,1,1,Nodal Stage,N2
241,1,1,Research lab p16,p16 unknown
241,1,1,Initial Chemotherapy Agent,carbo/doce/5-FU
241,1,1,Metastasis,M0
241,1,1,Treatment Modality,CTX-RT
241,1,1,Occurrence #,1st primary
241,1,1,Tumor Site,oropharynx
241,1,1,Overall Stage,IVa
241,1,1,1st Failure Type,no known failure
241,1,1,2nd Failure Type,no known failure
241,1,1,Radiation Dosage,70.2
241,1,1,Clinical lab p16,p16 unkown
242,1,1,Occurrence #,1st primary
242,1,1,Treatment Modality,CTX-RT
242,1,1,Nodal Stage,N2
242,1,1,Tumor Stage,T1
242,1,1,2nd Failure Type,no known failure
242,1,1,Research lab HPV,HPV unknown
242,1,1,Initial Chemotherapy Agent,carbo/doce
242,1,1,Radiation Dosage,70.2
242,1,1,Overall Stage,IVa
242,1,1,Clinical lab p16,p16 unkown
242,1,1,Research lab p16,p16 unknown
242,1,1,Metastasis,M0
242,1,1,Tumor Site,oropharynx
242,1,1,1st Failure Type,no known failure
243,1,1,1st Failure Type,no known failure
243,1,1,Tumor Site,oral cavity
243,1,1,Research lab HPV,HPV unknown
243,1,1,Metastasis,M0
243,1,1,2nd Failure Type,no known failure
243,1,1,Overall Stage,IVa
243,1,1,Research lab p16,p16 unknown
243,1,1,Tumor Stage,T4a
243,1,1,Occurrence #,1st primary
243,1,1,Treatment Modality,Sx
243,1,1,Nodal Stage,N1
243,1,1,Clinical lab p16,p16 unkown
244,1,1,Tumor Site,oropharynx
244,1,1,Research lab p16,p16 positive
244,1,1,Occurrence #,1st primary
244,1,1,Radiation Dosage,70.2
244,1,1,Overall Stage,IVa
244,1,1,1st Failure Type,no known failure
244,1,1,Metastasis,M0
244,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
244,1,1,2nd Failure Type,no known failure
244,1,1,Nodal Stage,N2
244,1,1,Tumor Stage,T2
244,1,1,Treatment Modality,CTX-RT
244,1,1,Clinical lab p16,p16 unkown
244,1,1,Research lab HPV,HPV positive
245,1,1,Overall Stage,Unknown
245,1,1,Clinical lab p16,p16 unkown
245,1,1,1st Failure Type,no known failure
245,1,1,Tumor Site,Unknown
245,1,1,Research lab p16,p16 unknown
245,1,1,Research lab HPV,HPV unknown
245,1,1,2nd Failure Type,no known failure
245,1,1,Nodal Stage,Unknown
245,1,1,Treatment Modality,Unknown
245,1,1,Occurrence #,1st primary
245,1,1,Metastasis,Unknown
245,1,1,Tumor Stage,Unknown
246,1,1,Research lab HPV,HPV unknown
246,1,1,Clinical lab p16,p16 unkown
246,1,1,1st Failure Type,no known failure
246,1,1,Tumor Stage,T4a
246,1,1,Research lab p16,p16 unknown
246,1,1,Occurrence #,1st primary
246,1,1,Overall Stage,IVa
246,1,1,Nodal Stage,N2
246,1,1,Initial Chemotherapy Agent,carbo/doce
246,1,1,Treatment Modality,CTX-RT
246,1,1,Metastasis,M0
246,1,1,2nd Failure Type,no known failure
246,1,1,Tumor Site,oropharynx
246,1,1,Radiation Dosage,70.2
247,1,1,Radiation Dosage,70.2
247,1,1,Nodal Stage,N2
247,1,1,Initial Chemotherapy Agent,PTX
247,1,1,Metastasis,M0
247,1,1,2nd Failure Type,no known failure
247,1,1,Tumor Stage,T4a
247,1,1,Clinical lab p16,p16 unkown
247,1,1,Treatment Modality,CTX-RT
247,1,1,Tumor Site,oropharynx
247,1,1,1st Failure Type,locoregional
247,1,1,Research lab p16,p16 negative
247,1,1,Overall Stage,IVa
247,1,1,Occurrence #,1st primary
247,1,1,Research lab HPV,HPV negative
248,1,1,Treatment Modality,Sx & RT
248,1,1,Research lab HPV,HPV positive
248,1,1,Tumor Stage,T1
248,1,1,Metastasis,M0
248,1,1,Occurrence #,1st primary
248,1,1,Radiation Dosage,unknown
248,1,1,Nodal Stage,N2
248,1,1,Tumor Site,oropharynx
248,1,1,Clinical lab p16,p16 unkown
248,1,1,1st Failure Type,no known failure
248,1,1,Research lab p16,p16 positive
248,1,1,Overall Stage,IVa
248,1,1,2nd Failure Type,no known failure
249,1,1,Nodal Stage,N3
249,1,1,Occurrence #,1st primary
249,1,1,Radiation Dosage,70.2
249,1,1,2nd Failure Type,no known failure
249,1,1,Tumor Stage,T4b
249,1,1,Tumor Site,oropharynx
249,1,1,Research lab p16,p16 unknown
249,1,1,1st Failure Type,no known failure
249,1,1,Overall Stage,IVb
249,1,1,Initial Chemotherapy Agent,carbo/doce
249,1,1,Clinical lab p16,p16 unkown
249,1,1,Metastasis,M0
249,1,1,Research lab HPV,HPV unknown
249,1,1,Treatment Modality,CTX-RT
250,1,1,Metastasis,M0
250,1,1,Clinical lab p16,p16 unkown
250,1,1,1st Failure Type,no known failure
250,1,1,Overall Stage,IVa
250,1,1,Treatment Modality,CTX-RT
250,1,1,Tumor Stage,T2
250,1,1,Occurrence #,1st primary
250,1,1,Radiation Dosage,70.2
250,1,1,Nodal Stage,N2
250,1,1,Research lab HPV,HPV positive
250,1,1,2nd Failure Type,no known failure
250,1,1,Research lab p16,p16 positive
250,1,1,Initial Chemotherapy Agent,PTX/cap
250,1,1,Tumor Site,oropharynx
251,1,1,Research lab p16,p16 negative
251,1,1,Metastasis,M0
251,1,1,2nd Failure Type,no known failure
251,1,1,Clinical lab p16,p16 unkown
251,1,1,1st Failure Type,distant
251,1,1,Radiation Dosage,61.2
251,1,1,Overall Stage,IVa
251,1,1,Tumor Site,oropharynx
251,1,1,Tumor Stage,T4a
251,1,1,Occurrence #,1st primary
251,1,1,Research lab HPV,HPV negative
251,1,1,1st Failure Treatment Modality,CTX
251,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
251,1,1,Nodal Stage,N1
251,1,1,Treatment Modality,Sx & RT
252,1,1,Nodal Stage,N2
252,1,1,Research lab p16,p16 negative
252,1,1,Occurrence #,1st primary
252,1,1,Overall Stage,IVa
252,1,1,Research lab HPV,HPV negative
252,1,1,Initial Chemotherapy Agent,carbo/PTX
252,1,1,Tumor Site,oropharynx
252,1,1,2nd Failure Type,no known failure
252,1,1,Radiation Dosage,70.2
252,1,1,Treatment Modality,CTX-RT
252,1,1,1st Failure Type,locoregional and distant
252,1,1,Tumor Stage,T4a
252,1,1,Clinical lab p16,p16 unkown
252,1,1,Metastasis,M0
253,1,1,1st Failure Site,oropharynx
253,1,1,1st Failure Treatment Modality,Sx
253,1,1,2nd Failure Type,no known failure
253,1,1,Initial Chemotherapy Agent,unknown
253,1,1,Nodal Stage,N2
253,1,1,Occurrence #,1st primary
253,1,1,Research lab HPV,HPV unknown
253,1,1,Tumor Stage,T3
253,1,1,Treatment Modality,CTX-RT
253,1,1,Tumor Site,oropharynx
253,1,1,Metastasis,M0
253,1,1,Overall Stage,IVa
253,1,1,1st Failure Type,locoregional
253,1,1,Clinical lab p16,p16 unkown
253,1,1,Research lab p16,p16 unknown
253,1,1,Radiation Dosage,unknown
254,1,1,Metastasis,M0
254,1,1,Research lab HPV,HPV unknown
254,1,1,Research lab p16,p16 unknown
254,1,1,1st Failure Site,oropharynx
254,1,1,1st Failure Type,locoregional
254,1,1,Radiation Dosage,68.4
254,1,1,Treatment Modality,RT
254,1,1,2nd Failure Type,no known failure
254,1,1,Occurrence #,1st primary
254,1,1,Nodal Stage,N0
254,1,1,Clinical lab p16,p16 unkown
254,1,1,Overall Stage,II
254,1,1,Tumor Site,oropharynx
254,1,1,Tumor Stage,T2
255,1,1,Treatment Modality,Sx
255,1,1,Tumor Site,oropharynx
255,1,1,Metastasis,M0
255,1,1,Research lab HPV,HPV unknown
255,1,1,Occurrence #,other primary
255,1,1,1st Failure Type,no known failure
255,1,1,2nd Failure Type,no known failure
255,1,1,Overall Stage,I
255,1,1,Research lab p16,p16 unknown
255,1,1,Tumor Stage,T1
255,1,1,Nodal Stage,N0
255,1,1,Clinical lab p16,p16 unkown
256,1,1,Clinical lab p16,p16 unkown
256,1,1,1st Failure Type,no known failure
256,1,1,Treatment Modality,Unknown
256,1,1,Tumor Site,oropharynx
256,1,1,Metastasis,Unknown
256,1,1,Occurrence #,1st primary
256,1,1,Tumor Stage,Unknown
256,1,1,Research lab p16,p16 unknown
256,1,1,2nd Failure Type,no known failure
256,1,1,Research lab HPV,HPV unknown
256,1,1,Nodal Stage,Unknown
256,1,1,Overall Stage,Unknown
257,1,1,Tumor Stage,T2
257,1,1,Nodal Stage,N0
257,1,1,Research lab HPV,HPV negative
257,1,1,1st Failure Type,no known failure
257,1,1,Research lab p16,p16 negative
257,1,1,Treatment Modality,RT
257,1,1,Radiation Dosage,72
257,1,1,Metastasis,M0
257,1,1,Clinical lab p16,p16 unkown
257,1,1,Occurrence #,1st primary
257,1,1,Overall Stage,II
257,1,1,Tumor Site,oropharynx
257,1,1,2nd Failure Type,no known failure
258,1,1,Treatment Modality,Sx & RT
258,1,1,Nodal Stage,N2
258,1,1,1st Failure Treatment Modality,Sx
258,1,1,1st Failure Site,oropharynx
258,1,1,2nd Failure Type,no known failure
258,1,1,Overall Stage,IVa
258,1,1,Occurrence #,1st primary
258,1,1,Clinical lab p16,p16 unkown
258,1,1,Research lab HPV,HPV positive
258,1,1,Research lab p16,p16 positive
258,1,1,Tumor Site,oropharynx
258,1,1,Metastasis,M0
258,1,1,Tumor Stage,T1
258,1,1,Radiation Dosage,66.6
258,1,1,1st Failure Type,locoregional
259,1,1,2nd Failure Type,no known failure
259,1,1,Nodal Stage,N0
259,1,1,Tumor Site,oropharynx
259,1,1,Research lab p16,p16 negative
259,1,1,Overall Stage,III
259,1,1,Treatment Modality,RT
259,1,1,Tumor Stage,T3
259,1,1,Research lab HPV,HPV negative
259,1,1,Radiation Dosage,72
259,1,1,Clinical lab p16,p16 unkown
259,1,1,Metastasis,M0
259,1,1,Occurrence #,1st primary
259,1,1,1st Failure Type,no known failure
260,1,1,Overall Stage,III
260,1,1,2nd Failure Type,no known failure
260,1,1,Tumor Site,oropharynx
260,1,1,Research lab p16,p16 positive
260,1,1,Initial Chemotherapy Agent,carbo/doce
260,1,1,Occurrence #,1st primary
260,1,1,Clinical lab p16,p16 unkown
260,1,1,1st Failure Treatment Modality,Sx
260,1,1,1st Failure Type,locoregional
260,1,1,1st Failure Site,oropharynx
260,1,1,Metastasis,M0
260,1,1,Radiation Dosage,70.2
260,1,1,Tumor Stage,T3
260,1,1,Research lab HPV,HPV unknown
260,1,1,Nodal Stage,N1
260,1,1,Treatment Modality,CTX-RT
261,1,1,Metastasis,M0
261,1,1,Tumor Stage,T1
261,1,1,Treatment Modality,Sx & CTX-RT
261,1,1,Clinical lab p16,p16 unkown
261,1,1,Nodal Stage,N3
261,1,1,2nd Failure Type,no known failure
261,1,1,Overall Stage,IVb
261,1,1,Occurrence #,1st primary
261,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
261,1,1,Radiation Dosage,70.2
261,1,1,Tumor Site,oropharynx
261,1,1,Research lab HPV,HPV unknown
261,1,1,1st Failure Type,no known failure
261,1,1,Research lab p16,p16 unknown
262,1,1,1st Failure Site,oropharynx
262,1,1,1st Failure Treatment Modality,CTX-RT
262,1,1,1st Failure Radiation Dosage,unk
262,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
262,1,1,1st Failure Type,locoregional and distant
262,1,1,2nd Failure Type,no known failure
262,1,1,Overall Stage,IVa
262,1,1,Tumor Site,oropharynx
262,1,1,Initial Chemotherapy Agent,carbo/doce
262,1,1,Treatment Modality,CTX-RT
262,1,1,Research lab HPV,HPV negative
262,1,1,Nodal Stage,N2
262,1,1,Radiation Dosage,unknown
262,1,1,Tumor Stage,T3
262,1,1,Clinical lab p16,p16 unkown
262,1,1,Metastasis,M0
262,1,1,Occurrence #,1st primary
262,1,1,Research lab p16,p16 negative
263,1,1,Tumor Stage,T4a
263,1,1,Clinical lab p16,p16 unkown
263,1,1,Overall Stage,IVc
263,1,1,Initial Chemotherapy Agent,cis
263,1,1,Research lab HPV,HPV unknown
263,1,1,Treatment Modality,CTX-RT
263,1,1,Radiation Dosage,50
263,1,1,1st Failure Type,locoregional and distant
263,1,1,Nodal Stage,N2
263,1,1,Occurrence #,1st primary
263,1,1,Metastasis,M1
263,1,1,Research lab p16,p16 unknown
263,1,1,2nd Failure Type,no known failure
263,1,1,Tumor Site,oropharynx
264,1,1,Metastasis,M0
264,1,1,Clinical lab p16,p16 unkown
264,1,1,2nd Failure Type,no known failure
264,1,1,Initial Chemotherapy Agent,unknown
264,1,1,Research lab HPV,HPV unknown
264,1,1,Nodal Stage,N2
264,1,1,Treatment Modality,CTX-RT
264,1,1,Tumor Stage,T4b
264,1,1,Overall Stage,IVb
264,1,1,Radiation Dosage,45
264,1,1,Research lab p16,p16 unknown
264,1,1,1st Failure Type,locoregional and distant
264,1,1,Occurrence #,1st primary
264,1,1,Tumor Site,oropharynx
265,1,1,Treatment Modality,Unknown
265,1,1,Tumor Stage,T2
265,1,1,Occurrence #,1st primary
265,1,1,Clinical lab p16,p16 unkown
265,1,1,Overall Stage,III
265,1,1,Metastasis,M0
265,1,1,Tumor Site,oropharynx
265,1,1,Research lab HPV,HPV positive
265,1,1,Research lab p16,p16 positive
265,1,1,Nodal Stage,N2
265,1,1,1st Failure Type,no known failure
265,1,1,2nd Failure Type,no known failure
266,1,1,Tumor Stage,T4a
266,1,1,Research lab p16,p16 negative
266,1,1,Research lab HPV,HPV negative
266,1,1,Occurrence #,1st primary
266,1,1,Metastasis,M0
266,1,1,Tumor Site,oropharynx
266,1,1,1st Failure Treatment Modality,CTX-RT
266,1,1,Clinical lab p16,p16 unkown
266,1,1,Overall Stage,IVa
266,1,1,1st Failure Site,oropharynx
266,1,1,Treatment Modality,CTX-RT
266,1,1,2nd Failure Type,no known failure
266,1,1,1st Failure Radiation Dosage,67.3
266,1,1,Radiation Dosage,70.2
266,1,1,1st Failure Type,locoregional
266,1,1,Initial Chemotherapy Agent,carbo/doce
266,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
266,1,1,Nodal Stage,N2
267,1,1,Overall Stage,IVa
267,1,1,Radiation Dosage,70.2
267,1,1,Occurrence #,1st primary
267,1,1,2nd Failure Type,no known failure
267,1,1,Research lab p16,p16 unknown
267,1,1,1st Failure Type,no known failure
267,1,1,Tumor Stage,T1
267,1,1,Clinical lab p16,p16 unkown
267,1,1,Tumor Site,oropharynx
267,1,1,Initial Chemotherapy Agent,cis/carbo
267,1,1,Treatment Modality,Sx & CTX-RT
267,1,1,Metastasis,M0
267,1,1,Research lab HPV,HPV unknown
267,1,1,Nodal Stage,N2
268,1,1,1st Failure Type,no known failure
268,1,1,Initial Chemotherapy Agent,carbo/doce
268,1,1,Nodal Stage,N2
268,1,1,Radiation Dosage,70.2
268,1,1,Research lab HPV,HPV unknown
268,1,1,Treatment Modality,CTX-RT
268,1,1,2nd Failure Type,no known failure
268,1,1,Clinical lab p16,p16 unkown
268,1,1,Tumor Site,oropharynx
268,1,1,Tumor Stage,T2
268,1,1,Research lab p16,p16 unknown
268,1,1,Overall Stage,IVa
268,1,1,Occurrence #,1st primary
268,1,1,Metastasis,M0
269,1,1,Nodal Stage,N2
269,1,1,Radiation Dosage,64.5
269,1,1,Initial Chemotherapy Agent,carbo/PTX
269,1,1,Treatment Modality,CTX-RT
269,1,1,Tumor Site,oropharynx
269,1,1,Clinical lab p16,p16 unkown
269,1,1,Tumor Stage,T4a
269,1,1,Overall Stage,IVa
269,1,1,Metastasis,M0
269,1,1,Research lab HPV,HPV negative
269,1,1,1st Failure Type,locoregional
269,1,1,Occurrence #,1st primary
269,1,1,1st Failure Site,oropharynx
269,1,1,2nd Failure Type,no known failure
269,1,1,Research lab p16,p16 negative
270,1,1,Research lab p16,p16 unknown
270,1,1,Treatment Modality,Unknown
270,1,1,1st Failure Type,no known failure
270,1,1,Metastasis,Unknown
270,1,1,Nodal Stage,Unknown
270,1,1,Occurrence #,1st primary
270,1,1,Overall Stage,Unknown
270,1,1,Tumor Stage,Unknown
270,1,1,Clinical lab p16,p16 unkown
270,1,1,2nd Failure Type,no known failure
270,1,1,Tumor Site,Unknown
270,1,1,Research lab HPV,HPV unknown
271,1,1,Initial Chemotherapy Agent,cis
271,1,1,1st Failure Type,no known failure
271,1,1,Research lab p16,p16 positive
271,1,1,Treatment Modality,CTX-RT
271,1,1,Occurrence #,1st primary
271,1,1,Clinical lab p16,p16 unkown
271,1,1,Tumor Stage,T2
271,1,1,Nodal Stage,N2
271,1,1,Research lab HPV,HPV positive
271,1,1,Overall Stage,IVa
271,1,1,2nd Failure Type,no known failure
271,1,1,Tumor Site,oropharynx
271,1,1,Metastasis,M0
271,1,1,Radiation Dosage,72
272,1,1,Treatment Modality,Unknown
272,1,1,Clinical lab p16,p16 unkown
272,1,1,Overall Stage,Unknown
272,1,1,Tumor Stage,Unknown
272,1,1,1st Failure Type,no known failure
272,1,1,Metastasis,Unknown
272,1,1,Tumor Site,oropharynx
272,1,1,Nodal Stage,Unknown
272,1,1,Research lab HPV,HPV unknown
272,1,1,Occurrence #,1st primary
272,1,1,Research lab p16,p16 unknown
272,1,1,2nd Failure Type,no known failure
273,1,1,1st Failure Type,no known failure
273,1,1,Clinical lab p16,p16 unkown
273,1,1,Occurrence #,1st primary
273,1,1,Research lab HPV,HPV unknown
273,1,1,Research lab p16,p16 unknown
273,1,1,Metastasis,M0
273,1,1,Tumor Stage,T4a
273,1,1,Nodal Stage,N0
273,1,1,2nd Failure Type,no known failure
273,1,1,Tumor Site,oropharynx
273,1,1,Overall Stage,IVa
273,1,1,Treatment Modality,Sx
274,1,1,Metastasis,M0
274,1,1,Research lab HPV,HPV positive
274,1,1,Overall Stage,IVa
274,1,1,Tumor Site,oropharynx
274,1,1,1st Failure Type,no known failure
274,1,1,Radiation Dosage,53
274,1,1,Occurrence #,1st primary
274,1,1,Nodal Stage,N1
274,1,1,Research lab p16,p16 positive
274,1,1,2nd Failure Type,no known failure
274,1,1,Tumor Stage,T4a
274,1,1,Treatment Modality,Sx & RT
274,1,1,Clinical lab p16,p16 unkown
275,1,1,Tumor Stage,T3
275,1,1,Tumor Site,oropharynx
275,1,1,Research lab p16,p16 negative
275,1,1,Initial Chemotherapy Agent,PTX/carbo
275,1,1,Overall Stage,IVa
275,1,1,Nodal Stage,N2
275,1,1,Research lab HPV,HPV negative
275,1,1,Treatment Modality,CTX-RT
275,1,1,2nd Failure Type,no known failure
275,1,1,Radiation Dosage,12.6
275,1,1,Clinical lab p16,p16 unkown
275,1,1,Occurrence #,1st primary
275,1,1,Metastasis,M0
275,1,1,1st Failure Type,no known failure
276,1,1,1st Failure Type,no known failure
276,1,1,Overall Stage,IVa
276,1,1,Research lab HPV,HPV negative
276,1,1,Occurrence #,1st primary
276,1,1,Tumor Stage,T4a
276,1,1,Nodal Stage,N2
276,1,1,Radiation Dosage,91
276,1,1,Treatment Modality,RT
276,1,1,2nd Failure Type,no known failure
276,1,1,Research lab p16,p16 negative
276,1,1,Metastasis,M0
276,1,1,Tumor Site,oropharynx
276,1,1,Clinical lab p16,p16 unkown
277,1,1,Tumor Stage,T4a
277,1,1,2nd Failure Type,no known failure
277,1,1,1st Failure Treatment Modality,Sx
277,1,1,Clinical lab p16,p16 unkown
277,1,1,Tumor Site,oropharynx
277,1,1,Research lab p16,p16 unknown
277,1,1,Treatment Modality,CTX-RT
277,1,1,1st Failure Site,oropharynx
277,1,1,Nodal Stage,N2
277,1,1,Overall Stage,IVa
277,1,1,Initial Chemotherapy Agent,unknown
277,1,1,Metastasis,M0
277,1,1,1st Failure Type,locoregional
277,1,1,Radiation Dosage,unknown
277,1,1,Research lab HPV,HPV unknown
277,1,1,Occurrence #,1st primary
278,1,1,Nodal Stage,N2
278,1,1,Clinical lab p16,p16 unkown
278,1,1,Initial Chemotherapy Agent,carbo/doce
278,1,1,Radiation Dosage,70.2
278,1,1,1st Failure Type,no known failure
278,1,1,2nd Failure Type,no known failure
278,1,1,Research lab HPV,HPV unknown
278,1,1,Overall Stage,IVa
278,1,1,Tumor Site,oropharynx
278,1,1,Occurrence #,Unknown
278,1,1,Metastasis,M0
278,1,1,Research lab p16,p16 unknown
278,1,1,Treatment Modality,CTX-RT
278,1,1,Tumor Stage,T2
279,1,1,Overall Stage,II
279,1,1,Metastasis,M0
279,1,1,2nd Failure Type,no known failure
279,1,1,Research lab p16,p16 negative
279,1,1,1st Failure Type,no known failure
279,1,1,Tumor Stage,T2
279,1,1,Nodal Stage,N0
279,1,1,Treatment Modality,RT
279,1,1,Research lab HPV,HPV unknown
279,1,1,Tumor Site,oropharynx
279,1,1,Clinical lab p16,p16 unkown
279,1,1,Radiation Dosage,58
279,1,1,Occurrence #,1st primary
280,1,1,Research lab HPV,HPV unknown
280,1,1,Tumor Stage,Unknown
280,1,1,Occurrence #,1st primary
280,1,1,Metastasis,Unknown
280,1,1,Research lab p16,p16 unknown
280,1,1,1st Failure Type,no known failure
280,1,1,Overall Stage,Unknown
280,1,1,2nd Failure Type,no known failure
280,1,1,Clinical lab p16,p16 unkown
280,1,1,Treatment Modality,Unknown
280,1,1,Tumor Site,oropharynx
280,1,1,Nodal Stage,Unknown
281,1,1,2nd Failure Type,no known failure
281,1,1,Occurrence #,1st primary
281,1,1,Tumor Stage,T2
281,1,1,Treatment Modality,Sx
281,1,1,Metastasis,M0
281,1,1,Nodal Stage,N1
281,1,1,Clinical lab p16,p16 unkown
281,1,1,Tumor Site,oropharynx
281,1,1,Research lab HPV,HPV negative
281,1,1,Overall Stage,III
281,1,1,1st Failure Type,no known failure
281,1,1,Research lab p16,p16 negative
282,1,1,Occurrence #,1st primary
282,1,1,1st Failure Type,no known failure
282,1,1,Research lab HPV,HPV unknown
282,1,1,Treatment Modality,CTX-RT
282,1,1,Initial Chemotherapy Agent,cap/doce
282,1,1,Overall Stage,IVa
282,1,1,Radiation Dosage,70.2
282,1,1,Clinical lab p16,p16 unkown
282,1,1,Metastasis,M0
282,1,1,2nd Failure Type,no known failure
282,1,1,Nodal Stage,N2
282,1,1,Tumor Site,oropharynx
282,1,1,Tumor Stage,T4b
282,1,1,Research lab p16,p16 unknown
283,1,1,Research lab HPV,HPV unknown
283,1,1,Clinical lab p16,p16 unkown
283,1,1,Tumor Stage,T3
283,1,1,1st Failure Type,no known failure
283,1,1,Metastasis,M0
283,1,1,Occurrence #,Unknown
283,1,1,Research lab p16,p16 unknown
283,1,1,Treatment Modality,CTX-RT
283,1,1,Radiation Dosage,70.2
283,1,1,Nodal Stage,N1
283,1,1,Initial Chemotherapy Agent,carbo/doce
283,1,1,Tumor Site,oropharynx
283,1,1,Overall Stage,III
283,1,1,2nd Failure Type,no known failure
284,1,1,2nd Failure Type,no known failure
284,1,1,Research lab p16,p16 unknown
284,1,1,1st Failure Type,locoregional
284,1,1,Research lab HPV,HPV unknown
284,1,1,Tumor Stage,T4a
284,1,1,Nodal Stage,N2
284,1,1,Initial Chemotherapy Agent,carbo/doce
284,1,1,Treatment Modality,CTX-RT
284,1,1,Radiation Dosage,70.2
284,1,1,Metastasis,M0
284,1,1,Tumor Site,oropharynx
284,1,1,Clinical lab p16,p16 unkown
284,1,1,Occurrence #,Unknown
284,1,1,Overall Stage,IVa
285,1,1,Research lab HPV,HPV unknown
285,1,1,Clinical lab p16,p16 unkown
285,1,1,Tumor Stage,Unknown
285,1,1,Overall Stage,Unknown
285,1,1,Tumor Site,oropharynx
285,1,1,Metastasis,Unknown
285,1,1,Treatment Modality,Unknown
285,1,1,Nodal Stage,Unknown
285,1,1,1st Failure Type,no known failure
285,1,1,Occurrence #,1st primary
285,1,1,2nd Failure Type,no known failure
285,1,1,Research lab p16,p16 unknown
286,1,1,Overall Stage,IVa
286,1,1,Tumor Site,oropharynx
286,1,1,Metastasis,M0
286,1,1,2nd Failure Type,no known failure
286,1,1,Nodal Stage,N2
286,1,1,Clinical lab p16,p16 unkown
286,1,1,Treatment Modality,CTX-RT
286,1,1,Radiation Dosage,70.2
286,1,1,Initial Chemotherapy Agent,carbo/doce
286,1,1,Occurrence #,other primary
286,1,1,Research lab p16,p16 unknown
286,1,1,Tumor Stage,T2
286,1,1,Research lab HPV,HPV unknown
286,1,1,1st Failure Type,locoregional
287,1,1,Research lab HPV,HPV unknown
287,1,1,Tumor Site,oropharynx
287,1,1,Clinical lab p16,p16 unkown
287,1,1,Initial Chemotherapy Agent,unk
287,1,1,Overall Stage,III
287,1,1,2nd Failure Type,no known failure
287,1,1,Nodal Stage,N0
287,1,1,Radiation Dosage,unk
287,1,1,Treatment Modality,CTX-RT
287,1,1,1st Failure Type,no known failure
287,1,1,Occurrence #,1st primary
287,1,1,Metastasis,M0
287,1,1,Research lab p16,p16 unknown
287,1,1,Tumor Stage,T3
288,1,1,Treatment Modality,CTX-RT
288,1,1,Tumor Site,oropharynx
288,1,1,Overall Stage,III
288,1,1,Nodal Stage,N0
288,1,1,Research lab HPV,HPV negative
288,1,1,Clinical lab p16,p16 unkown
288,1,1,Initial Chemotherapy Agent,cis
288,1,1,Research lab p16,p16 negative
288,1,1,1st Failure Type,no known failure
288,1,1,Metastasis,M0
288,1,1,Occurrence #,1st primary
288,1,1,Tumor Stage,T3
288,1,1,Radiation Dosage,70.2
288,1,1,2nd Failure Type,no known failure
289,1,1,Overall Stage,Unknown
289,1,1,Treatment Modality,Unknown
289,1,1,Research lab p16,p16 unknown
289,1,1,1st Failure Type,no known failure
289,1,1,Nodal Stage,Unknown
289,1,1,2nd Failure Type,no known failure
289,1,1,Research lab HPV,HPV unknown
289,1,1,Tumor Site,Unknown
289,1,1,Occurrence #,1st primary
289,1,1,Metastasis,Unknown
289,1,1,Clinical lab p16,p16 unkown
289,1,1,Tumor Stage,Unknown
290,1,1,Research lab p16,p16 unknown
290,1,1,Metastasis,Unknown
290,1,1,Nodal Stage,Unknown
290,1,1,Tumor Site,oropharynx
290,1,1,Research lab HPV,HPV unknown
290,1,1,1st Failure Type,no known failure
290,1,1,Occurrence #,1st primary
290,1,1,Overall Stage,Unknown
290,1,1,Tumor Stage,Unknown
290,1,1,Treatment Modality,Unknown
290,1,1,Clinical lab p16,p16 unkown
290,1,1,2nd Failure Type,no known failure
291,1,1,Research lab p16,p16 unknown
291,1,1,Treatment Modality,Unknown
291,1,1,2nd Failure Type,no known failure
291,1,1,Occurrence #,1st primary
291,1,1,1st Failure Type,no known failure
291,1,1,Tumor Site,oropharynx
291,1,1,Clinical lab p16,p16 unkown
291,1,1,Nodal Stage,Unknown
291,1,1,Research lab HPV,HPV unknown
291,1,1,Metastasis,Unknown
291,1,1,Overall Stage,Unknown
291,1,1,Tumor Stage,Unknown
292,1,1,Overall Stage,IVa
292,1,1,Nodal Stage,N2
292,1,1,Occurrence #,1st primary
292,1,1,Clinical lab p16,p16 unkown
292,1,1,Tumor Site,oropharynx
292,1,1,Initial Chemotherapy Agent,carbo/PTX
292,1,1,1st Failure Type,no known failure
292,1,1,Radiation Dosage,70.2
292,1,1,Research lab HPV,HPV positive
292,1,1,Metastasis,M0
292,1,1,Research lab p16,p16 positive
292,1,1,Treatment Modality,CTX-RT
292,1,1,Tumor Stage,T2
292,1,1,2nd Failure Type,no known failure
293,1,1,Treatment Modality,CTX
293,1,1,Initial Chemotherapy Agent,5FU/cis
293,1,1,Tumor Site,oropharynx
293,1,1,Research lab p16,p16 negative
293,1,1,Clinical lab p16,p16 unkown
293,1,1,1st Failure Type,no known failure
293,1,1,Research lab HPV,HPV negative
293,1,1,Occurrence #,other primary
293,1,1,Metastasis,M0
293,1,1,2nd Failure Type,no known failure
293,1,1,Tumor Stage,T4a
293,1,1,Nodal Stage,N0
293,1,1,Overall Stage,IVa
294,1,1,1st Failure Type,no known failure
294,1,1,Treatment Modality,CTX-RT
294,1,1,Occurrence #,1st primary
294,1,1,Metastasis,M0
294,1,1,Tumor Site,oropharynx
294,1,1,Research lab HPV,HPV unknown
294,1,1,2nd Failure Type,no known failure
294,1,1,Radiation Dosage,unk
294,1,1,Overall Stage,II
294,1,1,Tumor Stage,T2
294,1,1,Clinical lab p16,p16 unkown
294,1,1,Initial Chemotherapy Agent,unk
294,1,1,Research lab p16,p16 unknown
294,1,1,Nodal Stage,N0
295,1,1,Clinical lab p16,p16 unkown
295,1,1,Occurrence #,1st primary
295,1,1,Overall Stage,III
295,1,1,Radiation Dosage,70.2
295,1,1,Research lab p16,p16 positive
295,1,1,Metastasis,M0
295,1,1,Treatment Modality,RT
295,1,1,Nodal Stage,N0
295,1,1,1st Failure Type,no known failure
295,1,1,2nd Failure Type,no known failure
295,1,1,Tumor Stage,T3
295,1,1,Tumor Site,oropharynx
295,1,1,Research lab HPV,HPV positive
296,1,1,Research lab HPV,HPV negative
296,1,1,Clinical lab p16,p16 unkown
296,1,1,Research lab p16,p16 negative
296,1,1,Overall Stage,Unknown
296,1,1,Tumor Stage,Unknown
296,1,1,Occurrence #,Unknown
296,1,1,Nodal Stage,Unknown
296,1,1,Metastasis,Unknown
296,1,1,2nd Failure Type,no known failure
296,1,1,1st Failure Type,no known failure
296,1,1,Treatment Modality,Unknown
296,1,1,Tumor Site,oropharynx
297,1,1,Nodal Stage,N3
297,1,1,Occurrence #,recurrence
297,1,1,Tumor Stage,T2
297,1,1,Research lab p16,p16 unknown
297,1,1,Clinical lab p16,p16 unkown
297,1,1,Initial Chemotherapy Agent,unknown
297,1,1,1st Failure Type,no known failure
297,1,1,Research lab HPV,HPV unknown
297,1,1,2nd Failure Type,no known failure
297,1,1,Treatment Modality,Sx & CTX-RT
297,1,1,Radiation Dosage,unknown
297,1,1,Overall Stage,IVb
297,1,1,Tumor Site,oropharynx
297,1,1,Metastasis,M0
298,1,1,Overall Stage,III
298,1,1,Research lab p16,p16 unknown
298,1,1,Treatment Modality,CTX-RT
298,1,1,Metastasis,M0
298,1,1,Tumor Stage,T3
298,1,1,Radiation Dosage,70.2
298,1,1,2nd Failure Type,no known failure
298,1,1,Research lab HPV,HPV unknown
298,1,1,1st Failure Type,no known failure
298,1,1,Initial Chemotherapy Agent,carbo/PTX
298,1,1,Nodal Stage,N0
298,1,1,Occurrence #,1st primary
298,1,1,Clinical lab p16,p16 unkown
298,1,1,Tumor Site,oropharynx
299,1,1,Tumor Stage,T4a
299,1,1,Overall Stage,IVa
299,1,1,Metastasis,M0
299,1,1,Nodal Stage,N0
299,1,1,Research lab HPV,HPV unknown
299,1,1,Research lab p16,p16 unknown
299,1,1,Tumor Site,oropharynx
299,1,1,1st Failure Type,locoregional
299,1,1,2nd Failure Type,no known failure
299,1,1,Clinical lab p16,p16 unkown
299,1,1,Occurrence #,recurrence
299,1,1,Treatment Modality,Sx
300,1,1,Nodal Stage,Unknown
300,1,1,Tumor Stage,Unknown
300,1,1,Research lab HPV,HPV positive
300,1,1,Occurrence #,Unknown
300,1,1,1st Failure Type,no known failure
300,1,1,Overall Stage,Unknown
300,1,1,Research lab p16,p16 negative
300,1,1,2nd Failure Type,no known failure
300,1,1,Clinical lab p16,p16 unkown
300,1,1,Metastasis,Unknown
300,1,1,Tumor Site,oropharynx
300,1,1,Treatment Modality,Unknown
301,1,1,Metastasis,M0
301,1,1,Tumor Stage,T2
301,1,1,Research lab HPV,HPV unknown
301,1,1,Tumor Site,oral cavity
301,1,1,Occurrence #,1st primary
301,1,1,1st Failure Type,no known failure
301,1,1,2nd Failure Type,no known failure
301,1,1,Overall Stage,IVa
301,1,1,Research lab p16,p16 unknown
301,1,1,Nodal Stage,N2
301,1,1,Treatment Modality,Unknown
301,1,1,Clinical lab p16,p16 unkown
302,1,1,Clinical lab p16,p16 unkown
302,1,1,Occurrence #,1st primary
302,1,1,1st Failure Type,no known failure
302,1,1,Overall Stage,III
302,1,1,Research lab p16,p16 unknown
302,1,1,2nd Failure Type,no known failure
302,1,1,Tumor Site,oral cavity
302,1,1,Metastasis,M0
302,1,1,Research lab HPV,HPV unknown
302,1,1,Treatment Modality,Unknown
302,1,1,Nodal Stage,N1
302,1,1,Tumor Stage,T2
303,1,1,Occurrence #,1st primary
303,1,1,Initial Chemotherapy Agent,carbo/doce
303,1,1,Research lab p16,p16 positive
303,1,1,Clinical lab p16,p16 unkown
303,1,1,2nd Failure Type,no known failure
303,1,1,1st Failure Type,locoregional
303,1,1,Nodal Stage,N2
303,1,1,Overall Stage,IVa
303,1,1,Radiation Dosage,70.2
303,1,1,Tumor Site,oropharynx
303,1,1,Metastasis,M0
303,1,1,Treatment Modality,CTX-RT
303,1,1,Tumor Stage,T4a
303,1,1,Research lab HPV,HPV positive
304,1,1,2nd Failure Type,no known failure
304,1,1,Nodal Stage,N0
304,1,1,1st Failure Type,no known failure
304,1,1,Overall Stage,II
304,1,1,Occurrence #,other primary
304,1,1,Clinical lab p16,p16 unkown
304,1,1,Radiation Dosage,unknown
304,1,1,Research lab HPV,HPV negative
304,1,1,Research lab p16,p16 negative
304,1,1,Treatment Modality,RT
304,1,1,Tumor Stage,T2
304,1,1,Metastasis,M0
304,1,1,Tumor Site,oropharynx
305,1,1,Tumor Stage,T4a
305,1,1,Research lab p16,p16 unknown
305,1,1,Clinical lab p16,p16 unkown
305,1,1,2nd Failure Type,no known failure
305,1,1,Overall Stage,IVa
305,1,1,Initial Chemotherapy Agent,carbo/doce
305,1,1,Metastasis,M0
305,1,1,Occurrence #,1st primary
305,1,1,Treatment Modality,CTX-RT
305,1,1,Tumor Site,oropharynx
305,1,1,Research lab HPV,HPV unknown
305,1,1,Radiation Dosage,70.2
305,1,1,Nodal Stage,N0
305,1,1,1st Failure Type,no known failure
306,1,1,2nd Failure Type,no known failure
306,1,1,Tumor Site,oropharynx
306,1,1,Nodal Stage,N2
306,1,1,Treatment Modality,Unknown
306,1,1,Metastasis,M0
306,1,1,Clinical lab p16,p16 unkown
306,1,1,Research lab p16,p16 negative
306,1,1,1st Failure Type,no known failure
306,1,1,Research lab HPV,HPV negative
306,1,1,Overall Stage,IVa
306,1,1,Occurrence #,1st primary
306,1,1,Tumor Stage,T4a
307,1,1,Occurrence #,1st primary
307,1,1,Tumor Site,oropharynx
307,1,1,Nodal Stage,Unknown
307,1,1,Research lab HPV,HPV negative
307,1,1,Metastasis,Unknown
307,1,1,Treatment Modality,Unknown
307,1,1,1st Failure Type,no known failure
307,1,1,Clinical lab p16,p16 unkown
307,1,1,Research lab p16,p16 negative
307,1,1,Tumor Stage,Unknown
307,1,1,2nd Failure Type,no known failure
307,1,1,Overall Stage,Unknown
308,1,1,Overall Stage,Unknown
308,1,1,Clinical lab p16,p16 unkown
308,1,1,Research lab p16,p16 unknown
308,1,1,Research lab HPV,HPV unknown
308,1,1,Occurrence #,1st primary
308,1,1,Metastasis,Unknown
308,1,1,Tumor Site,Unknown
308,1,1,Tumor Stage,Unknown
308,1,1,Nodal Stage,Unknown
308,1,1,2nd Failure Type,no known failure
308,1,1,Treatment Modality,Unknown
308,1,1,1st Failure Type,no known failure
309,1,1,1st Failure Type,locoregional
309,1,1,Tumor Stage,T2
309,1,1,Treatment Modality,RT
309,1,1,Research lab p16,p16 negative
309,1,1,Overall Stage,IVa
309,1,1,Tumor Site,oropharynx
309,1,1,Radiation Dosage,72
309,1,1,Nodal Stage,N2
309,1,1,Metastasis,M0
309,1,1,2nd Failure Type,no known failure
309,1,1,Occurrence #,1st primary
309,1,1,Research lab HPV,HPV negative
309,1,1,Clinical lab p16,p16 unkown
310,1,1,Research lab p16,p16 unknown
310,1,1,Nodal Stage,Unknown
310,1,1,Tumor Site,oropharynx
310,1,1,Overall Stage,Unknown
310,1,1,Research lab HPV,HPV unknown
310,1,1,2nd Failure Type,no known failure
310,1,1,Tumor Stage,Unknown
310,1,1,Clinical lab p16,p16 unkown
310,1,1,Treatment Modality,Unknown
310,1,1,Occurrence #,1st primary
310,1,1,1st Failure Type,no known failure
310,1,1,Metastasis,Unknown
311,1,1,Metastasis,M1
311,1,1,Clinical lab p16,p16 unkown
311,1,1,Research lab p16,p16 negative
311,1,1,Initial Chemotherapy Agent,carbo/PTX
311,1,1,Treatment Modality,CTX-RT
311,1,1,1st Failure Type,no known failure
311,1,1,Tumor Stage,T4a
311,1,1,Nodal Stage,N0
311,1,1,Overall Stage,IVc
311,1,1,Occurrence #,1st primary
311,1,1,Tumor Site,oropharynx
311,1,1,Radiation Dosage,33
311,1,1,2nd Failure Type,no known failure
311,1,1,Research lab HPV,HPV negative
312,1,1,Nodal Stage,N3
312,1,1,Treatment Modality,Unknown
312,1,1,Clinical lab p16,p16 unkown
312,1,1,Metastasis,M0
312,1,1,Occurrence #,Unknown
312,1,1,2nd Failure Type,no known failure
312,1,1,Tumor Stage,T2
312,1,1,Overall Stage,IVb
312,1,1,Tumor Site,oropharynx
312,1,1,1st Failure Type,no known failure
312,1,1,Research lab p16,p16 positive
312,1,1,Research lab HPV,HPV positive
313,1,1,Initial Chemotherapy Agent,carbo/ PTX
313,1,1,Overall Stage,III
313,1,1,Radiation Dosage,70
313,1,1,Nodal Stage,N1
313,1,1,2nd Failure Type,no known failure
313,1,1,Research lab HPV,HPV positive
313,1,1,Research lab p16,p16 positive
313,1,1,1st Failure Type,no known failure
313,1,1,Occurrence #,1st primary
313,1,1,Clinical lab p16,p16 unkown
313,1,1,Tumor Stage,T3
313,1,1,Metastasis,M0
313,1,1,Tumor Site,oropharynx
313,1,1,Treatment Modality,CTX-RT
314,1,1,Metastasis,M0
314,1,1,Research lab p16,p16 unknown
314,1,1,1st Failure Type,no known failure
314,1,1,Clinical lab p16,p16 unkown
314,1,1,Overall Stage,IVa
314,1,1,Treatment Modality,CTX-RT
314,1,1,Tumor Site,oropharynx
314,1,1,Tumor Stage,T3
314,1,1,Nodal Stage,N2
314,1,1,Initial Chemotherapy Agent,cap/doce
314,1,1,Research lab HPV,HPV unknown
314,1,1,Radiation Dosage,70.2
314,1,1,2nd Failure Type,no known failure
314,1,1,Occurrence #,1st primary
315,1,1,Treatment Modality,Sx
315,1,1,Tumor Stage,T4a
315,1,1,Research lab HPV,HPV negative
315,1,1,Tumor Site,oropharynx
315,1,1,2nd Failure Type,no known failure
315,1,1,Occurrence #,1st primary
315,1,1,1st Failure Type,no known failure
315,1,1,Research lab p16,p16 negative
315,1,1,Nodal Stage,N2
315,1,1,Metastasis,M0
315,1,1,Overall Stage,IVa
315,1,1,Clinical lab p16,p16 unkown
316,1,1,Tumor Site,oropharynx
316,1,1,1st Failure Type,no known failure
316,1,1,Clinical lab p16,p16 unkown
316,1,1,Nodal Stage,Unknown
316,1,1,Tumor Stage,Unknown
316,1,1,Research lab p16,p16 unknown
316,1,1,Research lab HPV,HPV unknown
316,1,1,Treatment Modality,Unknown
316,1,1,Occurrence #,1st primary
316,1,1,Metastasis,Unknown
316,1,1,2nd Failure Type,no known failure
316,1,1,Overall Stage,Unknown
317,1,1,Overall Stage,IVb
317,1,1,Nodal Stage,N3
317,1,1,Tumor Site,oropharynx
317,1,1,Research lab p16,p16 positive
317,1,1,Initial Chemotherapy Agent,carbo/doce
317,1,1,2nd Failure Type,no known failure
317,1,1,Occurrence #,1st primary
317,1,1,Metastasis,M0
317,1,1,Radiation Dosage,70.2
317,1,1,Tumor Stage,T4a
317,1,1,Treatment Modality,CTX-RT
317,1,1,1st Failure Type,no known failure
317,1,1,Research lab HPV,HPV positive
317,1,1,Clinical lab p16,p16 unkown
318,1,1,Occurrence #,1st primary
318,1,1,Research lab p16,p16 unknown
318,1,1,Radiation Dosage,unknown
318,1,1,Tumor Site,oropharynx
318,1,1,Tumor Stage,T3
318,1,1,Treatment Modality,Sx & CTX-RT
318,1,1,Initial Chemotherapy Agent,unknown
318,1,1,Overall Stage,IVb
318,1,1,Research lab HPV,HPV unknown
318,1,1,2nd Failure Type,no known failure
318,1,1,1st Failure Type,no known failure
318,1,1,Nodal Stage,N3
318,1,1,Clinical lab p16,p16 unkown
318,1,1,Metastasis,M0
319,1,1,1st Failure Type,no known failure
319,1,1,2nd Failure Type,no known failure
319,1,1,Tumor Stage,T4a
319,1,1,Nodal Stage,N0
319,1,1,Occurrence #,1st primary
319,1,1,Research lab p16,p16 negative
319,1,1,Overall Stage,IVa
319,1,1,Research lab HPV,HPV negative
319,1,1,Metastasis,M0
319,1,1,Tumor Site,oropharynx
319,1,1,Treatment Modality,Unknown
319,1,1,Clinical lab p16,p16 unkown
320,1,1,2nd Failure Type,no known failure
320,1,1,Metastasis,M0
320,1,1,Nodal Stage,N2
320,1,1,Overall Stage,IVa
320,1,1,Research lab p16,p16 positive
320,1,1,Tumor Site,oropharynx
320,1,1,Occurrence #,1st primary
320,1,1,Clinical lab p16,p16 unkown
320,1,1,Treatment Modality,CTX-RT
320,1,1,1st Failure Type,distant
320,1,1,Radiation Dosage,70.2
320,1,1,Research lab HPV,HPV positive
320,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
320,1,1,Tumor Stage,T3
321,1,1,Research lab HPV,HPV positive
321,1,1,Overall Stage,IVa
321,1,1,Nodal Stage,N2
321,1,1,Treatment Modality,Sx & RT
321,1,1,Tumor Site,oropharynx
321,1,1,Tumor Stage,T2
321,1,1,Radiation Dosage,64
321,1,1,Occurrence #,1st primary
321,1,1,Clinical lab p16,p16 unkown
321,1,1,1st Failure Type,no known failure
321,1,1,Research lab p16,p16 positive
321,1,1,2nd Failure Type,no known failure
321,1,1,Metastasis,M0
322,1,1,Treatment Modality,CTX-RT
322,1,1,Radiation Dosage,70.2
322,1,1,Initial Chemotherapy Agent,carbo/doce
322,1,1,Overall Stage,IVa
322,1,1,1st Failure Type,no known failure
322,1,1,Metastasis,M0
322,1,1,Occurrence #,1st primary
322,1,1,Research lab HPV,HPV positive
322,1,1,2nd Failure Type,no known failure
322,1,1,Tumor Site,oropharynx
322,1,1,Tumor Stage,T4a
322,1,1,Nodal Stage,N2
322,1,1,Clinical lab p16,p16 unkown
322,1,1,Research lab p16,p16 positive
323,1,1,Nodal Stage,Unknown
323,1,1,Tumor Stage,Unknown
323,1,1,Metastasis,Unknown
323,1,1,1st Failure Type,no known failure
323,1,1,Research lab p16,p16 unknown
323,1,1,Overall Stage,Unknown
323,1,1,Research lab HPV,HPV unknown
323,1,1,2nd Failure Type,no known failure
323,1,1,Treatment Modality,Unknown
323,1,1,Clinical lab p16,p16 unkown
323,1,1,Tumor Site,oropharynx
323,1,1,Occurrence #,1st primary
324,1,1,Research lab HPV,HPV unknown
324,1,1,Tumor Site,Unknown
324,1,1,Clinical lab p16,p16 unkown
324,1,1,Metastasis,Unknown
324,1,1,Tumor Stage,Unknown
324,1,1,Treatment Modality,Unknown
324,1,1,Nodal Stage,Unknown
324,1,1,2nd Failure Type,no known failure
324,1,1,Research lab p16,p16 unknown
324,1,1,Overall Stage,Unknown
324,1,1,1st Failure Type,no known failure
324,1,1,Occurrence #,1st primary
325,1,1,2nd Failure Type,no known failure
325,1,1,Treatment Modality,CTX-RT
325,1,1,Overall Stage,IVa
325,1,1,Occurrence #,1st primary
325,1,1,Clinical lab p16,p16 unkown
325,1,1,Research lab HPV,HPV positive
325,1,1,Radiation Dosage,70.2
325,1,1,Tumor Site,oropharynx
325,1,1,Metastasis,M0
325,1,1,Nodal Stage,N2
325,1,1,Initial Chemotherapy Agent,unknown
325,1,1,Tumor Stage,T1
325,1,1,Research lab p16,p16 positive
325,1,1,1st Failure Type,no known failure
326,1,1,Initial Chemotherapy Agent,various
326,1,1,1st Failure Type,locoregional
326,1,1,2nd Failure Type,no known failure
326,1,1,Clinical lab p16,p16 unkown
326,1,1,Metastasis,M0
326,1,1,Research lab HPV,HPV negative
326,1,1,Treatment Modality,Sx & CTX
326,1,1,Overall Stage,IVa
326,1,1,Tumor Site,oropharynx
326,1,1,Occurrence #,recurrence
326,1,1,Tumor Stage,T4a
326,1,1,Research lab p16,p16 negative
326,1,1,Nodal Stage,N2
327,1,1,Tumor Site,Unknown
327,1,1,Overall Stage,Unknown
327,1,1,Nodal Stage,Unknown
327,1,1,2nd Failure Type,no known failure
327,1,1,Occurrence #,1st primary
327,1,1,1st Failure Type,no known failure
327,1,1,Research lab p16,p16 unknown
327,1,1,Treatment Modality,Unknown
327,1,1,Clinical lab p16,p16 unkown
327,1,1,Research lab HPV,HPV unknown
327,1,1,Metastasis,Unknown
327,1,1,Tumor Stage,Unknown
328,1,1,Metastasis,Unknown
328,1,1,2nd Failure Type,no known failure
328,1,1,Nodal Stage,Unknown
328,1,1,Treatment Modality,Unknown
328,1,1,Occurrence #,1st primary
328,1,1,Overall Stage,Unknown
328,1,1,Research lab p16,p16 unknown
328,1,1,Tumor Stage,Unknown
328,1,1,Tumor Site,Unknown
328,1,1,Research lab HPV,HPV unknown
328,1,1,Clinical lab p16,p16 unkown
328,1,1,1st Failure Type,no known failure
329,1,1,2nd Failure Type,no known failure
329,1,1,Nodal Stage,N2
329,1,1,Tumor Site,oropharynx
329,1,1,Occurrence #,1st primary
329,1,1,Overall Stage,IVa
329,1,1,Research lab p16,p16 unknown
329,1,1,Tumor Stage,T4a
329,1,1,Radiation Dosage,70.2
329,1,1,Initial Chemotherapy Agent,carbo/doce
329,1,1,Treatment Modality,CTX-RT
329,1,1,1st Failure Type,locoregional
329,1,1,Research lab HPV,HPV unknown
329,1,1,Metastasis,M0
329,1,1,Clinical lab p16,p16 unkown
330,1,1,1st Failure Treatment Modality,CTX
330,1,1,Tumor Site,oropharynx
330,1,1,Radiation Dosage,unknown
330,1,1,Research lab p16,p16 unknown
330,1,1,Metastasis,M0
330,1,1,2nd Failure Type,no known failure
330,1,1,Overall Stage,II
330,1,1,1st Failure Type,locoregional
330,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
330,1,1,Research lab HPV,HPV unknown
330,1,1,Treatment Modality,RT
330,1,1,1st Failure Site,oropharynx
330,1,1,Nodal Stage,N0
330,1,1,Tumor Stage,T2
330,1,1,Occurrence #,1st primary
330,1,1,1st Failure Second Line Chemotherapy Agent,doce/cap
330,1,1,Clinical lab p16,p16 unkown
331,1,1,Research lab HPV,HPV unknown
331,1,1,1st Failure Type,locoregional
331,1,1,Research lab p16,p16 unknown
331,1,1,Tumor Site,oropharynx
331,1,1,2nd Failure Type,no known failure
331,1,1,Clinical lab p16,p16 unkown
331,1,1,Radiation Dosage,70.2
331,1,1,Initial Chemotherapy Agent,carbo/doce
331,1,1,Nodal Stage,N0
331,1,1,Tumor Stage,T3
331,1,1,Occurrence #,1st primary
331,1,1,Treatment Modality,CTX-RT
331,1,1,Metastasis,M0
331,1,1,Overall Stage,III
332,1,1,Tumor Site,oropharynx
332,1,1,Tumor Stage,Unknown
332,1,1,Nodal Stage,Unknown
332,1,1,Research lab HPV,HPV unknown
332,1,1,Research lab p16,p16 unknown
332,1,1,Overall Stage,Unknown
332,1,1,1st Failure Type,no known failure
332,1,1,Occurrence #,recurrence
332,1,1,2nd Failure Type,no known failure
332,1,1,Clinical lab p16,p16 unkown
332,1,1,Treatment Modality,Unknown
332,1,1,Metastasis,Unknown
333,1,1,Treatment Modality,Sx
333,1,1,Research lab p16,p16 unknown
333,1,1,Metastasis,M0
333,1,1,Occurrence #,recurrence
333,1,1,Overall Stage,II
333,1,1,1st Failure Type,no known failure
333,1,1,2nd Failure Type,no known failure
333,1,1,Nodal Stage,N0
333,1,1,Tumor Stage,T2
333,1,1,Clinical lab p16,p16 unkown
333,1,1,Tumor Site,oropharynx
333,1,1,Research lab HPV,HPV unknown
334,1,1,Radiation Dosage,70.2
334,1,1,Occurrence #,1st primary
334,1,1,1st Failure Type,no known failure
334,1,1,Clinical lab p16,p16 unkown
334,1,1,Nodal Stage,N2
334,1,1,Metastasis,M0
334,1,1,Treatment Modality,Unknown
334,1,1,Research lab HPV,HPV unknown
334,1,1,Research lab p16,p16 unknown
334,1,1,2nd Failure Type,no known failure
334,1,1,Initial Chemotherapy Agent,cis/5-FU
334,1,1,Tumor Site,larynx
334,1,1,Overall Stage,IVa
334,1,1,Tumor Stage,T4a
335,1,1,Tumor Stage,Unknown
335,1,1,Research lab HPV,HPV unknown
335,1,1,Treatment Modality,Unknown
335,1,1,Tumor Site,Unknown
335,1,1,Metastasis,Unknown
335,1,1,Nodal Stage,Unknown
335,1,1,2nd Failure Type,no known failure
335,1,1,Overall Stage,Unknown
335,1,1,Clinical lab p16,p16 unkown
335,1,1,Research lab p16,p16 unknown
335,1,1,1st Failure Type,no known failure
335,1,1,Occurrence #,1st primary
336,1,1,Clinical lab p16,p16 unkown
336,1,1,Metastasis,Unknown
336,1,1,Occurrence #,1st primary
336,1,1,Tumor Site,oropharynx
336,1,1,Nodal Stage,Unknown
336,1,1,Research lab HPV,HPV unknown
336,1,1,2nd Failure Type,no known failure
336,1,1,Research lab p16,p16 unknown
336,1,1,Treatment Modality,Unknown
336,1,1,Tumor Stage,Unknown
336,1,1,1st Failure Type,no known failure
336,1,1,Overall Stage,Unknown
337,1,1,Metastasis,M0
337,1,1,Overall Stage,III
337,1,1,Clinical lab p16,p16 unkown
337,1,1,Research lab p16,p16 unknown
337,1,1,Research lab HPV,HPV unknown
337,1,1,2nd Failure Type,no known failure
337,1,1,Occurrence #,1st primary
337,1,1,Nodal Stage,N0
337,1,1,Tumor Stage,T3
337,1,1,Treatment Modality,CTX-RT
337,1,1,Radiation Dosage,70.2
337,1,1,Initial Chemotherapy Agent,cis
337,1,1,Tumor Site,oropharynx
337,1,1,1st Failure Type,locoregional
338,1,1,1st Failure Type,no known failure
338,1,1,Occurrence #,1st primary
338,1,1,Metastasis,M0
338,1,1,Research lab HPV,HPV negative
338,1,1,Overall Stage,IVa
338,1,1,Tumor Stage,T4a
338,1,1,Treatment Modality,Unknown
338,1,1,2nd Failure Type,no known failure
338,1,1,Clinical lab p16,p16 unkown
338,1,1,Research lab p16,p16 negative
338,1,1,Nodal Stage,N2
338,1,1,Tumor Site,oropharynx
339,1,1,Tumor Stage,T4a
339,1,1,Occurrence #,1st primary
339,1,1,1st Failure Type,no known failure
339,1,1,Overall Stage,IVa
339,1,1,2nd Failure Type,no known failure
339,1,1,Research lab p16,p16 negative
339,1,1,Initial Chemotherapy Agent,carbo/ PTX
339,1,1,Tumor Site,oropharynx
339,1,1,Radiation Dosage,70.2
339,1,1,Nodal Stage,N0
339,1,1,Research lab HPV,HPV unknown
339,1,1,Treatment Modality,CTX-RT
339,1,1,Metastasis,M0
339,1,1,Clinical lab p16,p16 unkown
340,1,1,Occurrence #,1st primary
340,1,1,Metastasis,M0
340,1,1,2nd Failure Type,no known failure
340,1,1,Treatment Modality,CTX-RT
340,1,1,1st Failure Type,no known failure
340,1,1,Initial Chemotherapy Agent,cis
340,1,1,Overall Stage,IVa
340,1,1,Research lab p16,p16 unknown
340,1,1,Tumor Site,oropharynx
340,1,1,Nodal Stage,N0
340,1,1,Tumor Stage,T4a
340,1,1,Research lab HPV,HPV unknown
340,1,1,Clinical lab p16,p16 unkown
340,1,1,Radiation Dosage,70.2
341,1,1,Research lab p16,p16 negative
341,1,1,2nd Failure Type,no known failure
341,1,1,Nodal Stage,N1
341,1,1,Treatment Modality,Sx
341,1,1,Tumor Site,oropharynx
341,1,1,Research lab HPV,HPV negative
341,1,1,Clinical lab p16,p16 unkown
341,1,1,Occurrence #,1st primary
341,1,1,Metastasis,M0
341,1,1,1st Failure Type,locoregional
341,1,1,Overall Stage,III
341,1,1,Tumor Stage,T1
342,1,1,Tumor Stage,T2
342,1,1,Radiation Dosage,70.2
342,1,1,Occurrence #,1st primary
342,1,1,Tumor Site,oropharynx
342,1,1,Treatment Modality,CTX-RT
342,1,1,Clinical lab p16,p16 unkown
342,1,1,Overall Stage,IVa
342,1,1,Research lab p16,p16 positive
342,1,1,Research lab HPV,HPV positive
342,1,1,1st Failure Type,no known failure
342,1,1,Metastasis,M0
342,1,1,Nodal Stage,N2
342,1,1,2nd Failure Type,no known failure
342,1,1,Initial Chemotherapy Agent,unknown
343,1,1,Clinical lab p16,p16 unkown
343,1,1,Treatment Modality,RT
343,1,1,Metastasis,M0
343,1,1,Overall Stage,I
343,1,1,1st Failure Type,no known failure
343,1,1,Research lab HPV,HPV negative
343,1,1,2nd Failure Type,no known failure
343,1,1,Research lab p16,p16 negative
343,1,1,Tumor Site,oropharynx
343,1,1,Radiation Dosage,70.2
343,1,1,Occurrence #,1st primary
343,1,1,Tumor Stage,T1
343,1,1,Nodal Stage,N0
344,1,1,Research lab HPV,HPV unknown
344,1,1,Radiation Dosage,70.2
344,1,1,Metastasis,M0
344,1,1,Treatment Modality,CTX-RT
344,1,1,2nd Failure Type,no known failure
344,1,1,Tumor Site,oropharynx
344,1,1,Research lab p16,p16 unknown
344,1,1,Overall Stage,III
344,1,1,Tumor Stage,T2
344,1,1,Occurrence #,1st primary
344,1,1,Initial Chemotherapy Agent,cis
344,1,1,Nodal Stage,N1
344,1,1,1st Failure Type,no known failure
344,1,1,Clinical lab p16,p16 unkown
345,1,1,Nodal Stage,N2
345,1,1,2nd Failure Type,no known failure
345,1,1,Clinical lab p16,p16 unkown
345,1,1,Tumor Site,oropharynx
345,1,1,Treatment Modality,CTX-RT
345,1,1,Research lab HPV,HPV unknown
345,1,1,Overall Stage,IVa
345,1,1,Tumor Stage,T3
345,1,1,1st Failure Type,no known failure
345,1,1,Radiation Dosage,70.2
345,1,1,Metastasis,M0
345,1,1,Initial Chemotherapy Agent,carbo/doce
345,1,1,Occurrence #,1st primary
345,1,1,Research lab p16,p16 unknown
346,1,1,1st Failure Type,locoregional
346,1,1,1st Failure Treatment Modality,Sx
346,1,1,Initial Chemotherapy Agent,PTX/cap
346,1,1,Overall Stage,IVa
346,1,1,Nodal Stage,N2
346,1,1,Treatment Modality,CTX-RT
346,1,1,Tumor Stage,T2
346,1,1,2nd Failure Type,no known failure
346,1,1,Research lab p16,p16 positive
346,1,1,Occurrence #,1st primary
346,1,1,Metastasis,M0
346,1,1,Tumor Site,oropharynx
346,1,1,Research lab HPV,HPV positive
346,1,1,1st Failure Site,oropharynx
346,1,1,Clinical lab p16,p16 unkown
346,1,1,Radiation Dosage,unkn
347,1,1,Clinical lab p16,p16 unkown
347,1,1,Tumor Stage,T3
347,1,1,Radiation Dosage,70.2
347,1,1,Nodal Stage,N0
347,1,1,2nd Failure Type,no known failure
347,1,1,Overall Stage,III
347,1,1,Tumor Site,oropharynx
347,1,1,1st Failure Type,no known failure
347,1,1,Occurrence #,1st primary
347,1,1,Treatment Modality,RT
347,1,1,Research lab HPV,HPV negative
347,1,1,Research lab p16,p16 negative
347,1,1,Metastasis,M0
348,1,1,1st Failure Type,no known failure
348,1,1,2nd Failure Type,no known failure
348,1,1,Treatment Modality,Unknown
348,1,1,Nodal Stage,Unknown
348,1,1,Metastasis,Unknown
348,1,1,Tumor Site,Unknown
348,1,1,Clinical lab p16,p16 unkown
348,1,1,Occurrence #,1st primary
348,1,1,Tumor Stage,Unknown
348,1,1,Overall Stage,Unknown
348,1,1,Research lab p16,p16 unknown
348,1,1,Research lab HPV,HPV unknown
349,1,1,Tumor Site,oropharynx
349,1,1,Nodal Stage,N2
349,1,1,Research lab p16,p16 positive
349,1,1,Metastasis,M0
349,1,1,Clinical lab p16,p16 unkown
349,1,1,Occurrence #,1st primary
349,1,1,Treatment Modality,RT
349,1,1,Research lab HPV,HPV positive
349,1,1,Radiation Dosage,59.4
349,1,1,Overall Stage,IVa
349,1,1,2nd Failure Type,no known failure
349,1,1,1st Failure Type,locoregional
349,1,1,Tumor Stage,T2
350,1,1,Nodal Stage,N2
350,1,1,1st Failure Type,no known failure
350,1,1,Radiation Dosage,70.2
350,1,1,Treatment Modality,Sx & RT
350,1,1,Metastasis,M0
350,1,1,Overall Stage,IVa
350,1,1,2nd Failure Type,no known failure
350,1,1,Research lab HPV,HPV positive
350,1,1,Clinical lab p16,p16 unkown
350,1,1,Tumor Stage,T1
350,1,1,Occurrence #,1st primary
350,1,1,Tumor Site,oropharynx
350,1,1,Research lab p16,p16 positive
351,1,1,Treatment Modality,Sx
351,1,1,Overall Stage,Unknown
351,1,1,1st Failure Type,no known failure
351,1,1,Nodal Stage,Unknown
351,1,1,Occurrence #,1st primary
351,1,1,2nd Failure Type,no known failure
351,1,1,Clinical lab p16,p16 unkown
351,1,1,Tumor Stage,Unknown
351,1,1,Tumor Site,oropharynx
351,1,1,Metastasis,Unknown
351,1,1,Research lab HPV,HPV positive
351,1,1,Research lab p16,p16 positive
352,1,1,Clinical lab p16,p16 unkown
352,1,1,Occurrence #,1st primary
352,1,1,Metastasis,M0
352,1,1,Treatment Modality,Sx & CTX-RT
352,1,1,Overall Stage,IVb
352,1,1,Radiation Dosage,70.2
352,1,1,Tumor Site,oropharynx
352,1,1,Initial Chemotherapy Agent,carbo/doce
352,1,1,1st Failure Treatment Modality,Sx
352,1,1,Research lab HPV,HPV negative
352,1,1,2nd Failure Type,no known failure
352,1,1,1st Failure Type,locoregional
352,1,1,Nodal Stage,N3
352,1,1,Research lab p16,p16 negative
352,1,1,Tumor Stage,T3
353,1,1,Tumor Stage,T2
353,1,1,Occurrence #,other primary
353,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
353,1,1,Treatment Modality,CTX-RT
353,1,1,Radiation Dosage,70.2
353,1,1,Tumor Site,oropharynx
353,1,1,2nd Failure Type,no known failure
353,1,1,Nodal Stage,N2
353,1,1,Research lab p16,p16 unknown
353,1,1,1st Failure Type,distant
353,1,1,Clinical lab p16,p16 unkown
353,1,1,Metastasis,M0
353,1,1,Overall Stage,IVa
353,1,1,Research lab HPV,HPV unknown
354,1,1,Research lab p16,p16 negative
354,1,1,Overall Stage,IVa
354,1,1,2nd Failure Type,no known failure
354,1,1,Clinical lab p16,p16 unkown
354,1,1,Tumor Stage,T4a
354,1,1,Radiation Dosage,70.2
354,1,1,Research lab HPV,HPV negative
354,1,1,1st Failure Type,no known failure
354,1,1,Nodal Stage,N0
354,1,1,Treatment Modality,CTX-RT
354,1,1,Occurrence #,1st primary
354,1,1,Tumor Site,oropharynx
354,1,1,Initial Chemotherapy Agent,doce/cap
354,1,1,Metastasis,M0
355,1,1,Metastasis,Unknown
355,1,1,Treatment Modality,Unknown
355,1,1,Tumor Site,oropharynx
355,1,1,Occurrence #,1st primary
355,1,1,Research lab HPV,HPV unknown
355,1,1,Nodal Stage,Unknown
355,1,1,Clinical lab p16,p16 unkown
355,1,1,Tumor Stage,Unknown
355,1,1,2nd Failure Type,no known failure
355,1,1,Research lab p16,p16 unknown
355,1,1,Overall Stage,Unknown
355,1,1,1st Failure Type,no known failure
356,1,1,Initial Chemotherapy Agent,carbo/doce
356,1,1,Research lab p16,p16 unknown
356,1,1,Metastasis,M0
356,1,1,Overall Stage,III
356,1,1,Research lab HPV,HPV unknown
356,1,1,Tumor Site,oropharynx
356,1,1,Treatment Modality,CTX-RT
356,1,1,Nodal Stage,N1
356,1,1,Tumor Stage,T3
356,1,1,2nd Failure Type,no known failure
356,1,1,1st Failure Type,no known failure
356,1,1,Clinical lab p16,p16 unkown
356,1,1,Occurrence #,1st primary
356,1,1,Radiation Dosage,70.2
357,1,1,Clinical lab p16,p16 unkown
357,1,1,Initial Chemotherapy Agent,PTX/cap
357,1,1,Tumor Stage,T4a
357,1,1,Nodal Stage,N0
357,1,1,Research lab p16,p16 unknown
357,1,1,Overall Stage,IVa
357,1,1,Tumor Site,oropharynx
357,1,1,Radiation Dosage,70.2
357,1,1,Research lab HPV,HPV unknown
357,1,1,Treatment Modality,CTX-RT
357,1,1,1st Failure Type,no known failure
357,1,1,Occurrence #,1st primary
357,1,1,2nd Failure Type,no known failure
357,1,1,Metastasis,M0
358,1,1,Tumor Site,oropharynx
358,1,1,Tumor Stage,T3
358,1,1,Overall Stage,IVa
358,1,1,2nd Failure Type,no known failure
358,1,1,Treatment Modality,CTX-RT
358,1,1,Nodal Stage,N2
358,1,1,Research lab p16,p16 unknown
358,1,1,Clinical lab p16,p16 unkown
358,1,1,Metastasis,M0
358,1,1,1st Failure Type,no known failure
358,1,1,Occurrence #,1st primary
358,1,1,Initial Chemotherapy Agent,cis
358,1,1,Radiation Dosage,70
358,1,1,Research lab HPV,HPV unknown
359,1,1,Initial Chemotherapy Agent,carbo/doce
359,1,1,2nd Failure Type,no known failure
359,1,1,Metastasis,M0
359,1,1,Tumor Site,oropharynx
359,1,1,Research lab p16,p16 positive
359,1,1,Treatment Modality,Sx & CTX-RT
359,1,1,Overall Stage,IVb
359,1,1,Occurrence #,1st primary
359,1,1,Clinical lab p16,p16 unkown
359,1,1,Radiation Dosage,63
359,1,1,Research lab HPV,HPV positive
359,1,1,Tumor Stage,T2
359,1,1,1st Failure Type,no known failure
359,1,1,Nodal Stage,N3
360,1,1,Research lab HPV,HPV unknown
360,1,1,1st Failure Type,no known failure
360,1,1,Radiation Dosage,68
360,1,1,Nodal Stage,N0
360,1,1,Occurrence #,1st primary
360,1,1,Treatment Modality,RT
360,1,1,Clinical lab p16,p16 unkown
360,1,1,Tumor Stage,T2
360,1,1,Tumor Site,oropharynx
360,1,1,Research lab p16,p16 unknown
360,1,1,Overall Stage,II
360,1,1,2nd Failure Type,no known failure
360,1,1,Metastasis,M0
361,1,1,Clinical lab p16,p16 unkown
361,1,1,Treatment Modality,CTX-RT
361,1,1,Occurrence #,1st primary
361,1,1,2nd Failure Type,no known failure
361,1,1,Initial Chemotherapy Agent,cis
361,1,1,Research lab p16,p16 positive
361,1,1,Metastasis,M0
361,1,1,Nodal Stage,N2
361,1,1,1st Failure Type,no known failure
361,1,1,Radiation Dosage,70.2
361,1,1,Overall Stage,IVa
361,1,1,Research lab HPV,HPV positive
361,1,1,Tumor Site,oropharynx
361,1,1,Tumor Stage,T1
362,1,1,Tumor Site,oropharynx
362,1,1,Occurrence #,1st primary
362,1,1,Research lab HPV,HPV unknown
362,1,1,1st Failure Type,locoregional
362,1,1,1st Failure Site,oropharynx
362,1,1,Metastasis,M0
362,1,1,2nd Failure Type,no known failure
362,1,1,Clinical lab p16,p16 unkown
362,1,1,Tumor Stage,T1
362,1,1,Research lab p16,p16 unknown
362,1,1,Nodal Stage,N0
362,1,1,Radiation Dosage,78.2
362,1,1,Treatment Modality,RT
362,1,1,1st Failure Radiation Dosage,60
362,1,1,1st Failure Treatment Modality,Sx & CTX-RT
362,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
362,1,1,Overall Stage,I
363,1,1,Tumor Stage,T4a
363,1,1,Nodal Stage,N2
363,1,1,Metastasis,M0
363,1,1,2nd Failure Type,no known failure
363,1,1,Research lab HPV,HPV unknown
363,1,1,Occurrence #,1st primary
363,1,1,Research lab p16,p16 unknown
363,1,1,Overall Stage,IVa
363,1,1,1st Failure Type,no known failure
363,1,1,Treatment Modality,Unknown
363,1,1,Clinical lab p16,p16 unkown
363,1,1,Tumor Site,oropharynx
364,1,1,Overall Stage,IVa
364,1,1,Occurrence #,1st primary
364,1,1,Tumor Site,oropharynx
364,1,1,Radiation Dosage,unknown
364,1,1,2nd Failure Type,no known failure
364,1,1,Research lab p16,p16 negative
364,1,1,Clinical lab p16,p16 unkown
364,1,1,Nodal Stage,N0
364,1,1,Treatment Modality,Sx & RT
364,1,1,Metastasis,M0
364,1,1,Research lab HPV,HPV negative
364,1,1,Tumor Stage,T4a
364,1,1,1st Failure Type,locoregional
365,1,1,Metastasis,M0
365,1,1,Radiation Dosage,61.2
365,1,1,Research lab HPV,HPV unknown
365,1,1,Tumor Site,oropharynx
365,1,1,Research lab p16,p16 unknown
365,1,1,Nodal Stage,N2
365,1,1,Initial Chemotherapy Agent,carbo/doce
365,1,1,Tumor Stage,T3
365,1,1,2nd Failure Type,no known failure
365,1,1,Clinical lab p16,p16 unkown
365,1,1,Overall Stage,IVa
365,1,1,Occurrence #,1st primary
365,1,1,1st Failure Type,no known failure
365,1,1,Treatment Modality,CTX-RT
366,1,1,Treatment Modality,RT
366,1,1,Tumor Site,oropharynx
366,1,1,Clinical lab p16,p16 unkown
366,1,1,Nodal Stage,N2
366,1,1,Tumor Stage,T1
366,1,1,2nd Failure Type,no known failure
366,1,1,Research lab HPV,HPV positive
366,1,1,Radiation Dosage,70.2
366,1,1,Metastasis,M0
366,1,1,Occurrence #,1st primary
366,1,1,1st Failure Type,no known failure
366,1,1,Research lab p16,p16 positive
366,1,1,Overall Stage,IVa
367,1,1,1st Failure Type,no known failure
367,1,1,Tumor Stage,T3
367,1,1,Occurrence #,1st primary
367,1,1,Research lab HPV,HPV negative
367,1,1,Clinical lab p16,p16 unkown
367,1,1,2nd Failure Type,no known failure
367,1,1,Tumor Site,oropharynx
367,1,1,Metastasis,M0
367,1,1,Treatment Modality,Unknown
367,1,1,Nodal Stage,N2
367,1,1,Research lab p16,p16 negative
367,1,1,Overall Stage,IVa
368,1,1,Initial Chemotherapy Agent,carbo/doce
368,1,1,Metastasis,M0
368,1,1,Clinical lab p16,p16 unkown
368,1,1,Occurrence #,1st primary
368,1,1,Overall Stage,IVa
368,1,1,Tumor Site,oropharynx
368,1,1,Tumor Stage,T3
368,1,1,Research lab p16,p16 positive
368,1,1,1st Failure Type,no known failure
368,1,1,Treatment Modality,CTX-RT
368,1,1,Nodal Stage,N2
368,1,1,2nd Failure Type,no known failure
368,1,1,Radiation Dosage,70.2
368,1,1,Research lab HPV,HPV positive
369,1,1,Tumor Site,oropharynx
369,1,1,Tumor Stage,T4a
369,1,1,1st Failure Type,locoregional and distant
369,1,1,Treatment Modality,CTX-RT
369,1,1,Research lab p16,p16 negative
369,1,1,Overall Stage,IVa
369,1,1,Radiation Dosage,70.2
369,1,1,Nodal Stage,N2
369,1,1,Occurrence #,1st primary
369,1,1,2nd Failure Type,no known failure
369,1,1,Clinical lab p16,p16 unkown
369,1,1,Research lab HPV,HPV negative
369,1,1,Initial Chemotherapy Agent,carbo/doce
369,1,1,Metastasis,M0
370,1,1,Occurrence #,1st primary
370,1,1,Overall Stage,IVa
370,1,1,1st Failure Type,no known failure
370,1,1,Treatment Modality,CTX-RT
370,1,1,Research lab p16,p16 positive
370,1,1,2nd Failure Type,no known failure
370,1,1,Clinical lab p16,p16 unkown
370,1,1,Metastasis,M0
370,1,1,Tumor Stage,T4a
370,1,1,Nodal Stage,N2
370,1,1,Initial Chemotherapy Agent,carbo/doce
370,1,1,Radiation Dosage,70.2
370,1,1,Research lab HPV,HPV positive
370,1,1,Tumor Site,oropharynx
371,1,1,Overall Stage,III
371,1,1,Metastasis,M0
371,1,1,Initial Chemotherapy Agent,unknown
371,1,1,1st Failure Type,locoregional
371,1,1,Nodal Stage,N1
371,1,1,Research lab p16,p16 negative
371,1,1,Clinical lab p16,p16 unkown
371,1,1,Tumor Site,oropharynx
371,1,1,Research lab HPV,HPV negative
371,1,1,2nd Failure Type,no known failure
371,1,1,Tumor Stage,T2
371,1,1,Treatment Modality,Sx & CTX-RT
371,1,1,Occurrence #,recurrence
372,1,1,Tumor Site,oropharynx
372,1,1,1st Failure Type,no known failure
372,1,1,Nodal Stage,Unknown
372,1,1,Research lab HPV,HPV unknown
372,1,1,Tumor Stage,T3
372,1,1,Research lab p16,p16 positive
372,1,1,Clinical lab p16,p16 unkown
372,1,1,Treatment Modality,Unknown
372,1,1,Metastasis,M0
372,1,1,Occurrence #,1st primary
372,1,1,Overall Stage,III
372,1,1,2nd Failure Type,no known failure
373,1,1,2nd Failure Type,no known failure
373,1,1,Tumor Stage,T2
373,1,1,Occurrence #,1st primary
373,1,1,Research lab HPV,HPV positive
373,1,1,Overall Stage,IVa
373,1,1,Research lab p16,p16 positive
373,1,1,Treatment Modality,Sx
373,1,1,Nodal Stage,N2
373,1,1,Clinical lab p16,p16 unkown
373,1,1,Metastasis,M0
373,1,1,Tumor Site,oropharynx
373,1,1,1st Failure Type,distant
374,1,1,Initial Chemotherapy Agent,doce/cap
374,1,1,Metastasis,M0
374,1,1,2nd Failure Type,no known failure
374,1,1,Radiation Dosage,72
374,1,1,1st Failure Type,no known failure
374,1,1,Clinical lab p16,p16 unkown
374,1,1,Tumor Stage,T4a
374,1,1,Research lab HPV,HPV unknown
374,1,1,Treatment Modality,CTX-RT
374,1,1,Research lab p16,p16 unknown
374,1,1,Occurrence #,1st primary
374,1,1,Overall Stage,IVa
374,1,1,Nodal Stage,N2
374,1,1,Tumor Site,oropharynx
375,1,1,Overall Stage,IVa
375,1,1,Initial Chemotherapy Agent,cis
375,1,1,Research lab HPV,HPV unknown
375,1,1,1st Failure Type,no known failure
375,1,1,Nodal Stage,N2
375,1,1,Radiation Dosage,70.2
375,1,1,Tumor Site,oropharynx
375,1,1,Metastasis,M0
375,1,1,2nd Failure Type,no known failure
375,1,1,Clinical lab p16,p16 unkown
375,1,1,Occurrence #,1st primary
375,1,1,Research lab p16,p16 unknown
375,1,1,Treatment Modality,CTX-RT
375,1,1,Tumor Stage,T3
376,1,1,Tumor Stage,T1
376,1,1,1st Failure Type,distant
376,1,1,Tumor Site,oropharynx
376,1,1,Research lab HPV,HPV positive
376,1,1,Metastasis,M1
376,1,1,Treatment Modality,CTX-RT
376,1,1,Research lab p16,p16 positive
376,1,1,Overall Stage,IVc
376,1,1,Clinical lab p16,p16 unkown
376,1,1,Initial Chemotherapy Agent,cis/doce
376,1,1,Radiation Dosage,70
376,1,1,Occurrence #,1st primary
376,1,1,Nodal Stage,N2
376,1,1,2nd Failure Type,no known failure
377,1,1,1st Failure Type,no known failure
377,1,1,Occurrence #,1st primary
377,1,1,Research lab HPV,HPV unknown
377,1,1,Initial Chemotherapy Agent,carbo/doce
377,1,1,Overall Stage,IVb
377,1,1,Radiation Dosage,70.2
377,1,1,Research lab p16,p16 unknown
377,1,1,Metastasis,M0
377,1,1,Nodal Stage,N3
377,1,1,Clinical lab p16,p16 unkown
377,1,1,2nd Failure Type,no known failure
377,1,1,Tumor Site,oropharynx
377,1,1,Tumor Stage,T4a
377,1,1,Treatment Modality,CTX-RT
378,1,1,Treatment Modality,CTX-RT
378,1,1,Metastasis,M0
378,1,1,Initial Chemotherapy Agent,carbo/PTX
378,1,1,2nd Failure Type,no known failure
378,1,1,Research lab p16,p16 positive
378,1,1,Occurrence #,1st primary
378,1,1,1st Failure Type,no known failure
378,1,1,Clinical lab p16,p16 unkown
378,1,1,Radiation Dosage,70.2
378,1,1,Tumor Site,oropharynx
378,1,1,Nodal Stage,N2
378,1,1,Overall Stage,IVa
378,1,1,Tumor Stage,T3
378,1,1,Research lab HPV,HPV positive
379,1,1,Radiation Dosage,18
379,1,1,Tumor Stage,T4a
379,1,1,2nd Failure Type,no known failure
379,1,1,Overall Stage,IVa
379,1,1,Occurrence #,1st primary
379,1,1,Research lab p16,p16 unknown
379,1,1,1st Failure Type,no known failure
379,1,1,Metastasis,M0
379,1,1,Treatment Modality,RT
379,1,1,Clinical lab p16,p16 unkown
379,1,1,Nodal Stage,N2
379,1,1,Tumor Site,oropharynx
379,1,1,Research lab HPV,HPV unknown
380,1,1,Tumor Site,oropharynx
380,1,1,Research lab HPV,HPV unknown
380,1,1,Occurrence #,1st primary
380,1,1,Metastasis,M0
380,1,1,2nd Failure Type,no known failure
380,1,1,Nodal Stage,N0
380,1,1,Clinical lab p16,p16 unkown
380,1,1,Treatment Modality,CTX-RT
380,1,1,Research lab p16,p16 unknown
380,1,1,Tumor Stage,T3
380,1,1,1st Failure Type,no known failure
380,1,1,Overall Stage,III
381,1,1,Treatment Modality,CTX-RT
381,1,1,Tumor Stage,T3
381,1,1,Tumor Site,oropharynx
381,1,1,2nd Failure Type,no known failure
381,1,1,Occurrence #,1st primary
381,1,1,Initial Chemotherapy Agent,carbo/doce
381,1,1,Nodal Stage,N2
381,1,1,Research lab p16,p16 positive
381,1,1,Research lab HPV,HPV positive
381,1,1,Clinical lab p16,p16 unkown
381,1,1,Overall Stage,IVa
381,1,1,Metastasis,M0
381,1,1,1st Failure Type,no known failure
381,1,1,Radiation Dosage,70.2
382,1,1,1st Failure Type,no known failure
382,1,1,Radiation Dosage,70.2
382,1,1,Nodal Stage,N2
382,1,1,Overall Stage,IVa
382,1,1,Tumor Site,oropharynx
382,1,1,Clinical lab p16,p16 unkown
382,1,1,Initial Chemotherapy Agent,carbo/PTX
382,1,1,2nd Failure Type,no known failure
382,1,1,Metastasis,M0
382,1,1,Tumor Stage,T1
382,1,1,Research lab HPV,HPV negative
382,1,1,Occurrence #,1st primary
382,1,1,Research lab p16,p16 negative
382,1,1,Treatment Modality,CTX-RT
383,1,1,Clinical lab p16,p16 unkown
383,1,1,Research lab p16,p16 unknown
383,1,1,Radiation Dosage,63
383,1,1,Research lab HPV,HPV unknown
383,1,1,Metastasis,M0
383,1,1,Nodal Stage,N2
383,1,1,1st Failure Type,no known failure
383,1,1,Tumor Stage,T1
383,1,1,Treatment Modality,Sx & RT
383,1,1,Tumor Site,oropharynx
383,1,1,Occurrence #,1st primary
383,1,1,2nd Failure Type,no known failure
383,1,1,Overall Stage,IVa
384,1,1,Overall Stage,IVb
384,1,1,Occurrence #,1st primary
384,1,1,Metastasis,M0
384,1,1,Treatment Modality,CTX-RT
384,1,1,1st Failure Type,no known failure
384,1,1,Research lab HPV,HPV negative
384,1,1,Clinical lab p16,p16 unkown
384,1,1,Radiation Dosage,25.2
384,1,1,Research lab p16,p16 negative
384,1,1,Initial Chemotherapy Agent,carbo/doce
384,1,1,Tumor Site,oropharynx
384,1,1,Tumor Stage,T4b
384,1,1,Nodal Stage,N2
384,1,1,2nd Failure Type,no known failure
385,1,1,Research lab HPV,HPV unknown
385,1,1,Tumor Site,oropharynx
385,1,1,Treatment Modality,CTX-RT
385,1,1,2nd Failure Type,no known failure
385,1,1,Radiation Dosage,70.2
385,1,1,1st Failure Type,no known failure
385,1,1,Overall Stage,IVa
385,1,1,Occurrence #,1st primary
385,1,1,Metastasis,M0
385,1,1,Tumor Stage,T4a
385,1,1,Initial Chemotherapy Agent,carbo/doce
385,1,1,Nodal Stage,N2
385,1,1,Research lab p16,p16 unknown
385,1,1,Clinical lab p16,p16 unkown
386,1,1,Research lab HPV,HPV unknown
386,1,1,Clinical lab p16,p16 unkown
386,1,1,Initial Chemotherapy Agent,carbo/PTX
386,1,1,Radiation Dosage,45
386,1,1,1st Failure Type,no known failure
386,1,1,Occurrence #,1st primary
386,1,1,Tumor Stage,T3
386,1,1,Overall Stage,IVa
386,1,1,2nd Failure Type,no known failure
386,1,1,Nodal Stage,N2
386,1,1,Research lab p16,p16 unknown
386,1,1,Treatment Modality,CTX-RT
386,1,1,Tumor Site,oropharynx
386,1,1,Metastasis,M0
387,1,1,Research lab HPV,HPV unknown
387,1,1,Radiation Dosage,unknown
387,1,1,Occurrence #,1st primary
387,1,1,Metastasis,M0
387,1,1,Overall Stage,IVa
387,1,1,Initial Chemotherapy Agent,unk
387,1,1,Research lab p16,p16 unknown
387,1,1,1st Failure Type,no known failure
387,1,1,Nodal Stage,N2
387,1,1,2nd Failure Type,no known failure
387,1,1,Clinical lab p16,p16 unkown
387,1,1,Treatment Modality,CTX-RT
387,1,1,Tumor Stage,T4a
387,1,1,Tumor Site,oropharynx
388,1,1,Tumor Site,oropharynx
388,1,1,Treatment Modality,CTX-RT
388,1,1,1st Failure Type,no known failure
388,1,1,Nodal Stage,N2
388,1,1,Research lab p16,p16 positive
388,1,1,Radiation Dosage,70
388,1,1,2nd Failure Type,no known failure
388,1,1,Occurrence #,1st primary
388,1,1,Initial Chemotherapy Agent,Cis
388,1,1,Overall Stage,IVa
388,1,1,Tumor Stage,T3
388,1,1,Metastasis,M0
388,1,1,Research lab HPV,HPV positive
388,1,1,Clinical lab p16,p16 unkown
389,1,1,Tumor Site,oropharynx
389,1,1,Overall Stage,IVa
389,1,1,Nodal Stage,N2
389,1,1,Occurrence #,1st primary
389,1,1,Research lab HPV,HPV negative
389,1,1,Initial Chemotherapy Agent,carbo/PTX
389,1,1,Metastasis,M0
389,1,1,Clinical lab p16,p16 unkown
389,1,1,1st Failure Type,locoregional
389,1,1,Research lab p16,p16 negative
389,1,1,2nd Failure Type,no known failure
389,1,1,Treatment Modality,CTX-RT
389,1,1,Radiation Dosage,70.2
389,1,1,Tumor Stage,T4a
390,1,1,Treatment Modality,Sx
390,1,1,Metastasis,M0
390,1,1,Tumor Stage,T3
390,1,1,Tumor Site,oropharynx
390,1,1,Clinical lab p16,p16 unkown
390,1,1,Research lab p16,p16 negative
390,1,1,Research lab HPV,HPV negative
390,1,1,Nodal Stage,N2
390,1,1,1st Failure Type,distant
390,1,1,Occurrence #,1st primary
390,1,1,2nd Failure Type,no known failure
390,1,1,Overall Stage,IVa
391,1,1,2nd Failure Type,no known failure
391,1,1,Initial Chemotherapy Agent,cis
391,1,1,Tumor Stage,T3
391,1,1,Occurrence #,1st primary
391,1,1,Overall Stage,IVa
391,1,1,Clinical lab p16,p16 unkown
391,1,1,Radiation Dosage,70.2
391,1,1,Treatment Modality,CTX-RT
391,1,1,Nodal Stage,N2
391,1,1,1st Failure Type,distant
391,1,1,Research lab p16,p16 negative
391,1,1,Metastasis,M0
391,1,1,Tumor Site,oropharynx
391,1,1,Research lab HPV,HPV negative
392,1,1,Overall Stage,IVa
392,1,1,Treatment Modality,Sx & RT
392,1,1,Radiation Dosage,45
392,1,1,Metastasis,M0
392,1,1,Clinical lab p16,p16 unkown
392,1,1,Tumor Stage,T4a
392,1,1,2nd Failure Type,no known failure
392,1,1,1st Failure Type,no known failure
392,1,1,Tumor Site,oropharynx
392,1,1,Nodal Stage,N0
392,1,1,Research lab p16,p16 negative
392,1,1,Occurrence #,1st primary
392,1,1,Research lab HPV,HPV negative
393,1,1,Occurrence #,1st primary
393,1,1,Radiation Dosage,70.2
393,1,1,Tumor Stage,T4a
393,1,1,1st Failure Type,no known failure
393,1,1,Overall Stage,IVa
393,1,1,Research lab p16,p16 unknown
393,1,1,Tumor Site,oropharynx
393,1,1,Metastasis,M0
393,1,1,Treatment Modality,Sx & CTX-RT
393,1,1,Nodal Stage,N2
393,1,1,2nd Failure Type,no known failure
393,1,1,Initial Chemotherapy Agent,carbo/doce
393,1,1,Research lab HPV,HPV unknown
393,1,1,Clinical lab p16,p16 unkown
394,1,1,Clinical lab p16,p16 unkown
394,1,1,Treatment Modality,CTX-RT
394,1,1,Research lab HPV,HPV unknown
394,1,1,1st Failure Second Line Chemotherapy Agent,vinblastine
394,1,1,Overall Stage,IVa
394,1,1,Research lab p16,p16 unknown
394,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
394,1,1,Occurrence #,1st primary
394,1,1,Initial Chemotherapy Agent,carbo/doce
394,1,1,1st Failure Site,oral cavity
394,1,1,2nd Failure Type,no known failure
394,1,1,Tumor Stage,T2
394,1,1,1st Failure Type,locoregional
394,1,1,1st Failure Treatment Modality,Sx & CTX
394,1,1,Nodal Stage,N2
394,1,1,Metastasis,M0
394,1,1,Tumor Site,oropharynx
394,1,1,Radiation Dosage,70.2
395,1,1,Overall Stage,III
395,1,1,2nd Failure Type,no known failure
395,1,1,Metastasis,M0
395,1,1,Tumor Stage,T2
395,1,1,Nodal Stage,N1
395,1,1,Clinical lab p16,p16 unkown
395,1,1,Occurrence #,1st primary
395,1,1,Research lab p16,p16 negative
395,1,1,Research lab HPV,HPV negative
395,1,1,1st Failure Type,no known failure
395,1,1,Tumor Site,oropharynx
395,1,1,Radiation Dosage,64.4
395,1,1,Treatment Modality,RT
396,1,1,Initial Chemotherapy Agent,carbo/doce
396,1,1,Research lab HPV,HPV unknown
396,1,1,2nd Failure Type,no known failure
396,1,1,Radiation Dosage,70.2
396,1,1,Occurrence #,1st primary
396,1,1,Metastasis,M0
396,1,1,Research lab p16,p16 unknown
396,1,1,Overall Stage,IVa
396,1,1,Clinical lab p16,p16 unkown
396,1,1,Tumor Site,oropharynx
396,1,1,Tumor Stage,T4a
396,1,1,Nodal Stage,N2
396,1,1,Treatment Modality,CTX-RT
396,1,1,1st Failure Type,no known failure
397,1,1,Research lab p16,p16 negative
397,1,1,Research lab HPV,HPV negative
397,1,1,Clinical lab p16,p16 unkown
397,1,1,Nodal Stage,N2
397,1,1,2nd Failure Type,no known failure
397,1,1,Occurrence #,1st primary
397,1,1,1st Failure Type,locoregional and distant
397,1,1,Treatment Modality,RT
397,1,1,Metastasis,M0
397,1,1,Tumor Stage,T4a
397,1,1,Tumor Site,oropharynx
397,1,1,Overall Stage,IVa
397,1,1,Radiation Dosage,55
398,1,1,Research lab HPV,HPV unknown
398,1,1,Clinical lab p16,p16 unkown
398,1,1,Research lab p16,p16 unknown
398,1,1,Overall Stage,Unknown
398,1,1,Tumor Site,Unknown
398,1,1,Treatment Modality,Unknown
398,1,1,Nodal Stage,Unknown
398,1,1,2nd Failure Type,no known failure
398,1,1,Metastasis,Unknown
398,1,1,Occurrence #,1st primary
398,1,1,1st Failure Type,no known failure
398,1,1,Tumor Stage,Unknown
399,1,1,Overall Stage,IVa
399,1,1,2nd Failure Type,no known failure
399,1,1,Research lab HPV,HPV unknown
399,1,1,1st Failure Type,locoregional
399,1,1,Initial Chemotherapy Agent,carbo/doce
399,1,1,Metastasis,M0
399,1,1,Radiation Dosage,68.4
399,1,1,Tumor Site,oral cavity
399,1,1,Research lab p16,p16 unknown
399,1,1,Nodal Stage,N2
399,1,1,Tumor Stage,T4a
399,1,1,Treatment Modality,CTX-RT
399,1,1,1st Failure Initial Chemotherapy Agent,cis/doce/cap
399,1,1,1st Failure Treatment Modality,Sx & CTX
399,1,1,Occurrence #,recurrence
399,1,1,1st Failure Site,oral cavity
399,1,1,Clinical lab p16,p16 unkown
400,1,1,Research lab HPV,HPV positive
400,1,1,Treatment Modality,RT
400,1,1,Research lab p16,p16 positive
400,1,1,Radiation Dosage,60.5
400,1,1,Tumor Stage,T2
400,1,1,Tumor Site,oropharynx
400,1,1,Overall Stage,IVb
400,1,1,Nodal Stage,N3
400,1,1,2nd Failure Type,no known failure
400,1,1,Clinical lab p16,p16 unkown
400,1,1,1st Failure Type,no known failure
400,1,1,Occurrence #,1st primary
400,1,1,Metastasis,M0
401,1,1,Research lab p16,p16 negative
401,1,1,2nd Failure Type,no known failure
401,1,1,Tumor Stage,T3
401,1,1,1st Failure Initial Chemotherapy Agent,cap
401,1,1,Metastasis,M0
401,1,1,1st Failure Treatment Modality,Sx & RT
401,1,1,Occurrence #,1st primary
401,1,1,Research lab HPV,HPV negative
401,1,1,Clinical lab p16,p16 unkown
401,1,1,Radiation Dosage,76.8
401,1,1,Overall Stage,III
401,1,1,Nodal Stage,N0
401,1,1,1st Failure Site,oropharynx
401,1,1,Treatment Modality,RT
401,1,1,1st Failure Type,locoregional
401,1,1,Tumor Site,oropharynx
402,1,1,Tumor Site,oropharynx
402,1,1,Research lab p16,p16 unknown
402,1,1,Research lab HPV,HPV unknown
402,1,1,Clinical lab p16,p16 unkown
402,1,1,Radiation Dosage,66.6
402,1,1,Overall Stage,IVb
402,1,1,Nodal Stage,N3
402,1,1,2nd Failure Type,no known failure
402,1,1,1st Failure Type,no known failure
402,1,1,Metastasis,M0
402,1,1,Tumor Stage,T4a
402,1,1,Occurrence #,1st primary
402,1,1,Initial Chemotherapy Agent,carbo/doce
402,1,1,Treatment Modality,CTX-RT
403,1,1,Overall Stage,Unknown
403,1,1,Occurrence #,1st primary
403,1,1,Research lab HPV,HPV unknown
403,1,1,Tumor Stage,Unknown
403,1,1,Treatment Modality,Unknown
403,1,1,Nodal Stage,Unknown
403,1,1,1st Failure Type,no known failure
403,1,1,Clinical lab p16,p16 unkown
403,1,1,Metastasis,Unknown
403,1,1,Research lab p16,p16 unknown
403,1,1,2nd Failure Type,no known failure
403,1,1,Tumor Site,Unknown
404,1,1,1st Failure Type,locoregional
404,1,1,Research lab p16,p16 unknown
404,1,1,Overall Stage,IVa
404,1,1,Radiation Dosage,72
404,1,1,Occurrence #,1st primary
404,1,1,Metastasis,M0
404,1,1,2nd Failure Type,no known failure
404,1,1,Tumor Stage,T3
404,1,1,Clinical lab p16,p16 unkown
404,1,1,Initial Chemotherapy Agent,carbo/doce
404,1,1,Research lab HPV,HPV unknown
404,1,1,Tumor Site,oropharynx
404,1,1,Nodal Stage,N2
404,1,1,Treatment Modality,CTX-RT
405,1,1,Nodal Stage,N0
405,1,1,Occurrence #,1st primary
405,1,1,Research lab HPV,HPV unknown
405,1,1,2nd Failure Type,no known failure
405,1,1,Treatment Modality,CTX-RT
405,1,1,Tumor Site,oropharynx
405,1,1,Research lab p16,p16 unknown
405,1,1,Initial Chemotherapy Agent,carbo/5FU
405,1,1,Radiation Dosage,70.2
405,1,1,Metastasis,M0
405,1,1,Tumor Stage,T4a
405,1,1,1st Failure Type,no known failure
405,1,1,Overall Stage,IVa
405,1,1,Clinical lab p16,p16 unkown
406,1,1,Tumor Site,oropharynx
406,1,1,Tumor Stage,T3
406,1,1,1st Failure Type,no known failure
406,1,1,Initial Chemotherapy Agent,PTX/cap
406,1,1,Overall Stage,IVa
406,1,1,Research lab p16,p16 unknown
406,1,1,Research lab HPV,HPV unknown
406,1,1,Clinical lab p16,p16 unkown
406,1,1,Treatment Modality,CTX-RT
406,1,1,Occurrence #,1st primary
406,1,1,Metastasis,M0
406,1,1,Nodal Stage,N2
406,1,1,2nd Failure Type,no known failure
406,1,1,Radiation Dosage,70.2
407,1,1,Metastasis,Unknown
407,1,1,2nd Failure Type,no known failure
407,1,1,Clinical lab p16,p16 unkown
407,1,1,Overall Stage,Unknown
407,1,1,1st Failure Type,no known failure
407,1,1,Nodal Stage,Unknown
407,1,1,Occurrence #,1st primary
407,1,1,Research lab p16,p16 unknown
407,1,1,Research lab HPV,HPV unknown
407,1,1,Tumor Stage,Unknown
407,1,1,Treatment Modality,Unknown
407,1,1,Tumor Site,larynx
408,1,1,Overall Stage,III
408,1,1,Research lab p16,p16 positive
408,1,1,Tumor Site,oropharynx
408,1,1,Initial Chemotherapy Agent,unknown
408,1,1,1st Failure Type,no known failure
408,1,1,Research lab HPV,HPV positive
408,1,1,Clinical lab p16,p16 unkown
408,1,1,Metastasis,M0
408,1,1,Tumor Stage,T2
408,1,1,Treatment Modality,CTX-RT
408,1,1,Radiation Dosage,70.2
408,1,1,Occurrence #,1st primary
408,1,1,2nd Failure Type,no known failure
408,1,1,Nodal Stage,N1
409,1,1,Treatment Modality,RT
409,1,1,Overall Stage,II
409,1,1,Clinical lab p16,p16 unkown
409,1,1,Tumor Stage,T2
409,1,1,Research lab p16,p16 positive
409,1,1,Radiation Dosage,76.8
409,1,1,Occurrence #,1st primary
409,1,1,Nodal Stage,N0
409,1,1,Research lab HPV,HPV positive
409,1,1,1st Failure Type,no known failure
409,1,1,2nd Failure Type,no known failure
409,1,1,Metastasis,M0
409,1,1,Tumor Site,oropharynx
410,1,1,Occurrence #,1st primary
410,1,1,Nodal Stage,Unknown
410,1,1,Overall Stage,Unknown
410,1,1,Research lab HPV,HPV unknown
410,1,1,Tumor Stage,Unknown
410,1,1,Metastasis,Unknown
410,1,1,Tumor Site,oropharynx
410,1,1,1st Failure Type,no known failure
410,1,1,2nd Failure Type,no known failure
410,1,1,Treatment Modality,Unknown
410,1,1,Clinical lab p16,p16 unkown
410,1,1,Research lab p16,p16 unknown
411,1,1,Clinical lab p16,p16 unkown
411,1,1,Radiation Dosage,70.2
411,1,1,Nodal Stage,N0
411,1,1,Occurrence #,other primary
411,1,1,Research lab HPV,HPV unknown
411,1,1,Metastasis,M0
411,1,1,1st Failure Type,no known failure
411,1,1,2nd Failure Type,no known failure
411,1,1,Tumor Stage,T4a
411,1,1,Overall Stage,IVa
411,1,1,Tumor Site,oropharynx
411,1,1,Research lab p16,p16 unknown
411,1,1,Treatment Modality,RT
412,1,1,1st Failure Type,no known failure
412,1,1,Metastasis,Unknown
412,1,1,Clinical lab p16,p16 unkown
412,1,1,Tumor Site,Unknown
412,1,1,Treatment Modality,Unknown
412,1,1,Nodal Stage,Unknown
412,1,1,Research lab p16,p16 unknown
412,1,1,2nd Failure Type,no known failure
412,1,1,Research lab HPV,HPV unknown
412,1,1,Overall Stage,Unknown
412,1,1,Tumor Stage,Unknown
412,1,1,Occurrence #,1st primary
413,1,1,Overall Stage,IVa
413,1,1,Research lab p16,p16 unknown
413,1,1,Radiation Dosage,74.4
413,1,1,Research lab HPV,HPV unknown
413,1,1,Nodal Stage,N0
413,1,1,Metastasis,M0
413,1,1,Occurrence #,1st primary
413,1,1,1st Failure Type,no known failure
413,1,1,Tumor Site,oropharynx
413,1,1,2nd Failure Type,no known failure
413,1,1,Clinical lab p16,p16 unkown
413,1,1,Tumor Stage,T2
413,1,1,Treatment Modality,RT
414,1,1,Treatment Modality,Unknown
414,1,1,Metastasis,Unknown
414,1,1,Occurrence #,1st primary
414,1,1,Tumor Stage,T4a
414,1,1,Overall Stage,Unknown
414,1,1,Tumor Site,oropharynx
414,1,1,Nodal Stage,Unknown
414,1,1,Research lab HPV,HPV unknown
414,1,1,Research lab p16,p16 unknown
414,1,1,Clinical lab p16,p16 unkown
414,1,1,1st Failure Type,no known failure
414,1,1,2nd Failure Type,no known failure
415,1,1,Clinical lab p16,p16 unkown
415,1,1,Radiation Dosage,70.2
415,1,1,Tumor Site,oral cavity
415,1,1,Occurrence #,recurrence
415,1,1,Initial Chemotherapy Agent,carbo/doce
415,1,1,Research lab HPV,HPV unknown
415,1,1,Treatment Modality,CTX-RT
415,1,1,Nodal Stage,N0
415,1,1,Overall Stage,IVa
415,1,1,1st Failure Type,locoregional and distant
415,1,1,1st Failure Site,oropharynx
415,1,1,2nd Failure Type,no known failure
415,1,1,Research lab p16,p16 unknown
415,1,1,Tumor Stage,T4a
415,1,1,Metastasis,M0
416,1,1,Research lab p16,p16 negative
416,1,1,Tumor Site,oropharynx
416,1,1,Overall Stage,III
416,1,1,Treatment Modality,Sx
416,1,1,Research lab HPV,HPV negative
416,1,1,Tumor Stage,T3
416,1,1,1st Failure Type,no known failure
416,1,1,Nodal Stage,N0
416,1,1,2nd Failure Type,no known failure
416,1,1,Clinical lab p16,p16 unkown
416,1,1,Metastasis,M0
416,1,1,Occurrence #,1st primary
417,1,1,Treatment Modality,CTX-RT
417,1,1,Metastasis,M0
417,1,1,Occurrence #,1st primary
417,1,1,Clinical lab p16,p16 unkown
417,1,1,Tumor Stage,T4a
417,1,1,1st Failure Type,locoregional
417,1,1,Tumor Site,oropharynx
417,1,1,Research lab HPV,HPV unknown
417,1,1,Initial Chemotherapy Agent,cap/doce/gemcitabine
417,1,1,Overall Stage,IVb
417,1,1,2nd Failure Type,no known failure
417,1,1,Nodal Stage,N3
417,1,1,Radiation Dosage,unknown
417,1,1,Research lab p16,p16 unknown
418,1,1,Tumor Stage,T1
418,1,1,2nd Failure Type,no known failure
418,1,1,Tumor Site,oropharynx
418,1,1,Nodal Stage,N0
418,1,1,Occurrence #,1st primary
418,1,1,Research lab HPV,HPV unknown
418,1,1,1st Failure Type,locoregional
418,1,1,Treatment Modality,Sx
418,1,1,Metastasis,M0
418,1,1,Overall Stage,I
418,1,1,Research lab p16,p16 positive
418,1,1,Clinical lab p16,p16 unkown
419,1,1,Nodal Stage,N1
419,1,1,Radiation Dosage,72.6
419,1,1,Occurrence #,1st primary
419,1,1,Tumor Stage,T2
419,1,1,2nd Failure Type,no known failure
419,1,1,Research lab p16,p16 unknown
419,1,1,Clinical lab p16,p16 unkown
419,1,1,Treatment Modality,RT
419,1,1,1st Failure Type,distant
419,1,1,Overall Stage,III
419,1,1,Research lab HPV,HPV unknown
419,1,1,Tumor Site,oropharynx
419,1,1,Metastasis,M0
420,1,1,Clinical lab p16,p16 unkown
420,1,1,Nodal Stage,Unknown
420,1,1,Research lab p16,p16 unknown
420,1,1,1st Failure Type,no known failure
420,1,1,Overall Stage,Unknown
420,1,1,Tumor Site,Unknown
420,1,1,Treatment Modality,Unknown
420,1,1,Metastasis,Unknown
420,1,1,Research lab HPV,HPV unknown
420,1,1,2nd Failure Type,no known failure
420,1,1,Tumor Stage,Unknown
420,1,1,Occurrence #,1st primary
421,1,1,Tumor Stage,T4a
421,1,1,1st Failure Type,distant
421,1,1,Occurrence #,1st primary
421,1,1,Radiation Dosage,70
421,1,1,Clinical lab p16,p16 unkown
421,1,1,Nodal Stage,N1
421,1,1,Research lab HPV,HPV negative
421,1,1,Initial Chemotherapy Agent,cis
421,1,1,Overall Stage,IVa
421,1,1,Metastasis,M0
421,1,1,2nd Failure Type,no known failure
421,1,1,Tumor Site,oropharynx
421,1,1,Treatment Modality,CTX-RT
421,1,1,Research lab p16,p16 negative
422,1,1,Research lab HPV,HPV unknown
422,1,1,2nd Failure Type,no known failure
422,1,1,Tumor Stage,Unknown
422,1,1,1st Failure Type,no known failure
422,1,1,Tumor Site,oropharynx
422,1,1,Overall Stage,Unknown
422,1,1,Treatment Modality,Unknown
422,1,1,Metastasis,Unknown
422,1,1,Nodal Stage,Unknown
422,1,1,Clinical lab p16,p16 unkown
422,1,1,Research lab p16,p16 unknown
422,1,1,Occurrence #,1st primary
423,1,1,Radiation Dosage,70.2
423,1,1,Research lab HPV,HPV unknown
423,1,1,Research lab p16,p16 unknown
423,1,1,Initial Chemotherapy Agent,cap/doce
423,1,1,2nd Failure Type,no known failure
423,1,1,Tumor Stage,T3
423,1,1,Overall Stage,IVa
423,1,1,Tumor Site,oropharynx
423,1,1,Metastasis,M0
423,1,1,Treatment Modality,CTX-RT
423,1,1,1st Failure Type,no known failure
423,1,1,Occurrence #,1st primary
423,1,1,Nodal Stage,N2
423,1,1,Clinical lab p16,p16 unkown
424,1,1,Clinical lab p16,p16 unkown
424,1,1,Occurrence #,1st primary
424,1,1,Research lab p16,p16 unknown
424,1,1,Metastasis,Unknown
424,1,1,2nd Failure Type,no known failure
424,1,1,Tumor Stage,Unknown
424,1,1,Research lab HPV,HPV unknown
424,1,1,Overall Stage,Unknown
424,1,1,Tumor Site,Unknown
424,1,1,1st Failure Type,no known failure
424,1,1,Nodal Stage,Unknown
424,1,1,Treatment Modality,Unknown
425,1,1,Nodal Stage,N1
425,1,1,Clinical lab p16,p16 unkown
425,1,1,Research lab p16,p16 positive
425,1,1,Research lab HPV,HPV positive
425,1,1,Occurrence #,1st primary
425,1,1,Overall Stage,III
425,1,1,Tumor Site,oropharynx
425,1,1,1st Failure Type,no known failure
425,1,1,Treatment Modality,RT
425,1,1,Tumor Stage,T2
425,1,1,2nd Failure Type,no known failure
425,1,1,Metastasis,M0
425,1,1,Radiation Dosage,66
426,1,1,Research lab HPV,HPV unknown
426,1,1,Overall Stage,Unknown
426,1,1,Tumor Site,oropharynx
426,1,1,2nd Failure Type,no known failure
426,1,1,Nodal Stage,Unknown
426,1,1,Treatment Modality,Unknown
426,1,1,Research lab p16,p16 unknown
426,1,1,Metastasis,Unknown
426,1,1,Tumor Stage,Unknown
426,1,1,Occurrence #,1st primary
426,1,1,Clinical lab p16,p16 unkown
426,1,1,1st Failure Type,no known failure
427,1,1,2nd Failure Type,no known failure
427,1,1,Tumor Site,Unknown
427,1,1,Occurrence #,1st primary
427,1,1,Metastasis,Unknown
427,1,1,Tumor Stage,Unknown
427,1,1,Treatment Modality,Unknown
427,1,1,Overall Stage,Unknown
427,1,1,Research lab p16,p16 unknown
427,1,1,Clinical lab p16,p16 unkown
427,1,1,Nodal Stage,Unknown
427,1,1,1st Failure Type,no known failure
427,1,1,Research lab HPV,HPV unknown
428,1,1,Overall Stage,IVa
428,1,1,Treatment Modality,Sx & CTX-RT
428,1,1,Radiation Dosage,66.6
428,1,1,2nd Failure Type,no known failure
428,1,1,Research lab HPV,HPV positive
428,1,1,Research lab p16,p16 positive
428,1,1,Tumor Site,oropharynx
428,1,1,Metastasis,M0
428,1,1,Occurrence #,1st primary
428,1,1,1st Failure Type,no known failure
428,1,1,Clinical lab p16,p16 unkown
428,1,1,Initial Chemotherapy Agent,carbo/PTX
428,1,1,Nodal Stage,N2
428,1,1,Tumor Stage,T1
429,1,1,Clinical lab p16,p16 unkown
429,1,1,Overall Stage,III
429,1,1,Nodal Stage,Unknown
429,1,1,Tumor Stage,Unknown
429,1,1,1st Failure Type,no known failure
429,1,1,Tumor Site,oropharynx
429,1,1,Research lab p16,p16 unknown
429,1,1,Occurrence #,1st primary
429,1,1,2nd Failure Type,no known failure
429,1,1,Metastasis,M0
429,1,1,Research lab HPV,HPV unknown
429,1,1,Treatment Modality,Unknown
430,1,1,Occurrence #,1st primary
430,1,1,Metastasis,M0
430,1,1,Radiation Dosage,14.4
430,1,1,Research lab HPV,HPV unknown
430,1,1,Tumor Site,oropharynx
430,1,1,2nd Failure Type,no known failure
430,1,1,Treatment Modality,RT
430,1,1,1st Failure Type,no known failure
430,1,1,Clinical lab p16,p16 unkown
430,1,1,Tumor Stage,T4a
430,1,1,Overall Stage,IVa
430,1,1,Research lab p16,p16 unknown
430,1,1,Nodal Stage,N0
431,1,1,1st Failure Type,no known failure
431,1,1,Occurrence #,1st primary
431,1,1,2nd Failure Type,no known failure
431,1,1,Research lab p16,p16 unknown
431,1,1,Radiation Dosage,72
431,1,1,Metastasis,M0
431,1,1,Overall Stage,IVa
431,1,1,Tumor Site,oropharynx
431,1,1,Clinical lab p16,p16 unkown
431,1,1,Research lab HPV,HPV unknown
431,1,1,Treatment Modality,CTX-RT
431,1,1,Initial Chemotherapy Agent,PTX/cap
431,1,1,Tumor Stage,T3
431,1,1,Nodal Stage,N2
432,1,1,2nd Failure Type,no known failure
432,1,1,Clinical lab p16,p16 unkown
432,1,1,Research lab HPV,HPV negative
432,1,1,Tumor Stage,T3
432,1,1,Nodal Stage,N0
432,1,1,Research lab p16,p16 negative
432,1,1,1st Failure Type,no known failure
432,1,1,Occurrence #,1st primary
432,1,1,Treatment Modality,Sx
432,1,1,Metastasis,M0
432,1,1,Tumor Site,oropharynx
432,1,1,Overall Stage,III
433,1,1,Research lab HPV,HPV unknown
433,1,1,Overall Stage,IVa
433,1,1,Tumor Stage,T3
433,1,1,2nd Failure Type,no known failure
433,1,1,Occurrence #,1st primary
433,1,1,Nodal Stage,N2
433,1,1,1st Failure Type,distant
433,1,1,Metastasis,M0
433,1,1,Initial Chemotherapy Agent,PTX/cap
433,1,1,Tumor Site,oropharynx
433,1,1,Treatment Modality,CTX-RT
433,1,1,Radiation Dosage,72
433,1,1,Clinical lab p16,p16 unkown
433,1,1,Research lab p16,p16 unknown
434,1,1,1st Failure Type,locoregional
434,1,1,Tumor Stage,T2
434,1,1,Clinical lab p16,p16 unkown
434,1,1,Radiation Dosage,66
434,1,1,2nd Failure Type,no known failure
434,1,1,Occurrence #,1st primary
434,1,1,Tumor Site,oropharynx
434,1,1,Overall Stage,II
434,1,1,Metastasis,M0
434,1,1,Treatment Modality,RT
434,1,1,Research lab p16,p16 negative
434,1,1,Research lab HPV,HPV positive
434,1,1,Nodal Stage,N0
435,1,1,Treatment Modality,CTX-RT
435,1,1,Radiation Dosage,70.2
435,1,1,Metastasis,M0
435,1,1,Research lab p16,p16 unknown
435,1,1,1st Failure Type,locoregional and distant
435,1,1,Tumor Site,oropharynx
435,1,1,Clinical lab p16,p16 unkown
435,1,1,Nodal Stage,N3
435,1,1,Research lab HPV,HPV unknown
435,1,1,Initial Chemotherapy Agent,carbo/doce
435,1,1,Occurrence #,1st primary
435,1,1,Overall Stage,IVb
435,1,1,Tumor Stage,T4a
435,1,1,2nd Failure Type,no known failure
436,1,1,2nd Failure Type,no known failure
436,1,1,Tumor Stage,T2
436,1,1,1st Failure Initial Chemotherapy Agent,cis
436,1,1,1st Failure Treatment Modality,Sx & CTX-RT
436,1,1,Metastasis,M0
436,1,1,Tumor Site,oropharynx
436,1,1,Occurrence #,1st primary
436,1,1,Overall Stage,II
436,1,1,1st Failure Type,locoregional
436,1,1,1st Failure Radiation Dosage,60
436,1,1,Treatment Modality,RT
436,1,1,Radiation Dosage,76.8
436,1,1,1st Failure Site,oropharynx
436,1,1,Research lab p16,p16 unknown
436,1,1,Research lab HPV,HPV unknown
436,1,1,Nodal Stage,N0
436,1,1,Clinical lab p16,p16 unkown
437,1,1,Nodal Stage,N0
437,1,1,Research lab HPV,HPV unknown
437,1,1,Tumor Site,oropharynx
437,1,1,Clinical lab p16,p16 unkown
437,1,1,Overall Stage,IVa
437,1,1,Metastasis,M0
437,1,1,Occurrence #,1st primary
437,1,1,2nd Failure Type,no known failure
437,1,1,Treatment Modality,RT
437,1,1,Radiation Dosage,70
437,1,1,1st Failure Type,no known failure
437,1,1,Tumor Stage,T4a
437,1,1,Research lab p16,p16 unknown
438,1,1,Treatment Modality,Sx & CTX-RT
438,1,1,2nd Failure Type,no known failure
438,1,1,Occurrence #,1st primary
438,1,1,Nodal Stage,N2
438,1,1,Clinical lab p16,p16 unkown
438,1,1,Metastasis,M0
438,1,1,Radiation Dosage,unknown
438,1,1,Research lab p16,p16 positive
438,1,1,Tumor Stage,T3
438,1,1,Tumor Site,oropharynx
438,1,1,Initial Chemotherapy Agent,doce
438,1,1,Research lab HPV,HPV positive
438,1,1,1st Failure Type,locoregional and distant
438,1,1,Overall Stage,IVa
439,1,1,Nodal Stage,N2
439,1,1,Clinical lab p16,p16 unkown
439,1,1,Treatment Modality,Sx
439,1,1,Research lab p16,p16 positive
439,1,1,Metastasis,M0
439,1,1,Overall Stage,IVa
439,1,1,1st Failure Type,no known failure
439,1,1,Occurrence #,1st primary
439,1,1,Tumor Site,oropharynx
439,1,1,Research lab HPV,HPV unknown
439,1,1,2nd Failure Type,no known failure
439,1,1,Tumor Stage,T2
440,1,1,Radiation Dosage,unknown
440,1,1,Overall Stage,III
440,1,1,Research lab p16,p16 unknown
440,1,1,Treatment Modality,RT
440,1,1,Clinical lab p16,p16 unkown
440,1,1,Tumor Site,oropharynx
440,1,1,Research lab HPV,HPV unknown
440,1,1,Occurrence #,1st primary
440,1,1,1st Failure Type,no known failure
440,1,1,Nodal Stage,Unknown
440,1,1,Metastasis,M0
440,1,1,2nd Failure Type,no known failure
440,1,1,Tumor Stage,Unknown
441,1,1,Tumor Site,Unknown
441,1,1,Overall Stage,Unknown
441,1,1,Research lab p16,p16 unknown
441,1,1,1st Failure Type,no known failure
441,1,1,Treatment Modality,Unknown
441,1,1,Clinical lab p16,p16 unkown
441,1,1,Occurrence #,1st primary
441,1,1,2nd Failure Type,no known failure
441,1,1,Nodal Stage,Unknown
441,1,1,Metastasis,Unknown
441,1,1,Research lab HPV,HPV unknown
441,1,1,Tumor Stage,Unknown
442,1,1,Metastasis,M0
442,1,1,Overall Stage,IVb
442,1,1,Radiation Dosage,70.2
442,1,1,Tumor Stage,T3
442,1,1,2nd Failure Type,no known failure
442,1,1,Initial Chemotherapy Agent,carbo/PTX
442,1,1,Research lab p16,p16 negative
442,1,1,1st Failure Type,no known failure
442,1,1,Nodal Stage,N3
442,1,1,Clinical lab p16,p16 unkown
442,1,1,Treatment Modality,CTX-RT
442,1,1,Tumor Site,oropharynx
442,1,1,Occurrence #,1st primary
442,1,1,Research lab HPV,HPV negative
443,1,1,Treatment Modality,Unknown
443,1,1,Research lab p16,p16 unknown
443,1,1,1st Failure Type,no known failure
443,1,1,Overall Stage,Unknown
443,1,1,Tumor Site,Unknown
443,1,1,Clinical lab p16,p16 unkown
443,1,1,Nodal Stage,Unknown
443,1,1,Metastasis,Unknown
443,1,1,Occurrence #,1st primary
443,1,1,2nd Failure Type,no known failure
443,1,1,Tumor Stage,Unknown
443,1,1,Research lab HPV,HPV unknown
444,1,1,Occurrence #,1st primary
444,1,1,Overall Stage,Unknown
444,1,1,1st Failure Type,no known failure
444,1,1,Tumor Stage,Unknown
444,1,1,Research lab p16,p16 unknown
444,1,1,2nd Failure Type,no known failure
444,1,1,Clinical lab p16,p16 unkown
444,1,1,Metastasis,Unknown
444,1,1,Nodal Stage,Unknown
444,1,1,Tumor Site,oropharynx
444,1,1,Treatment Modality,Unknown
444,1,1,Research lab HPV,HPV unknown
445,1,1,2nd Failure Type,no known failure
445,1,1,Initial Chemotherapy Agent,carbo/doce/amifostine
445,1,1,Clinical lab p16,p16 unkown
445,1,1,Treatment Modality,CTX-RT
445,1,1,Overall Stage,IVa
445,1,1,Research lab p16,p16 unknown
445,1,1,Tumor Site,oropharynx
445,1,1,1st Failure Site,oropharynx
445,1,1,Occurrence #,1st primary
445,1,1,Metastasis,M0
445,1,1,1st Failure Type,locoregional
445,1,1,Research lab HPV,HPV unknown
445,1,1,Radiation Dosage,702
445,1,1,Nodal Stage,N0
445,1,1,1st Failure Treatment Modality,Sx
445,1,1,Tumor Stage,T4a
446,1,1,1st Failure Type,distant
446,1,1,Clinical lab p16,p16 unkown
446,1,1,Nodal Stage,N2
446,1,1,Metastasis,M0
446,1,1,Research lab HPV,HPV unknown
446,1,1,Radiation Dosage,70
446,1,1,Research lab p16,p16 unknown
446,1,1,Tumor Stage,T4b
446,1,1,Overall Stage,IVb
446,1,1,Occurrence #,1st primary
446,1,1,2nd Failure Type,no known failure
446,1,1,Initial Chemotherapy Agent,carbo/PTX
446,1,1,Treatment Modality,CTX-RT
446,1,1,Tumor Site,oropharynx
447,1,1,Tumor Site,oropharynx
447,1,1,Research lab HPV,HPV unknown
447,1,1,Metastasis,M0
447,1,1,Nodal Stage,N0
447,1,1,Tumor Stage,T4a
447,1,1,Radiation Dosage,70.2
447,1,1,2nd Failure Type,no known failure
447,1,1,Initial Chemotherapy Agent,carbo/doce
447,1,1,Clinical lab p16,p16 unkown
447,1,1,1st Failure Type,no known failure
447,1,1,Occurrence #,1st primary
447,1,1,Overall Stage,IVa
447,1,1,Research lab p16,p16 unknown
447,1,1,Treatment Modality,CTX-RT
448,1,1,Nodal Stage,Unknown
448,1,1,Research lab p16,p16 unknown
448,1,1,Research lab HPV,HPV unknown
448,1,1,Tumor Stage,Unknown
448,1,1,Overall Stage,Unknown
448,1,1,Clinical lab p16,p16 unkown
448,1,1,Treatment Modality,RT
448,1,1,Occurrence #,1st primary
448,1,1,Metastasis,Unknown
448,1,1,2nd Failure Type,no known failure
448,1,1,Tumor Site,oropharynx
448,1,1,1st Failure Type,no known failure
448,1,1,Radiation Dosage,unknown
449,1,1,Research lab HPV,HPV negative
449,1,1,2nd Failure Type,no known failure
449,1,1,Overall Stage,IVa
449,1,1,Tumor Stage,T4a
449,1,1,Metastasis,M0
449,1,1,Tumor Site,oropharynx
449,1,1,Research lab p16,p16 negative
449,1,1,Treatment Modality,Sx & RT
449,1,1,Radiation Dosage,43.2
449,1,1,Nodal Stage,N0
449,1,1,1st Failure Type,no known failure
449,1,1,Occurrence #,1st primary
449,1,1,Clinical lab p16,p16 unkown
450,1,1,Research lab HPV,HPV unknown
450,1,1,Tumor Stage,Unknown
450,1,1,Research lab p16,p16 unknown
450,1,1,Tumor Site,Unknown
450,1,1,Nodal Stage,Unknown
450,1,1,1st Failure Type,no known failure
450,1,1,Overall Stage,Unknown
450,1,1,Metastasis,Unknown
450,1,1,Treatment Modality,Unknown
450,1,1,Clinical lab p16,p16 unkown
450,1,1,2nd Failure Type,no known failure
450,1,1,Occurrence #,1st primary
451,1,1,Initial Chemotherapy Agent,carbo/doce
451,1,1,1st Failure Type,no known failure
451,1,1,Clinical lab p16,p16 unkown
451,1,1,Occurrence #,1st primary
451,1,1,Nodal Stage,N0
451,1,1,Treatment Modality,CTX-RT
451,1,1,Metastasis,M0
451,1,1,Overall Stage,IVa
451,1,1,Tumor Site,oropharynx
451,1,1,Research lab p16,p16 negative
451,1,1,Radiation Dosage,70.2
451,1,1,Research lab HPV,HPV negative
451,1,1,Tumor Stage,T4a
451,1,1,2nd Failure Type,no known failure
452,1,1,Research lab HPV,HPV unknown
452,1,1,Tumor Stage,T3
452,1,1,Occurrence #,1st primary
452,1,1,1st Failure Type,distant
452,1,1,Overall Stage,IVa
452,1,1,2nd Failure Type,no known failure
452,1,1,Metastasis,M0
452,1,1,Research lab p16,p16 unknown
452,1,1,Initial Chemotherapy Agent,carbo/doce
452,1,1,Radiation Dosage,unknown
452,1,1,Tumor Site,oropharynx
452,1,1,Clinical lab p16,p16 unkown
452,1,1,Nodal Stage,N2
452,1,1,Treatment Modality,CTX-RT
453,1,1,Occurrence #,1st primary
453,1,1,Tumor Site,Unknown
453,1,1,Treatment Modality,Unknown
453,1,1,Research lab HPV,HPV unknown
453,1,1,Overall Stage,Unknown
453,1,1,1st Failure Type,no known failure
453,1,1,Nodal Stage,Unknown
453,1,1,Clinical lab p16,p16 unkown
453,1,1,Research lab p16,p16 unknown
453,1,1,2nd Failure Type,no known failure
453,1,1,Tumor Stage,Unknown
453,1,1,Metastasis,Unknown
454,1,1,Clinical lab p16,p16 unkown
454,1,1,2nd Failure Type,no known failure
454,1,1,Tumor Site,oropharynx
454,1,1,Nodal Stage,Unknown
454,1,1,Metastasis,Unknown
454,1,1,Occurrence #,1st primary
454,1,1,Research lab HPV,HPV unknown
454,1,1,Research lab p16,p16 unknown
454,1,1,Tumor Stage,Unknown
454,1,1,Overall Stage,Unknown
454,1,1,Treatment Modality,Unknown
454,1,1,1st Failure Type,no known failure
455,1,1,Tumor Site,oropharynx
455,1,1,Occurrence #,1st primary
455,1,1,Clinical lab p16,p16 unkown
455,1,1,2nd Failure Type,no known failure
455,1,1,Nodal Stage,N1
455,1,1,Overall Stage,III
455,1,1,1st Failure Type,no known failure
455,1,1,Research lab HPV,HPV unknown
455,1,1,Metastasis,M0
455,1,1,Treatment Modality,RT
455,1,1,Radiation Dosage,70.2
455,1,1,Tumor Stage,T2
455,1,1,Research lab p16,p16 unknown
456,1,1,Research lab HPV,HPV positive
456,1,1,Research lab p16,p16 positive
456,1,1,Radiation Dosage,70.2
456,1,1,Initial Chemotherapy Agent,cis
456,1,1,Occurrence #,1st primary
456,1,1,Overall Stage,IVa
456,1,1,Nodal Stage,N2
456,1,1,Clinical lab p16,p16 unkown
456,1,1,1st Failure Type,no known failure
456,1,1,Metastasis,M0
456,1,1,Treatment Modality,Sx & CTX-RT
456,1,1,Tumor Stage,T3
456,1,1,Tumor Site,oropharynx
456,1,1,2nd Failure Type,no known failure
457,1,1,2nd Failure Type,no known failure
457,1,1,Treatment Modality,CTX-RT
457,1,1,Occurrence #,1st primary
457,1,1,Metastasis,M0
457,1,1,Radiation Dosage,70
457,1,1,Initial Chemotherapy Agent,carbo/doce
457,1,1,1st Failure Type,no known failure
457,1,1,Clinical lab p16,p16 unkown
457,1,1,Nodal Stage,N3
457,1,1,Tumor Stage,T2
457,1,1,Overall Stage,IVb
457,1,1,Research lab p16,p16 unknown
457,1,1,Tumor Site,oropharynx
457,1,1,Research lab HPV,HPV unknown
458,1,1,Overall Stage,IVc
458,1,1,1st Failure Type,no known failure
458,1,1,Research lab p16,p16 unknown
458,1,1,Nodal Stage,N1
458,1,1,Clinical lab p16,p16 unkown
458,1,1,Research lab HPV,HPV unknown
458,1,1,2nd Failure Type,no known failure
458,1,1,Treatment Modality,CTX-RT
458,1,1,Metastasis,M1
458,1,1,Tumor Stage,T3
458,1,1,Initial Chemotherapy Agent,cis/alimta
458,1,1,Tumor Site,oropharynx
458,1,1,Radiation Dosage,50.4
458,1,1,Occurrence #,recurrence
459,1,1,Occurrence #,recurrence
459,1,1,2nd Failure Type,no known failure
459,1,1,Nodal Stage,N0
459,1,1,Research lab p16,p16 unknown
459,1,1,Research lab HPV,HPV positive
459,1,1,Overall Stage,I
459,1,1,Clinical lab p16,p16 unkown
459,1,1,Tumor Stage,T1
459,1,1,Treatment Modality,Sx
459,1,1,1st Failure Type,no known failure
459,1,1,Metastasis,M0
459,1,1,Tumor Site,oropharynx
460,1,1,Radiation Dosage,unknown
460,1,1,2nd Failure Type,no known failure
460,1,1,Research lab HPV,HPV unknown
460,1,1,Tumor Site,oropharynx
460,1,1,Nodal Stage,N0
460,1,1,Metastasis,M0
460,1,1,Treatment Modality,RT
460,1,1,Research lab p16,p16 unknown
460,1,1,Clinical lab p16,p16 unkown
460,1,1,Tumor Stage,T2
460,1,1,1st Failure Type,locoregional
460,1,1,Overall Stage,II
460,1,1,Occurrence #,1st primary
461,1,1,Overall Stage,III
461,1,1,1st Failure Type,no known failure
461,1,1,Treatment Modality,Sx
461,1,1,Metastasis,M0
461,1,1,Clinical lab p16,p16 unkown
461,1,1,Tumor Site,oropharynx
461,1,1,Tumor Stage,T3
461,1,1,Occurrence #,1st primary
461,1,1,Research lab HPV,HPV unknown
461,1,1,Research lab p16,p16 unknown
461,1,1,Nodal Stage,N0
461,1,1,2nd Failure Type,no known failure
462,1,1,Nodal Stage,N2
462,1,1,1st Failure Type,no known failure
462,1,1,Occurrence #,1st primary
462,1,1,Metastasis,M0
462,1,1,Radiation Dosage,72
462,1,1,Tumor Site,oropharynx
462,1,1,Research lab p16,p16 unknown
462,1,1,Tumor Stage,T3
462,1,1,Treatment Modality,CTX-RT
462,1,1,Research lab HPV,HPV unknown
462,1,1,Overall Stage,IVa
462,1,1,Initial Chemotherapy Agent,carbo/doce
462,1,1,2nd Failure Type,no known failure
462,1,1,Clinical lab p16,p16 unkown
463,1,1,1st Failure Type,no known failure
463,1,1,Research lab p16,p16 unknown
463,1,1,Occurrence #,1st primary
463,1,1,Overall Stage,Unknown
463,1,1,Tumor Site,Unknown
463,1,1,2nd Failure Type,no known failure
463,1,1,Tumor Stage,Unknown
463,1,1,Metastasis,Unknown
463,1,1,Nodal Stage,Unknown
463,1,1,Clinical lab p16,p16 unkown
463,1,1,Treatment Modality,Unknown
463,1,1,Research lab HPV,HPV unknown
464,1,1,Radiation Dosage,63
464,1,1,Overall Stage,IVa
464,1,1,2nd Failure Type,no known failure
464,1,1,Nodal Stage,N2
464,1,1,Treatment Modality,CTX-RT
464,1,1,Initial Chemotherapy Agent,carbo/ PTX
464,1,1,Research lab HPV,HPV negative
464,1,1,Clinical lab p16,p16 unkown
464,1,1,Tumor Stage,T4a
464,1,1,Tumor Site,oropharynx
464,1,1,Research lab p16,p16 negative
464,1,1,Occurrence #,1st primary
464,1,1,1st Failure Type,no known failure
464,1,1,Metastasis,M0
465,1,1,Tumor Stage,T2
465,1,1,Research lab p16,p16 unknown
465,1,1,2nd Failure Type,no known failure
465,1,1,1st Failure Type,no known failure
465,1,1,Initial Chemotherapy Agent,cis
465,1,1,Research lab HPV,HPV unknown
465,1,1,Overall Stage,IVa
465,1,1,Clinical lab p16,p16 unkown
465,1,1,Metastasis,M0
465,1,1,Occurrence #,1st primary
465,1,1,Radiation Dosage,70
465,1,1,Treatment Modality,CTX-RT
465,1,1,Tumor Site,oropharynx
465,1,1,Nodal Stage,N2
466,1,1,1st Failure Type,no known failure
466,1,1,Research lab HPV,HPV unknown
466,1,1,Treatment Modality,CTX-RT
466,1,1,Nodal Stage,N2
466,1,1,Metastasis,M0
466,1,1,Radiation Dosage,64
466,1,1,Tumor Site,oropharynx
466,1,1,Clinical lab p16,p16 unkown
466,1,1,Research lab p16,p16 unknown
466,1,1,Initial Chemotherapy Agent,cis/cetux
466,1,1,Tumor Stage,T1
466,1,1,Overall Stage,IVa
466,1,1,2nd Failure Type,no known failure
466,1,1,Occurrence #,1st primary
467,1,1,Metastasis,M0
467,1,1,Tumor Stage,T4a
467,1,1,Overall Stage,IVa
467,1,1,Treatment Modality,CTX-RT
467,1,1,Nodal Stage,N2
467,1,1,Research lab p16,p16 negative
467,1,1,Research lab HPV,HPV negative
467,1,1,Occurrence #,1st primary
467,1,1,2nd Failure Type,no known failure
467,1,1,Tumor Site,oropharynx
467,1,1,Radiation Dosage,70.2
467,1,1,Initial Chemotherapy Agent,carbo/PTX
467,1,1,1st Failure Type,locoregional
467,1,1,Clinical lab p16,p16 unkown
468,1,1,1st Failure Type,no known failure
468,1,1,2nd Failure Type,no known failure
468,1,1,Initial Chemotherapy Agent,carbo/doce
468,1,1,Clinical lab p16,p16 unkown
468,1,1,Tumor Stage,T3
468,1,1,Metastasis,M0
468,1,1,Tumor Site,oropharynx
468,1,1,Radiation Dosage,32.4
468,1,1,Occurrence #,1st primary
468,1,1,Overall Stage,III
468,1,1,Nodal Stage,N0
468,1,1,Research lab HPV,HPV unknown
468,1,1,Treatment Modality,CTX-RT
468,1,1,Research lab p16,p16 unknown
469,1,1,Occurrence #,1st primary
469,1,1,Nodal Stage,Unknown
469,1,1,Clinical lab p16,p16 unkown
469,1,1,Metastasis,Unknown
469,1,1,Tumor Site,oropharynx
469,1,1,1st Failure Type,no known failure
469,1,1,Treatment Modality,Sx & CTX-RT
469,1,1,Initial Chemotherapy Agent,unknown
469,1,1,Research lab HPV,HPV unknown
469,1,1,Research lab p16,p16 unknown
469,1,1,Tumor Stage,Unknown
469,1,1,2nd Failure Type,no known failure
469,1,1,Radiation Dosage,unknown
469,1,1,Overall Stage,Unknown
470,1,1,Occurrence #,1st primary
470,1,1,Research lab HPV,HPV negative
470,1,1,Tumor Site,oropharynx
470,1,1,2nd Failure Type,no known failure
470,1,1,Nodal Stage,N2
470,1,1,Research lab p16,p16 negative
470,1,1,Metastasis,M0
470,1,1,1st Failure Type,no known failure
470,1,1,Radiation Dosage,70.2
470,1,1,Treatment Modality,RT
470,1,1,Tumor Stage,T3
470,1,1,Clinical lab p16,p16 unkown
470,1,1,Overall Stage,IVa
471,1,1,Research lab HPV,HPV unknown
471,1,1,Overall Stage,Unknown
471,1,1,Occurrence #,1st primary
471,1,1,Nodal Stage,Unknown
471,1,1,Research lab p16,p16 unknown
471,1,1,2nd Failure Type,no known failure
471,1,1,Tumor Site,Unknown
471,1,1,1st Failure Type,no known failure
471,1,1,Treatment Modality,Unknown
471,1,1,Tumor Stage,Unknown
471,1,1,Clinical lab p16,p16 unkown
471,1,1,Metastasis,Unknown
472,1,1,2nd Failure Type,no known failure
472,1,1,1st Failure Type,no known failure
472,1,1,Tumor Stage,T3
472,1,1,Treatment Modality,CTX-RT
472,1,1,Research lab p16,p16 unknown
472,1,1,Research lab HPV,HPV unknown
472,1,1,Radiation Dosage,70.2
472,1,1,Initial Chemotherapy Agent,carbo/doce
472,1,1,Occurrence #,1st primary
472,1,1,Metastasis,M0
472,1,1,Tumor Site,oropharynx
472,1,1,Overall Stage,IVa
472,1,1,Nodal Stage,N2
472,1,1,Clinical lab p16,p16 unkown
473,1,1,Tumor Stage,T2
473,1,1,Overall Stage,IVb
473,1,1,1st Failure Type,locoregional
473,1,1,Clinical lab p16,p16 unkown
473,1,1,Treatment Modality,Sx & RT
473,1,1,Metastasis,M0
473,1,1,Occurrence #,1st primary
473,1,1,Nodal Stage,N3
473,1,1,Radiation Dosage,70.2
473,1,1,2nd Failure Type,no known failure
473,1,1,Research lab p16,p16 positive
473,1,1,Research lab HPV,HPV positive
473,1,1,Tumor Site,oropharynx
474,1,1,Occurrence #,1st primary
474,1,1,Overall Stage,IVa
474,1,1,Clinical lab p16,p16 unkown
474,1,1,1st Failure Type,no known failure
474,1,1,Treatment Modality,Sx
474,1,1,Tumor Site,oral cavity
474,1,1,Nodal Stage,N0
474,1,1,Research lab HPV,HPV unknown
474,1,1,Research lab p16,p16 unknown
474,1,1,Metastasis,M0
474,1,1,Tumor Stage,T4a
474,1,1,2nd Failure Type,no known failure
475,1,1,Treatment Modality,Unknown
475,1,1,2nd Failure Type,no known failure
475,1,1,Research lab HPV,HPV unknown
475,1,1,Nodal Stage,Unknown
475,1,1,Tumor Site,Unknown
475,1,1,Metastasis,Unknown
475,1,1,Occurrence #,1st primary
475,1,1,1st Failure Type,no known failure
475,1,1,Tumor Stage,Unknown
475,1,1,Overall Stage,Unknown
475,1,1,Research lab p16,p16 unknown
475,1,1,Clinical lab p16,p16 unkown
476,1,1,Metastasis,M0
476,1,1,Tumor Site,oral cavity
476,1,1,Overall Stage,II
476,1,1,Research lab HPV,HPV unknown
476,1,1,Radiation Dosage,66.6
476,1,1,Clinical lab p16,p16 unkown
476,1,1,Tumor Stage,T2
476,1,1,1st Failure Type,no known failure
476,1,1,2nd Failure Type,no known failure
476,1,1,Research lab p16,p16 unknown
476,1,1,Treatment Modality,Sx & RT
476,1,1,Occurrence #,1st primary
476,1,1,Nodal Stage,N0
477,1,1,Research lab p16,p16 unknown
477,1,1,Treatment Modality,Sx
477,1,1,2nd Failure Type,no known failure
477,1,1,Metastasis,M0
477,1,1,Clinical lab p16,p16 unkown
477,1,1,1st Failure Type,no known failure
477,1,1,Overall Stage,I
477,1,1,Research lab HPV,HPV unknown
477,1,1,Nodal Stage,N0
477,1,1,Tumor Site,oral cavity
477,1,1,Occurrence #,1st primary
477,1,1,Tumor Stage,T1
478,1,1,Research lab p16,p16 unknown
478,1,1,Tumor Stage,T4a
478,1,1,Research lab HPV,HPV unknown
478,1,1,Clinical lab p16,p16 unkown
478,1,1,Nodal Stage,N0
478,1,1,Overall Stage,IVa
478,1,1,Tumor Site,oral cavity
478,1,1,Occurrence #,1st primary
478,1,1,Treatment Modality,Sx
478,1,1,1st Failure Type,no known failure
478,1,1,Metastasis,M0
478,1,1,2nd Failure Type,no known failure
479,1,1,Tumor Site,oral cavity
479,1,1,Occurrence #,1st primary
479,1,1,Research lab p16,p16 unknown
479,1,1,2nd Failure Type,no known failure
479,1,1,Research lab HPV,HPV unknown
479,1,1,Treatment Modality,Sx
479,1,1,Overall Stage,IVa
479,1,1,Metastasis,M0
479,1,1,1st Failure Type,locoregional
479,1,1,Tumor Stage,T4a
479,1,1,Nodal Stage,N0
479,1,1,Clinical lab p16,p16 unkown
480,1,1,2nd Failure Type,no known failure
480,1,1,Clinical lab p16,p16 unkown
480,1,1,Metastasis,Unknown
480,1,1,Tumor Site,Unknown
480,1,1,Research lab HPV,HPV unknown
480,1,1,Overall Stage,Unknown
480,1,1,Occurrence #,1st primary
480,1,1,Treatment Modality,Unknown
480,1,1,Research lab p16,p16 unknown
480,1,1,Tumor Stage,Unknown
480,1,1,1st Failure Type,no known failure
480,1,1,Nodal Stage,Unknown
481,1,1,Research lab p16,p16 unknown
481,1,1,Metastasis,M0
481,1,1,Overall Stage,IVa
481,1,1,Nodal Stage,N2
481,1,1,Tumor Site,oropharynx
481,1,1,Occurrence #,recurrence
481,1,1,Clinical lab p16,p16 unkown
481,1,1,Initial Chemotherapy Agent,unknown
481,1,1,Treatment Modality,Sx
481,1,1,Research lab HPV,HPV unknown
481,1,1,Tumor Stage,T3
481,1,1,2nd Failure Type,no known failure
481,1,1,1st Failure Type,no known failure
482,1,1,Tumor Stage,T4a
482,1,1,Occurrence #,1st primary
482,1,1,Research lab HPV,HPV unknown
482,1,1,Treatment Modality,Sx
482,1,1,Overall Stage,IVa
482,1,1,Metastasis,M0
482,1,1,1st Failure Type,no known failure
482,1,1,Nodal Stage,N2
482,1,1,Research lab p16,p16 unknown
482,1,1,2nd Failure Type,no known failure
482,1,1,Tumor Site,oral cavity
482,1,1,Clinical lab p16,p16 unkown
484,1,1,Nodal Stage,Unknown
484,1,1,2nd Failure Type,no known failure
484,1,1,Overall Stage,Unknown
484,1,1,Research lab HPV,HPV unknown
484,1,1,Clinical lab p16,p16 unkown
484,1,1,Treatment Modality,Unknown
484,1,1,Research lab p16,p16 unknown
484,1,1,Tumor Site,Unknown
484,1,1,Occurrence #,1st primary
484,1,1,1st Failure Type,no known failure
484,1,1,Metastasis,Unknown
484,1,1,Tumor Stage,Unknown
485,1,1,Metastasis,M0
485,1,1,Research lab p16,p16 unknown
485,1,1,Overall Stage,II
485,1,1,1st Failure Type,no known failure
485,1,1,Nodal Stage,N0
485,1,1,Tumor Site,oral cavity
485,1,1,2nd Failure Type,no known failure
485,1,1,Occurrence #,1st primary
485,1,1,Tumor Stage,T2
485,1,1,Clinical lab p16,p16 unkown
485,1,1,Treatment Modality,Sx
485,1,1,Research lab HPV,HPV unknown
487,1,1,Tumor Site,oropharynx
487,1,1,Nodal Stage,N2
487,1,1,Overall Stage,IVa
487,1,1,Tumor Stage,T1
487,1,1,Metastasis,M0
487,1,1,Treatment Modality,Sx & CTX-RT
487,1,1,1st Failure Type,distant
487,1,1,Radiation Dosage,66.6
487,1,1,Clinical lab p16,p16 unkown
487,1,1,Occurrence #,1st primary
487,1,1,Initial Chemotherapy Agent,cis
487,1,1,Research lab p16,p16 unknown
487,1,1,Research lab HPV,HPV unknown
487,1,1,2nd Failure Type,no known failure
488,1,1,Nodal Stage,N2
488,1,1,Treatment Modality,Sx
488,1,1,Metastasis,M0
488,1,1,Research lab HPV,HPV unknown
488,1,1,Overall Stage,IVa
488,1,1,2nd Failure Type,no known failure
488,1,1,Clinical lab p16,p16 unkown
488,1,1,Tumor Site,hypopharynx
488,1,1,1st Failure Type,no known failure
488,1,1,Tumor Stage,T4a
488,1,1,Research lab p16,p16 unknown
488,1,1,Occurrence #,1st primary
490,1,1,Tumor Site,oropharynx
490,1,1,Occurrence #,1st primary
490,1,1,Tumor Stage,T4a
490,1,1,Radiation Dosage,54
490,1,1,Clinical lab p16,p16 unkown
490,1,1,Research lab HPV,HPV negative
490,1,1,Research lab p16,p16 negative
490,1,1,2nd Failure Type,no known failure
490,1,1,1st Failure Type,locoregional
490,1,1,Overall Stage,IVb
490,1,1,Treatment Modality,CTX-RT
490,1,1,Initial Chemotherapy Agent,5FU/cis
490,1,1,Nodal Stage,N3
490,1,1,Metastasis,M0
491,1,1,Research lab HPV,HPV negative
491,1,1,Metastasis,M0
491,1,1,Overall Stage,IVa
491,1,1,1st Failure Treatment Modality,Sx
491,1,1,Nodal Stage,N2
491,1,1,Radiation Dosage,70.2
491,1,1,Treatment Modality,CTX-RT
491,1,1,Clinical lab p16,p16 unkown
491,1,1,Tumor Stage,T3
491,1,1,Tumor Site,oropharynx
491,1,1,1st Failure Type,locoregional
491,1,1,Initial Chemotherapy Agent,carbo/PTX
491,1,1,1st Failure Site,larynx
491,1,1,Research lab p16,p16 negative
491,1,1,2nd Failure Type,no known failure
491,1,1,Occurrence #,1st primary
492,1,1,Research lab p16,p16 negative
492,1,1,Initial Chemotherapy Agent,cis
492,1,1,Metastasis,M0
492,1,1,Clinical lab p16,p16 unkown
492,1,1,2nd Failure Type,no known failure
492,1,1,1st Failure Type,no known failure
492,1,1,Research lab HPV,HPV negative
492,1,1,Tumor Stage,T3
492,1,1,Tumor Site,larynx
492,1,1,Occurrence #,1st primary
492,1,1,Treatment Modality,CTX-RT
492,1,1,Radiation Dosage,70
492,1,1,Nodal Stage,N0
492,1,1,Overall Stage,III
493,1,1,Nodal Stage,N2
493,1,1,Research lab HPV,HPV positive
493,1,1,1st Failure Site,hypopharynx
493,1,1,Clinical lab p16,p16 unkown
493,1,1,Overall Stage,IVa
493,1,1,1st Failure Type,locoregional
493,1,1,Treatment Modality,CTX-RT
493,1,1,Research lab p16,p16 unknown
493,1,1,Occurrence #,1st primary
493,1,1,Tumor Stage,T3
493,1,1,Metastasis,M0
493,1,1,Radiation Dosage,70.2
493,1,1,2nd Failure Type,no known failure
493,1,1,Initial Chemotherapy Agent,Carbo/PTX
493,1,1,1st Failure Treatment Modality,Sx
493,1,1,Tumor Site,hypopharynx
494,1,1,Occurrence #,1st primary
494,1,1,Overall Stage,IVa
494,1,1,1st Failure Type,locoregional
494,1,1,Research lab p16,p16 unknown
494,1,1,Radiation Dosage,70.2
494,1,1,Nodal Stage,N2
494,1,1,Tumor Stage,T2
494,1,1,Metastasis,M0
494,1,1,Tumor Site,oral cavity
494,1,1,1st Failure Radiation Dosage,60
494,1,1,1st Failure Treatment Modality,Sx & CTX-RT
494,1,1,Research lab HPV,HPV positive
494,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
494,1,1,Initial Chemotherapy Agent,carbo/PTX
494,1,1,1st Failure Site,oral cavity
494,1,1,Clinical lab p16,p16 unkown
494,1,1,2nd Failure Type,no known failure
494,1,1,Treatment Modality,CTX-RT
495,1,1,2nd Failure Type,no known failure
495,1,1,1st Failure Treatment Modality,CTX
495,1,1,Nodal Stage,N3
495,1,1,Radiation Dosage,70.2
495,1,1,Initial Chemotherapy Agent,doce/Carbo
495,1,1,Occurrence #,1st primary
495,1,1,Tumor Stage,T2
495,1,1,Research lab p16,p16 unknown
495,1,1,1st Failure Initial Chemotherapy Agent,cis/doce
495,1,1,Overall Stage,IVb
495,1,1,Clinical lab p16,p16 unkown
495,1,1,1st Failure Site,oropharynx
495,1,1,Tumor Site,larynx
495,1,1,1st Failure Type,locoregional and distant
495,1,1,Metastasis,M0
495,1,1,Research lab HPV,HPV unknown
495,1,1,Treatment Modality,CTX-RT
496,1,1,Nodal Stage,Unknown
496,1,1,1st Failure Type,no known failure
496,1,1,Metastasis,Unknown
496,1,1,Occurrence #,recurrence
496,1,1,Overall Stage,Unknown
496,1,1,Clinical lab p16,p16 unkown
496,1,1,Treatment Modality,Unknown
496,1,1,Research lab HPV,HPV unknown
496,1,1,Tumor Site,larynx
496,1,1,Tumor Stage,Unknown
496,1,1,2nd Failure Type,no known failure
496,1,1,Research lab p16,p16 unknown
497,1,1,2nd Failure Type,no known failure
497,1,1,Clinical lab p16,p16 unkown
497,1,1,Overall Stage,I
497,1,1,Treatment Modality,Sx
497,1,1,Research lab HPV,HPV unknown
497,1,1,Occurrence #,1st primary
497,1,1,Metastasis,M0
497,1,1,Tumor Stage,T1
497,1,1,Research lab p16,p16 unknown
497,1,1,Nodal Stage,N0
497,1,1,Tumor Site,oral cavity
497,1,1,1st Failure Type,no known failure
498,1,1,Research lab HPV,HPV unknown
498,1,1,Tumor Site,oral cavity
498,1,1,Occurrence #,1st primary
498,1,1,Overall Stage,I
498,1,1,Research lab p16,p16 unknown
498,1,1,Nodal Stage,N0
498,1,1,Treatment Modality,Sx
498,1,1,2nd Failure Type,no known failure
498,1,1,Clinical lab p16,p16 unkown
498,1,1,Metastasis,M0
498,1,1,1st Failure Type,no known failure
498,1,1,Tumor Stage,T1
499,1,1,1st Failure Type,no known failure
499,1,1,Occurrence #,1st primary
499,1,1,Tumor Stage,Unknown
499,1,1,Metastasis,M0
499,1,1,Overall Stage,IVa
499,1,1,Clinical lab p16,p16 unkown
499,1,1,Treatment Modality,Sx
499,1,1,Tumor Site,oral cavity
499,1,1,Research lab HPV,HPV unknown
499,1,1,2nd Failure Type,no known failure
499,1,1,Research lab p16,p16 unknown
499,1,1,Nodal Stage,N2
500,1,1,Clinical lab p16,p16 unkown
500,1,1,Research lab HPV,HPV unknown
500,1,1,Metastasis,M0
500,1,1,Tumor Site,oral cavity
500,1,1,Treatment Modality,Sx
500,1,1,Nodal Stage,N0
500,1,1,Research lab p16,p16 unknown
500,1,1,1st Failure Type,no known failure
500,1,1,Overall Stage,IVa
500,1,1,Occurrence #,1st primary
500,1,1,2nd Failure Type,no known failure
500,1,1,Tumor Stage,T4a
501,1,1,2nd Failure Type,no known failure
501,1,1,Clinical lab p16,p16 unkown
501,1,1,Occurrence #,1st primary
501,1,1,Research lab HPV,HPV unknown
501,1,1,Nodal Stage,N0
501,1,1,Tumor Site,oral cavity
501,1,1,Research lab p16,p16 unknown
501,1,1,Treatment Modality,Sx
501,1,1,1st Failure Type,no known failure
501,1,1,Overall Stage,II
501,1,1,Metastasis,M0
501,1,1,Tumor Stage,T2
502,1,1,1st Failure Type,no known failure
502,1,1,Research lab p16,p16 unknown
502,1,1,Research lab HPV,HPV unknown
502,1,1,Tumor Site,oral cavity
502,1,1,Treatment Modality,Sx
502,1,1,Metastasis,M0
502,1,1,2nd Failure Type,no known failure
502,1,1,Overall Stage,IVa
502,1,1,Occurrence #,1st primary
502,1,1,Nodal Stage,N2
502,1,1,Clinical lab p16,p16 unkown
502,1,1,Tumor Stage,T3
503,1,1,Metastasis,M0
503,1,1,Research lab p16,p16 unknown
503,1,1,Tumor Stage,T4a
503,1,1,Nodal Stage,N2
503,1,1,1st Failure Type,no known failure
503,1,1,Occurrence #,1st primary
503,1,1,2nd Failure Type,no known failure
503,1,1,Research lab HPV,HPV unknown
503,1,1,Clinical lab p16,p16 unkown
503,1,1,Treatment Modality,Sx
503,1,1,Tumor Site,oral cavity
503,1,1,Overall Stage,IVa
505,1,1,Nodal Stage,N0
505,1,1,Research lab p16,p16 unknown
505,1,1,1st Failure Treatment Modality,Sx & CTX-RT
505,1,1,Tumor Site,oral cavity
505,1,1,1st Failure Radiation Dosage,63
505,1,1,2nd Failure Type,no known failure
505,1,1,1st Failure Type,locoregional
505,1,1,Research lab HPV,HPV unknown
505,1,1,Treatment Modality,Sx
505,1,1,Tumor Stage,T1
505,1,1,Metastasis,M0
505,1,1,Occurrence #,1st primary
505,1,1,1st Failure Site,oral cavity
505,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
505,1,1,Overall Stage,I
505,1,1,Clinical lab p16,p16 unkown
506,1,1,2nd Failure Type,no known failure
506,1,1,Metastasis,M0
506,1,1,Clinical lab p16,p16 unkown
506,1,1,Treatment Modality,Sx
506,1,1,Tumor Stage,T1
506,1,1,1st Failure Type,no known failure
506,1,1,Nodal Stage,N0
506,1,1,Tumor Site,oral cavity
506,1,1,Occurrence #,1st primary
506,1,1,Research lab HPV,HPV unknown
506,1,1,Research lab p16,p16 unknown
506,1,1,Overall Stage,I
507,1,1,Overall Stage,I
507,1,1,1st Failure Treatment Modality,Sx
507,1,1,Tumor Stage,T1
507,1,1,1st Failure Type,locoregional
507,1,1,Occurrence #,1st primary
507,1,1,Tumor Site,oral cavity
507,1,1,Nodal Stage,N0
507,1,1,Research lab p16,p16 unknown
507,1,1,Treatment Modality,Sx
507,1,1,Clinical lab p16,p16 unkown
507,1,1,Research lab HPV,HPV unknown
507,1,1,Metastasis,M0
507,1,1,1st Failure Site,oral cavity
507,1,1,2nd Failure Type,no known failure
509,1,1,Research lab HPV,HPV unknown
509,1,1,Treatment Modality,Sx
509,1,1,1st Failure Type,no known failure
509,1,1,Clinical lab p16,p16 unkown
509,1,1,Occurrence #,1st primary
509,1,1,2nd Failure Type,no known failure
509,1,1,Overall Stage,II
509,1,1,Tumor Stage,T2
509,1,1,Nodal Stage,N0
509,1,1,Research lab p16,p16 unknown
509,1,1,Tumor Site,oral cavity
509,1,1,Metastasis,M0
510,1,1,1st Failure Radiation Dosage,70.2
510,1,1,Tumor Site,oral cavity
510,1,1,Clinical lab p16,p16 unkown
510,1,1,Treatment Modality,Sx
510,1,1,1st Failure Site,oral cavity
510,1,1,1st Failure Treatment Modality,CTX-RT
510,1,1,Occurrence #,1st primary
510,1,1,2nd Failure Type,no known failure
510,1,1,Research lab p16,p16 unknown
510,1,1,Research lab HPV,HPV unknown
510,1,1,1st Failure Initial Chemotherapy Agent,carbo/cap
510,1,1,Overall Stage,IVa
510,1,1,Nodal Stage,N1
510,1,1,Tumor Stage,T4a
510,1,1,Metastasis,M0
510,1,1,1st Failure Type,locoregional
511,1,1,2nd Failure Type,no known failure
511,1,1,Occurrence #,1st primary
511,1,1,Research lab p16,p16 unknown
511,1,1,Metastasis,M0
511,1,1,Overall Stage,I
511,1,1,Tumor Stage,T1
511,1,1,Tumor Site,oral cavity
511,1,1,Research lab HPV,HPV unknown
511,1,1,Nodal Stage,N0
511,1,1,Treatment Modality,Sx
511,1,1,Clinical lab p16,p16 unkown
511,1,1,1st Failure Type,no known failure
512,1,1,Nodal Stage,N0
512,1,1,2nd Failure Type,no known failure
512,1,1,Overall Stage,I
512,1,1,Tumor Stage,T1
512,1,1,Treatment Modality,Sx
512,1,1,Occurrence #,1st primary
512,1,1,Clinical lab p16,p16 unkown
512,1,1,Research lab p16,p16 unknown
512,1,1,Research lab HPV,HPV unknown
512,1,1,Tumor Site,oral cavity
512,1,1,Metastasis,M0
512,1,1,1st Failure Type,no known failure
513,1,1,2nd Failure Type,no known failure
513,1,1,Metastasis,M0
513,1,1,1st Failure Type,no known failure
513,1,1,Overall Stage,I
513,1,1,Occurrence #,1st primary
513,1,1,Research lab p16,p16 unknown
513,1,1,Tumor Stage,T1
513,1,1,Treatment Modality,Sx
513,1,1,Research lab HPV,HPV unknown
513,1,1,Clinical lab p16,p16 unkown
513,1,1,Nodal Stage,N0
513,1,1,Tumor Site,oral cavity
514,1,1,Research lab p16,p16 unknown
514,1,1,Clinical lab p16,p16 unkown
514,1,1,1st Failure Type,locoregional
514,1,1,Treatment Modality,Sx
514,1,1,Metastasis,M0
514,1,1,Tumor Site,oral cavity
514,1,1,Research lab HPV,HPV unknown
514,1,1,Tumor Stage,T4a
514,1,1,Nodal Stage,N0
514,1,1,Overall Stage,IVa
514,1,1,Occurrence #,other primary
514,1,1,2nd Failure Type,no known failure
515,1,1,Metastasis,M0
515,1,1,Nodal Stage,N0
515,1,1,Research lab HPV,HPV unknown
515,1,1,Tumor Site,oral cavity
515,1,1,Tumor Stage,T2
515,1,1,Occurrence #,1st primary
515,1,1,Research lab p16,p16 unknown
515,1,1,Treatment Modality,Sx
515,1,1,Clinical lab p16,p16 unkown
515,1,1,1st Failure Type,no known failure
515,1,1,2nd Failure Type,no known failure
515,1,1,Overall Stage,II
516,1,1,2nd Failure Type,no known failure
516,1,1,Overall Stage,IVa
516,1,1,Occurrence #,1st primary
516,1,1,Research lab p16,p16 unknown
516,1,1,1st Failure Type,locoregional and distant
516,1,1,Tumor Stage,T4a
516,1,1,Clinical lab p16,p16 unkown
516,1,1,Research lab HPV,HPV unknown
516,1,1,Tumor Site,oral cavity
516,1,1,Treatment Modality,Sx
516,1,1,Nodal Stage,N2
516,1,1,Metastasis,M0
517,1,1,Treatment Modality,Sx & RT
517,1,1,1st Failure Initial Chemotherapy Agent,unknown
517,1,1,Research lab p16,p16 unknown
517,1,1,1st Failure Type,locoregional
517,1,1,Radiation Dosage,63
517,1,1,Clinical lab p16,p16 unkown
517,1,1,1st Failure Radiation Dosage,60
517,1,1,1st Failure Treatment Modality,Sx & CTX-RT
517,1,1,1st Failure Site,oral cavity
517,1,1,2nd Failure Type,no known failure
517,1,1,Metastasis,M0
517,1,1,Tumor Site,oral cavity
517,1,1,Tumor Stage,T4a
517,1,1,Occurrence #,1st primary
517,1,1,Research lab HPV,HPV unknown
517,1,1,Overall Stage,IVa
517,1,1,Nodal Stage,N0
518,1,1,Treatment Modality,Sx
518,1,1,Research lab p16,p16 unknown
518,1,1,Tumor Stage,T4a
518,1,1,Tumor Site,oral cavity
518,1,1,Nodal Stage,N0
518,1,1,2nd Failure Type,no known failure
518,1,1,Overall Stage,IVa
518,1,1,Clinical lab p16,p16 unkown
518,1,1,1st Failure Type,no known failure
518,1,1,Research lab HPV,HPV unknown
518,1,1,Occurrence #,1st primary
518,1,1,Metastasis,M0
519,1,1,Overall Stage,II
519,1,1,Clinical lab p16,p16 unkown
519,1,1,Treatment Modality,RT
519,1,1,Nodal Stage,N0
519,1,1,Occurrence #,1st primary
519,1,1,2nd Failure Type,no known failure
519,1,1,1st Failure Type,no known failure
519,1,1,Research lab HPV,HPV unknown
519,1,1,Tumor Site,oral cavity
519,1,1,Metastasis,M0
519,1,1,Tumor Stage,T2
519,1,1,Radiation Dosage,32
519,1,1,Research lab p16,p16 unknown
520,1,1,Metastasis,M0
520,1,1,Research lab p16,p16 unknown
520,1,1,Treatment Modality,Sx
520,1,1,1st Failure Type,no known failure
520,1,1,2nd Failure Type,no known failure
520,1,1,Occurrence #,1st primary
520,1,1,Tumor Stage,T4a
520,1,1,Tumor Site,oral cavity
520,1,1,Clinical lab p16,p16 unkown
520,1,1,Research lab HPV,HPV unknown
520,1,1,Overall Stage,IVa
520,1,1,Nodal Stage,N0
521,1,1,Metastasis,M0
521,1,1,Research lab p16,p16 unknown
521,1,1,1st Failure Type,no known failure
521,1,1,Overall Stage,II
521,1,1,Tumor Site,oral cavity
521,1,1,Tumor Stage,T2
521,1,1,Research lab HPV,HPV unknown
521,1,1,Nodal Stage,N0
521,1,1,Clinical lab p16,p16 unkown
521,1,1,Treatment Modality,Sx
521,1,1,Occurrence #,1st primary
521,1,1,2nd Failure Type,no known failure
522,1,1,1st Failure Type,no known failure
522,1,1,Metastasis,M0
522,1,1,Treatment Modality,Sx
522,1,1,Research lab p16,p16 unknown
522,1,1,Tumor Stage,T1
522,1,1,Tumor Site,oral cavity
522,1,1,Overall Stage,I
522,1,1,Clinical lab p16,p16 unkown
522,1,1,Nodal Stage,N0
522,1,1,2nd Failure Type,no known failure
522,1,1,Research lab HPV,HPV unknown
522,1,1,Occurrence #,1st primary
524,1,1,1st Failure Treatment Modality,Sx
524,1,1,Research lab p16,p16 unknown
524,1,1,Treatment Modality,Sx
524,1,1,Occurrence #,1st primary
524,1,1,Nodal Stage,N0
524,1,1,Tumor Site,oral cavity
524,1,1,1st Failure Site,oral cavity
524,1,1,Metastasis,M0
524,1,1,Tumor Stage,T1
524,1,1,Research lab HPV,HPV unknown
524,1,1,Clinical lab p16,p16 unkown
524,1,1,1st Failure Type,no known failure
524,1,1,2nd Failure Type,no known failure
524,1,1,Overall Stage,I
525,1,1,Research lab HPV,HPV unknown
525,1,1,Tumor Stage,T2
525,1,1,Clinical lab p16,p16 unkown
525,1,1,Overall Stage,II
525,1,1,Metastasis,M0
525,1,1,Tumor Site,oral cavity
525,1,1,Research lab p16,p16 unknown
525,1,1,1st Failure Type,no known failure
525,1,1,2nd Failure Type,no known failure
525,1,1,Nodal Stage,N0
525,1,1,Occurrence #,1st primary
525,1,1,Treatment Modality,Sx
526,1,1,Research lab HPV,HPV unknown
526,1,1,Metastasis,M0
526,1,1,Tumor Site,oral cavity
526,1,1,Initial Chemotherapy Agent,carbo/PTX
526,1,1,Tumor Stage,T4a
526,1,1,Treatment Modality,CTX
526,1,1,Clinical lab p16,p16 unkown
526,1,1,2nd Failure Type,no known failure
526,1,1,Nodal Stage,N2
526,1,1,Overall Stage,IVa
526,1,1,Occurrence #,recurrence
526,1,1,Research lab p16,p16 unknown
526,1,1,1st Failure Type,locoregional
527,1,1,Occurrence #,1st primary
527,1,1,1st Failure Type,locoregional
527,1,1,Research lab HPV,HPV unknown
527,1,1,Metastasis,M0
527,1,1,Nodal Stage,N0
527,1,1,2nd Failure Type,no known failure
527,1,1,Overall Stage,IVa
527,1,1,Research lab p16,p16 unknown
527,1,1,Tumor Site,oral cavity
527,1,1,Clinical lab p16,p16 unkown
527,1,1,Tumor Stage,T4a
527,1,1,Treatment Modality,Sx
528,1,1,Research lab HPV,HPV unknown
528,1,1,Tumor Site,oral cavity
528,1,1,2nd Failure Type,no known failure
528,1,1,Metastasis,M0
528,1,1,Clinical lab p16,p16 unkown
528,1,1,Nodal Stage,N0
528,1,1,Tumor Stage,T1
528,1,1,Occurrence #,1st primary
528,1,1,1st Failure Type,no known failure
528,1,1,Treatment Modality,Sx
528,1,1,Overall Stage,I
528,1,1,Research lab p16,p16 unknown
529,1,1,Occurrence #,1st primary
529,1,1,2nd Failure Type,no known failure
529,1,1,Nodal Stage,N2
529,1,1,Metastasis,M0
529,1,1,Clinical lab p16,p16 unkown
529,1,1,Overall Stage,IVa
529,1,1,1st Failure Type,no known failure
529,1,1,Tumor Site,oral cavity
529,1,1,Tumor Stage,T4a
529,1,1,Treatment Modality,Sx
529,1,1,Research lab HPV,HPV unknown
529,1,1,Research lab p16,p16 unknown
530,1,1,Treatment Modality,Sx
530,1,1,Occurrence #,1st primary
530,1,1,Tumor Site,oral cavity
530,1,1,Research lab p16,p16 unknown
530,1,1,Tumor Stage,T1
530,1,1,1st Failure Type,no known failure
530,1,1,Overall Stage,I
530,1,1,Nodal Stage,N0
530,1,1,2nd Failure Type,no known failure
530,1,1,Clinical lab p16,p16 unkown
530,1,1,Research lab HPV,HPV unknown
530,1,1,Metastasis,M0
531,1,1,Research lab p16,p16 unknown
531,1,1,Overall Stage,IVa
531,1,1,1st Failure Type,no known failure
531,1,1,Nodal Stage,N2
531,1,1,Metastasis,M0
531,1,1,Tumor Site,oral cavity
531,1,1,Treatment Modality,Sx
531,1,1,Tumor Stage,T1
531,1,1,2nd Failure Type,no known failure
531,1,1,Research lab HPV,HPV unknown
531,1,1,Occurrence #,1st primary
531,1,1,Clinical lab p16,p16 unkown
532,1,1,Treatment Modality,CTX-RT
532,1,1,Research lab p16,p16 unknown
532,1,1,Overall Stage,IVa
532,1,1,Nodal Stage,N3
532,1,1,1st Failure Type,distant
532,1,1,Radiation Dosage,70.2
532,1,1,Occurrence #,1st primary
532,1,1,Metastasis,M0
532,1,1,2nd Failure Type,no known failure
532,1,1,Clinical lab p16,p16 unkown
532,1,1,Initial Chemotherapy Agent,carbo/PTX/amifostine
532,1,1,1st Failure Treatment Modality,CTX-RT
532,1,1,Research lab HPV,HPV unknown
532,1,1,Tumor Stage,T4a
532,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
532,1,1,Tumor Site,oral cavity
532,1,1,1st Failure Site,oral cavity
532,1,1,1st Failure Radiation Dosage,unknown
533,1,1,Clinical lab p16,p16 unkown
533,1,1,Research lab p16,p16 unknown
533,1,1,Treatment Modality,Sx
533,1,1,Metastasis,M0
533,1,1,Occurrence #,1st primary
533,1,1,Tumor Site,oral cavity
533,1,1,Nodal Stage,N0
533,1,1,Research lab HPV,HPV unknown
533,1,1,1st Failure Type,no known failure
533,1,1,Overall Stage,IVa
533,1,1,Tumor Stage,T4a
533,1,1,2nd Failure Type,no known failure
534,1,1,Research lab HPV,HPV unknown
534,1,1,Metastasis,M0
534,1,1,1st Failure Treatment Modality,Sx
534,1,1,Occurrence #,1st primary
534,1,1,2nd Failure Type,no known failure
534,1,1,Tumor Site,oral cavity
534,1,1,Clinical lab p16,p16 unkown
534,1,1,Nodal Stage,N1
534,1,1,Treatment Modality,Sx
534,1,1,1st Failure Type,no known failure
534,1,1,Tumor Stage,T2
534,1,1,Overall Stage,III
534,1,1,1st Failure Site,oral cavity
534,1,1,Research lab p16,p16 unknown
535,1,1,Tumor Site,oral cavity
535,1,1,Overall Stage,I
535,1,1,Occurrence #,1st primary
535,1,1,Treatment Modality,Sx
535,1,1,Research lab HPV,HPV unknown
535,1,1,2nd Failure Type,no known failure
535,1,1,Tumor Stage,T1
535,1,1,Clinical lab p16,p16 unkown
535,1,1,Nodal Stage,N0
535,1,1,Metastasis,M0
535,1,1,Research lab p16,p16 unknown
535,1,1,1st Failure Type,no known failure
536,1,1,Occurrence #,1st primary
536,1,1,Treatment Modality,Sx
536,1,1,Overall Stage,II
536,1,1,Metastasis,M0
536,1,1,Nodal Stage,N0
536,1,1,Clinical lab p16,p16 unkown
536,1,1,1st Failure Type,locoregional
536,1,1,2nd Failure Type,no known failure
536,1,1,Research lab p16,p16 unknown
536,1,1,Tumor Stage,T2
536,1,1,Tumor Site,oral cavity
536,1,1,Research lab HPV,HPV unknown
537,1,1,Treatment Modality,Sx
537,1,1,Overall Stage,I
537,1,1,1st Failure Type,no known failure
537,1,1,Metastasis,M0
537,1,1,Clinical lab p16,p16 unkown
537,1,1,Research lab HPV,HPV unknown
537,1,1,Tumor Site,oral cavity
537,1,1,Tumor Stage,T1
537,1,1,Nodal Stage,N0
537,1,1,Occurrence #,1st primary
537,1,1,Research lab p16,p16 unknown
537,1,1,2nd Failure Type,no known failure
538,1,1,Treatment Modality,Sx & CTX
538,1,1,Research lab p16,p16 unknown
538,1,1,2nd Failure Type,no known failure
538,1,1,1st Failure Treatment Modality,CTX
538,1,1,1st Failure Type,no known failure
538,1,1,1st Failure Second Line Chemotherapy Agent,gemcitabine/doce/cap
538,1,1,1st Failure Initial Chemotherapy Agent,cis/doce
538,1,1,Clinical lab p16,p16 unkown
538,1,1,Occurrence #,recurrence
538,1,1,Nodal Stage,N2
538,1,1,Initial Chemotherapy Agent,Cis/doce
538,1,1,Overall Stage,IVa
538,1,1,Tumor Stage,T3
538,1,1,1st Failure Site,oropharynx
538,1,1,Metastasis,M0
538,1,1,Tumor Site,oral cavity
538,1,1,Research lab HPV,HPV unknown
539,1,1,Research lab HPV,HPV unknown
539,1,1,Treatment Modality,Sx
539,1,1,2nd Failure Type,no known failure
539,1,1,Nodal Stage,N0
539,1,1,1st Failure Type,no known failure
539,1,1,Overall Stage,I
539,1,1,Tumor Site,oral cavity
539,1,1,Tumor Stage,T1
539,1,1,Occurrence #,1st primary
539,1,1,Research lab p16,p16 unknown
539,1,1,Clinical lab p16,p16 unkown
539,1,1,Metastasis,M0
540,1,1,Occurrence #,1st primary
540,1,1,Clinical lab p16,p16 unkown
540,1,1,1st Failure Type,no known failure
540,1,1,Tumor Site,oral cavity
540,1,1,Tumor Stage,T2
540,1,1,2nd Failure Type,no known failure
540,1,1,Metastasis,M0
540,1,1,Overall Stage,II
540,1,1,Research lab HPV,HPV unknown
540,1,1,Nodal Stage,N0
540,1,1,Treatment Modality,Sx
540,1,1,Research lab p16,p16 unknown
541,1,1,Occurrence #,1st primary
541,1,1,Tumor Stage,Unknown
541,1,1,Tumor Site,oral cavity
541,1,1,1st Failure Type,no known failure
541,1,1,Clinical lab p16,p16 unkown
541,1,1,Nodal Stage,Unknown
541,1,1,Research lab HPV,HPV unknown
541,1,1,Overall Stage,Unknown
541,1,1,Research lab p16,p16 unknown
541,1,1,Treatment Modality,Unknown
541,1,1,Metastasis,Unknown
541,1,1,2nd Failure Type,no known failure
542,1,1,Treatment Modality,Sx
542,1,1,Nodal Stage,N0
542,1,1,Research lab p16,p16 unknown
542,1,1,2nd Failure Type,no known failure
542,1,1,Tumor Site,oral cavity
542,1,1,Research lab HPV,HPV unknown
542,1,1,Clinical lab p16,p16 unkown
542,1,1,Metastasis,M0
542,1,1,Tumor Stage,T2
542,1,1,1st Failure Type,no known failure
542,1,1,Overall Stage,II
542,1,1,Occurrence #,1st primary
543,1,1,Occurrence #,1st primary
543,1,1,Research lab p16,p16 unknown
543,1,1,Research lab HPV,HPV unknown
543,1,1,Tumor Site,oral cavity
543,1,1,Nodal Stage,N0
543,1,1,Overall Stage,I
543,1,1,Tumor Stage,T1
543,1,1,2nd Failure Type,no known failure
543,1,1,Treatment Modality,Sx
543,1,1,Clinical lab p16,p16 unkown
543,1,1,1st Failure Type,no known failure
543,1,1,Metastasis,M0
544,1,1,Tumor Stage,T1
544,1,1,Research lab p16,p16 unknown
544,1,1,Clinical lab p16,p16 unkown
544,1,1,Treatment Modality,Sx
544,1,1,2nd Failure Type,no known failure
544,1,1,Overall Stage,I
544,1,1,Metastasis,M0
544,1,1,1st Failure Type,no known failure
544,1,1,Occurrence #,1st primary
544,1,1,Nodal Stage,N0
544,1,1,Tumor Site,oral cavity
544,1,1,Research lab HPV,HPV unknown
545,1,1,Research lab HPV,HPV unknown
545,1,1,1st Failure Site,oral cavity
545,1,1,Research lab p16,p16 unknown
545,1,1,1st Failure Treatment Modality,Sx
545,1,1,Clinical lab p16,p16 unkown
545,1,1,Overall Stage,I
545,1,1,1st Failure Type,locoregional
545,1,1,Occurrence #,1st primary
545,1,1,Metastasis,M0
545,1,1,Tumor Site,oral cavity
545,1,1,2nd Failure Type,no known failure
545,1,1,Tumor Stage,T1
545,1,1,Treatment Modality,Sx
545,1,1,Nodal Stage,N0
546,1,1,Clinical lab p16,p16 unkown
546,1,1,Tumor Stage,T4b
546,1,1,1st Failure Type,no known failure
546,1,1,Occurrence #,1st primary
546,1,1,Nodal Stage,N2
546,1,1,Treatment Modality,Sx
546,1,1,Research lab HPV,HPV unknown
546,1,1,Research lab p16,p16 unknown
546,1,1,Tumor Site,oral cavity
546,1,1,2nd Failure Type,no known failure
546,1,1,Metastasis,M0
546,1,1,Overall Stage,IVb
547,1,1,Overall Stage,II
547,1,1,2nd Failure Type,no known failure
547,1,1,Tumor Stage,T2
547,1,1,1st Failure Type,no known failure
547,1,1,Metastasis,M0
547,1,1,1st Failure Site,oral cavity
547,1,1,Radiation Dosage,unknown
547,1,1,Research lab HPV,HPV unknown
547,1,1,Nodal Stage,N0
547,1,1,Clinical lab p16,p16 unkown
547,1,1,Occurrence #,recurrence
547,1,1,Treatment Modality,RT
547,1,1,1st Failure Treatment Modality,Sx
547,1,1,Research lab p16,p16 unknown
547,1,1,Tumor Site,oral cavity
549,1,1,1st Failure Radiation Dosage,unk
549,1,1,Overall Stage,I
549,1,1,Tumor Site,oral cavity
549,1,1,Metastasis,M0
549,1,1,1st Failure Site,oral cavity
549,1,1,Treatment Modality,Sx
549,1,1,Occurrence #,1st primary
549,1,1,2nd Failure Type,no known failure
549,1,1,Clinical lab p16,p16 unkown
549,1,1,1st Failure Type,no known failure
549,1,1,Tumor Stage,T1
549,1,1,1st Failure Treatment Modality,Sx & RT
549,1,1,Research lab HPV,HPV unknown
549,1,1,Nodal Stage,N0
549,1,1,Research lab p16,p16 unknown
550,1,1,2nd Failure Type,no known failure
550,1,1,Tumor Stage,T1
550,1,1,Nodal Stage,N0
550,1,1,Research lab p16,p16 unknown
550,1,1,1st Failure Type,no known failure
550,1,1,Research lab HPV,HPV unknown
550,1,1,Overall Stage,I
550,1,1,Clinical lab p16,p16 unkown
550,1,1,Treatment Modality,Sx
550,1,1,Tumor Site,oral cavity
550,1,1,Occurrence #,1st primary
550,1,1,Metastasis,M0
551,1,1,Treatment Modality,Sx
551,1,1,1st Failure Type,no known failure
551,1,1,Tumor Site,oral cavity
551,1,1,Metastasis,M0
551,1,1,Research lab HPV,HPV unknown
551,1,1,Overall Stage,III
551,1,1,Occurrence #,1st primary
551,1,1,2nd Failure Type,no known failure
551,1,1,Nodal Stage,N1
551,1,1,Research lab p16,p16 unknown
551,1,1,Clinical lab p16,p16 unkown
551,1,1,Tumor Stage,T1
552,1,1,1st Failure Type,locoregional
552,1,1,Research lab HPV,HPV unknown
552,1,1,Nodal Stage,N0
552,1,1,Research lab p16,p16 unknown
552,1,1,Tumor Stage,T2
552,1,1,Clinical lab p16,p16 unkown
552,1,1,Metastasis,M0
552,1,1,Tumor Site,oral cavity
552,1,1,Treatment Modality,Sx
552,1,1,2nd Failure Type,no known failure
552,1,1,Overall Stage,II
552,1,1,Occurrence #,1st primary
553,1,1,Metastasis,M0
553,1,1,Research lab HPV,HPV unknown
553,1,1,Research lab p16,p16 unknown
553,1,1,Tumor Stage,T1
553,1,1,Clinical lab p16,p16 unkown
553,1,1,Nodal Stage,N0
553,1,1,2nd Failure Type,no known failure
553,1,1,Treatment Modality,Sx
553,1,1,1st Failure Type,locoregional
553,1,1,Tumor Site,oral cavity
553,1,1,Occurrence #,1st primary
553,1,1,Overall Stage,I
554,1,1,Tumor Site,oral cavity
554,1,1,Occurrence #,1st primary
554,1,1,1st Failure Type,no known failure
554,1,1,Tumor Stage,T4a
554,1,1,Clinical lab p16,p16 unkown
554,1,1,Research lab p16,p16 unknown
554,1,1,Metastasis,M0
554,1,1,Overall Stage,IVa
554,1,1,Treatment Modality,Sx
554,1,1,Nodal Stage,N0
554,1,1,Research lab HPV,HPV unknown
554,1,1,2nd Failure Type,no known failure
555,1,1,1st Failure Site,oral cavity
555,1,1,Occurrence #,1st primary
555,1,1,Research lab p16,p16 unknown
555,1,1,1st Failure Treatment Modality,Sx
555,1,1,Research lab HPV,HPV unknown
555,1,1,Clinical lab p16,p16 unkown
555,1,1,2nd Failure Type,no known failure
555,1,1,Tumor Site,oral cavity
555,1,1,Treatment Modality,Sx
555,1,1,Nodal Stage,N0
555,1,1,Tumor Stage,T1
555,1,1,1st Failure Type,locoregional
555,1,1,Metastasis,M0
555,1,1,Overall Stage,I
556,1,1,Clinical lab p16,p16 unkown
556,1,1,Metastasis,M0
556,1,1,1st Failure Type,no known failure
556,1,1,Occurrence #,1st primary
556,1,1,Treatment Modality,Unknown
556,1,1,Overall Stage,IVb
556,1,1,Tumor Stage,T4a
556,1,1,Nodal Stage,N3
556,1,1,Research lab p16,p16 unknown
556,1,1,2nd Failure Type,no known failure
556,1,1,Research lab HPV,HPV unknown
556,1,1,Tumor Site,oral cavity
557,1,1,Metastasis,M0
557,1,1,Treatment Modality,Sx
557,1,1,Occurrence #,1st primary
557,1,1,1st Failure Type,no known failure
557,1,1,Overall Stage,I
557,1,1,Nodal Stage,N0
557,1,1,2nd Failure Type,no known failure
557,1,1,Research lab p16,p16 unknown
557,1,1,Tumor Site,oral cavity
557,1,1,Tumor Stage,T1
557,1,1,Research lab HPV,HPV unknown
557,1,1,Clinical lab p16,p16 unkown
558,1,1,Tumor Stage,T1
558,1,1,Clinical lab p16,p16 unkown
558,1,1,2nd Failure Type,no known failure
558,1,1,Treatment Modality,Sx
558,1,1,Tumor Site,oral cavity
558,1,1,Overall Stage,I
558,1,1,Nodal Stage,N0
558,1,1,Occurrence #,1st primary
558,1,1,1st Failure Type,no known failure
558,1,1,Research lab HPV,HPV unknown
558,1,1,Research lab p16,p16 unknown
558,1,1,Metastasis,M0
559,1,1,Research lab p16,p16 unknown
559,1,1,Overall Stage,I
559,1,1,1st Failure Type,no known failure
559,1,1,Clinical lab p16,p16 unkown
559,1,1,Tumor Site,oral cavity
559,1,1,2nd Failure Type,no known failure
559,1,1,Metastasis,M0
559,1,1,Tumor Stage,T1
559,1,1,Nodal Stage,N0
559,1,1,Research lab HPV,HPV unknown
559,1,1,Occurrence #,1st primary
559,1,1,Treatment Modality,Sx
560,1,1,Metastasis,M0
560,1,1,Overall Stage,I
560,1,1,Nodal Stage,N0
560,1,1,1st Failure Type,no known failure
560,1,1,Tumor Site,oral cavity
560,1,1,Research lab HPV,HPV unknown
560,1,1,Research lab p16,p16 unknown
560,1,1,Treatment Modality,Sx
560,1,1,Tumor Stage,T1
560,1,1,Clinical lab p16,p16 unkown
560,1,1,Occurrence #,1st primary
560,1,1,2nd Failure Type,no known failure
561,1,1,Tumor Stage,T1
561,1,1,2nd Failure Type,no known failure
561,1,1,Metastasis,M0
561,1,1,Occurrence #,1st primary
561,1,1,Clinical lab p16,p16 unkown
561,1,1,Research lab HPV,HPV unknown
561,1,1,Tumor Site,oral cavity
561,1,1,Research lab p16,p16 unknown
561,1,1,Overall Stage,I
561,1,1,Treatment Modality,Sx
561,1,1,1st Failure Type,no known failure
561,1,1,Nodal Stage,N0
562,1,1,Tumor Site,oral cavity
562,1,1,Occurrence #,1st primary
562,1,1,Research lab p16,p16 unknown
562,1,1,Clinical lab p16,p16 unkown
562,1,1,Tumor Stage,T4a
562,1,1,2nd Failure Type,no known failure
562,1,1,Research lab HPV,HPV unknown
562,1,1,Metastasis,M0
562,1,1,Overall Stage,IVa
562,1,1,Treatment Modality,Sx
562,1,1,Nodal Stage,N2
562,1,1,1st Failure Type,no known failure
563,1,1,Research lab p16,p16 unknown
563,1,1,Overall Stage,IVa
563,1,1,1st Failure Type,locoregional
563,1,1,Radiation Dosage,unknown
563,1,1,Metastasis,M0
563,1,1,Nodal Stage,N2
563,1,1,Treatment Modality,Sx & RT
563,1,1,1st Failure Treatment Modality,Sx
563,1,1,Research lab HPV,HPV unknown
563,1,1,1st Failure Site,oral cavity
563,1,1,Tumor Site,oral cavity
563,1,1,Occurrence #,1st primary
563,1,1,Tumor Stage,T1
563,1,1,2nd Failure Type,no known failure
563,1,1,Clinical lab p16,p16 unkown
564,1,1,Research lab p16,p16 unknown
564,1,1,2nd Failure Type,no known failure
564,1,1,Tumor Site,oral cavity
564,1,1,Research lab HPV,HPV unknown
564,1,1,Nodal Stage,N1
564,1,1,Occurrence #,1st primary
564,1,1,Metastasis,M0
564,1,1,Clinical lab p16,p16 unkown
564,1,1,1st Failure Type,no known failure
564,1,1,Treatment Modality,Sx
564,1,1,Overall Stage,III
564,1,1,Tumor Stage,T1
565,1,1,1st Failure Type,no known failure
565,1,1,Treatment Modality,Sx
565,1,1,Research lab HPV,HPV unknown
565,1,1,Tumor Site,oral cavity
565,1,1,2nd Failure Type,no known failure
565,1,1,Overall Stage,IVa
565,1,1,Nodal Stage,N2
565,1,1,Metastasis,M0
565,1,1,Clinical lab p16,p16 unkown
565,1,1,Research lab p16,p16 unknown
565,1,1,Occurrence #,1st primary
565,1,1,Tumor Stage,T4a
566,1,1,Tumor Stage,T4b
566,1,1,Nodal Stage,N1
566,1,1,1st Failure Radiation Dosage,59.4
566,1,1,1st Failure Type,locoregional
566,1,1,Research lab p16,p16 unknown
566,1,1,Overall Stage,IVb
566,1,1,2nd Failure Type,no known failure
566,1,1,1st Failure Initial Chemotherapy Agent,doce
566,1,1,Treatment Modality,Sx
566,1,1,Tumor Site,oral cavity
566,1,1,1st Failure Site,oral cavity
566,1,1,Metastasis,M0
566,1,1,Research lab HPV,HPV unknown
566,1,1,Occurrence #,1st primary
566,1,1,1st Failure Treatment Modality,CTX-RT
566,1,1,Clinical lab p16,p16 unkown
567,1,1,Research lab p16,p16 unknown
567,1,1,Radiation Dosage,unknown
567,1,1,Research lab HPV,HPV unknown
567,1,1,Treatment Modality,Sx & RT
567,1,1,2nd Failure Type,no known failure
567,1,1,Tumor Stage,T1
567,1,1,Clinical lab p16,p16 unkown
567,1,1,Occurrence #,1st primary
567,1,1,Tumor Site,oral cavity
567,1,1,1st Failure Type,no known failure
567,1,1,Nodal Stage,N0
567,1,1,Overall Stage,I
567,1,1,Metastasis,M0
568,1,1,Research lab p16,p16 unknown
568,1,1,Tumor Stage,T1
568,1,1,Research lab HPV,HPV unknown
568,1,1,Initial Chemotherapy Agent,unknown
568,1,1,2nd Failure Type,no known failure
568,1,1,Clinical lab p16,p16 unkown
568,1,1,Metastasis,M0
568,1,1,Treatment Modality,Sx & CTX-RT
568,1,1,Overall Stage,IVa
568,1,1,Nodal Stage,N2
568,1,1,Tumor Site,oral cavity
568,1,1,Radiation Dosage,unknown
568,1,1,1st Failure Type,no known failure
568,1,1,Occurrence #,1st primary
569,1,1,1st Failure Type,no known failure
569,1,1,Occurrence #,recurrence
569,1,1,Research lab p16,p16 unknown
569,1,1,Research lab HPV,HPV unknown
569,1,1,Overall Stage,I
569,1,1,Clinical lab p16,p16 unkown
569,1,1,Tumor Site,oral cavity
569,1,1,2nd Failure Type,no known failure
569,1,1,Metastasis,M0
569,1,1,Treatment Modality,Sx
569,1,1,Nodal Stage,N0
569,1,1,Tumor Stage,T1
570,1,1,Research lab p16,p16 unknown
570,1,1,Treatment Modality,Sx
570,1,1,Occurrence #,1st primary
570,1,1,1st Failure Treatment Modality,Sx
570,1,1,Research lab HPV,HPV unknown
570,1,1,Overall Stage,I
570,1,1,Nodal Stage,N0
570,1,1,Clinical lab p16,p16 unkown
570,1,1,Tumor Site,oral cavity
570,1,1,Tumor Stage,T1
570,1,1,1st Failure Type,locoregional
570,1,1,2nd Failure Type,no known failure
570,1,1,Metastasis,M0
570,1,1,1st Failure Site,oral cavity
571,1,1,Overall Stage,I
571,1,1,2nd Failure Type,no known failure
571,1,1,Research lab HPV,HPV unknown
571,1,1,Clinical lab p16,p16 unkown
571,1,1,Treatment Modality,Sx
571,1,1,Tumor Site,oral cavity
571,1,1,Tumor Stage,T1
571,1,1,Occurrence #,recurrence
571,1,1,Metastasis,M0
571,1,1,1st Failure Type,no known failure
571,1,1,Nodal Stage,N0
571,1,1,Research lab p16,p16 unknown
572,1,1,Nodal Stage,N0
572,1,1,1st Failure Type,locoregional
572,1,1,1st Failure Initial Chemotherapy Agent,carbo
572,1,1,1st Failure Site,oral cavity
572,1,1,1st Failure Radiation Dosage,60
572,1,1,Metastasis,M0
572,1,1,Tumor Stage,T4a
572,1,1,2nd Failure Type,no known failure
572,1,1,Radiation Dosage,60
572,1,1,Research lab HPV,HPV unknown
572,1,1,Clinical lab p16,p16 unkown
572,1,1,Tumor Site,oral cavity
572,1,1,Overall Stage,IVa
572,1,1,1st Failure Treatment Modality,CTX-RT
572,1,1,Treatment Modality,Sx & RT
572,1,1,Research lab p16,p16 unknown
572,1,1,Occurrence #,1st primary
573,1,1,Tumor Site,oral cavity
573,1,1,Nodal Stage,N2
573,1,1,Research lab HPV,HPV unknown
573,1,1,Research lab p16,p16 unknown
573,1,1,Metastasis,M0
573,1,1,Tumor Stage,T1
573,1,1,Treatment Modality,Sx & RT
573,1,1,2nd Failure Type,no known failure
573,1,1,Occurrence #,1st primary
573,1,1,1st Failure Type,no known failure
573,1,1,Overall Stage,IVa
573,1,1,Clinical lab p16,p16 unkown
573,1,1,Radiation Dosage,unknown
574,1,1,2nd Failure Type,no known failure
574,1,1,Clinical lab p16,p16 unkown
574,1,1,Metastasis,M0
574,1,1,Tumor Stage,T2
574,1,1,Overall Stage,II
574,1,1,Occurrence #,1st primary
574,1,1,Research lab p16,p16 unknown
574,1,1,Tumor Site,oral cavity
574,1,1,Treatment Modality,Sx
574,1,1,1st Failure Type,no known failure
574,1,1,Research lab HPV,HPV unknown
574,1,1,Nodal Stage,N0
575,1,1,Overall Stage,I
575,1,1,Nodal Stage,N0
575,1,1,2nd Failure Type,no known failure
575,1,1,Metastasis,M0
575,1,1,Research lab HPV,HPV unknown
575,1,1,Treatment Modality,Sx
575,1,1,Tumor Stage,T1
575,1,1,Occurrence #,1st primary
575,1,1,Clinical lab p16,p16 unkown
575,1,1,Tumor Site,oral cavity
575,1,1,1st Failure Type,no known failure
575,1,1,Research lab p16,p16 unknown
576,1,1,Treatment Modality,Sx & RT
576,1,1,Tumor Site,oral cavity
576,1,1,Tumor Stage,T4a
576,1,1,Overall Stage,IVa
576,1,1,Metastasis,M0
576,1,1,Radiation Dosage,59.4
576,1,1,2nd Failure Type,no known failure
576,1,1,Research lab HPV,HPV unknown
576,1,1,Nodal Stage,N0
576,1,1,Occurrence #,1st primary
576,1,1,Clinical lab p16,p16 unkown
576,1,1,1st Failure Type,distant
576,1,1,Research lab p16,p16 unknown
577,1,1,Overall Stage,III
577,1,1,Tumor Site,oral cavity
577,1,1,Research lab p16,p16 unknown
577,1,1,2nd Failure Type,no known failure
577,1,1,Radiation Dosage,59.4
577,1,1,Occurrence #,1st primary
577,1,1,Research lab HPV,HPV unknown
577,1,1,1st Failure Type,no known failure
577,1,1,Treatment Modality,Sx & RT
577,1,1,Nodal Stage,N1
577,1,1,Metastasis,M0
577,1,1,Clinical lab p16,p16 unkown
577,1,1,Tumor Stage,T1
578,1,1,Metastasis,M0
578,1,1,Overall Stage,III
578,1,1,2nd Failure Type,no known failure
578,1,1,Research lab HPV,HPV unknown
578,1,1,1st Failure Type,no known failure
578,1,1,Research lab p16,p16 unknown
578,1,1,Nodal Stage,N1
578,1,1,Tumor Site,oral cavity
578,1,1,Occurrence #,1st primary
578,1,1,Clinical lab p16,p16 unkown
578,1,1,Treatment Modality,Sx
578,1,1,Tumor Stage,T1
580,1,1,1st Failure Type,no known failure
580,1,1,Nodal Stage,N0
580,1,1,Research lab p16,p16 unknown
580,1,1,Occurrence #,1st primary
580,1,1,Treatment Modality,Sx
580,1,1,Tumor Stage,T1
580,1,1,2nd Failure Type,no known failure
580,1,1,Tumor Site,oral cavity
580,1,1,Overall Stage,I
580,1,1,Research lab HPV,HPV unknown
580,1,1,Metastasis,M0
580,1,1,Clinical lab p16,p16 unkown
581,1,1,Tumor Site,oral cavity
581,1,1,Treatment Modality,Sx
581,1,1,Clinical lab p16,p16 unkown
581,1,1,1st Failure Type,no known failure
581,1,1,Research lab p16,p16 unknown
581,1,1,Nodal Stage,N2
581,1,1,Research lab HPV,HPV unknown
581,1,1,Metastasis,Unknown
581,1,1,Overall Stage,IVa
581,1,1,2nd Failure Type,no known failure
581,1,1,Tumor Stage,T2
581,1,1,Occurrence #,1st primary
582,1,1,Tumor Stage,T3
582,1,1,Clinical lab p16,p16 unkown
582,1,1,Research lab HPV,HPV unknown
582,1,1,Nodal Stage,N2
582,1,1,Tumor Site,oral cavity
582,1,1,Treatment Modality,Sx
582,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
582,1,1,1st Failure Radiation Dosage,70.2
582,1,1,1st Failure Second Line Chemotherapy Agent,carbo
582,1,1,Research lab p16,p16 unknown
582,1,1,Overall Stage,IVa
582,1,1,1st Failure Type,locoregional
582,1,1,Metastasis,M0
582,1,1,2nd Failure Type,no known failure
582,1,1,Occurrence #,1st primary
583,1,1,Research lab HPV,HPV unknown
583,1,1,Occurrence #,1st primary
583,1,1,Tumor Stage,T4a
583,1,1,2nd Failure Type,no known failure
583,1,1,Overall Stage,IVa
583,1,1,Metastasis,M0
583,1,1,Radiation Dosage,unknown
583,1,1,Research lab p16,p16 unknown
583,1,1,Nodal Stage,N1
583,1,1,1st Failure Type,no known failure
583,1,1,Treatment Modality,Sx & RT
583,1,1,Tumor Site,oral cavity
583,1,1,Clinical lab p16,p16 unkown
585,1,1,Nodal Stage,N0
585,1,1,Tumor Stage,T1
585,1,1,Research lab HPV,HPV unknown
585,1,1,Metastasis,M0
585,1,1,1st Failure Type,no known failure
585,1,1,Occurrence #,1st primary
585,1,1,Clinical lab p16,p16 unkown
585,1,1,2nd Failure Type,no known failure
585,1,1,Treatment Modality,Sx
585,1,1,Overall Stage,I
585,1,1,Tumor Site,oral cavity
585,1,1,1st Failure Treatment Modality,Sx
585,1,1,1st Failure Site,oral cavity
585,1,1,Research lab p16,p16 unknown
586,1,1,Nodal Stage,N1
586,1,1,1st Failure Type,no known failure
586,1,1,Tumor Site,oral cavity
586,1,1,Occurrence #,1st primary
586,1,1,Metastasis,M0
586,1,1,Tumor Stage,T1
586,1,1,Research lab HPV,HPV unknown
586,1,1,Research lab p16,p16 unknown
586,1,1,Radiation Dosage,unknown
586,1,1,2nd Failure Type,no known failure
586,1,1,Overall Stage,III
586,1,1,Clinical lab p16,p16 unkown
586,1,1,Treatment Modality,Sx & RT
587,1,1,Occurrence #,1st primary
587,1,1,Nodal Stage,N0
587,1,1,Tumor Site,oral cavity
587,1,1,Overall Stage,I
587,1,1,Tumor Stage,T1
587,1,1,2nd Failure Type,no known failure
587,1,1,Clinical lab p16,p16 unkown
587,1,1,1st Failure Type,no known failure
587,1,1,Research lab p16,p16 unknown
587,1,1,Metastasis,M0
587,1,1,Treatment Modality,Sx
587,1,1,Research lab HPV,HPV unknown
588,1,1,1st Failure Type,locoregional and distant
588,1,1,Radiation Dosage,unknown
588,1,1,Nodal Stage,N2
588,1,1,2nd Failure Type,no known failure
588,1,1,Metastasis,M0
588,1,1,Overall Stage,IVa
588,1,1,Tumor Stage,T3
588,1,1,Occurrence #,1st primary
588,1,1,Clinical lab p16,p16 unkown
588,1,1,Treatment Modality,Sx & CTX-RT
588,1,1,Initial Chemotherapy Agent,unknown
588,1,1,Tumor Site,oral cavity
588,1,1,Research lab HPV,HPV unknown
588,1,1,Research lab p16,p16 unknown
589,1,1,Tumor Site,oral cavity
589,1,1,Overall Stage,IVa
589,1,1,Metastasis,M0
589,1,1,Treatment Modality,Sx
589,1,1,Research lab HPV,HPV unknown
589,1,1,Tumor Stage,T4a
589,1,1,Occurrence #,1st primary
589,1,1,Nodal Stage,N2
589,1,1,Research lab p16,p16 unknown
589,1,1,2nd Failure Type,no known failure
589,1,1,1st Failure Type,locoregional
589,1,1,Clinical lab p16,p16 unkown
590,1,1,Research lab p16,p16 unknown
590,1,1,Metastasis,Unknown
590,1,1,Tumor Stage,T1
590,1,1,Occurrence #,1st primary
590,1,1,2nd Failure Type,no known failure
590,1,1,Tumor Site,oral cavity
590,1,1,Research lab HPV,HPV unknown
590,1,1,Clinical lab p16,p16 unkown
590,1,1,1st Failure Type,no known failure
590,1,1,Overall Stage,I
590,1,1,Treatment Modality,Sx
590,1,1,Nodal Stage,N0
591,1,1,2nd Failure Type,no known failure
591,1,1,Occurrence #,1st primary
591,1,1,Clinical lab p16,p16 unkown
591,1,1,1st Failure Type,no known failure
591,1,1,Treatment Modality,Sx
591,1,1,Metastasis,M0
591,1,1,Research lab HPV,HPV unknown
591,1,1,Tumor Stage,T1
591,1,1,Nodal Stage,N0
591,1,1,Research lab p16,p16 unknown
591,1,1,Overall Stage,I
591,1,1,Tumor Site,oral cavity
592,1,1,2nd Failure Type,no known failure
592,1,1,Clinical lab p16,p16 unkown
592,1,1,Research lab p16,p16 unknown
592,1,1,1st Failure Site,oral cavity
592,1,1,Research lab HPV,HPV unknown
592,1,1,Treatment Modality,Sx & RT
592,1,1,1st Failure Radiation Dosage,69.6
592,1,1,1st Failure Type,locoregional
592,1,1,Radiation Dosage,70.2
592,1,1,1st Failure Treatment Modality,Sx & RT
592,1,1,Tumor Stage,T3
592,1,1,Occurrence #,1st primary
592,1,1,Overall Stage,III
592,1,1,Tumor Site,oral cavity
592,1,1,Nodal Stage,N0
592,1,1,Metastasis,M0
593,1,1,Research lab p16,p16 unknown
593,1,1,Nodal Stage,N0
593,1,1,1st Failure Treatment Modality,Sx
593,1,1,Tumor Site,oral cavity
593,1,1,Treatment Modality,Sx
593,1,1,2nd Failure Type,no known failure
593,1,1,1st Failure Site,oral cavity
593,1,1,Overall Stage,II
593,1,1,Tumor Stage,T2
593,1,1,Occurrence #,recurrence
593,1,1,Clinical lab p16,p16 unkown
593,1,1,1st Failure Type,locoregional
593,1,1,Metastasis,M0
593,1,1,Research lab HPV,HPV unknown
594,1,1,Nodal Stage,N2
594,1,1,Research lab p16,p16 unknown
594,1,1,Research lab HPV,HPV unknown
594,1,1,Clinical lab p16,p16 unkown
594,1,1,Overall Stage,IVa
594,1,1,Tumor Stage,T4a
594,1,1,1st Failure Type,locoregional
594,1,1,Treatment Modality,Sx
594,1,1,Tumor Site,oral cavity
594,1,1,Occurrence #,1st primary
594,1,1,Metastasis,M0
594,1,1,2nd Failure Type,no known failure
595,1,1,Clinical lab p16,p16 unkown
595,1,1,Nodal Stage,N0
595,1,1,Tumor Stage,T4a
595,1,1,1st Failure Type,no known failure
595,1,1,Metastasis,M0
595,1,1,Occurrence #,1st primary
595,1,1,2nd Failure Type,no known failure
595,1,1,Overall Stage,IVa
595,1,1,Research lab HPV,HPV unknown
595,1,1,Research lab p16,p16 unknown
595,1,1,Treatment Modality,Sx
595,1,1,Tumor Site,oral cavity
596,1,1,1st Failure Type,distant
596,1,1,Overall Stage,IVb
596,1,1,Research lab HPV,HPV unknown
596,1,1,Initial Chemotherapy Agent,cis
596,1,1,Tumor Site,oral cavity
596,1,1,Clinical lab p16,p16 unkown
596,1,1,Tumor Stage,T4a
596,1,1,Research lab p16,p16 unknown
596,1,1,Nodal Stage,N3
596,1,1,Occurrence #,1st primary
596,1,1,Metastasis,M0
596,1,1,Treatment Modality,Sx & CTX
596,1,1,2nd Failure Type,no known failure
597,1,1,Metastasis,M0
597,1,1,Radiation Dosage,63
597,1,1,Treatment Modality,Sx & CTX-RT
597,1,1,Research lab HPV,HPV unknown
597,1,1,1st Failure Type,no known failure
597,1,1,Clinical lab p16,p16 unkown
597,1,1,Research lab p16,p16 unknown
597,1,1,Tumor Stage,T2
597,1,1,Occurrence #,recurrence
597,1,1,2nd Failure Type,no known failure
597,1,1,Overall Stage,II
597,1,1,Tumor Site,oral cavity
597,1,1,Nodal Stage,N0
597,1,1,Initial Chemotherapy Agent,cis
598,1,1,Research lab p16,p16 unknown
598,1,1,Tumor Stage,T2
598,1,1,Clinical lab p16,p16 unkown
598,1,1,Occurrence #,1st primary
598,1,1,Radiation Dosage,unknown
598,1,1,Nodal Stage,N2
598,1,1,2nd Failure Type,no known failure
598,1,1,Tumor Site,oral cavity
598,1,1,Treatment Modality,Sx & RT
598,1,1,Research lab HPV,HPV unknown
598,1,1,Metastasis,M0
598,1,1,Overall Stage,IVa
598,1,1,1st Failure Type,distant
599,1,1,2nd Failure Type,no known failure
599,1,1,Occurrence #,1st primary
599,1,1,1st Failure Type,no known failure
599,1,1,Tumor Site,oral cavity
599,1,1,Research lab HPV,HPV unknown
599,1,1,Treatment Modality,Sx
599,1,1,Metastasis,M0
599,1,1,Nodal Stage,N0
599,1,1,Overall Stage,I
599,1,1,Tumor Stage,T1
599,1,1,Clinical lab p16,p16 unkown
599,1,1,Research lab p16,p16 unknown
600,1,1,1st Failure Type,no known failure
600,1,1,Occurrence #,1st primary
600,1,1,Treatment Modality,Sx & RT
600,1,1,Metastasis,M0
600,1,1,Research lab HPV,HPV unknown
600,1,1,Tumor Site,oral cavity
600,1,1,Research lab p16,p16 unknown
600,1,1,Nodal Stage,N2
600,1,1,2nd Failure Type,no known failure
600,1,1,Tumor Stage,T2
600,1,1,Radiation Dosage,unknown
600,1,1,Overall Stage,IVa
600,1,1,Clinical lab p16,p16 unkown
601,1,1,Occurrence #,1st primary
601,1,1,Research lab p16,p16 unknown
601,1,1,Nodal Stage,N0
601,1,1,Clinical lab p16,p16 unkown
601,1,1,1st Failure Type,no known failure
601,1,1,Research lab HPV,HPV unknown
601,1,1,Tumor Stage,T1
601,1,1,Tumor Site,oral cavity
601,1,1,Treatment Modality,Sx
601,1,1,Metastasis,M0
601,1,1,Overall Stage,I
601,1,1,2nd Failure Type,no known failure
602,1,1,Tumor Site,oral cavity
602,1,1,1st Failure Radiation Dosage,60
602,1,1,Research lab p16,p16 unknown
602,1,1,Clinical lab p16,p16 unkown
602,1,1,Tumor Stage,T4a
602,1,1,Nodal Stage,N0
602,1,1,1st Failure Site,oral cavity
602,1,1,1st Failure Treatment Modality,Sx & CTX-RT
602,1,1,Metastasis,M0
602,1,1,Radiation Dosage,59.4
602,1,1,1st Failure Type,locoregional
602,1,1,Overall Stage,IVa
602,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
602,1,1,Treatment Modality,Sx & RT
602,1,1,Occurrence #,1st primary
602,1,1,2nd Failure Type,no known failure
602,1,1,Research lab HPV,HPV unknown
603,1,1,Overall Stage,II
603,1,1,Research lab p16,p16 unknown
603,1,1,Nodal Stage,N0
603,1,1,2nd Failure Type,no known failure
603,1,1,Metastasis,M0
603,1,1,Tumor Stage,T2
603,1,1,1st Failure Type,no known failure
603,1,1,Treatment Modality,Sx
603,1,1,Research lab HPV,HPV unknown
603,1,1,Occurrence #,other primary
603,1,1,Tumor Site,oral cavity
603,1,1,Clinical lab p16,p16 unkown
604,1,1,Clinical lab p16,p16 unkown
604,1,1,1st Failure Type,no known failure
604,1,1,Overall Stage,IVa
604,1,1,Research lab HPV,HPV unknown
604,1,1,Treatment Modality,Sx
604,1,1,Occurrence #,1st primary
604,1,1,Metastasis,M0
604,1,1,Tumor Site,oral cavity
604,1,1,Research lab p16,p16 unknown
604,1,1,Tumor Stage,T4a
604,1,1,2nd Failure Type,no known failure
604,1,1,Nodal Stage,N0
605,1,1,1st Failure Radiation Dosage,60
605,1,1,2nd Failure Type,no known failure
605,1,1,Radiation Dosage,70.2
605,1,1,Initial Chemotherapy Agent,carbo/PTX
605,1,1,Clinical lab p16,p16 unkown
605,1,1,Research lab p16,p16 unknown
605,1,1,1st Failure Type,locoregional
605,1,1,Metastasis,M0
605,1,1,Occurrence #,1st primary
605,1,1,1st Failure Treatment Modality,Sx & RT
605,1,1,Tumor Stage,T2
605,1,1,Nodal Stage,N1
605,1,1,Research lab HPV,HPV unknown
605,1,1,Treatment Modality,CTX-RT
605,1,1,Overall Stage,III
605,1,1,1st Failure Site,oral cavity
605,1,1,Tumor Site,oral cavity
606,1,1,1st Failure Treatment Modality,Sx
606,1,1,2nd Failure Type,no known failure
606,1,1,Research lab HPV,HPV unknown
606,1,1,Tumor Stage,T1
606,1,1,1st Failure Site,oral cavity
606,1,1,Tumor Site,oral cavity
606,1,1,Research lab p16,p16 unknown
606,1,1,Occurrence #,1st primary
606,1,1,Nodal Stage,N0
606,1,1,1st Failure Type,no known failure
606,1,1,Metastasis,M0
606,1,1,Clinical lab p16,p16 unkown
606,1,1,Treatment Modality,Sx
606,1,1,Overall Stage,I
607,1,1,Research lab p16,p16 unknown
607,1,1,Clinical lab p16,p16 unkown
607,1,1,Metastasis,M0
607,1,1,Overall Stage,I
607,1,1,Research lab HPV,HPV unknown
607,1,1,Nodal Stage,N0
607,1,1,Tumor Site,oral cavity
607,1,1,Occurrence #,1st primary
607,1,1,1st Failure Type,no known failure
607,1,1,Tumor Stage,T1
607,1,1,Treatment Modality,Sx
607,1,1,2nd Failure Type,no known failure
608,1,1,Tumor Stage,T1
608,1,1,Occurrence #,1st primary
608,1,1,2nd Failure Type,no known failure
608,1,1,Nodal Stage,N0
608,1,1,Overall Stage,I
608,1,1,Clinical lab p16,p16 unkown
608,1,1,Metastasis,M0
608,1,1,Research lab p16,p16 unknown
608,1,1,Tumor Site,oral cavity
608,1,1,Research lab HPV,HPV unknown
608,1,1,Treatment Modality,Sx
608,1,1,1st Failure Type,no known failure
609,1,1,Nodal Stage,N0
609,1,1,Clinical lab p16,p16 unkown
609,1,1,1st Failure Type,no known failure
609,1,1,Occurrence #,1st primary
609,1,1,Metastasis,M0
609,1,1,Treatment Modality,Sx
609,1,1,Tumor Site,oral cavity
609,1,1,Research lab p16,p16 unknown
609,1,1,Tumor Stage,T2
609,1,1,2nd Failure Type,no known failure
609,1,1,Research lab HPV,HPV unknown
609,1,1,Overall Stage,II
610,1,1,Clinical lab p16,p16 unkown
610,1,1,Metastasis,M0
610,1,1,Overall Stage,I
610,1,1,Treatment Modality,Sx
610,1,1,Tumor Site,oral cavity
610,1,1,1st Failure Treatment Modality,Sx
610,1,1,Occurrence #,1st primary
610,1,1,1st Failure Site,oral cavity
610,1,1,Nodal Stage,N0
610,1,1,Tumor Stage,T1
610,1,1,Research lab HPV,HPV unknown
610,1,1,2nd Failure Type,no known failure
610,1,1,Research lab p16,p16 unknown
610,1,1,1st Failure Type,no known failure
611,1,1,Research lab HPV,HPV unknown
611,1,1,Nodal Stage,N2
611,1,1,Metastasis,M0
611,1,1,1st Failure Treatment Modality,Sx
611,1,1,Radiation Dosage,62.6
611,1,1,Treatment Modality,Sx & RT
611,1,1,Occurrence #,1st primary
611,1,1,Tumor Stage,T1
611,1,1,2nd Failure Type,no known failure
611,1,1,1st Failure Site,oral cavity
611,1,1,Research lab p16,p16 unknown
611,1,1,1st Failure Type,no known failure
611,1,1,Tumor Site,oral cavity
611,1,1,Overall Stage,IVa
611,1,1,Clinical lab p16,p16 unkown
612,1,1,Overall Stage,IVa
612,1,1,2nd Failure Type,no known failure
612,1,1,Treatment Modality,Sx
612,1,1,1st Failure Type,no known failure
612,1,1,Occurrence #,1st primary
612,1,1,Research lab p16,p16 unknown
612,1,1,Tumor Stage,T2
612,1,1,Clinical lab p16,p16 unkown
612,1,1,Research lab HPV,HPV unknown
612,1,1,Metastasis,M0
612,1,1,Nodal Stage,N2
612,1,1,Tumor Site,oral cavity
613,1,1,Clinical lab p16,p16 unkown
613,1,1,Research lab p16,p16 unknown
613,1,1,Tumor Site,oral cavity
613,1,1,1st Failure Type,no known failure
613,1,1,Tumor Stage,T2
613,1,1,Occurrence #,1st primary
613,1,1,Treatment Modality,Sx
613,1,1,Research lab HPV,HPV unknown
613,1,1,Metastasis,M0
613,1,1,Nodal Stage,N1
613,1,1,Overall Stage,III
613,1,1,2nd Failure Type,no known failure
614,1,1,Tumor Stage,T2
614,1,1,Occurrence #,1st primary
614,1,1,Research lab p16,p16 unknown
614,1,1,2nd Failure Type,no known failure
614,1,1,1st Failure Type,no known failure
614,1,1,Tumor Site,oral cavity
614,1,1,Treatment Modality,Sx
614,1,1,Research lab HPV,HPV unknown
614,1,1,Clinical lab p16,p16 unkown
614,1,1,Metastasis,M0
614,1,1,Overall Stage,II
614,1,1,Nodal Stage,N0
615,1,1,Tumor Site,oral cavity
615,1,1,Research lab p16,p16 unknown
615,1,1,Metastasis,M0
615,1,1,Nodal Stage,N0
615,1,1,1st Failure Type,no known failure
615,1,1,Research lab HPV,HPV unknown
615,1,1,Treatment Modality,Sx
615,1,1,Clinical lab p16,p16 unkown
615,1,1,Overall Stage,I
615,1,1,Occurrence #,1st primary
615,1,1,Tumor Stage,T1
615,1,1,2nd Failure Type,no known failure
616,1,1,Metastasis,M0
616,1,1,Research lab HPV,HPV unknown
616,1,1,1st Failure Site,oral cavity
616,1,1,Research lab p16,p16 unknown
616,1,1,Occurrence #,recurrence
616,1,1,Clinical lab p16,p16 unkown
616,1,1,Tumor Site,oral cavity
616,1,1,1st Failure Type,locoregional
616,1,1,2nd Failure Type,no known failure
616,1,1,Treatment Modality,Sx
616,1,1,Overall Stage,II
616,1,1,Tumor Stage,T2
616,1,1,1st Failure Treatment Modality,Sx
616,1,1,Nodal Stage,N0
617,1,1,Overall Stage,IVa
617,1,1,Radiation Dosage,63
617,1,1,2nd Failure Type,no known failure
617,1,1,Tumor Stage,T4a
617,1,1,Occurrence #,1st primary
617,1,1,Metastasis,M0
617,1,1,Research lab p16,p16 unknown
617,1,1,Research lab HPV,HPV unknown
617,1,1,Tumor Site,oral cavity
617,1,1,Nodal Stage,N2
617,1,1,1st Failure Type,no known failure
617,1,1,Treatment Modality,Sx & RT
617,1,1,Clinical lab p16,p16 unkown
618,1,1,Tumor Stage,T1
618,1,1,2nd Failure Type,no known failure
618,1,1,Clinical lab p16,p16 unkown
618,1,1,Tumor Site,oral cavity
618,1,1,Nodal Stage,N0
618,1,1,Treatment Modality,Sx
618,1,1,Research lab p16,p16 unknown
618,1,1,Overall Stage,I
618,1,1,Occurrence #,1st primary
618,1,1,1st Failure Type,no known failure
618,1,1,Research lab HPV,HPV unknown
618,1,1,Metastasis,M0
619,1,1,Research lab p16,p16 unknown
619,1,1,Tumor Stage,T2
619,1,1,Overall Stage,II
619,1,1,Nodal Stage,N0
619,1,1,Clinical lab p16,p16 unkown
619,1,1,Research lab HPV,HPV unknown
619,1,1,Treatment Modality,Sx
619,1,1,Metastasis,M0
619,1,1,Tumor Site,oral cavity
619,1,1,1st Failure Type,no known failure
619,1,1,Occurrence #,1st primary
619,1,1,2nd Failure Type,no known failure
621,1,1,1st Failure Site,oral cavity
621,1,1,Tumor Stage,T1
621,1,1,Overall Stage,I
621,1,1,Research lab HPV,HPV unknown
621,1,1,Treatment Modality,Sx
621,1,1,Occurrence #,1st primary
621,1,1,1st Failure Radiation Dosage,unk
621,1,1,Clinical lab p16,p16 unkown
621,1,1,1st Failure Type,no known failure
621,1,1,Tumor Site,oral cavity
621,1,1,Nodal Stage,N0
621,1,1,2nd Failure Type,no known failure
621,1,1,Metastasis,M0
621,1,1,1st Failure Treatment Modality,Sx & RT
621,1,1,Research lab p16,p16 unknown
622,1,1,Research lab p16,p16 unknown
622,1,1,1st Failure Type,no known failure
622,1,1,Tumor Site,oral cavity
622,1,1,Occurrence #,1st primary
622,1,1,Treatment Modality,Sx
622,1,1,Tumor Stage,T2
622,1,1,2nd Failure Type,no known failure
622,1,1,Nodal Stage,N0
622,1,1,Overall Stage,II
622,1,1,Metastasis,M0
622,1,1,Clinical lab p16,p16 unkown
622,1,1,Research lab HPV,HPV unknown
623,1,1,Metastasis,M0
623,1,1,Research lab HPV,HPV unknown
623,1,1,Tumor Stage,T4a
623,1,1,Nodal Stage,N0
623,1,1,Treatment Modality,Sx
623,1,1,Occurrence #,1st primary
623,1,1,2nd Failure Type,no known failure
623,1,1,Tumor Site,oral cavity
623,1,1,Research lab p16,p16 unknown
623,1,1,1st Failure Type,no known failure
623,1,1,Overall Stage,IVa
623,1,1,Clinical lab p16,p16 unkown
624,1,1,Metastasis,M0
624,1,1,Treatment Modality,Sx
624,1,1,1st Failure Type,no known failure
624,1,1,Nodal Stage,N0
624,1,1,2nd Failure Type,no known failure
624,1,1,Research lab HPV,HPV unknown
624,1,1,Clinical lab p16,p16 unkown
624,1,1,Overall Stage,II
624,1,1,Tumor Site,oral cavity
624,1,1,Research lab p16,p16 unknown
624,1,1,Occurrence #,1st primary
624,1,1,Tumor Stage,T2
625,1,1,Occurrence #,1st primary
625,1,1,1st Failure Type,no known failure
625,1,1,Research lab HPV,HPV unknown
625,1,1,Tumor Site,oral cavity
625,1,1,Metastasis,M0
625,1,1,Nodal Stage,N2
625,1,1,2nd Failure Type,no known failure
625,1,1,Clinical lab p16,p16 unkown
625,1,1,Overall Stage,IVa
625,1,1,Tumor Stage,T4a
625,1,1,Research lab p16,p16 unknown
625,1,1,Treatment Modality,Sx
626,1,1,Research lab HPV,HPV unknown
626,1,1,1st Failure Type,no known failure
626,1,1,Research lab p16,p16 unknown
626,1,1,Treatment Modality,Sx
626,1,1,Metastasis,M0
626,1,1,Clinical lab p16,p16 unkown
626,1,1,2nd Failure Type,no known failure
626,1,1,Tumor Stage,T1
626,1,1,Occurrence #,1st primary
626,1,1,Tumor Site,oral cavity
626,1,1,Nodal Stage,N0
626,1,1,Overall Stage,I
627,1,1,Overall Stage,II
627,1,1,2nd Failure Type,no known failure
627,1,1,Research lab p16,p16 unknown
627,1,1,Clinical lab p16,p16 unkown
627,1,1,Tumor Site,oral cavity
627,1,1,Metastasis,M0
627,1,1,Nodal Stage,N0
627,1,1,Research lab HPV,HPV unknown
627,1,1,Occurrence #,1st primary
627,1,1,Tumor Stage,T2
627,1,1,1st Failure Type,no known failure
627,1,1,Treatment Modality,Sx
628,1,1,Tumor Stage,T2
628,1,1,2nd Failure Type,no known failure
628,1,1,Treatment Modality,Sx
628,1,1,Metastasis,M0
628,1,1,Research lab HPV,HPV unknown
628,1,1,Nodal Stage,N0
628,1,1,1st Failure Type,no known failure
628,1,1,Tumor Site,oral cavity
628,1,1,Occurrence #,1st primary
628,1,1,Clinical lab p16,p16 unkown
628,1,1,Research lab p16,p16 unknown
628,1,1,Overall Stage,II
629,1,1,Nodal Stage,N0
629,1,1,Clinical lab p16,p16 unkown
629,1,1,Tumor Site,oral cavity
629,1,1,Research lab HPV,HPV unknown
629,1,1,1st Failure Type,no known failure
629,1,1,Occurrence #,1st primary
629,1,1,Metastasis,M0
629,1,1,Overall Stage,I
629,1,1,Research lab p16,p16 unknown
629,1,1,Treatment Modality,Sx
629,1,1,2nd Failure Type,no known failure
629,1,1,Tumor Stage,T1
630,1,1,1st Failure Site,oral cavity
630,1,1,1st Failure Type,no known failure
630,1,1,Research lab HPV,HPV unknown
630,1,1,Tumor Site,oral cavity
630,1,1,Occurrence #,1st primary
630,1,1,Overall Stage,I
630,1,1,Metastasis,M0
630,1,1,Clinical lab p16,p16 unkown
630,1,1,1st Failure Treatment Modality,Sx
630,1,1,Research lab p16,p16 unknown
630,1,1,Nodal Stage,N0
630,1,1,2nd Failure Type,no known failure
630,1,1,Tumor Stage,T1
630,1,1,Treatment Modality,Sx
631,1,1,2nd Failure Type,no known failure
631,1,1,1st Failure Type,no known failure
631,1,1,Research lab HPV,HPV unknown
631,1,1,Treatment Modality,Sx
631,1,1,Occurrence #,1st primary
631,1,1,Overall Stage,II
631,1,1,Metastasis,M0
631,1,1,Nodal Stage,N0
631,1,1,Clinical lab p16,p16 unkown
631,1,1,Research lab p16,p16 unknown
631,1,1,Tumor Site,oral cavity
631,1,1,Tumor Stage,T2
632,1,1,Clinical lab p16,p16 unkown
632,1,1,Research lab p16,p16 unknown
632,1,1,Metastasis,M0
632,1,1,Overall Stage,IVa
632,1,1,2nd Failure Type,no known failure
632,1,1,Tumor Stage,T4a
632,1,1,Nodal Stage,N0
632,1,1,Occurrence #,1st primary
632,1,1,Tumor Site,oral cavity
632,1,1,Treatment Modality,Sx
632,1,1,1st Failure Type,no known failure
632,1,1,Research lab HPV,HPV unknown
633,1,1,1st Failure Type,no known failure
633,1,1,Clinical lab p16,p16 unkown
633,1,1,2nd Failure Type,no known failure
633,1,1,Tumor Stage,T4a
633,1,1,Research lab HPV,HPV unknown
633,1,1,Research lab p16,p16 unknown
633,1,1,Treatment Modality,Sx & RT
633,1,1,Metastasis,M0
633,1,1,Overall Stage,IVa
633,1,1,Tumor Site,oral cavity
633,1,1,Occurrence #,1st primary
633,1,1,Radiation Dosage,63
633,1,1,Nodal Stage,N0
634,1,1,Nodal Stage,N2
634,1,1,Research lab p16,p16 unknown
634,1,1,Metastasis,M0
634,1,1,Overall Stage,IVa
634,1,1,Occurrence #,1st primary
634,1,1,Tumor Site,oral cavity
634,1,1,Research lab HPV,HPV unknown
634,1,1,1st Failure Type,no known failure
634,1,1,Tumor Stage,T3
634,1,1,Treatment Modality,Sx
634,1,1,Clinical lab p16,p16 unkown
634,1,1,2nd Failure Type,no known failure
635,1,1,Occurrence #,1st primary
635,1,1,Nodal Stage,N0
635,1,1,1st Failure Type,no known failure
635,1,1,Research lab HPV,HPV unknown
635,1,1,Tumor Site,oral cavity
635,1,1,Research lab p16,p16 unknown
635,1,1,Clinical lab p16,p16 unkown
635,1,1,Tumor Stage,T1
635,1,1,Metastasis,M0
635,1,1,Overall Stage,I
635,1,1,Treatment Modality,Sx
635,1,1,2nd Failure Type,no known failure
636,1,1,Tumor Site,oral cavity
636,1,1,2nd Failure Type,no known failure
636,1,1,Nodal Stage,N2
636,1,1,Research lab HPV,HPV unknown
636,1,1,Research lab p16,p16 unknown
636,1,1,Clinical lab p16,p16 unkown
636,1,1,Radiation Dosage,unknown
636,1,1,Treatment Modality,Sx & RT
636,1,1,Tumor Stage,T2
636,1,1,Occurrence #,1st primary
636,1,1,Overall Stage,IVa
636,1,1,1st Failure Type,no known failure
636,1,1,Metastasis,M0
637,1,1,2nd Failure Type,no known failure
637,1,1,Overall Stage,I
637,1,1,Occurrence #,1st primary
637,1,1,Tumor Site,oral cavity
637,1,1,Research lab p16,p16 unknown
637,1,1,1st Failure Type,no known failure
637,1,1,Metastasis,M0
637,1,1,Tumor Stage,T1
637,1,1,Treatment Modality,Sx
637,1,1,Nodal Stage,N0
637,1,1,Research lab HPV,HPV unknown
637,1,1,Clinical lab p16,p16 unkown
638,1,1,2nd Failure Type,no known failure
638,1,1,Treatment Modality,Sx
638,1,1,Overall Stage,IVa
638,1,1,Research lab p16,p16 unknown
638,1,1,Tumor Site,oral cavity
638,1,1,Occurrence #,1st primary
638,1,1,Research lab HPV,HPV unknown
638,1,1,Metastasis,M0
638,1,1,1st Failure Type,no known failure
638,1,1,Clinical lab p16,p16 unkown
638,1,1,Nodal Stage,N1
638,1,1,Tumor Stage,T4a
639,1,1,2nd Failure Type,no known failure
639,1,1,Tumor Stage,T1
639,1,1,Treatment Modality,Sx
639,1,1,Nodal Stage,N0
639,1,1,Overall Stage,I
639,1,1,Research lab p16,p16 unknown
639,1,1,Metastasis,M0
639,1,1,Tumor Site,oral cavity
639,1,1,Occurrence #,1st primary
639,1,1,Research lab HPV,HPV unknown
639,1,1,Clinical lab p16,p16 unkown
639,1,1,1st Failure Type,no known failure
640,1,1,Metastasis,M0
640,1,1,Clinical lab p16,p16 unkown
640,1,1,Overall Stage,IVa
640,1,1,Research lab p16,p16 unknown
640,1,1,Tumor Site,oral cavity
640,1,1,Radiation Dosage,70.2
640,1,1,2nd Failure Type,no known failure
640,1,1,1st Failure Type,locoregional
640,1,1,Occurrence #,recurrence
640,1,1,Nodal Stage,N2
640,1,1,Treatment Modality,CTX-RT
640,1,1,Second Line Chemotherapy Agent,cap
640,1,1,Initial Chemotherapy Agent,carbo/PTX
640,1,1,Research lab HPV,HPV unknown
640,1,1,Tumor Stage,T3
642,1,1,1st Failure Treatment Modality,Sx
642,1,1,1st Failure Site,oral cavity
642,1,1,Tumor Site,oral cavity
642,1,1,Treatment Modality,Sx
642,1,1,1st Failure Type,no known failure
642,1,1,Clinical lab p16,p16 unkown
642,1,1,Nodal Stage,N0
642,1,1,Occurrence #,1st primary
642,1,1,Metastasis,M0
642,1,1,2nd Failure Type,no known failure
642,1,1,Overall Stage,III
642,1,1,Research lab HPV,HPV unknown
642,1,1,Tumor Stage,T3
642,1,1,Research lab p16,p16 unknown
643,1,1,Research lab p16,p16 unknown
643,1,1,Overall Stage,III
643,1,1,Research lab HPV,HPV unknown
643,1,1,Tumor Stage,T1
643,1,1,1st Failure Type,no known failure
643,1,1,Tumor Site,oral cavity
643,1,1,Metastasis,M0
643,1,1,Occurrence #,1st primary
643,1,1,Radiation Dosage,unknown
643,1,1,Treatment Modality,Sx & RT
643,1,1,2nd Failure Type,no known failure
643,1,1,Clinical lab p16,p16 unkown
643,1,1,Nodal Stage,N1
644,1,1,1st Failure Second Line Chemotherapy Agent,cap
644,1,1,Overall Stage,IVa
644,1,1,Tumor Site,oral cavity
644,1,1,2nd Failure Type,no known failure
644,1,1,Research lab HPV,HPV unknown
644,1,1,Metastasis,M0
644,1,1,Occurrence #,1st primary
644,1,1,1st Failure Site,oral cavity
644,1,1,Treatment Modality,Sx & RT
644,1,1,Clinical lab p16,p16 unkown
644,1,1,1st Failure Treatment Modality,CTX
644,1,1,Research lab p16,p16 unknown
644,1,1,Nodal Stage,N2
644,1,1,Tumor Stage,T1
644,1,1,1st Failure Type,locoregional
644,1,1,Radiation Dosage,63
644,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
645,1,1,Research lab HPV,HPV unknown
645,1,1,Nodal Stage,N0
645,1,1,1st Failure Type,no known failure
645,1,1,Occurrence #,1st primary
645,1,1,Tumor Site,oral cavity
645,1,1,Tumor Stage,T1
645,1,1,2nd Failure Type,no known failure
645,1,1,Treatment Modality,Sx
645,1,1,Research lab p16,p16 unknown
645,1,1,Clinical lab p16,p16 unkown
645,1,1,Metastasis,M0
645,1,1,Overall Stage,I
646,1,1,Tumor Site,oral cavity
646,1,1,Occurrence #,1st primary
646,1,1,2nd Failure Type,no known failure
646,1,1,Clinical lab p16,p16 unkown
646,1,1,Treatment Modality,Sx
646,1,1,Tumor Stage,T2
646,1,1,Nodal Stage,N1
646,1,1,Metastasis,M1
646,1,1,Research lab HPV,HPV unknown
646,1,1,1st Failure Type,no known failure
646,1,1,Research lab p16,p16 unknown
646,1,1,Overall Stage,III
647,1,1,1st Failure Site,oral cavity
647,1,1,Clinical lab p16,p16 unkown
647,1,1,1st Failure Type,locoregional
647,1,1,Tumor Stage,T2
647,1,1,Metastasis,M0
647,1,1,Research lab p16,p16 unknown
647,1,1,1st Failure Treatment Modality,Sx & RT
647,1,1,Treatment Modality,Sx
647,1,1,1st Failure Radiation Dosage,59.4
647,1,1,2nd Failure Type,no known failure
647,1,1,Tumor Site,oral cavity
647,1,1,Occurrence #,1st primary
647,1,1,Overall Stage,II
647,1,1,Nodal Stage,N0
647,1,1,Research lab HPV,HPV unknown
648,1,1,Tumor Stage,T1
648,1,1,Research lab HPV,HPV unknown
648,1,1,Treatment Modality,Sx
648,1,1,Nodal Stage,N0
648,1,1,Research lab p16,p16 unknown
648,1,1,Metastasis,M0
648,1,1,Occurrence #,1st primary
648,1,1,Clinical lab p16,p16 unkown
648,1,1,Tumor Site,oral cavity
648,1,1,2nd Failure Type,no known failure
648,1,1,1st Failure Type,no known failure
648,1,1,Overall Stage,I
649,1,1,Treatment Modality,Unknown
649,1,1,Tumor Site,oral cavity
649,1,1,Research lab p16,p16 unknown
649,1,1,Clinical lab p16,p16 unkown
649,1,1,Overall Stage,Unknown
649,1,1,Occurrence #,1st primary
649,1,1,1st Failure Type,no known failure
649,1,1,Metastasis,Unknown
649,1,1,Research lab HPV,HPV unknown
649,1,1,Nodal Stage,Unknown
649,1,1,Tumor Stage,Unknown
649,1,1,2nd Failure Type,no known failure
650,1,1,Treatment Modality,Sx
650,1,1,1st Failure Type,no known failure
650,1,1,Metastasis,M0
650,1,1,Research lab HPV,HPV unknown
650,1,1,Overall Stage,III
650,1,1,Nodal Stage,N1
650,1,1,Research lab p16,p16 unknown
650,1,1,Tumor Stage,T1
650,1,1,2nd Failure Type,no known failure
650,1,1,Tumor Site,oral cavity
650,1,1,Occurrence #,1st primary
650,1,1,Clinical lab p16,p16 unkown
651,1,1,Tumor Site,oral cavity
651,1,1,Treatment Modality,Sx & RT
651,1,1,Clinical lab p16,p16 unkown
651,1,1,Nodal Stage,N2
651,1,1,Tumor Stage,T4a
651,1,1,Radiation Dosage,63
651,1,1,Metastasis,M0
651,1,1,Occurrence #,1st primary
651,1,1,Research lab HPV,HPV unknown
651,1,1,Overall Stage,IVa
651,1,1,1st Failure Type,no known failure
651,1,1,2nd Failure Type,no known failure
651,1,1,Research lab p16,p16 unknown
652,1,1,Research lab p16,p16 unknown
652,1,1,Metastasis,M1
652,1,1,Research lab HPV,HPV unknown
652,1,1,Overall Stage,IVc
652,1,1,2nd Failure Type,no known failure
652,1,1,Clinical lab p16,p16 unkown
652,1,1,Tumor Stage,T2
652,1,1,Tumor Site,oral cavity
652,1,1,Occurrence #,recurrence
652,1,1,Treatment Modality,Sx
652,1,1,1st Failure Type,no known failure
652,1,1,Nodal Stage,Unknown
653,1,1,2nd Failure Type,no known failure
653,1,1,Overall Stage,IVa
653,1,1,1st Failure Type,no known failure
653,1,1,Treatment Modality,Sx
653,1,1,Research lab HPV,HPV unknown
653,1,1,Tumor Site,oral cavity
653,1,1,Research lab p16,p16 unknown
653,1,1,Metastasis,M0
653,1,1,Tumor Stage,T4a
653,1,1,Nodal Stage,N0
653,1,1,Occurrence #,1st primary
653,1,1,Clinical lab p16,p16 unkown
654,1,1,Clinical lab p16,p16 unkown
654,1,1,Tumor Site,oral cavity
654,1,1,2nd Failure Type,no known failure
654,1,1,Metastasis,M0
654,1,1,Tumor Stage,T4a
654,1,1,Nodal Stage,N2
654,1,1,Occurrence #,1st primary
654,1,1,Treatment Modality,Sx
654,1,1,Overall Stage,IVa
654,1,1,1st Failure Type,no known failure
654,1,1,Research lab HPV,HPV unknown
654,1,1,Research lab p16,p16 unknown
655,1,1,2nd Failure Type,no known failure
655,1,1,Research lab p16,p16 unknown
655,1,1,Research lab HPV,HPV unknown
655,1,1,Occurrence #,1st primary
655,1,1,Tumor Stage,T2
655,1,1,Metastasis,M0
655,1,1,Tumor Site,oral cavity
655,1,1,Treatment Modality,Sx & RT
655,1,1,Clinical lab p16,p16 unkown
655,1,1,Nodal Stage,N0
655,1,1,1st Failure Type,distant
655,1,1,Overall Stage,II
655,1,1,Radiation Dosage,59.4
656,1,1,Metastasis,M0
656,1,1,1st Failure Type,locoregional
656,1,1,Tumor Site,oral cavity
656,1,1,Overall Stage,IVa
656,1,1,Nodal Stage,N2
656,1,1,1st Failure Treatment Modality,Sx
656,1,1,Treatment Modality,Sx & RT
656,1,1,Tumor Stage,T2
656,1,1,Research lab p16,p16 unknown
656,1,1,Occurrence #,1st primary
656,1,1,Research lab HPV,HPV unknown
656,1,1,Clinical lab p16,p16 unkown
656,1,1,2nd Failure Type,no known failure
656,1,1,Radiation Dosage,unknown
656,1,1,1st Failure Site,oral cavity
657,1,1,Tumor Site,oral cavity
657,1,1,Clinical lab p16,p16 unkown
657,1,1,Treatment Modality,Sx & CTX-RT
657,1,1,Overall Stage,IVa
657,1,1,1st Failure Type,no known failure
657,1,1,Occurrence #,recurrence
657,1,1,Radiation Dosage,unknown
657,1,1,Nodal Stage,N2
657,1,1,Tumor Stage,T1
657,1,1,Initial Chemotherapy Agent,unknown
657,1,1,Metastasis,M0
657,1,1,2nd Failure Type,no known failure
657,1,1,Research lab HPV,HPV unknown
657,1,1,Research lab p16,p16 unknown
658,1,1,Overall Stage,I
658,1,1,Research lab p16,p16 unknown
658,1,1,Treatment Modality,Sx
658,1,1,2nd Failure Type,no known failure
658,1,1,Nodal Stage,N0
658,1,1,Clinical lab p16,p16 unkown
658,1,1,Occurrence #,1st primary
658,1,1,Tumor Site,oral cavity
658,1,1,Research lab HPV,HPV unknown
658,1,1,1st Failure Type,no known failure
658,1,1,Tumor Stage,T1
658,1,1,Metastasis,M0
659,1,1,Occurrence #,1st primary
659,1,1,Tumor Stage,T2
659,1,1,1st Failure Type,locoregional
659,1,1,Treatment Modality,Sx
659,1,1,1st Failure Site,oral cavity
659,1,1,Metastasis,M0
659,1,1,Research lab HPV,HPV unknown
659,1,1,1st Failure Treatment Modality,Sx
659,1,1,Research lab p16,p16 unknown
659,1,1,Nodal Stage,N0
659,1,1,Tumor Site,oral cavity
659,1,1,Overall Stage,II
659,1,1,2nd Failure Type,no known failure
659,1,1,Clinical lab p16,p16 unkown
660,1,1,Treatment Modality,Sx & CTX-RT
660,1,1,Radiation Dosage,68
660,1,1,Initial Chemotherapy Agent,cetux
660,1,1,Clinical lab p16,p16 unkown
660,1,1,Metastasis,Unknown
660,1,1,Research lab HPV,HPV unknown
660,1,1,Overall Stage,IVa
660,1,1,Research lab p16,p16 unknown
660,1,1,Tumor Stage,T4a
660,1,1,Nodal Stage,Unknown
660,1,1,Tumor Site,oral cavity
660,1,1,1st Failure Type,no known failure
660,1,1,2nd Failure Type,no known failure
660,1,1,Occurrence #,1st primary
661,1,1,Treatment Modality,Unknown
661,1,1,Clinical lab p16,p16 unkown
661,1,1,2nd Failure Type,no known failure
661,1,1,Tumor Stage,T4a
661,1,1,Research lab HPV,HPV unknown
661,1,1,Tumor Site,oral cavity
661,1,1,Overall Stage,IVa
661,1,1,Research lab p16,p16 unknown
661,1,1,Nodal Stage,N1
661,1,1,Occurrence #,1st primary
661,1,1,Metastasis,M0
661,1,1,1st Failure Type,no known failure
662,1,1,1st Failure Type,locoregional
662,1,1,1st Failure Site,oral cavity
662,1,1,Overall Stage,I
662,1,1,1st Failure Treatment Modality,Sx
662,1,1,Tumor Stage,T1
662,1,1,Treatment Modality,Sx
662,1,1,Metastasis,M0
662,1,1,Research lab HPV,HPV unknown
662,1,1,Nodal Stage,N0
662,1,1,Tumor Site,oral cavity
662,1,1,2nd Failure Type,no known failure
662,1,1,Research lab p16,p16 unknown
662,1,1,Occurrence #,1st primary
662,1,1,Clinical lab p16,p16 unkown
664,1,1,1st Failure Site,oral cavity
664,1,1,Metastasis,M0
664,1,1,1st Failure Treatment Modality,Sx
664,1,1,Overall Stage,I
664,1,1,Nodal Stage,N0
664,1,1,1st Failure Type,locoregional
664,1,1,Occurrence #,1st primary
664,1,1,Radiation Dosage,66.6
664,1,1,Research lab HPV,HPV unknown
664,1,1,Tumor Site,oral cavity
664,1,1,Research lab p16,p16 unknown
664,1,1,2nd Failure Type,no known failure
664,1,1,Tumor Stage,T1
664,1,1,Treatment Modality,RT
664,1,1,Clinical lab p16,p16 unkown
665,1,1,Treatment Modality,Sx
665,1,1,Research lab p16,p16 unknown
665,1,1,Clinical lab p16,p16 unkown
665,1,1,Nodal Stage,N1
665,1,1,Research lab HPV,HPV unknown
665,1,1,1st Failure Type,locoregional
665,1,1,1st Failure Treatment Modality,Sx
665,1,1,Occurrence #,1st primary
665,1,1,2nd Failure Type,no known failure
665,1,1,Overall Stage,IVa
665,1,1,Metastasis,M0
665,1,1,1st Failure Site,oral cavity
665,1,1,Tumor Stage,T4a
665,1,1,Tumor Site,oral cavity
666,1,1,Occurrence #,1st primary
666,1,1,Overall Stage,Unknown
666,1,1,Treatment Modality,Unknown
666,1,1,Metastasis,Unknown
666,1,1,Research lab p16,p16 unknown
666,1,1,Tumor Stage,Unknown
666,1,1,Tumor Site,oral cavity
666,1,1,Research lab HPV,HPV unknown
666,1,1,Clinical lab p16,p16 unkown
666,1,1,Nodal Stage,Unknown
666,1,1,1st Failure Type,no known failure
666,1,1,2nd Failure Type,no known failure
667,1,1,Metastasis,M0
667,1,1,Research lab p16,p16 unknown
667,1,1,Research lab HPV,HPV unknown
667,1,1,Radiation Dosage,59.4
667,1,1,Overall Stage,IVa
667,1,1,Tumor Site,oral cavity
667,1,1,2nd Failure Type,no known failure
667,1,1,Occurrence #,1st primary
667,1,1,Treatment Modality,Sx & RT
667,1,1,Nodal Stage,N0
667,1,1,Clinical lab p16,p16 unkown
667,1,1,1st Failure Type,no known failure
667,1,1,Tumor Stage,T4a
668,1,1,1st Failure Type,no known failure
668,1,1,Research lab p16,p16 unknown
668,1,1,2nd Failure Type,no known failure
668,1,1,Overall Stage,II
668,1,1,Occurrence #,1st primary
668,1,1,Clinical lab p16,p16 unkown
668,1,1,Research lab HPV,HPV unknown
668,1,1,Treatment Modality,Sx
668,1,1,Nodal Stage,N0
668,1,1,Tumor Stage,T2
668,1,1,Metastasis,M0
668,1,1,Tumor Site,oral cavity
669,1,1,Research lab p16,p16 unknown
669,1,1,Tumor Site,oral cavity
669,1,1,Occurrence #,1st primary
669,1,1,Nodal Stage,N0
669,1,1,Overall Stage,I
669,1,1,2nd Failure Type,no known failure
669,1,1,1st Failure Type,no known failure
669,1,1,Metastasis,M0
669,1,1,Research lab HPV,HPV unknown
669,1,1,Treatment Modality,Sx
669,1,1,Tumor Stage,T1
669,1,1,Clinical lab p16,p16 unkown
670,1,1,Tumor Site,oral cavity
670,1,1,Research lab HPV,HPV unknown
670,1,1,Radiation Dosage,63
670,1,1,Tumor Stage,T4a
670,1,1,Research lab p16,p16 unknown
670,1,1,1st Failure Type,no known failure
670,1,1,Overall Stage,IVa
670,1,1,Metastasis,M0
670,1,1,2nd Failure Type,no known failure
670,1,1,Nodal Stage,N2
670,1,1,Clinical lab p16,p16 unkown
670,1,1,Treatment Modality,Sx & CTX-RT
670,1,1,Occurrence #,recurrence
670,1,1,Initial Chemotherapy Agent,carbo/PTX
671,1,1,Clinical lab p16,p16 unkown
671,1,1,Metastasis,M1
671,1,1,Tumor Site,oral cavity
671,1,1,Research lab HPV,HPV unknown
671,1,1,Occurrence #,1st primary
671,1,1,Tumor Stage,T1
671,1,1,1st Failure Type,no known failure
671,1,1,Overall Stage,IVc
671,1,1,Treatment Modality,Sx
671,1,1,Research lab p16,p16 unknown
671,1,1,2nd Failure Type,no known failure
671,1,1,Nodal Stage,N0
672,1,1,Occurrence #,1st primary
672,1,1,Clinical lab p16,p16 unkown
672,1,1,Tumor Stage,T1
672,1,1,Tumor Site,oral cavity
672,1,1,Research lab p16,p16 unknown
672,1,1,Overall Stage,I
672,1,1,2nd Failure Type,no known failure
672,1,1,Research lab HPV,HPV unknown
672,1,1,Nodal Stage,N0
672,1,1,Metastasis,M0
672,1,1,1st Failure Type,no known failure
672,1,1,Treatment Modality,Sx
673,1,1,Research lab p16,p16 unknown
673,1,1,Metastasis,M0
673,1,1,2nd Failure Type,no known failure
673,1,1,Overall Stage,IVa
673,1,1,Nodal Stage,N1
673,1,1,1st Failure Type,no known failure
673,1,1,Tumor Site,oral cavity
673,1,1,Treatment Modality,Unknown
673,1,1,Research lab HPV,HPV unknown
673,1,1,Occurrence #,1st primary
673,1,1,Clinical lab p16,p16 unkown
673,1,1,Tumor Stage,T4a
674,1,1,2nd Failure Type,no known failure
674,1,1,Overall Stage,IVa
674,1,1,1st Failure Type,no known failure
674,1,1,Radiation Dosage,60
674,1,1,Occurrence #,1st primary
674,1,1,Nodal Stage,N1
674,1,1,Clinical lab p16,p16 unkown
674,1,1,Metastasis,M0
674,1,1,Research lab HPV,HPV unknown
674,1,1,Tumor Site,oral cavity
674,1,1,Tumor Stage,T4a
674,1,1,Research lab p16,p16 unknown
674,1,1,Treatment Modality,Sx & RT
675,1,1,Nodal Stage,N1
675,1,1,Tumor Stage,T4a
675,1,1,Occurrence #,1st primary
675,1,1,Treatment Modality,Sx
675,1,1,1st Failure Type,no known failure
675,1,1,Research lab p16,p16 unknown
675,1,1,Research lab HPV,HPV unknown
675,1,1,Tumor Site,oral cavity
675,1,1,Clinical lab p16,p16 unkown
675,1,1,Overall Stage,IVa
675,1,1,Metastasis,M0
675,1,1,2nd Failure Type,no known failure
676,1,1,Tumor Site,oral cavity
676,1,1,2nd Failure Type,no known failure
676,1,1,Research lab p16,p16 unknown
676,1,1,Tumor Stage,T1
676,1,1,Metastasis,M0
676,1,1,1st Failure Type,no known failure
676,1,1,Treatment Modality,Sx
676,1,1,Clinical lab p16,p16 unkown
676,1,1,Research lab HPV,HPV unknown
676,1,1,Nodal Stage,N0
676,1,1,Overall Stage,I
676,1,1,Occurrence #,1st primary
677,1,1,Research lab HPV,HPV unknown
677,1,1,1st Failure Treatment Modality,Sx
677,1,1,Treatment Modality,Sx
677,1,1,Metastasis,M0
677,1,1,2nd Failure Type,no known failure
677,1,1,1st Failure Type,locoregional
677,1,1,Tumor Site,oral cavity
677,1,1,1st Failure Site,oral cavity
677,1,1,Overall Stage,II
677,1,1,Occurrence #,1st primary
677,1,1,Nodal Stage,N0
677,1,1,Clinical lab p16,p16 unkown
677,1,1,Research lab p16,p16 unknown
677,1,1,Tumor Stage,T2
678,1,1,Occurrence #,1st primary
678,1,1,Research lab HPV,HPV unknown
678,1,1,Tumor Stage,T1
678,1,1,Research lab p16,p16 unknown
678,1,1,Radiation Dosage,unknown
678,1,1,Treatment Modality,Sx & RT
678,1,1,2nd Failure Type,no known failure
678,1,1,Overall Stage,III
678,1,1,Metastasis,M0
678,1,1,Clinical lab p16,p16 unkown
678,1,1,Nodal Stage,N1
678,1,1,1st Failure Type,no known failure
678,1,1,Tumor Site,oral cavity
679,1,1,Tumor Site,oral cavity
679,1,1,Research lab p16,p16 unknown
679,1,1,Treatment Modality,Sx
679,1,1,Research lab HPV,HPV unknown
679,1,1,Metastasis,M0
679,1,1,2nd Failure Type,no known failure
679,1,1,Tumor Stage,T1
679,1,1,Occurrence #,1st primary
679,1,1,Nodal Stage,N0
679,1,1,Overall Stage,I
679,1,1,1st Failure Type,no known failure
679,1,1,Clinical lab p16,p16 unkown
680,1,1,Metastasis,M0
680,1,1,2nd Failure Type,no known failure
680,1,1,Tumor Stage,T1
680,1,1,Occurrence #,1st primary
680,1,1,Treatment Modality,Sx & CTX-RT
680,1,1,Clinical lab p16,p16 unkown
680,1,1,Nodal Stage,N2
680,1,1,Overall Stage,IVa
680,1,1,Initial Chemotherapy Agent,carbo/PTX
680,1,1,Radiation Dosage,63
680,1,1,Research lab p16,p16 unknown
680,1,1,1st Failure Type,no known failure
680,1,1,Research lab HPV,HPV unknown
680,1,1,Tumor Site,oral cavity
681,1,1,Nodal Stage,N2
681,1,1,Overall Stage,IVa
681,1,1,Metastasis,M0
681,1,1,Research lab HPV,HPV unknown
681,1,1,2nd Failure Type,no known failure
681,1,1,Clinical lab p16,p16 unkown
681,1,1,Tumor Stage,T1
681,1,1,Occurrence #,1st primary
681,1,1,Tumor Site,oral cavity
681,1,1,Treatment Modality,Sx
681,1,1,1st Failure Type,no known failure
681,1,1,Research lab p16,p16 unknown
682,1,1,Research lab p16,p16 unknown
682,1,1,Overall Stage,IVa
682,1,1,2nd Failure Type,no known failure
682,1,1,Tumor Stage,T4a
682,1,1,Occurrence #,1st primary
682,1,1,Clinical lab p16,p16 unkown
682,1,1,Tumor Site,oral cavity
682,1,1,Nodal Stage,N0
682,1,1,Treatment Modality,Sx
682,1,1,Metastasis,M0
682,1,1,Research lab HPV,HPV unknown
682,1,1,1st Failure Type,no known failure
683,1,1,1st Failure Type,no known failure
683,1,1,Overall Stage,I
683,1,1,Occurrence #,1st primary
683,1,1,Nodal Stage,N0
683,1,1,Research lab HPV,HPV unknown
683,1,1,Tumor Site,oral cavity
683,1,1,Metastasis,M0
683,1,1,Research lab p16,p16 unknown
683,1,1,2nd Failure Type,no known failure
683,1,1,Tumor Stage,T1
683,1,1,Clinical lab p16,p16 unkown
683,1,1,Treatment Modality,Sx
684,1,1,Initial Chemotherapy Agent,cis/5 FU
684,1,1,Research lab p16,p16 unknown
684,1,1,Treatment Modality,Sx & CTX
684,1,1,Overall Stage,IVa
684,1,1,Research lab HPV,HPV unknown
684,1,1,Nodal Stage,N2
684,1,1,1st Failure Type,no known failure
684,1,1,Second Line Chemotherapy Agent,doce
684,1,1,Metastasis,M0
684,1,1,2nd Failure Type,no known failure
684,1,1,Clinical lab p16,p16 unkown
684,1,1,Tumor Stage,T2
684,1,1,Occurrence #,1st primary
684,1,1,Tumor Site,oral cavity
685,1,1,Treatment Modality,Sx
685,1,1,Overall Stage,IVa
685,1,1,Metastasis,M0
685,1,1,1st Failure Type,no known failure
685,1,1,Nodal Stage,N0
685,1,1,Occurrence #,1st primary
685,1,1,2nd Failure Type,no known failure
685,1,1,Tumor Stage,T4a
685,1,1,Tumor Site,oral cavity
685,1,1,Research lab p16,p16 unknown
685,1,1,Clinical lab p16,p16 unkown
685,1,1,Research lab HPV,HPV unknown
686,1,1,Metastasis,M0
686,1,1,Clinical lab p16,p16 unkown
686,1,1,1st Failure Type,no known failure
686,1,1,Treatment Modality,Sx
686,1,1,Tumor Stage,T1
686,1,1,2nd Failure Type,no known failure
686,1,1,Nodal Stage,N0
686,1,1,Research lab HPV,HPV unknown
686,1,1,Overall Stage,I
686,1,1,Occurrence #,1st primary
686,1,1,Tumor Site,oral cavity
686,1,1,Research lab p16,p16 unknown
688,1,1,Nodal Stage,N0
688,1,1,Occurrence #,1st primary
688,1,1,2nd Failure Type,no known failure
688,1,1,Overall Stage,I
688,1,1,Research lab p16,p16 unknown
688,1,1,Treatment Modality,Sx
688,1,1,Tumor Site,oral cavity
688,1,1,1st Failure Treatment Modality,Sx & RT
688,1,1,1st Failure Radiation Dosage,59.4
688,1,1,Tumor Stage,T1
688,1,1,1st Failure Type,locoregional
688,1,1,Clinical lab p16,p16 unkown
688,1,1,Research lab HPV,HPV unknown
688,1,1,Metastasis,M0
688,1,1,1st Failure Site,oral cavity
689,1,1,Nodal Stage,N1
689,1,1,Tumor Stage,T4a
689,1,1,Tumor Site,oral cavity
689,1,1,Metastasis,M0
689,1,1,Radiation Dosage,unknown
689,1,1,2nd Failure Type,no known failure
689,1,1,Clinical lab p16,p16 unkown
689,1,1,Research lab p16,p16 unknown
689,1,1,Occurrence #,1st primary
689,1,1,1st Failure Site,oral cavity
689,1,1,Treatment Modality,Sx & RT
689,1,1,Research lab HPV,HPV unknown
689,1,1,1st Failure Type,locoregional
689,1,1,Overall Stage,IVa
690,1,1,2nd Failure Type,no known failure
690,1,1,Tumor Stage,T4a
690,1,1,Tumor Site,oral cavity
690,1,1,Metastasis,M0
690,1,1,Research lab p16,p16 unknown
690,1,1,Overall Stage,IVa
690,1,1,Treatment Modality,Sx & RT
690,1,1,Research lab HPV,HPV unknown
690,1,1,Occurrence #,1st primary
690,1,1,Nodal Stage,N2
690,1,1,1st Failure Type,locoregional
690,1,1,Radiation Dosage,60
690,1,1,Clinical lab p16,p16 unkown
691,1,1,Occurrence #,1st primary
691,1,1,Research lab p16,p16 unknown
691,1,1,Overall Stage,IVa
691,1,1,1st Failure Type,distant
691,1,1,Treatment Modality,Sx & RT
691,1,1,Clinical lab p16,p16 unkown
691,1,1,Nodal Stage,N2
691,1,1,Tumor Stage,T2
691,1,1,Metastasis,M0
691,1,1,Radiation Dosage,unknown
691,1,1,2nd Failure Type,no known failure
691,1,1,Tumor Site,oral cavity
691,1,1,Research lab HPV,HPV unknown
692,1,1,Research lab HPV,HPV unknown
692,1,1,Clinical lab p16,p16 unkown
692,1,1,Tumor Site,oral cavity
692,1,1,Tumor Stage,T1
692,1,1,Metastasis,M0
692,1,1,2nd Failure Type,no known failure
692,1,1,Research lab p16,p16 unknown
692,1,1,Nodal Stage,N0
692,1,1,Occurrence #,1st primary
692,1,1,Overall Stage,I
692,1,1,Treatment Modality,Sx
692,1,1,1st Failure Type,no known failure
693,1,1,Clinical lab p16,p16 unkown
693,1,1,1st Failure Type,no known failure
693,1,1,Nodal Stage,N2
693,1,1,Tumor Stage,T2
693,1,1,2nd Failure Type,no known failure
693,1,1,Tumor Site,oral cavity
693,1,1,Metastasis,M0
693,1,1,Overall Stage,IVa
693,1,1,Treatment Modality,Sx & RT
693,1,1,Research lab HPV,HPV unknown
693,1,1,Occurrence #,1st primary
693,1,1,Research lab p16,p16 unknown
693,1,1,Radiation Dosage,63
694,1,1,Occurrence #,1st primary
694,1,1,Clinical lab p16,p16 unkown
694,1,1,Tumor Site,oral cavity
694,1,1,Treatment Modality,Sx & CTX-RT
694,1,1,Research lab HPV,HPV unknown
694,1,1,Tumor Stage,T4a
694,1,1,1st Failure Type,distant
694,1,1,2nd Failure Type,no known failure
694,1,1,Radiation Dosage,63
694,1,1,Metastasis,M0
694,1,1,Nodal Stage,N2
694,1,1,Overall Stage,IVa
694,1,1,Research lab p16,p16 unknown
694,1,1,Initial Chemotherapy Agent,cis
695,1,1,2nd Failure Type,no known failure
695,1,1,Metastasis,M0
695,1,1,Tumor Site,oral cavity
695,1,1,Research lab p16,p16 unknown
695,1,1,Occurrence #,1st primary
695,1,1,Tumor Stage,T2
695,1,1,Radiation Dosage,50
695,1,1,Nodal Stage,N0
695,1,1,1st Failure Type,no known failure
695,1,1,Treatment Modality,RT
695,1,1,Overall Stage,II
695,1,1,Research lab HPV,HPV unknown
695,1,1,Clinical lab p16,p16 unkown
696,1,1,2nd Failure Type,no known failure
696,1,1,1st Failure Treatment Modality,Sx
696,1,1,Treatment Modality,Sx
696,1,1,Research lab HPV,HPV unknown
696,1,1,Overall Stage,I
696,1,1,Nodal Stage,N0
696,1,1,1st Failure Site,oral cavity
696,1,1,Clinical lab p16,p16 unkown
696,1,1,Occurrence #,1st primary
696,1,1,Tumor Stage,T1
696,1,1,Research lab p16,p16 unknown
696,1,1,Metastasis,M0
696,1,1,1st Failure Type,locoregional
696,1,1,Tumor Site,oral cavity
698,1,1,Treatment Modality,Sx
698,1,1,Nodal Stage,N0
698,1,1,Tumor Stage,T1
698,1,1,Overall Stage,I
698,1,1,Tumor Site,oral cavity
698,1,1,1st Failure Type,no known failure
698,1,1,Research lab HPV,HPV unknown
698,1,1,Occurrence #,1st primary
698,1,1,Research lab p16,p16 unknown
698,1,1,Metastasis,M0
698,1,1,2nd Failure Type,no known failure
698,1,1,Clinical lab p16,p16 unkown
699,1,1,Metastasis,M0
699,1,1,Treatment Modality,Sx
699,1,1,Research lab p16,p16 unknown
699,1,1,Nodal Stage,N0
699,1,1,Overall Stage,I
699,1,1,1st Failure Type,no known failure
699,1,1,Clinical lab p16,p16 unkown
699,1,1,Research lab HPV,HPV unknown
699,1,1,Tumor Site,oral cavity
699,1,1,2nd Failure Type,no known failure
699,1,1,Occurrence #,1st primary
699,1,1,Tumor Stage,T1
700,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
700,1,1,Nodal Stage,N2
700,1,1,Research lab HPV,HPV unknown
700,1,1,Tumor Site,oral cavity
700,1,1,2nd Failure Type,no known failure
700,1,1,Clinical lab p16,p16 unkown
700,1,1,1st Failure Radiation Dosage,30.6
700,1,1,Tumor Stage,T1
700,1,1,1st Failure Type,locoregional
700,1,1,Occurrence #,1st primary
700,1,1,1st Failure Treatment Modality,Sx & CTX-RT
700,1,1,Metastasis,M0
700,1,1,Treatment Modality,Sx
700,1,1,Overall Stage,IVa
700,1,1,Research lab p16,p16 unknown
701,1,1,Tumor Stage,T2
701,1,1,2nd Failure Type,no known failure
701,1,1,Treatment Modality,Sx
701,1,1,Research lab p16,p16 unknown
701,1,1,Tumor Site,oral cavity
701,1,1,Occurrence #,1st primary
701,1,1,1st Failure Type,no known failure
701,1,1,Research lab HPV,HPV unknown
701,1,1,Nodal Stage,N1
701,1,1,Overall Stage,III
701,1,1,Metastasis,M0
701,1,1,Clinical lab p16,p16 unkown
702,1,1,Research lab HPV,HPV unknown
702,1,1,Research lab p16,p16 unknown
702,1,1,Clinical lab p16,p16 unkown
702,1,1,Occurrence #,1st primary
702,1,1,2nd Failure Type,no known failure
702,1,1,Metastasis,M0
702,1,1,1st Failure Type,no known failure
702,1,1,Overall Stage,I
702,1,1,Nodal Stage,N0
702,1,1,Tumor Stage,T1
702,1,1,Treatment Modality,Sx
702,1,1,Tumor Site,oral cavity
703,1,1,Overall Stage,IVa
703,1,1,Research lab p16,p16 unknown
703,1,1,Occurrence #,1st primary
703,1,1,Research lab HPV,HPV unknown
703,1,1,2nd Failure Type,no known failure
703,1,1,1st Failure Type,no known failure
703,1,1,Tumor Stage,T4a
703,1,1,Nodal Stage,N2
703,1,1,Metastasis,M0
703,1,1,Treatment Modality,Sx
703,1,1,Clinical lab p16,p16 unkown
703,1,1,Tumor Site,oral cavity
704,1,1,1st Failure Type,no known failure
704,1,1,Occurrence #,1st primary
704,1,1,Research lab HPV,HPV unknown
704,1,1,2nd Failure Type,no known failure
704,1,1,Metastasis,M0
704,1,1,Clinical lab p16,p16 unkown
704,1,1,Research lab p16,p16 unknown
704,1,1,Tumor Stage,T1
704,1,1,Overall Stage,I
704,1,1,Tumor Site,oral cavity
704,1,1,Treatment Modality,Sx
704,1,1,Nodal Stage,N0
705,1,1,Clinical lab p16,p16 unkown
705,1,1,2nd Failure Type,no known failure
705,1,1,Nodal Stage,N0
705,1,1,Tumor Stage,T3
705,1,1,Research lab HPV,HPV unknown
705,1,1,Occurrence #,1st primary
705,1,1,Tumor Site,oral cavity
705,1,1,1st Failure Type,no known failure
705,1,1,Metastasis,M0
705,1,1,Research lab p16,p16 unknown
705,1,1,Overall Stage,III
705,1,1,Treatment Modality,Sx
706,1,1,Occurrence #,1st primary
706,1,1,Research lab p16,p16 unknown
706,1,1,Overall Stage,IVa
706,1,1,1st Failure Type,no known failure
706,1,1,2nd Failure Type,no known failure
706,1,1,Metastasis,M0
706,1,1,Research lab HPV,HPV unknown
706,1,1,Nodal Stage,N2
706,1,1,Treatment Modality,Sx
706,1,1,Tumor Site,oral cavity
706,1,1,Tumor Stage,T4a
706,1,1,Clinical lab p16,p16 unkown
707,1,1,2nd Failure Type,no known failure
707,1,1,Research lab HPV,HPV unknown
707,1,1,Occurrence #,1st primary
707,1,1,Treatment Modality,Sx
707,1,1,Tumor Site,oral cavity
707,1,1,1st Failure Type,no known failure
707,1,1,Nodal Stage,N1
707,1,1,Tumor Stage,T4a
707,1,1,Overall Stage,IVa
707,1,1,Clinical lab p16,p16 unkown
707,1,1,Research lab p16,p16 unknown
707,1,1,Metastasis,M0
708,1,1,Research lab p16,p16 unknown
708,1,1,Occurrence #,1st primary
708,1,1,Nodal Stage,N0
708,1,1,Clinical lab p16,p16 unkown
708,1,1,Overall Stage,I
708,1,1,1st Failure Type,no known failure
708,1,1,Metastasis,M0
708,1,1,Tumor Site,oral cavity
708,1,1,Research lab HPV,HPV unknown
708,1,1,Treatment Modality,Sx
708,1,1,Tumor Stage,T1
708,1,1,2nd Failure Type,no known failure
709,1,1,2nd Failure Type,no known failure
709,1,1,Clinical lab p16,p16 unkown
709,1,1,Tumor Stage,T1
709,1,1,1st Failure Type,no known failure
709,1,1,Occurrence #,1st primary
709,1,1,Tumor Site,oral cavity
709,1,1,Metastasis,M0
709,1,1,Research lab HPV,HPV unknown
709,1,1,Treatment Modality,Sx
709,1,1,Nodal Stage,N0
709,1,1,Research lab p16,p16 unknown
709,1,1,Overall Stage,I
710,1,1,Research lab p16,p16 unknown
710,1,1,Research lab HPV,HPV unknown
710,1,1,Metastasis,M0
710,1,1,Tumor Site,oral cavity
710,1,1,Nodal Stage,N0
710,1,1,Treatment Modality,Sx
710,1,1,Occurrence #,1st primary
710,1,1,Clinical lab p16,p16 unkown
710,1,1,2nd Failure Type,no known failure
710,1,1,1st Failure Type,no known failure
710,1,1,Tumor Stage,T1
710,1,1,Overall Stage,I
711,1,1,Treatment Modality,Sx
711,1,1,Tumor Site,oral cavity
711,1,1,Research lab p16,p16 unknown
711,1,1,Nodal Stage,N0
711,1,1,Tumor Stage,T4a
711,1,1,Research lab HPV,HPV unknown
711,1,1,2nd Failure Type,no known failure
711,1,1,Overall Stage,IVa
711,1,1,Clinical lab p16,p16 unkown
711,1,1,1st Failure Type,no known failure
711,1,1,Metastasis,M0
711,1,1,Occurrence #,1st primary
712,1,1,Tumor Site,oral cavity
712,1,1,Radiation Dosage,60
712,1,1,Treatment Modality,Sx & RT
712,1,1,Clinical lab p16,p16 unkown
712,1,1,Overall Stage,IVa
712,1,1,Research lab p16,p16 unknown
712,1,1,Metastasis,M0
712,1,1,Nodal Stage,N0
712,1,1,2nd Failure Type,no known failure
712,1,1,1st Failure Treatment Modality,Sx
712,1,1,1st Failure Type,locoregional
712,1,1,Tumor Stage,T4a
712,1,1,Research lab HPV,HPV unknown
712,1,1,1st Failure Site,oral cavity
712,1,1,Occurrence #,recurrence
713,1,1,Metastasis,M0
713,1,1,Tumor Site,oral cavity
713,1,1,Nodal Stage,N0
713,1,1,Overall Stage,I
713,1,1,1st Failure Type,no known failure
713,1,1,Research lab p16,p16 unknown
713,1,1,Occurrence #,1st primary
713,1,1,Research lab HPV,HPV unknown
713,1,1,Clinical lab p16,p16 unkown
713,1,1,Treatment Modality,Sx
713,1,1,Tumor Stage,T1
713,1,1,2nd Failure Type,no known failure
714,1,1,Tumor Site,oral cavity
714,1,1,Research lab HPV,HPV unknown
714,1,1,Nodal Stage,Unknown
714,1,1,Clinical lab p16,p16 unkown
714,1,1,Research lab p16,p16 unknown
714,1,1,2nd Failure Type,no known failure
714,1,1,Treatment Modality,Unknown
714,1,1,Occurrence #,recurrence
714,1,1,Overall Stage,IVc
714,1,1,Metastasis,M1
714,1,1,Tumor Stage,Unknown
714,1,1,1st Failure Type,distant
715,1,1,Clinical lab p16,p16 unkown
715,1,1,Nodal Stage,N0
715,1,1,Treatment Modality,Sx
715,1,1,Overall Stage,I
715,1,1,Tumor Site,oral cavity
715,1,1,Research lab p16,p16 unknown
715,1,1,Tumor Stage,T1
715,1,1,2nd Failure Type,no known failure
715,1,1,1st Failure Type,no known failure
715,1,1,Metastasis,M0
715,1,1,Research lab HPV,HPV unknown
715,1,1,Occurrence #,1st primary
716,1,1,Metastasis,M0
716,1,1,Overall Stage,I
716,1,1,2nd Failure Type,no known failure
716,1,1,Research lab HPV,HPV unknown
716,1,1,Tumor Stage,T1
716,1,1,Research lab p16,p16 unknown
716,1,1,1st Failure Type,no known failure
716,1,1,Clinical lab p16,p16 unkown
716,1,1,Nodal Stage,N0
716,1,1,Occurrence #,1st primary
716,1,1,Tumor Site,oral cavity
716,1,1,Treatment Modality,Sx
717,1,1,Tumor Stage,T4a
717,1,1,Clinical lab p16,p16 unkown
717,1,1,Nodal Stage,N2
717,1,1,Occurrence #,1st primary
717,1,1,Research lab HPV,HPV unknown
717,1,1,Tumor Site,oral cavity
717,1,1,Overall Stage,IVa
717,1,1,Treatment Modality,Sx
717,1,1,1st Failure Type,no known failure
717,1,1,2nd Failure Type,no known failure
717,1,1,Research lab p16,p16 unknown
717,1,1,Metastasis,M0
718,1,1,Metastasis,M0
718,1,1,2nd Failure Type,no known failure
718,1,1,1st Failure Type,no known failure
718,1,1,Clinical lab p16,p16 unkown
718,1,1,Overall Stage,II
718,1,1,Tumor Site,oral cavity
718,1,1,Research lab p16,p16 unknown
718,1,1,Treatment Modality,Sx
718,1,1,Occurrence #,1st primary
718,1,1,Research lab HPV,HPV unknown
718,1,1,Nodal Stage,N0
718,1,1,Tumor Stage,T2
719,1,1,1st Failure Type,no known failure
719,1,1,Clinical lab p16,p16 unkown
719,1,1,Treatment Modality,Unknown
719,1,1,Metastasis,M0
719,1,1,Tumor Site,oral cavity
719,1,1,Overall Stage,II
719,1,1,Research lab p16,p16 unknown
719,1,1,Research lab HPV,HPV unknown
719,1,1,Occurrence #,1st primary
719,1,1,Tumor Stage,T2
719,1,1,2nd Failure Type,no known failure
719,1,1,Nodal Stage,N0
720,1,1,Research lab HPV,HPV unknown
720,1,1,Tumor Site,oral cavity
720,1,1,2nd Failure Type,no known failure
720,1,1,Occurrence #,1st primary
720,1,1,Overall Stage,III
720,1,1,Research lab p16,p16 unknown
720,1,1,Nodal Stage,N1
720,1,1,Tumor Stage,T2
720,1,1,Treatment Modality,Sx
720,1,1,Metastasis,M0
720,1,1,1st Failure Type,no known failure
720,1,1,Clinical lab p16,p16 unkown
721,1,1,Treatment Modality,Sx
721,1,1,Clinical lab p16,p16 unkown
721,1,1,1st Failure Treatment Modality,Sx
721,1,1,Overall Stage,I
721,1,1,2nd Failure Type,no known failure
721,1,1,Metastasis,M0
721,1,1,Tumor Site,oral cavity
721,1,1,Occurrence #,1st primary
721,1,1,Tumor Stage,T1
721,1,1,Nodal Stage,N0
721,1,1,1st Failure Site,oral cavity
721,1,1,1st Failure Type,locoregional
721,1,1,Research lab p16,p16 unknown
721,1,1,Research lab HPV,HPV unknown
722,1,1,Nodal Stage,N0
722,1,1,1st Failure Treatment Modality,Sx
722,1,1,2nd Failure Type,no known failure
722,1,1,Overall Stage,I
722,1,1,Clinical lab p16,p16 unkown
722,1,1,Research lab p16,p16 unknown
722,1,1,1st Failure Type,locoregional
722,1,1,Tumor Stage,T1
722,1,1,Metastasis,M0
722,1,1,Occurrence #,1st primary
722,1,1,Research lab HPV,HPV unknown
722,1,1,Treatment Modality,Sx
722,1,1,1st Failure Site,oral cavity
722,1,1,Tumor Site,oral cavity
723,1,1,Nodal Stage,N0
723,1,1,Treatment Modality,Sx
723,1,1,Clinical lab p16,p16 unkown
723,1,1,1st Failure Type,no known failure
723,1,1,Research lab p16,p16 unknown
723,1,1,Overall Stage,I
723,1,1,Tumor Site,oral cavity
723,1,1,Research lab HPV,HPV unknown
723,1,1,Occurrence #,1st primary
723,1,1,Metastasis,M0
723,1,1,Tumor Stage,T1
723,1,1,2nd Failure Type,no known failure
724,1,1,Tumor Site,oral cavity
724,1,1,Overall Stage,IVa
724,1,1,1st Failure Type,no known failure
724,1,1,Metastasis,M0
724,1,1,Occurrence #,1st primary
724,1,1,Tumor Stage,Unknown
724,1,1,Clinical lab p16,p16 unkown
724,1,1,2nd Failure Type,no known failure
724,1,1,Nodal Stage,N2
724,1,1,Research lab HPV,HPV unknown
724,1,1,Research lab p16,p16 unknown
724,1,1,Treatment Modality,Unknown
725,1,1,Tumor Stage,T1
725,1,1,Overall Stage,I
725,1,1,Treatment Modality,Sx
725,1,1,Nodal Stage,N0
725,1,1,Tumor Site,oral cavity
725,1,1,1st Failure Type,locoregional
725,1,1,1st Failure Treatment Modality,Sx
725,1,1,1st Failure Site,oral cavity
725,1,1,Metastasis,M0
725,1,1,2nd Failure Type,no known failure
725,1,1,Research lab HPV,HPV unknown
725,1,1,Research lab p16,p16 unknown
725,1,1,Occurrence #,1st primary
725,1,1,Clinical lab p16,p16 unkown
726,1,1,Research lab HPV,HPV unknown
726,1,1,Nodal Stage,N0
726,1,1,Tumor Site,oral cavity
726,1,1,Overall Stage,IVa
726,1,1,1st Failure Type,no known failure
726,1,1,Research lab p16,p16 unknown
726,1,1,Radiation Dosage,59.4
726,1,1,Tumor Stage,T4a
726,1,1,2nd Failure Type,no known failure
726,1,1,Occurrence #,1st primary
726,1,1,Metastasis,M0
726,1,1,Treatment Modality,Sx & RT
726,1,1,Clinical lab p16,p16 unkown
727,1,1,1st Failure Type,distant
727,1,1,Occurrence #,recurrence
727,1,1,2nd Failure Type,no known failure
727,1,1,Nodal Stage,N2
727,1,1,Treatment Modality,Sx
727,1,1,Radiation Dosage,unknown
727,1,1,Metastasis,M0
727,1,1,Research lab HPV,HPV unknown
727,1,1,Clinical lab p16,p16 unkown
727,1,1,Tumor Site,oral cavity
727,1,1,Overall Stage,IVa
727,1,1,Research lab p16,p16 unknown
727,1,1,Tumor Stage,T4a
728,1,1,1st Failure Treatment Modality,Sx
728,1,1,1st Failure Site,oral cavity
728,1,1,Occurrence #,1st primary
728,1,1,2nd Failure Type,no known failure
728,1,1,Research lab HPV,HPV unknown
728,1,1,Clinical lab p16,p16 unkown
728,1,1,Metastasis,M0
728,1,1,Overall Stage,I
728,1,1,Tumor Site,oral cavity
728,1,1,Research lab p16,p16 unknown
728,1,1,Tumor Stage,T1
728,1,1,Nodal Stage,N0
728,1,1,Treatment Modality,Sx
728,1,1,1st Failure Type,locoregional
729,1,1,Research lab p16,p16 unknown
729,1,1,Occurrence #,1st primary
729,1,1,1st Failure Type,locoregional
729,1,1,Tumor Stage,T4a
729,1,1,Research lab HPV,HPV unknown
729,1,1,Nodal Stage,N1
729,1,1,Tumor Site,oral cavity
729,1,1,Overall Stage,IVa
729,1,1,Treatment Modality,Sx
729,1,1,Clinical lab p16,p16 unkown
729,1,1,Metastasis,M0
729,1,1,2nd Failure Type,no known failure
730,1,1,Metastasis,M0
730,1,1,Overall Stage,IVa
730,1,1,Tumor Site,oral cavity
730,1,1,Research lab p16,p16 unknown
730,1,1,Research lab HPV,HPV unknown
730,1,1,1st Failure Type,locoregional and distant
730,1,1,Clinical lab p16,p16 unkown
730,1,1,Occurrence #,recurrence
730,1,1,Nodal Stage,N1
730,1,1,Treatment Modality,Sx
730,1,1,2nd Failure Type,no known failure
730,1,1,Tumor Stage,T4a
731,1,1,Nodal Stage,N0
731,1,1,Occurrence #,1st primary
731,1,1,Overall Stage,IVa
731,1,1,Metastasis,M0
731,1,1,Tumor Site,oral cavity
731,1,1,Research lab p16,p16 unknown
731,1,1,Tumor Stage,T4a
731,1,1,Research lab HPV,HPV unknown
731,1,1,2nd Failure Type,no known failure
731,1,1,1st Failure Type,no known failure
731,1,1,Clinical lab p16,p16 unkown
731,1,1,Treatment Modality,Sx
732,1,1,Tumor Stage,T4a
732,1,1,Research lab HPV,HPV unknown
732,1,1,1st Failure Site,oral cavity
732,1,1,2nd Failure Type,no known failure
732,1,1,Research lab p16,p16 unknown
732,1,1,Radiation Dosage,unknown
732,1,1,Clinical lab p16,p16 unkown
732,1,1,Occurrence #,1st primary
732,1,1,Nodal Stage,N0
732,1,1,Overall Stage,IVa
732,1,1,1st Failure Treatment Modality,Sx
732,1,1,Metastasis,M0
732,1,1,1st Failure Type,locoregional
732,1,1,Tumor Site,oral cavity
732,1,1,Treatment Modality,Sx & RT
733,1,1,Tumor Site,oral cavity
733,1,1,Nodal Stage,N3
733,1,1,2nd Failure Type,no known failure
733,1,1,Tumor Stage,T2
733,1,1,Occurrence #,recurrence
733,1,1,Overall Stage,IVb
733,1,1,Metastasis,M0
733,1,1,1st Failure Type,distant
733,1,1,Research lab HPV,HPV unknown
733,1,1,Clinical lab p16,p16 unkown
733,1,1,Research lab p16,p16 unknown
733,1,1,Treatment Modality,Sx
734,1,1,1st Failure Type,no known failure
734,1,1,Occurrence #,1st primary
734,1,1,Research lab HPV,HPV unknown
734,1,1,Tumor Stage,T2
734,1,1,Tumor Site,oral cavity
734,1,1,Research lab p16,p16 unknown
734,1,1,Overall Stage,II
734,1,1,Nodal Stage,N0
734,1,1,Clinical lab p16,p16 unkown
734,1,1,2nd Failure Type,no known failure
734,1,1,Treatment Modality,Sx
734,1,1,Metastasis,M0
735,1,1,Clinical lab p16,p16 unkown
735,1,1,1st Failure Treatment Modality,Sx
735,1,1,1st Failure Site,oral cavity
735,1,1,Treatment Modality,Sx
735,1,1,2nd Failure Type,no known failure
735,1,1,Research lab HPV,HPV unknown
735,1,1,Nodal Stage,N0
735,1,1,Tumor Site,oral cavity
735,1,1,Research lab p16,p16 unknown
735,1,1,Occurrence #,other primary
735,1,1,Tumor Stage,T1
735,1,1,Metastasis,M0
735,1,1,Overall Stage,I
735,1,1,1st Failure Type,no known failure
737,1,1,2nd Failure Type,no known failure
737,1,1,Nodal Stage,N2
737,1,1,Occurrence #,1st primary
737,1,1,Overall Stage,IVa
737,1,1,Tumor Site,oral cavity
737,1,1,Research lab p16,p16 unknown
737,1,1,Clinical lab p16,p16 unkown
737,1,1,Metastasis,M0
737,1,1,Radiation Dosage,unknown
737,1,1,Treatment Modality,Sx & CTX-RT
737,1,1,1st Failure Type,distant
737,1,1,Initial Chemotherapy Agent,carbo/doce/panitumab
737,1,1,Research lab HPV,HPV unknown
737,1,1,Tumor Stage,T4a
738,1,1,Nodal Stage,N0
738,1,1,Treatment Modality,Sx
738,1,1,Research lab p16,p16 unknown
738,1,1,Clinical lab p16,p16 unkown
738,1,1,Metastasis,M0
738,1,1,1st Failure Type,no known failure
738,1,1,2nd Failure Type,no known failure
738,1,1,Research lab HPV,HPV unknown
738,1,1,Overall Stage,I
738,1,1,Occurrence #,1st primary
738,1,1,Tumor Stage,T1
738,1,1,Tumor Site,oral cavity
739,1,1,2nd Failure Type,no known failure
739,1,1,Research lab HPV,HPV unknown
739,1,1,Tumor Site,oral cavity
739,1,1,Nodal Stage,Unknown
739,1,1,Overall Stage,Unknown
739,1,1,1st Failure Type,no known failure
739,1,1,Occurrence #,1st primary
739,1,1,Research lab p16,p16 unknown
739,1,1,Metastasis,Unknown
739,1,1,Clinical lab p16,p16 unkown
739,1,1,Treatment Modality,Unknown
739,1,1,Tumor Stage,Unknown
740,1,1,Nodal Stage,N0
740,1,1,2nd Failure Type,no known failure
740,1,1,Occurrence #,1st primary
740,1,1,1st Failure Type,no known failure
740,1,1,Metastasis,M0
740,1,1,Tumor Stage,T1
740,1,1,Research lab HPV,HPV unknown
740,1,1,Tumor Site,oral cavity
740,1,1,Treatment Modality,Sx
740,1,1,Clinical lab p16,p16 unkown
740,1,1,Research lab p16,p16 unknown
740,1,1,Overall Stage,I
741,1,1,2nd Failure Type,no known failure
741,1,1,1st Failure Type,locoregional
741,1,1,Nodal Stage,N0
741,1,1,Tumor Site,oral cavity
741,1,1,Treatment Modality,Sx & RT
741,1,1,Metastasis,M0
741,1,1,Research lab HPV,HPV unknown
741,1,1,Research lab p16,p16 unknown
741,1,1,Clinical lab p16,p16 unkown
741,1,1,Overall Stage,I
741,1,1,1st Failure Site,oral cavity
741,1,1,Occurrence #,1st primary
741,1,1,Tumor Stage,T1
741,1,1,Radiation Dosage,unknown
741,1,1,1st Failure Treatment Modality,Sx
742,1,1,2nd Failure Type,no known failure
742,1,1,Occurrence #,recurrence
742,1,1,1st Failure Treatment Modality,Sx
742,1,1,1st Failure Type,no known failure
742,1,1,Research lab HPV,HPV unknown
742,1,1,Treatment Modality,Sx
742,1,1,Metastasis,M0
742,1,1,Research lab p16,p16 unknown
742,1,1,Clinical lab p16,p16 unkown
742,1,1,Nodal Stage,N1
742,1,1,Tumor Site,oral cavity
742,1,1,Overall Stage,III
742,1,1,1st Failure Site,oral cavity
742,1,1,Tumor Stage,T2
743,1,1,Tumor Stage,T1
743,1,1,1st Failure Type,no known failure
743,1,1,Nodal Stage,N0
743,1,1,Overall Stage,I
743,1,1,Metastasis,M0
743,1,1,Treatment Modality,Sx
743,1,1,Research lab HPV,HPV unknown
743,1,1,Research lab p16,p16 unknown
743,1,1,Clinical lab p16,p16 unkown
743,1,1,2nd Failure Type,no known failure
743,1,1,Tumor Site,oral cavity
743,1,1,Occurrence #,1st primary
744,1,1,2nd Failure Type,no known failure
744,1,1,Overall Stage,II
744,1,1,Tumor Site,oral cavity
744,1,1,Tumor Stage,T2
744,1,1,1st Failure Type,no known failure
744,1,1,Research lab HPV,HPV unknown
744,1,1,Nodal Stage,N0
744,1,1,Metastasis,M0
744,1,1,Research lab p16,p16 unknown
744,1,1,Treatment Modality,Sx
744,1,1,Clinical lab p16,p16 unkown
744,1,1,Occurrence #,1st primary
745,1,1,Clinical lab p16,p16 unkown
745,1,1,Metastasis,M0
745,1,1,Radiation Dosage,unknown
745,1,1,Treatment Modality,CTX-RT
745,1,1,Tumor Stage,T3
745,1,1,Research lab p16,p16 unknown
745,1,1,Initial Chemotherapy Agent,PTX
745,1,1,Overall Stage,III
745,1,1,Nodal Stage,N0
745,1,1,Tumor Site,oral cavity
745,1,1,Occurrence #,1st primary
745,1,1,Research lab HPV,HPV unknown
745,1,1,2nd Failure Type,no known failure
745,1,1,1st Failure Type,locoregional
746,1,1,1st Failure Type,no known failure
746,1,1,Research lab HPV,HPV unknown
746,1,1,Clinical lab p16,p16 unkown
746,1,1,Research lab p16,p16 unknown
746,1,1,Treatment Modality,Sx
746,1,1,Metastasis,M0
746,1,1,Nodal Stage,N2
746,1,1,Overall Stage,IVa
746,1,1,2nd Failure Type,no known failure
746,1,1,Occurrence #,1st primary
746,1,1,Tumor Site,oral cavity
746,1,1,Tumor Stage,T4a
747,1,1,Overall Stage,I
747,1,1,1st Failure Site,oral cavity
747,1,1,2nd Failure Type,no known failure
747,1,1,Occurrence #,1st primary
747,1,1,Tumor Stage,T1
747,1,1,1st Failure Treatment Modality,Sx
747,1,1,Metastasis,M0
747,1,1,Research lab HPV,HPV unknown
747,1,1,Nodal Stage,N0
747,1,1,Tumor Site,oral cavity
747,1,1,Research lab p16,p16 unknown
747,1,1,1st Failure Type,locoregional
747,1,1,Treatment Modality,Sx
747,1,1,Clinical lab p16,p16 unkown
748,1,1,Tumor Site,oral cavity
748,1,1,Metastasis,M0
748,1,1,2nd Failure Type,no known failure
748,1,1,Nodal Stage,N2
748,1,1,Research lab p16,p16 unknown
748,1,1,Clinical lab p16,p16 unkown
748,1,1,Treatment Modality,Sx & RT
748,1,1,Research lab HPV,HPV unknown
748,1,1,Occurrence #,1st primary
748,1,1,Radiation Dosage,63
748,1,1,Tumor Stage,T2
748,1,1,1st Failure Type,no known failure
748,1,1,Overall Stage,IVa
749,1,1,Treatment Modality,Sx
749,1,1,Clinical lab p16,p16 unkown
749,1,1,Nodal Stage,N0
749,1,1,Overall Stage,I
749,1,1,Tumor Site,oral cavity
749,1,1,Tumor Stage,T1
749,1,1,2nd Failure Type,no known failure
749,1,1,Research lab p16,p16 unknown
749,1,1,Metastasis,M0
749,1,1,1st Failure Type,no known failure
749,1,1,Occurrence #,1st primary
749,1,1,Research lab HPV,HPV unknown
750,1,1,Occurrence #,1st primary
750,1,1,Nodal Stage,N2
750,1,1,Treatment Modality,Sx
750,1,1,2nd Failure Type,no known failure
750,1,1,Clinical lab p16,p16 unkown
750,1,1,Overall Stage,IVa
750,1,1,1st Failure Type,no known failure
750,1,1,Tumor Stage,T4a
750,1,1,Tumor Site,oral cavity
750,1,1,Research lab HPV,HPV unknown
750,1,1,Research lab p16,p16 unknown
750,1,1,Metastasis,M0
751,1,1,Tumor Stage,T2
751,1,1,Metastasis,M0
751,1,1,Clinical lab p16,p16 unkown
751,1,1,Treatment Modality,Sx
751,1,1,Research lab p16,p16 unknown
751,1,1,2nd Failure Type,no known failure
751,1,1,Tumor Site,oral cavity
751,1,1,Research lab HPV,HPV unknown
751,1,1,Overall Stage,II
751,1,1,1st Failure Type,no known failure
751,1,1,Nodal Stage,N0
751,1,1,Occurrence #,1st primary
752,1,1,Tumor Stage,T1
752,1,1,Tumor Site,oral cavity
752,1,1,Nodal Stage,N1
752,1,1,Occurrence #,1st primary
752,1,1,2nd Failure Type,no known failure
752,1,1,Overall Stage,III
752,1,1,1st Failure Type,no known failure
752,1,1,Metastasis,M0
752,1,1,Clinical lab p16,p16 unkown
752,1,1,Treatment Modality,Sx
752,1,1,Research lab p16,p16 unknown
752,1,1,Research lab HPV,HPV unknown
753,1,1,1st Failure Type,locoregional
753,1,1,Tumor Stage,T1
753,1,1,1st Failure Treatment Modality,Sx
753,1,1,Metastasis,M0
753,1,1,1st Failure Site,oral cavity
753,1,1,Tumor Site,oral cavity
753,1,1,Overall Stage,IVa
753,1,1,2nd Failure Type,no known failure
753,1,1,Nodal Stage,N0
753,1,1,Treatment Modality,Sx
753,1,1,Clinical lab p16,p16 unkown
753,1,1,Occurrence #,1st primary
753,1,1,Research lab p16,p16 unknown
753,1,1,Research lab HPV,HPV unknown
754,1,1,Tumor Stage,T1
754,1,1,Research lab p16,p16 unknown
754,1,1,Metastasis,M0
754,1,1,Overall Stage,I
754,1,1,2nd Failure Type,no known failure
754,1,1,Clinical lab p16,p16 unkown
754,1,1,Research lab HPV,HPV unknown
754,1,1,Nodal Stage,N0
754,1,1,Tumor Site,oral cavity
754,1,1,Occurrence #,1st primary
754,1,1,1st Failure Type,no known failure
754,1,1,Treatment Modality,Sx
755,1,1,Radiation Dosage,63
755,1,1,2nd Failure Type,no known failure
755,1,1,Research lab p16,p16 unknown
755,1,1,Metastasis,M0
755,1,1,Tumor Site,oral cavity
755,1,1,Research lab HPV,HPV unknown
755,1,1,1st Failure Type,no known failure
755,1,1,Tumor Stage,T4a
755,1,1,Nodal Stage,N0
755,1,1,Clinical lab p16,p16 unkown
755,1,1,Occurrence #,1st primary
755,1,1,Overall Stage,IVa
755,1,1,Treatment Modality,Sx & RT
756,1,1,1st Failure Type,no known failure
756,1,1,Occurrence #,1st primary
756,1,1,Overall Stage,IVa
756,1,1,Metastasis,M0
756,1,1,Treatment Modality,Sx
756,1,1,Tumor Stage,T4a
756,1,1,Research lab p16,p16 unknown
756,1,1,Nodal Stage,N0
756,1,1,2nd Failure Type,no known failure
756,1,1,Tumor Site,oral cavity
756,1,1,Research lab HPV,HPV unknown
756,1,1,Clinical lab p16,p16 unkown
757,1,1,Tumor Site,oral cavity
757,1,1,Research lab p16,p16 unknown
757,1,1,Nodal Stage,N2
757,1,1,Clinical lab p16,p16 unkown
757,1,1,Metastasis,M0
757,1,1,Research lab HPV,HPV unknown
757,1,1,1st Failure Type,locoregional
757,1,1,Radiation Dosage,2
757,1,1,Overall Stage,IVa
757,1,1,Occurrence #,1st primary
757,1,1,Treatment Modality,Sx & RT
757,1,1,Tumor Stage,T4a
757,1,1,2nd Failure Type,no known failure
758,1,1,Metastasis,M0
758,1,1,Treatment Modality,Sx
758,1,1,1st Failure Type,no known failure
758,1,1,Tumor Site,oral cavity
758,1,1,Research lab HPV,HPV unknown
758,1,1,Overall Stage,IVa
758,1,1,Nodal Stage,N0
758,1,1,Clinical lab p16,p16 unkown
758,1,1,Research lab p16,p16 unknown
758,1,1,Tumor Stage,T4a
758,1,1,Occurrence #,1st primary
758,1,1,2nd Failure Type,no known failure
759,1,1,Nodal Stage,N2
759,1,1,Overall Stage,IVa
759,1,1,1st Failure Type,no known failure
759,1,1,Research lab HPV,HPV unknown
759,1,1,Treatment Modality,Sx
759,1,1,Occurrence #,1st primary
759,1,1,Tumor Site,oral cavity
759,1,1,Clinical lab p16,p16 unkown
759,1,1,Research lab p16,p16 unknown
759,1,1,Metastasis,M0
759,1,1,Tumor Stage,T2
759,1,1,2nd Failure Type,no known failure
760,1,1,Nodal Stage,N2
760,1,1,Occurrence #,1st primary
760,1,1,Research lab p16,p16 unknown
760,1,1,Treatment Modality,Sx & CTX-RT
760,1,1,Research lab HPV,HPV unknown
760,1,1,Clinical lab p16,p16 unkown
760,1,1,Initial Chemotherapy Agent,cetux
760,1,1,2nd Failure Type,no known failure
760,1,1,Tumor Stage,T2
760,1,1,Radiation Dosage,50.4
760,1,1,Overall Stage,IVa
760,1,1,Metastasis,M0
760,1,1,Tumor Site,oral cavity
760,1,1,1st Failure Type,no known failure
761,1,1,Metastasis,M0
761,1,1,Nodal Stage,N0
761,1,1,Occurrence #,1st primary
761,1,1,Overall Stage,I
761,1,1,Treatment Modality,Sx
761,1,1,Clinical lab p16,p16 unkown
761,1,1,2nd Failure Type,no known failure
761,1,1,Tumor Stage,T1
761,1,1,Research lab p16,p16 unknown
761,1,1,Tumor Site,oral cavity
761,1,1,1st Failure Type,no known failure
761,1,1,Research lab HPV,HPV unknown
762,1,1,2nd Failure Type,no known failure
762,1,1,Treatment Modality,Sx
762,1,1,Tumor Stage,T4a
762,1,1,Overall Stage,IVa
762,1,1,Research lab p16,p16 unknown
762,1,1,Research lab HPV,HPV unknown
762,1,1,Tumor Site,oral cavity
762,1,1,1st Failure Type,no known failure
762,1,1,Metastasis,M0
762,1,1,Clinical lab p16,p16 unkown
762,1,1,Occurrence #,1st primary
762,1,1,Nodal Stage,N2
763,1,1,Tumor Stage,T2
763,1,1,Metastasis,M0
763,1,1,Clinical lab p16,p16 unkown
763,1,1,Tumor Site,oral cavity
763,1,1,Nodal Stage,N1
763,1,1,Occurrence #,1st primary
763,1,1,Research lab HPV,HPV unknown
763,1,1,Treatment Modality,Sx
763,1,1,2nd Failure Type,no known failure
763,1,1,Overall Stage,III
763,1,1,Research lab p16,p16 unknown
763,1,1,1st Failure Type,no known failure
765,1,1,Overall Stage,I
765,1,1,1st Failure Type,locoregional
765,1,1,Research lab p16,p16 unknown
765,1,1,2nd Failure Type,no known failure
765,1,1,Occurrence #,1st primary
765,1,1,Metastasis,M0
765,1,1,Tumor Stage,T1
765,1,1,Research lab HPV,HPV unknown
765,1,1,Treatment Modality,Sx
765,1,1,Tumor Site,oral cavity
765,1,1,1st Failure Treatment Modality,Sx
765,1,1,1st Failure Site,oral cavity
765,1,1,Nodal Stage,N0
765,1,1,Clinical lab p16,p16 unkown
766,1,1,Research lab HPV,HPV unknown
766,1,1,Radiation Dosage,64.8
766,1,1,Overall Stage,IVa
766,1,1,Nodal Stage,N2
766,1,1,Clinical lab p16,p16 unkown
766,1,1,Tumor Site,oral cavity
766,1,1,Research lab p16,p16 unknown
766,1,1,Occurrence #,1st primary
766,1,1,Tumor Stage,T4a
766,1,1,Metastasis,M0
766,1,1,1st Failure Type,locoregional
766,1,1,Treatment Modality,Sx & RT
766,1,1,2nd Failure Type,no known failure
768,1,1,Tumor Stage,T1
768,1,1,Metastasis,M0
768,1,1,1st Failure Site,oral cavity
768,1,1,Occurrence #,1st primary
768,1,1,1st Failure Type,locoregional
768,1,1,Overall Stage,I
768,1,1,2nd Failure Type,no known failure
768,1,1,Treatment Modality,Sx
768,1,1,Clinical lab p16,p16 unkown
768,1,1,Research lab HPV,HPV unknown
768,1,1,Nodal Stage,N0
768,1,1,Tumor Site,oral cavity
768,1,1,1st Failure Treatment Modality,Sx
768,1,1,Research lab p16,p16 unknown
769,1,1,Clinical lab p16,p16 unkown
769,1,1,Nodal Stage,N0
769,1,1,Tumor Stage,T1
769,1,1,1st Failure Type,no known failure
769,1,1,Metastasis,M0
769,1,1,Tumor Site,oral cavity
769,1,1,2nd Failure Type,no known failure
769,1,1,Treatment Modality,Sx
769,1,1,Research lab HPV,HPV unknown
769,1,1,Overall Stage,I
769,1,1,Research lab p16,p16 unknown
769,1,1,Occurrence #,1st primary
770,1,1,Clinical lab p16,p16 unkown
770,1,1,Tumor Stage,T2
770,1,1,2nd Failure Type,no known failure
770,1,1,Overall Stage,II
770,1,1,Research lab p16,p16 unknown
770,1,1,1st Failure Type,no known failure
770,1,1,Metastasis,M0
770,1,1,Occurrence #,1st primary
770,1,1,Tumor Site,oral cavity
770,1,1,Nodal Stage,N0
770,1,1,Treatment Modality,Sx
770,1,1,Research lab HPV,HPV unknown
771,1,1,Research lab HPV,HPV unknown
771,1,1,Metastasis,M0
771,1,1,Overall Stage,I
771,1,1,Tumor Site,oral cavity
771,1,1,Research lab p16,p16 unknown
771,1,1,2nd Failure Type,no known failure
771,1,1,Treatment Modality,Sx
771,1,1,Tumor Stage,T1
771,1,1,Occurrence #,1st primary
771,1,1,Clinical lab p16,p16 unkown
771,1,1,Nodal Stage,N0
771,1,1,1st Failure Type,no known failure
772,1,1,Metastasis,M0
772,1,1,Tumor Site,oral cavity
772,1,1,Research lab HPV,HPV unknown
772,1,1,Overall Stage,IVa
772,1,1,Occurrence #,1st primary
772,1,1,Tumor Stage,T4a
772,1,1,Clinical lab p16,p16 unkown
772,1,1,Nodal Stage,N1
772,1,1,2nd Failure Type,no known failure
772,1,1,1st Failure Type,no known failure
772,1,1,Research lab p16,p16 unknown
772,1,1,Treatment Modality,Sx & RT
772,1,1,Radiation Dosage,63
773,1,1,Research lab p16,p16 unknown
773,1,1,2nd Failure Type,no known failure
773,1,1,Overall Stage,I
773,1,1,Nodal Stage,N0
773,1,1,Metastasis,M0
773,1,1,Occurrence #,1st primary
773,1,1,Tumor Stage,T1
773,1,1,Research lab HPV,HPV unknown
773,1,1,Clinical lab p16,p16 unkown
773,1,1,Tumor Site,oral cavity
773,1,1,Treatment Modality,Sx
773,1,1,1st Failure Type,no known failure
774,1,1,Treatment Modality,Sx
774,1,1,Metastasis,M0
774,1,1,Overall Stage,I
774,1,1,Nodal Stage,N0
774,1,1,Clinical lab p16,p16 unkown
774,1,1,2nd Failure Type,no known failure
774,1,1,Tumor Site,oral cavity
774,1,1,Occurrence #,1st primary
774,1,1,Tumor Stage,T1
774,1,1,1st Failure Treatment Modality,Sx
774,1,1,1st Failure Type,locoregional
774,1,1,1st Failure Site,oral cavity
774,1,1,Research lab HPV,HPV unknown
774,1,1,Research lab p16,p16 unknown
775,1,1,Research lab HPV,HPV unknown
775,1,1,Nodal Stage,N0
775,1,1,Metastasis,M0
775,1,1,Tumor Stage,T1
775,1,1,Research lab p16,p16 unknown
775,1,1,1st Failure Type,no known failure
775,1,1,2nd Failure Type,no known failure
775,1,1,Treatment Modality,Sx
775,1,1,Tumor Site,oral cavity
775,1,1,Clinical lab p16,p16 unkown
775,1,1,Occurrence #,1st primary
775,1,1,Overall Stage,I
776,1,1,Treatment Modality,Sx
776,1,1,Research lab p16,p16 unknown
776,1,1,Clinical lab p16,p16 unkown
776,1,1,Occurrence #,1st primary
776,1,1,Overall Stage,IVa
776,1,1,Tumor Site,oral cavity
776,1,1,Tumor Stage,T4a
776,1,1,1st Failure Type,no known failure
776,1,1,Metastasis,M0
776,1,1,2nd Failure Type,no known failure
776,1,1,Research lab HPV,HPV unknown
776,1,1,Nodal Stage,N2
777,1,1,Research lab p16,p16 unknown
777,1,1,Clinical lab p16,p16 unkown
777,1,1,Nodal Stage,N0
777,1,1,2nd Failure Type,no known failure
777,1,1,1st Failure Type,no known failure
777,1,1,Tumor Stage,T1
777,1,1,Research lab HPV,HPV unknown
777,1,1,Metastasis,M0
777,1,1,Overall Stage,I
777,1,1,Tumor Site,oral cavity
777,1,1,Occurrence #,1st primary
777,1,1,Treatment Modality,Sx
778,1,1,Research lab p16,p16 unknown
778,1,1,Nodal Stage,N0
778,1,1,Overall Stage,II
778,1,1,Occurrence #,1st primary
778,1,1,Treatment Modality,Sx & RT
778,1,1,Research lab HPV,HPV unknown
778,1,1,Clinical lab p16,p16 unkown
778,1,1,Metastasis,M0
778,1,1,Tumor Stage,T2
778,1,1,1st Failure Type,no known failure
778,1,1,2nd Failure Type,no known failure
778,1,1,Tumor Site,oral cavity
779,1,1,Occurrence #,1st primary
779,1,1,Metastasis,M0
779,1,1,Research lab p16,p16 unknown
779,1,1,Tumor Stage,T1
779,1,1,1st Failure Type,no known failure
779,1,1,Research lab HPV,HPV unknown
779,1,1,Overall Stage,I
779,1,1,Tumor Site,oral cavity
779,1,1,2nd Failure Type,no known failure
779,1,1,Treatment Modality,Sx
779,1,1,Nodal Stage,N0
779,1,1,Clinical lab p16,p16 unkown
780,1,1,Nodal Stage,N2
780,1,1,Overall Stage,IVa
780,1,1,2nd Failure Type,no known failure
780,1,1,Occurrence #,1st primary
780,1,1,Tumor Site,oral cavity
780,1,1,Clinical lab p16,p16 unkown
780,1,1,Treatment Modality,Sx
780,1,1,Research lab HPV,HPV unknown
780,1,1,1st Failure Type,no known failure
780,1,1,Metastasis,M0
780,1,1,Tumor Stage,T2
780,1,1,Research lab p16,p16 unknown
781,1,1,Overall Stage,III
781,1,1,Occurrence #,1st primary
781,1,1,1st Failure Type,no known failure
781,1,1,Treatment Modality,Sx
781,1,1,Tumor Site,oral cavity
781,1,1,Tumor Stage,T2
781,1,1,2nd Failure Type,no known failure
781,1,1,Research lab p16,p16 unknown
781,1,1,Metastasis,M0
781,1,1,Research lab HPV,HPV unknown
781,1,1,Clinical lab p16,p16 unkown
781,1,1,Nodal Stage,N1
782,1,1,Clinical lab p16,p16 unkown
782,1,1,Tumor Site,oral cavity
782,1,1,Tumor Stage,T1
782,1,1,Research lab p16,p16 unknown
782,1,1,Metastasis,M0
782,1,1,Nodal Stage,N2
782,1,1,Radiation Dosage,63
782,1,1,Research lab HPV,HPV unknown
782,1,1,Overall Stage,IVa
782,1,1,Treatment Modality,Sx & RT
782,1,1,2nd Failure Type,no known failure
782,1,1,1st Failure Type,no known failure
782,1,1,Occurrence #,1st primary
783,1,1,Tumor Site,oral cavity
783,1,1,Overall Stage,II
783,1,1,Metastasis,M0
783,1,1,2nd Failure Type,no known failure
783,1,1,1st Failure Type,locoregional
783,1,1,Research lab p16,p16 unknown
783,1,1,Research lab HPV,HPV unknown
783,1,1,Tumor Stage,T2
783,1,1,Occurrence #,1st primary
783,1,1,Clinical lab p16,p16 unkown
783,1,1,Radiation Dosage,unknown
783,1,1,Treatment Modality,Sx & CTX-RT
783,1,1,Initial Chemotherapy Agent,unknown
783,1,1,Nodal Stage,N0
784,1,1,Overall Stage,I
784,1,1,Tumor Stage,T1
784,1,1,Clinical lab p16,p16 unkown
784,1,1,Nodal Stage,N0
784,1,1,Research lab p16,p16 unknown
784,1,1,Tumor Site,oral cavity
784,1,1,1st Failure Type,no known failure
784,1,1,Occurrence #,recurrence
784,1,1,Treatment Modality,Sx
784,1,1,2nd Failure Type,no known failure
784,1,1,Metastasis,M0
784,1,1,Research lab HPV,HPV unknown
785,1,1,Tumor Site,oral cavity
785,1,1,Research lab p16,p16 unknown
785,1,1,1st Failure Type,no known failure
785,1,1,2nd Failure Type,no known failure
785,1,1,Metastasis,M0
785,1,1,Tumor Stage,T2
785,1,1,Clinical lab p16,p16 unkown
785,1,1,Treatment Modality,Sx
785,1,1,Occurrence #,1st primary
785,1,1,Overall Stage,II
785,1,1,Nodal Stage,N0
785,1,1,Research lab HPV,HPV unknown
786,1,1,Treatment Modality,Sx & RT
786,1,1,Tumor Stage,T4a
786,1,1,Occurrence #,1st primary
786,1,1,Metastasis,M0
786,1,1,Overall Stage,IVa
786,1,1,Clinical lab p16,p16 unkown
786,1,1,Radiation Dosage,63
786,1,1,1st Failure Type,no known failure
786,1,1,Research lab HPV,HPV unknown
786,1,1,2nd Failure Type,no known failure
786,1,1,Tumor Site,oral cavity
786,1,1,Research lab p16,p16 unknown
786,1,1,Nodal Stage,N0
787,1,1,Tumor Site,oral cavity
787,1,1,Tumor Stage,T2
787,1,1,Overall Stage,II
787,1,1,Clinical lab p16,p16 unkown
787,1,1,1st Failure Type,no known failure
787,1,1,Treatment Modality,CTX-RT
787,1,1,Research lab HPV,HPV unknown
787,1,1,Metastasis,M0
787,1,1,2nd Failure Type,no known failure
787,1,1,Radiation Dosage,70.2
787,1,1,Occurrence #,other primary
787,1,1,Initial Chemotherapy Agent,carbo/PTX
787,1,1,Research lab p16,p16 unknown
787,1,1,Nodal Stage,N0
788,1,1,1st Failure Type,no known failure
788,1,1,Treatment Modality,Unknown
788,1,1,Metastasis,Unknown
788,1,1,Tumor Site,oral cavity
788,1,1,2nd Failure Type,no known failure
788,1,1,Occurrence #,1st primary
788,1,1,Research lab HPV,HPV unknown
788,1,1,Clinical lab p16,p16 unkown
788,1,1,Overall Stage,Unknown
788,1,1,Tumor Stage,Unknown
788,1,1,Nodal Stage,Unknown
788,1,1,Research lab p16,p16 unknown
789,1,1,2nd Failure Type,no known failure
789,1,1,Tumor Site,oral cavity
789,1,1,1st Failure Type,locoregional
789,1,1,1st Failure Treatment Modality,Sx
789,1,1,1st Failure Site,oral cavity
789,1,1,Research lab HPV,HPV unknown
789,1,1,Treatment Modality,Sx
789,1,1,Occurrence #,recurrence
789,1,1,Research lab p16,p16 unknown
789,1,1,Tumor Stage,T1
789,1,1,Metastasis,M0
789,1,1,Overall Stage,I
789,1,1,Clinical lab p16,p16 unkown
789,1,1,Nodal Stage,N0
790,1,1,Occurrence #,1st primary
790,1,1,Tumor Site,oral cavity
790,1,1,Research lab p16,p16 unknown
790,1,1,Radiation Dosage,63
790,1,1,Nodal Stage,N0
790,1,1,1st Failure Type,no known failure
790,1,1,2nd Failure Type,no known failure
790,1,1,Tumor Stage,T1
790,1,1,Treatment Modality,Sx & RT
790,1,1,Clinical lab p16,p16 unkown
790,1,1,Overall Stage,I
790,1,1,Metastasis,M0
790,1,1,Research lab HPV,HPV unknown
791,1,1,Treatment Modality,Sx
791,1,1,Clinical lab p16,p16 unkown
791,1,1,1st Failure Type,locoregional
791,1,1,Nodal Stage,N0
791,1,1,Research lab HPV,HPV unknown
791,1,1,2nd Failure Type,no known failure
791,1,1,Metastasis,M0
791,1,1,Overall Stage,I
791,1,1,Research lab p16,p16 unknown
791,1,1,1st Failure Treatment Modality,Sx & CTX-RT
791,1,1,1st Failure Radiation Dosage,70.2
791,1,1,Occurrence #,1st primary
791,1,1,Tumor Stage,T1
791,1,1,Tumor Site,oral cavity
791,1,1,1st Failure Initial Chemotherapy Agent,carbo
791,1,1,1st Failure Site,oral cavity
792,1,1,Overall Stage,I
792,1,1,Metastasis,M0
792,1,1,2nd Failure Type,no known failure
792,1,1,Research lab p16,p16 unknown
792,1,1,Nodal Stage,N0
792,1,1,Tumor Site,oral cavity
792,1,1,Clinical lab p16,p16 unkown
792,1,1,Occurrence #,recurrence
792,1,1,Tumor Stage,T1
792,1,1,Research lab HPV,HPV unknown
792,1,1,Treatment Modality,Sx
792,1,1,1st Failure Type,no known failure
793,1,1,Metastasis,M0
793,1,1,Overall Stage,IVa
793,1,1,Clinical lab p16,p16 unkown
793,1,1,Radiation Dosage,63
793,1,1,Nodal Stage,N2
793,1,1,Treatment Modality,Sx & RT
793,1,1,Research lab HPV,HPV unknown
793,1,1,1st Failure Type,no known failure
793,1,1,Tumor Stage,T3
793,1,1,Occurrence #,1st primary
793,1,1,Research lab p16,p16 unknown
793,1,1,Tumor Site,oral cavity
793,1,1,2nd Failure Type,no known failure
794,1,1,Clinical lab p16,p16 unkown
794,1,1,Occurrence #,1st primary
794,1,1,Research lab HPV,HPV unknown
794,1,1,Treatment Modality,Sx
794,1,1,Overall Stage,II
794,1,1,Tumor Stage,T2
794,1,1,Metastasis,M0
794,1,1,Tumor Site,oral cavity
794,1,1,Research lab p16,p16 unknown
794,1,1,1st Failure Type,no known failure
794,1,1,Nodal Stage,N0
794,1,1,2nd Failure Type,no known failure
795,1,1,Overall Stage,II
795,1,1,Occurrence #,1st primary
795,1,1,Research lab HPV,HPV unknown
795,1,1,Nodal Stage,N0
795,1,1,1st Failure Type,no known failure
795,1,1,Tumor Stage,T2
795,1,1,Research lab p16,p16 unknown
795,1,1,2nd Failure Type,no known failure
795,1,1,Treatment Modality,Sx
795,1,1,Clinical lab p16,p16 unkown
795,1,1,Metastasis,M0
795,1,1,Tumor Site,oral cavity
796,1,1,1st Failure Type,locoregional
796,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
796,1,1,1st Failure Treatment Modality,CTX
796,1,1,Tumor Stage,T3
796,1,1,Treatment Modality,Sx & RT
796,1,1,1st Failure Site,oral cavity
796,1,1,Clinical lab p16,p16 unkown
796,1,1,Nodal Stage,N0
796,1,1,Metastasis,M0
796,1,1,Overall Stage,III
796,1,1,Tumor Site,oral cavity
796,1,1,Occurrence #,recurrence
796,1,1,Research lab HPV,HPV unknown
796,1,1,Research lab p16,p16 unknown
796,1,1,2nd Failure Type,no known failure
796,1,1,Radiation Dosage,45
797,1,1,Occurrence #,1st primary
797,1,1,Tumor Stage,T2
797,1,1,Tumor Site,oral cavity
797,1,1,1st Failure Site,oropharynx
797,1,1,Treatment Modality,Sx
797,1,1,Research lab HPV,HPV unknown
797,1,1,1st Failure Type,locoregional
797,1,1,Research lab p16,p16 unknown
797,1,1,Clinical lab p16,p16 unkown
797,1,1,Metastasis,M0
797,1,1,Nodal Stage,N0
797,1,1,Overall Stage,II
797,1,1,2nd Failure Type,no known failure
797,1,1,1st Failure Treatment Modality,Sx
798,1,1,Nodal Stage,N2
798,1,1,Clinical lab p16,p16 unkown
798,1,1,Treatment Modality,Sx & CTX-RT
798,1,1,Occurrence #,1st primary
798,1,1,Tumor Stage,T2
798,1,1,Overall Stage,IVa
798,1,1,Tumor Site,oral cavity
798,1,1,Radiation Dosage,63
798,1,1,2nd Failure Type,no known failure
798,1,1,Research lab HPV,HPV unknown
798,1,1,Research lab p16,p16 unknown
798,1,1,Metastasis,M0
798,1,1,1st Failure Type,no known failure
798,1,1,Initial Chemotherapy Agent,carbo/PTX
799,1,1,Tumor Stage,T1
799,1,1,Clinical lab p16,p16 unkown
799,1,1,Overall Stage,I
799,1,1,Research lab HPV,HPV unknown
799,1,1,2nd Failure Type,no known failure
799,1,1,Metastasis,M0
799,1,1,Nodal Stage,N0
799,1,1,Research lab p16,p16 unknown
799,1,1,1st Failure Type,no known failure
799,1,1,Occurrence #,1st primary
799,1,1,Tumor Site,oral cavity
799,1,1,Treatment Modality,Sx
800,1,1,Clinical lab p16,p16 unkown
800,1,1,Nodal Stage,N2
800,1,1,Tumor Site,oral cavity
800,1,1,1st Failure Type,distant
800,1,1,2nd Failure Type,no known failure
800,1,1,Treatment Modality,Sx & RT
800,1,1,Metastasis,M0
800,1,1,Research lab p16,p16 unknown
800,1,1,Tumor Stage,T2
800,1,1,Occurrence #,1st primary
800,1,1,Radiation Dosage,unknown
800,1,1,Research lab HPV,HPV unknown
800,1,1,Overall Stage,IVa
801,1,1,Research lab p16,p16 unknown
801,1,1,Occurrence #,1st primary
801,1,1,Research lab HPV,HPV unknown
801,1,1,Nodal Stage,N0
801,1,1,Overall Stage,IVa
801,1,1,2nd Failure Type,no known failure
801,1,1,Metastasis,M0
801,1,1,Clinical lab p16,p16 unkown
801,1,1,1st Failure Type,no known failure
801,1,1,Treatment Modality,Sx
801,1,1,Tumor Site,oral cavity
801,1,1,Tumor Stage,T4a
802,1,1,2nd Failure Type,no known failure
802,1,1,1st Failure Site,oral cavity
802,1,1,Radiation Dosage,unknown
802,1,1,Nodal Stage,Unknown
802,1,1,Metastasis,M0
802,1,1,1st Failure Type,locoregional
802,1,1,Treatment Modality,Sx & RT
802,1,1,Tumor Site,oral cavity
802,1,1,Research lab p16,p16 unknown
802,1,1,1st Failure Treatment Modality,Sx & RT
802,1,1,Overall Stage,IVa
802,1,1,Research lab HPV,HPV unknown
802,1,1,Clinical lab p16,p16 unkown
802,1,1,Tumor Stage,T4a
802,1,1,Occurrence #,1st primary
803,1,1,Overall Stage,III
803,1,1,Nodal Stage,N1
803,1,1,Clinical lab p16,p16 unkown
803,1,1,Metastasis,M0
803,1,1,1st Failure Type,no known failure
803,1,1,Treatment Modality,Sx & RT
803,1,1,Tumor Site,oral cavity
803,1,1,Radiation Dosage,unknown
803,1,1,Research lab p16,p16 unknown
803,1,1,Tumor Stage,T1
803,1,1,Research lab HPV,HPV unknown
803,1,1,Occurrence #,1st primary
803,1,1,2nd Failure Type,no known failure
804,1,1,1st Failure Type,locoregional
804,1,1,Metastasis,Unknown
804,1,1,2nd Failure Type,no known failure
804,1,1,Treatment Modality,Sx & CTX
804,1,1,Initial Chemotherapy Agent,CPT/5-FU/leucovorin
804,1,1,Overall Stage,Unknown
804,1,1,Nodal Stage,Unknown
804,1,1,Research lab HPV,HPV unknown
804,1,1,Occurrence #,recurrence
804,1,1,Clinical lab p16,p16 unkown
804,1,1,Research lab p16,p16 unknown
804,1,1,Second Line Chemotherapy Agent,carbo/doce
804,1,1,Tumor Stage,Unknown
804,1,1,Tumor Site,oral cavity
805,1,1,Radiation Dosage,63
805,1,1,Treatment Modality,Sx & CTX-RT
805,1,1,Occurrence #,1st primary
805,1,1,1st Failure Type,no known failure
805,1,1,Initial Chemotherapy Agent,carbo/PTX
805,1,1,Research lab p16,p16 unknown
805,1,1,Tumor Site,oral cavity
805,1,1,Clinical lab p16,p16 unkown
805,1,1,Overall Stage,IVa
805,1,1,Metastasis,M0
805,1,1,2nd Failure Type,no known failure
805,1,1,Tumor Stage,T4a
805,1,1,Research lab HPV,HPV unknown
805,1,1,Nodal Stage,N0
806,1,1,Radiation Dosage,unknown
806,1,1,Occurrence #,1st primary
806,1,1,Treatment Modality,CTX-RT
806,1,1,Tumor Site,oral cavity
806,1,1,Nodal Stage,N1
806,1,1,Clinical lab p16,p16 unkown
806,1,1,Overall Stage,III
806,1,1,Initial Chemotherapy Agent,unknown
806,1,1,Research lab HPV,HPV unknown
806,1,1,1st Failure Type,no known failure
806,1,1,Research lab p16,p16 unknown
806,1,1,2nd Failure Type,no known failure
806,1,1,Metastasis,M0
806,1,1,Tumor Stage,T3
807,1,1,2nd Failure Type,no known failure
807,1,1,Overall Stage,IVa
807,1,1,Metastasis,M0
807,1,1,Nodal Stage,N0
807,1,1,Tumor Stage,T4a
807,1,1,Clinical lab p16,p16 unkown
807,1,1,1st Failure Type,no known failure
807,1,1,Treatment Modality,Sx
807,1,1,Tumor Site,oral cavity
807,1,1,Research lab p16,p16 unknown
807,1,1,Research lab HPV,HPV unknown
807,1,1,Occurrence #,recurrence
808,1,1,Tumor Site,oral cavity
808,1,1,2nd Failure Type,no known failure
808,1,1,Research lab HPV,HPV unknown
808,1,1,1st Failure Type,no known failure
808,1,1,Nodal Stage,N0
808,1,1,Occurrence #,1st primary
808,1,1,Treatment Modality,Sx
808,1,1,Tumor Stage,T1
808,1,1,Clinical lab p16,p16 unkown
808,1,1,Metastasis,M0
808,1,1,Research lab p16,p16 unknown
808,1,1,Overall Stage,I
809,1,1,Tumor Site,oral cavity
809,1,1,Occurrence #,1st primary
809,1,1,Clinical lab p16,p16 unkown
809,1,1,1st Failure Type,no known failure
809,1,1,Metastasis,M0
809,1,1,Nodal Stage,N0
809,1,1,Treatment Modality,Sx & RT
809,1,1,Radiation Dosage,60
809,1,1,Tumor Stage,T1
809,1,1,Research lab p16,p16 unknown
809,1,1,Research lab HPV,HPV unknown
809,1,1,2nd Failure Type,no known failure
809,1,1,Overall Stage,I
810,1,1,Overall Stage,I
810,1,1,Occurrence #,1st primary
810,1,1,Tumor Stage,T1
810,1,1,Research lab p16,p16 unknown
810,1,1,1st Failure Type,no known failure
810,1,1,Tumor Site,oral cavity
810,1,1,Treatment Modality,Sx
810,1,1,2nd Failure Type,no known failure
810,1,1,Nodal Stage,N0
810,1,1,Research lab HPV,HPV unknown
810,1,1,Clinical lab p16,p16 unkown
810,1,1,Metastasis,M0
811,1,1,2nd Failure Type,no known failure
811,1,1,Clinical lab p16,p16 unkown
811,1,1,1st Failure Type,locoregional
811,1,1,Treatment Modality,Sx
811,1,1,Occurrence #,other primary
811,1,1,1st Failure Site,oral cavity
811,1,1,Overall Stage,I
811,1,1,Tumor Stage,T1
811,1,1,Research lab HPV,HPV unknown
811,1,1,Metastasis,M0
811,1,1,Nodal Stage,N0
811,1,1,Research lab p16,p16 unknown
811,1,1,Tumor Site,oral cavity
811,1,1,1st Failure Treatment Modality,Sx
812,1,1,Metastasis,M0
812,1,1,Occurrence #,1st primary
812,1,1,Overall Stage,I
812,1,1,2nd Failure Type,no known failure
812,1,1,Treatment Modality,Sx
812,1,1,Nodal Stage,N0
812,1,1,Tumor Stage,T1
812,1,1,Tumor Site,oral cavity
812,1,1,Clinical lab p16,p16 unkown
812,1,1,1st Failure Type,no known failure
812,1,1,Research lab p16,p16 unknown
812,1,1,Research lab HPV,HPV unknown
813,1,1,Tumor Stage,T4a
813,1,1,1st Failure Type,locoregional and distant
813,1,1,Research lab p16,p16 unknown
813,1,1,Treatment Modality,Sx & RT
813,1,1,Nodal Stage,N2
813,1,1,Radiation Dosage,61.2
813,1,1,Clinical lab p16,p16 unkown
813,1,1,2nd Failure Type,no known failure
813,1,1,1st Failure Treatment Modality,CTX
813,1,1,Metastasis,M0
813,1,1,Research lab HPV,HPV unknown
813,1,1,1st Failure Site,oral cavity
813,1,1,Tumor Site,oral cavity
813,1,1,Occurrence #,1st primary
813,1,1,1st Failure Initial Chemotherapy Agent,doce/cap/gemcitibine
813,1,1,Overall Stage,IVa
814,1,1,Tumor Site,oral cavity
814,1,1,2nd Failure Type,no known failure
814,1,1,Tumor Stage,T1
814,1,1,Clinical lab p16,p16 unkown
814,1,1,Metastasis,M0
814,1,1,Overall Stage,III
814,1,1,Nodal Stage,N1
814,1,1,Research lab p16,p16 unknown
814,1,1,Occurrence #,1st primary
814,1,1,Treatment Modality,Sx
814,1,1,Research lab HPV,HPV unknown
814,1,1,1st Failure Type,no known failure
815,1,1,Clinical lab p16,p16 unkown
815,1,1,Nodal Stage,N2
815,1,1,Tumor Stage,T3
815,1,1,Treatment Modality,Sx
815,1,1,2nd Failure Type,no known failure
815,1,1,Research lab p16,p16 unknown
815,1,1,Tumor Site,oral cavity
815,1,1,Research lab HPV,HPV unknown
815,1,1,Occurrence #,1st primary
815,1,1,1st Failure Type,no known failure
815,1,1,Overall Stage,IVa
815,1,1,Metastasis,M0
816,1,1,Tumor Site,oral cavity
816,1,1,Overall Stage,IVa
816,1,1,1st Failure Type,no known failure
816,1,1,Metastasis,M0
816,1,1,Tumor Stage,T4a
816,1,1,Nodal Stage,N1
816,1,1,2nd Failure Type,no known failure
816,1,1,Clinical lab p16,p16 unkown
816,1,1,Occurrence #,1st primary
816,1,1,Treatment Modality,Sx
816,1,1,Research lab p16,p16 unknown
816,1,1,Research lab HPV,HPV unknown
817,1,1,Occurrence #,1st primary
817,1,1,Metastasis,M0
817,1,1,Research lab p16,p16 unknown
817,1,1,Research lab HPV,HPV unknown
817,1,1,Nodal Stage,N1
817,1,1,Clinical lab p16,p16 unkown
817,1,1,2nd Failure Type,no known failure
817,1,1,Overall Stage,III
817,1,1,Tumor Stage,T2
817,1,1,Tumor Site,oral cavity
817,1,1,1st Failure Type,no known failure
817,1,1,Treatment Modality,Sx
818,1,1,Nodal Stage,N2
818,1,1,Research lab p16,p16 unknown
818,1,1,2nd Failure Type,no known failure
818,1,1,Research lab HPV,HPV unknown
818,1,1,Clinical lab p16,p16 unkown
818,1,1,1st Failure Type,no known failure
818,1,1,Tumor Site,oral cavity
818,1,1,Overall Stage,IVa
818,1,1,Tumor Stage,T4a
818,1,1,Treatment Modality,Sx
818,1,1,Metastasis,M0
818,1,1,Occurrence #,1st primary
819,1,1,Clinical lab p16,p16 unkown
819,1,1,1st Failure Type,no known failure
819,1,1,Research lab HPV,HPV unknown
819,1,1,Overall Stage,I
819,1,1,Occurrence #,1st primary
819,1,1,Metastasis,M0
819,1,1,2nd Failure Type,no known failure
819,1,1,Tumor Site,oral cavity
819,1,1,Research lab p16,p16 unknown
819,1,1,Nodal Stage,N0
819,1,1,Treatment Modality,Sx
819,1,1,Tumor Stage,T1
820,1,1,1st Failure Type,no known failure
820,1,1,Tumor Site,oral cavity
820,1,1,Research lab HPV,HPV unknown
820,1,1,Metastasis,M0
820,1,1,Occurrence #,1st primary
820,1,1,Treatment Modality,Sx
820,1,1,Clinical lab p16,p16 unkown
820,1,1,Nodal Stage,N0
820,1,1,2nd Failure Type,no known failure
820,1,1,Overall Stage,I
820,1,1,Research lab p16,p16 unknown
820,1,1,Tumor Stage,T1
821,1,1,Nodal Stage,N1
821,1,1,Research lab p16,p16 unknown
821,1,1,Research lab HPV,HPV unknown
821,1,1,Initial Chemotherapy Agent,carbo/PTX
821,1,1,2nd Failure Type,no known failure
821,1,1,Radiation Dosage,70.2
821,1,1,Tumor Stage,T3
821,1,1,Overall Stage,III
821,1,1,Clinical lab p16,p16 unkown
821,1,1,Treatment Modality,CTX-RT
821,1,1,Occurrence #,1st primary
821,1,1,Metastasis,M0
821,1,1,1st Failure Type,no known failure
821,1,1,Tumor Site,oral cavity
822,1,1,Occurrence #,1st primary
822,1,1,1st Failure Type,no known failure
822,1,1,Metastasis,M0
822,1,1,Nodal Stage,N0
822,1,1,2nd Failure Type,no known failure
822,1,1,Treatment Modality,Sx
822,1,1,Research lab HPV,HPV unknown
822,1,1,Tumor Stage,T1
822,1,1,Clinical lab p16,p16 unkown
822,1,1,Overall Stage,I
822,1,1,Research lab p16,p16 unknown
822,1,1,Tumor Site,oral cavity
823,1,1,Metastasis,M0
823,1,1,Nodal Stage,N0
823,1,1,Overall Stage,IVa
823,1,1,Occurrence #,recurrence
823,1,1,Treatment Modality,Sx
823,1,1,Clinical lab p16,p16 unkown
823,1,1,Tumor Site,oral cavity
823,1,1,2nd Failure Type,no known failure
823,1,1,Research lab HPV,HPV unknown
823,1,1,Tumor Stage,T4a
823,1,1,1st Failure Type,no known failure
823,1,1,Research lab p16,p16 unknown
824,1,1,2nd Failure Type,no known failure
824,1,1,Tumor Site,oral cavity
824,1,1,Tumor Stage,T1
824,1,1,1st Failure Type,no known failure
824,1,1,Treatment Modality,Sx
824,1,1,Overall Stage,I
824,1,1,Clinical lab p16,p16 unkown
824,1,1,Research lab p16,p16 unknown
824,1,1,Research lab HPV,HPV unknown
824,1,1,Occurrence #,1st primary
824,1,1,Metastasis,M0
824,1,1,Nodal Stage,N0
825,1,1,1st Failure Treatment Modality,Sx
825,1,1,Treatment Modality,Sx
825,1,1,Tumor Stage,T1
825,1,1,Overall Stage,I
825,1,1,Research lab HPV,HPV unknown
825,1,1,Clinical lab p16,p16 unkown
825,1,1,Research lab p16,p16 unknown
825,1,1,Metastasis,M0
825,1,1,1st Failure Site,oral cavity
825,1,1,2nd Failure Type,no known failure
825,1,1,Tumor Site,oral cavity
825,1,1,Nodal Stage,N0
825,1,1,1st Failure Type,locoregional
825,1,1,Occurrence #,1st primary
826,1,1,Nodal Stage,N0
826,1,1,Treatment Modality,Sx
826,1,1,Occurrence #,1st primary
826,1,1,Tumor Stage,T2
826,1,1,Research lab HPV,HPV unknown
826,1,1,1st Failure Type,no known failure
826,1,1,Overall Stage,II
826,1,1,Tumor Site,oral cavity
826,1,1,Research lab p16,p16 unknown
826,1,1,Clinical lab p16,p16 unkown
826,1,1,Metastasis,M0
826,1,1,2nd Failure Type,no known failure
827,1,1,Research lab p16,p16 unknown
827,1,1,Metastasis,M0
827,1,1,Nodal Stage,N0
827,1,1,Clinical lab p16,p16 unkown
827,1,1,1st Failure Type,no known failure
827,1,1,Research lab HPV,HPV unknown
827,1,1,2nd Failure Type,no known failure
827,1,1,Tumor Stage,T1
827,1,1,Occurrence #,1st primary
827,1,1,Tumor Site,oral cavity
827,1,1,Overall Stage,I
827,1,1,Treatment Modality,Sx
828,1,1,Clinical lab p16,p16 unkown
828,1,1,2nd Failure Type,no known failure
828,1,1,Research lab HPV,HPV unknown
828,1,1,1st Failure Type,no known failure
828,1,1,Tumor Site,oral cavity
828,1,1,Treatment Modality,Sx
828,1,1,Tumor Stage,T4a
828,1,1,Overall Stage,IVa
828,1,1,Occurrence #,1st primary
828,1,1,Research lab p16,p16 unknown
828,1,1,Nodal Stage,N0
828,1,1,Metastasis,M0
829,1,1,Occurrence #,1st primary
829,1,1,2nd Failure Type,no known failure
829,1,1,Treatment Modality,RT
829,1,1,Tumor Stage,T2
829,1,1,Research lab HPV,HPV unknown
829,1,1,Tumor Site,oral cavity
829,1,1,Clinical lab p16,p16 unkown
829,1,1,Overall Stage,II
829,1,1,Nodal Stage,N0
829,1,1,1st Failure Type,no known failure
829,1,1,Radiation Dosage,69
829,1,1,Metastasis,M0
829,1,1,Research lab p16,p16 unknown
830,1,1,1st Failure Site,oral cavity
830,1,1,Metastasis,M0
830,1,1,Tumor Site,oral cavity
830,1,1,Research lab p16,p16 unknown
830,1,1,Nodal Stage,N2
830,1,1,Occurrence #,1st primary
830,1,1,1st Failure Type,distant
830,1,1,Research lab HPV,HPV unknown
830,1,1,1st Failure Radiation Dosage,unknown
830,1,1,Clinical lab p16,p16 unkown
830,1,1,1st Failure Initial Chemotherapy Agent,cap
830,1,1,1st Failure Treatment Modality,CTX-RT
830,1,1,Treatment Modality,Sx & RT
830,1,1,2nd Failure Type,no known failure
830,1,1,Tumor Stage,T2
830,1,1,Radiation Dosage,66
830,1,1,Overall Stage,IVa
831,1,1,Research lab HPV,HPV unknown
831,1,1,1st Failure Type,locoregional and distant
831,1,1,Research lab p16,p16 unknown
831,1,1,Initial Chemotherapy Agent,cis
831,1,1,Clinical lab p16,p16 unkown
831,1,1,Metastasis,M0
831,1,1,2nd Failure Type,no known failure
831,1,1,Occurrence #,1st primary
831,1,1,Tumor Site,oral cavity
831,1,1,Tumor Stage,T3
831,1,1,Nodal Stage,N2
831,1,1,Radiation Dosage,70.2
831,1,1,Treatment Modality,Sx & CTX-RT
831,1,1,Overall Stage,IVa
832,1,1,Metastasis,M0
832,1,1,Tumor Site,oral cavity
832,1,1,Research lab HPV,HPV unknown
832,1,1,Nodal Stage,N0
832,1,1,Treatment Modality,Sx
832,1,1,Research lab p16,p16 unknown
832,1,1,1st Failure Type,no known failure
832,1,1,Occurrence #,1st primary
832,1,1,Overall Stage,IVa
832,1,1,2nd Failure Type,no known failure
832,1,1,Clinical lab p16,p16 unkown
832,1,1,Tumor Stage,T4a
833,1,1,Treatment Modality,Sx
833,1,1,1st Failure Type,no known failure
833,1,1,Occurrence #,1st primary
833,1,1,Tumor Stage,T1
833,1,1,Overall Stage,I
833,1,1,Metastasis,M0
833,1,1,Research lab p16,p16 unknown
833,1,1,2nd Failure Type,no known failure
833,1,1,Clinical lab p16,p16 unkown
833,1,1,Research lab HPV,HPV unknown
833,1,1,Nodal Stage,N0
833,1,1,Tumor Site,oral cavity
834,1,1,2nd Failure Type,no known failure
834,1,1,Clinical lab p16,p16 unkown
834,1,1,Treatment Modality,Sx
834,1,1,1st Failure Type,locoregional
834,1,1,Research lab HPV,HPV unknown
834,1,1,Nodal Stage,N0
834,1,1,Tumor Site,oral cavity
834,1,1,Research lab p16,p16 unknown
834,1,1,Occurrence #,recurrence
834,1,1,Tumor Stage,T1
834,1,1,1st Failure Site,oral cavity
834,1,1,1st Failure Treatment Modality,Sx & RT
834,1,1,Overall Stage,I
834,1,1,1st Failure Radiation Dosage,unknown
834,1,1,Metastasis,M0
836,1,1,1st Failure Treatment Modality,Sx
836,1,1,Radiation Dosage,63
836,1,1,Tumor Stage,T4a
836,1,1,Tumor Site,oral cavity
836,1,1,Overall Stage,IVa
836,1,1,Research lab p16,p16 unknown
836,1,1,1st Failure Site,oral cavity
836,1,1,Treatment Modality,Sx & RT
836,1,1,1st Failure Type,locoregional
836,1,1,Metastasis,M0
836,1,1,2nd Failure Type,no known failure
836,1,1,Clinical lab p16,p16 unkown
836,1,1,Occurrence #,1st primary
836,1,1,Research lab HPV,HPV unknown
836,1,1,Nodal Stage,N2
837,1,1,Research lab p16,p16 unknown
837,1,1,Treatment Modality,Sx
837,1,1,Nodal Stage,N0
837,1,1,Overall Stage,I
837,1,1,Tumor Site,oral cavity
837,1,1,Research lab HPV,HPV unknown
837,1,1,1st Failure Type,no known failure
837,1,1,Occurrence #,1st primary
837,1,1,Metastasis,M0
837,1,1,Tumor Stage,T1
837,1,1,Clinical lab p16,p16 unkown
837,1,1,2nd Failure Type,no known failure
838,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
838,1,1,Metastasis,M0
838,1,1,Research lab HPV,HPV unknown
838,1,1,Occurrence #,1st primary
838,1,1,1st Failure Site,oral cavity
838,1,1,Treatment Modality,Sx & CTX-RT
838,1,1,2nd Failure Type,no known failure
838,1,1,1st Failure Radiation Dosage,30
838,1,1,1st Failure Type,distant
838,1,1,Clinical lab p16,p16 unkown
838,1,1,Nodal Stage,N1
838,1,1,Initial Chemotherapy Agent,"vandetanib, cis"
838,1,1,Tumor Site,oral cavity
838,1,1,Radiation Dosage,63
838,1,1,Overall Stage,III
838,1,1,Research lab p16,p16 unknown
838,1,1,Tumor Stage,T2
838,1,1,1st Failure Treatment Modality,CTX-RT
839,1,1,Tumor Stage,T1
839,1,1,Occurrence #,1st primary
839,1,1,Research lab HPV,HPV unknown
839,1,1,Metastasis,M0
839,1,1,2nd Failure Type,no known failure
839,1,1,Treatment Modality,Sx
839,1,1,1st Failure Type,no known failure
839,1,1,Clinical lab p16,p16 unkown
839,1,1,Overall Stage,I
839,1,1,Tumor Site,oral cavity
839,1,1,Research lab p16,p16 unknown
839,1,1,Nodal Stage,N0
840,1,1,Nodal Stage,N0
840,1,1,Research lab p16,p16 unknown
840,1,1,Metastasis,M0
840,1,1,1st Failure Type,no known failure
840,1,1,Occurrence #,recurrence
840,1,1,Tumor Site,oral cavity
840,1,1,Treatment Modality,Sx
840,1,1,2nd Failure Type,no known failure
840,1,1,Overall Stage,II
840,1,1,Tumor Stage,T2
840,1,1,Research lab HPV,HPV unknown
840,1,1,Clinical lab p16,p16 unkown
841,1,1,1st Failure Type,locoregional
841,1,1,Nodal Stage,N1
841,1,1,Treatment Modality,Sx & CTX-RT
841,1,1,2nd Failure Type,no known failure
841,1,1,1st Failure Site,oral cavity
841,1,1,Research lab HPV,HPV unknown
841,1,1,Clinical lab p16,p16 unkown
841,1,1,Initial Chemotherapy Agent,unknown
841,1,1,Tumor Stage,T2
841,1,1,Overall Stage,III
841,1,1,Tumor Site,oral cavity
841,1,1,Radiation Dosage,unknown
841,1,1,1st Failure Treatment Modality,Sx & RT
841,1,1,Occurrence #,1st primary
841,1,1,Research lab p16,p16 unknown
841,1,1,Metastasis,M0
842,1,1,Research lab HPV,HPV unknown
842,1,1,2nd Failure Type,no known failure
842,1,1,Treatment Modality,Sx & RT
842,1,1,Research lab p16,p16 unknown
842,1,1,Clinical lab p16,p16 unkown
842,1,1,1st Failure Type,no known failure
842,1,1,Tumor Site,oral cavity
842,1,1,Metastasis,M0
842,1,1,Radiation Dosage,64
842,1,1,Overall Stage,IVa
842,1,1,Occurrence #,1st primary
842,1,1,Nodal Stage,N2
842,1,1,Tumor Stage,T1
843,1,1,Research lab p16,p16 unknown
843,1,1,Metastasis,M0
843,1,1,Occurrence #,1st primary
843,1,1,2nd Failure Type,no known failure
843,1,1,Overall Stage,I
843,1,1,Clinical lab p16,p16 unkown
843,1,1,Research lab HPV,HPV unknown
843,1,1,1st Failure Type,no known failure
843,1,1,Nodal Stage,N0
843,1,1,Tumor Stage,T1
843,1,1,Tumor Site,oral cavity
843,1,1,Treatment Modality,Sx
844,1,1,1st Failure Type,no known failure
844,1,1,Tumor Stage,T1
844,1,1,Research lab HPV,HPV unknown
844,1,1,Metastasis,M0
844,1,1,Treatment Modality,Sx
844,1,1,Occurrence #,1st primary
844,1,1,Research lab p16,p16 unknown
844,1,1,2nd Failure Type,no known failure
844,1,1,Tumor Site,oral cavity
844,1,1,Clinical lab p16,p16 unkown
844,1,1,Overall Stage,I
844,1,1,Nodal Stage,N0
845,1,1,Nodal Stage,N0
845,1,1,1st Failure Type,no known failure
845,1,1,Occurrence #,1st primary
845,1,1,Research lab p16,p16 unknown
845,1,1,Metastasis,M0
845,1,1,Research lab HPV,HPV unknown
845,1,1,Treatment Modality,Sx
845,1,1,Tumor Site,oral cavity
845,1,1,Clinical lab p16,p16 unkown
845,1,1,Overall Stage,IVa
845,1,1,2nd Failure Type,no known failure
845,1,1,Tumor Stage,T4a
846,1,1,Nodal Stage,N0
846,1,1,Tumor Site,oral cavity
846,1,1,Metastasis,M0
846,1,1,Clinical lab p16,p16 unkown
846,1,1,Occurrence #,other primary
846,1,1,Overall Stage,I
846,1,1,2nd Failure Type,no known failure
846,1,1,1st Failure Type,no known failure
846,1,1,Research lab HPV,HPV unknown
846,1,1,Treatment Modality,Sx
846,1,1,Research lab p16,p16 unknown
846,1,1,Tumor Stage,T1
847,1,1,Occurrence #,1st primary
847,1,1,Overall Stage,IVa
847,1,1,Metastasis,M0
847,1,1,1st Failure Type,no known failure
847,1,1,Research lab HPV,HPV unknown
847,1,1,Research lab p16,p16 unknown
847,1,1,Treatment Modality,Sx
847,1,1,Nodal Stage,N0
847,1,1,Clinical lab p16,p16 unkown
847,1,1,Tumor Stage,T4a
847,1,1,Tumor Site,oral cavity
847,1,1,2nd Failure Type,no known failure
848,1,1,Treatment Modality,Sx
848,1,1,Tumor Site,oral cavity
848,1,1,Research lab HPV,HPV unknown
848,1,1,Tumor Stage,T1
848,1,1,Research lab p16,p16 unknown
848,1,1,1st Failure Type,no known failure
848,1,1,Metastasis,M0
848,1,1,Clinical lab p16,p16 unkown
848,1,1,Occurrence #,1st primary
848,1,1,Overall Stage,I
848,1,1,Nodal Stage,N0
848,1,1,2nd Failure Type,no known failure
849,1,1,Research lab p16,p16 unknown
849,1,1,Treatment Modality,Sx
849,1,1,Metastasis,M0
849,1,1,1st Failure Type,no known failure
849,1,1,Nodal Stage,N0
849,1,1,Tumor Stage,T1
849,1,1,Clinical lab p16,p16 unkown
849,1,1,2nd Failure Type,no known failure
849,1,1,Occurrence #,1st primary
849,1,1,Research lab HPV,HPV unknown
849,1,1,Overall Stage,I
849,1,1,Tumor Site,oral cavity
850,1,1,Initial Chemotherapy Agent,unknown
850,1,1,Overall Stage,IVa
850,1,1,Tumor Site,oral cavity
850,1,1,1st Failure Type,no known failure
850,1,1,Occurrence #,1st primary
850,1,1,2nd Failure Type,no known failure
850,1,1,Treatment Modality,Sx & CTX-RT
850,1,1,Nodal Stage,N2
850,1,1,Research lab HPV,HPV unknown
850,1,1,Clinical lab p16,p16 unkown
850,1,1,Metastasis,M0
850,1,1,Research lab p16,p16 unknown
850,1,1,Tumor Stage,T2
850,1,1,Radiation Dosage,unknown
851,1,1,Research lab HPV,HPV unknown
851,1,1,Overall Stage,I
851,1,1,2nd Failure Type,no known failure
851,1,1,1st Failure Type,no known failure
851,1,1,Tumor Site,oral cavity
851,1,1,Metastasis,M0
851,1,1,Treatment Modality,Sx
851,1,1,Clinical lab p16,p16 unkown
851,1,1,Tumor Stage,T1
851,1,1,Occurrence #,1st primary
851,1,1,Research lab p16,p16 unknown
851,1,1,Nodal Stage,N0
852,1,1,Research lab p16,p16 unknown
852,1,1,Metastasis,M0
852,1,1,Tumor Site,oral cavity
852,1,1,Treatment Modality,Sx
852,1,1,1st Failure Type,no known failure
852,1,1,Occurrence #,1st primary
852,1,1,Research lab HPV,HPV unknown
852,1,1,Nodal Stage,N0
852,1,1,2nd Failure Type,no known failure
852,1,1,Overall Stage,I
852,1,1,Clinical lab p16,p16 unkown
852,1,1,Tumor Stage,T1
853,1,1,1st Failure Type,no known failure
853,1,1,Tumor Stage,T4a
853,1,1,Research lab p16,p16 unknown
853,1,1,Tumor Site,oral cavity
853,1,1,Research lab HPV,HPV unknown
853,1,1,Clinical lab p16,p16 unkown
853,1,1,Occurrence #,1st primary
853,1,1,2nd Failure Type,no known failure
853,1,1,Nodal Stage,N3
853,1,1,Overall Stage,IVb
853,1,1,Treatment Modality,Sx
853,1,1,Metastasis,M0
854,1,1,Metastasis,M0
854,1,1,Research lab p16,p16 unknown
854,1,1,Nodal Stage,N0
854,1,1,1st Failure Type,no known failure
854,1,1,Research lab HPV,HPV unknown
854,1,1,Tumor Site,oral cavity
854,1,1,Tumor Stage,T2
854,1,1,2nd Failure Type,no known failure
854,1,1,Overall Stage,II
854,1,1,Treatment Modality,Sx
854,1,1,Occurrence #,1st primary
854,1,1,Clinical lab p16,p16 unkown
855,1,1,Overall Stage,IVa
855,1,1,2nd Failure Type,no known failure
855,1,1,Tumor Stage,T4a
855,1,1,Research lab HPV,HPV unknown
855,1,1,Treatment Modality,Sx
855,1,1,Metastasis,M0
855,1,1,1st Failure Type,no known failure
855,1,1,Nodal Stage,N1
855,1,1,Research lab p16,p16 unknown
855,1,1,Clinical lab p16,p16 unkown
855,1,1,Occurrence #,1st primary
855,1,1,Tumor Site,oral cavity
856,1,1,Nodal Stage,N0
856,1,1,Research lab HPV,HPV unknown
856,1,1,Occurrence #,1st primary
856,1,1,Tumor Site,oral cavity
856,1,1,Research lab p16,p16 unknown
856,1,1,Overall Stage,IVa
856,1,1,2nd Failure Type,no known failure
856,1,1,Tumor Stage,T4a
856,1,1,Metastasis,M0
856,1,1,Treatment Modality,Sx
856,1,1,Clinical lab p16,p16 unkown
856,1,1,1st Failure Type,no known failure
857,1,1,Clinical lab p16,p16 unkown
857,1,1,1st Failure Second Line Chemotherapy Agent,cis
857,1,1,Research lab HPV,HPV unknown
857,1,1,1st Failure Treatment Modality,Sx & CTX
857,1,1,Research lab p16,p16 unknown
857,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
857,1,1,Overall Stage,I
857,1,1,Nodal Stage,N0
857,1,1,1st Failure Type,locoregional
857,1,1,Radiation Dosage,unknown
857,1,1,Treatment Modality,Sx & RT
857,1,1,1st Failure Site,oral cavity
857,1,1,Tumor Stage,T1
857,1,1,2nd Failure Type,no known failure
857,1,1,Tumor Site,oral cavity
857,1,1,Metastasis,M0
857,1,1,Occurrence #,1st primary
858,1,1,Tumor Site,oral cavity
858,1,1,Occurrence #,1st primary
858,1,1,Metastasis,M1
858,1,1,1st Failure Type,no known failure
858,1,1,Initial Chemotherapy Agent,cis/PTX
858,1,1,Overall Stage,IVc
858,1,1,Treatment Modality,Sx & CTX
858,1,1,Research lab p16,p16 unknown
858,1,1,Clinical lab p16,p16 unkown
858,1,1,Research lab HPV,HPV unknown
858,1,1,Nodal Stage,N2
858,1,1,Tumor Stage,T3
858,1,1,2nd Failure Type,no known failure
859,1,1,2nd Failure Type,no known failure
859,1,1,Occurrence #,1st primary
859,1,1,Metastasis,M0
859,1,1,Clinical lab p16,p16 unkown
859,1,1,Tumor Site,oral cavity
859,1,1,Overall Stage,I
859,1,1,Nodal Stage,N0
859,1,1,Treatment Modality,Sx
859,1,1,Research lab p16,p16 unknown
859,1,1,Research lab HPV,HPV unknown
859,1,1,Tumor Stage,T1
859,1,1,1st Failure Type,no known failure
860,1,1,Tumor Site,oral cavity
860,1,1,Research lab p16,p16 unknown
860,1,1,Tumor Stage,T1
860,1,1,2nd Failure Type,no known failure
860,1,1,Occurrence #,recurrence
860,1,1,Treatment Modality,Sx & RT
860,1,1,Nodal Stage,N0
860,1,1,Metastasis,M0
860,1,1,1st Failure Type,no known failure
860,1,1,Clinical lab p16,p16 unkown
860,1,1,Research lab HPV,HPV unknown
860,1,1,Overall Stage,I
860,1,1,Radiation Dosage,55.2
861,1,1,Metastasis,M0
861,1,1,Nodal Stage,N0
861,1,1,Treatment Modality,Sx
861,1,1,Tumor Stage,T2
861,1,1,Occurrence #,1st primary
861,1,1,Research lab HPV,HPV unknown
861,1,1,Overall Stage,II
861,1,1,2nd Failure Type,no known failure
861,1,1,Tumor Site,oral cavity
861,1,1,Clinical lab p16,p16 unkown
861,1,1,Research lab p16,p16 unknown
861,1,1,1st Failure Type,no known failure
862,1,1,1st Failure Type,no known failure
862,1,1,Nodal Stage,N2
862,1,1,Tumor Stage,T1
862,1,1,Research lab HPV,HPV unknown
862,1,1,Metastasis,M0
862,1,1,2nd Failure Type,no known failure
862,1,1,Overall Stage,IVa
862,1,1,Tumor Site,oral cavity
862,1,1,Research lab p16,p16 unknown
862,1,1,Radiation Dosage,63
862,1,1,Clinical lab p16,p16 unkown
862,1,1,Occurrence #,1st primary
862,1,1,Treatment Modality,Sx & RT
863,1,1,Occurrence #,1st primary
863,1,1,Tumor Stage,Unknown
863,1,1,Clinical lab p16,p16 unkown
863,1,1,Research lab p16,p16 unknown
863,1,1,Treatment Modality,Unknown
863,1,1,Tumor Site,oral cavity
863,1,1,Overall Stage,Unknown
863,1,1,2nd Failure Type,no known failure
863,1,1,Research lab HPV,HPV unknown
863,1,1,1st Failure Type,no known failure
863,1,1,Metastasis,Unknown
863,1,1,Nodal Stage,Unknown
864,1,1,Treatment Modality,CTX-RT
864,1,1,Radiation Dosage,16.2
864,1,1,Clinical lab p16,p16 unkown
864,1,1,Tumor Site,oral cavity
864,1,1,2nd Failure Type,no known failure
864,1,1,Nodal Stage,N2
864,1,1,Research lab p16,p16 unknown
864,1,1,Metastasis,M0
864,1,1,Overall Stage,IVa
864,1,1,Occurrence #,1st primary
864,1,1,1st Failure Type,locoregional
864,1,1,Tumor Stage,T2
864,1,1,Research lab HPV,HPV unknown
864,1,1,Initial Chemotherapy Agent,cis
865,1,1,Research lab p16,p16 unknown
865,1,1,Metastasis,M0
865,1,1,Tumor Stage,T1
865,1,1,Tumor Site,oral cavity
865,1,1,Overall Stage,I
865,1,1,Research lab HPV,HPV unknown
865,1,1,Clinical lab p16,p16 unkown
865,1,1,Occurrence #,1st primary
865,1,1,1st Failure Type,no known failure
865,1,1,2nd Failure Type,no known failure
865,1,1,Treatment Modality,Sx
865,1,1,Nodal Stage,N0
866,1,1,2nd Failure Type,no known failure
866,1,1,Tumor Site,oral cavity
866,1,1,Treatment Modality,Sx
866,1,1,Overall Stage,IVa
866,1,1,Nodal Stage,N1
866,1,1,Tumor Stage,T4a
866,1,1,Research lab p16,p16 unknown
866,1,1,Clinical lab p16,p16 unkown
866,1,1,1st Failure Type,no known failure
866,1,1,Research lab HPV,HPV unknown
866,1,1,Metastasis,M0
866,1,1,Occurrence #,1st primary
867,1,1,Occurrence #,1st primary
867,1,1,Overall Stage,IVa
867,1,1,Radiation Dosage,60.1
867,1,1,1st Failure Type,no known failure
867,1,1,Research lab HPV,HPV unknown
867,1,1,Clinical lab p16,p16 unkown
867,1,1,Treatment Modality,Sx & RT
867,1,1,Nodal Stage,N0
867,1,1,Research lab p16,p16 unknown
867,1,1,2nd Failure Type,no known failure
867,1,1,Tumor Site,oral cavity
867,1,1,Tumor Stage,T4a
867,1,1,Metastasis,M0
868,1,1,Radiation Dosage,unknown
868,1,1,Clinical lab p16,p16 unkown
868,1,1,Research lab p16,p16 unknown
868,1,1,Nodal Stage,N2
868,1,1,1st Failure Type,locoregional
868,1,1,Treatment Modality,Sx & RT
868,1,1,Occurrence #,1st primary
868,1,1,2nd Failure Type,no known failure
868,1,1,Tumor Stage,T1
868,1,1,Metastasis,M0
868,1,1,Research lab HPV,HPV unknown
868,1,1,Overall Stage,IVa
868,1,1,Tumor Site,oral cavity
869,1,1,Metastasis,M0
869,1,1,Nodal Stage,N0
869,1,1,Clinical lab p16,p16 unkown
869,1,1,Tumor Site,oral cavity
869,1,1,1st Failure Type,no known failure
869,1,1,Treatment Modality,Sx
869,1,1,Research lab p16,p16 unknown
869,1,1,Occurrence #,1st primary
869,1,1,2nd Failure Type,no known failure
869,1,1,Tumor Stage,T2
869,1,1,Research lab HPV,HPV unknown
869,1,1,Overall Stage,II
870,1,1,Clinical lab p16,p16 unkown
870,1,1,Research lab p16,p16 unknown
870,1,1,Occurrence #,1st primary
870,1,1,Tumor Stage,T2
870,1,1,Treatment Modality,Sx
870,1,1,2nd Failure Type,no known failure
870,1,1,Research lab HPV,HPV unknown
870,1,1,Metastasis,M0
870,1,1,Nodal Stage,N0
870,1,1,Overall Stage,II
870,1,1,Tumor Site,oral cavity
870,1,1,1st Failure Type,no known failure
871,1,1,Clinical lab p16,p16 unkown
871,1,1,1st Failure Type,no known failure
871,1,1,Tumor Site,oral cavity
871,1,1,Nodal Stage,N0
871,1,1,Occurrence #,1st primary
871,1,1,Research lab HPV,HPV unknown
871,1,1,Tumor Stage,T4a
871,1,1,Treatment Modality,Sx
871,1,1,Research lab p16,p16 unknown
871,1,1,2nd Failure Type,no known failure
871,1,1,Overall Stage,IVa
871,1,1,Metastasis,M0
872,1,1,2nd Failure Type,no known failure
872,1,1,Metastasis,M0
872,1,1,Research lab p16,p16 unknown
872,1,1,Treatment Modality,Sx
872,1,1,1st Failure Type,locoregional
872,1,1,Research lab HPV,HPV unknown
872,1,1,Tumor Stage,T4a
872,1,1,Overall Stage,IVa
872,1,1,Nodal Stage,N0
872,1,1,Occurrence #,1st primary
872,1,1,Clinical lab p16,p16 unkown
872,1,1,Tumor Site,oral cavity
873,1,1,Research lab p16,p16 unknown
873,1,1,Treatment Modality,Sx
873,1,1,Metastasis,M0
873,1,1,2nd Failure Type,no known failure
873,1,1,Research lab HPV,HPV unknown
873,1,1,Tumor Site,oral cavity
873,1,1,Overall Stage,II
873,1,1,1st Failure Type,no known failure
873,1,1,Clinical lab p16,p16 unkown
873,1,1,Occurrence #,other primary
873,1,1,Nodal Stage,N0
873,1,1,Tumor Stage,T2
874,1,1,Treatment Modality,Sx
874,1,1,Tumor Stage,T4a
874,1,1,Metastasis,M0
874,1,1,2nd Failure Type,no known failure
874,1,1,Research lab HPV,HPV unknown
874,1,1,Occurrence #,1st primary
874,1,1,1st Failure Treatment Modality,Sx
874,1,1,Research lab p16,p16 unknown
874,1,1,1st Failure Site,oral cavity
874,1,1,Nodal Stage,N0
874,1,1,Clinical lab p16,p16 unkown
874,1,1,1st Failure Type,no known failure
874,1,1,Tumor Site,oral cavity
874,1,1,Overall Stage,IVa
875,1,1,1st Failure Type,no known failure
875,1,1,Treatment Modality,Sx
875,1,1,Overall Stage,IVa
875,1,1,Tumor Stage,T4a
875,1,1,2nd Failure Type,no known failure
875,1,1,Research lab p16,p16 unknown
875,1,1,Research lab HPV,HPV unknown
875,1,1,Metastasis,M0
875,1,1,Clinical lab p16,p16 unkown
875,1,1,Nodal Stage,N2
875,1,1,Occurrence #,1st primary
875,1,1,Tumor Site,oral cavity
876,1,1,Clinical lab p16,p16 unkown
876,1,1,1st Failure Treatment Modality,CTX-RT
876,1,1,1st Failure Type,no known failure
876,1,1,Metastasis,M0
876,1,1,1st Failure Initial Chemotherapy Agent,Cis
876,1,1,2nd Failure Type,no known failure
876,1,1,1st Failure Site,oropharynx
876,1,1,1st Failure Radiation Dosage,70
876,1,1,Overall Stage,I
876,1,1,Tumor Site,oral cavity
876,1,1,Nodal Stage,N0
876,1,1,Occurrence #,1st primary
876,1,1,Treatment Modality,Sx
876,1,1,Tumor Stage,T1
876,1,1,Research lab p16,p16 unknown
876,1,1,Research lab HPV,HPV unknown
877,1,1,1st Failure Type,no known failure
877,1,1,Tumor Site,oral cavity
877,1,1,Overall Stage,I
877,1,1,2nd Failure Type,no known failure
877,1,1,Nodal Stage,N0
877,1,1,Treatment Modality,Sx
877,1,1,Research lab p16,p16 unknown
877,1,1,Research lab HPV,HPV unknown
877,1,1,Tumor Stage,T1
877,1,1,Metastasis,M0
877,1,1,Occurrence #,1st primary
877,1,1,Clinical lab p16,p16 unkown
878,1,1,2nd Failure Type,no known failure
878,1,1,Tumor Site,oral cavity
878,1,1,1st Failure Type,no known failure
878,1,1,Clinical lab p16,p16 unkown
878,1,1,Treatment Modality,Sx
878,1,1,Overall Stage,II
878,1,1,Research lab p16,p16 unknown
878,1,1,Nodal Stage,N0
878,1,1,Research lab HPV,HPV unknown
878,1,1,Occurrence #,1st primary
878,1,1,Tumor Stage,T2
878,1,1,Metastasis,M0
879,1,1,Occurrence #,recurrence
879,1,1,Tumor Site,oral cavity
879,1,1,Treatment Modality,Unknown
879,1,1,1st Failure Type,no known failure
879,1,1,Clinical lab p16,p16 unkown
879,1,1,Overall Stage,IVa
879,1,1,Tumor Stage,T4a
879,1,1,Research lab HPV,HPV unknown
879,1,1,Research lab p16,p16 unknown
879,1,1,2nd Failure Type,no known failure
879,1,1,Metastasis,M0
879,1,1,Nodal Stage,N0
880,1,1,Clinical lab p16,p16 unkown
880,1,1,Tumor Stage,T1
880,1,1,Overall Stage,I
880,1,1,Nodal Stage,N0
880,1,1,Metastasis,M0
880,1,1,Research lab HPV,HPV unknown
880,1,1,Research lab p16,p16 unknown
880,1,1,Occurrence #,1st primary
880,1,1,1st Failure Type,no known failure
880,1,1,Treatment Modality,Sx
880,1,1,2nd Failure Type,no known failure
880,1,1,Tumor Site,oral cavity
881,1,1,Overall Stage,II
881,1,1,Occurrence #,1st primary
881,1,1,2nd Failure Type,no known failure
881,1,1,Tumor Site,oral cavity
881,1,1,Tumor Stage,T2
881,1,1,Research lab HPV,HPV unknown
881,1,1,Research lab p16,p16 unknown
881,1,1,Nodal Stage,N0
881,1,1,1st Failure Type,no known failure
881,1,1,Radiation Dosage,unknown
881,1,1,Metastasis,M0
881,1,1,Treatment Modality,Sx & RT
881,1,1,Clinical lab p16,p16 unkown
882,1,1,Overall Stage,IVa
882,1,1,Research lab p16,p16 unknown
882,1,1,Research lab HPV,HPV unknown
882,1,1,1st Failure Type,no known failure
882,1,1,Clinical lab p16,p16 unkown
882,1,1,Tumor Site,oral cavity
882,1,1,Initial Chemotherapy Agent,unknown
882,1,1,Radiation Dosage,unknown
882,1,1,2nd Failure Type,no known failure
882,1,1,Metastasis,M0
882,1,1,Nodal Stage,N2
882,1,1,Occurrence #,1st primary
882,1,1,Tumor Stage,T1
882,1,1,Treatment Modality,Sx & CTX-RT
883,1,1,Tumor Site,oral cavity
883,1,1,Occurrence #,recurrence
883,1,1,Research lab p16,p16 unknown
883,1,1,Tumor Stage,T4a
883,1,1,Metastasis,M0
883,1,1,2nd Failure Type,no known failure
883,1,1,1st Failure Type,no known failure
883,1,1,Clinical lab p16,p16 unkown
883,1,1,Treatment Modality,Sx
883,1,1,Overall Stage,IVa
883,1,1,Research lab HPV,HPV unknown
883,1,1,Nodal Stage,N1
884,1,1,Tumor Stage,T1
884,1,1,Metastasis,M0
884,1,1,Research lab HPV,HPV unknown
884,1,1,Tumor Site,oral cavity
884,1,1,2nd Failure Type,no known failure
884,1,1,Initial Chemotherapy Agent,unknown
884,1,1,Occurrence #,recurrence
884,1,1,Treatment Modality,Sx & CTX-RT
884,1,1,Research lab p16,p16 unknown
884,1,1,1st Failure Type,no known failure
884,1,1,Nodal Stage,N2
884,1,1,Radiation Dosage,unknown
884,1,1,Overall Stage,III
884,1,1,Clinical lab p16,p16 unkown
885,1,1,Clinical lab p16,p16 unkown
885,1,1,Overall Stage,II
885,1,1,Research lab HPV,HPV unknown
885,1,1,1st Failure Site,oral cavity
885,1,1,1st Failure Treatment Modality,Sx
885,1,1,2nd Failure Type,no known failure
885,1,1,Metastasis,M0
885,1,1,Treatment Modality,Sx
885,1,1,Nodal Stage,N0
885,1,1,1st Failure Type,no known failure
885,1,1,Tumor Stage,T2
885,1,1,Tumor Site,oral cavity
885,1,1,Research lab p16,p16 unknown
885,1,1,Occurrence #,1st primary
886,1,1,2nd Failure Type,no known failure
886,1,1,Clinical lab p16,p16 unkown
886,1,1,Metastasis,M0
886,1,1,Occurrence #,1st primary
886,1,1,Tumor Stage,T4a
886,1,1,Tumor Site,oral cavity
886,1,1,1st Failure Type,no known failure
886,1,1,Research lab p16,p16 unknown
886,1,1,Treatment Modality,Sx
886,1,1,Research lab HPV,HPV unknown
886,1,1,Overall Stage,IVa
886,1,1,Nodal Stage,N0
887,1,1,Research lab HPV,HPV unknown
887,1,1,Overall Stage,IVa
887,1,1,Research lab p16,p16 unknown
887,1,1,Metastasis,M0
887,1,1,Nodal Stage,N2
887,1,1,Tumor Stage,T4a
887,1,1,Tumor Site,oral cavity
887,1,1,2nd Failure Type,no known failure
887,1,1,Clinical lab p16,p16 unkown
887,1,1,Treatment Modality,Sx
887,1,1,Occurrence #,1st primary
887,1,1,1st Failure Type,no known failure
888,1,1,Research lab p16,p16 unknown
888,1,1,Tumor Site,oral cavity
888,1,1,Clinical lab p16,p16 unkown
888,1,1,1st Failure Treatment Modality,Sx
888,1,1,1st Failure Site,oral cavity
888,1,1,Nodal Stage,N2
888,1,1,Overall Stage,IVa
888,1,1,Treatment Modality,Sx
888,1,1,Research lab HPV,HPV unknown
888,1,1,1st Failure Type,locoregional
888,1,1,Tumor Stage,T4a
888,1,1,Metastasis,M0
888,1,1,Occurrence #,1st primary
888,1,1,2nd Failure Type,no known failure
889,1,1,Nodal Stage,N0
889,1,1,1st Failure Type,no known failure
889,1,1,Research lab p16,p16 unknown
889,1,1,Occurrence #,other primary
889,1,1,Tumor Stage,T3
889,1,1,Treatment Modality,Sx
889,1,1,Overall Stage,III
889,1,1,Research lab HPV,HPV unknown
889,1,1,Metastasis,M0
889,1,1,Clinical lab p16,p16 unkown
889,1,1,2nd Failure Type,no known failure
889,1,1,Tumor Site,oral cavity
890,1,1,Tumor Stage,T2
890,1,1,Tumor Site,oral cavity
890,1,1,Overall Stage,II
890,1,1,Research lab p16,p16 unknown
890,1,1,1st Failure Type,no known failure
890,1,1,Treatment Modality,Sx
890,1,1,Research lab HPV,HPV unknown
890,1,1,Nodal Stage,N0
890,1,1,2nd Failure Type,no known failure
890,1,1,Clinical lab p16,p16 unkown
890,1,1,Occurrence #,1st primary
890,1,1,Metastasis,M0
891,1,1,Tumor Stage,T4a
891,1,1,Tumor Site,oral cavity
891,1,1,Initial Chemotherapy Agent,Carbo/PTX
891,1,1,Radiation Dosage,40.8
891,1,1,Nodal Stage,N0
891,1,1,Occurrence #,1st primary
891,1,1,Clinical lab p16,p16 unkown
891,1,1,2nd Failure Type,no known failure
891,1,1,Overall Stage,IVa
891,1,1,Metastasis,M0
891,1,1,Treatment Modality,Sx & CTX-RT
891,1,1,Research lab p16,p16 unknown
891,1,1,1st Failure Type,locoregional
891,1,1,Research lab HPV,HPV unknown
892,1,1,Occurrence #,1st primary
892,1,1,Treatment Modality,Sx & RT
892,1,1,Tumor Stage,T2
892,1,1,Metastasis,M0
892,1,1,Nodal Stage,N0
892,1,1,2nd Failure Type,no known failure
892,1,1,Tumor Site,oral cavity
892,1,1,Research lab HPV,HPV unknown
892,1,1,1st Failure Type,no known failure
892,1,1,Research lab p16,p16 unknown
892,1,1,Radiation Dosage,60
892,1,1,Overall Stage,II
892,1,1,Clinical lab p16,p16 unkown
893,1,1,Research lab HPV,HPV unknown
893,1,1,Treatment Modality,Unknown
893,1,1,Research lab p16,p16 unknown
893,1,1,Occurrence #,other primary
893,1,1,2nd Failure Type,no known failure
893,1,1,Metastasis,Unknown
893,1,1,Tumor Stage,T2
893,1,1,Nodal Stage,Unknown
893,1,1,Overall Stage,IVa
893,1,1,Clinical lab p16,p16 unkown
893,1,1,Tumor Site,oral cavity
893,1,1,1st Failure Type,no known failure
894,1,1,1st Failure Treatment Modality,Sx
894,1,1,1st Failure Type,locoregional
894,1,1,2nd Failure Type,no known failure
894,1,1,Overall Stage,I
894,1,1,Metastasis,M0
894,1,1,Nodal Stage,N0
894,1,1,Clinical lab p16,p16 unkown
894,1,1,1st Failure Site,oral cavity
894,1,1,Tumor Site,oral cavity
894,1,1,Research lab HPV,HPV unknown
894,1,1,Tumor Stage,T1
894,1,1,Occurrence #,1st primary
894,1,1,Research lab p16,p16 unknown
894,1,1,Treatment Modality,Sx
895,1,1,Occurrence #,1st primary
895,1,1,Radiation Dosage,63
895,1,1,Overall Stage,III
895,1,1,Tumor Stage,T1
895,1,1,2nd Failure Type,no known failure
895,1,1,1st Failure Type,no known failure
895,1,1,Second Line Chemotherapy Agent,carbo
895,1,1,Research lab HPV,HPV unknown
895,1,1,Initial Chemotherapy Agent,cis
895,1,1,Treatment Modality,Sx & CTX-RT
895,1,1,Research lab p16,p16 unknown
895,1,1,Clinical lab p16,p16 unkown
895,1,1,Metastasis,M0
895,1,1,Nodal Stage,N1
895,1,1,Tumor Site,oral cavity
896,1,1,Metastasis,M0
896,1,1,Tumor Stage,T1
896,1,1,Research lab p16,p16 unknown
896,1,1,Tumor Site,oral cavity
896,1,1,Occurrence #,1st primary
896,1,1,Treatment Modality,Sx
896,1,1,2nd Failure Type,no known failure
896,1,1,Research lab HPV,HPV unknown
896,1,1,Clinical lab p16,p16 unkown
896,1,1,Overall Stage,I
896,1,1,1st Failure Type,no known failure
896,1,1,Nodal Stage,N0
897,1,1,Research lab p16,p16 unknown
897,1,1,1st Failure Type,no known failure
897,1,1,Metastasis,M0
897,1,1,Treatment Modality,Sx & RT
897,1,1,Nodal Stage,N0
897,1,1,Overall Stage,IVa
897,1,1,Occurrence #,1st primary
897,1,1,Tumor Stage,T4a
897,1,1,Radiation Dosage,66
897,1,1,Clinical lab p16,p16 unkown
897,1,1,Tumor Site,oral cavity
897,1,1,Research lab HPV,HPV unknown
897,1,1,2nd Failure Type,no known failure
898,1,1,Clinical lab p16,p16 unkown
898,1,1,Overall Stage,IVa
898,1,1,Initial Chemotherapy Agent,carbo/PTX
898,1,1,Research lab HPV,HPV unknown
898,1,1,1st Failure Type,no known failure
898,1,1,Research lab p16,p16 unknown
898,1,1,Tumor Site,oral cavity
898,1,1,Occurrence #,other primary
898,1,1,Metastasis,M0
898,1,1,Nodal Stage,N2
898,1,1,Radiation Dosage,60
898,1,1,2nd Failure Type,no known failure
898,1,1,Tumor Stage,T1
898,1,1,Treatment Modality,Sx & CTX-RT
899,1,1,Clinical lab p16,p16 unkown
899,1,1,Overall Stage,IVa
899,1,1,Tumor Stage,T4a
899,1,1,Research lab HPV,HPV unknown
899,1,1,Research lab p16,p16 unknown
899,1,1,Nodal Stage,N0
899,1,1,Tumor Site,oral cavity
899,1,1,2nd Failure Type,no known failure
899,1,1,Metastasis,M0
899,1,1,Treatment Modality,Sx
899,1,1,Occurrence #,1st primary
899,1,1,1st Failure Type,no known failure
900,1,1,Nodal Stage,N0
900,1,1,Tumor Stage,T2
900,1,1,Research lab p16,p16 unknown
900,1,1,Overall Stage,II
900,1,1,Clinical lab p16,p16 unkown
900,1,1,1st Failure Type,no known failure
900,1,1,Tumor Site,oral cavity
900,1,1,Treatment Modality,Sx
900,1,1,2nd Failure Type,no known failure
900,1,1,Occurrence #,1st primary
900,1,1,Metastasis,M0
900,1,1,Research lab HPV,HPV unknown
901,1,1,Research lab p16,p16 unknown
901,1,1,Tumor Site,oral cavity
901,1,1,Research lab HPV,HPV unknown
901,1,1,Overall Stage,IVa
901,1,1,Occurrence #,1st primary
901,1,1,Clinical lab p16,p16 unkown
901,1,1,1st Failure Type,no known failure
901,1,1,Treatment Modality,Sx
901,1,1,2nd Failure Type,no known failure
901,1,1,Tumor Stage,T4a
901,1,1,Metastasis,M0
901,1,1,Nodal Stage,N0
902,1,1,Overall Stage,IVa
902,1,1,1st Failure Type,no known failure
902,1,1,Tumor Site,oropharynx
902,1,1,2nd Failure Type,no known failure
902,1,1,Occurrence #,recurrence
902,1,1,Metastasis,M0
902,1,1,Research lab p16,p16 unknown
902,1,1,Clinical lab p16,p16 unkown
902,1,1,Research lab HPV,HPV unknown
902,1,1,Tumor Stage,T4a
902,1,1,Nodal Stage,N2
902,1,1,Treatment Modality,Sx
903,1,1,Overall Stage,I
903,1,1,Metastasis,M0
903,1,1,Tumor Stage,T1
903,1,1,2nd Failure Type,no known failure
903,1,1,Clinical lab p16,p16 unkown
903,1,1,Treatment Modality,Sx
903,1,1,Nodal Stage,N0
903,1,1,Tumor Site,oral cavity
903,1,1,Research lab p16,p16 unknown
903,1,1,Research lab HPV,HPV unknown
903,1,1,Occurrence #,1st primary
903,1,1,1st Failure Type,no known failure
904,1,1,2nd Failure Type,no known failure
904,1,1,Metastasis,M0
904,1,1,Treatment Modality,Sx
904,1,1,1st Failure Type,no known failure
904,1,1,Clinical lab p16,p16 unkown
904,1,1,Nodal Stage,N1
904,1,1,Overall Stage,III
904,1,1,Occurrence #,recurrence
904,1,1,Research lab HPV,HPV unknown
904,1,1,Tumor Site,oral cavity
904,1,1,Research lab p16,p16 unknown
904,1,1,Tumor Stage,T2
905,1,1,Overall Stage,IVb
905,1,1,2nd Failure Type,no known failure
905,1,1,Occurrence #,1st primary
905,1,1,Clinical lab p16,p16 unkown
905,1,1,Treatment Modality,Sx
905,1,1,1st Failure Type,no known failure
905,1,1,Nodal Stage,Unknown
905,1,1,Tumor Site,oral cavity
905,1,1,Research lab p16,p16 unknown
905,1,1,Research lab HPV,HPV unknown
905,1,1,Metastasis,M0
905,1,1,Tumor Stage,T4b
906,1,1,Overall Stage,IVa
906,1,1,Tumor Site,oral cavity
906,1,1,Nodal Stage,N2
906,1,1,Research lab HPV,HPV unknown
906,1,1,Occurrence #,1st primary
906,1,1,Metastasis,M0
906,1,1,1st Failure Type,locoregional
906,1,1,Research lab p16,p16 unknown
906,1,1,Tumor Stage,T4a
906,1,1,2nd Failure Type,no known failure
906,1,1,Treatment Modality,Sx
906,1,1,Clinical lab p16,p16 unkown
907,1,1,Clinical lab p16,p16 unkown
907,1,1,Treatment Modality,Sx
907,1,1,1st Failure Type,no known failure
907,1,1,Nodal Stage,N2
907,1,1,2nd Failure Type,no known failure
907,1,1,Tumor Site,oral cavity
907,1,1,Metastasis,M0
907,1,1,Overall Stage,IVa
907,1,1,Research lab HPV,HPV unknown
907,1,1,Tumor Stage,T1
907,1,1,Research lab p16,p16 unknown
907,1,1,Occurrence #,1st primary
908,1,1,Overall Stage,II
908,1,1,Clinical lab p16,p16 unkown
908,1,1,Treatment Modality,Sx
908,1,1,2nd Failure Type,no known failure
908,1,1,1st Failure Type,no known failure
908,1,1,Occurrence #,recurrence
908,1,1,Research lab HPV,HPV unknown
908,1,1,Nodal Stage,N0
908,1,1,Tumor Site,oral cavity
908,1,1,Tumor Stage,T2
908,1,1,Research lab p16,p16 unknown
908,1,1,Metastasis,M0
909,1,1,Metastasis,M0
909,1,1,Clinical lab p16,p16 unkown
909,1,1,Nodal Stage,N0
909,1,1,Tumor Site,oral cavity
909,1,1,Tumor Stage,T1
909,1,1,Research lab p16,p16 unknown
909,1,1,Occurrence #,1st primary
909,1,1,Research lab HPV,HPV unknown
909,1,1,Treatment Modality,Sx
909,1,1,1st Failure Type,no known failure
909,1,1,2nd Failure Type,no known failure
909,1,1,Overall Stage,I
910,1,1,2nd Failure Type,no known failure
910,1,1,Clinical lab p16,p16 unkown
910,1,1,Nodal Stage,N0
910,1,1,1st Failure Type,no known failure
910,1,1,Treatment Modality,Sx
910,1,1,Tumor Site,oral cavity
910,1,1,Tumor Stage,T1
910,1,1,Research lab p16,p16 unknown
910,1,1,Overall Stage,I
910,1,1,Research lab HPV,HPV unknown
910,1,1,Occurrence #,1st primary
910,1,1,Metastasis,M0
911,1,1,1st Failure Type,no known failure
911,1,1,Tumor Stage,T4a
911,1,1,Nodal Stage,N1
911,1,1,Clinical lab p16,p16 unkown
911,1,1,Overall Stage,IVa
911,1,1,Research lab p16,p16 unknown
911,1,1,Research lab HPV,HPV unknown
911,1,1,Treatment Modality,Sx & RT
911,1,1,Radiation Dosage,63
911,1,1,Occurrence #,1st primary
911,1,1,Tumor Site,oral cavity
911,1,1,Metastasis,M0
911,1,1,2nd Failure Type,no known failure
912,1,1,2nd Failure Type,no known failure
912,1,1,1st Failure Type,no known failure
912,1,1,Tumor Stage,T2
912,1,1,Clinical lab p16,p16 unkown
912,1,1,Occurrence #,1st primary
912,1,1,Research lab p16,p16 unknown
912,1,1,Overall Stage,II
912,1,1,Nodal Stage,N0
912,1,1,Tumor Site,oral cavity
912,1,1,Research lab HPV,HPV unknown
912,1,1,Treatment Modality,Sx
912,1,1,Metastasis,M0
913,1,1,Tumor Stage,T4a
913,1,1,Research lab p16,p16 unknown
913,1,1,Tumor Site,oral cavity
913,1,1,Treatment Modality,Sx
913,1,1,Research lab HPV,HPV unknown
913,1,1,Clinical lab p16,p16 unkown
913,1,1,2nd Failure Type,no known failure
913,1,1,1st Failure Type,no known failure
913,1,1,Nodal Stage,N0
913,1,1,Occurrence #,1st primary
913,1,1,Metastasis,M0
913,1,1,Overall Stage,IVa
914,1,1,Clinical lab p16,p16 unkown
914,1,1,Research lab p16,p16 unknown
914,1,1,Tumor Site,oral cavity
914,1,1,Research lab HPV,HPV unknown
914,1,1,Treatment Modality,Sx
914,1,1,Overall Stage,IVa
914,1,1,2nd Failure Type,no known failure
914,1,1,Tumor Stage,T4a
914,1,1,Nodal Stage,N1
914,1,1,Metastasis,M0
914,1,1,Occurrence #,1st primary
914,1,1,1st Failure Type,no known failure
915,1,1,Research lab p16,p16 unknown
915,1,1,Metastasis,M0
915,1,1,Research lab HPV,HPV unknown
915,1,1,Overall Stage,IVa
915,1,1,Occurrence #,1st primary
915,1,1,Tumor Site,oral cavity
915,1,1,Nodal Stage,N2
915,1,1,Treatment Modality,Sx & CTX-RT
915,1,1,1st Failure Type,no known failure
915,1,1,2nd Failure Type,no known failure
915,1,1,Clinical lab p16,p16 unkown
915,1,1,Radiation Dosage,59.4
915,1,1,Tumor Stage,T4a
915,1,1,Initial Chemotherapy Agent,cis
916,1,1,Tumor Site,oral cavity
916,1,1,Nodal Stage,N0
916,1,1,Metastasis,M0
916,1,1,Treatment Modality,Sx
916,1,1,Research lab p16,p16 unknown
916,1,1,Research lab HPV,HPV unknown
916,1,1,Overall Stage,I
916,1,1,1st Failure Type,locoregional
916,1,1,2nd Failure Type,no known failure
916,1,1,1st Failure Radiation Dosage,unknown
916,1,1,Clinical lab p16,p16 unkown
916,1,1,1st Failure Site,oral cavity
916,1,1,Occurrence #,1st primary
916,1,1,1st Failure Treatment Modality,Sx
916,1,1,Tumor Stage,T1
917,1,1,Research lab p16,p16 unknown
917,1,1,1st Failure Type,locoregional
917,1,1,Nodal Stage,N0
917,1,1,Occurrence #,1st primary
917,1,1,Tumor Stage,T1
917,1,1,Clinical lab p16,p16 unkown
917,1,1,Treatment Modality,Sx
917,1,1,Tumor Site,oral cavity
917,1,1,Research lab HPV,HPV unknown
917,1,1,2nd Failure Type,no known failure
917,1,1,Metastasis,M0
917,1,1,Overall Stage,I
919,1,1,Tumor Site,oral cavity
919,1,1,Occurrence #,1st primary
919,1,1,Overall Stage,II
919,1,1,Clinical lab p16,p16 unkown
919,1,1,Treatment Modality,Sx
919,1,1,Nodal Stage,N0
919,1,1,Tumor Stage,T2
919,1,1,1st Failure Type,no known failure
919,1,1,2nd Failure Type,no known failure
919,1,1,Research lab HPV,HPV unknown
919,1,1,Metastasis,M0
919,1,1,Research lab p16,p16 unknown
920,1,1,1st Failure Site,oral cavity
920,1,1,Nodal Stage,N2
920,1,1,Treatment Modality,Sx & RT
920,1,1,Radiation Dosage,unknown
920,1,1,Research lab p16,p16 unknown
920,1,1,Clinical lab p16,p16 unkown
920,1,1,Tumor Stage,T2
920,1,1,Metastasis,M0
920,1,1,Tumor Site,oral cavity
920,1,1,1st Failure Type,distant
920,1,1,Research lab HPV,HPV unknown
920,1,1,1st Failure Radiation Dosage,unk
920,1,1,Occurrence #,1st primary
920,1,1,2nd Failure Type,no known failure
920,1,1,1st Failure Treatment Modality,Sx & RT
920,1,1,Overall Stage,IVa
921,1,1,2nd Failure Type,no known failure
921,1,1,1st Failure Type,no known failure
921,1,1,Research lab p16,p16 unknown
921,1,1,Treatment Modality,Sx & RT
921,1,1,Tumor Site,oral cavity
921,1,1,Metastasis,M0
921,1,1,Research lab HPV,HPV unknown
921,1,1,Tumor Stage,T2
921,1,1,Overall Stage,III
921,1,1,Radiation Dosage,unknown
921,1,1,Clinical lab p16,p16 unkown
921,1,1,Occurrence #,1st primary
921,1,1,Nodal Stage,N1
922,1,1,Research lab HPV,HPV unknown
922,1,1,Metastasis,M0
922,1,1,1st Failure Type,no known failure
922,1,1,Radiation Dosage,unknown
922,1,1,2nd Failure Type,no known failure
922,1,1,Overall Stage,IVa
922,1,1,Treatment Modality,Sx & RT
922,1,1,Tumor Site,oral cavity
922,1,1,1st Failure Treatment Modality,Sx
922,1,1,Clinical lab p16,p16 unkown
922,1,1,Occurrence #,1st primary
922,1,1,Nodal Stage,N2
922,1,1,1st Failure Site,oral cavity
922,1,1,Tumor Stage,T4a
922,1,1,Research lab p16,p16 unknown
923,1,1,Occurrence #,1st primary
923,1,1,Tumor Site,oral cavity
923,1,1,Metastasis,M0
923,1,1,Overall Stage,I
923,1,1,Clinical lab p16,p16 unkown
923,1,1,Research lab HPV,HPV unknown
923,1,1,1st Failure Type,no known failure
923,1,1,Research lab p16,p16 unknown
923,1,1,Nodal Stage,N0
923,1,1,Treatment Modality,Sx
923,1,1,2nd Failure Type,no known failure
923,1,1,Tumor Stage,T1
924,1,1,Tumor Stage,T1
924,1,1,Occurrence #,1st primary
924,1,1,1st Failure Type,no known failure
924,1,1,Initial Chemotherapy Agent,cis
924,1,1,Treatment Modality,Sx & CTX-RT
924,1,1,Clinical lab p16,p16 unkown
924,1,1,Nodal Stage,N2
924,1,1,Metastasis,M0
924,1,1,Research lab p16,p16 unknown
924,1,1,Radiation Dosage,70.2
924,1,1,Tumor Site,oral cavity
924,1,1,Overall Stage,III
924,1,1,Research lab HPV,HPV unknown
924,1,1,2nd Failure Type,no known failure
925,1,1,Research lab p16,p16 unknown
925,1,1,1st Failure Radiation Dosage,60
925,1,1,Research lab HPV,HPV unknown
925,1,1,Occurrence #,other primary
925,1,1,Tumor Stage,T4a
925,1,1,Nodal Stage,N0
925,1,1,1st Failure Site,oral cavity
925,1,1,2nd Failure Type,no known failure
925,1,1,1st Failure Type,locoregional
925,1,1,1st Failure Initial Chemotherapy Agent,cis/doce
925,1,1,Overall Stage,IVa
925,1,1,1st Failure Treatment Modality,Sx & CTX-RT
925,1,1,Tumor Site,oral cavity
925,1,1,Metastasis,M0
925,1,1,Treatment Modality,Sx
925,1,1,Clinical lab p16,p16 unkown
926,1,1,Research lab p16,p16 unknown
926,1,1,Nodal Stage,N0
926,1,1,Metastasis,M0
926,1,1,Occurrence #,1st primary
926,1,1,1st Failure Type,no known failure
926,1,1,Overall Stage,I
926,1,1,Clinical lab p16,p16 unkown
926,1,1,Treatment Modality,Sx
926,1,1,Research lab HPV,HPV unknown
926,1,1,2nd Failure Type,no known failure
926,1,1,Tumor Site,oral cavity
926,1,1,Tumor Stage,T1
927,1,1,1st Failure Type,no known failure
927,1,1,2nd Failure Type,no known failure
927,1,1,Treatment Modality,Sx
927,1,1,Research lab HPV,HPV unknown
927,1,1,Research lab p16,p16 unknown
927,1,1,Tumor Stage,T1
927,1,1,Occurrence #,1st primary
927,1,1,Metastasis,M0
927,1,1,Overall Stage,I
927,1,1,Nodal Stage,N0
927,1,1,Tumor Site,oral cavity
927,1,1,Clinical lab p16,p16 unkown
928,1,1,1st Failure Type,no known failure
928,1,1,Research lab p16,p16 unknown
928,1,1,2nd Failure Type,no known failure
928,1,1,Clinical lab p16,p16 unkown
928,1,1,Overall Stage,III
928,1,1,Tumor Site,oral cavity
928,1,1,Treatment Modality,Sx
928,1,1,Research lab HPV,HPV unknown
928,1,1,Occurrence #,1st primary
928,1,1,Tumor Stage,T1
928,1,1,Metastasis,M0
928,1,1,Nodal Stage,N1
929,1,1,Occurrence #,1st primary
929,1,1,Tumor Site,oral cavity
929,1,1,Tumor Stage,T2
929,1,1,Research lab p16,p16 unknown
929,1,1,Research lab HPV,HPV unknown
929,1,1,Overall Stage,II
929,1,1,Nodal Stage,N0
929,1,1,Treatment Modality,Sx
929,1,1,Metastasis,M0
929,1,1,1st Failure Type,no known failure
929,1,1,2nd Failure Type,no known failure
929,1,1,Clinical lab p16,p16 unkown
930,1,1,Metastasis,M0
930,1,1,Overall Stage,IVa
930,1,1,Tumor Stage,T4a
930,1,1,Tumor Site,oral cavity
930,1,1,1st Failure Type,no known failure
930,1,1,2nd Failure Type,no known failure
930,1,1,Research lab HPV,HPV unknown
930,1,1,Clinical lab p16,p16 unkown
930,1,1,Treatment Modality,Sx
930,1,1,Research lab p16,p16 unknown
930,1,1,Nodal Stage,N2
930,1,1,Occurrence #,1st primary
931,1,1,2nd Failure Type,no known failure
931,1,1,Occurrence #,1st primary
931,1,1,Metastasis,M0
931,1,1,1st Failure Treatment Modality,Sx & RT
931,1,1,Research lab HPV,HPV unknown
931,1,1,1st Failure Radiation Dosage,unknown
931,1,1,Overall Stage,I
931,1,1,1st Failure Site,oral cavity
931,1,1,Tumor Stage,T1
931,1,1,Research lab p16,p16 unknown
931,1,1,1st Failure Type,locoregional
931,1,1,Treatment Modality,Sx
931,1,1,Tumor Site,oral cavity
931,1,1,Nodal Stage,N0
931,1,1,Clinical lab p16,p16 unkown
932,1,1,Nodal Stage,N0
932,1,1,Tumor Site,oral cavity
932,1,1,Clinical lab p16,p16 unkown
932,1,1,Research lab p16,p16 unknown
932,1,1,Tumor Stage,T1
932,1,1,Research lab HPV,HPV unknown
932,1,1,2nd Failure Type,no known failure
932,1,1,Occurrence #,1st primary
932,1,1,1st Failure Type,no known failure
932,1,1,Metastasis,M0
932,1,1,Overall Stage,I
932,1,1,Treatment Modality,Sx
933,1,1,Metastasis,M0
933,1,1,2nd Failure Type,no known failure
933,1,1,Second Line Chemotherapy Agent,carbo
933,1,1,Tumor Site,oral cavity
933,1,1,Overall Stage,IVa
933,1,1,1st Failure Treatment Modality,Sx & CTX
933,1,1,Occurrence #,1st primary
933,1,1,1st Failure Type,locoregional
933,1,1,Treatment Modality,Sx & CTX-RT
933,1,1,Clinical lab p16,p16 unkown
933,1,1,Research lab HPV,HPV unknown
933,1,1,1st Failure Site,oral cavity
933,1,1,Tumor Stage,T4a
933,1,1,Nodal Stage,N2
933,1,1,Initial Chemotherapy Agent,cis/PTX/5-FU
933,1,1,1st Failure Initial Chemotherapy Agent,cis/doce/5-FU
933,1,1,Radiation Dosage,60
933,1,1,Research lab p16,p16 unknown
934,1,1,Occurrence #,1st primary
934,1,1,Overall Stage,III
934,1,1,1st Failure Type,locoregional
934,1,1,Radiation Dosage,unknown
934,1,1,Treatment Modality,Sx & CTX-RT
934,1,1,Research lab p16,p16 unknown
934,1,1,Tumor Site,oral cavity
934,1,1,Nodal Stage,N1
934,1,1,Initial Chemotherapy Agent,unknown
934,1,1,Research lab HPV,HPV unknown
934,1,1,Metastasis,M0
934,1,1,2nd Failure Type,no known failure
934,1,1,Tumor Stage,T2
934,1,1,Clinical lab p16,p16 unkown
935,1,1,Clinical lab p16,p16 unkown
935,1,1,Nodal Stage,N0
935,1,1,Treatment Modality,Sx
935,1,1,Metastasis,M0
935,1,1,2nd Failure Type,no known failure
935,1,1,Tumor Stage,T1
935,1,1,Tumor Site,oral cavity
935,1,1,Overall Stage,I
935,1,1,1st Failure Type,no known failure
935,1,1,Occurrence #,1st primary
935,1,1,Research lab p16,p16 unknown
935,1,1,Research lab HPV,HPV unknown
936,1,1,Research lab HPV,HPV unknown
936,1,1,Research lab p16,p16 unknown
936,1,1,Tumor Site,oral cavity
936,1,1,Initial Chemotherapy Agent,cetux
936,1,1,1st Failure Site,oral cavity
936,1,1,Tumor Stage,T2
936,1,1,Overall Stage,III
936,1,1,Treatment Modality,Sx & CTX-RT
936,1,1,Radiation Dosage,70.2
936,1,1,1st Failure Type,locoregional
936,1,1,Metastasis,M0
936,1,1,2nd Failure Type,no known failure
936,1,1,1st Failure Treatment Modality,CTX-RT
936,1,1,Nodal Stage,N1
936,1,1,Occurrence #,1st primary
936,1,1,Clinical lab p16,p16 unkown
937,1,1,Occurrence #,1st primary
937,1,1,Nodal Stage,N0
937,1,1,Tumor Site,oral cavity
937,1,1,1st Failure Site,oral cavity
937,1,1,Tumor Stage,T2
937,1,1,1st Failure Radiation Dosage,63
937,1,1,Treatment Modality,Sx
937,1,1,1st Failure Treatment Modality,Sx & RT
937,1,1,1st Failure Type,locoregional
937,1,1,Clinical lab p16,p16 unkown
937,1,1,Research lab HPV,HPV unknown
937,1,1,Overall Stage,II
937,1,1,Metastasis,M0
937,1,1,Research lab p16,p16 unknown
937,1,1,2nd Failure Type,no known failure
938,1,1,Occurrence #,1st primary
938,1,1,2nd Failure Type,no known failure
938,1,1,Clinical lab p16,p16 unkown
938,1,1,Nodal Stage,N0
938,1,1,1st Failure Type,no known failure
938,1,1,Tumor Site,oral cavity
938,1,1,Treatment Modality,Sx
938,1,1,Overall Stage,I
938,1,1,Tumor Stage,T1
938,1,1,Research lab p16,p16 unknown
938,1,1,Metastasis,M0
938,1,1,Research lab HPV,HPV unknown
939,1,1,Nodal Stage,N1
939,1,1,Clinical lab p16,p16 unkown
939,1,1,Research lab p16,p16 unknown
939,1,1,2nd Failure Type,no known failure
939,1,1,Radiation Dosage,63
939,1,1,Treatment Modality,Sx & RT
939,1,1,Tumor Site,oral cavity
939,1,1,Research lab HPV,HPV unknown
939,1,1,Overall Stage,III
939,1,1,1st Failure Type,locoregional
939,1,1,Metastasis,M0
939,1,1,Occurrence #,1st primary
939,1,1,Tumor Stage,T1
940,1,1,Research lab HPV,HPV unknown
940,1,1,1st Failure Type,no known failure
940,1,1,Treatment Modality,Sx
940,1,1,Tumor Stage,T2
940,1,1,Metastasis,M0
940,1,1,Tumor Site,oral cavity
940,1,1,2nd Failure Type,no known failure
940,1,1,Research lab p16,p16 unknown
940,1,1,Overall Stage,II
940,1,1,Occurrence #,1st primary
940,1,1,Nodal Stage,N0
940,1,1,Clinical lab p16,p16 unkown
941,1,1,1st Failure Type,no known failure
941,1,1,Tumor Site,oral cavity
941,1,1,Nodal Stage,N2
941,1,1,Research lab HPV,HPV unknown
941,1,1,Treatment Modality,Sx
941,1,1,Clinical lab p16,p16 unkown
941,1,1,2nd Failure Type,no known failure
941,1,1,Occurrence #,1st primary
941,1,1,Overall Stage,IVa
941,1,1,Tumor Stage,T1
941,1,1,Metastasis,M0
941,1,1,Research lab p16,p16 unknown
942,1,1,Nodal Stage,N0
942,1,1,2nd Failure Type,no known failure
942,1,1,Metastasis,M0
942,1,1,Clinical lab p16,p16 unkown
942,1,1,Tumor Site,oral cavity
942,1,1,Treatment Modality,Sx
942,1,1,Occurrence #,1st primary
942,1,1,Research lab p16,p16 unknown
942,1,1,Overall Stage,II
942,1,1,Tumor Stage,T2
942,1,1,1st Failure Type,no known failure
942,1,1,Research lab HPV,HPV unknown
943,1,1,Tumor Stage,T2
943,1,1,Overall Stage,II
943,1,1,2nd Failure Type,no known failure
943,1,1,Tumor Site,oral cavity
943,1,1,Metastasis,M0
943,1,1,Nodal Stage,N0
943,1,1,Research lab HPV,HPV unknown
943,1,1,Occurrence #,1st primary
943,1,1,Clinical lab p16,p16 unkown
943,1,1,1st Failure Type,no known failure
943,1,1,Treatment Modality,Sx
943,1,1,Research lab p16,p16 unknown
944,1,1,2nd Failure Type,no known failure
944,1,1,1st Failure Type,locoregional
944,1,1,Research lab HPV,HPV unknown
944,1,1,Nodal Stage,N1
944,1,1,Tumor Stage,T3
944,1,1,Treatment Modality,Sx
944,1,1,Overall Stage,III
944,1,1,Occurrence #,1st primary
944,1,1,Tumor Site,oral cavity
944,1,1,Radiation Dosage,60
944,1,1,Clinical lab p16,p16 unkown
944,1,1,Research lab p16,p16 unknown
944,1,1,Metastasis,M0
945,1,1,Overall Stage,IVa
945,1,1,Research lab p16,p16 unknown
945,1,1,Occurrence #,1st primary
945,1,1,1st Failure Treatment Modality,CTX
945,1,1,Nodal Stage,N2
945,1,1,Clinical lab p16,p16 unkown
945,1,1,1st Failure Site,oral cavity
945,1,1,Research lab HPV,HPV unknown
945,1,1,Tumor Site,oral cavity
945,1,1,Metastasis,M0
945,1,1,Radiation Dosage,unknown
945,1,1,1st Failure Initial Chemotherapy Agent,cis/doce
945,1,1,Treatment Modality,Sx & RT
945,1,1,Tumor Stage,T2
945,1,1,1st Failure Type,distant
945,1,1,2nd Failure Type,no known failure
946,1,1,Overall Stage,IVa
946,1,1,Tumor Stage,T4a
946,1,1,Research lab HPV,HPV unknown
946,1,1,Tumor Site,oral cavity
946,1,1,Clinical lab p16,p16 unkown
946,1,1,Research lab p16,p16 unknown
946,1,1,Occurrence #,recurrence
946,1,1,1st Failure Type,no known failure
946,1,1,Treatment Modality,Sx
946,1,1,Nodal Stage,N0
946,1,1,Metastasis,M0
946,1,1,2nd Failure Type,no known failure
947,1,1,Radiation Dosage,unknown
947,1,1,Tumor Site,oral cavity
947,1,1,Treatment Modality,Sx & CTX-RT
947,1,1,Metastasis,M0
947,1,1,Clinical lab p16,p16 unkown
947,1,1,2nd Failure Type,no known failure
947,1,1,Tumor Stage,T1
947,1,1,Initial Chemotherapy Agent,unknown
947,1,1,Overall Stage,IVa
947,1,1,Research lab p16,p16 unknown
947,1,1,1st Failure Type,no known failure
947,1,1,Nodal Stage,N2
947,1,1,Occurrence #,recurrence
947,1,1,Research lab HPV,HPV unknown
948,1,1,Tumor Stage,T1
948,1,1,Research lab p16,p16 unknown
948,1,1,1st Failure Type,no known failure
948,1,1,Tumor Site,oral cavity
948,1,1,2nd Failure Type,no known failure
948,1,1,Metastasis,M0
948,1,1,Occurrence #,1st primary
948,1,1,Research lab HPV,HPV unknown
948,1,1,Treatment Modality,Sx
948,1,1,Nodal Stage,N0
948,1,1,Clinical lab p16,p16 unkown
948,1,1,Overall Stage,I
949,1,1,2nd Failure Type,no known failure
949,1,1,Clinical lab p16,p16 unkown
949,1,1,Metastasis,M0
949,1,1,Nodal Stage,N0
949,1,1,Occurrence #,1st primary
949,1,1,Treatment Modality,Sx
949,1,1,1st Failure Treatment Modality,Sx & CTX-RT
949,1,1,Tumor Stage,T1
949,1,1,Overall Stage,I
949,1,1,1st Failure Initial Chemotherapy Agent,unknown
949,1,1,Research lab HPV,HPV unknown
949,1,1,1st Failure Type,locoregional
949,1,1,1st Failure Radiation Dosage,63
949,1,1,Tumor Site,oral cavity
949,1,1,1st Failure Site,oral cavity
949,1,1,Research lab p16,p16 unknown
950,1,1,Tumor Site,oral cavity
950,1,1,Occurrence #,recurrence
950,1,1,Research lab HPV,HPV unknown
950,1,1,Nodal Stage,N2
950,1,1,Clinical lab p16,p16 unkown
950,1,1,Research lab p16,p16 unknown
950,1,1,Overall Stage,IVa
950,1,1,Tumor Stage,T1
950,1,1,1st Failure Type,no known failure
950,1,1,2nd Failure Type,no known failure
950,1,1,Treatment Modality,Sx
950,1,1,Metastasis,M0
951,1,1,Tumor Stage,T2
951,1,1,Overall Stage,III
951,1,1,1st Failure Type,no known failure
951,1,1,Clinical lab p16,p16 unkown
951,1,1,Nodal Stage,N1
951,1,1,Metastasis,M0
951,1,1,Research lab HPV,HPV unknown
951,1,1,2nd Failure Type,no known failure
951,1,1,Tumor Site,oral cavity
951,1,1,Research lab p16,p16 unknown
951,1,1,Treatment Modality,Sx
951,1,1,Occurrence #,1st primary
952,1,1,Nodal Stage,N0
952,1,1,1st Failure Type,locoregional
952,1,1,Radiation Dosage,68
952,1,1,Research lab p16,p16 unknown
952,1,1,Tumor Site,oral cavity
952,1,1,Treatment Modality,RT
952,1,1,2nd Failure Type,no known failure
952,1,1,Overall Stage,III
952,1,1,Tumor Stage,T3
952,1,1,Occurrence #,1st primary
952,1,1,Research lab HPV,HPV unknown
952,1,1,Clinical lab p16,p16 unkown
952,1,1,Metastasis,M0
953,1,1,Occurrence #,1st primary
953,1,1,Nodal Stage,N1
953,1,1,Research lab p16,p16 unknown
953,1,1,Clinical lab p16,p16 unkown
953,1,1,1st Failure Type,no known failure
953,1,1,Metastasis,M0
953,1,1,Overall Stage,III
953,1,1,Research lab HPV,HPV unknown
953,1,1,Tumor Stage,T2
953,1,1,Treatment Modality,Sx
953,1,1,Tumor Site,oral cavity
953,1,1,2nd Failure Type,no known failure
954,1,1,Treatment Modality,Sx
954,1,1,Metastasis,M0
954,1,1,Tumor Stage,T1
954,1,1,2nd Failure Type,no known failure
954,1,1,Research lab HPV,HPV unknown
954,1,1,Research lab p16,p16 unknown
954,1,1,Occurrence #,1st primary
954,1,1,Clinical lab p16,p16 unkown
954,1,1,Tumor Site,oral cavity
954,1,1,1st Failure Type,no known failure
954,1,1,Nodal Stage,N1
954,1,1,Overall Stage,III
955,1,1,Nodal Stage,N0
955,1,1,Treatment Modality,Sx
955,1,1,Tumor Stage,T4a
955,1,1,Overall Stage,IVa
955,1,1,Occurrence #,1st primary
955,1,1,Tumor Site,oral cavity
955,1,1,2nd Failure Type,no known failure
955,1,1,Metastasis,M0
955,1,1,Research lab HPV,HPV unknown
955,1,1,Clinical lab p16,p16 unkown
955,1,1,1st Failure Type,no known failure
955,1,1,Research lab p16,p16 unknown
956,1,1,Overall Stage,I
956,1,1,2nd Failure Type,no known failure
956,1,1,Tumor Site,oral cavity
956,1,1,Metastasis,M0
956,1,1,Research lab p16,p16 unknown
956,1,1,Clinical lab p16,p16 unkown
956,1,1,1st Failure Type,no known failure
956,1,1,Occurrence #,1st primary
956,1,1,Nodal Stage,N0
956,1,1,Treatment Modality,Sx
956,1,1,Research lab HPV,HPV unknown
956,1,1,Tumor Stage,T1
957,1,1,Nodal Stage,N2
957,1,1,1st Failure Type,no known failure
957,1,1,2nd Failure Type,no known failure
957,1,1,Tumor Site,oral cavity
957,1,1,Overall Stage,IVa
957,1,1,Research lab p16,p16 unknown
957,1,1,Research lab HPV,HPV unknown
957,1,1,Treatment Modality,Sx
957,1,1,Clinical lab p16,p16 unkown
957,1,1,Occurrence #,1st primary
957,1,1,Tumor Stage,T3
957,1,1,Metastasis,M0
958,1,1,Research lab HPV,HPV unknown
958,1,1,Tumor Site,oral cavity
958,1,1,Clinical lab p16,p16 unkown
958,1,1,Nodal Stage,N0
958,1,1,Metastasis,M0
958,1,1,Research lab p16,p16 unknown
958,1,1,2nd Failure Type,no known failure
958,1,1,Overall Stage,IVa
958,1,1,Tumor Stage,T4a
958,1,1,Treatment Modality,Sx
958,1,1,1st Failure Type,no known failure
958,1,1,Occurrence #,1st primary
959,1,1,Treatment Modality,Sx
959,1,1,Metastasis,M0
959,1,1,Overall Stage,II
959,1,1,Tumor Stage,T2
959,1,1,1st Failure Type,locoregional
959,1,1,Occurrence #,1st primary
959,1,1,2nd Failure Type,no known failure
959,1,1,Tumor Site,oral cavity
959,1,1,Nodal Stage,N0
959,1,1,Clinical lab p16,p16 unkown
959,1,1,Research lab HPV,HPV unknown
959,1,1,Research lab p16,p16 unknown
960,1,1,Metastasis,M0
960,1,1,Clinical lab p16,p16 unkown
960,1,1,2nd Failure Type,no known failure
960,1,1,Research lab p16,p16 unknown
960,1,1,Research lab HPV,HPV unknown
960,1,1,Overall Stage,I
960,1,1,Tumor Stage,T1
960,1,1,1st Failure Type,no known failure
960,1,1,Nodal Stage,N0
960,1,1,Occurrence #,1st primary
960,1,1,Treatment Modality,Sx
960,1,1,Tumor Site,oral cavity
961,1,1,2nd Failure Type,no known failure
961,1,1,Clinical lab p16,p16 unkown
961,1,1,Research lab p16,p16 unknown
961,1,1,Research lab HPV,HPV unknown
961,1,1,Overall Stage,III
961,1,1,Tumor Stage,T3
961,1,1,1st Failure Type,no known failure
961,1,1,Nodal Stage,N0
961,1,1,Occurrence #,1st primary
961,1,1,Metastasis,M0
961,1,1,Tumor Site,oral cavity
961,1,1,Treatment Modality,Sx
962,1,1,Research lab HPV,HPV unknown
962,1,1,Tumor Site,oral cavity
962,1,1,Clinical lab p16,p16 unkown
962,1,1,Research lab p16,p16 unknown
962,1,1,2nd Failure Type,no known failure
962,1,1,Tumor Stage,T1
962,1,1,Occurrence #,1st primary
962,1,1,1st Failure Type,no known failure
962,1,1,Treatment Modality,Sx
962,1,1,Overall Stage,IVa
962,1,1,Nodal Stage,N2
962,1,1,Metastasis,M0
963,1,1,Overall Stage,IVa
963,1,1,Occurrence #,1st primary
963,1,1,Treatment Modality,Sx & RT
963,1,1,Tumor Site,oral cavity
963,1,1,Nodal Stage,N0
963,1,1,Research lab HPV,HPV unknown
963,1,1,1st Failure Type,no known failure
963,1,1,Tumor Stage,T4a
963,1,1,Clinical lab p16,p16 unkown
963,1,1,Radiation Dosage,unknown
963,1,1,Metastasis,M0
963,1,1,Research lab p16,p16 unknown
963,1,1,2nd Failure Type,no known failure
964,1,1,Treatment Modality,Sx
964,1,1,Overall Stage,IVa
964,1,1,Tumor Stage,T4a
964,1,1,Research lab p16,p16 unknown
964,1,1,1st Failure Type,no known failure
964,1,1,Nodal Stage,Unknown
964,1,1,Tumor Site,oral cavity
964,1,1,Metastasis,Unknown
964,1,1,Occurrence #,1st primary
964,1,1,2nd Failure Type,no known failure
964,1,1,Research lab HPV,HPV unknown
964,1,1,Clinical lab p16,p16 unkown
965,1,1,Metastasis,M0
965,1,1,1st Failure Site,oral cavity
965,1,1,1st Failure Initial Chemotherapy Agent,unknown
965,1,1,Tumor Site,oral cavity
965,1,1,Occurrence #,1st primary
965,1,1,Research lab p16,p16 unknown
965,1,1,1st Failure Type,locoregional
965,1,1,Nodal Stage,N0
965,1,1,1st Failure Radiation Dosage,unknown
965,1,1,Tumor Stage,T4a
965,1,1,1st Failure Treatment Modality,CTX-RT
965,1,1,Treatment Modality,Sx
965,1,1,2nd Failure Type,no known failure
965,1,1,Research lab HPV,HPV unknown
965,1,1,Clinical lab p16,p16 unkown
965,1,1,Overall Stage,IVa
966,1,1,Tumor Site,oral cavity
966,1,1,2nd Failure Type,no known failure
966,1,1,Overall Stage,IVa
966,1,1,Tumor Stage,T2
966,1,1,Metastasis,M0
966,1,1,Treatment Modality,Sx
966,1,1,Occurrence #,1st primary
966,1,1,Research lab HPV,HPV unknown
966,1,1,1st Failure Type,no known failure
966,1,1,Nodal Stage,N2
966,1,1,Clinical lab p16,p16 unkown
966,1,1,Research lab p16,p16 unknown
967,1,1,Clinical lab p16,p16 unkown
967,1,1,Overall Stage,II
967,1,1,Tumor Stage,T2
967,1,1,Tumor Site,oral cavity
967,1,1,1st Failure Type,no known failure
967,1,1,Treatment Modality,Sx
967,1,1,Nodal Stage,N0
967,1,1,Research lab HPV,HPV unknown
967,1,1,2nd Failure Type,no known failure
967,1,1,Metastasis,M0
967,1,1,Research lab p16,p16 unknown
967,1,1,Occurrence #,1st primary
968,1,1,Research lab HPV,HPV unknown
968,1,1,Overall Stage,II
968,1,1,Treatment Modality,Sx
968,1,1,Occurrence #,1st primary
968,1,1,Metastasis,M0
968,1,1,2nd Failure Type,no known failure
968,1,1,Tumor Site,oral cavity
968,1,1,Clinical lab p16,p16 unkown
968,1,1,Nodal Stage,N0
968,1,1,1st Failure Radiation Dosage,68.4
968,1,1,1st Failure Treatment Modality,Sx & RT
968,1,1,Tumor Stage,T2
968,1,1,1st Failure Site,oral cavity
968,1,1,Research lab p16,p16 unknown
968,1,1,1st Failure Type,no known failure
970,1,1,Metastasis,M0
970,1,1,Overall Stage,I
970,1,1,Tumor Site,oral cavity
970,1,1,Treatment Modality,RT
970,1,1,Research lab p16,p16 unknown
970,1,1,Occurrence #,other primary
970,1,1,Nodal Stage,N0
970,1,1,Tumor Stage,T1
970,1,1,Research lab HPV,HPV unknown
970,1,1,1st Failure Type,no known failure
970,1,1,Radiation Dosage,70.2
970,1,1,Clinical lab p16,p16 unkown
970,1,1,2nd Failure Type,no known failure
971,1,1,Tumor Site,oral cavity
971,1,1,Clinical lab p16,p16 unkown
971,1,1,2nd Failure Type,no known failure
971,1,1,Research lab p16,p16 unknown
971,1,1,Treatment Modality,Sx
971,1,1,Nodal Stage,N0
971,1,1,Research lab HPV,HPV unknown
971,1,1,Metastasis,M0
971,1,1,Tumor Stage,T1
971,1,1,Overall Stage,I
971,1,1,Occurrence #,1st primary
971,1,1,1st Failure Type,no known failure
972,1,1,Research lab p16,p16 unknown
972,1,1,2nd Failure Type,no known failure
972,1,1,Metastasis,M0
972,1,1,Occurrence #,1st primary
972,1,1,Tumor Stage,T2
972,1,1,Treatment Modality,Sx
972,1,1,Overall Stage,IVa
972,1,1,Nodal Stage,N2
972,1,1,Research lab HPV,HPV unknown
972,1,1,1st Failure Type,no known failure
972,1,1,Tumor Site,oral cavity
972,1,1,Clinical lab p16,p16 unkown
973,1,1,Occurrence #,1st primary
973,1,1,2nd Failure Type,no known failure
973,1,1,Research lab HPV,HPV unknown
973,1,1,Tumor Stage,T2
973,1,1,Clinical lab p16,p16 unkown
973,1,1,Metastasis,Unknown
973,1,1,Treatment Modality,Sx
973,1,1,Research lab p16,p16 unknown
973,1,1,Tumor Site,oral cavity
973,1,1,1st Failure Type,no known failure
973,1,1,Nodal Stage,Unknown
973,1,1,Overall Stage,Unknown
974,1,1,Tumor Stage,T1
974,1,1,Treatment Modality,Sx
974,1,1,Nodal Stage,N0
974,1,1,Research lab HPV,HPV unknown
974,1,1,Research lab p16,p16 unknown
974,1,1,Tumor Site,oral cavity
974,1,1,Occurrence #,1st primary
974,1,1,Overall Stage,I
974,1,1,Clinical lab p16,p16 unkown
974,1,1,Metastasis,M0
974,1,1,1st Failure Type,no known failure
974,1,1,2nd Failure Type,no known failure
975,1,1,Overall Stage,IVa
975,1,1,Research lab HPV,HPV unknown
975,1,1,Clinical lab p16,p16 unkown
975,1,1,Occurrence #,1st primary
975,1,1,Tumor Stage,T2
975,1,1,Treatment Modality,Sx
975,1,1,2nd Failure Type,no known failure
975,1,1,Nodal Stage,N2
975,1,1,Research lab p16,p16 unknown
975,1,1,Tumor Site,oral cavity
975,1,1,1st Failure Type,no known failure
975,1,1,Metastasis,M0
976,1,1,Research lab HPV,HPV unknown
976,1,1,Nodal Stage,N0
976,1,1,Tumor Stage,T1
976,1,1,1st Failure Type,no known failure
976,1,1,Clinical lab p16,p16 unkown
976,1,1,2nd Failure Type,no known failure
976,1,1,Research lab p16,p16 unknown
976,1,1,Tumor Site,oral cavity
976,1,1,Treatment Modality,Sx
976,1,1,Overall Stage,I
976,1,1,Metastasis,M0
976,1,1,Occurrence #,1st primary
977,1,1,Research lab p16,p16 unknown
977,1,1,Clinical lab p16,p16 unkown
977,1,1,Tumor Site,oral cavity
977,1,1,Nodal Stage,N0
977,1,1,Occurrence #,1st primary
977,1,1,Metastasis,M0
977,1,1,2nd Failure Type,no known failure
977,1,1,Overall Stage,II
977,1,1,Research lab HPV,HPV unknown
977,1,1,Tumor Stage,T2
977,1,1,Treatment Modality,Sx
977,1,1,1st Failure Type,no known failure
978,1,1,Overall Stage,II
978,1,1,Occurrence #,1st primary
978,1,1,Research lab HPV,HPV unknown
978,1,1,Nodal Stage,N0
978,1,1,Research lab p16,p16 unknown
978,1,1,Tumor Stage,T2
978,1,1,Treatment Modality,Sx
978,1,1,2nd Failure Type,no known failure
978,1,1,Tumor Site,oral cavity
978,1,1,Metastasis,M0
978,1,1,Clinical lab p16,p16 unkown
978,1,1,1st Failure Type,no known failure
979,1,1,Research lab p16,p16 unknown
979,1,1,1st Failure Type,no known failure
979,1,1,Tumor Stage,T2
979,1,1,Overall Stage,III
979,1,1,Treatment Modality,Sx
979,1,1,Metastasis,M0
979,1,1,2nd Failure Type,no known failure
979,1,1,Clinical lab p16,p16 unkown
979,1,1,Occurrence #,1st primary
979,1,1,Tumor Site,oral cavity
979,1,1,Nodal Stage,N1
979,1,1,Research lab HPV,HPV unknown
980,1,1,Research lab HPV,HPV unknown
980,1,1,Treatment Modality,Sx
980,1,1,2nd Failure Type,no known failure
980,1,1,Tumor Site,oral cavity
980,1,1,Overall Stage,III
980,1,1,Metastasis,M0
980,1,1,Occurrence #,1st primary
980,1,1,Clinical lab p16,p16 unkown
980,1,1,1st Failure Site,oropharynx
980,1,1,Research lab p16,p16 unknown
980,1,1,Tumor Stage,T3
980,1,1,Nodal Stage,N0
980,1,1,1st Failure Type,locoregional
981,1,1,Clinical lab p16,p16 unkown
981,1,1,Overall Stage,III
981,1,1,Research lab HPV,HPV unknown
981,1,1,Occurrence #,1st primary
981,1,1,Nodal Stage,N1
981,1,1,Tumor Site,oral cavity
981,1,1,Research lab p16,p16 unknown
981,1,1,Metastasis,M0
981,1,1,1st Failure Type,no known failure
981,1,1,Tumor Stage,T2
981,1,1,Treatment Modality,Sx
981,1,1,2nd Failure Type,no known failure
982,1,1,Occurrence #,1st primary
982,1,1,Tumor Stage,T1
982,1,1,Research lab p16,p16 unknown
982,1,1,Metastasis,M0
982,1,1,Tumor Site,oral cavity
982,1,1,Treatment Modality,Sx
982,1,1,Clinical lab p16,p16 unkown
982,1,1,1st Failure Type,no known failure
982,1,1,Research lab HPV,HPV unknown
982,1,1,Overall Stage,I
982,1,1,2nd Failure Type,no known failure
982,1,1,Nodal Stage,N0
983,1,1,Tumor Site,oral cavity
983,1,1,1st Failure Treatment Modality,CTX
983,1,1,1st Failure Site,oral cavity
983,1,1,Clinical lab p16,p16 unkown
983,1,1,1st Failure Type,locoregional and distant
983,1,1,Research lab HPV,HPV unknown
983,1,1,Overall Stage,III
983,1,1,Treatment Modality,Sx & RT
983,1,1,Nodal Stage,N1
983,1,1,2nd Failure Type,no known failure
983,1,1,Metastasis,M0
983,1,1,Radiation Dosage,63
983,1,1,Research lab p16,p16 unknown
983,1,1,Tumor Stage,T3
983,1,1,1st Failure Initial Chemotherapy Agent,cis/doce/5-FU
983,1,1,Occurrence #,1st primary
984,1,1,1st Failure Type,no known failure
984,1,1,Metastasis,M0
984,1,1,Tumor Stage,T1
984,1,1,Overall Stage,I
984,1,1,Clinical lab p16,p16 unkown
984,1,1,2nd Failure Type,no known failure
984,1,1,Research lab HPV,HPV unknown
984,1,1,Treatment Modality,Sx
984,1,1,Tumor Site,oral cavity
984,1,1,Nodal Stage,N0
984,1,1,Occurrence #,recurrence
984,1,1,Research lab p16,p16 unknown
985,1,1,Metastasis,M0
985,1,1,Clinical lab p16,p16 unkown
985,1,1,2nd Failure Type,no known failure
985,1,1,1st Failure Type,no known failure
985,1,1,Overall Stage,I
985,1,1,Nodal Stage,N0
985,1,1,Treatment Modality,Sx
985,1,1,Research lab p16,p16 unknown
985,1,1,Occurrence #,1st primary
985,1,1,Tumor Stage,T1
985,1,1,Research lab HPV,HPV unknown
985,1,1,Tumor Site,oral cavity
986,1,1,2nd Failure Type,no known failure
986,1,1,Nodal Stage,N0
986,1,1,Clinical lab p16,p16 unkown
986,1,1,Occurrence #,1st primary
986,1,1,Tumor Stage,T1
986,1,1,Research lab p16,p16 unknown
986,1,1,Tumor Site,oral cavity
986,1,1,Metastasis,M0
986,1,1,1st Failure Type,no known failure
986,1,1,Overall Stage,I
986,1,1,Research lab HPV,HPV unknown
986,1,1,Treatment Modality,Sx
987,1,1,Occurrence #,1st primary
987,1,1,Clinical lab p16,p16 unkown
987,1,1,Research lab HPV,HPV unknown
987,1,1,Tumor Site,oral cavity
987,1,1,Tumor Stage,T4a
987,1,1,2nd Failure Type,no known failure
987,1,1,Research lab p16,p16 unknown
987,1,1,1st Failure Type,no known failure
987,1,1,Metastasis,M0
987,1,1,Overall Stage,IVa
987,1,1,Treatment Modality,Sx
987,1,1,Nodal Stage,N0
988,1,1,Overall Stage,IVa
988,1,1,2nd Failure Type,no known failure
988,1,1,1st Failure Type,no known failure
988,1,1,Nodal Stage,N2
988,1,1,Research lab p16,p16 unknown
988,1,1,Metastasis,M0
988,1,1,Research lab HPV,HPV unknown
988,1,1,Occurrence #,1st primary
988,1,1,Treatment Modality,Sx
988,1,1,Tumor Stage,T4a
988,1,1,Clinical lab p16,p16 unkown
988,1,1,Tumor Site,oral cavity
989,1,1,Research lab p16,p16 unknown
989,1,1,Radiation Dosage,unknown
989,1,1,Nodal Stage,N0
989,1,1,Metastasis,M0
989,1,1,1st Failure Treatment Modality,Sx
989,1,1,1st Failure Type,locoregional
989,1,1,Overall Stage,IVa
989,1,1,Occurrence #,1st primary
989,1,1,2nd Failure Type,no known failure
989,1,1,Tumor Stage,T4a
989,1,1,Tumor Site,oral cavity
989,1,1,Clinical lab p16,p16 unkown
989,1,1,Research lab HPV,HPV unknown
989,1,1,Treatment Modality,Sx & RT
989,1,1,1st Failure Site,oropharynx
990,1,1,Occurrence #,1st primary
990,1,1,Metastasis,M0
990,1,1,1st Failure Type,no known failure
990,1,1,Research lab p16,p16 unknown
990,1,1,2nd Failure Type,no known failure
990,1,1,Clinical lab p16,p16 unkown
990,1,1,Treatment Modality,Sx
990,1,1,Research lab HPV,HPV unknown
990,1,1,Tumor Site,oral cavity
990,1,1,Nodal Stage,N0
990,1,1,Tumor Stage,T1
990,1,1,Overall Stage,I
991,1,1,Research lab HPV,HPV unknown
991,1,1,Research lab p16,p16 unknown
991,1,1,Metastasis,M0
991,1,1,Tumor Stage,T4a
991,1,1,Nodal Stage,N0
991,1,1,Tumor Site,oral cavity
991,1,1,Clinical lab p16,p16 unkown
991,1,1,Treatment Modality,Sx
991,1,1,1st Failure Type,no known failure
991,1,1,Occurrence #,1st primary
991,1,1,2nd Failure Type,no known failure
991,1,1,Overall Stage,IVa
992,1,1,Occurrence #,1st primary
992,1,1,Metastasis,M0
992,1,1,Tumor Stage,T2
992,1,1,2nd Failure Type,no known failure
992,1,1,Clinical lab p16,p16 unkown
992,1,1,1st Failure Type,no known failure
992,1,1,Tumor Site,oral cavity
992,1,1,Nodal Stage,N0
992,1,1,Treatment Modality,Sx
992,1,1,Research lab HPV,HPV unknown
992,1,1,Overall Stage,II
992,1,1,Research lab p16,p16 unknown
993,1,1,1st Failure Type,no known failure
993,1,1,Clinical lab p16,p16 unkown
993,1,1,Research lab p16,p16 unknown
993,1,1,Occurrence #,1st primary
993,1,1,Research lab HPV,HPV unknown
993,1,1,Nodal Stage,N0
993,1,1,Tumor Site,oral cavity
993,1,1,2nd Failure Type,no known failure
993,1,1,Treatment Modality,Sx
993,1,1,Metastasis,M0
993,1,1,Overall Stage,I
993,1,1,Tumor Stage,T1
994,1,1,Nodal Stage,N2
994,1,1,Research lab p16,p16 unknown
994,1,1,1st Failure Type,no known failure
994,1,1,Overall Stage,IVa
994,1,1,Tumor Stage,T2
994,1,1,Tumor Site,oral cavity
994,1,1,Initial Chemotherapy Agent,cis
994,1,1,Occurrence #,1st primary
994,1,1,Treatment Modality,Sx & CTX-RT
994,1,1,2nd Failure Type,no known failure
994,1,1,Metastasis,M0
994,1,1,Research lab HPV,HPV unknown
994,1,1,Radiation Dosage,70.2
994,1,1,Clinical lab p16,p16 unkown
995,1,1,Research lab HPV,HPV unknown
995,1,1,1st Failure Type,no known failure
995,1,1,Occurrence #,1st primary
995,1,1,Treatment Modality,Sx
995,1,1,2nd Failure Type,no known failure
995,1,1,Clinical lab p16,p16 unkown
995,1,1,Nodal Stage,N0
995,1,1,Tumor Stage,T1
995,1,1,Tumor Site,oral cavity
995,1,1,Metastasis,M0
995,1,1,Research lab p16,p16 unknown
995,1,1,Overall Stage,I
996,1,1,Overall Stage,I
996,1,1,Tumor Stage,T1
996,1,1,Nodal Stage,N0
996,1,1,1st Failure Type,no known failure
996,1,1,Treatment Modality,Sx
996,1,1,Research lab HPV,HPV unknown
996,1,1,Tumor Site,oral cavity
996,1,1,Clinical lab p16,p16 unkown
996,1,1,Research lab p16,p16 unknown
996,1,1,Occurrence #,1st primary
996,1,1,2nd Failure Type,no known failure
996,1,1,Metastasis,M0
997,1,1,Radiation Dosage,63
997,1,1,Tumor Site,oral cavity
997,1,1,Nodal Stage,N2
997,1,1,Tumor Stage,T4a
997,1,1,Overall Stage,IVa
997,1,1,Research lab p16,p16 unknown
997,1,1,Research lab HPV,HPV unknown
997,1,1,Occurrence #,1st primary
997,1,1,Initial Chemotherapy Agent,cis
997,1,1,Treatment Modality,Sx & CTX-RT
997,1,1,1st Failure Type,distant
997,1,1,Clinical lab p16,p16 unkown
997,1,1,Metastasis,M0
997,1,1,2nd Failure Type,no known failure
998,1,1,Metastasis,M0
998,1,1,Tumor Site,oral cavity
998,1,1,Tumor Stage,T4a
998,1,1,2nd Failure Type,no known failure
998,1,1,Overall Stage,IVa
998,1,1,Nodal Stage,N2
998,1,1,Clinical lab p16,p16 unkown
998,1,1,Occurrence #,1st primary
998,1,1,Research lab p16,p16 unknown
998,1,1,1st Failure Type,no known failure
998,1,1,Treatment Modality,Sx
998,1,1,Research lab HPV,HPV unknown
999,1,1,Treatment Modality,Sx
999,1,1,Research lab HPV,HPV unknown
999,1,1,Tumor Site,oral cavity
999,1,1,Occurrence #,1st primary
999,1,1,Tumor Stage,T1
999,1,1,Metastasis,M0
999,1,1,1st Failure Type,no known failure
999,1,1,Overall Stage,I
999,1,1,Research lab p16,p16 unknown
999,1,1,2nd Failure Type,no known failure
999,1,1,Clinical lab p16,p16 unkown
999,1,1,Nodal Stage,N0
1000,1,1,Research lab HPV,HPV unknown
1000,1,1,Tumor Site,oral cavity
1000,1,1,2nd Failure Type,no known failure
1000,1,1,Clinical lab p16,p16 unkown
1000,1,1,Research lab p16,p16 unknown
1000,1,1,Treatment Modality,Sx
1000,1,1,Metastasis,M0
1000,1,1,1st Failure Type,no known failure
1000,1,1,Occurrence #,1st primary
1000,1,1,Overall Stage,IVa
1000,1,1,Nodal Stage,N1
1000,1,1,Tumor Stage,T4a
1001,1,1,Overall Stage,I
1001,1,1,2nd Failure Type,no known failure
1001,1,1,Tumor Stage,T1
1001,1,1,1st Failure Site,oral cavity
1001,1,1,Treatment Modality,Sx
1001,1,1,Metastasis,M0
1001,1,1,Research lab p16,p16 unknown
1001,1,1,1st Failure Type,locoregional
1001,1,1,Nodal Stage,N0
1001,1,1,Research lab HPV,HPV unknown
1001,1,1,1st Failure Treatment Modality,Sx
1001,1,1,Tumor Site,oral cavity
1001,1,1,Clinical lab p16,p16 unkown
1001,1,1,Occurrence #,other primary
1003,1,1,Occurrence #,1st primary
1003,1,1,1st Failure Type,no known failure
1003,1,1,Treatment Modality,Unknown
1003,1,1,Metastasis,Unknown
1003,1,1,Nodal Stage,Unknown
1003,1,1,Research lab p16,p16 unknown
1003,1,1,Tumor Stage,Unknown
1003,1,1,Research lab HPV,HPV unknown
1003,1,1,2nd Failure Type,no known failure
1003,1,1,Tumor Site,oral cavity
1003,1,1,Clinical lab p16,p16 unkown
1003,1,1,Overall Stage,Unknown
1004,1,1,Clinical lab p16,p16 unkown
1004,1,1,Treatment Modality,Sx & CTX-RT
1004,1,1,Research lab HPV,HPV unknown
1004,1,1,Initial Chemotherapy Agent,cis
1004,1,1,Tumor Stage,T4a
1004,1,1,Metastasis,M0
1004,1,1,Overall Stage,IVa
1004,1,1,Occurrence #,1st primary
1004,1,1,1st Failure Type,locoregional and distant
1004,1,1,Nodal Stage,N2
1004,1,1,Tumor Site,oral cavity
1004,1,1,Research lab p16,p16 unknown
1004,1,1,Radiation Dosage,52.2
1004,1,1,2nd Failure Type,no known failure
1005,1,1,Research lab p16,p16 unknown
1005,1,1,Clinical lab p16,p16 unkown
1005,1,1,2nd Failure Type,no known failure
1005,1,1,Treatment Modality,Sx & RT
1005,1,1,Nodal Stage,N2
1005,1,1,Radiation Dosage,66
1005,1,1,1st Failure Type,no known failure
1005,1,1,Occurrence #,1st primary
1005,1,1,Overall Stage,IVa
1005,1,1,Research lab HPV,HPV unknown
1005,1,1,Metastasis,M0
1005,1,1,Tumor Stage,T2
1005,1,1,Tumor Site,oral cavity
1006,1,1,Tumor Site,oral cavity
1006,1,1,Overall Stage,II
1006,1,1,1st Failure Type,locoregional
1006,1,1,Metastasis,M0
1006,1,1,Tumor Stage,T2
1006,1,1,Radiation Dosage,unknown
1006,1,1,Clinical lab p16,p16 unkown
1006,1,1,Research lab HPV,HPV unknown
1006,1,1,Nodal Stage,N0
1006,1,1,1st Failure Site,oral cavity
1006,1,1,2nd Failure Type,no known failure
1006,1,1,1st Failure Treatment Modality,Sx
1006,1,1,Occurrence #,recurrence
1006,1,1,Treatment Modality,Sx & RT
1006,1,1,Research lab p16,p16 unknown
1007,1,1,Tumor Stage,T4a
1007,1,1,Occurrence #,1st primary
1007,1,1,Clinical lab p16,p16 unkown
1007,1,1,Nodal Stage,N1
1007,1,1,2nd Failure Type,no known failure
1007,1,1,Tumor Site,oral cavity
1007,1,1,1st Failure Type,no known failure
1007,1,1,Treatment Modality,Sx & CTX
1007,1,1,Overall Stage,IVa
1007,1,1,Initial Chemotherapy Agent,unknown
1007,1,1,Research lab HPV,HPV unknown
1007,1,1,Research lab p16,p16 unknown
1007,1,1,Metastasis,M0
1008,1,1,2nd Failure Type,no known failure
1008,1,1,Nodal Stage,N0
1008,1,1,Clinical lab p16,p16 unkown
1008,1,1,1st Failure Type,no known failure
1008,1,1,Metastasis,M0
1008,1,1,Research lab p16,p16 unknown
1008,1,1,Overall Stage,I
1008,1,1,Occurrence #,1st primary
1008,1,1,Treatment Modality,Sx
1008,1,1,Tumor Stage,T1
1008,1,1,Research lab HPV,HPV unknown
1008,1,1,Tumor Site,oral cavity
1009,1,1,Overall Stage,II
1009,1,1,Metastasis,M0
1009,1,1,1st Failure Type,no known failure
1009,1,1,Radiation Dosage,60
1009,1,1,Research lab p16,p16 unknown
1009,1,1,Treatment Modality,Sx & RT
1009,1,1,Tumor Site,oral cavity
1009,1,1,Tumor Stage,T2
1009,1,1,Clinical lab p16,p16 unkown
1009,1,1,Occurrence #,1st primary
1009,1,1,2nd Failure Type,no known failure
1009,1,1,Nodal Stage,N0
1009,1,1,Research lab HPV,HPV unknown
1010,1,1,Occurrence #,1st primary
1010,1,1,Research lab p16,p16 unknown
1010,1,1,Metastasis,M0
1010,1,1,2nd Failure Type,no known failure
1010,1,1,Research lab HPV,HPV unknown
1010,1,1,Treatment Modality,Sx
1010,1,1,Overall Stage,IVa
1010,1,1,Tumor Stage,T4a
1010,1,1,Clinical lab p16,p16 unkown
1010,1,1,Nodal Stage,N0
1010,1,1,Tumor Site,oral cavity
1010,1,1,1st Failure Type,no known failure
1011,1,1,Overall Stage,I
1011,1,1,Treatment Modality,Sx & CTX-RT
1011,1,1,Occurrence #,other primary
1011,1,1,Clinical lab p16,p16 unkown
1011,1,1,2nd Failure Type,no known failure
1011,1,1,Tumor Stage,T1
1011,1,1,Nodal Stage,N0
1011,1,1,Research lab HPV,HPV unknown
1011,1,1,Metastasis,M0
1011,1,1,Research lab p16,p16 unknown
1011,1,1,1st Failure Type,no known failure
1011,1,1,Initial Chemotherapy Agent,carbo/PTX
1011,1,1,Radiation Dosage,60
1011,1,1,Tumor Site,oral cavity
1012,1,1,Treatment Modality,Sx & CTX-RT
1012,1,1,Clinical lab p16,p16 unkown
1012,1,1,Metastasis,M0
1012,1,1,Tumor Site,oral cavity
1012,1,1,Initial Chemotherapy Agent,carbo/PTX
1012,1,1,Radiation Dosage,63
1012,1,1,Overall Stage,IVa
1012,1,1,2nd Failure Type,no known failure
1012,1,1,1st Failure Type,no known failure
1012,1,1,Research lab HPV,HPV unknown
1012,1,1,Nodal Stage,N2
1012,1,1,Occurrence #,1st primary
1012,1,1,Research lab p16,p16 unknown
1012,1,1,Tumor Stage,T4a
1013,1,1,Tumor Site,oral cavity
1013,1,1,Research lab HPV,HPV unknown
1013,1,1,Research lab p16,p16 unknown
1013,1,1,Treatment Modality,RT
1013,1,1,2nd Failure Type,no known failure
1013,1,1,1st Failure Type,no known failure
1013,1,1,Occurrence #,1st primary
1013,1,1,Overall Stage,II
1013,1,1,Radiation Dosage,63
1013,1,1,Metastasis,M0
1013,1,1,Nodal Stage,N0
1013,1,1,Tumor Stage,T2
1013,1,1,Clinical lab p16,p16 unkown
1014,1,1,2nd Failure Type,no known failure
1014,1,1,1st Failure Type,no known failure
1014,1,1,Occurrence #,1st primary
1014,1,1,Overall Stage,II
1014,1,1,Tumor Stage,T2
1014,1,1,Tumor Site,oral cavity
1014,1,1,Metastasis,M0
1014,1,1,Nodal Stage,N0
1014,1,1,Treatment Modality,Sx
1014,1,1,Clinical lab p16,p16 unkown
1014,1,1,Research lab p16,p16 unknown
1014,1,1,Research lab HPV,HPV unknown
1015,1,1,Tumor Site,oral cavity
1015,1,1,Occurrence #,1st primary
1015,1,1,Tumor Stage,T2
1015,1,1,Clinical lab p16,p16 unkown
1015,1,1,Metastasis,M0
1015,1,1,Research lab p16,p16 unknown
1015,1,1,1st Failure Type,no known failure
1015,1,1,Research lab HPV,HPV unknown
1015,1,1,Nodal Stage,N0
1015,1,1,Radiation Dosage,60
1015,1,1,Initial Chemotherapy Agent,cetux
1015,1,1,Treatment Modality,Sx & CTX-RT
1015,1,1,2nd Failure Type,no known failure
1015,1,1,Overall Stage,II
1016,1,1,Research lab HPV,HPV unknown
1016,1,1,Initial Chemotherapy Agent,unknown
1016,1,1,Overall Stage,IVa
1016,1,1,Radiation Dosage,unknown
1016,1,1,Metastasis,M0
1016,1,1,Occurrence #,recurrence
1016,1,1,Nodal Stage,N2
1016,1,1,Treatment Modality,Sx & CTX-RT
1016,1,1,2nd Failure Type,no known failure
1016,1,1,Tumor Stage,T2
1016,1,1,1st Failure Type,locoregional and distant
1016,1,1,Research lab p16,p16 unknown
1016,1,1,Tumor Site,oral cavity
1016,1,1,Clinical lab p16,p16 unkown
1017,1,1,Nodal Stage,N0
1017,1,1,Tumor Site,oral cavity
1017,1,1,Research lab p16,p16 unknown
1017,1,1,Clinical lab p16,p16 unkown
1017,1,1,Tumor Stage,T2
1017,1,1,Occurrence #,1st primary
1017,1,1,Treatment Modality,Sx
1017,1,1,Metastasis,M0
1017,1,1,1st Failure Type,no known failure
1017,1,1,Overall Stage,II
1017,1,1,Research lab HPV,HPV unknown
1017,1,1,2nd Failure Type,no known failure
1018,1,1,Treatment Modality,Sx
1018,1,1,Research lab p16,p16 unknown
1018,1,1,Occurrence #,1st primary
1018,1,1,Research lab HPV,HPV unknown
1018,1,1,Clinical lab p16,p16 unkown
1018,1,1,Nodal Stage,N0
1018,1,1,2nd Failure Type,no known failure
1018,1,1,Tumor Site,oral cavity
1018,1,1,Tumor Stage,T1
1018,1,1,Metastasis,M0
1018,1,1,Overall Stage,I
1018,1,1,1st Failure Type,no known failure
1019,1,1,1st Failure Type,no known failure
1019,1,1,2nd Failure Type,no known failure
1019,1,1,Treatment Modality,Sx
1019,1,1,Overall Stage,II
1019,1,1,Research lab HPV,HPV unknown
1019,1,1,Nodal Stage,N0
1019,1,1,Clinical lab p16,p16 unkown
1019,1,1,Tumor Stage,T2
1019,1,1,Research lab p16,p16 unknown
1019,1,1,Occurrence #,1st primary
1019,1,1,Metastasis,M0
1019,1,1,Tumor Site,oral cavity
1020,1,1,Nodal Stage,N2
1020,1,1,Treatment Modality,Sx
1020,1,1,Metastasis,M0
1020,1,1,Research lab HPV,HPV unknown
1020,1,1,Tumor Site,oral cavity
1020,1,1,Clinical lab p16,p16 unkown
1020,1,1,2nd Failure Type,no known failure
1020,1,1,Overall Stage,IVa
1020,1,1,Occurrence #,1st primary
1020,1,1,Tumor Stage,T2
1020,1,1,1st Failure Type,no known failure
1020,1,1,Research lab p16,p16 unknown
1021,1,1,Tumor Site,oral cavity
1021,1,1,2nd Failure Type,no known failure
1021,1,1,Occurrence #,1st primary
1021,1,1,Treatment Modality,Sx
1021,1,1,Research lab HPV,HPV unknown
1021,1,1,Research lab p16,p16 unknown
1021,1,1,Nodal Stage,N0
1021,1,1,Clinical lab p16,p16 unkown
1021,1,1,Tumor Stage,T1
1021,1,1,Metastasis,M0
1021,1,1,1st Failure Type,no known failure
1021,1,1,Overall Stage,I
1022,1,1,Clinical lab p16,p16 unkown
1022,1,1,Tumor Stage,T3
1022,1,1,Metastasis,M0
1022,1,1,Nodal Stage,N1
1022,1,1,Research lab p16,p16 unknown
1022,1,1,Research lab HPV,HPV unknown
1022,1,1,Tumor Site,oral cavity
1022,1,1,Overall Stage,III
1022,1,1,2nd Failure Type,no known failure
1022,1,1,1st Failure Type,no known failure
1022,1,1,Treatment Modality,Sx
1022,1,1,Occurrence #,1st primary
1023,1,1,Treatment Modality,Sx
1023,1,1,Overall Stage,I
1023,1,1,Clinical lab p16,p16 unkown
1023,1,1,2nd Failure Type,no known failure
1023,1,1,Tumor Site,oral cavity
1023,1,1,Research lab HPV,HPV unknown
1023,1,1,Research lab p16,p16 unknown
1023,1,1,Nodal Stage,N0
1023,1,1,1st Failure Type,no known failure
1023,1,1,Tumor Stage,T1
1023,1,1,Metastasis,M0
1023,1,1,Occurrence #,1st primary
1024,1,1,Occurrence #,1st primary
1024,1,1,Overall Stage,I
1024,1,1,1st Failure Type,no known failure
1024,1,1,Research lab p16,p16 unknown
1024,1,1,Research lab HPV,HPV unknown
1024,1,1,Tumor Stage,T1
1024,1,1,Metastasis,M0
1024,1,1,Tumor Site,oral cavity
1024,1,1,Nodal Stage,N0
1024,1,1,2nd Failure Type,no known failure
1024,1,1,Treatment Modality,Sx
1024,1,1,Clinical lab p16,p16 unkown
1025,1,1,2nd Failure Type,no known failure
1025,1,1,1st Failure Type,no known failure
1025,1,1,Research lab HPV,HPV unknown
1025,1,1,Occurrence #,1st primary
1025,1,1,Overall Stage,IVa
1025,1,1,Treatment Modality,Sx
1025,1,1,Metastasis,M0
1025,1,1,Tumor Site,oral cavity
1025,1,1,Tumor Stage,T4a
1025,1,1,Research lab p16,p16 unknown
1025,1,1,Clinical lab p16,p16 unkown
1025,1,1,Nodal Stage,N2
1026,1,1,Occurrence #,1st primary
1026,1,1,Tumor Stage,T4a
1026,1,1,Nodal Stage,N2
1026,1,1,Metastasis,M0
1026,1,1,2nd Failure Type,no known failure
1026,1,1,Overall Stage,IVa
1026,1,1,1st Failure Type,no known failure
1026,1,1,Research lab HPV,HPV unknown
1026,1,1,Tumor Site,oral cavity
1026,1,1,Research lab p16,p16 unknown
1026,1,1,Treatment Modality,Sx
1026,1,1,Clinical lab p16,p16 unkown
1027,1,1,Tumor Site,oral cavity
1027,1,1,Treatment Modality,CTX-RT
1027,1,1,1st Failure Type,locoregional
1027,1,1,Occurrence #,1st primary
1027,1,1,Clinical lab p16,p16 unkown
1027,1,1,Overall Stage,IVa
1027,1,1,1st Failure Site,oral cavity
1027,1,1,Initial Chemotherapy Agent,PTX
1027,1,1,Radiation Dosage,70.2
1027,1,1,Research lab HPV,HPV unknown
1027,1,1,Research lab p16,p16 unknown
1027,1,1,Nodal Stage,N2
1027,1,1,Metastasis,M0
1027,1,1,Tumor Stage,T4a
1027,1,1,2nd Failure Type,no known failure
1028,1,1,Clinical lab p16,p16 unkown
1028,1,1,Tumor Stage,T2
1028,1,1,Overall Stage,II
1028,1,1,Metastasis,M0
1028,1,1,2nd Failure Type,no known failure
1028,1,1,Occurrence #,1st primary
1028,1,1,Tumor Site,oral cavity
1028,1,1,1st Failure Type,no known failure
1028,1,1,Research lab p16,p16 unknown
1028,1,1,Nodal Stage,N0
1028,1,1,Research lab HPV,HPV unknown
1028,1,1,Treatment Modality,Sx
1029,1,1,Metastasis,M0
1029,1,1,Research lab p16,p16 unknown
1029,1,1,Overall Stage,II
1029,1,1,Treatment Modality,Sx
1029,1,1,Research lab HPV,HPV unknown
1029,1,1,2nd Failure Type,no known failure
1029,1,1,Tumor Stage,T2
1029,1,1,Nodal Stage,N0
1029,1,1,Clinical lab p16,p16 unkown
1029,1,1,Tumor Site,oral cavity
1029,1,1,Occurrence #,1st primary
1029,1,1,1st Failure Type,no known failure
1030,1,1,1st Failure Type,no known failure
1030,1,1,Clinical lab p16,p16 unkown
1030,1,1,Occurrence #,1st primary
1030,1,1,Tumor Stage,T1
1030,1,1,Metastasis,M0
1030,1,1,Research lab HPV,HPV unknown
1030,1,1,Research lab p16,p16 unknown
1030,1,1,Nodal Stage,N0
1030,1,1,Overall Stage,I
1030,1,1,Treatment Modality,Sx
1030,1,1,2nd Failure Type,no known failure
1030,1,1,Tumor Site,oral cavity
1031,1,1,Overall Stage,IVa
1031,1,1,Clinical lab p16,p16 unkown
1031,1,1,Treatment Modality,Sx
1031,1,1,Research lab p16,p16 unknown
1031,1,1,Research lab HPV,HPV unknown
1031,1,1,Nodal Stage,N2
1031,1,1,Occurrence #,recurrence
1031,1,1,1st Failure Type,locoregional
1031,1,1,2nd Failure Type,no known failure
1031,1,1,Tumor Site,oral cavity
1031,1,1,Metastasis,M0
1031,1,1,Tumor Stage,T4a
1032,1,1,Metastasis,M0
1032,1,1,Clinical lab p16,p16 unkown
1032,1,1,2nd Failure Type,no known failure
1032,1,1,Research lab p16,p16 unknown
1032,1,1,Tumor Stage,T1
1032,1,1,Nodal Stage,N0
1032,1,1,Treatment Modality,Sx
1032,1,1,Research lab HPV,HPV unknown
1032,1,1,Occurrence #,1st primary
1032,1,1,1st Failure Type,no known failure
1032,1,1,Overall Stage,I
1032,1,1,Tumor Site,oral cavity
1033,1,1,1st Failure Type,no known failure
1033,1,1,Occurrence #,1st primary
1033,1,1,Tumor Site,oral cavity
1033,1,1,Radiation Dosage,63
1033,1,1,Metastasis,M0
1033,1,1,2nd Failure Type,no known failure
1033,1,1,Treatment Modality,Sx & RT
1033,1,1,Overall Stage,IVa
1033,1,1,Clinical lab p16,p16 unkown
1033,1,1,Research lab p16,p16 unknown
1033,1,1,Tumor Stage,T4a
1033,1,1,Nodal Stage,N2
1033,1,1,Research lab HPV,HPV unknown
1034,1,1,Research lab HPV,HPV unknown
1034,1,1,Radiation Dosage,unknown
1034,1,1,Nodal Stage,N1
1034,1,1,Occurrence #,1st primary
1034,1,1,Treatment Modality,Sx & RT
1034,1,1,1st Failure Type,locoregional
1034,1,1,2nd Failure Type,no known failure
1034,1,1,Metastasis,M0
1034,1,1,Tumor Site,oral cavity
1034,1,1,Overall Stage,IVa
1034,1,1,Tumor Stage,T4a
1034,1,1,Research lab p16,p16 unknown
1034,1,1,Clinical lab p16,p16 unkown
1035,1,1,Research lab p16,p16 unknown
1035,1,1,2nd Failure Type,no known failure
1035,1,1,Occurrence #,other primary
1035,1,1,Tumor Site,oral cavity
1035,1,1,Nodal Stage,N0
1035,1,1,Clinical lab p16,p16 unkown
1035,1,1,Treatment Modality,Unknown
1035,1,1,1st Failure Type,no known failure
1035,1,1,Tumor Stage,T1
1035,1,1,Research lab HPV,HPV unknown
1035,1,1,Metastasis,M0
1035,1,1,Overall Stage,I
1036,1,1,Tumor Stage,T4a
1036,1,1,Occurrence #,1st primary
1036,1,1,Research lab p16,p16 unknown
1036,1,1,Tumor Site,oral cavity
1036,1,1,Treatment Modality,Sx
1036,1,1,Overall Stage,IVa
1036,1,1,Metastasis,M0
1036,1,1,1st Failure Type,no known failure
1036,1,1,Clinical lab p16,p16 unkown
1036,1,1,2nd Failure Type,no known failure
1036,1,1,Research lab HPV,HPV unknown
1036,1,1,Nodal Stage,N2
1037,1,1,Tumor Stage,T4a
1037,1,1,1st Failure Type,no known failure
1037,1,1,Metastasis,M0
1037,1,1,Research lab HPV,HPV unknown
1037,1,1,2nd Failure Type,no known failure
1037,1,1,Nodal Stage,N1
1037,1,1,Treatment Modality,Unknown
1037,1,1,Tumor Site,oral cavity
1037,1,1,Occurrence #,1st primary
1037,1,1,Research lab p16,p16 unknown
1037,1,1,Clinical lab p16,p16 unkown
1037,1,1,Overall Stage,IVa
1038,1,1,Tumor Site,oral cavity
1038,1,1,Nodal Stage,N0
1038,1,1,Overall Stage,IVa
1038,1,1,Metastasis,M0
1038,1,1,Tumor Stage,T4a
1038,1,1,Research lab p16,p16 unknown
1038,1,1,2nd Failure Type,no known failure
1038,1,1,Clinical lab p16,p16 unkown
1038,1,1,Occurrence #,1st primary
1038,1,1,Treatment Modality,Sx
1038,1,1,1st Failure Type,no known failure
1038,1,1,Research lab HPV,HPV unknown
1039,1,1,1st Failure Type,no known failure
1039,1,1,Metastasis,M0
1039,1,1,Research lab HPV,HPV unknown
1039,1,1,Occurrence #,1st primary
1039,1,1,Nodal Stage,N0
1039,1,1,Research lab p16,p16 unknown
1039,1,1,Overall Stage,I
1039,1,1,Clinical lab p16,p16 unkown
1039,1,1,Treatment Modality,Sx
1039,1,1,Tumor Site,oral cavity
1039,1,1,Tumor Stage,T1
1039,1,1,2nd Failure Type,no known failure
1040,1,1,Research lab HPV,HPV unknown
1040,1,1,Occurrence #,1st primary
1040,1,1,Nodal Stage,N0
1040,1,1,2nd Failure Type,no known failure
1040,1,1,Clinical lab p16,p16 unkown
1040,1,1,Metastasis,M0
1040,1,1,Overall Stage,I
1040,1,1,Tumor Site,oral cavity
1040,1,1,1st Failure Type,no known failure
1040,1,1,Tumor Stage,T1
1040,1,1,Treatment Modality,Sx
1040,1,1,Research lab p16,p16 unknown
1041,1,1,Occurrence #,1st primary
1041,1,1,Metastasis,M0
1041,1,1,2nd Failure Type,no known failure
1041,1,1,1st Failure Type,no known failure
1041,1,1,Overall Stage,I
1041,1,1,Research lab p16,p16 unknown
1041,1,1,Tumor Stage,T1
1041,1,1,Tumor Site,oral cavity
1041,1,1,Nodal Stage,N0
1041,1,1,Clinical lab p16,p16 unkown
1041,1,1,Research lab HPV,HPV unknown
1041,1,1,Treatment Modality,Sx
1042,1,1,Nodal Stage,N0
1042,1,1,Tumor Site,oral cavity
1042,1,1,Research lab HPV,HPV unknown
1042,1,1,Research lab p16,p16 unknown
1042,1,1,1st Failure Type,no known failure
1042,1,1,Metastasis,M0
1042,1,1,Clinical lab p16,p16 unkown
1042,1,1,Treatment Modality,Sx
1042,1,1,Occurrence #,recurrence
1042,1,1,Overall Stage,IVb
1042,1,1,2nd Failure Type,no known failure
1042,1,1,Tumor Stage,T4b
1043,1,1,2nd Failure Type,no known failure
1043,1,1,Overall Stage,IVa
1043,1,1,Tumor Stage,T4a
1043,1,1,Research lab HPV,HPV unknown
1043,1,1,Treatment Modality,Sx & RT
1043,1,1,Clinical lab p16,p16 unkown
1043,1,1,1st Failure Type,no known failure
1043,1,1,Radiation Dosage,59.4
1043,1,1,Metastasis,M0
1043,1,1,Tumor Site,oral cavity
1043,1,1,Research lab p16,p16 unknown
1043,1,1,Nodal Stage,N0
1043,1,1,Occurrence #,1st primary
1044,1,1,2nd Failure Type,no known failure
1044,1,1,Occurrence #,1st primary
1044,1,1,Tumor Stage,T2
1044,1,1,Metastasis,M0
1044,1,1,Research lab HPV,HPV unknown
1044,1,1,Overall Stage,II
1044,1,1,Clinical lab p16,p16 unkown
1044,1,1,Tumor Site,oral cavity
1044,1,1,1st Failure Type,no known failure
1044,1,1,Nodal Stage,N0
1044,1,1,Research lab p16,p16 unknown
1044,1,1,Treatment Modality,Sx
1045,1,1,1st Failure Type,no known failure
1045,1,1,Treatment Modality,Sx
1045,1,1,Tumor Stage,T4a
1045,1,1,Clinical lab p16,p16 unkown
1045,1,1,Occurrence #,recurrence
1045,1,1,2nd Failure Type,no known failure
1045,1,1,Research lab p16,p16 unknown
1045,1,1,Research lab HPV,HPV unknown
1045,1,1,Metastasis,M0
1045,1,1,Tumor Site,oral cavity
1045,1,1,Overall Stage,IVa
1045,1,1,Nodal Stage,N0
1046,1,1,1st Failure Type,no known failure
1046,1,1,Overall Stage,IVa
1046,1,1,Tumor Stage,T4a
1046,1,1,Occurrence #,1st primary
1046,1,1,Treatment Modality,CTX-RT
1046,1,1,Nodal Stage,N2
1046,1,1,Radiation Dosage,70.2
1046,1,1,Initial Chemotherapy Agent,unknown
1046,1,1,Research lab p16,p16 unknown
1046,1,1,2nd Failure Type,no known failure
1046,1,1,Tumor Site,oral cavity
1046,1,1,Clinical lab p16,p16 unkown
1046,1,1,Metastasis,M0
1046,1,1,Research lab HPV,HPV unknown
1047,1,1,2nd Failure Type,no known failure
1047,1,1,Overall Stage,I
1047,1,1,Research lab p16,p16 unknown
1047,1,1,Nodal Stage,N0
1047,1,1,Treatment Modality,Unknown
1047,1,1,Tumor Stage,T1
1047,1,1,Clinical lab p16,p16 unkown
1047,1,1,Tumor Site,oral cavity
1047,1,1,Occurrence #,recurrence
1047,1,1,Research lab HPV,HPV unknown
1047,1,1,1st Failure Type,no known failure
1047,1,1,Metastasis,M0
1048,1,1,Research lab HPV,HPV unknown
1048,1,1,1st Failure Type,no known failure
1048,1,1,Metastasis,M0
1048,1,1,Nodal Stage,N0
1048,1,1,Occurrence #,1st primary
1048,1,1,Tumor Site,oral cavity
1048,1,1,Research lab p16,p16 unknown
1048,1,1,2nd Failure Type,no known failure
1048,1,1,Treatment Modality,Sx
1048,1,1,Tumor Stage,T2
1048,1,1,Clinical lab p16,p16 unkown
1048,1,1,Overall Stage,II
1049,1,1,Clinical lab p16,p16 unkown
1049,1,1,Nodal Stage,N0
1049,1,1,Overall Stage,I
1049,1,1,Tumor Site,oral cavity
1049,1,1,Treatment Modality,Sx
1049,1,1,Research lab p16,p16 unknown
1049,1,1,1st Failure Type,no known failure
1049,1,1,2nd Failure Type,no known failure
1049,1,1,Research lab HPV,HPV unknown
1049,1,1,Tumor Stage,T1
1049,1,1,Occurrence #,1st primary
1049,1,1,Metastasis,M0
1050,1,1,Treatment Modality,Sx
1050,1,1,Tumor Stage,T1
1050,1,1,Research lab p16,p16 unknown
1050,1,1,2nd Failure Type,no known failure
1050,1,1,Metastasis,M0
1050,1,1,Occurrence #,1st primary
1050,1,1,Overall Stage,I
1050,1,1,Tumor Site,oral cavity
1050,1,1,Clinical lab p16,p16 unkown
1050,1,1,Nodal Stage,N0
1050,1,1,1st Failure Type,no known failure
1050,1,1,Research lab HPV,HPV unknown
1052,1,1,1st Failure Treatment Modality,Sx
1052,1,1,Overall Stage,I
1052,1,1,2nd Failure Type,no known failure
1052,1,1,Metastasis,M0
1052,1,1,Tumor Site,oral cavity
1052,1,1,1st Failure Type,locoregional
1052,1,1,Occurrence #,other primary
1052,1,1,Clinical lab p16,p16 unkown
1052,1,1,Research lab HPV,HPV unknown
1052,1,1,Nodal Stage,N0
1052,1,1,Tumor Stage,T1
1052,1,1,1st Failure Site,oral cavity
1052,1,1,Treatment Modality,Sx
1052,1,1,Research lab p16,p16 unknown
1053,1,1,Research lab p16,p16 unknown
1053,1,1,Overall Stage,IVa
1053,1,1,Treatment Modality,Sx
1053,1,1,Tumor Stage,T4a
1053,1,1,1st Failure Treatment Modality,Sx
1053,1,1,Tumor Site,oral cavity
1053,1,1,Clinical lab p16,p16 unkown
1053,1,1,Research lab HPV,HPV unknown
1053,1,1,Metastasis,Unknown
1053,1,1,Occurrence #,1st primary
1053,1,1,1st Failure Site,oral cavity
1053,1,1,2nd Failure Type,no known failure
1053,1,1,1st Failure Type,locoregional
1053,1,1,Nodal Stage,Unknown
1054,1,1,Clinical lab p16,p16 unkown
1054,1,1,Tumor Stage,T2
1054,1,1,Occurrence #,recurrence
1054,1,1,Overall Stage,II
1054,1,1,Nodal Stage,N0
1054,1,1,Treatment Modality,Sx
1054,1,1,2nd Failure Type,no known failure
1054,1,1,Metastasis,M0
1054,1,1,1st Failure Type,locoregional
1054,1,1,1st Failure Site,oral cavity
1054,1,1,Research lab p16,p16 unknown
1054,1,1,1st Failure Treatment Modality,Sx
1054,1,1,Research lab HPV,HPV unknown
1054,1,1,Tumor Site,oral cavity
1055,1,1,Treatment Modality,Sx
1055,1,1,Nodal Stage,N0
1055,1,1,1st Failure Type,no known failure
1055,1,1,Clinical lab p16,p16 unkown
1055,1,1,Research lab p16,p16 unknown
1055,1,1,Tumor Stage,T1
1055,1,1,Occurrence #,1st primary
1055,1,1,Metastasis,M0
1055,1,1,2nd Failure Type,no known failure
1055,1,1,Overall Stage,I
1055,1,1,Research lab HPV,HPV unknown
1055,1,1,Tumor Site,oral cavity
1056,1,1,Clinical lab p16,p16 unkown
1056,1,1,1st Failure Radiation Dosage,unknown
1056,1,1,Treatment Modality,Sx
1056,1,1,Research lab p16,p16 unknown
1056,1,1,1st Failure Treatment Modality,Sx & RT
1056,1,1,Tumor Stage,T1
1056,1,1,Occurrence #,1st primary
1056,1,1,Overall Stage,I
1056,1,1,2nd Failure Type,no known failure
1056,1,1,Tumor Site,oral cavity
1056,1,1,1st Failure Site,oral cavity
1056,1,1,Nodal Stage,N0
1056,1,1,1st Failure Type,locoregional
1056,1,1,Research lab HPV,HPV unknown
1056,1,1,Metastasis,M0
1057,1,1,Clinical lab p16,p16 unkown
1057,1,1,Occurrence #,1st primary
1057,1,1,Treatment Modality,Sx
1057,1,1,Metastasis,M0
1057,1,1,Tumor Site,oral cavity
1057,1,1,Nodal Stage,N0
1057,1,1,Tumor Stage,T1
1057,1,1,2nd Failure Type,no known failure
1057,1,1,Research lab HPV,HPV unknown
1057,1,1,1st Failure Type,no known failure
1057,1,1,Overall Stage,I
1057,1,1,Research lab p16,p16 unknown
1058,1,1,Tumor Stage,T3
1058,1,1,Initial Chemotherapy Agent,cis
1058,1,1,Occurrence #,1st primary
1058,1,1,Treatment Modality,Sx & CTX-RT
1058,1,1,Clinical lab p16,p16 unkown
1058,1,1,2nd Failure Type,no known failure
1058,1,1,Radiation Dosage,63
1058,1,1,Overall Stage,III
1058,1,1,Research lab p16,p16 unknown
1058,1,1,Research lab HPV,HPV unknown
1058,1,1,Tumor Site,oral cavity
1058,1,1,Nodal Stage,N1
1058,1,1,1st Failure Type,locoregional
1058,1,1,Metastasis,M0
1059,1,1,Overall Stage,I
1059,1,1,2nd Failure Type,no known failure
1059,1,1,Research lab p16,p16 unknown
1059,1,1,Tumor Stage,T1
1059,1,1,Clinical lab p16,p16 unkown
1059,1,1,Nodal Stage,N0
1059,1,1,Tumor Site,oral cavity
1059,1,1,1st Failure Type,no known failure
1059,1,1,Treatment Modality,Sx
1059,1,1,Metastasis,M0
1059,1,1,Occurrence #,1st primary
1059,1,1,Research lab HPV,HPV unknown
1060,1,1,Tumor Stage,T1
1060,1,1,Research lab HPV,HPV unknown
1060,1,1,Metastasis,M0
1060,1,1,Clinical lab p16,p16 unkown
1060,1,1,2nd Failure Type,no known failure
1060,1,1,Treatment Modality,Sx
1060,1,1,Occurrence #,1st primary
1060,1,1,Research lab p16,p16 unknown
1060,1,1,Tumor Site,oral cavity
1060,1,1,Nodal Stage,N0
1060,1,1,Overall Stage,I
1060,1,1,1st Failure Type,no known failure
1061,1,1,1st Failure Type,no known failure
1061,1,1,Clinical lab p16,p16 unkown
1061,1,1,2nd Failure Type,no known failure
1061,1,1,Treatment Modality,Sx
1061,1,1,Nodal Stage,N0
1061,1,1,Occurrence #,1st primary
1061,1,1,Tumor Site,oral cavity
1061,1,1,Research lab p16,p16 unknown
1061,1,1,Overall Stage,II
1061,1,1,Metastasis,M0
1061,1,1,Tumor Stage,T2
1061,1,1,Research lab HPV,HPV unknown
1062,1,1,Occurrence #,1st primary
1062,1,1,Clinical lab p16,p16 unkown
1062,1,1,Treatment Modality,Sx
1062,1,1,Research lab HPV,HPV unknown
1062,1,1,Tumor Site,oral cavity
1062,1,1,Nodal Stage,N0
1062,1,1,1st Failure Type,no known failure
1062,1,1,Tumor Stage,T1
1062,1,1,Overall Stage,I
1062,1,1,Research lab p16,p16 unknown
1062,1,1,2nd Failure Type,no known failure
1062,1,1,Metastasis,M0
1063,1,1,Metastasis,M0
1063,1,1,Nodal Stage,N0
1063,1,1,Overall Stage,IVa
1063,1,1,Tumor Stage,T4a
1063,1,1,Tumor Site,oral cavity
1063,1,1,1st Failure Type,no known failure
1063,1,1,Treatment Modality,Sx
1063,1,1,Occurrence #,1st primary
1063,1,1,Research lab HPV,HPV unknown
1063,1,1,Clinical lab p16,p16 unkown
1063,1,1,2nd Failure Type,no known failure
1063,1,1,Research lab p16,p16 unknown
1064,1,1,Research lab p16,p16 unknown
1064,1,1,1st Failure Type,no known failure
1064,1,1,Overall Stage,I
1064,1,1,Clinical lab p16,p16 unkown
1064,1,1,Occurrence #,1st primary
1064,1,1,Metastasis,M0
1064,1,1,Tumor Site,oral cavity
1064,1,1,Treatment Modality,Sx
1064,1,1,Nodal Stage,N0
1064,1,1,Tumor Stage,T1
1064,1,1,Research lab HPV,HPV unknown
1064,1,1,2nd Failure Type,no known failure
1065,1,1,2nd Failure Type,no known failure
1065,1,1,Metastasis,M0
1065,1,1,Research lab p16,p16 unknown
1065,1,1,Overall Stage,IVa
1065,1,1,Radiation Dosage,unknown
1065,1,1,Tumor Site,oral cavity
1065,1,1,1st Failure Type,no known failure
1065,1,1,Tumor Stage,T3
1065,1,1,Research lab HPV,HPV unknown
1065,1,1,Treatment Modality,Sx & RT
1065,1,1,Occurrence #,1st primary
1065,1,1,Clinical lab p16,p16 unkown
1065,1,1,Nodal Stage,N2
1066,1,1,Tumor Stage,T2
1066,1,1,1st Failure Type,no known failure
1066,1,1,Nodal Stage,N0
1066,1,1,Metastasis,M0
1066,1,1,Treatment Modality,Sx
1066,1,1,Research lab p16,p16 unknown
1066,1,1,Research lab HPV,HPV unknown
1066,1,1,Occurrence #,1st primary
1066,1,1,Clinical lab p16,p16 unkown
1066,1,1,Overall Stage,II
1066,1,1,Tumor Site,oral cavity
1066,1,1,2nd Failure Type,no known failure
1067,1,1,Research lab p16,p16 unknown
1067,1,1,Occurrence #,1st primary
1067,1,1,Nodal Stage,N0
1067,1,1,Overall Stage,I
1067,1,1,Treatment Modality,RT
1067,1,1,Radiation Dosage,66
1067,1,1,Tumor Site,oral cavity
1067,1,1,2nd Failure Type,no known failure
1067,1,1,Research lab HPV,HPV unknown
1067,1,1,Metastasis,M0
1067,1,1,1st Failure Type,no known failure
1067,1,1,Tumor Stage,T1
1067,1,1,Clinical lab p16,p16 unkown
1068,1,1,Occurrence #,1st primary
1068,1,1,Research lab HPV,HPV unknown
1068,1,1,Tumor Site,oral cavity
1068,1,1,Research lab p16,p16 unknown
1068,1,1,Overall Stage,II
1068,1,1,1st Failure Type,no known failure
1068,1,1,Nodal Stage,N0
1068,1,1,Radiation Dosage,58
1068,1,1,Treatment Modality,Sx & RT
1068,1,1,Tumor Stage,T2
1068,1,1,2nd Failure Type,no known failure
1068,1,1,Metastasis,M0
1068,1,1,Clinical lab p16,p16 unkown
1071,1,1,2nd Failure Type,no known failure
1071,1,1,Tumor Site,oral cavity
1071,1,1,1st Failure Treatment Modality,Sx
1071,1,1,Occurrence #,1st primary
1071,1,1,Nodal Stage,N0
1071,1,1,Research lab p16,p16 unknown
1071,1,1,Overall Stage,I
1071,1,1,Clinical lab p16,p16 unkown
1071,1,1,Metastasis,M0
1071,1,1,Tumor Stage,T1
1071,1,1,1st Failure Site,oral cavity
1071,1,1,Treatment Modality,Sx
1071,1,1,1st Failure Type,locoregional
1071,1,1,Research lab HPV,HPV unknown
1072,1,1,Metastasis,M0
1072,1,1,Clinical lab p16,p16 negative
1072,1,1,Radiation Dosage,60
1072,1,1,2nd Failure Type,no known failure
1072,1,1,1st Failure Type,distant
1072,1,1,Nodal Stage,N0
1072,1,1,Overall Stage,II
1072,1,1,Research lab HPV,HPV negative
1072,1,1,Treatment Modality,Sx & RT
1072,1,1,Tumor Site,oral cavity
1072,1,1,Occurrence #,1st primary
1072,1,1,Tumor Stage,T2
1072,1,1,Research lab p16,p16 unknown
1073,1,1,Clinical lab p16,p16 unkown
1073,1,1,Tumor Site,oral cavity
1073,1,1,2nd Failure Type,no known failure
1073,1,1,Tumor Stage,T2
1073,1,1,Research lab HPV,HPV unknown
1073,1,1,Overall Stage,II
1073,1,1,Nodal Stage,N0
1073,1,1,Treatment Modality,Sx
1073,1,1,Occurrence #,1st primary
1073,1,1,Research lab p16,p16 unknown
1073,1,1,1st Failure Type,no known failure
1073,1,1,Metastasis,M0
1074,1,1,2nd Failure Type,no known failure
1074,1,1,Nodal Stage,N0
1074,1,1,Research lab p16,p16 unknown
1074,1,1,Radiation Dosage,74.4
1074,1,1,Initial Chemotherapy Agent,cis
1074,1,1,Tumor Stage,T4a
1074,1,1,Overall Stage,IVa
1074,1,1,Metastasis,M0
1074,1,1,Treatment Modality,CTX-RT
1074,1,1,Occurrence #,1st primary
1074,1,1,Tumor Site,oral cavity
1074,1,1,Clinical lab p16,p16 unkown
1074,1,1,Research lab HPV,HPV unknown
1074,1,1,1st Failure Type,no known failure
1075,1,1,Overall Stage,III
1075,1,1,Nodal Stage,N1
1075,1,1,Research lab HPV,HPV unknown
1075,1,1,Treatment Modality,Sx
1075,1,1,2nd Failure Type,no known failure
1075,1,1,Tumor Stage,T3
1075,1,1,Tumor Site,oral cavity
1075,1,1,Occurrence #,1st primary
1075,1,1,Research lab p16,p16 unknown
1075,1,1,Clinical lab p16,p16 unkown
1075,1,1,Metastasis,M0
1075,1,1,1st Failure Type,no known failure
1076,1,1,Research lab p16,p16 unknown
1076,1,1,Research lab HPV,HPV unknown
1076,1,1,1st Failure Type,no known failure
1076,1,1,Occurrence #,1st primary
1076,1,1,Nodal Stage,N0
1076,1,1,Tumor Site,oral cavity
1076,1,1,Overall Stage,I
1076,1,1,Metastasis,M0
1076,1,1,2nd Failure Type,no known failure
1076,1,1,Treatment Modality,Sx
1076,1,1,Tumor Stage,T1
1076,1,1,Clinical lab p16,p16 unkown
1077,1,1,Metastasis,M0
1077,1,1,Tumor Stage,T4a
1077,1,1,Occurrence #,1st primary
1077,1,1,2nd Failure Type,no known failure
1077,1,1,Clinical lab p16,p16 unkown
1077,1,1,Research lab p16,p16 unknown
1077,1,1,Tumor Site,oral cavity
1077,1,1,1st Failure Type,no known failure
1077,1,1,Nodal Stage,N2
1077,1,1,Overall Stage,IVa
1077,1,1,Treatment Modality,Sx
1077,1,1,Research lab HPV,HPV unknown
1078,1,1,Treatment Modality,Sx
1078,1,1,Metastasis,M0
1078,1,1,Research lab p16,p16 unknown
1078,1,1,Clinical lab p16,p16 unkown
1078,1,1,Tumor Stage,T4a
1078,1,1,Tumor Site,oral cavity
1078,1,1,Research lab HPV,HPV unknown
1078,1,1,2nd Failure Type,no known failure
1078,1,1,Occurrence #,1st primary
1078,1,1,Overall Stage,IVa
1078,1,1,Nodal Stage,N0
1078,1,1,1st Failure Type,no known failure
1079,1,1,Occurrence #,1st primary
1079,1,1,Clinical lab p16,p16 unkown
1079,1,1,Tumor Stage,T4a
1079,1,1,1st Failure Type,locoregional
1079,1,1,Research lab HPV,HPV unknown
1079,1,1,Treatment Modality,Sx
1079,1,1,Research lab p16,p16 unknown
1079,1,1,Radiation Dosage,unknown
1079,1,1,Nodal Stage,N0
1079,1,1,2nd Failure Type,no known failure
1079,1,1,Overall Stage,IVa
1079,1,1,Tumor Site,oral cavity
1079,1,1,Metastasis,M0
1081,1,1,Metastasis,M0
1081,1,1,Occurrence #,1st primary
1081,1,1,Nodal Stage,N0
1081,1,1,1st Failure Treatment Modality,Sx
1081,1,1,Treatment Modality,Sx
1081,1,1,1st Failure Site,oral cavity
1081,1,1,Research lab p16,p16 unknown
1081,1,1,Tumor Stage,T1
1081,1,1,Clinical lab p16,p16 unkown
1081,1,1,Tumor Site,oral cavity
1081,1,1,Overall Stage,I
1081,1,1,2nd Failure Type,no known failure
1081,1,1,Research lab HPV,HPV unknown
1081,1,1,1st Failure Type,locoregional
1082,1,1,Clinical lab p16,p16 unkown
1082,1,1,Occurrence #,1st primary
1082,1,1,Treatment Modality,Sx
1082,1,1,Metastasis,M0
1082,1,1,Research lab p16,p16 unknown
1082,1,1,Overall Stage,IVa
1082,1,1,Research lab HPV,HPV unknown
1082,1,1,Tumor Site,oral cavity
1082,1,1,Nodal Stage,N2
1082,1,1,2nd Failure Type,no known failure
1082,1,1,Tumor Stage,T2
1082,1,1,1st Failure Type,no known failure
1083,1,1,2nd Failure Type,no known failure
1083,1,1,Metastasis,M0
1083,1,1,Nodal Stage,N0
1083,1,1,Clinical lab p16,p16 unkown
1083,1,1,1st Failure Type,no known failure
1083,1,1,Research lab p16,p16 unknown
1083,1,1,Treatment Modality,Sx & RT
1083,1,1,Overall Stage,II
1083,1,1,Radiation Dosage,57.6
1083,1,1,Tumor Stage,T2
1083,1,1,Tumor Site,oral cavity
1083,1,1,Research lab HPV,HPV unknown
1083,1,1,Occurrence #,1st primary
1084,1,1,1st Failure Type,distant
1084,1,1,Tumor Site,oral cavity
1084,1,1,Research lab HPV,HPV unknown
1084,1,1,Research lab p16,p16 unknown
1084,1,1,Metastasis,M0
1084,1,1,Clinical lab p16,p16 unkown
1084,1,1,Treatment Modality,Sx & RT
1084,1,1,Overall Stage,II
1084,1,1,Tumor Stage,T2
1084,1,1,Occurrence #,1st primary
1084,1,1,2nd Failure Type,no known failure
1084,1,1,Nodal Stage,N0
1084,1,1,Radiation Dosage,unknown
1085,1,1,Treatment Modality,Sx
1085,1,1,Research lab p16,p16 unknown
1085,1,1,Occurrence #,1st primary
1085,1,1,1st Failure Type,no known failure
1085,1,1,Overall Stage,I
1085,1,1,Tumor Site,oral cavity
1085,1,1,Metastasis,M0
1085,1,1,Nodal Stage,N0
1085,1,1,2nd Failure Type,no known failure
1085,1,1,Tumor Stage,T1
1085,1,1,Clinical lab p16,p16 unkown
1085,1,1,Research lab HPV,HPV unknown
1086,1,1,Tumor Site,oral cavity
1086,1,1,Research lab p16,p16 unknown
1086,1,1,Treatment Modality,Sx
1086,1,1,Occurrence #,1st primary
1086,1,1,Overall Stage,II
1086,1,1,Tumor Stage,T2
1086,1,1,Research lab HPV,HPV unknown
1086,1,1,Clinical lab p16,p16 unkown
1086,1,1,1st Failure Type,no known failure
1086,1,1,Nodal Stage,N0
1086,1,1,Metastasis,M0
1086,1,1,2nd Failure Type,no known failure
1087,1,1,Initial Chemotherapy Agent,unknown
1087,1,1,1st Failure Type,no known failure
1087,1,1,Overall Stage,IVa
1087,1,1,Research lab p16,p16 unknown
1087,1,1,Tumor Site,oral cavity
1087,1,1,Occurrence #,1st primary
1087,1,1,Tumor Stage,T4a
1087,1,1,Metastasis,M0
1087,1,1,Treatment Modality,Sx & CTX
1087,1,1,2nd Failure Type,no known failure
1087,1,1,Research lab HPV,HPV unknown
1087,1,1,Clinical lab p16,p16 unkown
1087,1,1,Nodal Stage,N2
1088,1,1,Occurrence #,1st primary
1088,1,1,1st Failure Initial Chemotherapy Agent,carbo
1088,1,1,1st Failure Site,oral cavity
1088,1,1,Clinical lab p16,p16 unkown
1088,1,1,1st Failure Radiation Dosage,51.6
1088,1,1,Metastasis,M0
1088,1,1,Tumor Stage,T3
1088,1,1,2nd Failure Type,no known failure
1088,1,1,1st Failure Treatment Modality,Sx & CTX-RT
1088,1,1,1st Failure Type,locoregional
1088,1,1,Research lab p16,p16 unknown
1088,1,1,Treatment Modality,Sx & RT
1088,1,1,Radiation Dosage,59.4
1088,1,1,Overall Stage,IVa
1088,1,1,Research lab HPV,HPV unknown
1088,1,1,Nodal Stage,N2
1088,1,1,Tumor Site,oral cavity
1089,1,1,Research lab HPV,HPV unknown
1089,1,1,Nodal Stage,N1
1089,1,1,Overall Stage,III
1089,1,1,Tumor Site,oral cavity
1089,1,1,Research lab p16,p16 unknown
1089,1,1,Metastasis,M0
1089,1,1,Treatment Modality,Sx & RT
1089,1,1,Clinical lab p16,p16 unkown
1089,1,1,2nd Failure Type,no known failure
1089,1,1,Radiation Dosage,unknown
1089,1,1,1st Failure Type,no known failure
1089,1,1,Tumor Stage,T2
1089,1,1,Occurrence #,1st primary
1090,1,1,Clinical lab p16,p16 unkown
1090,1,1,Tumor Site,oral cavity
1090,1,1,Metastasis,M0
1090,1,1,Tumor Stage,T1
1090,1,1,Occurrence #,1st primary
1090,1,1,1st Failure Type,no known failure
1090,1,1,2nd Failure Type,no known failure
1090,1,1,Research lab p16,p16 unknown
1090,1,1,Research lab HPV,HPV unknown
1090,1,1,Overall Stage,I
1090,1,1,Nodal Stage,N0
1090,1,1,Treatment Modality,Sx
1091,1,1,Occurrence #,recurrence
1091,1,1,Research lab p16,p16 unknown
1091,1,1,Overall Stage,IVa
1091,1,1,Tumor Site,oral cavity
1091,1,1,Metastasis,M0
1091,1,1,Clinical lab p16,p16 unkown
1091,1,1,Nodal Stage,N1
1091,1,1,Tumor Stage,T4a
1091,1,1,1st Failure Type,no known failure
1091,1,1,Treatment Modality,Sx
1091,1,1,Research lab HPV,HPV unknown
1091,1,1,2nd Failure Type,no known failure
1092,1,1,1st Failure Type,no known failure
1092,1,1,Research lab p16,p16 unknown
1092,1,1,Clinical lab p16,p16 unkown
1092,1,1,Overall Stage,IVa
1092,1,1,Tumor Site,oral cavity
1092,1,1,2nd Failure Type,no known failure
1092,1,1,Nodal Stage,N2
1092,1,1,Metastasis,M0
1092,1,1,Tumor Stage,T4a
1092,1,1,Occurrence #,1st primary
1092,1,1,Treatment Modality,Sx
1092,1,1,Research lab HPV,HPV unknown
1093,1,1,Overall Stage,IVa
1093,1,1,Treatment Modality,Sx & CTX-RT
1093,1,1,Research lab HPV,HPV unknown
1093,1,1,Clinical lab p16,p16 unkown
1093,1,1,Metastasis,M0
1093,1,1,Initial Chemotherapy Agent,cis
1093,1,1,Tumor Stage,T4a
1093,1,1,2nd Failure Type,no known failure
1093,1,1,Nodal Stage,N2
1093,1,1,Radiation Dosage,63
1093,1,1,1st Failure Type,locoregional
1093,1,1,Occurrence #,1st primary
1093,1,1,Research lab p16,p16 unknown
1093,1,1,Tumor Site,oral cavity
1094,1,1,1st Failure Type,no known failure
1094,1,1,Overall Stage,IVa
1094,1,1,2nd Failure Type,no known failure
1094,1,1,Research lab p16,p16 unknown
1094,1,1,Treatment Modality,Sx
1094,1,1,Research lab HPV,HPV unknown
1094,1,1,Clinical lab p16,p16 unkown
1094,1,1,Tumor Site,oral cavity
1094,1,1,Metastasis,M0
1094,1,1,Nodal Stage,N0
1094,1,1,Occurrence #,1st primary
1094,1,1,Tumor Stage,T4a
1095,1,1,Treatment Modality,Sx
1095,1,1,Research lab HPV,HPV unknown
1095,1,1,Research lab p16,p16 unknown
1095,1,1,Metastasis,M0
1095,1,1,Tumor Site,oral cavity
1095,1,1,Nodal Stage,N0
1095,1,1,Clinical lab p16,p16 unkown
1095,1,1,Overall Stage,I
1095,1,1,1st Failure Type,no known failure
1095,1,1,Occurrence #,1st primary
1095,1,1,2nd Failure Type,no known failure
1095,1,1,Tumor Stage,T1
1096,1,1,Clinical lab p16,p16 unkown
1096,1,1,Tumor Stage,T1
1096,1,1,Metastasis,M0
1096,1,1,2nd Failure Type,no known failure
1096,1,1,Occurrence #,1st primary
1096,1,1,Tumor Site,oral cavity
1096,1,1,Treatment Modality,Sx
1096,1,1,Research lab p16,p16 unknown
1096,1,1,1st Failure Type,no known failure
1096,1,1,Overall Stage,I
1096,1,1,Nodal Stage,N0
1096,1,1,Research lab HPV,HPV unknown
1097,1,1,Research lab HPV,HPV unknown
1097,1,1,Tumor Site,oral cavity
1097,1,1,Overall Stage,I
1097,1,1,Metastasis,M0
1097,1,1,Occurrence #,1st primary
1097,1,1,Treatment Modality,Sx
1097,1,1,Clinical lab p16,p16 unkown
1097,1,1,1st Failure Type,no known failure
1097,1,1,Nodal Stage,N0
1097,1,1,Tumor Stage,T1
1097,1,1,2nd Failure Type,no known failure
1097,1,1,Research lab p16,p16 unknown
1098,1,1,Treatment Modality,Sx & RT
1098,1,1,Nodal Stage,N1
1098,1,1,1st Failure Type,no known failure
1098,1,1,Overall Stage,IVa
1098,1,1,2nd Failure Type,no known failure
1098,1,1,Tumor Stage,T4a
1098,1,1,Research lab p16,p16 unknown
1098,1,1,Occurrence #,1st primary
1098,1,1,Radiation Dosage,unknown
1098,1,1,Tumor Site,oral cavity
1098,1,1,Clinical lab p16,p16 unkown
1098,1,1,Metastasis,M0
1098,1,1,Research lab HPV,HPV unknown
1099,1,1,Clinical lab p16,p16 unkown
1099,1,1,2nd Failure Type,no known failure
1099,1,1,Tumor Site,oral cavity
1099,1,1,1st Failure Type,no known failure
1099,1,1,Overall Stage,IVa
1099,1,1,Research lab p16,p16 unknown
1099,1,1,Metastasis,M0
1099,1,1,Research lab HPV,HPV unknown
1099,1,1,Tumor Stage,T4a
1099,1,1,Treatment Modality,Sx
1099,1,1,Nodal Stage,N0
1099,1,1,Occurrence #,1st primary
1100,1,1,2nd Failure Type,no known failure
1100,1,1,Treatment Modality,Sx
1100,1,1,Tumor Stage,T1
1100,1,1,Research lab p16,p16 unknown
1100,1,1,Metastasis,M0
1100,1,1,1st Failure Type,no known failure
1100,1,1,Research lab HPV,HPV unknown
1100,1,1,Nodal Stage,N0
1100,1,1,Tumor Site,oral cavity
1100,1,1,Overall Stage,I
1100,1,1,Clinical lab p16,p16 unkown
1100,1,1,Occurrence #,1st primary
1101,1,1,Research lab p16,p16 unknown
1101,1,1,Clinical lab p16,p16 unkown
1101,1,1,Nodal Stage,N2
1101,1,1,Tumor Stage,T2
1101,1,1,Treatment Modality,Sx
1101,1,1,Tumor Site,oral cavity
1101,1,1,Overall Stage,IVa
1101,1,1,Occurrence #,1st primary
1101,1,1,1st Failure Type,no known failure
1101,1,1,Metastasis,M0
1101,1,1,2nd Failure Type,no known failure
1101,1,1,Research lab HPV,HPV unknown
1102,1,1,Research lab HPV,HPV unknown
1102,1,1,Nodal Stage,Unknown
1102,1,1,Metastasis,M0
1102,1,1,Treatment Modality,Sx
1102,1,1,Occurrence #,recurrence
1102,1,1,Tumor Stage,T4a
1102,1,1,Overall Stage,IVa
1102,1,1,Clinical lab p16,p16 unkown
1102,1,1,Tumor Site,oral cavity
1102,1,1,Research lab p16,p16 unknown
1102,1,1,1st Failure Type,no known failure
1102,1,1,2nd Failure Type,no known failure
1103,1,1,Research lab HPV,HPV unknown
1103,1,1,Treatment Modality,Sx
1103,1,1,Overall Stage,I
1103,1,1,1st Failure Type,no known failure
1103,1,1,Tumor Stage,T1
1103,1,1,Clinical lab p16,p16 unkown
1103,1,1,Nodal Stage,N0
1103,1,1,Research lab p16,p16 unknown
1103,1,1,2nd Failure Type,no known failure
1103,1,1,Metastasis,M0
1103,1,1,Occurrence #,1st primary
1103,1,1,Tumor Site,oral cavity
1104,1,1,Metastasis,M0
1104,1,1,Research lab HPV,HPV unknown
1104,1,1,Nodal Stage,N2
1104,1,1,Treatment Modality,Sx
1104,1,1,Research lab p16,p16 unknown
1104,1,1,1st Failure Type,no known failure
1104,1,1,2nd Failure Type,no known failure
1104,1,1,Tumor Site,oral cavity
1104,1,1,Occurrence #,1st primary
1104,1,1,Tumor Stage,T2
1104,1,1,Overall Stage,IVa
1104,1,1,Clinical lab p16,p16 unkown
1105,1,1,Treatment Modality,Sx
1105,1,1,Occurrence #,1st primary
1105,1,1,Nodal Stage,N0
1105,1,1,Tumor Site,oral cavity
1105,1,1,Overall Stage,II
1105,1,1,Research lab p16,p16 unknown
1105,1,1,Clinical lab p16,p16 unkown
1105,1,1,1st Failure Site,oral cavity
1105,1,1,Research lab HPV,HPV unknown
1105,1,1,2nd Failure Type,no known failure
1105,1,1,1st Failure Type,locoregional
1105,1,1,Tumor Stage,T2
1105,1,1,1st Failure Treatment Modality,Sx
1105,1,1,Metastasis,M0
1106,1,1,Clinical lab p16,p16 unkown
1106,1,1,Research lab HPV,HPV unknown
1106,1,1,Metastasis,M0
1106,1,1,1st Failure Type,no known failure
1106,1,1,Overall Stage,IVa
1106,1,1,2nd Failure Type,no known failure
1106,1,1,Tumor Site,oral cavity
1106,1,1,Research lab p16,p16 unknown
1106,1,1,Nodal Stage,N0
1106,1,1,Treatment Modality,Sx
1106,1,1,Tumor Stage,T4a
1106,1,1,Occurrence #,recurrence
1107,1,1,Nodal Stage,N2
1107,1,1,Overall Stage,IVa
1107,1,1,Tumor Stage,T4a
1107,1,1,1st Failure Type,no known failure
1107,1,1,2nd Failure Type,no known failure
1107,1,1,Treatment Modality,Sx
1107,1,1,Occurrence #,1st primary
1107,1,1,Tumor Site,oral cavity
1107,1,1,Research lab HPV,HPV unknown
1107,1,1,Research lab p16,p16 unknown
1107,1,1,Clinical lab p16,p16 unkown
1107,1,1,Metastasis,M0
1108,1,1,1st Failure Type,no known failure
1108,1,1,Research lab p16,p16 unknown
1108,1,1,Tumor Site,oral cavity
1108,1,1,2nd Failure Type,no known failure
1108,1,1,Tumor Stage,T2
1108,1,1,Nodal Stage,N0
1108,1,1,Metastasis,M0
1108,1,1,Treatment Modality,Sx & RT
1108,1,1,Overall Stage,II
1108,1,1,Radiation Dosage,63
1108,1,1,Clinical lab p16,p16 unkown
1108,1,1,Research lab HPV,HPV unknown
1108,1,1,Occurrence #,1st primary
1109,1,1,1st Failure Treatment Modality,Sx
1109,1,1,Overall Stage,I
1109,1,1,1st Failure Site,oral cavity
1109,1,1,Research lab p16,p16 unknown
1109,1,1,Nodal Stage,N0
1109,1,1,1st Failure Type,locoregional
1109,1,1,Metastasis,M0
1109,1,1,Tumor Site,oral cavity
1109,1,1,2nd Failure Type,no known failure
1109,1,1,Occurrence #,1st primary
1109,1,1,Research lab HPV,HPV unknown
1109,1,1,Tumor Stage,T1
1109,1,1,Treatment Modality,Sx
1109,1,1,Clinical lab p16,p16 unkown
1110,1,1,Nodal Stage,N2
1110,1,1,Clinical lab p16,p16 unkown
1110,1,1,Tumor Site,oral cavity
1110,1,1,Tumor Stage,T4a
1110,1,1,Treatment Modality,Sx
1110,1,1,Research lab HPV,HPV unknown
1110,1,1,Occurrence #,1st primary
1110,1,1,Research lab p16,p16 unknown
1110,1,1,2nd Failure Type,no known failure
1110,1,1,1st Failure Type,no known failure
1110,1,1,Metastasis,M0
1110,1,1,Overall Stage,IVa
1111,1,1,Tumor Stage,T2
1111,1,1,Initial Chemotherapy Agent,carbo/PTX
1111,1,1,1st Failure Type,locoregional and distant
1111,1,1,Treatment Modality,Sx & CTX-RT
1111,1,1,Overall Stage,IVb
1111,1,1,Nodal Stage,N3
1111,1,1,Radiation Dosage,70.2
1111,1,1,Metastasis,M0
1111,1,1,Research lab HPV,HPV unknown
1111,1,1,Occurrence #,1st primary
1111,1,1,Research lab p16,p16 unknown
1111,1,1,2nd Failure Type,no known failure
1111,1,1,Clinical lab p16,p16 unkown
1111,1,1,Tumor Site,oral cavity
1112,1,1,Occurrence #,recurrence
1112,1,1,Research lab p16,p16 unknown
1112,1,1,Tumor Site,oral cavity
1112,1,1,2nd Failure Type,no known failure
1112,1,1,1st Failure Type,locoregional
1112,1,1,Clinical lab p16,p16 unkown
1112,1,1,Overall Stage,II
1112,1,1,Nodal Stage,N0
1112,1,1,Research lab HPV,HPV unknown
1112,1,1,Treatment Modality,Sx
1112,1,1,Metastasis,M0
1112,1,1,Tumor Stage,T2
1113,1,1,1st Failure Type,locoregional
1113,1,1,Clinical lab p16,p16 unkown
1113,1,1,1st Failure Treatment Modality,Sx
1113,1,1,Tumor Stage,T1
1113,1,1,Overall Stage,I
1113,1,1,Metastasis,M0
1113,1,1,Treatment Modality,Sx
1113,1,1,2nd Failure Type,no known failure
1113,1,1,Tumor Site,oral cavity
1113,1,1,Occurrence #,other primary
1113,1,1,Research lab HPV,HPV unknown
1113,1,1,Nodal Stage,N0
1113,1,1,1st Failure Site,oral cavity
1113,1,1,Research lab p16,p16 unknown
1114,1,1,Tumor Stage,T1
1114,1,1,Research lab p16,p16 unknown
1114,1,1,Research lab HPV,HPV unknown
1114,1,1,Tumor Site,oral cavity
1114,1,1,1st Failure Site,oral cavity
1114,1,1,Occurrence #,recurrence
1114,1,1,Nodal Stage,N1
1114,1,1,Treatment Modality,Sx
1114,1,1,Metastasis,M0
1114,1,1,Overall Stage,III
1114,1,1,2nd Failure Type,no known failure
1114,1,1,Clinical lab p16,p16 unkown
1114,1,1,1st Failure Type,locoregional
1114,1,1,1st Failure Treatment Modality,Sx
1115,1,1,1st Failure Type,no known failure
1115,1,1,Treatment Modality,Sx
1115,1,1,Nodal Stage,N0
1115,1,1,Metastasis,M0
1115,1,1,Clinical lab p16,p16 unkown
1115,1,1,Occurrence #,recurrence
1115,1,1,Research lab HPV,HPV unknown
1115,1,1,Overall Stage,I
1115,1,1,2nd Failure Type,no known failure
1115,1,1,Research lab p16,p16 unknown
1115,1,1,Tumor Site,oral cavity
1115,1,1,Tumor Stage,T1
1116,1,1,Tumor Stage,T4a
1116,1,1,Radiation Dosage,36
1116,1,1,Clinical lab p16,p16 unkown
1116,1,1,2nd Failure Type,no known failure
1116,1,1,Occurrence #,recurrence
1116,1,1,Treatment Modality,Sx & RT
1116,1,1,1st Failure Type,no known failure
1116,1,1,Overall Stage,IVc
1116,1,1,Research lab p16,p16 unknown
1116,1,1,Research lab HPV,HPV unknown
1116,1,1,Tumor Site,oral cavity
1116,1,1,Metastasis,M1
1116,1,1,Nodal Stage,N0
1117,1,1,Metastasis,M0
1117,1,1,Clinical lab p16,p16 unkown
1117,1,1,Treatment Modality,Sx
1117,1,1,1st Failure Type,no known failure
1117,1,1,Overall Stage,IVa
1117,1,1,Tumor Site,oral cavity
1117,1,1,Occurrence #,1st primary
1117,1,1,2nd Failure Type,no known failure
1117,1,1,Nodal Stage,N2
1117,1,1,Research lab HPV,HPV unknown
1117,1,1,Tumor Stage,T2
1117,1,1,Research lab p16,p16 unknown
1118,1,1,Research lab p16,p16 unknown
1118,1,1,2nd Failure Type,no known failure
1118,1,1,Overall Stage,I
1118,1,1,1st Failure Type,no known failure
1118,1,1,Occurrence #,recurrence
1118,1,1,Tumor Stage,T1
1118,1,1,Nodal Stage,N0
1118,1,1,Tumor Site,oral cavity
1118,1,1,Metastasis,M0
1118,1,1,Treatment Modality,Sx
1118,1,1,Clinical lab p16,p16 unkown
1118,1,1,Research lab HPV,HPV unknown
1119,1,1,Tumor Stage,T1
1119,1,1,Metastasis,M0
1119,1,1,Research lab p16,p16 unknown
1119,1,1,Research lab HPV,HPV unknown
1119,1,1,Occurrence #,1st primary
1119,1,1,Tumor Site,oral cavity
1119,1,1,2nd Failure Type,no known failure
1119,1,1,Overall Stage,I
1119,1,1,Nodal Stage,N0
1119,1,1,Clinical lab p16,p16 unkown
1119,1,1,1st Failure Type,no known failure
1119,1,1,Treatment Modality,Sx
1120,1,1,Clinical lab p16,p16 unkown
1120,1,1,Tumor Stage,T1
1120,1,1,Occurrence #,1st primary
1120,1,1,2nd Failure Type,no known failure
1120,1,1,Metastasis,M0
1120,1,1,Research lab HPV,HPV unknown
1120,1,1,Overall Stage,I
1120,1,1,1st Failure Type,no known failure
1120,1,1,Treatment Modality,Sx
1120,1,1,Nodal Stage,N0
1120,1,1,Tumor Site,oral cavity
1120,1,1,Research lab p16,p16 unknown
1121,1,1,Research lab HPV,HPV unknown
1121,1,1,Occurrence #,1st primary
1121,1,1,Tumor Site,oral cavity
1121,1,1,Treatment Modality,Sx
1121,1,1,Tumor Stage,T1
1121,1,1,Clinical lab p16,p16 unkown
1121,1,1,Overall Stage,I
1121,1,1,Nodal Stage,N0
1121,1,1,Research lab p16,p16 unknown
1121,1,1,2nd Failure Type,no known failure
1121,1,1,Metastasis,M0
1121,1,1,1st Failure Type,no known failure
1122,1,1,Treatment Modality,Sx
1122,1,1,Tumor Stage,T1
1122,1,1,1st Failure Type,no known failure
1122,1,1,Clinical lab p16,p16 unkown
1122,1,1,Overall Stage,III
1122,1,1,Research lab p16,p16 unknown
1122,1,1,Metastasis,M0
1122,1,1,Tumor Site,oral cavity
1122,1,1,2nd Failure Type,no known failure
1122,1,1,Nodal Stage,N1
1122,1,1,Research lab HPV,HPV unknown
1122,1,1,Occurrence #,1st primary
1123,1,1,Research lab p16,p16 unknown
1123,1,1,Nodal Stage,Unknown
1123,1,1,Tumor Site,oral cavity
1123,1,1,Occurrence #,1st primary
1123,1,1,Treatment Modality,Sx
1123,1,1,Overall Stage,IVb
1123,1,1,1st Failure Type,no known failure
1123,1,1,Research lab HPV,HPV unknown
1123,1,1,Tumor Stage,T4b
1123,1,1,2nd Failure Type,no known failure
1123,1,1,Metastasis,M0
1123,1,1,Clinical lab p16,p16 unkown
1124,1,1,1st Failure Type,no known failure
1124,1,1,Tumor Stage,T2
1124,1,1,Metastasis,M0
1124,1,1,Occurrence #,1st primary
1124,1,1,Research lab HPV,HPV unknown
1124,1,1,Overall Stage,III
1124,1,1,2nd Failure Type,no known failure
1124,1,1,Clinical lab p16,p16 unkown
1124,1,1,Nodal Stage,N1
1124,1,1,Treatment Modality,Sx
1124,1,1,Research lab p16,p16 unknown
1124,1,1,Tumor Site,oral cavity
1125,1,1,Nodal Stage,N0
1125,1,1,Clinical lab p16,p16 unkown
1125,1,1,Metastasis,M0
1125,1,1,2nd Failure Type,no known failure
1125,1,1,Research lab p16,p16 unknown
1125,1,1,Overall Stage,IVa
1125,1,1,Tumor Site,oral cavity
1125,1,1,Research lab HPV,HPV unknown
1125,1,1,Treatment Modality,Sx
1125,1,1,1st Failure Type,no known failure
1125,1,1,Occurrence #,1st primary
1125,1,1,Tumor Stage,T4a
1126,1,1,Nodal Stage,N0
1126,1,1,Research lab HPV,HPV unknown
1126,1,1,Treatment Modality,Sx
1126,1,1,1st Failure Treatment Modality,Sx
1126,1,1,Tumor Stage,T1
1126,1,1,2nd Failure Type,no known failure
1126,1,1,Clinical lab p16,p16 unkown
1126,1,1,Metastasis,M0
1126,1,1,Tumor Site,oral cavity
1126,1,1,Overall Stage,I
1126,1,1,Research lab p16,p16 unknown
1126,1,1,1st Failure Site,oral cavity
1126,1,1,1st Failure Type,locoregional
1126,1,1,Occurrence #,1st primary
1127,1,1,Treatment Modality,Sx
1127,1,1,Clinical lab p16,p16 unkown
1127,1,1,1st Failure Type,no known failure
1127,1,1,Nodal Stage,N1
1127,1,1,Research lab p16,p16 unknown
1127,1,1,2nd Failure Type,no known failure
1127,1,1,Tumor Site,oral cavity
1127,1,1,Occurrence #,1st primary
1127,1,1,Tumor Stage,T4a
1127,1,1,Research lab HPV,HPV unknown
1127,1,1,Metastasis,M0
1127,1,1,Overall Stage,IVa
1128,1,1,Metastasis,M0
1128,1,1,Tumor Site,oral cavity
1128,1,1,Overall Stage,III
1128,1,1,2nd Failure Type,no known failure
1128,1,1,Tumor Stage,T2
1128,1,1,Research lab HPV,HPV unknown
1128,1,1,Research lab p16,p16 unknown
1128,1,1,1st Failure Type,locoregional and distant
1128,1,1,Nodal Stage,N1
1128,1,1,Occurrence #,1st primary
1128,1,1,Clinical lab p16,p16 unkown
1128,1,1,Treatment Modality,Sx & RT
1128,1,1,Radiation Dosage,unknown
1129,1,1,Occurrence #,1st primary
1129,1,1,Tumor Site,oral cavity
1129,1,1,Metastasis,M0
1129,1,1,1st Failure Type,no known failure
1129,1,1,Overall Stage,IVa
1129,1,1,2nd Failure Type,no known failure
1129,1,1,Radiation Dosage,70.2
1129,1,1,Research lab p16,p16 unknown
1129,1,1,Nodal Stage,N1
1129,1,1,Initial Chemotherapy Agent,carbo/PTX
1129,1,1,Clinical lab p16,p16 unkown
1129,1,1,Treatment Modality,CTX-RT
1129,1,1,Research lab HPV,HPV unknown
1129,1,1,Tumor Stage,T4a
1130,1,1,Occurrence #,1st primary
1130,1,1,Research lab HPV,HPV unknown
1130,1,1,Tumor Stage,T1
1130,1,1,1st Failure Type,no known failure
1130,1,1,Clinical lab p16,p16 unkown
1130,1,1,Research lab p16,p16 unknown
1130,1,1,Tumor Site,oral cavity
1130,1,1,2nd Failure Type,no known failure
1130,1,1,Nodal Stage,N0
1130,1,1,Treatment Modality,Sx
1130,1,1,Metastasis,M0
1130,1,1,Overall Stage,I
1131,1,1,Occurrence #,1st primary
1131,1,1,Nodal Stage,N2
1131,1,1,Tumor Stage,T3
1131,1,1,Metastasis,M0
1131,1,1,1st Failure Type,no known failure
1131,1,1,Overall Stage,IVa
1131,1,1,Tumor Site,oral cavity
1131,1,1,Research lab p16,p16 unknown
1131,1,1,2nd Failure Type,no known failure
1131,1,1,Treatment Modality,Sx
1131,1,1,Clinical lab p16,p16 unkown
1131,1,1,Research lab HPV,HPV unknown
1132,1,1,Tumor Site,oral cavity
1132,1,1,Research lab HPV,HPV unknown
1132,1,1,Clinical lab p16,p16 unkown
1132,1,1,Research lab p16,p16 unknown
1132,1,1,Treatment Modality,Sx
1132,1,1,Overall Stage,I
1132,1,1,Nodal Stage,N0
1132,1,1,Metastasis,M0
1132,1,1,2nd Failure Type,no known failure
1132,1,1,Occurrence #,1st primary
1132,1,1,Tumor Stage,T1
1132,1,1,1st Failure Type,no known failure
1133,1,1,Tumor Stage,T1
1133,1,1,Overall Stage,I
1133,1,1,Occurrence #,1st primary
1133,1,1,Research lab p16,p16 unknown
1133,1,1,Treatment Modality,Sx
1133,1,1,Nodal Stage,N0
1133,1,1,Metastasis,M0
1133,1,1,Research lab HPV,HPV unknown
1133,1,1,2nd Failure Type,no known failure
1133,1,1,Clinical lab p16,p16 unkown
1133,1,1,1st Failure Type,no known failure
1133,1,1,Tumor Site,oral cavity
1134,1,1,2nd Failure Type,no known failure
1134,1,1,Overall Stage,II
1134,1,1,Treatment Modality,Sx
1134,1,1,Occurrence #,1st primary
1134,1,1,Nodal Stage,N0
1134,1,1,Clinical lab p16,p16 unkown
1134,1,1,1st Failure Type,no known failure
1134,1,1,Metastasis,M0
1134,1,1,Tumor Site,oral cavity
1134,1,1,Tumor Stage,T2
1134,1,1,Research lab p16,p16 unknown
1134,1,1,Research lab HPV,HPV unknown
1135,1,1,Clinical lab p16,p16 unkown
1135,1,1,Radiation Dosage,53
1135,1,1,Metastasis,M0
1135,1,1,Treatment Modality,Sx & RT
1135,1,1,1st Failure Type,no known failure
1135,1,1,Tumor Site,oral cavity
1135,1,1,Nodal Stage,N0
1135,1,1,Research lab HPV,HPV unknown
1135,1,1,Occurrence #,1st primary
1135,1,1,Tumor Stage,T2
1135,1,1,Research lab p16,p16 unknown
1135,1,1,2nd Failure Type,no known failure
1135,1,1,Overall Stage,II
1136,1,1,Research lab HPV,HPV unknown
1136,1,1,Overall Stage,II
1136,1,1,Radiation Dosage,unknown
1136,1,1,Research lab p16,p16 unknown
1136,1,1,2nd Failure Type,no known failure
1136,1,1,Tumor Site,oral cavity
1136,1,1,Initial Chemotherapy Agent,unknown
1136,1,1,1st Failure Type,no known failure
1136,1,1,Occurrence #,1st primary
1136,1,1,Clinical lab p16,p16 unkown
1136,1,1,Metastasis,M0
1136,1,1,Tumor Stage,T2
1136,1,1,Treatment Modality,Sx & CTX-RT
1136,1,1,Nodal Stage,N0
1137,1,1,Treatment Modality,Sx
1137,1,1,Tumor Site,oral cavity
1137,1,1,1st Failure Type,no known failure
1137,1,1,Tumor Stage,T1
1137,1,1,2nd Failure Type,no known failure
1137,1,1,Occurrence #,1st primary
1137,1,1,Nodal Stage,N0
1137,1,1,Metastasis,M0
1137,1,1,Clinical lab p16,p16 unkown
1137,1,1,Overall Stage,I
1137,1,1,Research lab p16,p16 unknown
1137,1,1,Research lab HPV,HPV unknown
1138,1,1,Nodal Stage,N0
1138,1,1,Treatment Modality,Sx
1138,1,1,Overall Stage,IVa
1138,1,1,Occurrence #,1st primary
1138,1,1,2nd Failure Type,no known failure
1138,1,1,1st Failure Type,locoregional
1138,1,1,Tumor Site,oral cavity
1138,1,1,Research lab p16,p16 unknown
1138,1,1,Tumor Stage,T4a
1138,1,1,Metastasis,M0
1138,1,1,Clinical lab p16,p16 unkown
1138,1,1,Research lab HPV,HPV unknown
1139,1,1,Tumor Stage,T2
1139,1,1,Metastasis,M0
1139,1,1,Nodal Stage,N1
1139,1,1,Clinical lab p16,p16 unkown
1139,1,1,Treatment Modality,Sx
1139,1,1,Research lab p16,p16 unknown
1139,1,1,2nd Failure Type,no known failure
1139,1,1,1st Failure Type,no known failure
1139,1,1,Occurrence #,1st primary
1139,1,1,Research lab HPV,HPV unknown
1139,1,1,Tumor Site,oral cavity
1139,1,1,Overall Stage,III
1140,1,1,Clinical lab p16,p16 unkown
1140,1,1,Overall Stage,IVa
1140,1,1,Occurrence #,1st primary
1140,1,1,Research lab HPV,HPV unknown
1140,1,1,Research lab p16,p16 unknown
1140,1,1,Nodal Stage,N0
1140,1,1,Tumor Site,oral cavity
1140,1,1,2nd Failure Type,no known failure
1140,1,1,Treatment Modality,Sx & RT
1140,1,1,Radiation Dosage,unknown
1140,1,1,1st Failure Type,no known failure
1140,1,1,Tumor Stage,T4a
1140,1,1,Metastasis,M0
1141,1,1,Research lab HPV,HPV unknown
1141,1,1,Clinical lab p16,p16 unkown
1141,1,1,Occurrence #,recurrence
1141,1,1,Nodal Stage,N0
1141,1,1,1st Failure Type,locoregional
1141,1,1,Tumor Site,oral cavity
1141,1,1,Metastasis,M0
1141,1,1,Treatment Modality,Sx
1141,1,1,Tumor Stage,T1
1141,1,1,Overall Stage,I
1141,1,1,Research lab p16,p16 unknown
1141,1,1,2nd Failure Type,no known failure
1142,1,1,Metastasis,M0
1142,1,1,Tumor Stage,T4a
1142,1,1,Research lab HPV,HPV unknown
1142,1,1,Treatment Modality,Sx
1142,1,1,1st Failure Type,no known failure
1142,1,1,Tumor Site,oral cavity
1142,1,1,Nodal Stage,N0
1142,1,1,Occurrence #,1st primary
1142,1,1,Overall Stage,IVa
1142,1,1,Clinical lab p16,p16 unkown
1142,1,1,Research lab p16,p16 unknown
1142,1,1,2nd Failure Type,no known failure
1143,1,1,Occurrence #,1st primary
1143,1,1,Tumor Stage,T1
1143,1,1,Tumor Site,oral cavity
1143,1,1,1st Failure Type,no known failure
1143,1,1,Metastasis,M0
1143,1,1,2nd Failure Type,no known failure
1143,1,1,Research lab p16,p16 unknown
1143,1,1,Treatment Modality,Sx
1143,1,1,Nodal Stage,N0
1143,1,1,Overall Stage,I
1143,1,1,Clinical lab p16,p16 unkown
1143,1,1,Research lab HPV,HPV unknown
1144,1,1,Clinical lab p16,p16 unkown
1144,1,1,Metastasis,M0
1144,1,1,Research lab HPV,HPV unknown
1144,1,1,Tumor Stage,T4a
1144,1,1,Nodal Stage,N2
1144,1,1,Research lab p16,p16 unknown
1144,1,1,Occurrence #,1st primary
1144,1,1,2nd Failure Type,no known failure
1144,1,1,Treatment Modality,Sx
1144,1,1,Overall Stage,IVa
1144,1,1,Tumor Site,oral cavity
1144,1,1,1st Failure Type,no known failure
1145,1,1,1st Failure Type,no known failure
1145,1,1,Metastasis,M0
1145,1,1,Research lab p16,p16 unknown
1145,1,1,Nodal Stage,N2
1145,1,1,Clinical lab p16,p16 unkown
1145,1,1,Tumor Stage,T3
1145,1,1,Research lab HPV,HPV unknown
1145,1,1,Treatment Modality,Sx
1145,1,1,2nd Failure Type,no known failure
1145,1,1,Tumor Site,oral cavity
1145,1,1,Overall Stage,IVa
1145,1,1,Occurrence #,1st primary
1146,1,1,Radiation Dosage,70.2
1146,1,1,Research lab p16,p16 unknown
1146,1,1,Nodal Stage,N2
1146,1,1,Tumor Stage,T4a
1146,1,1,Clinical lab p16,p16 unkown
1146,1,1,Initial Chemotherapy Agent,carbo/PTX
1146,1,1,Research lab HPV,HPV unknown
1146,1,1,Treatment Modality,CTX-RT
1146,1,1,Occurrence #,1st primary
1146,1,1,Metastasis,M0
1146,1,1,1st Failure Type,no known failure
1146,1,1,Overall Stage,IVa
1146,1,1,Tumor Site,oral cavity
1146,1,1,2nd Failure Type,no known failure
1147,1,1,Research lab HPV,HPV unknown
1147,1,1,Tumor Stage,T4a
1147,1,1,2nd Failure Type,no known failure
1147,1,1,Clinical lab p16,p16 unkown
1147,1,1,Nodal Stage,N2
1147,1,1,Research lab p16,p16 unknown
1147,1,1,Occurrence #,1st primary
1147,1,1,1st Failure Type,no known failure
1147,1,1,Overall Stage,IVa
1147,1,1,Metastasis,M0
1147,1,1,Treatment Modality,Sx
1147,1,1,Tumor Site,oral cavity
1148,1,1,Occurrence #,1st primary
1148,1,1,Clinical lab p16,p16 unkown
1148,1,1,Overall Stage,II
1148,1,1,Metastasis,M0
1148,1,1,Research lab p16,p16 unknown
1148,1,1,Tumor Site,oral cavity
1148,1,1,Nodal Stage,N0
1148,1,1,1st Failure Type,no known failure
1148,1,1,Tumor Stage,T2
1148,1,1,Research lab HPV,HPV unknown
1148,1,1,Treatment Modality,Sx
1148,1,1,2nd Failure Type,no known failure
1149,1,1,Overall Stage,III
1149,1,1,Research lab p16,p16 unknown
1149,1,1,Metastasis,M0
1149,1,1,Clinical lab p16,p16 unkown
1149,1,1,1st Failure Type,locoregional
1149,1,1,Treatment Modality,Sx
1149,1,1,Occurrence #,recurrence
1149,1,1,2nd Failure Type,no known failure
1149,1,1,Tumor Site,oral cavity
1149,1,1,Tumor Stage,T3
1149,1,1,Nodal Stage,N0
1149,1,1,Research lab HPV,HPV unknown
1150,1,1,Research lab HPV,HPV unknown
1150,1,1,Tumor Site,oral cavity
1150,1,1,Nodal Stage,N0
1150,1,1,Overall Stage,I
1150,1,1,Occurrence #,1st primary
1150,1,1,1st Failure Type,no known failure
1150,1,1,Treatment Modality,Sx
1150,1,1,Metastasis,M0
1150,1,1,2nd Failure Type,no known failure
1150,1,1,Tumor Stage,T1
1150,1,1,Research lab p16,p16 unknown
1150,1,1,Clinical lab p16,p16 unkown
1151,1,1,Tumor Site,oral cavity
1151,1,1,Occurrence #,1st primary
1151,1,1,1st Failure Type,no known failure
1151,1,1,2nd Failure Type,no known failure
1151,1,1,Clinical lab p16,p16 unkown
1151,1,1,Overall Stage,II
1151,1,1,Tumor Stage,T2
1151,1,1,Nodal Stage,N0
1151,1,1,Metastasis,M0
1151,1,1,Research lab p16,p16 unknown
1151,1,1,Research lab HPV,HPV unknown
1151,1,1,Treatment Modality,Sx
1152,1,1,Tumor Stage,T1
1152,1,1,Research lab p16,p16 unknown
1152,1,1,2nd Failure Type,no known failure
1152,1,1,Clinical lab p16,p16 unkown
1152,1,1,Metastasis,M0
1152,1,1,Tumor Site,oral cavity
1152,1,1,Treatment Modality,Sx
1152,1,1,Research lab HPV,HPV unknown
1152,1,1,Overall Stage,III
1152,1,1,Occurrence #,1st primary
1152,1,1,Nodal Stage,N1
1152,1,1,1st Failure Type,no known failure
1153,1,1,Tumor Stage,T4a
1153,1,1,Radiation Dosage,59.4
1153,1,1,Research lab p16,p16 unknown
1153,1,1,Treatment Modality,Sx & RT
1153,1,1,Overall Stage,IVa
1153,1,1,Nodal Stage,N2
1153,1,1,1st Failure Type,no known failure
1153,1,1,Metastasis,M0
1153,1,1,Tumor Site,oral cavity
1153,1,1,Research lab HPV,HPV unknown
1153,1,1,Occurrence #,1st primary
1153,1,1,2nd Failure Type,no known failure
1153,1,1,Clinical lab p16,p16 unkown
1154,1,1,Clinical lab p16,p16 unkown
1154,1,1,2nd Failure Type,no known failure
1154,1,1,1st Failure Type,no known failure
1154,1,1,Research lab p16,p16 unknown
1154,1,1,Research lab HPV,HPV unknown
1154,1,1,Metastasis,M0
1154,1,1,Occurrence #,1st primary
1154,1,1,Initial Chemotherapy Agent,unknown
1154,1,1,Tumor Stage,T2
1154,1,1,Nodal Stage,N2
1154,1,1,Treatment Modality,Sx & CTX-RT
1154,1,1,Overall Stage,IVa
1154,1,1,Radiation Dosage,unknown
1154,1,1,Tumor Site,oral cavity
1155,1,1,1st Failure Type,no known failure
1155,1,1,2nd Failure Type,no known failure
1155,1,1,Treatment Modality,Sx
1155,1,1,Research lab p16,p16 unknown
1155,1,1,Occurrence #,1st primary
1155,1,1,Tumor Site,oral cavity
1155,1,1,Nodal Stage,N0
1155,1,1,Metastasis,M0
1155,1,1,Overall Stage,I
1155,1,1,Tumor Stage,T1
1155,1,1,Clinical lab p16,p16 unkown
1155,1,1,Research lab HPV,HPV unknown
1156,1,1,Nodal Stage,N2
1156,1,1,Occurrence #,recurrence
1156,1,1,Radiation Dosage,unknown
1156,1,1,Clinical lab p16,p16 unkown
1156,1,1,Tumor Stage,T4a
1156,1,1,Research lab p16,p16 unknown
1156,1,1,Overall Stage,IVa
1156,1,1,Treatment Modality,Sx & RT
1156,1,1,Tumor Site,oral cavity
1156,1,1,Research lab HPV,HPV unknown
1156,1,1,1st Failure Type,locoregional
1156,1,1,Metastasis,M0
1156,1,1,2nd Failure Type,no known failure
1157,1,1,Overall Stage,II
1157,1,1,Tumor Site,oral cavity
1157,1,1,Nodal Stage,N0
1157,1,1,Tumor Stage,T2
1157,1,1,Clinical lab p16,p16 unkown
1157,1,1,Metastasis,M0
1157,1,1,1st Failure Type,no known failure
1157,1,1,Occurrence #,1st primary
1157,1,1,2nd Failure Type,no known failure
1157,1,1,Treatment Modality,Sx
1157,1,1,Research lab HPV,HPV unknown
1157,1,1,Research lab p16,p16 unknown
1158,1,1,Research lab p16,p16 unknown
1158,1,1,1st Failure Type,locoregional
1158,1,1,Nodal Stage,N2
1158,1,1,Metastasis,M0
1158,1,1,Occurrence #,1st primary
1158,1,1,Treatment Modality,Sx & CTX-RT
1158,1,1,Initial Chemotherapy Agent,unknown
1158,1,1,Research lab HPV,HPV unknown
1158,1,1,Tumor Stage,T4a
1158,1,1,Radiation Dosage,unknown
1158,1,1,Tumor Site,oral cavity
1158,1,1,Clinical lab p16,p16 unkown
1158,1,1,2nd Failure Type,no known failure
1158,1,1,Overall Stage,IVa
1159,1,1,Nodal Stage,N0
1159,1,1,Tumor Stage,T1
1159,1,1,Metastasis,M0
1159,1,1,Treatment Modality,Sx
1159,1,1,Research lab p16,p16 unknown
1159,1,1,Research lab HPV,HPV unknown
1159,1,1,Tumor Site,oral cavity
1159,1,1,1st Failure Type,no known failure
1159,1,1,Clinical lab p16,p16 unkown
1159,1,1,Occurrence #,1st primary
1159,1,1,2nd Failure Type,no known failure
1159,1,1,Overall Stage,I
1160,1,1,1st Failure Type,no known failure
1160,1,1,Metastasis,M0
1160,1,1,2nd Failure Type,no known failure
1160,1,1,Overall Stage,IVa
1160,1,1,Nodal Stage,N0
1160,1,1,Research lab HPV,HPV unknown
1160,1,1,Tumor Site,oral cavity
1160,1,1,Research lab p16,p16 unknown
1160,1,1,Clinical lab p16,p16 unkown
1160,1,1,Treatment Modality,Sx
1160,1,1,Occurrence #,1st primary
1160,1,1,Tumor Stage,T4a
1161,1,1,2nd Failure Type,no known failure
1161,1,1,Clinical lab p16,p16 unkown
1161,1,1,Metastasis,M0
1161,1,1,Occurrence #,1st primary
1161,1,1,Tumor Site,oral cavity
1161,1,1,Overall Stage,IVa
1161,1,1,Tumor Stage,T4a
1161,1,1,Nodal Stage,N1
1161,1,1,1st Failure Type,no known failure
1161,1,1,Treatment Modality,Sx
1161,1,1,Research lab p16,p16 unknown
1161,1,1,Research lab HPV,HPV unknown
1162,1,1,Research lab HPV,HPV unknown
1162,1,1,Research lab p16,p16 unknown
1162,1,1,Treatment Modality,Sx
1162,1,1,Clinical lab p16,p16 unkown
1162,1,1,Overall Stage,I
1162,1,1,Occurrence #,1st primary
1162,1,1,1st Failure Site,oral cavity
1162,1,1,1st Failure Treatment Modality,Sx
1162,1,1,2nd Failure Type,no known failure
1162,1,1,Tumor Stage,T1
1162,1,1,Tumor Site,oral cavity
1162,1,1,1st Failure Type,locoregional
1162,1,1,Nodal Stage,N0
1162,1,1,Metastasis,M0
1163,1,1,2nd Failure Type,no known failure
1163,1,1,Tumor Site,oropharynx
1163,1,1,Occurrence #,1st primary
1163,1,1,1st Failure Type,locoregional
1163,1,1,Tumor Stage,T2
1163,1,1,Overall Stage,IVa
1163,1,1,Metastasis,M0
1163,1,1,Treatment Modality,Sx & RT
1163,1,1,Research lab HPV,HPV unknown
1163,1,1,Radiation Dosage,unknown
1163,1,1,Research lab p16,p16 unknown
1163,1,1,Clinical lab p16,p16 unkown
1163,1,1,Nodal Stage,N2
1164,1,1,Nodal Stage,N0
1164,1,1,Clinical lab p16,p16 unkown
1164,1,1,1st Failure Type,no known failure
1164,1,1,Occurrence #,1st primary
1164,1,1,Research lab p16,p16 unknown
1164,1,1,Treatment Modality,Sx
1164,1,1,Metastasis,M0
1164,1,1,2nd Failure Type,no known failure
1164,1,1,Research lab HPV,HPV unknown
1164,1,1,Overall Stage,I
1164,1,1,Tumor Stage,T1
1164,1,1,Tumor Site,oropharynx
1165,1,1,Overall Stage,IVb
1165,1,1,2nd Failure Type,no known failure
1165,1,1,Tumor Stage,T1
1165,1,1,Nodal Stage,N3
1165,1,1,Tumor Site,oropharynx
1165,1,1,Treatment Modality,CTX-RT
1165,1,1,1st Failure Type,no known failure
1165,1,1,Initial Chemotherapy Agent,cis/PTX
1165,1,1,Research lab HPV,HPV unknown
1165,1,1,Second Line Chemotherapy Agent,cis/5-FU
1165,1,1,Occurrence #,other primary
1165,1,1,Clinical lab p16,p16 unkown
1165,1,1,Radiation Dosage,61.6
1165,1,1,Research lab p16,p16 unknown
1165,1,1,Metastasis,M0
1166,1,1,Tumor Stage,T2
1166,1,1,1st Failure Type,no known failure
1166,1,1,Tumor Site,oropharynx
1166,1,1,2nd Failure Type,no known failure
1166,1,1,Treatment Modality,Sx
1166,1,1,Overall Stage,IVa
1166,1,1,Nodal Stage,N2
1166,1,1,Research lab p16,p16 unknown
1166,1,1,Occurrence #,recurrence
1166,1,1,Research lab HPV,HPV unknown
1166,1,1,Metastasis,M0
1166,1,1,Clinical lab p16,p16 unkown
1167,1,1,Clinical lab p16,p16 unkown
1167,1,1,Second Line Chemotherapy Agent,carbo
1167,1,1,Nodal Stage,N2
1167,1,1,Treatment Modality,CTX-RT
1167,1,1,2nd Failure Type,no known failure
1167,1,1,Occurrence #,1st primary
1167,1,1,Tumor Site,oropharynx
1167,1,1,Tumor Stage,T3
1167,1,1,Overall Stage,IVa
1167,1,1,1st Failure Type,no known failure
1167,1,1,Radiation Dosage,70.2
1167,1,1,Metastasis,M0
1167,1,1,Research lab HPV,HPV unknown
1167,1,1,Initial Chemotherapy Agent,cis
1167,1,1,Research lab p16,p16 unknown
1168,1,1,Nodal Stage,Unknown
1168,1,1,Overall Stage,Unknown
1168,1,1,Treatment Modality,Unknown
1168,1,1,Research lab HPV,HPV unknown
1168,1,1,Metastasis,Unknown
1168,1,1,2nd Failure Type,no known failure
1168,1,1,Occurrence #,1st primary
1168,1,1,1st Failure Type,no known failure
1168,1,1,Clinical lab p16,p16 unkown
1168,1,1,Tumor Stage,Unknown
1168,1,1,Research lab p16,p16 unknown
1168,1,1,Tumor Site,oropharynx
1169,1,1,Nodal Stage,N2
1169,1,1,Occurrence #,1st primary
1169,1,1,Clinical lab p16,p16 unkown
1169,1,1,Overall Stage,IVa
1169,1,1,Tumor Site,oropharynx
1169,1,1,2nd Failure Type,no known failure
1169,1,1,1st Failure Type,no known failure
1169,1,1,Metastasis,M0
1169,1,1,Treatment Modality,Unknown
1169,1,1,Tumor Stage,T4a
1169,1,1,Research lab p16,p16 unknown
1169,1,1,Research lab HPV,HPV unknown
1170,1,1,Research lab HPV,HPV unknown
1170,1,1,Overall Stage,III
1170,1,1,Nodal Stage,Unknown
1170,1,1,Research lab p16,p16 unknown
1170,1,1,Tumor Stage,Unknown
1170,1,1,Treatment Modality,CTX-RT
1170,1,1,Radiation Dosage,unknown
1170,1,1,Initial Chemotherapy Agent,unknown
1170,1,1,Metastasis,M0
1170,1,1,2nd Failure Type,no known failure
1170,1,1,Occurrence #,1st primary
1170,1,1,Tumor Site,oropharynx
1170,1,1,1st Failure Type,no known failure
1170,1,1,Clinical lab p16,p16 unkown
1171,1,1,Research lab p16,p16 unknown
1171,1,1,Radiation Dosage,70.2
1171,1,1,Occurrence #,1st primary
1171,1,1,2nd Failure Type,no known failure
1171,1,1,Tumor Site,oropharynx
1171,1,1,Overall Stage,III
1171,1,1,Treatment Modality,CTX-RT
1171,1,1,Tumor Stage,T2
1171,1,1,Nodal Stage,N1
1171,1,1,Initial Chemotherapy Agent,cis
1171,1,1,1st Failure Type,no known failure
1171,1,1,Metastasis,M0
1171,1,1,Clinical lab p16,p16 unkown
1171,1,1,Research lab HPV,HPV positive
1172,1,1,Nodal Stage,N0
1172,1,1,2nd Failure Type,no known failure
1172,1,1,Research lab HPV,HPV unknown
1172,1,1,Initial Chemotherapy Agent,unknown
1172,1,1,Overall Stage,III
1172,1,1,Occurrence #,1st primary
1172,1,1,Radiation Dosage,unknown
1172,1,1,Clinical lab p16,p16 unkown
1172,1,1,Tumor Site,oropharynx
1172,1,1,Tumor Stage,T3
1172,1,1,Metastasis,M0
1172,1,1,1st Failure Type,locoregional
1172,1,1,Research lab p16,p16 unknown
1172,1,1,Treatment Modality,Sx & CTX-RT
1174,1,1,Tumor Stage,T2
1174,1,1,1st Failure Type,no known failure
1174,1,1,2nd Failure Type,no known failure
1174,1,1,Radiation Dosage,63
1174,1,1,Research lab HPV,HPV unknown
1174,1,1,Metastasis,M0
1174,1,1,Tumor Site,oropharynx
1174,1,1,Research lab p16,p16 unknown
1174,1,1,Overall Stage,II
1174,1,1,Occurrence #,other primary
1174,1,1,Clinical lab p16,p16 unkown
1174,1,1,Treatment Modality,Sx & RT
1174,1,1,Nodal Stage,N0
1175,1,1,1st Failure Type,no known failure
1175,1,1,Radiation Dosage,70.2
1175,1,1,Research lab HPV,HPV unknown
1175,1,1,Nodal Stage,N2
1175,1,1,Research lab p16,p16 unknown
1175,1,1,Overall Stage,IVa
1175,1,1,Initial Chemotherapy Agent,carbo
1175,1,1,Metastasis,M0
1175,1,1,Clinical lab p16,p16 unkown
1175,1,1,Tumor Site,oropharynx
1175,1,1,Treatment Modality,CTX-RT
1175,1,1,Occurrence #,1st primary
1175,1,1,2nd Failure Type,no known failure
1175,1,1,Tumor Stage,T2
1176,1,1,Clinical lab p16,p16 unkown
1176,1,1,Occurrence #,recurrence
1176,1,1,Tumor Stage,T2
1176,1,1,Radiation Dosage,unknown
1176,1,1,Initial Chemotherapy Agent,carbo/PTX
1176,1,1,2nd Failure Type,no known failure
1176,1,1,Overall Stage,II
1176,1,1,Treatment Modality,Sx & CTX-RT
1176,1,1,Research lab p16,p16 unknown
1176,1,1,Nodal Stage,N0
1176,1,1,Metastasis,M0
1176,1,1,Research lab HPV,HPV unknown
1176,1,1,1st Failure Type,no known failure
1176,1,1,Tumor Site,oropharynx
1177,1,1,Research lab p16,p16 unknown
1177,1,1,Overall Stage,Unknown
1177,1,1,Clinical lab p16,p16 unkown
1177,1,1,Occurrence #,recurrence
1177,1,1,Research lab HPV,HPV unknown
1177,1,1,2nd Failure Type,no known failure
1177,1,1,Treatment Modality,Unknown
1177,1,1,Tumor Site,oropharynx
1177,1,1,Nodal Stage,Unknown
1177,1,1,Tumor Stage,Unknown
1177,1,1,Metastasis,Unknown
1177,1,1,1st Failure Type,no known failure
1178,1,1,Overall Stage,III
1178,1,1,Research lab HPV,HPV positive
1178,1,1,Occurrence #,1st primary
1178,1,1,2nd Failure Type,no known failure
1178,1,1,Nodal Stage,N1
1178,1,1,Research lab p16,p16 unknown
1178,1,1,Clinical lab p16,p16 positive
1178,1,1,Tumor Stage,T1
1178,1,1,Metastasis,M0
1178,1,1,Radiation Dosage,64
1178,1,1,Tumor Site,oropharynx
1178,1,1,Treatment Modality,Sx & RT
1178,1,1,1st Failure Type,no known failure
1179,1,1,Research lab HPV,HPV unknown
1179,1,1,Research lab p16,p16 unknown
1179,1,1,1st Failure Type,no known failure
1179,1,1,Radiation Dosage,66
1179,1,1,Metastasis,M0
1179,1,1,Tumor Stage,T1
1179,1,1,Tumor Site,oropharynx
1179,1,1,Treatment Modality,RT
1179,1,1,Clinical lab p16,p16 unkown
1179,1,1,Overall Stage,I
1179,1,1,Occurrence #,1st primary
1179,1,1,2nd Failure Type,no known failure
1179,1,1,Nodal Stage,N0
1180,1,1,Research lab HPV,HPV unknown
1180,1,1,Treatment Modality,RT
1180,1,1,1st Failure Type,no known failure
1180,1,1,Metastasis,M0
1180,1,1,Tumor Site,oropharynx
1180,1,1,Clinical lab p16,p16 unkown
1180,1,1,Overall Stage,II
1180,1,1,2nd Failure Type,no known failure
1180,1,1,Tumor Stage,T2
1180,1,1,Research lab p16,p16 unknown
1180,1,1,Occurrence #,1st primary
1180,1,1,Radiation Dosage,66.6
1180,1,1,Nodal Stage,N0
1181,1,1,Treatment Modality,Unknown
1181,1,1,Research lab HPV,HPV unknown
1181,1,1,1st Failure Type,no known failure
1181,1,1,Nodal Stage,N2
1181,1,1,2nd Failure Type,no known failure
1181,1,1,Overall Stage,IVa
1181,1,1,Research lab p16,p16 unknown
1181,1,1,Occurrence #,1st primary
1181,1,1,Metastasis,M0
1181,1,1,Tumor Site,oropharynx
1181,1,1,Tumor Stage,T3
1181,1,1,Clinical lab p16,p16 unkown
1182,1,1,Metastasis,M0
1182,1,1,Clinical lab p16,p16 unkown
1182,1,1,Tumor Site,oropharynx
1182,1,1,Treatment Modality,Sx
1182,1,1,1st Failure Type,no known failure
1182,1,1,Overall Stage,II
1182,1,1,Nodal Stage,N0
1182,1,1,Occurrence #,other primary
1182,1,1,Tumor Stage,T2
1182,1,1,Research lab p16,p16 unknown
1182,1,1,Research lab HPV,HPV unknown
1182,1,1,2nd Failure Type,no known failure
1183,1,1,2nd Failure Type,no known failure
1183,1,1,Research lab HPV,HPV positive
1183,1,1,Treatment Modality,Unknown
1183,1,1,Research lab p16,p16 unknown
1183,1,1,Nodal Stage,N2
1183,1,1,Tumor Stage,T2
1183,1,1,Tumor Site,oropharynx
1183,1,1,Clinical lab p16,p16 unkown
1183,1,1,Metastasis,M0
1183,1,1,Overall Stage,IVa
1183,1,1,1st Failure Type,no known failure
1183,1,1,Occurrence #,1st primary
1184,1,1,Research lab HPV,HPV unknown
1184,1,1,Nodal Stage,N2
1184,1,1,Research lab p16,p16 unknown
1184,1,1,1st Failure Type,no known failure
1184,1,1,Tumor Stage,T4a
1184,1,1,Metastasis,M0
1184,1,1,Occurrence #,1st primary
1184,1,1,Radiation Dosage,34.2
1184,1,1,Tumor Site,oropharynx
1184,1,1,Clinical lab p16,p16 unkown
1184,1,1,2nd Failure Type,no known failure
1184,1,1,Treatment Modality,CTX-RT
1184,1,1,Initial Chemotherapy Agent,unknown
1184,1,1,Overall Stage,IVa
1185,1,1,Overall Stage,I
1185,1,1,Clinical lab p16,p16 unkown
1185,1,1,Research lab p16,p16 unknown
1185,1,1,Research lab HPV,HPV unknown
1185,1,1,Metastasis,M0
1185,1,1,Tumor Site,oropharynx
1185,1,1,2nd Failure Type,no known failure
1185,1,1,Treatment Modality,Sx
1185,1,1,Tumor Stage,T1
1185,1,1,Nodal Stage,N0
1185,1,1,1st Failure Type,no known failure
1185,1,1,Occurrence #,other primary
1186,1,1,Clinical lab p16,p16 unkown
1186,1,1,Occurrence #,1st primary
1186,1,1,Overall Stage,I
1186,1,1,Metastasis,M0
1186,1,1,Treatment Modality,Sx
1186,1,1,2nd Failure Type,no known failure
1186,1,1,Research lab p16,p16 unknown
1186,1,1,Tumor Stage,T1
1186,1,1,1st Failure Type,no known failure
1186,1,1,Research lab HPV,HPV unknown
1186,1,1,Tumor Site,oral cavity
1186,1,1,Nodal Stage,N0
1187,1,1,Treatment Modality,CTX-RT
1187,1,1,1st Failure Type,no known failure
1187,1,1,Research lab p16,p16 unknown
1187,1,1,Radiation Dosage,70.2
1187,1,1,Research lab HPV,HPV unknown
1187,1,1,Tumor Stage,T2
1187,1,1,Occurrence #,1st primary
1187,1,1,Clinical lab p16,p16 unkown
1187,1,1,Initial Chemotherapy Agent,cis
1187,1,1,2nd Failure Type,no known failure
1187,1,1,Metastasis,M0
1187,1,1,Overall Stage,IVa
1187,1,1,Tumor Site,oropharynx
1187,1,1,Nodal Stage,N2
1188,1,1,Overall Stage,IVa
1188,1,1,Tumor Site,oropharynx
1188,1,1,Tumor Stage,T2
1188,1,1,Research lab p16,p16 unknown
1188,1,1,Treatment Modality,CTX-RT
1188,1,1,Nodal Stage,N2
1188,1,1,Research lab HPV,HPV unknown
1188,1,1,Clinical lab p16,p16 unkown
1188,1,1,Radiation Dosage,70.2
1188,1,1,Initial Chemotherapy Agent,cis
1188,1,1,1st Failure Type,no known failure
1188,1,1,Occurrence #,1st primary
1188,1,1,Metastasis,M0
1188,1,1,2nd Failure Type,no known failure
1189,1,1,Nodal Stage,N1
1189,1,1,Occurrence #,1st primary
1189,1,1,Research lab HPV,HPV unknown
1189,1,1,1st Failure Type,no known failure
1189,1,1,Tumor Stage,T2
1189,1,1,2nd Failure Type,no known failure
1189,1,1,Overall Stage,III
1189,1,1,Radiation Dosage,70.2
1189,1,1,Metastasis,M0
1189,1,1,Initial Chemotherapy Agent,cis
1189,1,1,Research lab p16,p16 unknown
1189,1,1,Tumor Site,oropharynx
1189,1,1,Treatment Modality,CTX-RT
1189,1,1,Clinical lab p16,p16 unkown
1190,1,1,2nd Failure Type,no known failure
1190,1,1,1st Failure Type,no known failure
1190,1,1,Nodal Stage,N1
1190,1,1,Research lab HPV,HPV unknown
1190,1,1,Occurrence #,1st primary
1190,1,1,Tumor Site,oropharynx
1190,1,1,Initial Chemotherapy Agent,carbo
1190,1,1,Metastasis,M0
1190,1,1,Treatment Modality,CTX-RT
1190,1,1,Overall Stage,III
1190,1,1,Tumor Stage,T3
1190,1,1,Research lab p16,p16 unknown
1190,1,1,Clinical lab p16,p16 unkown
1190,1,1,Radiation Dosage,unknown
1191,1,1,Research lab HPV,HPV unknown
1191,1,1,Clinical lab p16,p16 unkown
1191,1,1,Occurrence #,recurrence
1191,1,1,Overall Stage,IVa
1191,1,1,Tumor Site,oropharynx
1191,1,1,1st Failure Type,no known failure
1191,1,1,Nodal Stage,N2
1191,1,1,2nd Failure Type,no known failure
1191,1,1,Treatment Modality,CTX-RT
1191,1,1,Radiation Dosage,72
1191,1,1,Research lab p16,p16 unknown
1191,1,1,Metastasis,M0
1191,1,1,Tumor Stage,T1
1191,1,1,Initial Chemotherapy Agent,carbo/PTX
1192,1,1,Tumor Site,oral cavity
1192,1,1,Nodal Stage,N0
1192,1,1,Treatment Modality,Sx
1192,1,1,Tumor Stage,T4a
1192,1,1,Research lab p16,p16 unknown
1192,1,1,Metastasis,M0
1192,1,1,2nd Failure Type,no known failure
1192,1,1,Clinical lab p16,p16 unkown
1192,1,1,1st Failure Type,locoregional
1192,1,1,Research lab HPV,HPV unknown
1192,1,1,Overall Stage,IVa
1192,1,1,Occurrence #,recurrence
1193,1,1,2nd Failure Type,no known failure
1193,1,1,Tumor Site,oropharynx
1193,1,1,Initial Chemotherapy Agent,cis
1193,1,1,Metastasis,M0
1193,1,1,Nodal Stage,N2
1193,1,1,Treatment Modality,CTX-RT
1193,1,1,Radiation Dosage,70.2
1193,1,1,Clinical lab p16,p16 unkown
1193,1,1,Occurrence #,1st primary
1193,1,1,Research lab HPV,HPV positive
1193,1,1,Overall Stage,IVa
1193,1,1,1st Failure Type,no known failure
1193,1,1,Research lab p16,p16 unknown
1193,1,1,Tumor Stage,T1
1194,1,1,Nodal Stage,N3
1194,1,1,Metastasis,M0
1194,1,1,Clinical lab p16,p16 unkown
1194,1,1,Occurrence #,1st primary
1194,1,1,Initial Chemotherapy Agent,cis
1194,1,1,Radiation Dosage,70.2
1194,1,1,Tumor Site,oropharynx
1194,1,1,2nd Failure Type,no known failure
1194,1,1,Tumor Stage,T1
1194,1,1,Research lab HPV,HPV unknown
1194,1,1,Overall Stage,IVb
1194,1,1,1st Failure Type,no known failure
1194,1,1,Treatment Modality,CTX-RT
1194,1,1,Research lab p16,p16 unknown
1195,1,1,Tumor Stage,Unknown
1195,1,1,Overall Stage,Unknown
1195,1,1,Research lab p16,p16 unknown
1195,1,1,Occurrence #,1st primary
1195,1,1,2nd Failure Type,no known failure
1195,1,1,Tumor Site,oropharynx
1195,1,1,Clinical lab p16,p16 unkown
1195,1,1,Metastasis,Unknown
1195,1,1,Treatment Modality,Unknown
1195,1,1,1st Failure Type,no known failure
1195,1,1,Research lab HPV,HPV unknown
1195,1,1,Nodal Stage,Unknown
1196,1,1,Tumor Stage,T4a
1196,1,1,Initial Chemotherapy Agent,cis/PTX/5-FU
1196,1,1,Tumor Site,oropharynx
1196,1,1,Research lab HPV,HPV negative
1196,1,1,Research lab p16,p16 unknown
1196,1,1,1st Failure Type,no known failure
1196,1,1,Occurrence #,1st primary
1196,1,1,Metastasis,M1
1196,1,1,Clinical lab p16,p16 negative
1196,1,1,2nd Failure Type,no known failure
1196,1,1,Overall Stage,IVc
1196,1,1,Nodal Stage,N3
1196,1,1,Treatment Modality,CTX
1197,1,1,Initial Chemotherapy Agent,cis
1197,1,1,Occurrence #,1st primary
1197,1,1,1st Failure Type,no known failure
1197,1,1,2nd Failure Type,no known failure
1197,1,1,Research lab HPV,HPV positive
1197,1,1,Nodal Stage,N2
1197,1,1,Radiation Dosage,70.2
1197,1,1,Overall Stage,IVa
1197,1,1,Metastasis,M0
1197,1,1,Tumor Stage,T4a
1197,1,1,Clinical lab p16,p16 unkown
1197,1,1,Second Line Chemotherapy Agent,carbo
1197,1,1,Treatment Modality,CTX-RT
1197,1,1,Tumor Site,oropharynx
1197,1,1,Research lab p16,p16 unknown
1198,1,1,Clinical lab p16,p16 unkown
1198,1,1,Nodal Stage,N2
1198,1,1,Research lab HPV,HPV unknown
1198,1,1,2nd Failure Type,no known failure
1198,1,1,Overall Stage,IVa
1198,1,1,Metastasis,M0
1198,1,1,Treatment Modality,CTX-RT
1198,1,1,Tumor Site,oropharynx
1198,1,1,Radiation Dosage,70.2
1198,1,1,Occurrence #,1st primary
1198,1,1,Tumor Stage,T2
1198,1,1,1st Failure Type,no known failure
1198,1,1,Research lab p16,p16 unknown
1198,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1199,1,1,Overall Stage,IVb
1199,1,1,Research lab p16,p16 unknown
1199,1,1,Occurrence #,1st primary
1199,1,1,Treatment Modality,CTX-RT
1199,1,1,Tumor Stage,T3
1199,1,1,Clinical lab p16,p16 unkown
1199,1,1,1st Failure Type,no known failure
1199,1,1,Metastasis,M0
1199,1,1,Radiation Dosage,70.2
1199,1,1,Research lab HPV,HPV unknown
1199,1,1,Initial Chemotherapy Agent,unknown
1199,1,1,Nodal Stage,N3
1199,1,1,Tumor Site,oropharynx
1199,1,1,2nd Failure Type,no known failure
1200,1,1,Initial Chemotherapy Agent,cis
1200,1,1,Occurrence #,1st primary
1200,1,1,2nd Failure Type,no known failure
1200,1,1,Tumor Stage,T3
1200,1,1,Second Line Chemotherapy Agent,carbo/doce
1200,1,1,Overall Stage,IVb
1200,1,1,Treatment Modality,Sx & CTX-RT
1200,1,1,Tumor Site,oropharynx
1200,1,1,Research lab p16,p16 unknown
1200,1,1,Clinical lab p16,p16 unkown
1200,1,1,Research lab HPV,HPV unknown
1200,1,1,1st Failure Type,locoregional and distant
1200,1,1,Metastasis,M0
1200,1,1,Radiation Dosage,70.2
1200,1,1,Nodal Stage,N3
1201,1,1,Radiation Dosage,70.2
1201,1,1,2nd Failure Type,no known failure
1201,1,1,Initial Chemotherapy Agent,carbo/PTX
1201,1,1,Clinical lab p16,p16 unkown
1201,1,1,Research lab HPV,HPV unknown
1201,1,1,Overall Stage,IVa
1201,1,1,Occurrence #,1st primary
1201,1,1,Treatment Modality,Sx & CTX-RT
1201,1,1,Research lab p16,p16 unknown
1201,1,1,Tumor Stage,T3
1201,1,1,Tumor Site,oropharynx
1201,1,1,Nodal Stage,N2
1201,1,1,1st Failure Type,no known failure
1201,1,1,Metastasis,M0
1202,1,1,2nd Failure Type,no known failure
1202,1,1,Tumor Stage,Unknown
1202,1,1,Tumor Site,oropharynx
1202,1,1,1st Failure Type,no known failure
1202,1,1,Nodal Stage,Unknown
1202,1,1,Overall Stage,IVc
1202,1,1,Research lab p16,p16 unknown
1202,1,1,Treatment Modality,RT
1202,1,1,Metastasis,M1
1202,1,1,Occurrence #,1st primary
1202,1,1,Radiation Dosage,105
1202,1,1,Clinical lab p16,p16 unkown
1202,1,1,Research lab HPV,HPV unknown
1203,1,1,Clinical lab p16,p16 positive
1203,1,1,1st Failure Type,no known failure
1203,1,1,2nd Failure Type,no known failure
1203,1,1,Nodal Stage,N2
1203,1,1,Research lab HPV,HPV positive
1203,1,1,Metastasis,M0
1203,1,1,Research lab p16,p16 unknown
1203,1,1,Treatment Modality,Sx & CTX-RT
1203,1,1,Overall Stage,IVa
1203,1,1,Radiation Dosage,59.4
1203,1,1,Initial Chemotherapy Agent,cis
1203,1,1,Occurrence #,1st primary
1203,1,1,Tumor Site,oropharynx
1203,1,1,Tumor Stage,T1
1204,1,1,2nd Failure Type,no known failure
1204,1,1,Research lab p16,p16 unknown
1204,1,1,Tumor Stage,T1
1204,1,1,Metastasis,M0
1204,1,1,Nodal Stage,N2
1204,1,1,Radiation Dosage,70
1204,1,1,1st Failure Type,no known failure
1204,1,1,Clinical lab p16,p16 unkown
1204,1,1,Research lab HPV,HPV positive
1204,1,1,Tumor Site,oropharynx
1204,1,1,Occurrence #,1st primary
1204,1,1,Overall Stage,IVa
1204,1,1,Treatment Modality,RT
1205,1,1,1st Failure Type,no known failure
1205,1,1,Nodal Stage,N2
1205,1,1,Tumor Stage,T3
1205,1,1,Research lab HPV,HPV positive
1205,1,1,Clinical lab p16,p16 positive
1205,1,1,Metastasis,M0
1205,1,1,Overall Stage,IVa
1205,1,1,Tumor Site,oropharynx
1205,1,1,2nd Failure Type,no known failure
1205,1,1,Treatment Modality,Unknown
1205,1,1,Occurrence #,1st primary
1205,1,1,Research lab p16,p16 unknown
1206,1,1,Occurrence #,1st primary
1206,1,1,Tumor Stage,T2
1206,1,1,Tumor Site,oropharynx
1206,1,1,Research lab HPV,HPV unknown
1206,1,1,2nd Failure Type,no known failure
1206,1,1,Metastasis,M0
1206,1,1,1st Failure Type,no known failure
1206,1,1,Clinical lab p16,p16 unkown
1206,1,1,Overall Stage,IVb
1206,1,1,Treatment Modality,Unknown
1206,1,1,Nodal Stage,N3
1206,1,1,Research lab p16,p16 unknown
1207,1,1,Metastasis,M0
1207,1,1,Radiation Dosage,70.2
1207,1,1,2nd Failure Type,no known failure
1207,1,1,Research lab HPV,HPV unknown
1207,1,1,Clinical lab p16,p16 unkown
1207,1,1,Tumor Stage,T1
1207,1,1,Tumor Site,oropharynx
1207,1,1,Research lab p16,p16 unknown
1207,1,1,Occurrence #,1st primary
1207,1,1,Nodal Stage,N2
1207,1,1,Treatment Modality,CTX-RT
1207,1,1,Overall Stage,IVa
1207,1,1,1st Failure Type,no known failure
1207,1,1,Initial Chemotherapy Agent,cis
1208,1,1,Tumor Stage,T1
1208,1,1,Nodal Stage,N2
1208,1,1,1st Failure Type,no known failure
1208,1,1,Occurrence #,1st primary
1208,1,1,Initial Chemotherapy Agent,cis/carbo
1208,1,1,Tumor Site,oropharynx
1208,1,1,Treatment Modality,Sx & CTX-RT
1208,1,1,Metastasis,M0
1208,1,1,Clinical lab p16,p16 unkown
1208,1,1,2nd Failure Type,no known failure
1208,1,1,Research lab p16,p16 unknown
1208,1,1,Radiation Dosage,70.2
1208,1,1,Overall Stage,IVa
1208,1,1,Research lab HPV,HPV unknown
1209,1,1,Nodal Stage,Unknown
1209,1,1,2nd Failure Type,no known failure
1209,1,1,Occurrence #,1st primary
1209,1,1,Research lab p16,p16 unknown
1209,1,1,1st Failure Type,no known failure
1209,1,1,Research lab HPV,HPV unknown
1209,1,1,Treatment Modality,Unknown
1209,1,1,Overall Stage,Unknown
1209,1,1,Tumor Stage,Unknown
1209,1,1,Metastasis,Unknown
1209,1,1,Tumor Site,oropharynx
1209,1,1,Clinical lab p16,p16 unkown
1210,1,1,Research lab p16,p16 unknown
1210,1,1,Tumor Stage,T3
1210,1,1,Radiation Dosage,15
1210,1,1,1st Failure Type,no known failure
1210,1,1,Research lab HPV,HPV unknown
1210,1,1,Nodal Stage,N3
1210,1,1,Initial Chemotherapy Agent,cis/PTX
1210,1,1,2nd Failure Type,no known failure
1210,1,1,Occurrence #,1st primary
1210,1,1,Metastasis,M0
1210,1,1,Treatment Modality,CTX-RT
1210,1,1,Tumor Site,oropharynx
1210,1,1,Clinical lab p16,p16 unkown
1210,1,1,Overall Stage,IVb
1211,1,1,2nd Failure Type,no known failure
1211,1,1,Initial Chemotherapy Agent,cetux
1211,1,1,Research lab HPV,HPV unknown
1211,1,1,Metastasis,M0
1211,1,1,Occurrence #,other primary
1211,1,1,Clinical lab p16,p16 unkown
1211,1,1,Overall Stage,III
1211,1,1,Research lab p16,p16 unknown
1211,1,1,Tumor Site,oropharynx
1211,1,1,Treatment Modality,Sx & CTX
1211,1,1,Tumor Stage,T3
1211,1,1,Nodal Stage,N0
1211,1,1,1st Failure Type,locoregional
1212,1,1,Occurrence #,1st primary
1212,1,1,Tumor Stage,T1
1212,1,1,Tumor Site,oropharynx
1212,1,1,2nd Failure Type,no known failure
1212,1,1,Treatment Modality,Sx
1212,1,1,Clinical lab p16,p16 unkown
1212,1,1,Overall Stage,I
1212,1,1,Metastasis,M0
1212,1,1,Research lab p16,p16 unknown
1212,1,1,Research lab HPV,HPV unknown
1212,1,1,Nodal Stage,N0
1212,1,1,1st Failure Type,no known failure
1213,1,1,Research lab p16,p16 unknown
1213,1,1,1st Failure Type,locoregional
1213,1,1,Treatment Modality,CTX-RT
1213,1,1,Metastasis,M0
1213,1,1,Initial Chemotherapy Agent,carbo
1213,1,1,Clinical lab p16,p16 unkown
1213,1,1,Overall Stage,IVa
1213,1,1,Tumor Stage,T2
1213,1,1,Tumor Site,oropharynx
1213,1,1,Occurrence #,1st primary
1213,1,1,Nodal Stage,N2
1213,1,1,Research lab HPV,HPV positive
1213,1,1,Radiation Dosage,70.2
1213,1,1,2nd Failure Type,no known failure
1214,1,1,2nd Failure Type,no known failure
1214,1,1,Tumor Stage,T3
1214,1,1,Research lab p16,p16 unknown
1214,1,1,Occurrence #,recurrence
1214,1,1,1st Failure Type,no known failure
1214,1,1,Treatment Modality,Sx
1214,1,1,Metastasis,M0
1214,1,1,Overall Stage,III
1214,1,1,Clinical lab p16,p16 unkown
1214,1,1,Tumor Site,oropharynx
1214,1,1,Nodal Stage,N0
1214,1,1,Research lab HPV,HPV unknown
1215,1,1,Occurrence #,1st primary
1215,1,1,Tumor Stage,T3
1215,1,1,Tumor Site,oropharynx
1215,1,1,Clinical lab p16,p16 unkown
1215,1,1,Overall Stage,III
1215,1,1,Initial Chemotherapy Agent,cis
1215,1,1,Metastasis,M0
1215,1,1,Treatment Modality,CTX-RT
1215,1,1,Research lab p16,p16 unknown
1215,1,1,2nd Failure Type,no known failure
1215,1,1,Research lab HPV,HPV unknown
1215,1,1,Radiation Dosage,70.2
1215,1,1,1st Failure Type,no known failure
1215,1,1,Nodal Stage,N1
1216,1,1,Tumor Stage,Unknown
1216,1,1,Clinical lab p16,p16 unkown
1216,1,1,1st Failure Type,distant
1216,1,1,Overall Stage,IVc
1216,1,1,Initial Chemotherapy Agent,carbo/PTX
1216,1,1,Metastasis,M1
1216,1,1,1st Failure Radiation Dosage,40
1216,1,1,Treatment Modality,CTX
1216,1,1,2nd Failure Type,no known failure
1216,1,1,Research lab p16,p16 unknown
1216,1,1,Tumor Site,oropharynx
1216,1,1,Nodal Stage,Unknown
1216,1,1,1st Failure Treatment Modality,CTX-RT
1216,1,1,Research lab HPV,HPV unknown
1216,1,1,Occurrence #,recurrence
1216,1,1,1st Failure Initial Chemotherapy Agent,HPV/MAGE
1217,1,1,Research lab HPV,HPV positive
1217,1,1,Overall Stage,IVa
1217,1,1,Treatment Modality,CTX-RT
1217,1,1,Nodal Stage,N2
1217,1,1,Tumor Site,oropharynx
1217,1,1,Metastasis,M0
1217,1,1,Radiation Dosage,unknown
1217,1,1,Initial Chemotherapy Agent,cetux
1217,1,1,2nd Failure Type,no known failure
1217,1,1,Occurrence #,1st primary
1217,1,1,1st Failure Site,oropharynx
1217,1,1,Tumor Stage,T1
1217,1,1,Research lab p16,p16 unknown
1217,1,1,1st Failure Type,locoregional
1217,1,1,1st Failure Treatment Modality,Sx
1217,1,1,Clinical lab p16,p16 unkown
1218,1,1,Nodal Stage,Unknown
1218,1,1,Clinical lab p16,p16 unkown
1218,1,1,Tumor Stage,Unknown
1218,1,1,Occurrence #,recurrence
1218,1,1,1st Failure Type,no known failure
1218,1,1,Overall Stage,IVc
1218,1,1,Tumor Site,oropharynx
1218,1,1,Research lab p16,p16 unknown
1218,1,1,Metastasis,M1
1218,1,1,Treatment Modality,Unknown
1218,1,1,2nd Failure Type,no known failure
1218,1,1,Research lab HPV,HPV unknown
1219,1,1,Treatment Modality,Sx & CTX-RT
1219,1,1,Occurrence #,1st primary
1219,1,1,Second Line Chemotherapy Agent,carbo/PTX
1219,1,1,1st Failure Type,no known failure
1219,1,1,Clinical lab p16,p16 unkown
1219,1,1,Tumor Site,oropharynx
1219,1,1,Tumor Stage,T1
1219,1,1,Research lab p16,p16 unknown
1219,1,1,2nd Failure Type,no known failure
1219,1,1,Overall Stage,IVa
1219,1,1,Research lab HPV,HPV unknown
1219,1,1,Radiation Dosage,70.2
1219,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
1219,1,1,Nodal Stage,N2
1219,1,1,Metastasis,M0
1220,1,1,2nd Failure Type,no known failure
1220,1,1,Radiation Dosage,70.2
1220,1,1,Research lab HPV,HPV unknown
1220,1,1,Tumor Site,oropharynx
1220,1,1,Research lab p16,p16 unknown
1220,1,1,Nodal Stage,N2
1220,1,1,Occurrence #,1st primary
1220,1,1,1st Failure Type,no known failure
1220,1,1,Initial Chemotherapy Agent,cis
1220,1,1,Tumor Stage,T2
1220,1,1,Treatment Modality,CTX-RT
1220,1,1,Metastasis,M0
1220,1,1,Overall Stage,IVa
1220,1,1,Clinical lab p16,p16 unkown
1221,1,1,1st Failure Site,hypopharynx
1221,1,1,Occurrence #,1st primary
1221,1,1,Nodal Stage,N1
1221,1,1,Treatment Modality,Sx
1221,1,1,Research lab HPV,HPV unknown
1221,1,1,Overall Stage,IVa
1221,1,1,Tumor Site,oropharynx
1221,1,1,2nd Failure Type,no known failure
1221,1,1,1st Failure Type,locoregional
1221,1,1,Clinical lab p16,p16 unkown
1221,1,1,Metastasis,M0
1221,1,1,Tumor Stage,T4a
1221,1,1,Research lab p16,p16 unknown
1223,1,1,Overall Stage,II
1223,1,1,1st Failure Type,locoregional
1223,1,1,Metastasis,M0
1223,1,1,Treatment Modality,RT
1223,1,1,Clinical lab p16,p16 negative
1223,1,1,Occurrence #,1st primary
1223,1,1,Tumor Site,oropharynx
1223,1,1,Radiation Dosage,74.4
1223,1,1,Research lab HPV,HPV unknown
1223,1,1,1st Failure Treatment Modality,Sx
1223,1,1,Tumor Stage,T2
1223,1,1,Nodal Stage,N0
1223,1,1,1st Failure Site,oropharynx
1223,1,1,Research lab p16,p16 unknown
1223,1,1,2nd Failure Type,no known failure
1224,1,1,2nd Failure Type,no known failure
1224,1,1,Metastasis,M0
1224,1,1,Tumor Stage,T1
1224,1,1,Overall Stage,IVb
1224,1,1,Treatment Modality,Sx
1224,1,1,Occurrence #,1st primary
1224,1,1,Clinical lab p16,p16 unkown
1224,1,1,Nodal Stage,N3
1224,1,1,Tumor Site,oropharynx
1224,1,1,1st Failure Type,no known failure
1224,1,1,Research lab HPV,HPV unknown
1224,1,1,Research lab p16,p16 unknown
1225,1,1,Treatment Modality,Unknown
1225,1,1,Occurrence #,1st primary
1225,1,1,Overall Stage,IVa
1225,1,1,Research lab p16,p16 unknown
1225,1,1,Nodal Stage,N2
1225,1,1,Metastasis,M0
1225,1,1,Tumor Stage,T4a
1225,1,1,2nd Failure Type,no known failure
1225,1,1,Tumor Site,oropharynx
1225,1,1,Clinical lab p16,p16 unkown
1225,1,1,1st Failure Type,no known failure
1225,1,1,Research lab HPV,HPV unknown
1226,1,1,Treatment Modality,Sx
1226,1,1,Research lab HPV,HPV unknown
1226,1,1,Metastasis,M0
1226,1,1,Occurrence #,1st primary
1226,1,1,Tumor Site,oropharynx
1226,1,1,Research lab p16,p16 unknown
1226,1,1,Tumor Stage,T2
1226,1,1,1st Failure Type,no known failure
1226,1,1,Nodal Stage,N1
1226,1,1,Overall Stage,III
1226,1,1,2nd Failure Type,no known failure
1226,1,1,Clinical lab p16,p16 unkown
1227,1,1,Clinical lab p16,p16 unkown
1227,1,1,2nd Failure Type,no known failure
1227,1,1,Nodal Stage,N2
1227,1,1,Occurrence #,1st primary
1227,1,1,Tumor Stage,Unknown
1227,1,1,Treatment Modality,Sx
1227,1,1,Overall Stage,IVa
1227,1,1,1st Failure Type,no known failure
1227,1,1,Metastasis,M0
1227,1,1,Tumor Site,oropharynx
1227,1,1,Research lab p16,p16 unknown
1227,1,1,Research lab HPV,HPV unknown
1228,1,1,Tumor Stage,T4a
1228,1,1,Treatment Modality,CTX-RT
1228,1,1,Overall Stage,IVa
1228,1,1,Metastasis,M0
1228,1,1,Occurrence #,1st primary
1228,1,1,Research lab HPV,HPV unknown
1228,1,1,2nd Failure Type,no known failure
1228,1,1,Tumor Site,oropharynx
1228,1,1,Research lab p16,p16 unknown
1228,1,1,Initial Chemotherapy Agent,cis
1228,1,1,Clinical lab p16,p16 unkown
1228,1,1,Nodal Stage,N2
1228,1,1,Radiation Dosage,70.2
1228,1,1,1st Failure Type,no known failure
1229,1,1,Initial Chemotherapy Agent,Carbo/PTX/cetux
1229,1,1,Nodal Stage,N3
1229,1,1,Research lab p16,p16 unknown
1229,1,1,Tumor Stage,T2
1229,1,1,2nd Failure Type,no known failure
1229,1,1,1st Failure Type,distant
1229,1,1,Second Line Chemotherapy Agent,cetux/cis/doce
1229,1,1,Metastasis,M0
1229,1,1,Occurrence #,1st primary
1229,1,1,Clinical lab p16,p16 unkown
1229,1,1,Overall Stage,IVb
1229,1,1,Tumor Site,oropharynx
1229,1,1,Radiation Dosage,70.2
1229,1,1,Research lab HPV,HPV unknown
1229,1,1,Treatment Modality,CTX-RT
1230,1,1,Occurrence #,1st primary
1230,1,1,Tumor Stage,T3
1230,1,1,Radiation Dosage,70.2
1230,1,1,1st Failure Type,no known failure
1230,1,1,Metastasis,M0
1230,1,1,Treatment Modality,Sx & CTX-RT
1230,1,1,Clinical lab p16,p16 positive
1230,1,1,2nd Failure Type,no known failure
1230,1,1,Overall Stage,III
1230,1,1,Tumor Site,oropharynx
1230,1,1,Research lab p16,p16 unknown
1230,1,1,Nodal Stage,N0
1230,1,1,Research lab HPV,HPV positive
1230,1,1,Initial Chemotherapy Agent,carbo/cetux
1231,1,1,Metastasis,M0
1231,1,1,Tumor Site,oropharynx
1231,1,1,Research lab HPV,HPV unknown
1231,1,1,Radiation Dosage,70.2
1231,1,1,Occurrence #,1st primary
1231,1,1,1st Failure Type,locoregional
1231,1,1,Treatment Modality,CTX-RT
1231,1,1,Initial Chemotherapy Agent,carbo/PTX
1231,1,1,2nd Failure Type,no known failure
1231,1,1,Research lab p16,p16 unknown
1231,1,1,Overall Stage,IVa
1231,1,1,Tumor Stage,T4a
1231,1,1,Nodal Stage,N0
1231,1,1,Clinical lab p16,p16 unkown
1232,1,1,Research lab HPV,HPV unknown
1232,1,1,Radiation Dosage,70.2
1232,1,1,Initial Chemotherapy Agent,cis
1232,1,1,Occurrence #,1st primary
1232,1,1,2nd Failure Type,no known failure
1232,1,1,Metastasis,M0
1232,1,1,Nodal Stage,N2
1232,1,1,Research lab p16,p16 unknown
1232,1,1,Tumor Site,oropharynx
1232,1,1,Treatment Modality,Sx & CTX-RT
1232,1,1,Overall Stage,IVa
1232,1,1,Tumor Stage,T1
1232,1,1,1st Failure Type,no known failure
1232,1,1,Clinical lab p16,p16 unkown
1234,1,1,Research lab p16,p16 unknown
1234,1,1,Initial Chemotherapy Agent,cis
1234,1,1,1st Failure Type,no known failure
1234,1,1,Clinical lab p16,p16 unkown
1234,1,1,Overall Stage,IVc
1234,1,1,Tumor Site,oropharynx
1234,1,1,Nodal Stage,N2
1234,1,1,Occurrence #,1st primary
1234,1,1,Tumor Stage,T2
1234,1,1,Metastasis,M1
1234,1,1,Radiation Dosage,52.2
1234,1,1,Research lab HPV,HPV unknown
1234,1,1,Treatment Modality,CTX-RT
1234,1,1,2nd Failure Type,no known failure
1235,1,1,Research lab HPV,HPV unknown
1235,1,1,Research lab p16,p16 unknown
1235,1,1,Radiation Dosage,72
1235,1,1,Occurrence #,1st primary
1235,1,1,Nodal Stage,N0
1235,1,1,Metastasis,M0
1235,1,1,Treatment Modality,Sx & RT
1235,1,1,Tumor Stage,T2
1235,1,1,1st Failure Type,no known failure
1235,1,1,2nd Failure Type,no known failure
1235,1,1,Overall Stage,II
1235,1,1,Clinical lab p16,p16 unkown
1235,1,1,Tumor Site,oropharynx
1236,1,1,Research lab HPV,HPV unknown
1236,1,1,Tumor Stage,T4a
1236,1,1,Treatment Modality,Sx
1236,1,1,Research lab p16,p16 unknown
1236,1,1,Overall Stage,IVa
1236,1,1,Nodal Stage,Unknown
1236,1,1,2nd Failure Type,no known failure
1236,1,1,Clinical lab p16,p16 unkown
1236,1,1,Metastasis,M0
1236,1,1,Tumor Site,oropharynx
1236,1,1,Occurrence #,recurrence
1236,1,1,1st Failure Type,locoregional
1237,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
1237,1,1,Nodal Stage,N2
1237,1,1,Overall Stage,IVa
1237,1,1,Clinical lab p16,p16 unkown
1237,1,1,Tumor Stage,T3
1237,1,1,Tumor Site,oropharynx
1237,1,1,2nd Failure Type,no known failure
1237,1,1,1st Failure Treatment Modality,Sx & CTX-RT
1237,1,1,Treatment Modality,CTX-RT
1237,1,1,1st Failure Radiation Dosage,60
1237,1,1,1st Failure Site,oropharynx
1237,1,1,Radiation Dosage,70.2
1237,1,1,1st Failure Type,locoregional
1237,1,1,Research lab p16,p16 unknown
1237,1,1,Metastasis,M0
1237,1,1,Initial Chemotherapy Agent,cis
1237,1,1,Research lab HPV,HPV unknown
1237,1,1,Occurrence #,1st primary
1238,1,1,Treatment Modality,Sx & CTX-RT
1238,1,1,1st Failure Type,no known failure
1238,1,1,Initial Chemotherapy Agent,unk
1238,1,1,Overall Stage,IVc
1238,1,1,Tumor Site,oropharynx
1238,1,1,Radiation Dosage,unknown
1238,1,1,Clinical lab p16,p16 negative
1238,1,1,Nodal Stage,N2
1238,1,1,Metastasis,M1
1238,1,1,2nd Failure Type,no known failure
1238,1,1,Occurrence #,1st primary
1238,1,1,Research lab HPV,HPV unknown
1238,1,1,Tumor Stage,T4a
1238,1,1,Research lab p16,p16 unknown
1239,1,1,1st Failure Type,no known failure
1239,1,1,Treatment Modality,CTX-RT
1239,1,1,Clinical lab p16,p16 unkown
1239,1,1,Metastasis,M0
1239,1,1,Radiation Dosage,60
1239,1,1,Research lab p16,p16 unknown
1239,1,1,Occurrence #,1st primary
1239,1,1,Tumor Site,oropharynx
1239,1,1,Tumor Stage,T3
1239,1,1,Research lab HPV,HPV unknown
1239,1,1,Overall Stage,IVa
1239,1,1,Nodal Stage,N2
1239,1,1,Initial Chemotherapy Agent,carbo/PTX
1239,1,1,2nd Failure Type,no known failure
1240,1,1,Overall Stage,IVa
1240,1,1,Clinical lab p16,p16 unkown
1240,1,1,Research lab p16,p16 unknown
1240,1,1,Metastasis,M0
1240,1,1,Tumor Site,oropharynx
1240,1,1,2nd Failure Type,no known failure
1240,1,1,Research lab HPV,HPV positive
1240,1,1,Treatment Modality,CTX-RT
1240,1,1,Initial Chemotherapy Agent,cis
1240,1,1,Tumor Stage,T1
1240,1,1,Radiation Dosage,70.2
1240,1,1,Occurrence #,1st primary
1240,1,1,1st Failure Type,locoregional
1240,1,1,Nodal Stage,N2
1241,1,1,Initial Chemotherapy Agent,carbo/doce/cetux
1241,1,1,Clinical lab p16,p16 unkown
1241,1,1,Research lab p16,p16 unknown
1241,1,1,Nodal Stage,N2
1241,1,1,1st Failure Type,no known failure
1241,1,1,Tumor Site,oropharynx
1241,1,1,Tumor Stage,T2
1241,1,1,Radiation Dosage,70.2
1241,1,1,Treatment Modality,Sx & CTX-RT
1241,1,1,Occurrence #,1st primary
1241,1,1,Overall Stage,IVa
1241,1,1,Metastasis,M0
1241,1,1,Research lab HPV,HPV unknown
1241,1,1,2nd Failure Type,no known failure
1243,1,1,Metastasis,M0
1243,1,1,Occurrence #,1st primary
1243,1,1,1st Failure Type,no known failure
1243,1,1,Tumor Site,oropharynx
1243,1,1,Research lab p16,p16 unknown
1243,1,1,Research lab HPV,HPV unknown
1243,1,1,2nd Failure Type,no known failure
1243,1,1,Overall Stage,IVa
1243,1,1,Treatment Modality,Sx & CTX-RT
1243,1,1,Tumor Stage,T1
1243,1,1,Clinical lab p16,p16 unkown
1243,1,1,Radiation Dosage,63
1243,1,1,Nodal Stage,N2
1243,1,1,Initial Chemotherapy Agent,cis
1244,1,1,Tumor Stage,T4a
1244,1,1,Treatment Modality,CTX-RT
1244,1,1,Nodal Stage,N2
1244,1,1,Occurrence #,1st primary
1244,1,1,2nd Failure Type,no known failure
1244,1,1,1st Failure Type,no known failure
1244,1,1,Metastasis,M0
1244,1,1,Tumor Site,oropharynx
1244,1,1,Overall Stage,IVa
1244,1,1,Radiation Dosage,70.2
1244,1,1,Initial Chemotherapy Agent,unk
1244,1,1,Research lab HPV,HPV unknown
1244,1,1,Research lab p16,p16 unknown
1244,1,1,Clinical lab p16,p16 unkown
1245,1,1,1st Failure Type,distant
1245,1,1,Research lab p16,p16 unknown
1245,1,1,Nodal Stage,N2
1245,1,1,Clinical lab p16,p16 unkown
1245,1,1,Tumor Stage,T4a
1245,1,1,Treatment Modality,CTX-RT
1245,1,1,Overall Stage,IVa
1245,1,1,Tumor Site,oropharynx
1245,1,1,2nd Failure Type,no known failure
1245,1,1,Research lab HPV,HPV unknown
1245,1,1,Radiation Dosage,70.2
1245,1,1,Initial Chemotherapy Agent,unkn
1245,1,1,Occurrence #,1st primary
1245,1,1,Metastasis,M0
1246,1,1,Nodal Stage,N3
1246,1,1,Initial Chemotherapy Agent,doce/cis/5 FU
1246,1,1,Tumor Stage,T3
1246,1,1,Occurrence #,1st primary
1246,1,1,Clinical lab p16,p16 positive
1246,1,1,Overall Stage,IVb
1246,1,1,Tumor Site,oropharynx
1246,1,1,2nd Failure Type,no known failure
1246,1,1,Research lab HPV,HPV positive
1246,1,1,Radiation Dosage,70.2
1246,1,1,Metastasis,M0
1246,1,1,Treatment Modality,CTX-RT
1246,1,1,Research lab p16,p16 unknown
1246,1,1,1st Failure Type,no known failure
1247,1,1,Tumor Site,oropharynx
1247,1,1,Overall Stage,II
1247,1,1,Research lab HPV,HPV unknown
1247,1,1,Tumor Stage,T2
1247,1,1,Treatment Modality,Sx & RT
1247,1,1,1st Failure Type,no known failure
1247,1,1,2nd Failure Type,no known failure
1247,1,1,Clinical lab p16,p16 unkown
1247,1,1,Radiation Dosage,60
1247,1,1,Occurrence #,1st primary
1247,1,1,Nodal Stage,N0
1247,1,1,Research lab p16,p16 unknown
1247,1,1,Metastasis,M0
1248,1,1,Tumor Site,oropharynx
1248,1,1,Metastasis,M0
1248,1,1,1st Failure Type,no known failure
1248,1,1,Clinical lab p16,p16 unkown
1248,1,1,Treatment Modality,RT
1248,1,1,Nodal Stage,N1
1248,1,1,Overall Stage,III
1248,1,1,Occurrence #,1st primary
1248,1,1,Research lab p16,p16 unknown
1248,1,1,2nd Failure Type,no known failure
1248,1,1,Radiation Dosage,70.2
1248,1,1,Research lab HPV,HPV unknown
1248,1,1,Tumor Stage,T1
1249,1,1,2nd Failure Type,no known failure
1249,1,1,Research lab HPV,HPV unknown
1249,1,1,Occurrence #,recurrence
1249,1,1,1st Failure Type,no known failure
1249,1,1,Treatment Modality,Sx
1249,1,1,Nodal Stage,N2
1249,1,1,Metastasis,M1
1249,1,1,Research lab p16,p16 unknown
1249,1,1,Clinical lab p16,p16 unkown
1249,1,1,Tumor Stage,T1
1249,1,1,Tumor Site,oropharynx
1249,1,1,Overall Stage,IVc
1250,1,1,1st Failure Type,no known failure
1250,1,1,Treatment Modality,CTX-RT
1250,1,1,Initial Chemotherapy Agent,cis
1250,1,1,Overall Stage,IVa
1250,1,1,Metastasis,M0
1250,1,1,2nd Failure Type,no known failure
1250,1,1,Research lab p16,p16 unknown
1250,1,1,Tumor Stage,T2
1250,1,1,Occurrence #,1st primary
1250,1,1,Research lab HPV,HPV unknown
1250,1,1,Radiation Dosage,70.2
1250,1,1,Nodal Stage,N2
1250,1,1,Clinical lab p16,p16 unkown
1250,1,1,Tumor Site,oropharynx
1251,1,1,Metastasis,M0
1251,1,1,Initial Chemotherapy Agent,unk
1251,1,1,Overall Stage,IVa
1251,1,1,Tumor Stage,T2
1251,1,1,Radiation Dosage,unknown
1251,1,1,Clinical lab p16,p16 unkown
1251,1,1,1st Failure Type,no known failure
1251,1,1,Tumor Site,oropharynx
1251,1,1,2nd Failure Type,no known failure
1251,1,1,Nodal Stage,N2
1251,1,1,Treatment Modality,CTX-RT
1251,1,1,Research lab p16,p16 unknown
1251,1,1,Research lab HPV,HPV unknown
1251,1,1,Occurrence #,1st primary
1252,1,1,Tumor Stage,T3
1252,1,1,Overall Stage,III
1252,1,1,Research lab p16,p16 unknown
1252,1,1,Clinical lab p16,p16 unkown
1252,1,1,Research lab HPV,HPV unknown
1252,1,1,Nodal Stage,N0
1252,1,1,Treatment Modality,Sx
1252,1,1,Metastasis,M0
1252,1,1,Tumor Site,oropharynx
1252,1,1,Occurrence #,other primary
1252,1,1,1st Failure Type,no known failure
1252,1,1,2nd Failure Type,no known failure
1253,1,1,Initial Chemotherapy Agent,cis
1253,1,1,Overall Stage,IVa
1253,1,1,Tumor Site,oropharynx
1253,1,1,2nd Failure Type,no known failure
1253,1,1,Metastasis,M0
1253,1,1,Treatment Modality,CTX-RT
1253,1,1,Nodal Stage,N2
1253,1,1,Clinical lab p16,p16 negative
1253,1,1,Research lab HPV,HPV negative
1253,1,1,1st Failure Type,distant
1253,1,1,Research lab p16,p16 unknown
1253,1,1,Radiation Dosage,70.2
1253,1,1,Tumor Stage,T3
1253,1,1,Occurrence #,1st primary
1254,1,1,Nodal Stage,N0
1254,1,1,Tumor Site,oropharynx
1254,1,1,Research lab p16,p16 unknown
1254,1,1,Overall Stage,I
1254,1,1,Research lab HPV,HPV unknown
1254,1,1,Treatment Modality,Sx
1254,1,1,Metastasis,M0
1254,1,1,1st Failure Type,no known failure
1254,1,1,2nd Failure Type,no known failure
1254,1,1,Tumor Stage,T1
1254,1,1,Clinical lab p16,p16 unkown
1254,1,1,Occurrence #,other primary
1255,1,1,Tumor Stage,T3
1255,1,1,Research lab p16,p16 unknown
1255,1,1,Initial Chemotherapy Agent,cis
1255,1,1,1st Failure Type,distant
1255,1,1,Overall Stage,IVc
1255,1,1,Radiation Dosage,70.2
1255,1,1,Occurrence #,1st primary
1255,1,1,Treatment Modality,CTX-RT
1255,1,1,2nd Failure Type,no known failure
1255,1,1,Tumor Site,oropharynx
1255,1,1,Clinical lab p16,p16 unkown
1255,1,1,Metastasis,M1
1255,1,1,Nodal Stage,N2
1255,1,1,Research lab HPV,HPV unknown
1256,1,1,Nodal Stage,N0
1256,1,1,Clinical lab p16,p16 unkown
1256,1,1,Overall Stage,IVa
1256,1,1,Tumor Site,oropharynx
1256,1,1,Tumor Stage,T4a
1256,1,1,Radiation Dosage,70.2
1256,1,1,1st Failure Type,no known failure
1256,1,1,Metastasis,M0
1256,1,1,Initial Chemotherapy Agent,carbo
1256,1,1,2nd Failure Type,no known failure
1256,1,1,Occurrence #,1st primary
1256,1,1,Research lab p16,p16 unknown
1256,1,1,Research lab HPV,HPV unknown
1256,1,1,Treatment Modality,CTX-RT
1257,1,1,Occurrence #,1st primary
1257,1,1,Initial Chemotherapy Agent,cis
1257,1,1,Research lab HPV,HPV unknown
1257,1,1,Nodal Stage,N1
1257,1,1,Tumor Stage,T2
1257,1,1,Research lab p16,p16 unknown
1257,1,1,Treatment Modality,CTX-RT
1257,1,1,Overall Stage,III
1257,1,1,Clinical lab p16,p16 unkown
1257,1,1,1st Failure Type,no known failure
1257,1,1,Metastasis,M0
1257,1,1,Tumor Site,oropharynx
1257,1,1,2nd Failure Type,no known failure
1257,1,1,Radiation Dosage,70.2
1258,1,1,Metastasis,M0
1258,1,1,Radiation Dosage,70.2
1258,1,1,Tumor Stage,T2
1258,1,1,1st Failure Type,no known failure
1258,1,1,Nodal Stage,N2
1258,1,1,Occurrence #,1st primary
1258,1,1,Tumor Site,oropharynx
1258,1,1,Clinical lab p16,p16 positive
1258,1,1,2nd Failure Type,no known failure
1258,1,1,Research lab HPV,HPV positive
1258,1,1,Initial Chemotherapy Agent,cis
1258,1,1,Research lab p16,p16 unknown
1258,1,1,Overall Stage,IVa
1258,1,1,Treatment Modality,CTX-RT
1259,1,1,Overall Stage,Unknown
1259,1,1,Treatment Modality,CTX-RT
1259,1,1,Clinical lab p16,p16 unkown
1259,1,1,Research lab HPV,HPV unknown
1259,1,1,Tumor Site,oropharynx
1259,1,1,1st Failure Type,locoregional
1259,1,1,1st Failure Treatment Modality,Sx & CTX
1259,1,1,1st Failure Site,oropharynx
1259,1,1,Metastasis,M0
1259,1,1,Tumor Stage,Unknown
1259,1,1,Radiation Dosage,56.4
1259,1,1,Research lab p16,p16 unknown
1259,1,1,Occurrence #,other primary
1259,1,1,1st Failure Initial Chemotherapy Agent,HPV/MAGE
1259,1,1,2nd Failure Type,no known failure
1259,1,1,Nodal Stage,N0
1259,1,1,Initial Chemotherapy Agent,carbo/PTX
1260,1,1,Research lab p16,p16 unknown
1260,1,1,1st Failure Type,no known failure
1260,1,1,Tumor Site,oropharynx
1260,1,1,Research lab HPV,HPV unknown
1260,1,1,Tumor Stage,T2
1260,1,1,Clinical lab p16,p16 unkown
1260,1,1,Nodal Stage,N2
1260,1,1,2nd Failure Type,no known failure
1260,1,1,Overall Stage,IVa
1260,1,1,Treatment Modality,Sx & RT
1260,1,1,Metastasis,M0
1260,1,1,Occurrence #,1st primary
1260,1,1,Radiation Dosage,66.6
1261,1,1,Research lab p16,p16 unknown
1261,1,1,2nd Failure Type,no known failure
1261,1,1,Metastasis,M0
1261,1,1,Research lab HPV,HPV unknown
1261,1,1,Overall Stage,IVa
1261,1,1,Occurrence #,1st primary
1261,1,1,Tumor Stage,T2
1261,1,1,Treatment Modality,Sx
1261,1,1,1st Failure Type,no known failure
1261,1,1,Clinical lab p16,p16 unkown
1261,1,1,Tumor Site,oropharynx
1261,1,1,Nodal Stage,N2
1262,1,1,Treatment Modality,CTX-RT
1262,1,1,Research lab HPV,HPV unknown
1262,1,1,Research lab p16,p16 unknown
1262,1,1,Initial Chemotherapy Agent,carbo/PTX
1262,1,1,2nd Failure Type,no known failure
1262,1,1,Clinical lab p16,p16 unkown
1262,1,1,Nodal Stage,N1
1262,1,1,Tumor Stage,T2
1262,1,1,Metastasis,M0
1262,1,1,1st Failure Type,no known failure
1262,1,1,Tumor Site,oropharynx
1262,1,1,Occurrence #,1st primary
1262,1,1,Overall Stage,III
1262,1,1,Radiation Dosage,70.2
1263,1,1,Clinical lab p16,p16 unkown
1263,1,1,1st Failure Type,no known failure
1263,1,1,Nodal Stage,N2
1263,1,1,Overall Stage,IVa
1263,1,1,Treatment Modality,Unknown
1263,1,1,Research lab HPV,HPV unknown
1263,1,1,Tumor Site,oropharynx
1263,1,1,Occurrence #,1st primary
1263,1,1,2nd Failure Type,no known failure
1263,1,1,Research lab p16,p16 unknown
1263,1,1,Tumor Stage,T2
1263,1,1,Metastasis,M0
1264,1,1,Research lab HPV,HPV unknown
1264,1,1,Occurrence #,1st primary
1264,1,1,Radiation Dosage,70.2
1264,1,1,Overall Stage,III
1264,1,1,Nodal Stage,N1
1264,1,1,1st Failure Type,no known failure
1264,1,1,Clinical lab p16,p16 unkown
1264,1,1,Metastasis,M0
1264,1,1,Tumor Stage,T2
1264,1,1,Initial Chemotherapy Agent,cis
1264,1,1,2nd Failure Type,no known failure
1264,1,1,Treatment Modality,CTX-RT
1264,1,1,Research lab p16,p16 unknown
1264,1,1,Tumor Site,oropharynx
1265,1,1,Metastasis,Unknown
1265,1,1,Overall Stage,Unknown
1265,1,1,Nodal Stage,Unknown
1265,1,1,Initial Chemotherapy Agent,HPV/MAGE
1265,1,1,Occurrence #,recurrence
1265,1,1,Treatment Modality,Unknown
1265,1,1,1st Failure Type,locoregional and distant
1265,1,1,Research lab p16,p16 unknown
1265,1,1,Tumor Stage,Unknown
1265,1,1,2nd Failure Type,no known failure
1265,1,1,Tumor Site,oropharynx
1265,1,1,Research lab HPV,HPV unknown
1265,1,1,Clinical lab p16,p16 unkown
1266,1,1,Tumor Stage,T3
1266,1,1,Radiation Dosage,70.2
1266,1,1,Initial Chemotherapy Agent,cis
1266,1,1,Research lab p16,p16 unknown
1266,1,1,1st Failure Type,locoregional
1266,1,1,Nodal Stage,N1
1266,1,1,2nd Failure Type,no known failure
1266,1,1,Overall Stage,III
1266,1,1,Tumor Site,oropharynx
1266,1,1,1st Failure Treatment Modality,Sx
1266,1,1,Metastasis,M0
1266,1,1,Clinical lab p16,p16 unkown
1266,1,1,Research lab HPV,HPV unknown
1266,1,1,Occurrence #,1st primary
1266,1,1,1st Failure Site,oropharynx
1266,1,1,Treatment Modality,CTX-RT
1267,1,1,2nd Failure Type,no known failure
1267,1,1,Tumor Stage,T2
1267,1,1,Nodal Stage,N2
1267,1,1,1st Failure Type,distant
1267,1,1,Treatment Modality,Unknown
1267,1,1,Clinical lab p16,p16 unkown
1267,1,1,Radiation Dosage,8
1267,1,1,Research lab HPV,HPV unknown
1267,1,1,Overall Stage,IVa
1267,1,1,Occurrence #,recurrence
1267,1,1,Research lab p16,p16 unknown
1267,1,1,Metastasis,M0
1267,1,1,Initial Chemotherapy Agent,dendritic cells
1267,1,1,Tumor Site,oropharynx
1268,1,1,Metastasis,M0
1268,1,1,Occurrence #,recurrence
1268,1,1,Nodal Stage,N3
1268,1,1,Overall Stage,IVb
1268,1,1,2nd Failure Type,no known failure
1268,1,1,Tumor Site,oropharynx
1268,1,1,1st Failure Type,no known failure
1268,1,1,Radiation Dosage,25.2
1268,1,1,Treatment Modality,RT
1268,1,1,Research lab HPV,HPV unknown
1268,1,1,Research lab p16,p16 unknown
1268,1,1,Clinical lab p16,p16 unkown
1268,1,1,Tumor Stage,T3
1269,1,1,Overall Stage,Unknown
1269,1,1,Radiation Dosage,50.4
1269,1,1,1st Failure Type,locoregional and distant
1269,1,1,Tumor Site,oropharynx
1269,1,1,Treatment Modality,Sx & CTX-RT
1269,1,1,Research lab p16,p16 unknown
1269,1,1,Second Line Chemotherapy Agent,carbo
1269,1,1,Research lab HPV,HPV unknown
1269,1,1,Initial Chemotherapy Agent,cis/doce/5 FU
1269,1,1,Tumor Stage,Unknown
1269,1,1,2nd Failure Type,no known failure
1269,1,1,Metastasis,Unknown
1269,1,1,Nodal Stage,Unknown
1269,1,1,Occurrence #,recurrence
1269,1,1,Clinical lab p16,p16 unkown
1270,1,1,Research lab p16,p16 unknown
1270,1,1,Nodal Stage,N0
1270,1,1,Metastasis,M0
1270,1,1,Research lab HPV,HPV unknown
1270,1,1,Tumor Stage,T4a
1270,1,1,Overall Stage,IVa
1270,1,1,2nd Failure Type,no known failure
1270,1,1,1st Failure Type,no known failure
1270,1,1,Treatment Modality,Sx
1270,1,1,Clinical lab p16,p16 unkown
1270,1,1,Tumor Site,oropharynx
1270,1,1,Occurrence #,recurrence
1271,1,1,Nodal Stage,N3
1271,1,1,Metastasis,M0
1271,1,1,2nd Failure Type,no known failure
1271,1,1,Research lab HPV,HPV unknown
1271,1,1,Tumor Site,oropharynx
1271,1,1,Radiation Dosage,70.2
1271,1,1,Clinical lab p16,p16 unkown
1271,1,1,Initial Chemotherapy Agent,cis
1271,1,1,Occurrence #,1st primary
1271,1,1,Research lab p16,p16 unknown
1271,1,1,Treatment Modality,CTX-RT
1271,1,1,Overall Stage,IVb
1271,1,1,1st Failure Type,no known failure
1271,1,1,Tumor Stage,T2
1272,1,1,Overall Stage,II
1272,1,1,2nd Failure Type,no known failure
1272,1,1,1st Failure Type,locoregional and distant
1272,1,1,Metastasis,M0
1272,1,1,Clinical lab p16,p16 unkown
1272,1,1,Radiation Dosage,9
1272,1,1,Research lab p16,p16 unknown
1272,1,1,Initial Chemotherapy Agent,dendritic cells
1272,1,1,Occurrence #,recurrence
1272,1,1,Research lab HPV,HPV unknown
1272,1,1,Treatment Modality,RT
1272,1,1,Tumor Stage,T2
1272,1,1,Tumor Site,oropharynx
1272,1,1,Nodal Stage,N0
1273,1,1,Occurrence #,1st primary
1273,1,1,Treatment Modality,CTX-RT
1273,1,1,Tumor Stage,T1
1273,1,1,Clinical lab p16,p16 unkown
1273,1,1,Initial Chemotherapy Agent,cis
1273,1,1,Research lab HPV,HPV unknown
1273,1,1,Nodal Stage,N3
1273,1,1,Research lab p16,p16 unknown
1273,1,1,Radiation Dosage,66.6
1273,1,1,Overall Stage,IVb
1273,1,1,2nd Failure Type,no known failure
1273,1,1,Metastasis,M0
1273,1,1,Tumor Site,oropharynx
1273,1,1,1st Failure Type,distant
1274,1,1,Occurrence #,1st primary
1274,1,1,Research lab p16,p16 unknown
1274,1,1,Tumor Site,oropharynx
1274,1,1,Treatment Modality,Unknown
1274,1,1,Nodal Stage,N0
1274,1,1,Tumor Stage,T3
1274,1,1,Overall Stage,III
1274,1,1,Research lab HPV,HPV unknown
1274,1,1,Clinical lab p16,p16 unkown
1274,1,1,1st Failure Type,no known failure
1274,1,1,Metastasis,M0
1274,1,1,2nd Failure Type,no known failure
1275,1,1,Tumor Stage,T1
1275,1,1,Research lab HPV,HPV unknown
1275,1,1,Occurrence #,other primary
1275,1,1,Research lab p16,p16 unknown
1275,1,1,Clinical lab p16,p16 unkown
1275,1,1,Nodal Stage,N0
1275,1,1,Treatment Modality,Sx
1275,1,1,Overall Stage,I
1275,1,1,Tumor Site,oropharynx
1275,1,1,2nd Failure Type,no known failure
1275,1,1,1st Failure Type,no known failure
1275,1,1,Metastasis,M0
1276,1,1,Research lab HPV,HPV unknown
1276,1,1,Tumor Stage,Unknown
1276,1,1,1st Failure Type,distant
1276,1,1,Occurrence #,recurrence
1276,1,1,Tumor Site,oropharynx
1276,1,1,Metastasis,M1
1276,1,1,Overall Stage,IVc
1276,1,1,Treatment Modality,Sx
1276,1,1,Nodal Stage,Unknown
1276,1,1,Clinical lab p16,p16 unkown
1276,1,1,2nd Failure Type,no known failure
1276,1,1,Research lab p16,p16 unknown
1277,1,1,Research lab p16,p16 unknown
1277,1,1,1st Failure Type,no known failure
1277,1,1,Overall Stage,IVa
1277,1,1,Metastasis,M0
1277,1,1,Research lab HPV,HPV positive
1277,1,1,Occurrence #,1st primary
1277,1,1,Clinical lab p16,p16 unkown
1277,1,1,Initial Chemotherapy Agent,cis
1277,1,1,Treatment Modality,CTX-RT
1277,1,1,Tumor Stage,T3
1277,1,1,2nd Failure Type,no known failure
1277,1,1,Nodal Stage,N2
1277,1,1,Tumor Site,oropharynx
1277,1,1,Radiation Dosage,64.8
1278,1,1,Metastasis,M0
1278,1,1,Tumor Stage,T3
1278,1,1,Nodal Stage,N2
1278,1,1,Research lab p16,p16 unknown
1278,1,1,Occurrence #,1st primary
1278,1,1,Initial Chemotherapy Agent,cis
1278,1,1,Overall Stage,IVa
1278,1,1,Radiation Dosage,70.2
1278,1,1,Treatment Modality,CTX-RT
1278,1,1,2nd Failure Type,no known failure
1278,1,1,1st Failure Type,no known failure
1278,1,1,Tumor Site,oropharynx
1278,1,1,Clinical lab p16,p16 unkown
1278,1,1,Research lab HPV,HPV positive
1279,1,1,Tumor Stage,T2
1279,1,1,Metastasis,M0
1279,1,1,Tumor Site,oropharynx
1279,1,1,2nd Failure Type,no known failure
1279,1,1,Clinical lab p16,p16 unkown
1279,1,1,Research lab HPV,HPV unknown
1279,1,1,Occurrence #,1st primary
1279,1,1,1st Failure Type,distant
1279,1,1,Research lab p16,p16 unknown
1279,1,1,Treatment Modality,CTX-RT
1279,1,1,Overall Stage,IVa
1279,1,1,Nodal Stage,N2
1279,1,1,Radiation Dosage,70.2
1279,1,1,Initial Chemotherapy Agent,carbo
1280,1,1,Research lab p16,p16 unknown
1280,1,1,Metastasis,M0
1280,1,1,Occurrence #,1st primary
1280,1,1,Tumor Site,oropharynx
1280,1,1,2nd Failure Type,no known failure
1280,1,1,Research lab HPV,HPV unknown
1280,1,1,Nodal Stage,N0
1280,1,1,Overall Stage,I
1280,1,1,1st Failure Type,no known failure
1280,1,1,Clinical lab p16,p16 unkown
1280,1,1,Treatment Modality,Sx
1280,1,1,Tumor Stage,T1
1281,1,1,Treatment Modality,CTX-RT
1281,1,1,2nd Failure Type,no known failure
1281,1,1,Tumor Site,oropharynx
1281,1,1,Clinical lab p16,p16 unkown
1281,1,1,1st Failure Type,no known failure
1281,1,1,Nodal Stage,N2
1281,1,1,Radiation Dosage,70.2
1281,1,1,Metastasis,M0
1281,1,1,Initial Chemotherapy Agent,cis
1281,1,1,Occurrence #,1st primary
1281,1,1,Tumor Stage,T3
1281,1,1,Research lab p16,p16 unknown
1281,1,1,Overall Stage,IVa
1281,1,1,Research lab HPV,HPV unknown
1282,1,1,Overall Stage,III
1282,1,1,Occurrence #,recurrence
1282,1,1,Tumor Site,oropharynx
1282,1,1,Research lab p16,p16 unknown
1282,1,1,Radiation Dosage,60
1282,1,1,Tumor Stage,T3
1282,1,1,Treatment Modality,Sx & CTX-RT
1282,1,1,2nd Failure Type,no known failure
1282,1,1,1st Failure Type,locoregional and distant
1282,1,1,Nodal Stage,N0
1282,1,1,Initial Chemotherapy Agent,carbo/PTX
1282,1,1,Clinical lab p16,p16 unkown
1282,1,1,Research lab HPV,HPV unknown
1282,1,1,Metastasis,M0
1283,1,1,Research lab HPV,HPV unknown
1283,1,1,Tumor Site,oropharynx
1283,1,1,Metastasis,M0
1283,1,1,Radiation Dosage,66
1283,1,1,Overall Stage,II
1283,1,1,2nd Failure Type,no known failure
1283,1,1,Tumor Stage,T2
1283,1,1,Research lab p16,p16 unknown
1283,1,1,Nodal Stage,N0
1283,1,1,Occurrence #,1st primary
1283,1,1,Clinical lab p16,p16 unkown
1283,1,1,1st Failure Type,locoregional and distant
1283,1,1,Treatment Modality,Sx & RT
1284,1,1,Tumor Stage,T1
1284,1,1,Overall Stage,IVa
1284,1,1,Research lab HPV,HPV unknown
1284,1,1,Clinical lab p16,p16 unkown
1284,1,1,Tumor Site,oropharynx
1284,1,1,Treatment Modality,Sx & CTX-RT
1284,1,1,Radiation Dosage,66.6
1284,1,1,Metastasis,M0
1284,1,1,Occurrence #,1st primary
1284,1,1,1st Failure Type,no known failure
1284,1,1,Initial Chemotherapy Agent,cis
1284,1,1,Nodal Stage,N2
1284,1,1,Research lab p16,p16 unknown
1284,1,1,2nd Failure Type,no known failure
1285,1,1,Tumor Site,oropharynx
1285,1,1,Metastasis,M1
1285,1,1,Tumor Stage,T2
1285,1,1,Research lab p16,p16 unknown
1285,1,1,Nodal Stage,N2
1285,1,1,1st Failure Type,no known failure
1285,1,1,Treatment Modality,Sx
1285,1,1,Research lab HPV,HPV unknown
1285,1,1,Clinical lab p16,p16 unkown
1285,1,1,2nd Failure Type,no known failure
1285,1,1,Overall Stage,IVc
1285,1,1,Occurrence #,recurrence
1286,1,1,1st Failure Treatment Modality,Sx
1286,1,1,Occurrence #,1st primary
1286,1,1,Initial Chemotherapy Agent,cetux
1286,1,1,2nd Failure Type,no known failure
1286,1,1,Metastasis,M0
1286,1,1,Tumor Stage,T4a
1286,1,1,Radiation Dosage,unknown
1286,1,1,1st Failure Site,oropharynx
1286,1,1,Research lab HPV,HPV unknown
1286,1,1,Overall Stage,IVa
1286,1,1,Treatment Modality,CTX-RT
1286,1,1,1st Failure Type,locoregional
1286,1,1,Nodal Stage,N0
1286,1,1,Tumor Site,oropharynx
1286,1,1,Research lab p16,p16 unknown
1286,1,1,Clinical lab p16,p16 unkown
1287,1,1,Metastasis,M0
1287,1,1,2nd Failure Type,no known failure
1287,1,1,Tumor Stage,T1
1287,1,1,Clinical lab p16,p16 unkown
1287,1,1,Overall Stage,I
1287,1,1,Occurrence #,other primary
1287,1,1,Research lab p16,p16 unknown
1287,1,1,1st Failure Type,locoregional
1287,1,1,Nodal Stage,N0
1287,1,1,Research lab HPV,HPV unknown
1287,1,1,Treatment Modality,RT
1287,1,1,Radiation Dosage,70.2
1287,1,1,Tumor Site,oropharynx
1288,1,1,2nd Failure Type,no known failure
1288,1,1,Research lab HPV,HPV unknown
1288,1,1,Research lab p16,p16 unknown
1288,1,1,Nodal Stage,N2
1288,1,1,Tumor Stage,T3
1288,1,1,Occurrence #,1st primary
1288,1,1,1st Failure Type,no known failure
1288,1,1,Clinical lab p16,p16 unkown
1288,1,1,Treatment Modality,Unknown
1288,1,1,Tumor Site,oropharynx
1288,1,1,Overall Stage,IVa
1288,1,1,Metastasis,M0
1289,1,1,Research lab p16,p16 unknown
1289,1,1,Nodal Stage,N2
1289,1,1,Treatment Modality,CTX
1289,1,1,Tumor Stage,T4a
1289,1,1,Occurrence #,1st primary
1289,1,1,Tumor Site,oropharynx
1289,1,1,Clinical lab p16,p16 unkown
1289,1,1,Research lab HPV,HPV unknown
1289,1,1,Initial Chemotherapy Agent,cis/PTX/5-FU
1289,1,1,2nd Failure Type,no known failure
1289,1,1,Metastasis,M1
1289,1,1,1st Failure Type,no known failure
1289,1,1,Overall Stage,IVc
1290,1,1,Overall Stage,IVa
1290,1,1,1st Failure Site,oropharynx
1290,1,1,1st Failure Type,locoregional
1290,1,1,Tumor Stage,T3
1290,1,1,Research lab p16,p16 unknown
1290,1,1,Treatment Modality,CTX-RT
1290,1,1,1st Failure Treatment Modality,Sx
1290,1,1,Initial Chemotherapy Agent,doce/5-FU/cis
1290,1,1,Metastasis,M0
1290,1,1,Clinical lab p16,p16 unkown
1290,1,1,Radiation Dosage,70.2
1290,1,1,Nodal Stage,N2
1290,1,1,Occurrence #,1st primary
1290,1,1,Research lab HPV,HPV unknown
1290,1,1,Tumor Site,oropharynx
1290,1,1,2nd Failure Type,no known failure
1291,1,1,Clinical lab p16,p16 unkown
1291,1,1,Nodal Stage,N2
1291,1,1,2nd Failure Type,no known failure
1291,1,1,Research lab HPV,HPV unknown
1291,1,1,1st Failure Type,no known failure
1291,1,1,Research lab p16,p16 unknown
1291,1,1,Treatment Modality,CTX-RT
1291,1,1,Overall Stage,IVa
1291,1,1,Initial Chemotherapy Agent,cis
1291,1,1,Metastasis,M0
1291,1,1,Tumor Site,oropharynx
1291,1,1,Occurrence #,1st primary
1291,1,1,Tumor Stage,T3
1291,1,1,Radiation Dosage,70.2
1292,1,1,Nodal Stage,Unknown
1292,1,1,Research lab p16,p16 unknown
1292,1,1,Treatment Modality,Unknown
1292,1,1,1st Failure Type,distant
1292,1,1,Overall Stage,IVc
1292,1,1,Occurrence #,recurrence
1292,1,1,2nd Failure Type,no known failure
1292,1,1,Tumor Site,oropharynx
1292,1,1,Metastasis,M1
1292,1,1,Clinical lab p16,p16 unkown
1292,1,1,Research lab HPV,HPV unknown
1292,1,1,Tumor Stage,Unknown
1293,1,1,Treatment Modality,Sx
1293,1,1,1st Failure Type,no known failure
1293,1,1,Research lab HPV,HPV unknown
1293,1,1,Occurrence #,other primary
1293,1,1,2nd Failure Type,no known failure
1293,1,1,Metastasis,M0
1293,1,1,Clinical lab p16,p16 unkown
1293,1,1,Overall Stage,II
1293,1,1,Nodal Stage,N0
1293,1,1,Tumor Stage,T2
1293,1,1,Tumor Site,oropharynx
1293,1,1,Research lab p16,p16 unknown
1294,1,1,Occurrence #,recurrence
1294,1,1,Treatment Modality,Sx
1294,1,1,Nodal Stage,N1
1294,1,1,Metastasis,M0
1294,1,1,Tumor Stage,T2
1294,1,1,2nd Failure Type,no known failure
1294,1,1,1st Failure Type,no known failure
1294,1,1,Tumor Site,oropharynx
1294,1,1,Research lab HPV,HPV unknown
1294,1,1,Clinical lab p16,p16 unkown
1294,1,1,Research lab p16,p16 unknown
1294,1,1,Overall Stage,III
1295,1,1,Research lab HPV,HPV unknown
1295,1,1,Overall Stage,III
1295,1,1,Treatment Modality,CTX-RT
1295,1,1,1st Failure Treatment Modality,Sx
1295,1,1,2nd Failure Type,no known failure
1295,1,1,Tumor Site,oropharynx
1295,1,1,1st Failure Type,locoregional and distant
1295,1,1,Nodal Stage,N0
1295,1,1,Tumor Stage,T3
1295,1,1,Clinical lab p16,p16 unkown
1295,1,1,Radiation Dosage,70.2
1295,1,1,Metastasis,M0
1295,1,1,1st Failure Site,oropharynx
1295,1,1,Occurrence #,1st primary
1295,1,1,Initial Chemotherapy Agent,cis
1295,1,1,Research lab p16,p16 unknown
1296,1,1,Nodal Stage,N2
1296,1,1,2nd Failure Type,no known failure
1296,1,1,Metastasis,M0
1296,1,1,1st Failure Treatment Modality,CTX-RT
1296,1,1,Occurrence #,1st primary
1296,1,1,Radiation Dosage,67
1296,1,1,Research lab p16,p16 unknown
1296,1,1,1st Failure Type,distant
1296,1,1,Tumor Stage,T1
1296,1,1,Tumor Site,oropharynx
1296,1,1,Clinical lab p16,p16 unkown
1296,1,1,Initial Chemotherapy Agent,carbo/doce
1296,1,1,1st Failure Initial Chemotherapy Agent,cis/doce/carbo
1296,1,1,Overall Stage,IVa
1296,1,1,Research lab HPV,HPV positive
1296,1,1,Treatment Modality,Sx & CTX-RT
1296,1,1,1st Failure Radiation Dosage,50.4
1297,1,1,2nd Failure Type,no known failure
1297,1,1,Tumor Site,oropharynx
1297,1,1,Nodal Stage,Unknown
1297,1,1,Clinical lab p16,p16 unkown
1297,1,1,Tumor Stage,Unknown
1297,1,1,Research lab p16,p16 unknown
1297,1,1,Occurrence #,recurrence
1297,1,1,1st Failure Type,locoregional
1297,1,1,Overall Stage,Unknown
1297,1,1,Metastasis,Unknown
1297,1,1,Treatment Modality,Sx
1297,1,1,Research lab HPV,HPV unknown
1298,1,1,Metastasis,M0
1298,1,1,2nd Failure Type,no known failure
1298,1,1,Overall Stage,III
1298,1,1,Radiation Dosage,60
1298,1,1,Treatment Modality,Sx & CTX-RT
1298,1,1,Research lab HPV,HPV unknown
1298,1,1,1st Failure Type,no known failure
1298,1,1,Occurrence #,other primary
1298,1,1,Initial Chemotherapy Agent,carbo/PTX
1298,1,1,Research lab p16,p16 unknown
1298,1,1,Tumor Site,oropharynx
1298,1,1,Clinical lab p16,p16 unkown
1298,1,1,Tumor Stage,T3
1298,1,1,Nodal Stage,N0
1299,1,1,Nodal Stage,N2
1299,1,1,2nd Failure Type,no known failure
1299,1,1,Treatment Modality,CTX-RT
1299,1,1,Metastasis,M0
1299,1,1,Research lab HPV,HPV unknown
1299,1,1,Research lab p16,p16 unknown
1299,1,1,1st Failure Type,no known failure
1299,1,1,Tumor Stage,T2
1299,1,1,Overall Stage,IVa
1299,1,1,Clinical lab p16,p16 unkown
1299,1,1,Tumor Site,oropharynx
1299,1,1,Radiation Dosage,70.2
1299,1,1,Initial Chemotherapy Agent,cis
1299,1,1,Occurrence #,1st primary
1300,1,1,Occurrence #,recurrence
1300,1,1,Clinical lab p16,p16 unkown
1300,1,1,2nd Failure Type,no known failure
1300,1,1,Overall Stage,IVc
1300,1,1,Tumor Stage,Unknown
1300,1,1,Research lab p16,p16 unknown
1300,1,1,Metastasis,M1
1300,1,1,Nodal Stage,Unknown
1300,1,1,1st Failure Type,no known failure
1300,1,1,Research lab HPV,HPV unknown
1300,1,1,Treatment Modality,Unknown
1300,1,1,Tumor Site,oropharynx
1301,1,1,Overall Stage,IVa
1301,1,1,Radiation Dosage,70.2
1301,1,1,Nodal Stage,N2
1301,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1301,1,1,Metastasis,M0
1301,1,1,Occurrence #,1st primary
1301,1,1,Clinical lab p16,p16 unkown
1301,1,1,Tumor Site,oropharynx
1301,1,1,Treatment Modality,CTX-RT
1301,1,1,Research lab HPV,HPV unknown
1301,1,1,1st Failure Type,no known failure
1301,1,1,Research lab p16,p16 unknown
1301,1,1,2nd Failure Type,no known failure
1301,1,1,Tumor Stage,T3
1302,1,1,Research lab HPV,HPV unknown
1302,1,1,Treatment Modality,CTX-RT
1302,1,1,Initial Chemotherapy Agent,cis
1302,1,1,Radiation Dosage,70.2
1302,1,1,Occurrence #,1st primary
1302,1,1,Overall Stage,III
1302,1,1,Tumor Stage,T3
1302,1,1,Clinical lab p16,p16 unkown
1302,1,1,Metastasis,M0
1302,1,1,Research lab p16,p16 unknown
1302,1,1,Tumor Site,oropharynx
1302,1,1,2nd Failure Type,no known failure
1302,1,1,1st Failure Type,no known failure
1302,1,1,Nodal Stage,N0
1303,1,1,Treatment Modality,CTX-RT
1303,1,1,Nodal Stage,N1
1303,1,1,Occurrence #,1st primary
1303,1,1,Research lab HPV,HPV unknown
1303,1,1,Second Line Chemotherapy Agent,Carbo
1303,1,1,1st Failure Type,distant
1303,1,1,Initial Chemotherapy Agent,cis
1303,1,1,Research lab p16,p16 unknown
1303,1,1,Tumor Stage,T1
1303,1,1,Radiation Dosage,70.2
1303,1,1,Metastasis,M0
1303,1,1,2nd Failure Type,no known failure
1303,1,1,Tumor Site,oropharynx
1303,1,1,Overall Stage,III
1303,1,1,Clinical lab p16,p16 unkown
1304,1,1,Initial Chemotherapy Agent,cis
1304,1,1,Second Line Chemotherapy Agent,carbo/PTX
1304,1,1,Clinical lab p16,p16 unkown
1304,1,1,Occurrence #,1st primary
1304,1,1,Overall Stage,IVa
1304,1,1,Tumor Site,oropharynx
1304,1,1,2nd Failure Type,no known failure
1304,1,1,1st Failure Type,no known failure
1304,1,1,Nodal Stage,N2
1304,1,1,Research lab p16,p16 unknown
1304,1,1,Metastasis,M0
1304,1,1,Radiation Dosage,70.2
1304,1,1,Tumor Stage,T1
1304,1,1,Treatment Modality,CTX-RT
1304,1,1,Research lab HPV,HPV unknown
1305,1,1,Overall Stage,IVb
1305,1,1,Metastasis,M0
1305,1,1,1st Failure Type,no known failure
1305,1,1,Research lab p16,p16 unknown
1305,1,1,Tumor Site,oropharynx
1305,1,1,2nd Failure Type,no known failure
1305,1,1,Treatment Modality,CTX-RT
1305,1,1,Occurrence #,1st primary
1305,1,1,Clinical lab p16,p16 unkown
1305,1,1,Tumor Stage,T3
1305,1,1,Initial Chemotherapy Agent,unknown
1305,1,1,Nodal Stage,N3
1305,1,1,Research lab HPV,HPV unknown
1305,1,1,Radiation Dosage,70.2
1306,1,1,1st Failure Type,locoregional and distant
1306,1,1,Radiation Dosage,70.2
1306,1,1,Metastasis,M0
1306,1,1,Initial Chemotherapy Agent,cetux/PTX/carbo
1306,1,1,Overall Stage,II
1306,1,1,Occurrence #,1st primary
1306,1,1,Research lab HPV,HPV unknown
1306,1,1,Treatment Modality,CTX-RT
1306,1,1,Tumor Stage,T2
1306,1,1,Clinical lab p16,p16 unkown
1306,1,1,Tumor Site,oropharynx
1306,1,1,2nd Failure Type,no known failure
1306,1,1,Research lab p16,p16 unknown
1306,1,1,Nodal Stage,N2
1307,1,1,1st Failure Treatment Modality,Sx
1307,1,1,Occurrence #,1st primary
1307,1,1,Treatment Modality,Sx & CTX-RT
1307,1,1,Nodal Stage,N0
1307,1,1,Research lab HPV,HPV unknown
1307,1,1,Metastasis,M0
1307,1,1,Tumor Stage,T4a
1307,1,1,1st Failure Type,locoregional
1307,1,1,2nd Failure Type,no known failure
1307,1,1,Initial Chemotherapy Agent,carbo/PTX
1307,1,1,Overall Stage,IVa
1307,1,1,Clinical lab p16,p16 unkown
1307,1,1,1st Failure Site,oropharynx
1307,1,1,Research lab p16,p16 unknown
1307,1,1,Radiation Dosage,unknown
1307,1,1,Tumor Site,oropharynx
1309,1,1,Metastasis,M0
1309,1,1,Tumor Site,oropharynx
1309,1,1,Clinical lab p16,p16 unkown
1309,1,1,Treatment Modality,CTX-RT
1309,1,1,Overall Stage,IVb
1309,1,1,Radiation Dosage,unknown
1309,1,1,2nd Failure Type,no known failure
1309,1,1,Occurrence #,1st primary
1309,1,1,Nodal Stage,N3
1309,1,1,1st Failure Type,no known failure
1309,1,1,Research lab p16,p16 unknown
1309,1,1,Initial Chemotherapy Agent,carbo/PTX
1309,1,1,Tumor Stage,T3
1309,1,1,Research lab HPV,HPV unknown
1310,1,1,Metastasis,M0
1310,1,1,2nd Failure Type,no known failure
1310,1,1,Treatment Modality,Sx
1310,1,1,Tumor Site,oropharynx
1310,1,1,Occurrence #,recurrence
1310,1,1,Nodal Stage,N0
1310,1,1,Tumor Stage,T1
1310,1,1,Overall Stage,I
1310,1,1,Clinical lab p16,p16 unkown
1310,1,1,1st Failure Type,no known failure
1310,1,1,Research lab HPV,HPV unknown
1310,1,1,Research lab p16,p16 unknown
1311,1,1,Nodal Stage,N0
1311,1,1,1st Failure Type,no known failure
1311,1,1,Tumor Site,oropharynx
1311,1,1,Research lab p16,p16 unknown
1311,1,1,Occurrence #,other primary
1311,1,1,Treatment Modality,Sx
1311,1,1,2nd Failure Type,no known failure
1311,1,1,Research lab HPV,HPV unknown
1311,1,1,Metastasis,M0
1311,1,1,Tumor Stage,T4a
1311,1,1,Clinical lab p16,p16 unkown
1311,1,1,Overall Stage,IVa
1312,1,1,Research lab HPV,HPV unknown
1312,1,1,Tumor Stage,T3
1312,1,1,1st Failure Type,no known failure
1312,1,1,Overall Stage,III
1312,1,1,Clinical lab p16,p16 unkown
1312,1,1,Treatment Modality,Unknown
1312,1,1,Metastasis,M0
1312,1,1,2nd Failure Type,no known failure
1312,1,1,Research lab p16,p16 unknown
1312,1,1,Tumor Site,oropharynx
1312,1,1,Occurrence #,1st primary
1312,1,1,Nodal Stage,N0
1313,1,1,Occurrence #,1st primary
1313,1,1,Nodal Stage,N2
1313,1,1,Tumor Site,oropharynx
1313,1,1,Tumor Stage,T1
1313,1,1,Clinical lab p16,p16 unkown
1313,1,1,Initial Chemotherapy Agent,cis/vandetanib
1313,1,1,Research lab p16,p16 unknown
1313,1,1,1st Failure Type,no known failure
1313,1,1,Research lab HPV,HPV unknown
1313,1,1,Radiation Dosage,62.9
1313,1,1,Treatment Modality,Sx & CTX-RT
1313,1,1,Overall Stage,IVa
1313,1,1,2nd Failure Type,no known failure
1313,1,1,Metastasis,M0
1314,1,1,Tumor Site,oropharynx
1314,1,1,Tumor Stage,T3
1314,1,1,Metastasis,M0
1314,1,1,Occurrence #,1st primary
1314,1,1,1st Failure Type,no known failure
1314,1,1,Clinical lab p16,p16 unkown
1314,1,1,Overall Stage,IVb
1314,1,1,Treatment Modality,Sx & CTX-RT
1314,1,1,Research lab p16,p16 unknown
1314,1,1,Radiation Dosage,70.2
1314,1,1,Nodal Stage,N3
1314,1,1,Initial Chemotherapy Agent,cis
1314,1,1,Research lab HPV,HPV unknown
1314,1,1,2nd Failure Type,no known failure
1315,1,1,Nodal Stage,N0
1315,1,1,Research lab p16,p16 unknown
1315,1,1,Overall Stage,IVa
1315,1,1,Occurrence #,1st primary
1315,1,1,Metastasis,M0
1315,1,1,1st Failure Type,locoregional
1315,1,1,Tumor Site,oropharynx
1315,1,1,Tumor Stage,T4a
1315,1,1,Treatment Modality,RT
1315,1,1,2nd Failure Type,no known failure
1315,1,1,Research lab HPV,HPV unknown
1315,1,1,Radiation Dosage,unknown
1315,1,1,Clinical lab p16,p16 unkown
1316,1,1,Tumor Site,oropharynx
1316,1,1,Overall Stage,IVa
1316,1,1,Research lab p16,p16 unknown
1316,1,1,Treatment Modality,Sx
1316,1,1,Research lab HPV,HPV unknown
1316,1,1,Clinical lab p16,p16 unkown
1316,1,1,2nd Failure Type,no known failure
1316,1,1,Tumor Stage,T4a
1316,1,1,Metastasis,M0
1316,1,1,Occurrence #,recurrence
1316,1,1,1st Failure Type,no known failure
1316,1,1,Nodal Stage,N0
1317,1,1,Tumor Site,oropharynx
1317,1,1,Research lab HPV,HPV unknown
1317,1,1,Clinical lab p16,p16 unkown
1317,1,1,Occurrence #,1st primary
1317,1,1,2nd Failure Type,no known failure
1317,1,1,Research lab p16,p16 unknown
1317,1,1,Tumor Stage,T3
1317,1,1,Overall Stage,III
1317,1,1,Treatment Modality,Sx
1317,1,1,Nodal Stage,N0
1317,1,1,Metastasis,M0
1317,1,1,1st Failure Type,no known failure
1318,1,1,Tumor Stage,T3
1318,1,1,Occurrence #,1st primary
1318,1,1,Tumor Site,oropharynx
1318,1,1,Treatment Modality,Sx
1318,1,1,Clinical lab p16,p16 unkown
1318,1,1,Nodal Stage,N1
1318,1,1,1st Failure Type,no known failure
1318,1,1,Metastasis,M0
1318,1,1,2nd Failure Type,no known failure
1318,1,1,Overall Stage,III
1318,1,1,Research lab p16,p16 unknown
1318,1,1,Research lab HPV,HPV positive
1319,1,1,Tumor Stage,T2
1319,1,1,Metastasis,M0
1319,1,1,Clinical lab p16,p16 unkown
1319,1,1,Research lab p16,p16 unknown
1319,1,1,Occurrence #,1st primary
1319,1,1,Research lab HPV,HPV unknown
1319,1,1,Overall Stage,II
1319,1,1,Radiation Dosage,74.4
1319,1,1,2nd Failure Type,no known failure
1319,1,1,Tumor Site,oropharynx
1319,1,1,1st Failure Type,no known failure
1319,1,1,Nodal Stage,N0
1319,1,1,Treatment Modality,RT
1320,1,1,Occurrence #,1st primary
1320,1,1,Treatment Modality,RT
1320,1,1,Tumor Site,oropharynx
1320,1,1,Overall Stage,IVc
1320,1,1,Metastasis,M1
1320,1,1,2nd Failure Type,no known failure
1320,1,1,1st Failure Type,locoregional and distant
1320,1,1,Tumor Stage,Unknown
1320,1,1,Clinical lab p16,p16 unkown
1320,1,1,Nodal Stage,Unknown
1320,1,1,Research lab p16,p16 unknown
1320,1,1,Radiation Dosage,37.5
1320,1,1,Research lab HPV,HPV unknown
1322,1,1,Research lab HPV,HPV unknown
1322,1,1,Overall Stage,IVa
1322,1,1,Metastasis,M0
1322,1,1,2nd Failure Type,no known failure
1322,1,1,1st Failure Type,distant
1322,1,1,Tumor Stage,T4a
1322,1,1,Research lab p16,p16 unknown
1322,1,1,Tumor Site,oropharynx
1322,1,1,Radiation Dosage,72
1322,1,1,Initial Chemotherapy Agent,PTX/cap
1322,1,1,Treatment Modality,CTX-RT
1322,1,1,Clinical lab p16,p16 unkown
1322,1,1,Occurrence #,1st primary
1322,1,1,Nodal Stage,N2
1323,1,1,Treatment Modality,CTX-RT
1323,1,1,2nd Failure Type,no known failure
1323,1,1,Clinical lab p16,p16 unkown
1323,1,1,Occurrence #,1st primary
1323,1,1,1st Failure Type,no known failure
1323,1,1,Nodal Stage,N0
1323,1,1,Tumor Site,oropharynx
1323,1,1,Research lab HPV,HPV unknown
1323,1,1,Initial Chemotherapy Agent,unknown
1323,1,1,Tumor Stage,T4a
1323,1,1,Research lab p16,p16 unknown
1323,1,1,Overall Stage,IVa
1323,1,1,Radiation Dosage,72
1323,1,1,Metastasis,M0
1324,1,1,Metastasis,Unknown
1324,1,1,Overall Stage,Unknown
1324,1,1,2nd Failure Type,no known failure
1324,1,1,Occurrence #,recurrence
1324,1,1,Tumor Site,oropharynx
1324,1,1,Nodal Stage,Unknown
1324,1,1,1st Failure Type,no known failure
1324,1,1,Research lab HPV,HPV unknown
1324,1,1,Tumor Stage,T3
1324,1,1,Research lab p16,p16 unknown
1324,1,1,Treatment Modality,Sx
1324,1,1,Clinical lab p16,p16 unkown
1325,1,1,Occurrence #,1st primary
1325,1,1,Clinical lab p16,p16 unkown
1325,1,1,Metastasis,M0
1325,1,1,Radiation Dosage,66.6
1325,1,1,1st Failure Type,no known failure
1325,1,1,Nodal Stage,N0
1325,1,1,Overall Stage,II
1325,1,1,Research lab HPV,HPV unknown
1325,1,1,Tumor Stage,T2
1325,1,1,Research lab p16,p16 unknown
1325,1,1,Tumor Site,oropharynx
1325,1,1,Treatment Modality,RT
1325,1,1,2nd Failure Type,no known failure
1326,1,1,Research lab HPV,HPV unknown
1326,1,1,2nd Failure Type,no known failure
1326,1,1,Overall Stage,IVa
1326,1,1,Metastasis,M0
1326,1,1,Occurrence #,other primary
1326,1,1,Clinical lab p16,p16 unkown
1326,1,1,Nodal Stage,N0
1326,1,1,Tumor Stage,T4a
1326,1,1,Tumor Site,oropharynx
1326,1,1,Treatment Modality,CTX-RT
1326,1,1,Radiation Dosage,9.6
1326,1,1,Research lab p16,p16 unknown
1326,1,1,Initial Chemotherapy Agent,doce/carbo/5FU
1326,1,1,1st Failure Type,no known failure
1327,1,1,Nodal Stage,N2
1327,1,1,Overall Stage,IVa
1327,1,1,Metastasis,M0
1327,1,1,Research lab p16,p16 unknown
1327,1,1,Tumor Stage,T2
1327,1,1,1st Failure Type,no known failure
1327,1,1,Research lab HPV,HPV unknown
1327,1,1,Treatment Modality,Unknown
1327,1,1,Tumor Site,oropharynx
1327,1,1,Clinical lab p16,p16 unkown
1327,1,1,2nd Failure Type,no known failure
1327,1,1,Occurrence #,1st primary
1328,1,1,Research lab HPV,HPV unknown
1328,1,1,1st Failure Type,no known failure
1328,1,1,Clinical lab p16,p16 unkown
1328,1,1,2nd Failure Type,no known failure
1328,1,1,Tumor Stage,T2
1328,1,1,Metastasis,M0
1328,1,1,Research lab p16,p16 unknown
1328,1,1,Overall Stage,II
1328,1,1,Nodal Stage,N0
1328,1,1,Radiation Dosage,70.2
1328,1,1,Treatment Modality,RT
1328,1,1,Tumor Site,larynx
1328,1,1,Occurrence #,1st primary
1329,1,1,2nd Failure Type,no known failure
1329,1,1,Research lab p16,p16 unknown
1329,1,1,Metastasis,M0
1329,1,1,Tumor Stage,T1
1329,1,1,1st Failure Type,no known failure
1329,1,1,Tumor Site,larynx
1329,1,1,Treatment Modality,RT
1329,1,1,Nodal Stage,N0
1329,1,1,Radiation Dosage,50
1329,1,1,Occurrence #,1st primary
1329,1,1,Research lab HPV,HPV unknown
1329,1,1,Overall Stage,I
1329,1,1,Clinical lab p16,p16 unkown
1330,1,1,Tumor Stage,T4a
1330,1,1,Tumor Site,larynx
1330,1,1,Occurrence #,1st primary
1330,1,1,1st Failure Type,no known failure
1330,1,1,Overall Stage,IVa
1330,1,1,Nodal Stage,N0
1330,1,1,Research lab HPV,HPV unknown
1330,1,1,Treatment Modality,Sx
1330,1,1,Metastasis,M0
1330,1,1,Research lab p16,p16 unknown
1330,1,1,Clinical lab p16,p16 unkown
1330,1,1,2nd Failure Type,no known failure
1331,1,1,Research lab HPV,HPV unknown
1331,1,1,Tumor Stage,T1
1331,1,1,Clinical lab p16,p16 unkown
1331,1,1,Radiation Dosage,unknown
1331,1,1,Occurrence #,1st primary
1331,1,1,Metastasis,M0
1331,1,1,Treatment Modality,Sx & RT
1331,1,1,Overall Stage,IVa
1331,1,1,Tumor Site,larynx
1331,1,1,Nodal Stage,N2
1331,1,1,Research lab p16,p16 unknown
1331,1,1,2nd Failure Type,no known failure
1331,1,1,1st Failure Type,locoregional
1332,1,1,1st Failure Type,no known failure
1332,1,1,Overall Stage,I
1332,1,1,2nd Failure Type,no known failure
1332,1,1,Nodal Stage,N0
1332,1,1,Tumor Site,larynx
1332,1,1,Clinical lab p16,p16 unkown
1332,1,1,Research lab p16,p16 unknown
1332,1,1,Tumor Stage,T1
1332,1,1,Research lab HPV,HPV unknown
1332,1,1,Treatment Modality,Sx
1332,1,1,Metastasis,M0
1332,1,1,Occurrence #,1st primary
1333,1,1,1st Failure Type,no known failure
1333,1,1,Tumor Site,larynx
1333,1,1,Occurrence #,1st primary
1333,1,1,Research lab HPV,HPV unknown
1333,1,1,Treatment Modality,Sx & CTX-RT
1333,1,1,Overall Stage,IVa
1333,1,1,Radiation Dosage,59.4
1333,1,1,Initial Chemotherapy Agent,cis
1333,1,1,Research lab p16,p16 unknown
1333,1,1,Tumor Stage,T3
1333,1,1,Clinical lab p16,p16 unkown
1333,1,1,Nodal Stage,N2
1333,1,1,Metastasis,M0
1333,1,1,2nd Failure Type,no known failure
1334,1,1,Tumor Stage,T4a
1334,1,1,Overall Stage,IVa
1334,1,1,Clinical lab p16,p16 unkown
1334,1,1,Nodal Stage,N2
1334,1,1,Research lab HPV,HPV unknown
1334,1,1,Tumor Site,larynx
1334,1,1,Research lab p16,p16 unknown
1334,1,1,Occurrence #,1st primary
1334,1,1,Metastasis,M0
1334,1,1,Treatment Modality,Sx
1334,1,1,1st Failure Type,no known failure
1334,1,1,2nd Failure Type,no known failure
1335,1,1,Tumor Site,larynx
1335,1,1,Clinical lab p16,p16 unkown
1335,1,1,Occurrence #,1st primary
1335,1,1,Treatment Modality,Sx & RT
1335,1,1,2nd Failure Type,no known failure
1335,1,1,Research lab p16,p16 unknown
1335,1,1,Research lab HPV,HPV unknown
1335,1,1,Metastasis,M0
1335,1,1,Tumor Stage,T4a
1335,1,1,Radiation Dosage,unknown
1335,1,1,Overall Stage,IVa
1335,1,1,1st Failure Type,no known failure
1335,1,1,Nodal Stage,N0
1336,1,1,Tumor Site,larynx
1336,1,1,1st Failure Type,no known failure
1336,1,1,Tumor Stage,T3
1336,1,1,Treatment Modality,RT
1336,1,1,Metastasis,M0
1336,1,1,2nd Failure Type,no known failure
1336,1,1,Radiation Dosage,74.4
1336,1,1,Research lab HPV,HPV unknown
1336,1,1,Research lab p16,p16 unknown
1336,1,1,Nodal Stage,N0
1336,1,1,Overall Stage,III
1336,1,1,Occurrence #,1st primary
1336,1,1,Clinical lab p16,p16 unkown
1337,1,1,Tumor Site,larynx
1337,1,1,Research lab p16,p16 unknown
1337,1,1,Clinical lab p16,p16 unkown
1337,1,1,Treatment Modality,Sx
1337,1,1,Occurrence #,recurrence
1337,1,1,1st Failure Type,no known failure
1337,1,1,2nd Failure Type,no known failure
1337,1,1,Tumor Stage,T2
1337,1,1,Research lab HPV,HPV unknown
1337,1,1,Metastasis,M0
1337,1,1,Nodal Stage,N0
1337,1,1,Overall Stage,II
1338,1,1,Tumor Stage,T4a
1338,1,1,Research lab p16,p16 unknown
1338,1,1,1st Failure Type,locoregional
1338,1,1,Metastasis,M0
1338,1,1,Radiation Dosage,59.4
1338,1,1,Treatment Modality,Sx & RT
1338,1,1,1st Failure Initial Chemotherapy Agent,carbo
1338,1,1,Research lab HPV,HPV unknown
1338,1,1,2nd Failure Type,no known failure
1338,1,1,Nodal Stage,N0
1338,1,1,1st Failure Radiation Dosage,60
1338,1,1,Overall Stage,IVa
1338,1,1,1st Failure Treatment Modality,CTX-RT
1338,1,1,Tumor Site,larynx
1338,1,1,Clinical lab p16,p16 unkown
1338,1,1,Occurrence #,1st primary
1338,1,1,1st Failure Site,larynx
1339,1,1,Research lab p16,p16 unknown
1339,1,1,2nd Failure Type,no known failure
1339,1,1,Tumor Site,larynx
1339,1,1,Clinical lab p16,p16 unkown
1339,1,1,Tumor Stage,T1
1339,1,1,Overall Stage,I
1339,1,1,Nodal Stage,N0
1339,1,1,Occurrence #,recurrence
1339,1,1,Metastasis,M0
1339,1,1,Treatment Modality,Sx
1339,1,1,1st Failure Type,no known failure
1339,1,1,Research lab HPV,HPV unknown
1340,1,1,Radiation Dosage,63
1340,1,1,Tumor Site,larynx
1340,1,1,Tumor Stage,T1
1340,1,1,Nodal Stage,N0
1340,1,1,2nd Failure Type,no known failure
1340,1,1,Research lab p16,p16 unknown
1340,1,1,Research lab HPV,HPV unknown
1340,1,1,Clinical lab p16,p16 unkown
1340,1,1,Overall Stage,I
1340,1,1,Metastasis,M0
1340,1,1,Occurrence #,1st primary
1340,1,1,1st Failure Type,no known failure
1340,1,1,Treatment Modality,RT
1341,1,1,Radiation Dosage,63
1341,1,1,1st Failure Type,no known failure
1341,1,1,Research lab HPV,HPV unknown
1341,1,1,Treatment Modality,RT
1341,1,1,Metastasis,M0
1341,1,1,Research lab p16,p16 unknown
1341,1,1,Tumor Stage,T2
1341,1,1,2nd Failure Type,no known failure
1341,1,1,Occurrence #,1st primary
1341,1,1,Overall Stage,II
1341,1,1,Tumor Site,larynx
1341,1,1,Clinical lab p16,p16 unkown
1341,1,1,Nodal Stage,N0
1342,1,1,Occurrence #,1st primary
1342,1,1,Treatment Modality,Sx
1342,1,1,Overall Stage,IVa
1342,1,1,2nd Failure Type,no known failure
1342,1,1,Tumor Stage,T4a
1342,1,1,Research lab p16,p16 unknown
1342,1,1,Nodal Stage,N0
1342,1,1,Clinical lab p16,p16 unkown
1342,1,1,1st Failure Type,no known failure
1342,1,1,Metastasis,M0
1342,1,1,Tumor Site,larynx
1342,1,1,Research lab HPV,HPV unknown
1343,1,1,Research lab HPV,HPV unknown
1343,1,1,Occurrence #,recurrence
1343,1,1,Tumor Site,larynx
1343,1,1,Overall Stage,III
1343,1,1,2nd Failure Type,no known failure
1343,1,1,Clinical lab p16,p16 unkown
1343,1,1,Nodal Stage,N0
1343,1,1,Research lab p16,p16 unknown
1343,1,1,Treatment Modality,Sx
1343,1,1,1st Failure Type,no known failure
1343,1,1,Metastasis,M0
1343,1,1,Tumor Stage,T3
1344,1,1,Metastasis,M0
1344,1,1,Radiation Dosage,72
1344,1,1,Research lab p16,p16 unknown
1344,1,1,Tumor Stage,T3
1344,1,1,2nd Failure Type,no known failure
1344,1,1,Clinical lab p16,p16 unkown
1344,1,1,Nodal Stage,N2
1344,1,1,Treatment Modality,RT
1344,1,1,Overall Stage,IVa
1344,1,1,Tumor Site,larynx
1344,1,1,Research lab HPV,HPV unknown
1344,1,1,Occurrence #,1st primary
1344,1,1,1st Failure Type,no known failure
1345,1,1,1st Failure Type,no known failure
1345,1,1,Tumor Site,larynx
1345,1,1,Metastasis,M0
1345,1,1,Tumor Stage,T2
1345,1,1,Clinical lab p16,p16 unkown
1345,1,1,Nodal Stage,N0
1345,1,1,Research lab HPV,HPV unknown
1345,1,1,Radiation Dosage,unknown
1345,1,1,Occurrence #,1st primary
1345,1,1,Overall Stage,II
1345,1,1,2nd Failure Type,no known failure
1345,1,1,Treatment Modality,RT
1345,1,1,Research lab p16,p16 unknown
1346,1,1,Tumor Site,larynx
1346,1,1,Overall Stage,IVa
1346,1,1,Occurrence #,recurrence
1346,1,1,2nd Failure Type,no known failure
1346,1,1,Tumor Stage,T3
1346,1,1,Treatment Modality,Sx & CTX-RT
1346,1,1,Metastasis,M0
1346,1,1,Initial Chemotherapy Agent,cis
1346,1,1,1st Failure Type,distant
1346,1,1,Nodal Stage,N2
1346,1,1,Radiation Dosage,unknown
1346,1,1,Research lab p16,p16 unknown
1346,1,1,Clinical lab p16,p16 unkown
1346,1,1,Research lab HPV,HPV unknown
1347,1,1,Nodal Stage,N0
1347,1,1,Treatment Modality,RT
1347,1,1,2nd Failure Type,no known failure
1347,1,1,Overall Stage,I
1347,1,1,Metastasis,M0
1347,1,1,Research lab HPV,HPV unknown
1347,1,1,Tumor Site,larynx
1347,1,1,1st Failure Type,no known failure
1347,1,1,Research lab p16,p16 unknown
1347,1,1,Radiation Dosage,63
1347,1,1,Tumor Stage,T1
1347,1,1,Occurrence #,1st primary
1347,1,1,Clinical lab p16,p16 unkown
1348,1,1,Research lab p16,p16 unknown
1348,1,1,Initial Chemotherapy Agent,carbo/PTX
1348,1,1,Overall Stage,IVa
1348,1,1,Tumor Stage,T4a
1348,1,1,Treatment Modality,Sx & CTX-RT
1348,1,1,Metastasis,M0
1348,1,1,Tumor Site,larynx
1348,1,1,Clinical lab p16,p16 unkown
1348,1,1,Occurrence #,recurrence
1348,1,1,2nd Failure Type,no known failure
1348,1,1,Research lab HPV,HPV unknown
1348,1,1,1st Failure Type,no known failure
1348,1,1,Radiation Dosage,60
1348,1,1,Nodal Stage,N2
1349,1,1,Tumor Site,larynx
1349,1,1,Research lab HPV,HPV unknown
1349,1,1,Metastasis,M0
1349,1,1,2nd Failure Type,no known failure
1349,1,1,Treatment Modality,Sx
1349,1,1,Occurrence #,other primary
1349,1,1,1st Failure Type,no known failure
1349,1,1,Nodal Stage,N1
1349,1,1,Clinical lab p16,p16 unkown
1349,1,1,Tumor Stage,T4a
1349,1,1,Overall Stage,IVa
1349,1,1,Research lab p16,p16 unknown
1350,1,1,1st Failure Treatment Modality,Sx
1350,1,1,Overall Stage,I
1350,1,1,1st Failure Type,locoregional
1350,1,1,Research lab p16,p16 unknown
1350,1,1,Treatment Modality,RT
1350,1,1,Occurrence #,1st primary
1350,1,1,Research lab HPV,HPV unknown
1350,1,1,Metastasis,M0
1350,1,1,2nd Failure Type,no known failure
1350,1,1,Clinical lab p16,p16 unkown
1350,1,1,Tumor Site,larynx
1350,1,1,Tumor Stage,T1
1350,1,1,Nodal Stage,N0
1350,1,1,Radiation Dosage,63
1350,1,1,1st Failure Site,larynx
1351,1,1,Research lab HPV,HPV unknown
1351,1,1,Radiation Dosage,unknown
1351,1,1,Overall Stage,Unknown
1351,1,1,Research lab p16,p16 unknown
1351,1,1,Treatment Modality,RT
1351,1,1,Tumor Stage,Unknown
1351,1,1,Clinical lab p16,p16 unkown
1351,1,1,2nd Failure Type,no known failure
1351,1,1,Metastasis,Unknown
1351,1,1,Nodal Stage,Unknown
1351,1,1,Occurrence #,recurrence
1351,1,1,1st Failure Type,no known failure
1351,1,1,Tumor Site,larynx
1352,1,1,1st Failure Type,no known failure
1352,1,1,Occurrence #,1st primary
1352,1,1,Clinical lab p16,p16 unkown
1352,1,1,Research lab p16,p16 unknown
1352,1,1,Initial Chemotherapy Agent,cis
1352,1,1,Nodal Stage,N0
1352,1,1,Overall Stage,III
1352,1,1,2nd Failure Type,no known failure
1352,1,1,Research lab HPV,HPV unknown
1352,1,1,Radiation Dosage,70.2
1352,1,1,Tumor Site,larynx
1352,1,1,Tumor Stage,T3
1352,1,1,Treatment Modality,CTX-RT
1352,1,1,Metastasis,M0
1353,1,1,2nd Failure Type,no known failure
1353,1,1,Overall Stage,II
1353,1,1,Research lab HPV,HPV unknown
1353,1,1,Treatment Modality,Sx
1353,1,1,Nodal Stage,N0
1353,1,1,Clinical lab p16,p16 unkown
1353,1,1,1st Failure Type,no known failure
1353,1,1,Tumor Site,larynx
1353,1,1,Tumor Stage,T2
1353,1,1,Research lab p16,p16 unknown
1353,1,1,Metastasis,M0
1353,1,1,Occurrence #,1st primary
1354,1,1,Tumor Site,larynx
1354,1,1,Treatment Modality,Sx
1354,1,1,1st Failure Initial Chemotherapy Agent,cis/doce
1354,1,1,Research lab p16,p16 unknown
1354,1,1,1st Failure Site,larynx
1354,1,1,Nodal Stage,N2
1354,1,1,1st Failure Treatment Modality,CTX
1354,1,1,1st Failure Type,locoregional
1354,1,1,Tumor Stage,T3
1354,1,1,2nd Failure Type,no known failure
1354,1,1,Research lab HPV,HPV unknown
1354,1,1,Overall Stage,IVa
1354,1,1,Clinical lab p16,p16 unkown
1354,1,1,Metastasis,M0
1354,1,1,Occurrence #,recurrence
1355,1,1,Metastasis,M0
1355,1,1,Treatment Modality,Unknown
1355,1,1,Clinical lab p16,p16 unkown
1355,1,1,1st Failure Type,no known failure
1355,1,1,2nd Failure Type,no known failure
1355,1,1,Tumor Site,larynx
1355,1,1,Nodal Stage,N1
1355,1,1,Research lab p16,p16 unknown
1355,1,1,Overall Stage,III
1355,1,1,Research lab HPV,HPV unknown
1355,1,1,Occurrence #,1st primary
1355,1,1,Tumor Stage,T3
1356,1,1,Radiation Dosage,unknown
1356,1,1,Tumor Stage,T4a
1356,1,1,Occurrence #,1st primary
1356,1,1,Metastasis,M0
1356,1,1,Treatment Modality,Sx & RT
1356,1,1,1st Failure Type,no known failure
1356,1,1,2nd Failure Type,no known failure
1356,1,1,Research lab p16,p16 unknown
1356,1,1,Research lab HPV,HPV unknown
1356,1,1,Nodal Stage,N1
1356,1,1,Tumor Site,larynx
1356,1,1,Clinical lab p16,p16 unkown
1356,1,1,Overall Stage,IVa
1357,1,1,Tumor Site,larynx
1357,1,1,Metastasis,M0
1357,1,1,Research lab p16,p16 unknown
1357,1,1,Tumor Stage,T3
1357,1,1,1st Failure Type,no known failure
1357,1,1,Occurrence #,1st primary
1357,1,1,Overall Stage,IVa
1357,1,1,Clinical lab p16,p16 unkown
1357,1,1,2nd Failure Type,no known failure
1357,1,1,Nodal Stage,N2
1357,1,1,Treatment Modality,Sx & RT
1357,1,1,Research lab HPV,HPV unknown
1357,1,1,Radiation Dosage,63
1358,1,1,Overall Stage,I
1358,1,1,Radiation Dosage,63
1358,1,1,Research lab p16,p16 unknown
1358,1,1,Tumor Site,larynx
1358,1,1,Research lab HPV,HPV unknown
1358,1,1,Tumor Stage,T1
1358,1,1,2nd Failure Type,no known failure
1358,1,1,1st Failure Type,no known failure
1358,1,1,Clinical lab p16,p16 unkown
1358,1,1,Nodal Stage,N0
1358,1,1,Treatment Modality,RT
1358,1,1,Occurrence #,1st primary
1358,1,1,Metastasis,M0
1359,1,1,Research lab HPV,HPV unknown
1359,1,1,Treatment Modality,CTX-RT
1359,1,1,Clinical lab p16,p16 unkown
1359,1,1,Nodal Stage,N2
1359,1,1,Tumor Site,larynx
1359,1,1,Occurrence #,1st primary
1359,1,1,Radiation Dosage,unknown
1359,1,1,Tumor Stage,T3
1359,1,1,Overall Stage,IVa
1359,1,1,2nd Failure Type,no known failure
1359,1,1,1st Failure Type,no known failure
1359,1,1,Initial Chemotherapy Agent,unknown
1359,1,1,Research lab p16,p16 unknown
1359,1,1,Metastasis,M0
1360,1,1,Metastasis,M0
1360,1,1,Research lab HPV,HPV unknown
1360,1,1,Occurrence #,1st primary
1360,1,1,Tumor Stage,T4a
1360,1,1,1st Failure Type,no known failure
1360,1,1,Nodal Stage,N0
1360,1,1,Treatment Modality,Sx
1360,1,1,Overall Stage,IVa
1360,1,1,Research lab p16,p16 unknown
1360,1,1,2nd Failure Type,no known failure
1360,1,1,Tumor Site,larynx
1360,1,1,Clinical lab p16,p16 unkown
1361,1,1,1st Failure Type,no known failure
1361,1,1,Clinical lab p16,p16 unkown
1361,1,1,Nodal Stage,N0
1361,1,1,Occurrence #,1st primary
1361,1,1,Treatment Modality,RT
1361,1,1,Overall Stage,III
1361,1,1,2nd Failure Type,no known failure
1361,1,1,Tumor Stage,T3
1361,1,1,Research lab p16,p16 unknown
1361,1,1,Radiation Dosage,74.4
1361,1,1,Metastasis,M0
1361,1,1,Research lab HPV,HPV unknown
1361,1,1,Tumor Site,larynx
1362,1,1,Metastasis,M1
1362,1,1,Research lab p16,p16 unknown
1362,1,1,Tumor Site,larynx
1362,1,1,2nd Failure Type,no known failure
1362,1,1,Clinical lab p16,p16 unkown
1362,1,1,Treatment Modality,CTX
1362,1,1,Overall Stage,IVc
1362,1,1,Tumor Stage,T3
1362,1,1,Research lab HPV,HPV unknown
1362,1,1,Occurrence #,1st primary
1362,1,1,Initial Chemotherapy Agent,cis/doce/PTX
1362,1,1,Nodal Stage,N3
1362,1,1,1st Failure Type,no known failure
1363,1,1,Overall Stage,IVa
1363,1,1,Research lab p16,p16 unknown
1363,1,1,Initial Chemotherapy Agent,carbo/PTX
1363,1,1,Tumor Site,larynx
1363,1,1,Radiation Dosage,unknown
1363,1,1,2nd Failure Type,no known failure
1363,1,1,Occurrence #,1st primary
1363,1,1,Research lab HPV,HPV unknown
1363,1,1,Tumor Stage,T3
1363,1,1,Treatment Modality,CTX-RT
1363,1,1,1st Failure Type,no known failure
1363,1,1,Clinical lab p16,p16 unkown
1363,1,1,Nodal Stage,N2
1363,1,1,Metastasis,M0
1364,1,1,Nodal Stage,N0
1364,1,1,2nd Failure Type,no known failure
1364,1,1,Research lab p16,p16 unknown
1364,1,1,Tumor Site,larynx
1364,1,1,Occurrence #,1st primary
1364,1,1,Metastasis,M0
1364,1,1,Tumor Stage,T1
1364,1,1,1st Failure Type,no known failure
1364,1,1,Treatment Modality,Sx
1364,1,1,Clinical lab p16,p16 unkown
1364,1,1,Research lab HPV,HPV unknown
1364,1,1,Overall Stage,I
1365,1,1,Tumor Site,larynx
1365,1,1,Overall Stage,III
1365,1,1,Tumor Stage,T3
1365,1,1,1st Failure Type,no known failure
1365,1,1,2nd Failure Type,no known failure
1365,1,1,Metastasis,M0
1365,1,1,Treatment Modality,Sx
1365,1,1,Nodal Stage,N0
1365,1,1,Research lab p16,p16 unknown
1365,1,1,Occurrence #,1st primary
1365,1,1,Clinical lab p16,p16 unkown
1365,1,1,Research lab HPV,HPV unknown
1366,1,1,Clinical lab p16,p16 unkown
1366,1,1,1st Failure Treatment Modality,Sx
1366,1,1,Overall Stage,II
1366,1,1,1st Failure Site,larynx
1366,1,1,Metastasis,M0
1366,1,1,Research lab p16,p16 unknown
1366,1,1,Research lab HPV,HPV unknown
1366,1,1,1st Failure Type,locoregional
1366,1,1,Treatment Modality,RT
1366,1,1,Tumor Stage,T2
1366,1,1,Nodal Stage,N0
1366,1,1,2nd Failure Type,no known failure
1366,1,1,Tumor Site,larynx
1366,1,1,Occurrence #,1st primary
1366,1,1,Radiation Dosage,74.4
1367,1,1,Metastasis,M0
1367,1,1,Radiation Dosage,74.4
1367,1,1,1st Failure Type,no known failure
1367,1,1,Occurrence #,1st primary
1367,1,1,Research lab HPV,HPV unknown
1367,1,1,Nodal Stage,N0
1367,1,1,Tumor Stage,T2
1367,1,1,Overall Stage,II
1367,1,1,Research lab p16,p16 unknown
1367,1,1,Tumor Site,larynx
1367,1,1,Clinical lab p16,p16 unkown
1367,1,1,Treatment Modality,RT
1367,1,1,2nd Failure Type,no known failure
1368,1,1,Initial Chemotherapy Agent,cis
1368,1,1,Radiation Dosage,70.2
1368,1,1,Overall Stage,IVa
1368,1,1,Nodal Stage,N2
1368,1,1,Tumor Stage,T4a
1368,1,1,Research lab HPV,HPV unknown
1368,1,1,1st Failure Type,no known failure
1368,1,1,Metastasis,M0
1368,1,1,Treatment Modality,CTX-RT
1368,1,1,Research lab p16,p16 unknown
1368,1,1,2nd Failure Type,no known failure
1368,1,1,Clinical lab p16,p16 unkown
1368,1,1,Tumor Site,larynx
1368,1,1,Occurrence #,1st primary
1369,1,1,Metastasis,M0
1369,1,1,Radiation Dosage,63
1369,1,1,Occurrence #,1st primary
1369,1,1,Tumor Stage,T1
1369,1,1,Clinical lab p16,p16 unkown
1369,1,1,Research lab HPV,HPV unknown
1369,1,1,Nodal Stage,N0
1369,1,1,2nd Failure Type,no known failure
1369,1,1,Treatment Modality,RT
1369,1,1,Research lab p16,p16 unknown
1369,1,1,Tumor Site,larynx
1369,1,1,Overall Stage,I
1369,1,1,1st Failure Type,no known failure
1370,1,1,Clinical lab p16,p16 unkown
1370,1,1,Radiation Dosage,unknown
1370,1,1,Tumor Site,larynx
1370,1,1,2nd Failure Type,no known failure
1370,1,1,Research lab HPV,HPV unknown
1370,1,1,Nodal Stage,N0
1370,1,1,1st Failure Type,no known failure
1370,1,1,Tumor Stage,T4a
1370,1,1,Treatment Modality,Sx & RT
1370,1,1,Research lab p16,p16 unknown
1370,1,1,Metastasis,M0
1370,1,1,Overall Stage,IVa
1370,1,1,Occurrence #,1st primary
1371,1,1,Overall Stage,IVa
1371,1,1,Initial Chemotherapy Agent,cis
1371,1,1,1st Failure Type,no known failure
1371,1,1,Research lab p16,p16 unknown
1371,1,1,2nd Failure Type,no known failure
1371,1,1,Treatment Modality,CTX-RT
1371,1,1,Tumor Site,larynx
1371,1,1,Metastasis,M0
1371,1,1,Tumor Stage,T3
1371,1,1,Radiation Dosage,70.2
1371,1,1,Research lab HPV,HPV unknown
1371,1,1,Occurrence #,1st primary
1371,1,1,Nodal Stage,N2
1371,1,1,Clinical lab p16,p16 unkown
1372,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1372,1,1,Metastasis,M0
1372,1,1,Research lab p16,p16 unknown
1372,1,1,Research lab HPV,HPV unknown
1372,1,1,Treatment Modality,CTX-RT
1372,1,1,Tumor Site,larynx
1372,1,1,2nd Failure Type,no known failure
1372,1,1,Nodal Stage,N2
1372,1,1,Tumor Stage,T2
1372,1,1,1st Failure Type,no known failure
1372,1,1,Radiation Dosage,70.2
1372,1,1,Clinical lab p16,p16 unkown
1372,1,1,Overall Stage,IVa
1372,1,1,Occurrence #,1st primary
1373,1,1,Tumor Stage,T1
1373,1,1,Metastasis,M0
1373,1,1,Nodal Stage,N0
1373,1,1,1st Failure Type,no known failure
1373,1,1,Tumor Site,larynx
1373,1,1,Overall Stage,I
1373,1,1,Occurrence #,1st primary
1373,1,1,Clinical lab p16,p16 unkown
1373,1,1,Research lab p16,p16 unknown
1373,1,1,Treatment Modality,Sx
1373,1,1,2nd Failure Type,no known failure
1373,1,1,Research lab HPV,HPV unknown
1374,1,1,Metastasis,M0
1374,1,1,Tumor Stage,T2
1374,1,1,Overall Stage,II
1374,1,1,Research lab p16,p16 unknown
1374,1,1,Treatment Modality,RT
1374,1,1,Occurrence #,1st primary
1374,1,1,Nodal Stage,N0
1374,1,1,Research lab HPV,HPV unknown
1374,1,1,1st Failure Type,no known failure
1374,1,1,Tumor Site,larynx
1374,1,1,Radiation Dosage,74.4
1374,1,1,2nd Failure Type,no known failure
1374,1,1,Clinical lab p16,p16 unkown
1375,1,1,Tumor Site,larynx
1375,1,1,Research lab p16,p16 unknown
1375,1,1,Occurrence #,1st primary
1375,1,1,Initial Chemotherapy Agent,carbo/PTX
1375,1,1,Overall Stage,IVa
1375,1,1,Nodal Stage,N2
1375,1,1,Treatment Modality,Sx & CTX-RT
1375,1,1,Radiation Dosage,70.2
1375,1,1,2nd Failure Type,no known failure
1375,1,1,Clinical lab p16,p16 unkown
1375,1,1,Metastasis,M0
1375,1,1,1st Failure Type,no known failure
1375,1,1,Research lab HPV,HPV unknown
1375,1,1,Tumor Stage,T4a
1376,1,1,Tumor Site,larynx
1376,1,1,Metastasis,M0
1376,1,1,Research lab HPV,HPV unknown
1376,1,1,Clinical lab p16,p16 unkown
1376,1,1,Treatment Modality,Sx
1376,1,1,1st Failure Treatment Modality,CTX
1376,1,1,2nd Failure Type,no known failure
1376,1,1,Nodal Stage,N2
1376,1,1,Tumor Stage,T4a
1376,1,1,1st Failure Type,locoregional
1376,1,1,Overall Stage,IVa
1376,1,1,1st Failure Second Line Chemotherapy Agent,carbo/doce
1376,1,1,Occurrence #,other primary
1376,1,1,1st Failure Initial Chemotherapy Agent,cap
1376,1,1,Research lab p16,p16 unknown
1377,1,1,2nd Failure Type,no known failure
1377,1,1,Radiation Dosage,60
1377,1,1,Nodal Stage,N0
1377,1,1,1st Failure Type,no known failure
1377,1,1,Tumor Site,larynx
1377,1,1,Clinical lab p16,p16 unkown
1377,1,1,Overall Stage,IVa
1377,1,1,Research lab p16,p16 unknown
1377,1,1,Research lab HPV,HPV unknown
1377,1,1,Metastasis,M0
1377,1,1,Occurrence #,1st primary
1377,1,1,Tumor Stage,T4a
1377,1,1,Treatment Modality,Sx & RT
1378,1,1,Occurrence #,1st primary
1378,1,1,Research lab HPV,HPV unknown
1378,1,1,Research lab p16,p16 unknown
1378,1,1,Overall Stage,II
1378,1,1,Clinical lab p16,p16 unkown
1378,1,1,1st Failure Type,no known failure
1378,1,1,Treatment Modality,RT
1378,1,1,2nd Failure Type,no known failure
1378,1,1,Metastasis,M0
1378,1,1,Tumor Stage,T2
1378,1,1,Radiation Dosage,74.4
1378,1,1,Nodal Stage,N0
1378,1,1,Tumor Site,larynx
1379,1,1,Occurrence #,1st primary
1379,1,1,Clinical lab p16,p16 unkown
1379,1,1,Overall Stage,IVb
1379,1,1,2nd Failure Type,no known failure
1379,1,1,Treatment Modality,Sx
1379,1,1,1st Failure Type,no known failure
1379,1,1,Metastasis,M0
1379,1,1,Research lab HPV,HPV unknown
1379,1,1,Nodal Stage,N3
1379,1,1,Research lab p16,p16 unknown
1379,1,1,Tumor Site,larynx
1379,1,1,Tumor Stage,T3
1380,1,1,Radiation Dosage,70.2
1380,1,1,Research lab HPV,HPV unknown
1380,1,1,2nd Failure Type,no known failure
1380,1,1,Nodal Stage,N0
1380,1,1,Tumor Site,larynx
1380,1,1,1st Failure Type,distant
1380,1,1,Treatment Modality,CTX-RT
1380,1,1,Metastasis,M0
1380,1,1,Tumor Stage,T3
1380,1,1,1st Failure Treatment Modality,CTX
1380,1,1,Research lab p16,p16 unknown
1380,1,1,Clinical lab p16,p16 unkown
1380,1,1,Occurrence #,1st primary
1380,1,1,Overall Stage,III
1380,1,1,1st Failure Site,larynx
1380,1,1,Initial Chemotherapy Agent,cis
1380,1,1,1st Failure Initial Chemotherapy Agent,doce
1381,1,1,Research lab HPV,HPV unknown
1381,1,1,Occurrence #,1st primary
1381,1,1,Tumor Site,larynx
1381,1,1,Tumor Stage,T4a
1381,1,1,Clinical lab p16,p16 unkown
1381,1,1,Research lab p16,p16 unknown
1381,1,1,Nodal Stage,N3
1381,1,1,Overall Stage,IVb
1381,1,1,Treatment Modality,Sx & RT
1381,1,1,2nd Failure Type,no known failure
1381,1,1,1st Failure Type,locoregional and distant
1381,1,1,Metastasis,M0
1381,1,1,Radiation Dosage,64
1382,1,1,Treatment Modality,Sx
1382,1,1,1st Failure Type,no known failure
1382,1,1,Overall Stage,IVa
1382,1,1,Research lab HPV,HPV unknown
1382,1,1,Tumor Site,larynx
1382,1,1,Tumor Stage,T4a
1382,1,1,Clinical lab p16,p16 unkown
1382,1,1,Occurrence #,recurrence
1382,1,1,Nodal Stage,N0
1382,1,1,2nd Failure Type,no known failure
1382,1,1,Research lab p16,p16 unknown
1382,1,1,Metastasis,M0
1383,1,1,Treatment Modality,Sx & RT
1383,1,1,Research lab p16,p16 unknown
1383,1,1,Research lab HPV,HPV unknown
1383,1,1,Tumor Stage,T1
1383,1,1,Metastasis,M0
1383,1,1,Overall Stage,IVa
1383,1,1,Nodal Stage,N2
1383,1,1,Occurrence #,recurrence
1383,1,1,Tumor Site,larynx
1383,1,1,Radiation Dosage,63
1383,1,1,1st Failure Type,no known failure
1383,1,1,Clinical lab p16,p16 unkown
1383,1,1,2nd Failure Type,no known failure
1384,1,1,Clinical lab p16,p16 unkown
1384,1,1,Research lab p16,p16 unknown
1384,1,1,Tumor Site,larynx
1384,1,1,Nodal Stage,N2
1384,1,1,Metastasis,M0
1384,1,1,Radiation Dosage,74.4
1384,1,1,Overall Stage,IVa
1384,1,1,Research lab HPV,HPV unknown
1384,1,1,Tumor Stage,T3
1384,1,1,1st Failure Type,no known failure
1384,1,1,Treatment Modality,RT
1384,1,1,Occurrence #,1st primary
1384,1,1,2nd Failure Type,no known failure
1385,1,1,2nd Failure Type,no known failure
1385,1,1,Metastasis,M0
1385,1,1,Tumor Site,larynx
1385,1,1,Research lab HPV,HPV unknown
1385,1,1,Overall Stage,IVa
1385,1,1,Research lab p16,p16 unknown
1385,1,1,Clinical lab p16,p16 unkown
1385,1,1,Treatment Modality,Unknown
1385,1,1,Occurrence #,1st primary
1385,1,1,Nodal Stage,Unknown
1385,1,1,1st Failure Type,no known failure
1385,1,1,Tumor Stage,T4a
1386,1,1,Overall Stage,II
1386,1,1,2nd Failure Type,no known failure
1386,1,1,Treatment Modality,RT
1386,1,1,Clinical lab p16,p16 unkown
1386,1,1,Tumor Stage,T2
1386,1,1,Occurrence #,1st primary
1386,1,1,Tumor Site,larynx
1386,1,1,Nodal Stage,N0
1386,1,1,Research lab p16,p16 unknown
1386,1,1,Radiation Dosage,74.4
1386,1,1,1st Failure Type,no known failure
1386,1,1,Research lab HPV,HPV unknown
1386,1,1,Metastasis,M0
1387,1,1,1st Failure Type,locoregional
1387,1,1,2nd Failure Type,no known failure
1387,1,1,Research lab p16,p16 unknown
1387,1,1,Radiation Dosage,70
1387,1,1,Research lab HPV,HPV unknown
1387,1,1,Clinical lab p16,p16 unkown
1387,1,1,1st Failure Treatment Modality,Sx
1387,1,1,Tumor Stage,T2
1387,1,1,Nodal Stage,N1
1387,1,1,Metastasis,M0
1387,1,1,Tumor Site,larynx
1387,1,1,Occurrence #,1st primary
1387,1,1,Treatment Modality,RT
1387,1,1,1st Failure Site,larynx
1387,1,1,Overall Stage,III
1388,1,1,Nodal Stage,N2
1388,1,1,Research lab p16,p16 unknown
1388,1,1,Tumor Stage,T4a
1388,1,1,Research lab HPV,HPV unknown
1388,1,1,1st Failure Type,no known failure
1388,1,1,Tumor Site,larynx
1388,1,1,2nd Failure Type,no known failure
1388,1,1,Occurrence #,1st primary
1388,1,1,Treatment Modality,Sx
1388,1,1,Clinical lab p16,p16 unkown
1388,1,1,Metastasis,M0
1388,1,1,Overall Stage,IVa
1389,1,1,Nodal Stage,N0
1389,1,1,2nd Failure Type,no known failure
1389,1,1,Occurrence #,recurrence
1389,1,1,Treatment Modality,Sx
1389,1,1,Research lab p16,p16 unknown
1389,1,1,Clinical lab p16,p16 unkown
1389,1,1,Research lab HPV,HPV unknown
1389,1,1,Metastasis,M0
1389,1,1,Tumor Stage,T4b
1389,1,1,Overall Stage,IVb
1389,1,1,Tumor Site,larynx
1389,1,1,1st Failure Type,locoregional
1390,1,1,Overall Stage,I
1390,1,1,Nodal Stage,N0
1390,1,1,Occurrence #,recurrence
1390,1,1,Research lab p16,p16 unknown
1390,1,1,2nd Failure Type,no known failure
1390,1,1,1st Failure Type,no known failure
1390,1,1,Research lab HPV,HPV unknown
1390,1,1,Tumor Site,larynx
1390,1,1,Tumor Stage,T1
1390,1,1,Metastasis,M0
1390,1,1,Treatment Modality,Sx
1390,1,1,Clinical lab p16,p16 unkown
1391,1,1,Tumor Stage,T4a
1391,1,1,Clinical lab p16,p16 unkown
1391,1,1,Research lab HPV,HPV unknown
1391,1,1,Metastasis,M0
1391,1,1,Radiation Dosage,70.2
1391,1,1,Tumor Site,larynx
1391,1,1,Overall Stage,IVa
1391,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1391,1,1,Occurrence #,1st primary
1391,1,1,Treatment Modality,CTX-RT
1391,1,1,1st Failure Type,no known failure
1391,1,1,2nd Failure Type,no known failure
1391,1,1,Research lab p16,p16 unknown
1391,1,1,Nodal Stage,N1
1392,1,1,Occurrence #,1st primary
1392,1,1,Research lab p16,p16 unknown
1392,1,1,Overall Stage,IVa
1392,1,1,Nodal Stage,N2
1392,1,1,Radiation Dosage,63
1392,1,1,Tumor Site,larynx
1392,1,1,Clinical lab p16,p16 unkown
1392,1,1,1st Failure Type,no known failure
1392,1,1,Metastasis,M0
1392,1,1,Tumor Stage,T3
1392,1,1,Treatment Modality,Sx & RT
1392,1,1,Research lab HPV,HPV unknown
1392,1,1,2nd Failure Type,no known failure
1393,1,1,1st Failure Type,no known failure
1393,1,1,2nd Failure Type,no known failure
1393,1,1,Radiation Dosage,63
1393,1,1,Research lab HPV,HPV unknown
1393,1,1,Treatment Modality,Sx & RT
1393,1,1,Clinical lab p16,p16 unkown
1393,1,1,Nodal Stage,N2
1393,1,1,Metastasis,M1
1393,1,1,Tumor Site,larynx
1393,1,1,Research lab p16,p16 unknown
1393,1,1,Occurrence #,1st primary
1393,1,1,Tumor Stage,T4a
1393,1,1,Overall Stage,IVc
1394,1,1,Clinical lab p16,p16 unkown
1394,1,1,Treatment Modality,CTX-RT
1394,1,1,2nd Failure Type,no known failure
1394,1,1,Nodal Stage,N0
1394,1,1,Occurrence #,1st primary
1394,1,1,Tumor Stage,T3
1394,1,1,Metastasis,M0
1394,1,1,1st Failure Type,no known failure
1394,1,1,Initial Chemotherapy Agent,cis
1394,1,1,Research lab HPV,HPV unknown
1394,1,1,Overall Stage,III
1394,1,1,Research lab p16,p16 unknown
1394,1,1,Tumor Site,larynx
1394,1,1,Radiation Dosage,70.2
1395,1,1,Occurrence #,1st primary
1395,1,1,Nodal Stage,N0
1395,1,1,Radiation Dosage,70.2
1395,1,1,Research lab HPV,HPV unknown
1395,1,1,Overall Stage,IVc
1395,1,1,2nd Failure Type,no known failure
1395,1,1,Research lab p16,p16 unknown
1395,1,1,Treatment Modality,Sx & CTX-RT
1395,1,1,Clinical lab p16,p16 unkown
1395,1,1,Initial Chemotherapy Agent,carbo/PTX
1395,1,1,Tumor Site,larynx
1395,1,1,1st Failure Type,no known failure
1395,1,1,Tumor Stage,T3
1395,1,1,Metastasis,M1
1396,1,1,Overall Stage,I
1396,1,1,1st Failure Type,no known failure
1396,1,1,2nd Failure Type,no known failure
1396,1,1,Research lab p16,p16 unknown
1396,1,1,Occurrence #,1st primary
1396,1,1,Radiation Dosage,63
1396,1,1,Nodal Stage,N0
1396,1,1,Tumor Site,larynx
1396,1,1,Metastasis,M0
1396,1,1,Research lab HPV,HPV unknown
1396,1,1,Treatment Modality,RT
1396,1,1,Tumor Stage,T1
1396,1,1,Clinical lab p16,p16 unkown
1397,1,1,Second Line Chemotherapy Agent,gemcitabine/doce
1397,1,1,Tumor Stage,T4a
1397,1,1,Nodal Stage,N1
1397,1,1,Occurrence #,1st primary
1397,1,1,Research lab HPV,HPV unknown
1397,1,1,Metastasis,M1
1397,1,1,Tumor Site,larynx
1397,1,1,1st Failure Type,locoregional
1397,1,1,Research lab p16,p16 unknown
1397,1,1,2nd Failure Type,no known failure
1397,1,1,Overall Stage,IVc
1397,1,1,Initial Chemotherapy Agent,cis/PTX
1397,1,1,Clinical lab p16,p16 unkown
1397,1,1,Treatment Modality,CTX
1398,1,1,Tumor Stage,T1
1398,1,1,Nodal Stage,N0
1398,1,1,Clinical lab p16,p16 unkown
1398,1,1,Metastasis,M0
1398,1,1,2nd Failure Type,no known failure
1398,1,1,Treatment Modality,Sx & RT
1398,1,1,1st Failure Type,no known failure
1398,1,1,Research lab p16,p16 unknown
1398,1,1,Radiation Dosage,63
1398,1,1,Occurrence #,1st primary
1398,1,1,Overall Stage,I
1398,1,1,Research lab HPV,HPV unknown
1398,1,1,Tumor Site,larynx
1399,1,1,Clinical lab p16,p16 unkown
1399,1,1,Metastasis,M0
1399,1,1,1st Failure Type,no known failure
1399,1,1,Research lab HPV,HPV unknown
1399,1,1,Research lab p16,p16 unknown
1399,1,1,Tumor Site,larynx
1399,1,1,Tumor Stage,T2
1399,1,1,Radiation Dosage,63
1399,1,1,Occurrence #,1st primary
1399,1,1,Nodal Stage,N0
1399,1,1,2nd Failure Type,no known failure
1399,1,1,Overall Stage,II
1399,1,1,Treatment Modality,Sx & RT
1400,1,1,Tumor Stage,T1
1400,1,1,Clinical lab p16,p16 unkown
1400,1,1,Nodal Stage,N0
1400,1,1,Occurrence #,1st primary
1400,1,1,Metastasis,M0
1400,1,1,Tumor Site,larynx
1400,1,1,Treatment Modality,RT
1400,1,1,Radiation Dosage,unknown
1400,1,1,Overall Stage,I
1400,1,1,Research lab HPV,HPV unknown
1400,1,1,2nd Failure Type,no known failure
1400,1,1,Research lab p16,p16 unknown
1400,1,1,1st Failure Type,no known failure
1401,1,1,Clinical lab p16,p16 unkown
1401,1,1,Treatment Modality,RT
1401,1,1,Tumor Stage,T1
1401,1,1,2nd Failure Type,no known failure
1401,1,1,Radiation Dosage,63
1401,1,1,Research lab HPV,HPV unknown
1401,1,1,1st Failure Type,no known failure
1401,1,1,Occurrence #,1st primary
1401,1,1,Metastasis,M0
1401,1,1,Research lab p16,p16 unknown
1401,1,1,Tumor Site,larynx
1401,1,1,Overall Stage,I
1401,1,1,Nodal Stage,N0
1402,1,1,Research lab p16,p16 unknown
1402,1,1,Metastasis,M0
1402,1,1,2nd Failure Type,no known failure
1402,1,1,Overall Stage,IVa
1402,1,1,1st Failure Type,no known failure
1402,1,1,Initial Chemotherapy Agent,carbo/PTX
1402,1,1,Tumor Stage,T3
1402,1,1,Tumor Site,larynx
1402,1,1,Nodal Stage,N2
1402,1,1,Radiation Dosage,70.2
1402,1,1,Treatment Modality,CTX-RT
1402,1,1,Occurrence #,1st primary
1402,1,1,Clinical lab p16,p16 unkown
1402,1,1,Research lab HPV,HPV unknown
1403,1,1,Research lab HPV,HPV unknown
1403,1,1,Metastasis,M0
1403,1,1,2nd Failure Type,no known failure
1403,1,1,Nodal Stage,N0
1403,1,1,Overall Stage,IVa
1403,1,1,Treatment Modality,Sx & RT
1403,1,1,Occurrence #,1st primary
1403,1,1,Research lab p16,p16 unknown
1403,1,1,Tumor Stage,T4a
1403,1,1,Clinical lab p16,p16 unkown
1403,1,1,Tumor Site,larynx
1403,1,1,1st Failure Type,no known failure
1403,1,1,Radiation Dosage,64
1404,1,1,Nodal Stage,N1
1404,1,1,1st Failure Type,no known failure
1404,1,1,Tumor Stage,T4a
1404,1,1,Tumor Site,larynx
1404,1,1,Treatment Modality,Sx
1404,1,1,2nd Failure Type,no known failure
1404,1,1,Metastasis,M0
1404,1,1,Research lab p16,p16 unknown
1404,1,1,Clinical lab p16,p16 unkown
1404,1,1,Occurrence #,1st primary
1404,1,1,Overall Stage,IVa
1404,1,1,Research lab HPV,HPV unknown
1405,1,1,Treatment Modality,RT
1405,1,1,2nd Failure Type,no known failure
1405,1,1,Radiation Dosage,74.4
1405,1,1,Overall Stage,II
1405,1,1,Research lab HPV,HPV unknown
1405,1,1,Research lab p16,p16 unknown
1405,1,1,Clinical lab p16,p16 unkown
1405,1,1,1st Failure Type,no known failure
1405,1,1,Tumor Site,larynx
1405,1,1,Tumor Stage,T2
1405,1,1,Metastasis,M0
1405,1,1,Nodal Stage,N0
1405,1,1,Occurrence #,1st primary
1406,1,1,Occurrence #,1st primary
1406,1,1,1st Failure Type,no known failure
1406,1,1,Research lab HPV,HPV unknown
1406,1,1,Treatment Modality,RT
1406,1,1,Tumor Site,larynx
1406,1,1,Clinical lab p16,p16 unkown
1406,1,1,Research lab p16,p16 unknown
1406,1,1,Tumor Stage,T1
1406,1,1,Radiation Dosage,68
1406,1,1,Overall Stage,I
1406,1,1,Metastasis,M0
1406,1,1,Nodal Stage,N0
1406,1,1,2nd Failure Type,no known failure
1407,1,1,Tumor Site,larynx
1407,1,1,Clinical lab p16,p16 unkown
1407,1,1,Radiation Dosage,59.4
1407,1,1,Research lab p16,p16 unknown
1407,1,1,Tumor Stage,T4a
1407,1,1,Nodal Stage,N1
1407,1,1,Overall Stage,IVa
1407,1,1,1st Failure Type,distant
1407,1,1,Research lab HPV,HPV unknown
1407,1,1,2nd Failure Type,no known failure
1407,1,1,Metastasis,M0
1407,1,1,Occurrence #,1st primary
1407,1,1,Treatment Modality,Sx & RT
1408,1,1,Research lab p16,p16 unknown
1408,1,1,Overall Stage,III
1408,1,1,Nodal Stage,N0
1408,1,1,Research lab HPV,HPV unknown
1408,1,1,Metastasis,M0
1408,1,1,Radiation Dosage,unknown
1408,1,1,1st Failure Type,locoregional
1408,1,1,Tumor Stage,T3
1408,1,1,Clinical lab p16,p16 unkown
1408,1,1,2nd Failure Type,no known failure
1408,1,1,Occurrence #,1st primary
1408,1,1,Tumor Site,larynx
1408,1,1,Treatment Modality,CTX-RT
1408,1,1,Initial Chemotherapy Agent,unknown
1409,1,1,Metastasis,M0
1409,1,1,Radiation Dosage,59.4
1409,1,1,Treatment Modality,Sx & RT
1409,1,1,Research lab HPV,HPV unknown
1409,1,1,Clinical lab p16,p16 unkown
1409,1,1,Occurrence #,1st primary
1409,1,1,Nodal Stage,N0
1409,1,1,Research lab p16,p16 unknown
1409,1,1,Tumor Stage,T4a
1409,1,1,Overall Stage,IVa
1409,1,1,2nd Failure Type,no known failure
1409,1,1,Tumor Site,larynx
1409,1,1,1st Failure Type,locoregional and distant
1410,1,1,Treatment Modality,Sx & RT
1410,1,1,1st Failure Type,no known failure
1410,1,1,Research lab HPV,HPV unknown
1410,1,1,Occurrence #,1st primary
1410,1,1,Metastasis,M0
1410,1,1,Nodal Stage,N0
1410,1,1,2nd Failure Type,no known failure
1410,1,1,Clinical lab p16,p16 unkown
1410,1,1,Tumor Site,larynx
1410,1,1,Overall Stage,II
1410,1,1,Research lab p16,p16 unknown
1410,1,1,Tumor Stage,T2
1410,1,1,Radiation Dosage,unknown
1411,1,1,Metastasis,M0
1411,1,1,Research lab p16,p16 unknown
1411,1,1,Treatment Modality,Sx
1411,1,1,Tumor Site,larynx
1411,1,1,Tumor Stage,T3
1411,1,1,1st Failure Type,distant
1411,1,1,Occurrence #,1st primary
1411,1,1,Overall Stage,III
1411,1,1,Research lab HPV,HPV unknown
1411,1,1,2nd Failure Type,no known failure
1411,1,1,Clinical lab p16,p16 unkown
1411,1,1,Nodal Stage,N1
1412,1,1,Tumor Site,larynx
1412,1,1,Occurrence #,1st primary
1412,1,1,Tumor Stage,T3
1412,1,1,Radiation Dosage,74.4
1412,1,1,2nd Failure Type,no known failure
1412,1,1,Initial Chemotherapy Agent,unknown
1412,1,1,1st Failure Type,no known failure
1412,1,1,Treatment Modality,CTX-RT
1412,1,1,Overall Stage,IVa
1412,1,1,Research lab HPV,HPV unknown
1412,1,1,Research lab p16,p16 unknown
1412,1,1,Clinical lab p16,p16 unkown
1412,1,1,Nodal Stage,N2
1412,1,1,Metastasis,M0
1413,1,1,Occurrence #,1st primary
1413,1,1,Clinical lab p16,p16 unkown
1413,1,1,2nd Failure Type,no known failure
1413,1,1,Tumor Site,larynx
1413,1,1,Metastasis,M0
1413,1,1,Treatment Modality,RT
1413,1,1,Research lab HPV,HPV unknown
1413,1,1,Nodal Stage,N0
1413,1,1,Radiation Dosage,63
1413,1,1,Tumor Stage,T1
1413,1,1,Overall Stage,I
1413,1,1,1st Failure Type,no known failure
1413,1,1,Research lab p16,p16 unknown
1414,1,1,Nodal Stage,N1
1414,1,1,1st Failure Site,larynx
1414,1,1,1st Failure Type,locoregional
1414,1,1,Research lab p16,p16 unknown
1414,1,1,Tumor Stage,T4a
1414,1,1,2nd Failure Type,no known failure
1414,1,1,Treatment Modality,Sx
1414,1,1,Tumor Site,larynx
1414,1,1,Metastasis,M0
1414,1,1,Occurrence #,other primary
1414,1,1,Clinical lab p16,p16 unkown
1414,1,1,Overall Stage,IVa
1414,1,1,1st Failure Initial Chemotherapy Agent,cis/doce
1414,1,1,Research lab HPV,HPV unknown
1414,1,1,1st Failure Treatment Modality,CTX
1415,1,1,Overall Stage,IVb
1415,1,1,Metastasis,M0
1415,1,1,Research lab p16,p16 unknown
1415,1,1,Initial Chemotherapy Agent,unknown
1415,1,1,Treatment Modality,CTX-RT
1415,1,1,Tumor Site,larynx
1415,1,1,Nodal Stage,N3
1415,1,1,1st Failure Type,no known failure
1415,1,1,Occurrence #,1st primary
1415,1,1,Clinical lab p16,p16 unkown
1415,1,1,Tumor Stage,T1
1415,1,1,Research lab HPV,HPV unknown
1415,1,1,2nd Failure Type,no known failure
1415,1,1,Radiation Dosage,54
1416,1,1,Research lab p16,p16 unknown
1416,1,1,Nodal Stage,N2
1416,1,1,Occurrence #,1st primary
1416,1,1,2nd Failure Type,no known failure
1416,1,1,Tumor Site,larynx
1416,1,1,Metastasis,M0
1416,1,1,Tumor Stage,T4a
1416,1,1,Overall Stage,IVa
1416,1,1,Clinical lab p16,p16 unkown
1416,1,1,Treatment Modality,Sx
1416,1,1,1st Failure Type,no known failure
1416,1,1,Research lab HPV,HPV unknown
1417,1,1,Research lab HPV,HPV unknown
1417,1,1,Occurrence #,1st primary
1417,1,1,1st Failure Type,no known failure
1417,1,1,Tumor Site,larynx
1417,1,1,2nd Failure Type,no known failure
1417,1,1,Radiation Dosage,74.4
1417,1,1,Nodal Stage,N0
1417,1,1,Metastasis,M0
1417,1,1,Overall Stage,II
1417,1,1,Treatment Modality,RT
1417,1,1,Research lab p16,p16 unknown
1417,1,1,Tumor Stage,T2
1417,1,1,Clinical lab p16,p16 unkown
1418,1,1,Clinical lab p16,p16 unkown
1418,1,1,2nd Failure Type,no known failure
1418,1,1,1st Failure Type,locoregional
1418,1,1,Overall Stage,IVa
1418,1,1,Research lab HPV,HPV unknown
1418,1,1,Treatment Modality,Sx & CTX
1418,1,1,Research lab p16,p16 unknown
1418,1,1,Metastasis,Unknown
1418,1,1,Initial Chemotherapy Agent,doce
1418,1,1,Tumor Stage,T4a
1418,1,1,Tumor Site,larynx
1418,1,1,Nodal Stage,N0
1418,1,1,Occurrence #,other primary
1419,1,1,Occurrence #,recurrence
1419,1,1,Overall Stage,III
1419,1,1,Clinical lab p16,p16 unkown
1419,1,1,Tumor Site,larynx
1419,1,1,1st Failure Type,no known failure
1419,1,1,Metastasis,M0
1419,1,1,Research lab HPV,HPV unknown
1419,1,1,2nd Failure Type,no known failure
1419,1,1,Treatment Modality,Sx
1419,1,1,Research lab p16,p16 unknown
1419,1,1,Nodal Stage,N1
1419,1,1,Tumor Stage,T2
1420,1,1,Metastasis,M0
1420,1,1,2nd Failure Type,no known failure
1420,1,1,Clinical lab p16,p16 unkown
1420,1,1,Tumor Stage,Unknown
1420,1,1,Occurrence #,recurrence
1420,1,1,Radiation Dosage,unknown
1420,1,1,Tumor Site,larynx
1420,1,1,Treatment Modality,CTX-RT
1420,1,1,Initial Chemotherapy Agent,carbo/PTX
1420,1,1,Overall Stage,IVa
1420,1,1,Nodal Stage,Unknown
1420,1,1,Research lab HPV,HPV unknown
1420,1,1,1st Failure Type,locoregional
1420,1,1,Research lab p16,p16 unknown
1421,1,1,Overall Stage,IVa
1421,1,1,Tumor Stage,T4a
1421,1,1,Occurrence #,recurrence
1421,1,1,Clinical lab p16,p16 unkown
1421,1,1,Tumor Site,larynx
1421,1,1,2nd Failure Type,no known failure
1421,1,1,Research lab p16,p16 unknown
1421,1,1,Research lab HPV,HPV unknown
1421,1,1,1st Failure Type,no known failure
1421,1,1,Metastasis,M0
1421,1,1,Nodal Stage,N0
1421,1,1,Treatment Modality,Sx
1422,1,1,Clinical lab p16,p16 unkown
1422,1,1,2nd Failure Type,no known failure
1422,1,1,Occurrence #,1st primary
1422,1,1,Research lab HPV,HPV unknown
1422,1,1,Initial Chemotherapy Agent,cis
1422,1,1,Tumor Site,larynx
1422,1,1,Radiation Dosage,70.2
1422,1,1,Metastasis,M0
1422,1,1,Tumor Stage,T4a
1422,1,1,Overall Stage,IVa
1422,1,1,Nodal Stage,N2
1422,1,1,Treatment Modality,CTX-RT
1422,1,1,Research lab p16,p16 unknown
1422,1,1,1st Failure Type,no known failure
1423,1,1,Nodal Stage,Unknown
1423,1,1,Occurrence #,recurrence
1423,1,1,Overall Stage,Unknown
1423,1,1,Tumor Stage,Unknown
1423,1,1,Research lab p16,p16 unknown
1423,1,1,Treatment Modality,Sx
1423,1,1,1st Failure Type,no known failure
1423,1,1,Clinical lab p16,p16 unkown
1423,1,1,Research lab HPV,HPV unknown
1423,1,1,2nd Failure Type,no known failure
1423,1,1,Tumor Site,larynx
1423,1,1,Metastasis,Unknown
1424,1,1,Treatment Modality,Sx
1424,1,1,Tumor Stage,T3
1424,1,1,Metastasis,M0
1424,1,1,Occurrence #,1st primary
1424,1,1,Tumor Site,larynx
1424,1,1,2nd Failure Type,no known failure
1424,1,1,1st Failure Type,no known failure
1424,1,1,Clinical lab p16,p16 unkown
1424,1,1,Research lab p16,p16 unknown
1424,1,1,Nodal Stage,N0
1424,1,1,Research lab HPV,HPV unknown
1424,1,1,Overall Stage,III
1425,1,1,Tumor Site,larynx
1425,1,1,Overall Stage,III
1425,1,1,Treatment Modality,Sx & RT
1425,1,1,Clinical lab p16,p16 unkown
1425,1,1,Metastasis,M0
1425,1,1,Occurrence #,1st primary
1425,1,1,1st Failure Type,no known failure
1425,1,1,Research lab p16,p16 unknown
1425,1,1,Nodal Stage,N1
1425,1,1,Radiation Dosage,59.9
1425,1,1,Tumor Stage,T3
1425,1,1,2nd Failure Type,no known failure
1425,1,1,Research lab HPV,HPV unknown
1426,1,1,Research lab p16,p16 unknown
1426,1,1,Treatment Modality,Sx
1426,1,1,Clinical lab p16,p16 unkown
1426,1,1,Metastasis,M0
1426,1,1,Overall Stage,II
1426,1,1,1st Failure Type,no known failure
1426,1,1,Tumor Site,larynx
1426,1,1,Tumor Stage,T2
1426,1,1,Nodal Stage,N0
1426,1,1,Occurrence #,1st primary
1426,1,1,Research lab HPV,HPV unknown
1426,1,1,2nd Failure Type,no known failure
1427,1,1,Tumor Stage,T3
1427,1,1,1st Failure Radiation Dosage,72
1427,1,1,1st Failure Type,locoregional
1427,1,1,Overall Stage,III
1427,1,1,Research lab p16,p16 unknown
1427,1,1,Research lab HPV,HPV unknown
1427,1,1,Tumor Site,larynx
1427,1,1,1st Failure Site,oropharynx
1427,1,1,1st Failure Initial Chemotherapy Agent,unknown
1427,1,1,Nodal Stage,N0
1427,1,1,Treatment Modality,Sx
1427,1,1,1st Failure Treatment Modality,Sx & CTX-RT
1427,1,1,Metastasis,M0
1427,1,1,Clinical lab p16,p16 unkown
1427,1,1,2nd Failure Type,no known failure
1427,1,1,Occurrence #,1st primary
1428,1,1,Research lab p16,p16 unknown
1428,1,1,Metastasis,M0
1428,1,1,Tumor Site,larynx
1428,1,1,Research lab HPV,HPV unknown
1428,1,1,Nodal Stage,N0
1428,1,1,Occurrence #,recurrence
1428,1,1,2nd Failure Type,no known failure
1428,1,1,Treatment Modality,Sx
1428,1,1,Clinical lab p16,p16 unkown
1428,1,1,Overall Stage,I
1428,1,1,Tumor Stage,T1
1428,1,1,1st Failure Type,distant
1429,1,1,Tumor Site,larynx
1429,1,1,Research lab p16,p16 unknown
1429,1,1,Radiation Dosage,70.2
1429,1,1,Treatment Modality,CTX-RT
1429,1,1,Overall Stage,III
1429,1,1,Nodal Stage,N0
1429,1,1,Research lab HPV,HPV unknown
1429,1,1,2nd Failure Type,no known failure
1429,1,1,Metastasis,M0
1429,1,1,1st Failure Type,no known failure
1429,1,1,Initial Chemotherapy Agent,cis
1429,1,1,Clinical lab p16,p16 unkown
1429,1,1,Occurrence #,1st primary
1429,1,1,Tumor Stage,T3
1430,1,1,Overall Stage,III
1430,1,1,2nd Failure Type,no known failure
1430,1,1,Occurrence #,1st primary
1430,1,1,Tumor Site,larynx
1430,1,1,Nodal Stage,N1
1430,1,1,Research lab HPV,HPV unknown
1430,1,1,Metastasis,M0
1430,1,1,Clinical lab p16,p16 unkown
1430,1,1,Tumor Stage,T2
1430,1,1,Treatment Modality,Sx
1430,1,1,Research lab p16,p16 unknown
1430,1,1,1st Failure Type,no known failure
1431,1,1,Overall Stage,II
1431,1,1,Clinical lab p16,p16 unkown
1431,1,1,Metastasis,M0
1431,1,1,Treatment Modality,RT
1431,1,1,1st Failure Type,no known failure
1431,1,1,Tumor Stage,T2
1431,1,1,Research lab p16,p16 unknown
1431,1,1,Nodal Stage,N0
1431,1,1,2nd Failure Type,no known failure
1431,1,1,Occurrence #,1st primary
1431,1,1,Tumor Site,larynx
1431,1,1,Research lab HPV,HPV unknown
1431,1,1,Radiation Dosage,74.4
1432,1,1,Clinical lab p16,p16 unkown
1432,1,1,Overall Stage,I
1432,1,1,Research lab HPV,HPV unknown
1432,1,1,Occurrence #,1st primary
1432,1,1,Tumor Stage,T1
1432,1,1,1st Failure Type,no known failure
1432,1,1,2nd Failure Type,no known failure
1432,1,1,Nodal Stage,N0
1432,1,1,Metastasis,M0
1432,1,1,Tumor Site,larynx
1432,1,1,Treatment Modality,Sx
1432,1,1,Research lab p16,p16 unknown
1433,1,1,Nodal Stage,N0
1433,1,1,1st Failure Type,no known failure
1433,1,1,Tumor Site,larynx
1433,1,1,Overall Stage,I
1433,1,1,Treatment Modality,RT
1433,1,1,Metastasis,M0
1433,1,1,Clinical lab p16,p16 unkown
1433,1,1,Research lab p16,p16 unknown
1433,1,1,Research lab HPV,HPV unknown
1433,1,1,Tumor Stage,T1
1433,1,1,Occurrence #,1st primary
1433,1,1,Radiation Dosage,63
1433,1,1,2nd Failure Type,no known failure
1434,1,1,Nodal Stage,N0
1434,1,1,Treatment Modality,Unknown
1434,1,1,Overall Stage,III
1434,1,1,Occurrence #,1st primary
1434,1,1,1st Failure Type,no known failure
1434,1,1,Clinical lab p16,p16 unkown
1434,1,1,Tumor Stage,T3
1434,1,1,Research lab HPV,HPV unknown
1434,1,1,2nd Failure Type,no known failure
1434,1,1,Metastasis,M0
1434,1,1,Research lab p16,p16 unknown
1434,1,1,Tumor Site,larynx
1435,1,1,Tumor Site,larynx
1435,1,1,Overall Stage,III
1435,1,1,Research lab HPV,HPV unknown
1435,1,1,Occurrence #,1st primary
1435,1,1,Tumor Stage,T3
1435,1,1,Nodal Stage,N0
1435,1,1,2nd Failure Type,no known failure
1435,1,1,Initial Chemotherapy Agent,cis
1435,1,1,Radiation Dosage,43.2
1435,1,1,1st Failure Type,no known failure
1435,1,1,Metastasis,M0
1435,1,1,Treatment Modality,CTX-RT
1435,1,1,Clinical lab p16,p16 unkown
1435,1,1,Research lab p16,p16 unknown
1436,1,1,2nd Failure Type,no known failure
1436,1,1,Treatment Modality,Unknown
1436,1,1,Nodal Stage,N1
1436,1,1,Metastasis,M0
1436,1,1,1st Failure Type,no known failure
1436,1,1,Overall Stage,IVa
1436,1,1,Clinical lab p16,p16 unkown
1436,1,1,Research lab HPV,HPV unknown
1436,1,1,Tumor Site,larynx
1436,1,1,Occurrence #,1st primary
1436,1,1,Tumor Stage,T4a
1436,1,1,Research lab p16,p16 unknown
1437,1,1,Clinical lab p16,p16 unkown
1437,1,1,1st Failure Treatment Modality,Sx & CTX
1437,1,1,Research lab HPV,HPV unknown
1437,1,1,Overall Stage,IVa
1437,1,1,1st Failure Type,locoregional
1437,1,1,Tumor Site,larynx
1437,1,1,Metastasis,M0
1437,1,1,Occurrence #,1st primary
1437,1,1,Treatment Modality,Sx & RT
1437,1,1,1st Failure Second Line Chemotherapy Agent,doxycycline/doce
1437,1,1,Radiation Dosage,unknown
1437,1,1,1st Failure Initial Chemotherapy Agent,cis/doce
1437,1,1,Research lab p16,p16 unknown
1437,1,1,Nodal Stage,N2
1437,1,1,Tumor Stage,T3
1437,1,1,2nd Failure Type,no known failure
1437,1,1,1st Failure Site,larynx
1438,1,1,Occurrence #,1st primary
1438,1,1,Overall Stage,IVa
1438,1,1,Nodal Stage,N2
1438,1,1,Research lab p16,p16 unknown
1438,1,1,Tumor Site,larynx
1438,1,1,Radiation Dosage,70.2
1438,1,1,Metastasis,M0
1438,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1438,1,1,1st Failure Type,locoregional
1438,1,1,Second Line Chemotherapy Agent,carbo/doce
1438,1,1,1st Failure Site,larynx
1438,1,1,Treatment Modality,CTX-RT
1438,1,1,Tumor Stage,T4a
1438,1,1,Research lab HPV,HPV unknown
1438,1,1,Clinical lab p16,p16 unkown
1438,1,1,1st Failure Treatment Modality,Sx
1438,1,1,2nd Failure Type,no known failure
1439,1,1,Tumor Site,larynx
1439,1,1,Treatment Modality,Sx
1439,1,1,Clinical lab p16,p16 unkown
1439,1,1,Research lab p16,p16 unknown
1439,1,1,Occurrence #,recurrence
1439,1,1,2nd Failure Type,no known failure
1439,1,1,Tumor Stage,T4a
1439,1,1,Metastasis,M0
1439,1,1,Research lab HPV,HPV unknown
1439,1,1,1st Failure Type,no known failure
1439,1,1,Overall Stage,IVa
1439,1,1,Nodal Stage,N0
1440,1,1,Overall Stage,IVc
1440,1,1,Research lab p16,p16 unknown
1440,1,1,Clinical lab p16,p16 unkown
1440,1,1,Tumor Site,larynx
1440,1,1,1st Failure Type,distant
1440,1,1,Nodal Stage,N2
1440,1,1,Metastasis,M1
1440,1,1,Tumor Stage,T2
1440,1,1,Treatment Modality,Sx
1440,1,1,Research lab HPV,HPV unknown
1440,1,1,Occurrence #,recurrence
1440,1,1,2nd Failure Type,no known failure
1441,1,1,Tumor Stage,Unknown
1441,1,1,Research lab HPV,HPV unknown
1441,1,1,Clinical lab p16,p16 unkown
1441,1,1,2nd Failure Type,no known failure
1441,1,1,Occurrence #,1st primary
1441,1,1,Research lab p16,p16 unknown
1441,1,1,Overall Stage,Unknown
1441,1,1,Nodal Stage,Unknown
1441,1,1,Treatment Modality,Unknown
1441,1,1,Tumor Site,larynx
1441,1,1,Metastasis,Unknown
1441,1,1,1st Failure Type,no known failure
1442,1,1,2nd Failure Type,no known failure
1442,1,1,Radiation Dosage,74.4
1442,1,1,Tumor Site,larynx
1442,1,1,Metastasis,M0
1442,1,1,Tumor Stage,T2
1442,1,1,Research lab HPV,HPV unknown
1442,1,1,Nodal Stage,N0
1442,1,1,Treatment Modality,RT
1442,1,1,Research lab p16,p16 unknown
1442,1,1,1st Failure Type,no known failure
1442,1,1,Clinical lab p16,p16 unkown
1442,1,1,Overall Stage,II
1442,1,1,Occurrence #,1st primary
1443,1,1,Tumor Stage,T1
1443,1,1,Occurrence #,1st primary
1443,1,1,Tumor Site,larynx
1443,1,1,Research lab p16,p16 unknown
1443,1,1,Clinical lab p16,p16 unkown
1443,1,1,2nd Failure Type,no known failure
1443,1,1,Research lab HPV,HPV unknown
1443,1,1,1st Failure Type,no known failure
1443,1,1,Overall Stage,I
1443,1,1,Nodal Stage,N0
1443,1,1,Treatment Modality,Sx
1443,1,1,Metastasis,M0
1444,1,1,2nd Failure Type,no known failure
1444,1,1,Nodal Stage,N0
1444,1,1,Overall Stage,II
1444,1,1,Research lab p16,p16 unknown
1444,1,1,Initial Chemotherapy Agent,unknown
1444,1,1,Metastasis,M0
1444,1,1,Tumor Stage,T2
1444,1,1,Occurrence #,1st primary
1444,1,1,Treatment Modality,CTX-RT
1444,1,1,Research lab HPV,HPV unknown
1444,1,1,Radiation Dosage,unknown
1444,1,1,Tumor Site,larynx
1444,1,1,1st Failure Type,no known failure
1444,1,1,Clinical lab p16,p16 unkown
1445,1,1,Metastasis,M0
1445,1,1,Research lab p16,p16 unknown
1445,1,1,Overall Stage,II
1445,1,1,Tumor Site,larynx
1445,1,1,Research lab HPV,HPV unknown
1445,1,1,1st Failure Type,no known failure
1445,1,1,Tumor Stage,T2
1445,1,1,Occurrence #,1st primary
1445,1,1,Treatment Modality,Sx
1445,1,1,Clinical lab p16,p16 unkown
1445,1,1,2nd Failure Type,no known failure
1445,1,1,Nodal Stage,N0
1446,1,1,Tumor Stage,T3
1446,1,1,Radiation Dosage,28.8
1446,1,1,Overall Stage,III
1446,1,1,2nd Failure Type,no known failure
1446,1,1,Initial Chemotherapy Agent,cis
1446,1,1,1st Failure Type,no known failure
1446,1,1,Tumor Site,larynx
1446,1,1,Research lab HPV,HPV unknown
1446,1,1,Occurrence #,1st primary
1446,1,1,Metastasis,M0
1446,1,1,Nodal Stage,N0
1446,1,1,Clinical lab p16,p16 unkown
1446,1,1,Research lab p16,p16 unknown
1446,1,1,Treatment Modality,CTX-RT
1447,1,1,2nd Failure Type,no known failure
1447,1,1,Tumor Site,larynx
1447,1,1,Clinical lab p16,p16 unkown
1447,1,1,Treatment Modality,Sx
1447,1,1,Tumor Stage,T4a
1447,1,1,Overall Stage,IVa
1447,1,1,Research lab p16,p16 unknown
1447,1,1,Research lab HPV,HPV unknown
1447,1,1,Nodal Stage,N0
1447,1,1,Occurrence #,recurrence
1447,1,1,1st Failure Type,no known failure
1447,1,1,Metastasis,M0
1448,1,1,Metastasis,M0
1448,1,1,Nodal Stage,N0
1448,1,1,Occurrence #,1st primary
1448,1,1,Tumor Stage,T4a
1448,1,1,Radiation Dosage,63
1448,1,1,1st Failure Site,larynx
1448,1,1,1st Failure Type,distant
1448,1,1,Clinical lab p16,p16 unkown
1448,1,1,Research lab HPV,HPV unknown
1448,1,1,1st Failure Treatment Modality,Sx
1448,1,1,Tumor Site,larynx
1448,1,1,Treatment Modality,Sx & RT
1448,1,1,Overall Stage,IVa
1448,1,1,2nd Failure Type,no known failure
1448,1,1,Research lab p16,p16 unknown
1449,1,1,2nd Failure Type,no known failure
1449,1,1,Clinical lab p16,p16 unkown
1449,1,1,1st Failure Type,distant
1449,1,1,Nodal Stage,N2
1449,1,1,Tumor Stage,T2
1449,1,1,Radiation Dosage,70.2
1449,1,1,Initial Chemotherapy Agent,cis
1449,1,1,Research lab HPV,HPV unknown
1449,1,1,Tumor Site,larynx
1449,1,1,Treatment Modality,CTX-RT
1449,1,1,Research lab p16,p16 unknown
1449,1,1,Overall Stage,IVa
1449,1,1,Occurrence #,1st primary
1449,1,1,Metastasis,M0
1450,1,1,Research lab HPV,HPV unknown
1450,1,1,Clinical lab p16,p16 unkown
1450,1,1,Research lab p16,p16 unknown
1450,1,1,Metastasis,M0
1450,1,1,Tumor Stage,T4a
1450,1,1,2nd Failure Type,no known failure
1450,1,1,Nodal Stage,N0
1450,1,1,Occurrence #,1st primary
1450,1,1,1st Failure Type,no known failure
1450,1,1,Tumor Site,larynx
1450,1,1,Overall Stage,IVa
1450,1,1,Treatment Modality,Sx
1451,1,1,Radiation Dosage,74.4
1451,1,1,Nodal Stage,N0
1451,1,1,Research lab p16,p16 unknown
1451,1,1,Overall Stage,II
1451,1,1,Treatment Modality,RT
1451,1,1,Metastasis,M0
1451,1,1,Tumor Site,larynx
1451,1,1,Occurrence #,1st primary
1451,1,1,Research lab HPV,HPV unknown
1451,1,1,Tumor Stage,T2
1451,1,1,2nd Failure Type,no known failure
1451,1,1,Clinical lab p16,p16 unkown
1451,1,1,1st Failure Type,no known failure
1452,1,1,Tumor Site,larynx
1452,1,1,2nd Failure Type,no known failure
1452,1,1,Nodal Stage,N0
1452,1,1,Metastasis,M0
1452,1,1,Tumor Stage,T1
1452,1,1,Research lab HPV,HPV unknown
1452,1,1,Overall Stage,I
1452,1,1,Occurrence #,1st primary
1452,1,1,Treatment Modality,RT
1452,1,1,Radiation Dosage,63
1452,1,1,Research lab p16,p16 unknown
1452,1,1,Clinical lab p16,p16 unkown
1452,1,1,1st Failure Type,no known failure
1453,1,1,Metastasis,M0
1453,1,1,Clinical lab p16,p16 unkown
1453,1,1,2nd Failure Type,no known failure
1453,1,1,Tumor Stage,T4a
1453,1,1,Treatment Modality,RT
1453,1,1,Research lab p16,p16 unknown
1453,1,1,Overall Stage,IVa
1453,1,1,Radiation Dosage,70.2
1453,1,1,Nodal Stage,N0
1453,1,1,1st Failure Type,no known failure
1453,1,1,Tumor Site,larynx
1453,1,1,Research lab HPV,HPV unknown
1453,1,1,Occurrence #,1st primary
1454,1,1,Metastasis,M0
1454,1,1,Clinical lab p16,p16 unkown
1454,1,1,Occurrence #,1st primary
1454,1,1,Overall Stage,IVb
1454,1,1,1st Failure Type,no known failure
1454,1,1,2nd Failure Type,no known failure
1454,1,1,Research lab p16,p16 unknown
1454,1,1,Tumor Site,larynx
1454,1,1,Research lab HPV,HPV unknown
1454,1,1,Nodal Stage,N3
1454,1,1,Tumor Stage,T4a
1454,1,1,Treatment Modality,Unknown
1455,1,1,Radiation Dosage,60
1455,1,1,Tumor Site,larynx
1455,1,1,Research lab HPV,HPV unknown
1455,1,1,Occurrence #,other primary
1455,1,1,Overall Stage,I
1455,1,1,2nd Failure Type,no known failure
1455,1,1,Treatment Modality,RT
1455,1,1,Metastasis,M0
1455,1,1,Tumor Stage,T1
1455,1,1,Nodal Stage,N0
1455,1,1,1st Failure Type,no known failure
1455,1,1,Clinical lab p16,p16 unkown
1455,1,1,Research lab p16,p16 unknown
1456,1,1,Research lab p16,p16 unknown
1456,1,1,Overall Stage,II
1456,1,1,Clinical lab p16,p16 unkown
1456,1,1,Metastasis,M0
1456,1,1,Tumor Site,larynx
1456,1,1,Occurrence #,1st primary
1456,1,1,1st Failure Type,no known failure
1456,1,1,Tumor Stage,T2
1456,1,1,Treatment Modality,RT
1456,1,1,2nd Failure Type,no known failure
1456,1,1,Research lab HPV,HPV unknown
1456,1,1,Radiation Dosage,67.2
1456,1,1,Nodal Stage,N0
1457,1,1,Treatment Modality,Sx
1457,1,1,Nodal Stage,N0
1457,1,1,2nd Failure Type,no known failure
1457,1,1,Tumor Site,larynx
1457,1,1,Clinical lab p16,p16 unkown
1457,1,1,Research lab p16,p16 unknown
1457,1,1,Occurrence #,1st primary
1457,1,1,Research lab HPV,HPV unknown
1457,1,1,Overall Stage,IVa
1457,1,1,Tumor Stage,T4a
1457,1,1,1st Failure Type,no known failure
1457,1,1,Metastasis,M0
1458,1,1,2nd Failure Type,no known failure
1458,1,1,Research lab HPV,HPV unknown
1458,1,1,Research lab p16,p16 unknown
1458,1,1,Overall Stage,II
1458,1,1,Tumor Site,larynx
1458,1,1,Metastasis,M0
1458,1,1,Clinical lab p16,p16 unkown
1458,1,1,1st Failure Site,larynx
1458,1,1,Tumor Stage,T2
1458,1,1,Radiation Dosage,74.4
1458,1,1,1st Failure Treatment Modality,Sx
1458,1,1,Occurrence #,1st primary
1458,1,1,Treatment Modality,RT
1458,1,1,Nodal Stage,N0
1458,1,1,1st Failure Type,locoregional
1459,1,1,Research lab p16,p16 unknown
1459,1,1,Clinical lab p16,p16 unkown
1459,1,1,Research lab HPV,HPV unknown
1459,1,1,Nodal Stage,N0
1459,1,1,Metastasis,M0
1459,1,1,Overall Stage,IVa
1459,1,1,Occurrence #,recurrence
1459,1,1,Tumor Site,larynx
1459,1,1,1st Failure Type,no known failure
1459,1,1,Treatment Modality,Sx
1459,1,1,Tumor Stage,T4a
1459,1,1,2nd Failure Type,no known failure
1460,1,1,2nd Failure Type,no known failure
1460,1,1,Nodal Stage,N1
1460,1,1,Radiation Dosage,63
1460,1,1,Occurrence #,1st primary
1460,1,1,Metastasis,M0
1460,1,1,Treatment Modality,Sx & CTX-RT
1460,1,1,Tumor Site,larynx
1460,1,1,Research lab HPV,HPV unknown
1460,1,1,Clinical lab p16,p16 unkown
1460,1,1,Research lab p16,p16 unknown
1460,1,1,Overall Stage,IVa
1460,1,1,1st Failure Type,no known failure
1460,1,1,Initial Chemotherapy Agent,unknown
1460,1,1,Tumor Stage,T4a
1461,1,1,Research lab HPV,HPV unknown
1461,1,1,Occurrence #,recurrence
1461,1,1,Tumor Site,larynx
1461,1,1,1st Failure Type,no known failure
1461,1,1,Nodal Stage,N0
1461,1,1,Research lab p16,p16 unknown
1461,1,1,2nd Failure Type,no known failure
1461,1,1,Treatment Modality,Sx
1461,1,1,Overall Stage,II
1461,1,1,Clinical lab p16,p16 unkown
1461,1,1,Tumor Stage,T2
1461,1,1,Metastasis,M0
1462,1,1,Research lab HPV,HPV unknown
1462,1,1,1st Failure Treatment Modality,Sx
1462,1,1,Treatment Modality,RT
1462,1,1,1st Failure Site,larynx
1462,1,1,Radiation Dosage,66
1462,1,1,1st Failure Type,locoregional
1462,1,1,Metastasis,M0
1462,1,1,Overall Stage,I
1462,1,1,Research lab p16,p16 unknown
1462,1,1,2nd Failure Type,no known failure
1462,1,1,Tumor Stage,T1
1462,1,1,Clinical lab p16,p16 unkown
1462,1,1,Tumor Site,larynx
1462,1,1,Occurrence #,1st primary
1462,1,1,Nodal Stage,N0
1463,1,1,Occurrence #,recurrence
1463,1,1,Overall Stage,IVa
1463,1,1,Tumor Site,larynx
1463,1,1,2nd Failure Type,no known failure
1463,1,1,1st Failure Type,no known failure
1463,1,1,Treatment Modality,Sx
1463,1,1,Tumor Stage,T2
1463,1,1,Nodal Stage,N2
1463,1,1,Research lab HPV,HPV unknown
1463,1,1,Metastasis,M0
1463,1,1,Research lab p16,p16 unknown
1463,1,1,Clinical lab p16,p16 unkown
1464,1,1,Tumor Stage,T3
1464,1,1,Tumor Site,larynx
1464,1,1,1st Failure Type,no known failure
1464,1,1,Treatment Modality,CTX-RT
1464,1,1,Clinical lab p16,p16 unkown
1464,1,1,Radiation Dosage,70.2
1464,1,1,Occurrence #,1st primary
1464,1,1,Research lab p16,p16 unknown
1464,1,1,Initial Chemotherapy Agent,unknown
1464,1,1,Nodal Stage,N1
1464,1,1,Research lab HPV,HPV unknown
1464,1,1,2nd Failure Type,no known failure
1464,1,1,Metastasis,M0
1464,1,1,Overall Stage,III
1465,1,1,Metastasis,M0
1465,1,1,2nd Failure Type,no known failure
1465,1,1,1st Failure Treatment Modality,Sx
1465,1,1,Nodal Stage,N0
1465,1,1,1st Failure Site,larynx
1465,1,1,Occurrence #,1st primary
1465,1,1,Radiation Dosage,64.5
1465,1,1,Tumor Site,larynx
1465,1,1,Research lab p16,p16 unknown
1465,1,1,Clinical lab p16,p16 unkown
1465,1,1,Overall Stage,I
1465,1,1,1st Failure Type,locoregional
1465,1,1,Treatment Modality,RT
1465,1,1,Research lab HPV,HPV unknown
1465,1,1,Tumor Stage,T1
1466,1,1,Tumor Site,larynx
1466,1,1,Tumor Stage,T3
1466,1,1,Occurrence #,1st primary
1466,1,1,Overall Stage,III
1466,1,1,Research lab p16,p16 unknown
1466,1,1,Clinical lab p16,p16 unkown
1466,1,1,Nodal Stage,N1
1466,1,1,2nd Failure Type,no known failure
1466,1,1,1st Failure Type,no known failure
1466,1,1,Research lab HPV,HPV unknown
1466,1,1,Treatment Modality,Unknown
1466,1,1,Metastasis,M0
1467,1,1,Occurrence #,1st primary
1467,1,1,Tumor Site,larynx
1467,1,1,2nd Failure Type,no known failure
1467,1,1,Research lab p16,p16 unknown
1467,1,1,Clinical lab p16,p16 unkown
1467,1,1,1st Failure Type,no known failure
1467,1,1,Initial Chemotherapy Agent,unknown
1467,1,1,Metastasis,M0
1467,1,1,Research lab HPV,HPV unknown
1467,1,1,Tumor Stage,T3
1467,1,1,Overall Stage,III
1467,1,1,Treatment Modality,CTX-RT
1467,1,1,Nodal Stage,N1
1467,1,1,Radiation Dosage,70
1468,1,1,1st Failure Treatment Modality,Sx
1468,1,1,Occurrence #,recurrence
1468,1,1,1st Failure Type,locoregional
1468,1,1,Tumor Stage,T4a
1468,1,1,Overall Stage,IVa
1468,1,1,2nd Failure Type,no known failure
1468,1,1,1st Failure Site,larynx
1468,1,1,Research lab p16,p16 unknown
1468,1,1,Clinical lab p16,p16 unkown
1468,1,1,Research lab HPV,HPV unknown
1468,1,1,Nodal Stage,N1
1468,1,1,Metastasis,M0
1468,1,1,Treatment Modality,Sx
1468,1,1,Tumor Site,larynx
1469,1,1,Nodal Stage,Unknown
1469,1,1,2nd Failure Type,no known failure
1469,1,1,1st Failure Type,distant
1469,1,1,Tumor Site,larynx
1469,1,1,Radiation Dosage,unknown
1469,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
1469,1,1,Tumor Stage,T4a
1469,1,1,Overall Stage,IVa
1469,1,1,Clinical lab p16,p16 unkown
1469,1,1,1st Failure Site,larynx
1469,1,1,Research lab p16,p16 unknown
1469,1,1,1st Failure Treatment Modality,Sx & CTX
1469,1,1,Initial Chemotherapy Agent,carbo/PTX/amifostine
1469,1,1,Treatment Modality,CTX-RT
1469,1,1,Research lab HPV,HPV positive
1469,1,1,Occurrence #,1st primary
1469,1,1,1st Failure Second Line Chemotherapy Agent,pemetrexed
1469,1,1,Metastasis,M0
1470,1,1,Research lab p16,p16 unknown
1470,1,1,Overall Stage,Unknown
1470,1,1,2nd Failure Type,no known failure
1470,1,1,Clinical lab p16,p16 unkown
1470,1,1,Research lab HPV,HPV unknown
1470,1,1,Tumor Site,larynx
1470,1,1,Metastasis,Unknown
1470,1,1,1st Failure Type,no known failure
1470,1,1,Occurrence #,1st primary
1470,1,1,Treatment Modality,Unknown
1470,1,1,Tumor Stage,Unknown
1470,1,1,Nodal Stage,Unknown
1471,1,1,Tumor Site,larynx
1471,1,1,Research lab HPV,HPV unknown
1471,1,1,Metastasis,Unknown
1471,1,1,Research lab p16,p16 unknown
1471,1,1,Treatment Modality,Unknown
1471,1,1,Clinical lab p16,p16 unkown
1471,1,1,Nodal Stage,Unknown
1471,1,1,Occurrence #,recurrence
1471,1,1,1st Failure Type,no known failure
1471,1,1,2nd Failure Type,no known failure
1471,1,1,Tumor Stage,Unknown
1471,1,1,Overall Stage,Unknown
1472,1,1,2nd Failure Type,no known failure
1472,1,1,Research lab p16,p16 unknown
1472,1,1,Nodal Stage,N0
1472,1,1,Clinical lab p16,p16 unkown
1472,1,1,Overall Stage,I
1472,1,1,Tumor Stage,T1
1472,1,1,Occurrence #,1st primary
1472,1,1,1st Failure Type,no known failure
1472,1,1,Research lab HPV,HPV unknown
1472,1,1,Metastasis,M0
1472,1,1,Tumor Site,larynx
1472,1,1,Treatment Modality,Sx
1473,1,1,Overall Stage,III
1473,1,1,Metastasis,M0
1473,1,1,Occurrence #,1st primary
1473,1,1,Clinical lab p16,p16 unkown
1473,1,1,Tumor Stage,T3
1473,1,1,2nd Failure Type,no known failure
1473,1,1,Nodal Stage,N0
1473,1,1,Research lab p16,p16 unknown
1473,1,1,Tumor Site,larynx
1473,1,1,Treatment Modality,Unknown
1473,1,1,1st Failure Type,no known failure
1473,1,1,Research lab HPV,HPV unknown
1474,1,1,Tumor Site,larynx
1474,1,1,Clinical lab p16,p16 unkown
1474,1,1,Radiation Dosage,59.4
1474,1,1,Overall Stage,IVa
1474,1,1,Tumor Stage,T4a
1474,1,1,Occurrence #,1st primary
1474,1,1,2nd Failure Type,no known failure
1474,1,1,Metastasis,M0
1474,1,1,1st Failure Type,distant
1474,1,1,Treatment Modality,Sx & RT
1474,1,1,Nodal Stage,N0
1474,1,1,Research lab p16,p16 unknown
1474,1,1,Research lab HPV,HPV unknown
1475,1,1,Treatment Modality,CTX-RT
1475,1,1,2nd Failure Type,no known failure
1475,1,1,Overall Stage,III
1475,1,1,Research lab HPV,HPV unknown
1475,1,1,Tumor Stage,T3
1475,1,1,Research lab p16,p16 unknown
1475,1,1,Occurrence #,1st primary
1475,1,1,Initial Chemotherapy Agent,cis
1475,1,1,1st Failure Type,locoregional
1475,1,1,Nodal Stage,N0
1475,1,1,Metastasis,M0
1475,1,1,Tumor Site,larynx
1475,1,1,Clinical lab p16,p16 unkown
1475,1,1,Radiation Dosage,70.2
1476,1,1,Metastasis,M0
1476,1,1,1st Failure Type,no known failure
1476,1,1,Tumor Site,larynx
1476,1,1,Research lab HPV,HPV unknown
1476,1,1,2nd Failure Type,no known failure
1476,1,1,Occurrence #,1st primary
1476,1,1,Overall Stage,II
1476,1,1,Clinical lab p16,p16 unkown
1476,1,1,Tumor Stage,T2
1476,1,1,Treatment Modality,RT
1476,1,1,Radiation Dosage,74.4
1476,1,1,Research lab p16,p16 unknown
1476,1,1,Nodal Stage,N0
1477,1,1,Initial Chemotherapy Agent,cis
1477,1,1,Treatment Modality,CTX-RT
1477,1,1,2nd Failure Type,no known failure
1477,1,1,Overall Stage,IVa
1477,1,1,Occurrence #,1st primary
1477,1,1,Nodal Stage,N2
1477,1,1,Tumor Site,larynx
1477,1,1,1st Failure Type,no known failure
1477,1,1,Research lab p16,p16 unknown
1477,1,1,Metastasis,M0
1477,1,1,Research lab HPV,HPV unknown
1477,1,1,Tumor Stage,T2
1477,1,1,Clinical lab p16,p16 unkown
1477,1,1,Radiation Dosage,70.2
1478,1,1,Tumor Site,larynx
1478,1,1,Nodal Stage,N0
1478,1,1,Radiation Dosage,70.2
1478,1,1,1st Failure Type,no known failure
1478,1,1,Research lab p16,p16 unknown
1478,1,1,Initial Chemotherapy Agent,cis
1478,1,1,2nd Failure Type,no known failure
1478,1,1,Metastasis,M0
1478,1,1,Research lab HPV,HPV unknown
1478,1,1,Clinical lab p16,p16 unkown
1478,1,1,Tumor Stage,T4a
1478,1,1,Overall Stage,IVa
1478,1,1,Occurrence #,1st primary
1478,1,1,Treatment Modality,CTX-RT
1479,1,1,Clinical lab p16,p16 unkown
1479,1,1,1st Failure Type,no known failure
1479,1,1,2nd Failure Type,no known failure
1479,1,1,Nodal Stage,Unknown
1479,1,1,Occurrence #,1st primary
1479,1,1,Overall Stage,Unknown
1479,1,1,Tumor Stage,Unknown
1479,1,1,Research lab HPV,HPV unknown
1479,1,1,Tumor Site,larynx
1479,1,1,Treatment Modality,Unknown
1479,1,1,Metastasis,Unknown
1479,1,1,Research lab p16,p16 unknown
1480,1,1,Research lab HPV,HPV unknown
1480,1,1,Clinical lab p16,p16 unkown
1480,1,1,Nodal Stage,N3
1480,1,1,Overall Stage,IVb
1480,1,1,Occurrence #,1st primary
1480,1,1,Research lab p16,p16 unknown
1480,1,1,Tumor Stage,T4a
1480,1,1,1st Failure Type,no known failure
1480,1,1,2nd Failure Type,no known failure
1480,1,1,Metastasis,M0
1480,1,1,Treatment Modality,Sx
1480,1,1,Tumor Site,larynx
1481,1,1,Nodal Stage,N0
1481,1,1,Research lab p16,p16 unknown
1481,1,1,Clinical lab p16,p16 unkown
1481,1,1,2nd Failure Type,no known failure
1481,1,1,Tumor Stage,T1
1481,1,1,Occurrence #,1st primary
1481,1,1,Tumor Site,larynx
1481,1,1,Metastasis,M0
1481,1,1,Overall Stage,I
1481,1,1,Treatment Modality,Sx
1481,1,1,Research lab HPV,HPV unknown
1481,1,1,1st Failure Type,no known failure
1482,1,1,Research lab p16,p16 unknown
1482,1,1,2nd Failure Type,no known failure
1482,1,1,Tumor Site,larynx
1482,1,1,Research lab HPV,HPV unknown
1482,1,1,Treatment Modality,Sx
1482,1,1,Clinical lab p16,p16 unkown
1482,1,1,Occurrence #,1st primary
1482,1,1,Metastasis,M0
1482,1,1,Overall Stage,II
1482,1,1,Tumor Stage,T2
1482,1,1,Nodal Stage,N0
1482,1,1,1st Failure Type,no known failure
1483,1,1,2nd Failure Type,no known failure
1483,1,1,Overall Stage,III
1483,1,1,Research lab p16,p16 unknown
1483,1,1,Radiation Dosage,59.4
1483,1,1,Metastasis,M0
1483,1,1,Clinical lab p16,p16 unkown
1483,1,1,1st Failure Type,no known failure
1483,1,1,Treatment Modality,Sx & RT
1483,1,1,Research lab HPV,HPV unknown
1483,1,1,Tumor Site,larynx
1483,1,1,Tumor Stage,T3
1483,1,1,Occurrence #,1st primary
1483,1,1,Nodal Stage,N0
1484,1,1,2nd Failure Type,no known failure
1484,1,1,Overall Stage,IVa
1484,1,1,1st Failure Type,no known failure
1484,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1484,1,1,Metastasis,M0
1484,1,1,Research lab HPV,HPV unknown
1484,1,1,Nodal Stage,N2
1484,1,1,Tumor Stage,T3
1484,1,1,Occurrence #,1st primary
1484,1,1,Tumor Site,larynx
1484,1,1,Radiation Dosage,70.2
1484,1,1,Research lab p16,p16 unknown
1484,1,1,Treatment Modality,CTX-RT
1484,1,1,Clinical lab p16,p16 unkown
1485,1,1,Metastasis,Unknown
1485,1,1,Research lab p16,p16 unknown
1485,1,1,1st Failure Type,no known failure
1485,1,1,Tumor Site,larynx
1485,1,1,2nd Failure Type,no known failure
1485,1,1,Nodal Stage,Unknown
1485,1,1,Treatment Modality,Unknown
1485,1,1,Occurrence #,recurrence
1485,1,1,Tumor Stage,T4a
1485,1,1,Clinical lab p16,p16 unkown
1485,1,1,Research lab HPV,HPV unknown
1485,1,1,Overall Stage,IVa
1486,1,1,Research lab HPV,HPV unknown
1486,1,1,Tumor Site,larynx
1486,1,1,Treatment Modality,Sx & CTX
1486,1,1,2nd Failure Type,no known failure
1486,1,1,Initial Chemotherapy Agent,gemcitabine/PTX/cap
1486,1,1,Nodal Stage,N2
1486,1,1,Tumor Stage,T2
1486,1,1,Occurrence #,recurrence
1486,1,1,Research lab p16,p16 unknown
1486,1,1,1st Failure Type,locoregional
1486,1,1,Overall Stage,IVa
1486,1,1,Metastasis,M0
1486,1,1,Clinical lab p16,p16 unkown
1487,1,1,Metastasis,M0
1487,1,1,1st Failure Site,larynx
1487,1,1,Treatment Modality,CTX-RT
1487,1,1,Research lab p16,p16 unknown
1487,1,1,1st Failure Type,locoregional
1487,1,1,Clinical lab p16,p16 unkown
1487,1,1,Initial Chemotherapy Agent,cis
1487,1,1,2nd Failure Type,no known failure
1487,1,1,Tumor Site,larynx
1487,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
1487,1,1,Research lab HPV,HPV unknown
1487,1,1,1st Failure Radiation Dosage,60
1487,1,1,Tumor Stage,T3
1487,1,1,Overall Stage,III
1487,1,1,Radiation Dosage,70.2
1487,1,1,1st Failure Treatment Modality,Sx & CTX-RT
1487,1,1,Nodal Stage,N0
1487,1,1,Occurrence #,1st primary
1488,1,1,Radiation Dosage,63
1488,1,1,Tumor Stage,T4a
1488,1,1,Nodal Stage,N0
1488,1,1,Occurrence #,1st primary
1488,1,1,Clinical lab p16,p16 unkown
1488,1,1,2nd Failure Type,no known failure
1488,1,1,Metastasis,M0
1488,1,1,Tumor Site,larynx
1488,1,1,Research lab p16,p16 unknown
1488,1,1,Research lab HPV,HPV unknown
1488,1,1,Overall Stage,IVa
1488,1,1,1st Failure Type,no known failure
1488,1,1,Treatment Modality,Sx & RT
1489,1,1,Nodal Stage,N0
1489,1,1,1st Failure Type,no known failure
1489,1,1,Tumor Stage,T3
1489,1,1,Occurrence #,1st primary
1489,1,1,2nd Failure Type,no known failure
1489,1,1,Research lab HPV,HPV unknown
1489,1,1,Treatment Modality,Sx
1489,1,1,Tumor Site,larynx
1489,1,1,Overall Stage,III
1489,1,1,Metastasis,M0
1489,1,1,Clinical lab p16,p16 unkown
1489,1,1,Research lab p16,p16 unknown
1490,1,1,Nodal Stage,N0
1490,1,1,Occurrence #,1st primary
1490,1,1,Tumor Stage,T3
1490,1,1,Research lab HPV,HPV unknown
1490,1,1,Treatment Modality,Sx
1490,1,1,Research lab p16,p16 unknown
1490,1,1,Tumor Site,larynx
1490,1,1,1st Failure Type,no known failure
1490,1,1,Clinical lab p16,p16 unkown
1490,1,1,2nd Failure Type,no known failure
1490,1,1,Overall Stage,III
1490,1,1,Metastasis,M0
1491,1,1,Research lab HPV,HPV unknown
1491,1,1,Overall Stage,IVa
1491,1,1,2nd Failure Type,no known failure
1491,1,1,Tumor Stage,T3
1491,1,1,Occurrence #,1st primary
1491,1,1,Clinical lab p16,p16 unkown
1491,1,1,Tumor Site,larynx
1491,1,1,Metastasis,M0
1491,1,1,Radiation Dosage,70.2
1491,1,1,Research lab p16,p16 unknown
1491,1,1,Treatment Modality,CTX-RT
1491,1,1,Initial Chemotherapy Agent,cis
1491,1,1,1st Failure Type,no known failure
1491,1,1,Nodal Stage,N2
1492,1,1,Research lab HPV,HPV unknown
1492,1,1,Clinical lab p16,p16 unkown
1492,1,1,Tumor Site,larynx
1492,1,1,1st Failure Type,no known failure
1492,1,1,Treatment Modality,Sx
1492,1,1,Nodal Stage,N0
1492,1,1,Occurrence #,1st primary
1492,1,1,2nd Failure Type,no known failure
1492,1,1,Metastasis,M0
1492,1,1,Overall Stage,I
1492,1,1,Research lab p16,p16 unknown
1492,1,1,Tumor Stage,T1
1493,1,1,1st Failure Type,no known failure
1493,1,1,Overall Stage,III
1493,1,1,Tumor Site,larynx
1493,1,1,Tumor Stage,T3
1493,1,1,Research lab p16,p16 unknown
1493,1,1,2nd Failure Type,no known failure
1493,1,1,Research lab HPV,HPV unknown
1493,1,1,Metastasis,M0
1493,1,1,Clinical lab p16,p16 unkown
1493,1,1,Nodal Stage,N0
1493,1,1,Occurrence #,1st primary
1493,1,1,Initial Chemotherapy Agent,cis
1493,1,1,Treatment Modality,CTX-RT
1493,1,1,Radiation Dosage,70.2
1494,1,1,1st Failure Treatment Modality,CTX-RT
1494,1,1,Initial Chemotherapy Agent,unknown
1494,1,1,1st Failure Site,larynx
1494,1,1,Metastasis,M0
1494,1,1,1st Failure Type,distant
1494,1,1,Research lab p16,p16 unknown
1494,1,1,Radiation Dosage,63
1494,1,1,Nodal Stage,N1
1494,1,1,Tumor Stage,T3
1494,1,1,Overall Stage,III
1494,1,1,Tumor Site,larynx
1494,1,1,Treatment Modality,Sx & CTX-RT
1494,1,1,Occurrence #,recurrence
1494,1,1,1st Failure Radiation Dosage,50.4
1494,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
1494,1,1,2nd Failure Type,no known failure
1494,1,1,Research lab HPV,HPV unknown
1494,1,1,Clinical lab p16,p16 unkown
1495,1,1,Overall Stage,IVa
1495,1,1,Occurrence #,1st primary
1495,1,1,Research lab p16,p16 unknown
1495,1,1,Metastasis,M0
1495,1,1,Tumor Site,larynx
1495,1,1,Nodal Stage,N2
1495,1,1,Clinical lab p16,p16 unkown
1495,1,1,Research lab HPV,HPV unknown
1495,1,1,2nd Failure Type,no known failure
1495,1,1,Tumor Stage,T4a
1495,1,1,Treatment Modality,Sx
1495,1,1,1st Failure Type,no known failure
1496,1,1,Clinical lab p16,p16 unkown
1496,1,1,Nodal Stage,N0
1496,1,1,1st Failure Type,no known failure
1496,1,1,Overall Stage,II
1496,1,1,Occurrence #,1st primary
1496,1,1,Metastasis,M0
1496,1,1,Tumor Stage,T2
1496,1,1,Treatment Modality,RT
1496,1,1,Research lab HPV,HPV unknown
1496,1,1,Tumor Site,larynx
1496,1,1,2nd Failure Type,no known failure
1496,1,1,Radiation Dosage,70
1496,1,1,Research lab p16,p16 unknown
1497,1,1,Research lab p16,p16 unknown
1497,1,1,Occurrence #,1st primary
1497,1,1,Research lab HPV,HPV unknown
1497,1,1,2nd Failure Type,no known failure
1497,1,1,Overall Stage,I
1497,1,1,Metastasis,M0
1497,1,1,Radiation Dosage,63
1497,1,1,Clinical lab p16,p16 unkown
1497,1,1,Tumor Stage,T1
1497,1,1,Nodal Stage,N0
1497,1,1,1st Failure Type,no known failure
1497,1,1,Tumor Site,larynx
1497,1,1,Treatment Modality,RT
1498,1,1,Overall Stage,Unknown
1498,1,1,Clinical lab p16,p16 unkown
1498,1,1,Treatment Modality,Unknown
1498,1,1,Research lab p16,p16 unknown
1498,1,1,Research lab HPV,HPV unknown
1498,1,1,Tumor Stage,Unknown
1498,1,1,2nd Failure Type,no known failure
1498,1,1,Metastasis,Unknown
1498,1,1,Occurrence #,1st primary
1498,1,1,Nodal Stage,Unknown
1498,1,1,1st Failure Type,no known failure
1498,1,1,Tumor Site,larynx
1499,1,1,Occurrence #,1st primary
1499,1,1,2nd Failure Type,no known failure
1499,1,1,Tumor Stage,T2
1499,1,1,1st Failure Type,no known failure
1499,1,1,Research lab p16,p16 unknown
1499,1,1,Clinical lab p16,p16 unkown
1499,1,1,Research lab HPV,HPV unknown
1499,1,1,Metastasis,M0
1499,1,1,Overall Stage,II
1499,1,1,Nodal Stage,N0
1499,1,1,Tumor Site,larynx
1499,1,1,Treatment Modality,Unknown
1500,1,1,Metastasis,M0
1500,1,1,Nodal Stage,N2
1500,1,1,Radiation Dosage,70.2
1500,1,1,Treatment Modality,CTX-RT
1500,1,1,Overall Stage,IVa
1500,1,1,1st Failure Type,locoregional and distant
1500,1,1,Research lab HPV,HPV unknown
1500,1,1,Clinical lab p16,p16 unkown
1500,1,1,Research lab p16,p16 unknown
1500,1,1,Initial Chemotherapy Agent,cis
1500,1,1,Occurrence #,recurrence
1500,1,1,Tumor Stage,T3
1500,1,1,2nd Failure Type,no known failure
1500,1,1,Tumor Site,larynx
1501,1,1,Research lab HPV,HPV unknown
1501,1,1,1st Failure Treatment Modality,Sx
1501,1,1,1st Failure Site,larynx
1501,1,1,1st Failure Type,locoregional
1501,1,1,Nodal Stage,N0
1501,1,1,Research lab p16,p16 unknown
1501,1,1,Tumor Site,larynx
1501,1,1,Occurrence #,1st primary
1501,1,1,Radiation Dosage,66
1501,1,1,Metastasis,M0
1501,1,1,Tumor Stage,T1
1501,1,1,2nd Failure Type,no known failure
1501,1,1,Treatment Modality,RT
1501,1,1,Overall Stage,I
1501,1,1,Clinical lab p16,p16 unkown
1502,1,1,Overall Stage,Unknown
1502,1,1,Tumor Site,larynx
1502,1,1,Treatment Modality,Unknown
1502,1,1,Clinical lab p16,p16 unkown
1502,1,1,Research lab p16,p16 unknown
1502,1,1,2nd Failure Type,no known failure
1502,1,1,Nodal Stage,Unknown
1502,1,1,Tumor Stage,Unknown
1502,1,1,Metastasis,Unknown
1502,1,1,Research lab HPV,HPV unknown
1502,1,1,Occurrence #,recurrence
1502,1,1,1st Failure Type,no known failure
1503,1,1,Nodal Stage,N0
1503,1,1,Metastasis,M0
1503,1,1,Research lab HPV,HPV unknown
1503,1,1,Clinical lab p16,p16 unkown
1503,1,1,1st Failure Type,no known failure
1503,1,1,Tumor Stage,T2
1503,1,1,2nd Failure Type,no known failure
1503,1,1,Research lab p16,p16 unknown
1503,1,1,Tumor Site,larynx
1503,1,1,Treatment Modality,Sx
1503,1,1,Overall Stage,II
1503,1,1,Occurrence #,1st primary
1504,1,1,2nd Failure Type,no known failure
1504,1,1,Metastasis,Unknown
1504,1,1,Tumor Stage,Unknown
1504,1,1,Overall Stage,Unknown
1504,1,1,Occurrence #,1st primary
1504,1,1,1st Failure Type,no known failure
1504,1,1,Treatment Modality,Sx & RT
1504,1,1,Tumor Site,larynx
1504,1,1,Nodal Stage,Unknown
1504,1,1,Radiation Dosage,unknown
1504,1,1,Research lab p16,p16 unknown
1504,1,1,Clinical lab p16,p16 unkown
1504,1,1,Research lab HPV,HPV unknown
1505,1,1,Nodal Stage,N0
1505,1,1,Treatment Modality,RT
1505,1,1,Tumor Site,larynx
1505,1,1,Research lab HPV,HPV unknown
1505,1,1,Clinical lab p16,p16 unkown
1505,1,1,Research lab p16,p16 unknown
1505,1,1,1st Failure Type,no known failure
1505,1,1,Tumor Stage,T2
1505,1,1,2nd Failure Type,no known failure
1505,1,1,Radiation Dosage,74.4
1505,1,1,Occurrence #,1st primary
1505,1,1,Overall Stage,II
1505,1,1,Metastasis,M0
1506,1,1,Tumor Site,larynx
1506,1,1,Overall Stage,IVc
1506,1,1,Nodal Stage,Unknown
1506,1,1,Tumor Stage,Unknown
1506,1,1,2nd Failure Type,no known failure
1506,1,1,Treatment Modality,CTX
1506,1,1,Research lab p16,p16 unknown
1506,1,1,Clinical lab p16,p16 unkown
1506,1,1,1st Failure Type,locoregional and distant
1506,1,1,Second Line Chemotherapy Agent,cap
1506,1,1,Initial Chemotherapy Agent,erlotinib/bev
1506,1,1,Research lab HPV,HPV unknown
1506,1,1,Metastasis,M1
1506,1,1,Occurrence #,recurrence
1507,1,1,Overall Stage,IVa
1507,1,1,2nd Failure Type,no known failure
1507,1,1,Tumor Site,larynx
1507,1,1,Tumor Stage,T4a
1507,1,1,Research lab p16,p16 unknown
1507,1,1,Nodal Stage,N2
1507,1,1,Clinical lab p16,p16 unkown
1507,1,1,1st Failure Type,no known failure
1507,1,1,Research lab HPV,HPV unknown
1507,1,1,Metastasis,M0
1507,1,1,Treatment Modality,Unknown
1507,1,1,Occurrence #,1st primary
1508,1,1,Nodal Stage,N0
1508,1,1,2nd Failure Type,no known failure
1508,1,1,Overall Stage,III
1508,1,1,Treatment Modality,RT
1508,1,1,Metastasis,M0
1508,1,1,Tumor Site,larynx
1508,1,1,1st Failure Type,locoregional
1508,1,1,Radiation Dosage,70.2
1508,1,1,Tumor Stage,T3
1508,1,1,Clinical lab p16,p16 unkown
1508,1,1,Research lab p16,p16 unknown
1508,1,1,Research lab HPV,HPV unknown
1508,1,1,Occurrence #,1st primary
1509,1,1,Overall Stage,IVa
1509,1,1,Metastasis,M0
1509,1,1,1st Failure Type,no known failure
1509,1,1,Treatment Modality,CTX-RT
1509,1,1,Radiation Dosage,70.2
1509,1,1,Clinical lab p16,p16 unkown
1509,1,1,Research lab p16,p16 unknown
1509,1,1,Nodal Stage,N2
1509,1,1,Occurrence #,1st primary
1509,1,1,Initial Chemotherapy Agent,cetux
1509,1,1,2nd Failure Type,no known failure
1509,1,1,Research lab HPV,HPV unknown
1509,1,1,Tumor Stage,T3
1509,1,1,Tumor Site,larynx
1510,1,1,Tumor Stage,Unknown
1510,1,1,Tumor Site,larynx
1510,1,1,Metastasis,M0
1510,1,1,2nd Failure Type,no known failure
1510,1,1,Research lab p16,p16 unknown
1510,1,1,Research lab HPV,HPV unknown
1510,1,1,Overall Stage,IVa
1510,1,1,Occurrence #,recurrence
1510,1,1,Nodal Stage,N2
1510,1,1,1st Failure Type,no known failure
1510,1,1,Clinical lab p16,p16 unkown
1510,1,1,Treatment Modality,Sx
1511,1,1,Clinical lab p16,p16 unkown
1511,1,1,Overall Stage,III
1511,1,1,1st Failure Type,no known failure
1511,1,1,Treatment Modality,CTX-RT
1511,1,1,Metastasis,M0
1511,1,1,Research lab HPV,HPV unknown
1511,1,1,Radiation Dosage,70.2
1511,1,1,Nodal Stage,N0
1511,1,1,2nd Failure Type,no known failure
1511,1,1,Occurrence #,1st primary
1511,1,1,Initial Chemotherapy Agent,cis
1511,1,1,Tumor Site,larynx
1511,1,1,Tumor Stage,T3
1511,1,1,Research lab p16,p16 unknown
1512,1,1,Research lab HPV,HPV unknown
1512,1,1,Overall Stage,II
1512,1,1,Tumor Stage,T2
1512,1,1,1st Failure Type,no known failure
1512,1,1,Metastasis,M0
1512,1,1,Research lab p16,p16 unknown
1512,1,1,Clinical lab p16,p16 unkown
1512,1,1,Treatment Modality,Unknown
1512,1,1,Tumor Site,larynx
1512,1,1,2nd Failure Type,no known failure
1512,1,1,Occurrence #,1st primary
1512,1,1,Nodal Stage,N0
1513,1,1,Radiation Dosage,70
1513,1,1,Tumor Stage,T2
1513,1,1,Treatment Modality,RT
1513,1,1,Overall Stage,II
1513,1,1,Metastasis,M0
1513,1,1,Tumor Site,larynx
1513,1,1,1st Failure Type,no known failure
1513,1,1,Research lab HPV,HPV unknown
1513,1,1,Nodal Stage,N0
1513,1,1,Occurrence #,1st primary
1513,1,1,Research lab p16,p16 unknown
1513,1,1,2nd Failure Type,no known failure
1513,1,1,Clinical lab p16,p16 unkown
1514,1,1,Clinical lab p16,p16 unkown
1514,1,1,Overall Stage,IVa
1514,1,1,Metastasis,M0
1514,1,1,Tumor Site,larynx
1514,1,1,Nodal Stage,N0
1514,1,1,1st Failure Type,no known failure
1514,1,1,Research lab HPV,HPV unknown
1514,1,1,Occurrence #,1st primary
1514,1,1,Research lab p16,p16 unknown
1514,1,1,Treatment Modality,Sx
1514,1,1,2nd Failure Type,no known failure
1514,1,1,Tumor Stage,T4a
1515,1,1,Overall Stage,III
1515,1,1,Metastasis,M0
1515,1,1,Nodal Stage,N1
1515,1,1,Tumor Site,larynx
1515,1,1,1st Failure Type,no known failure
1515,1,1,Research lab HPV,HPV unknown
1515,1,1,Occurrence #,1st primary
1515,1,1,Research lab p16,p16 unknown
1515,1,1,Clinical lab p16,p16 unkown
1515,1,1,2nd Failure Type,no known failure
1515,1,1,Radiation Dosage,59.4
1515,1,1,Tumor Stage,T3
1515,1,1,Treatment Modality,Sx & RT
1516,1,1,Nodal Stage,N0
1516,1,1,1st Failure Type,no known failure
1516,1,1,2nd Failure Type,no known failure
1516,1,1,Research lab p16,p16 unknown
1516,1,1,Research lab HPV,HPV unknown
1516,1,1,Metastasis,M0
1516,1,1,Overall Stage,II
1516,1,1,Tumor Stage,T2
1516,1,1,Tumor Site,larynx
1516,1,1,Clinical lab p16,p16 unkown
1516,1,1,Occurrence #,1st primary
1516,1,1,Treatment Modality,Sx
1517,1,1,Radiation Dosage,70.4
1517,1,1,2nd Failure Type,no known failure
1517,1,1,Treatment Modality,RT
1517,1,1,Nodal Stage,N0
1517,1,1,Overall Stage,II
1517,1,1,1st Failure Type,no known failure
1517,1,1,Research lab p16,p16 unknown
1517,1,1,Tumor Stage,T2
1517,1,1,Clinical lab p16,p16 unkown
1517,1,1,Occurrence #,1st primary
1517,1,1,Research lab HPV,HPV unknown
1517,1,1,Tumor Site,larynx
1517,1,1,Metastasis,M0
1518,1,1,Occurrence #,recurrence
1518,1,1,2nd Failure Type,no known failure
1518,1,1,1st Failure Type,locoregional
1518,1,1,Research lab HPV,HPV unknown
1518,1,1,Treatment Modality,Sx
1518,1,1,Tumor Stage,T1
1518,1,1,Clinical lab p16,p16 unkown
1518,1,1,Overall Stage,I
1518,1,1,Tumor Site,larynx
1518,1,1,Research lab p16,p16 unknown
1518,1,1,Metastasis,M0
1518,1,1,Nodal Stage,N0
1519,1,1,1st Failure Type,no known failure
1519,1,1,Radiation Dosage,74.4
1519,1,1,Clinical lab p16,p16 unkown
1519,1,1,Tumor Stage,T2
1519,1,1,Research lab p16,p16 unknown
1519,1,1,Metastasis,M0
1519,1,1,Nodal Stage,N0
1519,1,1,Tumor Site,larynx
1519,1,1,Overall Stage,II
1519,1,1,Occurrence #,1st primary
1519,1,1,2nd Failure Type,no known failure
1519,1,1,Research lab HPV,HPV unknown
1519,1,1,Treatment Modality,RT
1520,1,1,2nd Failure Type,no known failure
1520,1,1,Radiation Dosage,63
1520,1,1,Treatment Modality,RT
1520,1,1,Clinical lab p16,p16 unkown
1520,1,1,Tumor Stage,T1
1520,1,1,Overall Stage,I
1520,1,1,Research lab p16,p16 unknown
1520,1,1,Nodal Stage,N0
1520,1,1,1st Failure Type,no known failure
1520,1,1,Metastasis,M0
1520,1,1,Occurrence #,1st primary
1520,1,1,Research lab HPV,HPV unknown
1520,1,1,Tumor Site,larynx
1521,1,1,Tumor Stage,T1
1521,1,1,2nd Failure Type,no known failure
1521,1,1,Research lab HPV,HPV unknown
1521,1,1,Clinical lab p16,p16 unkown
1521,1,1,Tumor Site,larynx
1521,1,1,Overall Stage,I
1521,1,1,1st Failure Type,no known failure
1521,1,1,Research lab p16,p16 unknown
1521,1,1,Metastasis,M0
1521,1,1,Nodal Stage,N0
1521,1,1,Occurrence #,recurrence
1521,1,1,Treatment Modality,Sx
1522,1,1,Treatment Modality,Sx & RT
1522,1,1,Clinical lab p16,p16 unkown
1522,1,1,1st Failure Type,locoregional and distant
1522,1,1,2nd Failure Type,no known failure
1522,1,1,Nodal Stage,N2
1522,1,1,Tumor Site,larynx
1522,1,1,Research lab p16,p16 unknown
1522,1,1,Radiation Dosage,59.4
1522,1,1,Metastasis,M0
1522,1,1,Tumor Stage,T4a
1522,1,1,Overall Stage,IVa
1522,1,1,Occurrence #,1st primary
1522,1,1,Research lab HPV,HPV unknown
1523,1,1,Nodal Stage,N0
1523,1,1,Occurrence #,1st primary
1523,1,1,Radiation Dosage,74.4
1523,1,1,Tumor Site,larynx
1523,1,1,Research lab p16,p16 unknown
1523,1,1,Treatment Modality,RT
1523,1,1,Clinical lab p16,p16 unkown
1523,1,1,1st Failure Type,no known failure
1523,1,1,Research lab HPV,HPV unknown
1523,1,1,Overall Stage,II
1523,1,1,Metastasis,M0
1523,1,1,Tumor Stage,T2
1523,1,1,2nd Failure Type,no known failure
1524,1,1,Metastasis,M0
1524,1,1,Nodal Stage,N1
1524,1,1,Occurrence #,1st primary
1524,1,1,Research lab HPV,HPV unknown
1524,1,1,1st Failure Type,locoregional
1524,1,1,Initial Chemotherapy Agent,cis
1524,1,1,Overall Stage,III
1524,1,1,Tumor Site,larynx
1524,1,1,Research lab p16,p16 unknown
1524,1,1,Treatment Modality,CTX-RT
1524,1,1,1st Failure Treatment Modality,Sx
1524,1,1,Clinical lab p16,p16 unkown
1524,1,1,Radiation Dosage,70.2
1524,1,1,Tumor Stage,T2
1524,1,1,2nd Failure Type,no known failure
1524,1,1,Second Line Chemotherapy Agent,carbo
1524,1,1,1st Failure Site,larynx
1525,1,1,Tumor Stage,T1
1525,1,1,Research lab p16,p16 unknown
1525,1,1,Overall Stage,I
1525,1,1,Tumor Site,larynx
1525,1,1,Radiation Dosage,63
1525,1,1,Treatment Modality,RT
1525,1,1,Metastasis,M0
1525,1,1,Research lab HPV,HPV unknown
1525,1,1,Occurrence #,1st primary
1525,1,1,1st Failure Type,no known failure
1525,1,1,2nd Failure Type,no known failure
1525,1,1,Nodal Stage,N0
1525,1,1,Clinical lab p16,p16 unkown
1526,1,1,Metastasis,M0
1526,1,1,Research lab HPV,HPV unknown
1526,1,1,Initial Chemotherapy Agent,unknown
1526,1,1,1st Failure Type,no known failure
1526,1,1,Radiation Dosage,unknown
1526,1,1,Tumor Site,larynx
1526,1,1,Occurrence #,1st primary
1526,1,1,Nodal Stage,N2
1526,1,1,Tumor Stage,T2
1526,1,1,Clinical lab p16,p16 unkown
1526,1,1,Treatment Modality,Sx & CTX-RT
1526,1,1,2nd Failure Type,no known failure
1526,1,1,Overall Stage,IVa
1526,1,1,Research lab p16,p16 unknown
1527,1,1,Tumor Site,larynx
1527,1,1,Metastasis,M0
1527,1,1,Overall Stage,IVa
1527,1,1,Research lab HPV,HPV unknown
1527,1,1,Research lab p16,p16 unknown
1527,1,1,Tumor Stage,T4a
1527,1,1,Clinical lab p16,p16 unkown
1527,1,1,Nodal Stage,N0
1527,1,1,2nd Failure Type,no known failure
1527,1,1,Treatment Modality,Sx
1527,1,1,1st Failure Type,no known failure
1527,1,1,Occurrence #,recurrence
1528,1,1,Initial Chemotherapy Agent,cis/PTX
1528,1,1,Occurrence #,1st primary
1528,1,1,Treatment Modality,CTX-RT
1528,1,1,Nodal Stage,N2
1528,1,1,Radiation Dosage,70.2
1528,1,1,Overall Stage,IVc
1528,1,1,1st Failure Type,distant
1528,1,1,Research lab HPV,HPV unknown
1528,1,1,Clinical lab p16,p16 unkown
1528,1,1,Metastasis,M1
1528,1,1,Tumor Stage,T2
1528,1,1,Research lab p16,p16 unknown
1528,1,1,Tumor Site,larynx
1528,1,1,2nd Failure Type,no known failure
1529,1,1,Research lab p16,p16 unknown
1529,1,1,Treatment Modality,RT
1529,1,1,Clinical lab p16,p16 unkown
1529,1,1,Nodal Stage,N0
1529,1,1,Occurrence #,1st primary
1529,1,1,Tumor Stage,T2
1529,1,1,Overall Stage,II
1529,1,1,Tumor Site,larynx
1529,1,1,2nd Failure Type,no known failure
1529,1,1,Metastasis,M0
1529,1,1,Radiation Dosage,74.4
1529,1,1,1st Failure Type,no known failure
1529,1,1,Research lab HPV,HPV unknown
1530,1,1,Nodal Stage,N2
1530,1,1,Tumor Stage,T4a
1530,1,1,Tumor Site,larynx
1530,1,1,1st Failure Type,no known failure
1530,1,1,Treatment Modality,RT
1530,1,1,Occurrence #,1st primary
1530,1,1,Clinical lab p16,p16 unkown
1530,1,1,Research lab p16,p16 unknown
1530,1,1,2nd Failure Type,no known failure
1530,1,1,Metastasis,M0
1530,1,1,Overall Stage,IVa
1530,1,1,Radiation Dosage,41.4
1530,1,1,Research lab HPV,HPV unknown
1531,1,1,Nodal Stage,N1
1531,1,1,Metastasis,M0
1531,1,1,Occurrence #,1st primary
1531,1,1,Overall Stage,III
1531,1,1,Initial Chemotherapy Agent,unknown
1531,1,1,1st Failure Type,no known failure
1531,1,1,Radiation Dosage,unknown
1531,1,1,Research lab p16,p16 unknown
1531,1,1,Treatment Modality,CTX-RT
1531,1,1,Tumor Site,larynx
1531,1,1,Research lab HPV,HPV unknown
1531,1,1,2nd Failure Type,no known failure
1531,1,1,Clinical lab p16,p16 unkown
1531,1,1,Tumor Stage,T3
1532,1,1,Research lab p16,p16 unknown
1532,1,1,Metastasis,M0
1532,1,1,Nodal Stage,N0
1532,1,1,Occurrence #,1st primary
1532,1,1,Treatment Modality,RT
1532,1,1,Overall Stage,I
1532,1,1,Radiation Dosage,63
1532,1,1,Research lab HPV,HPV unknown
1532,1,1,2nd Failure Type,no known failure
1532,1,1,Clinical lab p16,p16 unkown
1532,1,1,Tumor Site,larynx
1532,1,1,Tumor Stage,T1
1532,1,1,1st Failure Type,no known failure
1533,1,1,Tumor Stage,T1
1533,1,1,Nodal Stage,N0
1533,1,1,Tumor Site,larynx
1533,1,1,Metastasis,M0
1533,1,1,Research lab HPV,HPV unknown
1533,1,1,1st Failure Type,no known failure
1533,1,1,2nd Failure Type,no known failure
1533,1,1,Occurrence #,1st primary
1533,1,1,Overall Stage,I
1533,1,1,Clinical lab p16,p16 unkown
1533,1,1,Treatment Modality,RT
1533,1,1,Radiation Dosage,66
1533,1,1,Research lab p16,p16 unknown
1534,1,1,Radiation Dosage,74.4
1534,1,1,Tumor Site,larynx
1534,1,1,2nd Failure Type,no known failure
1534,1,1,Research lab p16,p16 unknown
1534,1,1,Clinical lab p16,p16 unkown
1534,1,1,Tumor Stage,T2
1534,1,1,Treatment Modality,RT
1534,1,1,Research lab HPV,HPV unknown
1534,1,1,1st Failure Type,no known failure
1534,1,1,Overall Stage,II
1534,1,1,Nodal Stage,N0
1534,1,1,Occurrence #,1st primary
1534,1,1,Metastasis,M0
1535,1,1,1st Failure Type,no known failure
1535,1,1,Research lab p16,p16 unknown
1535,1,1,Treatment Modality,Unknown
1535,1,1,Clinical lab p16,p16 unkown
1535,1,1,Overall Stage,Unknown
1535,1,1,Research lab HPV,HPV unknown
1535,1,1,Occurrence #,recurrence
1535,1,1,Tumor Stage,Unknown
1535,1,1,Metastasis,Unknown
1535,1,1,Nodal Stage,Unknown
1535,1,1,Tumor Site,larynx
1535,1,1,2nd Failure Type,no known failure
1536,1,1,Research lab HPV,HPV unknown
1536,1,1,1st Failure Type,no known failure
1536,1,1,2nd Failure Type,no known failure
1536,1,1,Initial Chemotherapy Agent,cis
1536,1,1,Research lab p16,p16 unknown
1536,1,1,Treatment Modality,Sx & CTX-RT
1536,1,1,Tumor Stage,T4a
1536,1,1,Nodal Stage,N1
1536,1,1,Overall Stage,IVa
1536,1,1,Occurrence #,1st primary
1536,1,1,Clinical lab p16,p16 unkown
1536,1,1,Radiation Dosage,70.2
1536,1,1,Tumor Site,larynx
1536,1,1,Metastasis,M0
1537,1,1,Tumor Site,larynx
1537,1,1,Tumor Stage,T1
1537,1,1,1st Failure Type,no known failure
1537,1,1,Metastasis,M0
1537,1,1,Occurrence #,1st primary
1537,1,1,Research lab HPV,HPV unknown
1537,1,1,Clinical lab p16,p16 unkown
1537,1,1,Nodal Stage,N0
1537,1,1,Overall Stage,I
1537,1,1,2nd Failure Type,no known failure
1537,1,1,Treatment Modality,Sx
1537,1,1,Research lab p16,p16 unknown
1538,1,1,Tumor Stage,T3
1538,1,1,Tumor Site,larynx
1538,1,1,Occurrence #,1st primary
1538,1,1,Nodal Stage,N1
1538,1,1,Radiation Dosage,70.2
1538,1,1,Overall Stage,III
1538,1,1,Research lab p16,p16 unknown
1538,1,1,Research lab HPV,HPV unknown
1538,1,1,Metastasis,M0
1538,1,1,1st Failure Type,no known failure
1538,1,1,Treatment Modality,CTX-RT
1538,1,1,Initial Chemotherapy Agent,unknown
1538,1,1,Clinical lab p16,p16 unkown
1538,1,1,2nd Failure Type,no known failure
1539,1,1,Tumor Stage,T1
1539,1,1,1st Failure Type,no known failure
1539,1,1,Occurrence #,1st primary
1539,1,1,Research lab p16,p16 unknown
1539,1,1,Radiation Dosage,65.25
1539,1,1,Metastasis,M0
1539,1,1,Overall Stage,I
1539,1,1,Treatment Modality,RT
1539,1,1,2nd Failure Type,no known failure
1539,1,1,Clinical lab p16,p16 unkown
1539,1,1,Nodal Stage,N0
1539,1,1,Research lab HPV,HPV unknown
1539,1,1,Tumor Site,larynx
1540,1,1,1st Failure Type,no known failure
1540,1,1,Research lab p16,p16 unknown
1540,1,1,Research lab HPV,HPV unknown
1540,1,1,Tumor Stage,T3
1540,1,1,Treatment Modality,CTX-RT
1540,1,1,Initial Chemotherapy Agent,carbo/PTX
1540,1,1,Occurrence #,1st primary
1540,1,1,Metastasis,M0
1540,1,1,Overall Stage,IVa
1540,1,1,2nd Failure Type,no known failure
1540,1,1,Nodal Stage,N2
1540,1,1,Tumor Site,larynx
1540,1,1,Clinical lab p16,p16 unkown
1540,1,1,Radiation Dosage,70.2
1541,1,1,Metastasis,M0
1541,1,1,Nodal Stage,N0
1541,1,1,Research lab HPV,HPV unknown
1541,1,1,Tumor Stage,T3
1541,1,1,Occurrence #,recurrence
1541,1,1,1st Failure Type,no known failure
1541,1,1,Tumor Site,larynx
1541,1,1,Overall Stage,III
1541,1,1,Clinical lab p16,p16 unkown
1541,1,1,Research lab p16,p16 unknown
1541,1,1,Treatment Modality,Sx
1541,1,1,2nd Failure Type,no known failure
1542,1,1,Research lab HPV,HPV unknown
1542,1,1,Nodal Stage,N0
1542,1,1,Occurrence #,1st primary
1542,1,1,Treatment Modality,Sx & RT
1542,1,1,2nd Failure Type,no known failure
1542,1,1,Research lab p16,p16 unknown
1542,1,1,1st Failure Type,no known failure
1542,1,1,Clinical lab p16,p16 unkown
1542,1,1,Metastasis,M0
1542,1,1,Tumor Stage,T1
1542,1,1,Radiation Dosage,63.6
1542,1,1,Overall Stage,I
1542,1,1,Tumor Site,larynx
1543,1,1,Overall Stage,IVa
1543,1,1,Nodal Stage,N1
1543,1,1,Treatment Modality,CTX-RT
1543,1,1,1st Failure Type,no known failure
1543,1,1,Research lab p16,p16 unknown
1543,1,1,Metastasis,M0
1543,1,1,Tumor Site,larynx
1543,1,1,Initial Chemotherapy Agent,PTX/cap
1543,1,1,Clinical lab p16,p16 unkown
1543,1,1,Tumor Stage,T4a
1543,1,1,Radiation Dosage,70.2
1543,1,1,Research lab HPV,HPV unknown
1543,1,1,2nd Failure Type,no known failure
1543,1,1,Occurrence #,1st primary
1544,1,1,2nd Failure Type,no known failure
1544,1,1,Tumor Site,larynx
1544,1,1,Overall Stage,IVa
1544,1,1,Clinical lab p16,p16 unkown
1544,1,1,1st Failure Site,larynx
1544,1,1,Nodal Stage,N0
1544,1,1,Research lab HPV,HPV unknown
1544,1,1,Tumor Stage,T4a
1544,1,1,Occurrence #,1st primary
1544,1,1,1st Failure Type,locoregional
1544,1,1,Treatment Modality,Sx
1544,1,1,Research lab p16,p16 unknown
1544,1,1,1st Failure Treatment Modality,Sx
1544,1,1,Metastasis,M0
1545,1,1,Overall Stage,I
1545,1,1,2nd Failure Type,no known failure
1545,1,1,1st Failure Type,no known failure
1545,1,1,Tumor Stage,T1
1545,1,1,Tumor Site,larynx
1545,1,1,Research lab HPV,HPV unknown
1545,1,1,Clinical lab p16,p16 unkown
1545,1,1,Research lab p16,p16 unknown
1545,1,1,Metastasis,M0
1545,1,1,Nodal Stage,N0
1545,1,1,Radiation Dosage,63
1545,1,1,Treatment Modality,RT
1545,1,1,Occurrence #,1st primary
1546,1,1,2nd Failure Type,no known failure
1546,1,1,Research lab p16,p16 unknown
1546,1,1,Research lab HPV,HPV unknown
1546,1,1,Overall Stage,IVa
1546,1,1,Tumor Site,larynx
1546,1,1,Tumor Stage,T4a
1546,1,1,Clinical lab p16,p16 unkown
1546,1,1,Occurrence #,1st primary
1546,1,1,Treatment Modality,Sx
1546,1,1,Metastasis,M0
1546,1,1,Nodal Stage,N2
1546,1,1,1st Failure Type,locoregional
1547,1,1,Overall Stage,I
1547,1,1,2nd Failure Type,no known failure
1547,1,1,Clinical lab p16,p16 unkown
1547,1,1,Tumor Stage,T1
1547,1,1,1st Failure Treatment Modality,Sx & RT
1547,1,1,1st Failure Radiation Dosage,unknown
1547,1,1,Nodal Stage,N0
1547,1,1,Research lab p16,p16 unknown
1547,1,1,Tumor Site,larynx
1547,1,1,1st Failure Type,locoregional
1547,1,1,Treatment Modality,RT
1547,1,1,Research lab HPV,HPV unknown
1547,1,1,1st Failure Site,larynx
1547,1,1,Radiation Dosage,63
1547,1,1,Metastasis,M0
1547,1,1,Occurrence #,1st primary
1548,1,1,Tumor Site,larynx
1548,1,1,Occurrence #,1st primary
1548,1,1,Initial Chemotherapy Agent,carbo/PTX
1548,1,1,Research lab HPV,HPV unknown
1548,1,1,1st Failure Type,distant
1548,1,1,Research lab p16,p16 unknown
1548,1,1,Nodal Stage,N0
1548,1,1,Treatment Modality,CTX-RT
1548,1,1,Metastasis,M0
1548,1,1,Clinical lab p16,p16 unkown
1548,1,1,Tumor Stage,T2
1548,1,1,Radiation Dosage,50.4
1548,1,1,Overall Stage,II
1548,1,1,2nd Failure Type,no known failure
1549,1,1,Occurrence #,1st primary
1549,1,1,Radiation Dosage,63
1549,1,1,Tumor Site,larynx
1549,1,1,Research lab p16,p16 unknown
1549,1,1,1st Failure Type,no known failure
1549,1,1,Nodal Stage,N2
1549,1,1,Metastasis,M0
1549,1,1,Clinical lab p16,p16 unkown
1549,1,1,Research lab HPV,HPV unknown
1549,1,1,2nd Failure Type,no known failure
1549,1,1,Overall Stage,IVa
1549,1,1,Tumor Stage,T4a
1549,1,1,Treatment Modality,Sx & RT
1550,1,1,Research lab p16,p16 unknown
1550,1,1,Treatment Modality,Sx
1550,1,1,Clinical lab p16,p16 unkown
1550,1,1,2nd Failure Type,no known failure
1550,1,1,Metastasis,M0
1550,1,1,Tumor Site,larynx
1550,1,1,1st Failure Type,no known failure
1550,1,1,Nodal Stage,N0
1550,1,1,Occurrence #,1st primary
1550,1,1,Overall Stage,III
1550,1,1,Tumor Stage,T3
1550,1,1,Research lab HPV,HPV unknown
1551,1,1,Research lab HPV,HPV unknown
1551,1,1,1st Failure Type,no known failure
1551,1,1,Occurrence #,1st primary
1551,1,1,Tumor Stage,Unknown
1551,1,1,Metastasis,Unknown
1551,1,1,2nd Failure Type,no known failure
1551,1,1,Nodal Stage,Unknown
1551,1,1,Overall Stage,Unknown
1551,1,1,Tumor Site,larynx
1551,1,1,Research lab p16,p16 unknown
1551,1,1,Treatment Modality,Unknown
1551,1,1,Clinical lab p16,p16 unkown
1552,1,1,Nodal Stage,N0
1552,1,1,Treatment Modality,Sx
1552,1,1,Occurrence #,1st primary
1552,1,1,Tumor Stage,T4a
1552,1,1,1st Failure Type,no known failure
1552,1,1,Research lab p16,p16 unknown
1552,1,1,2nd Failure Type,no known failure
1552,1,1,Tumor Site,larynx
1552,1,1,Metastasis,M0
1552,1,1,Clinical lab p16,p16 unkown
1552,1,1,Research lab HPV,HPV unknown
1552,1,1,Overall Stage,IVa
1553,1,1,Occurrence #,1st primary
1553,1,1,Overall Stage,IVa
1553,1,1,1st Failure Type,locoregional
1553,1,1,1st Failure Site,larynx
1553,1,1,2nd Failure Type,no known failure
1553,1,1,Radiation Dosage,72
1553,1,1,Clinical lab p16,p16 unkown
1553,1,1,Research lab p16,p16 unknown
1553,1,1,Nodal Stage,N2
1553,1,1,Tumor Site,larynx
1553,1,1,Tumor Stage,T3
1553,1,1,Treatment Modality,RT
1553,1,1,1st Failure Treatment Modality,Sx
1553,1,1,Research lab HPV,HPV unknown
1553,1,1,Metastasis,M0
1554,1,1,Clinical lab p16,p16 unkown
1554,1,1,Radiation Dosage,unknown
1554,1,1,Initial Chemotherapy Agent,unknown
1554,1,1,Treatment Modality,Sx & CTX-RT
1554,1,1,Metastasis,M0
1554,1,1,Tumor Stage,T2
1554,1,1,1st Failure Type,no known failure
1554,1,1,Research lab p16,p16 unknown
1554,1,1,Tumor Site,larynx
1554,1,1,2nd Failure Type,no known failure
1554,1,1,Nodal Stage,N2
1554,1,1,Research lab HPV,HPV unknown
1554,1,1,Overall Stage,IVa
1554,1,1,Occurrence #,1st primary
1555,1,1,1st Failure Type,no known failure
1555,1,1,Treatment Modality,Unknown
1555,1,1,Overall Stage,IVa
1555,1,1,Tumor Site,larynx
1555,1,1,Research lab p16,p16 unknown
1555,1,1,2nd Failure Type,no known failure
1555,1,1,Clinical lab p16,p16 unkown
1555,1,1,Tumor Stage,T4a
1555,1,1,Nodal Stage,N0
1555,1,1,Metastasis,M0
1555,1,1,Research lab HPV,HPV unknown
1555,1,1,Occurrence #,1st primary
1556,1,1,Tumor Stage,T1
1556,1,1,Research lab p16,p16 unknown
1556,1,1,Occurrence #,1st primary
1556,1,1,Radiation Dosage,66
1556,1,1,Metastasis,M0
1556,1,1,1st Failure Type,no known failure
1556,1,1,Tumor Site,larynx
1556,1,1,Nodal Stage,N0
1556,1,1,Research lab HPV,HPV unknown
1556,1,1,Treatment Modality,RT
1556,1,1,2nd Failure Type,no known failure
1556,1,1,Overall Stage,I
1556,1,1,Clinical lab p16,p16 unkown
1557,1,1,Metastasis,Unknown
1557,1,1,Clinical lab p16,p16 unkown
1557,1,1,Occurrence #,1st primary
1557,1,1,Nodal Stage,Unknown
1557,1,1,Tumor Stage,Unknown
1557,1,1,Treatment Modality,Unknown
1557,1,1,Research lab p16,p16 unknown
1557,1,1,Overall Stage,Unknown
1557,1,1,Tumor Site,larynx
1557,1,1,2nd Failure Type,no known failure
1557,1,1,1st Failure Type,no known failure
1557,1,1,Research lab HPV,HPV unknown
1558,1,1,1st Failure Site,larynx
1558,1,1,Nodal Stage,N2
1558,1,1,Tumor Stage,T3
1558,1,1,Treatment Modality,CTX-RT
1558,1,1,2nd Failure Type,no known failure
1558,1,1,Research lab p16,p16 unknown
1558,1,1,Clinical lab p16,p16 unkown
1558,1,1,1st Failure Type,locoregional and distant
1558,1,1,Initial Chemotherapy Agent,cis
1558,1,1,Overall Stage,IVa
1558,1,1,Radiation Dosage,70.2
1558,1,1,Tumor Site,larynx
1558,1,1,1st Failure Treatment Modality,Sx
1558,1,1,Research lab HPV,HPV unknown
1558,1,1,Occurrence #,1st primary
1558,1,1,Metastasis,M0
1559,1,1,Metastasis,M0
1559,1,1,Tumor Site,larynx
1559,1,1,Treatment Modality,Sx
1559,1,1,Tumor Stage,T4a
1559,1,1,Overall Stage,IVa
1559,1,1,Research lab HPV,HPV unknown
1559,1,1,Occurrence #,1st primary
1559,1,1,1st Failure Type,no known failure
1559,1,1,Clinical lab p16,p16 unkown
1559,1,1,Research lab p16,p16 unknown
1559,1,1,Nodal Stage,N0
1559,1,1,2nd Failure Type,no known failure
1560,1,1,Clinical lab p16,p16 unkown
1560,1,1,Research lab HPV,HPV unknown
1560,1,1,Tumor Site,larynx
1560,1,1,1st Failure Type,locoregional
1560,1,1,2nd Failure Type,no known failure
1560,1,1,Overall Stage,IVa
1560,1,1,Metastasis,M0
1560,1,1,Occurrence #,1st primary
1560,1,1,Radiation Dosage,50
1560,1,1,Nodal Stage,N2
1560,1,1,Research lab p16,p16 unknown
1560,1,1,Treatment Modality,RT
1560,1,1,Tumor Stage,T1
1561,1,1,Clinical lab p16,p16 unkown
1561,1,1,Research lab p16,p16 unknown
1561,1,1,1st Failure Type,no known failure
1561,1,1,Research lab HPV,HPV unknown
1561,1,1,Occurrence #,other primary
1561,1,1,Tumor Site,larynx
1561,1,1,Tumor Stage,T2
1561,1,1,Treatment Modality,Sx
1561,1,1,2nd Failure Type,no known failure
1561,1,1,Metastasis,M0
1561,1,1,Nodal Stage,N0
1561,1,1,Overall Stage,II
1562,1,1,Clinical lab p16,p16 unkown
1562,1,1,Tumor Site,larynx
1562,1,1,1st Failure Type,no known failure
1562,1,1,Research lab p16,p16 unknown
1562,1,1,Research lab HPV,HPV unknown
1562,1,1,Radiation Dosage,70.2
1562,1,1,Treatment Modality,RT
1562,1,1,Metastasis,M0
1562,1,1,Nodal Stage,N1
1562,1,1,2nd Failure Type,no known failure
1562,1,1,Occurrence #,1st primary
1562,1,1,Tumor Stage,T3
1562,1,1,Overall Stage,III
1563,1,1,Treatment Modality,Unknown
1563,1,1,Tumor Stage,T3
1563,1,1,1st Failure Type,no known failure
1563,1,1,Clinical lab p16,p16 unkown
1563,1,1,2nd Failure Type,no known failure
1563,1,1,Research lab p16,p16 unknown
1563,1,1,Occurrence #,1st primary
1563,1,1,Overall Stage,IVa
1563,1,1,Metastasis,M0
1563,1,1,Nodal Stage,N2
1563,1,1,Research lab HPV,HPV unknown
1563,1,1,Tumor Site,larynx
1564,1,1,Metastasis,M0
1564,1,1,Clinical lab p16,p16 unkown
1564,1,1,Treatment Modality,RT
1564,1,1,Radiation Dosage,74.4
1564,1,1,1st Failure Type,no known failure
1564,1,1,2nd Failure Type,no known failure
1564,1,1,Research lab p16,p16 unknown
1564,1,1,Occurrence #,1st primary
1564,1,1,Tumor Stage,T2
1564,1,1,Overall Stage,II
1564,1,1,Tumor Site,larynx
1564,1,1,Research lab HPV,HPV unknown
1564,1,1,Nodal Stage,N0
1565,1,1,Overall Stage,II
1565,1,1,2nd Failure Type,no known failure
1565,1,1,Occurrence #,1st primary
1565,1,1,Nodal Stage,N0
1565,1,1,Research lab HPV,HPV unknown
1565,1,1,Metastasis,M0
1565,1,1,Radiation Dosage,74.4
1565,1,1,1st Failure Type,no known failure
1565,1,1,Clinical lab p16,p16 unkown
1565,1,1,Tumor Stage,T2
1565,1,1,Treatment Modality,RT
1565,1,1,Research lab p16,p16 unknown
1565,1,1,Tumor Site,larynx
1566,1,1,1st Failure Site,larynx
1566,1,1,Research lab HPV,HPV unknown
1566,1,1,Initial Chemotherapy Agent,unknown
1566,1,1,Tumor Stage,T2
1566,1,1,1st Failure Type,locoregional
1566,1,1,Occurrence #,1st primary
1566,1,1,Tumor Site,larynx
1566,1,1,1st Failure Treatment Modality,Sx
1566,1,1,Metastasis,M0
1566,1,1,Nodal Stage,N2
1566,1,1,Radiation Dosage,unknown
1566,1,1,2nd Failure Type,no known failure
1566,1,1,Treatment Modality,Sx & CTX-RT
1566,1,1,Clinical lab p16,p16 unkown
1566,1,1,Overall Stage,IVa
1566,1,1,Research lab p16,p16 unknown
1567,1,1,Research lab p16,p16 unknown
1567,1,1,Treatment Modality,Sx
1567,1,1,Overall Stage,II
1567,1,1,1st Failure Type,no known failure
1567,1,1,Clinical lab p16,p16 unkown
1567,1,1,Tumor Site,larynx
1567,1,1,Metastasis,M0
1567,1,1,Research lab HPV,HPV unknown
1567,1,1,Occurrence #,1st primary
1567,1,1,Nodal Stage,N0
1567,1,1,2nd Failure Type,no known failure
1567,1,1,Tumor Stage,T2
1568,1,1,1st Failure Type,distant
1568,1,1,Nodal Stage,N2
1568,1,1,Research lab HPV,HPV unknown
1568,1,1,Tumor Site,larynx
1568,1,1,2nd Failure Type,no known failure
1568,1,1,Clinical lab p16,p16 unkown
1568,1,1,Metastasis,M0
1568,1,1,Initial Chemotherapy Agent,cis
1568,1,1,Radiation Dosage,70.2
1568,1,1,Tumor Stage,T3
1568,1,1,Occurrence #,1st primary
1568,1,1,Treatment Modality,CTX-RT
1568,1,1,Overall Stage,IVa
1568,1,1,Research lab p16,p16 unknown
1569,1,1,Tumor Stage,T1
1569,1,1,Metastasis,M0
1569,1,1,2nd Failure Type,no known failure
1569,1,1,Nodal Stage,N0
1569,1,1,Tumor Site,larynx
1569,1,1,Clinical lab p16,p16 unkown
1569,1,1,Research lab p16,p16 unknown
1569,1,1,Occurrence #,1st primary
1569,1,1,Treatment Modality,Sx
1569,1,1,Overall Stage,I
1569,1,1,Research lab HPV,HPV unknown
1569,1,1,1st Failure Type,no known failure
1570,1,1,Initial Chemotherapy Agent,cis
1570,1,1,Tumor Site,larynx
1570,1,1,Overall Stage,III
1570,1,1,Treatment Modality,CTX-RT
1570,1,1,Clinical lab p16,p16 unkown
1570,1,1,2nd Failure Type,no known failure
1570,1,1,Occurrence #,1st primary
1570,1,1,Radiation Dosage,72
1570,1,1,Research lab p16,p16 unknown
1570,1,1,Research lab HPV,HPV unknown
1570,1,1,Tumor Stage,T3
1570,1,1,1st Failure Type,no known failure
1570,1,1,Metastasis,M0
1570,1,1,Nodal Stage,N0
1571,1,1,Tumor Stage,T3
1571,1,1,Treatment Modality,CTX-RT
1571,1,1,Clinical lab p16,p16 unkown
1571,1,1,Research lab HPV,HPV unknown
1571,1,1,Initial Chemotherapy Agent,cis
1571,1,1,Nodal Stage,N1
1571,1,1,Occurrence #,1st primary
1571,1,1,Radiation Dosage,70.2
1571,1,1,Research lab p16,p16 unknown
1571,1,1,2nd Failure Type,no known failure
1571,1,1,Tumor Site,larynx
1571,1,1,Metastasis,M0
1571,1,1,1st Failure Type,no known failure
1571,1,1,Overall Stage,III
1572,1,1,Tumor Stage,T3
1572,1,1,Metastasis,M0
1572,1,1,Occurrence #,1st primary
1572,1,1,Treatment Modality,Sx & RT
1572,1,1,Nodal Stage,N2
1572,1,1,Research lab p16,p16 unknown
1572,1,1,Radiation Dosage,63
1572,1,1,2nd Failure Type,no known failure
1572,1,1,Research lab HPV,HPV unknown
1572,1,1,Overall Stage,IVa
1572,1,1,1st Failure Type,no known failure
1572,1,1,Tumor Site,larynx
1572,1,1,Clinical lab p16,p16 unkown
1573,1,1,Nodal Stage,N0
1573,1,1,2nd Failure Type,no known failure
1573,1,1,Occurrence #,1st primary
1573,1,1,1st Failure Type,no known failure
1573,1,1,Research lab HPV,HPV unknown
1573,1,1,Research lab p16,p16 unknown
1573,1,1,Treatment Modality,RT
1573,1,1,Clinical lab p16,p16 unkown
1573,1,1,Radiation Dosage,74.4
1573,1,1,Metastasis,M0
1573,1,1,Tumor Site,larynx
1573,1,1,Tumor Stage,T2
1573,1,1,Overall Stage,II
1574,1,1,Tumor Site,larynx
1574,1,1,Occurrence #,1st primary
1574,1,1,Metastasis,M0
1574,1,1,Tumor Stage,T4a
1574,1,1,Nodal Stage,N0
1574,1,1,1st Failure Type,no known failure
1574,1,1,Initial Chemotherapy Agent,cis
1574,1,1,Research lab HPV,HPV unknown
1574,1,1,Overall Stage,IVa
1574,1,1,Clinical lab p16,p16 unkown
1574,1,1,Treatment Modality,CTX-RT
1574,1,1,Research lab p16,p16 unknown
1574,1,1,Radiation Dosage,70.2
1574,1,1,2nd Failure Type,no known failure
1575,1,1,Overall Stage,II
1575,1,1,1st Failure Site,larynx
1575,1,1,Research lab HPV,HPV unknown
1575,1,1,Metastasis,M0
1575,1,1,Treatment Modality,Sx
1575,1,1,1st Failure Treatment Modality,Sx & CTX-RT
1575,1,1,1st Failure Type,locoregional
1575,1,1,Occurrence #,recurrence
1575,1,1,1st Failure Radiation Dosage,60
1575,1,1,Tumor Stage,T2
1575,1,1,Tumor Site,larynx
1575,1,1,Nodal Stage,N0
1575,1,1,Research lab p16,p16 unknown
1575,1,1,2nd Failure Type,no known failure
1575,1,1,Clinical lab p16,p16 unkown
1575,1,1,1st Failure Initial Chemotherapy Agent,unknown
1576,1,1,Occurrence #,1st primary
1576,1,1,1st Failure Type,no known failure
1576,1,1,Treatment Modality,Sx & CTX-RT
1576,1,1,Initial Chemotherapy Agent,carbo/PTX
1576,1,1,Research lab HPV,HPV unknown
1576,1,1,Tumor Site,larynx
1576,1,1,Tumor Stage,T2
1576,1,1,Nodal Stage,N3
1576,1,1,Overall Stage,IVb
1576,1,1,Clinical lab p16,p16 unkown
1576,1,1,Research lab p16,p16 unknown
1576,1,1,Metastasis,M0
1576,1,1,Radiation Dosage,70.2
1576,1,1,2nd Failure Type,no known failure
1577,1,1,Treatment Modality,RT
1577,1,1,1st Failure Type,no known failure
1577,1,1,Research lab p16,p16 unknown
1577,1,1,Overall Stage,II
1577,1,1,Clinical lab p16,p16 unkown
1577,1,1,Tumor Stage,T2
1577,1,1,Nodal Stage,N0
1577,1,1,Metastasis,M0
1577,1,1,Radiation Dosage,70.2
1577,1,1,Tumor Site,larynx
1577,1,1,2nd Failure Type,no known failure
1577,1,1,Research lab HPV,HPV unknown
1577,1,1,Occurrence #,1st primary
1578,1,1,Research lab HPV,HPV unknown
1578,1,1,Occurrence #,1st primary
1578,1,1,Nodal Stage,N0
1578,1,1,2nd Failure Type,no known failure
1578,1,1,Tumor Stage,T1
1578,1,1,1st Failure Type,no known failure
1578,1,1,Treatment Modality,RT
1578,1,1,Radiation Dosage,63
1578,1,1,Research lab p16,p16 unknown
1578,1,1,Overall Stage,I
1578,1,1,Tumor Site,larynx
1578,1,1,Metastasis,M0
1578,1,1,Clinical lab p16,p16 unkown
1579,1,1,Radiation Dosage,70.2
1579,1,1,2nd Failure Type,no known failure
1579,1,1,Clinical lab p16,p16 unkown
1579,1,1,Tumor Site,larynx
1579,1,1,Occurrence #,1st primary
1579,1,1,Nodal Stage,N1
1579,1,1,Metastasis,M0
1579,1,1,Tumor Stage,T3
1579,1,1,Treatment Modality,CTX-RT
1579,1,1,Overall Stage,III
1579,1,1,Research lab p16,p16 unknown
1579,1,1,Initial Chemotherapy Agent,unknown
1579,1,1,Research lab HPV,HPV unknown
1579,1,1,1st Failure Type,no known failure
1580,1,1,Occurrence #,1st primary
1580,1,1,Research lab HPV,HPV unknown
1580,1,1,Overall Stage,IVa
1580,1,1,Metastasis,M0
1580,1,1,Clinical lab p16,p16 unkown
1580,1,1,Tumor Stage,T2
1580,1,1,Research lab p16,p16 unknown
1580,1,1,Nodal Stage,N2
1580,1,1,2nd Failure Type,no known failure
1580,1,1,Tumor Site,larynx
1580,1,1,Radiation Dosage,70.2
1580,1,1,1st Failure Type,distant
1580,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1580,1,1,Treatment Modality,CTX-RT
1581,1,1,Treatment Modality,RT
1581,1,1,1st Failure Treatment Modality,Sx
1581,1,1,Clinical lab p16,p16 unkown
1581,1,1,Radiation Dosage,unknown
1581,1,1,2nd Failure Type,no known failure
1581,1,1,Research lab p16,p16 unknown
1581,1,1,Nodal Stage,N0
1581,1,1,1st Failure Type,locoregional
1581,1,1,Research lab HPV,HPV unknown
1581,1,1,Tumor Stage,T1
1581,1,1,Tumor Site,larynx
1581,1,1,1st Failure Site,larynx
1581,1,1,Overall Stage,I
1581,1,1,Metastasis,M0
1581,1,1,Occurrence #,other primary
1582,1,1,Research lab HPV,HPV unknown
1582,1,1,Occurrence #,1st primary
1582,1,1,Nodal Stage,N0
1582,1,1,Research lab p16,p16 unknown
1582,1,1,Treatment Modality,RT
1582,1,1,Radiation Dosage,66
1582,1,1,1st Failure Type,no known failure
1582,1,1,Tumor Stage,T1
1582,1,1,Overall Stage,I
1582,1,1,Clinical lab p16,p16 unkown
1582,1,1,2nd Failure Type,no known failure
1582,1,1,Tumor Site,larynx
1582,1,1,Metastasis,M0
1583,1,1,Tumor Site,larynx
1583,1,1,Overall Stage,III
1583,1,1,Nodal Stage,N0
1583,1,1,Research lab p16,p16 unknown
1583,1,1,Radiation Dosage,70.2
1583,1,1,2nd Failure Type,no known failure
1583,1,1,Clinical lab p16,p16 unkown
1583,1,1,Tumor Stage,T3
1583,1,1,Metastasis,M0
1583,1,1,Occurrence #,1st primary
1583,1,1,Treatment Modality,RT
1583,1,1,Research lab HPV,HPV unknown
1583,1,1,1st Failure Type,no known failure
1584,1,1,Treatment Modality,CTX-RT
1584,1,1,Overall Stage,IVb
1584,1,1,Radiation Dosage,70.2
1584,1,1,Metastasis,M0
1584,1,1,2nd Failure Type,no known failure
1584,1,1,Tumor Stage,T1
1584,1,1,1st Failure Type,no known failure
1584,1,1,Occurrence #,1st primary
1584,1,1,Research lab HPV,HPV unknown
1584,1,1,Initial Chemotherapy Agent,carbo/PTX/5-FU
1584,1,1,Nodal Stage,N3
1584,1,1,Research lab p16,p16 unknown
1584,1,1,Tumor Site,larynx
1584,1,1,Clinical lab p16,p16 unkown
1585,1,1,Tumor Site,larynx
1585,1,1,Metastasis,M1
1585,1,1,Research lab p16,p16 unknown
1585,1,1,Tumor Stage,T4a
1585,1,1,2nd Failure Type,no known failure
1585,1,1,Clinical lab p16,p16 unkown
1585,1,1,Overall Stage,IVc
1585,1,1,Occurrence #,1st primary
1585,1,1,Initial Chemotherapy Agent,gemcetabine/PTX/cap
1585,1,1,1st Failure Type,no known failure
1585,1,1,Treatment Modality,Sx & CTX
1585,1,1,Research lab HPV,HPV unknown
1585,1,1,Nodal Stage,N0
1586,1,1,Research lab HPV,HPV unknown
1586,1,1,Clinical lab p16,p16 unkown
1586,1,1,Tumor Site,larynx
1586,1,1,1st Failure Type,no known failure
1586,1,1,Tumor Stage,T4a
1586,1,1,Occurrence #,1st primary
1586,1,1,Nodal Stage,N0
1586,1,1,Research lab p16,p16 unknown
1586,1,1,2nd Failure Type,no known failure
1586,1,1,Metastasis,M0
1586,1,1,Treatment Modality,Sx
1586,1,1,Overall Stage,IVa
1587,1,1,Occurrence #,1st primary
1587,1,1,Nodal Stage,N2
1587,1,1,Treatment Modality,CTX-RT
1587,1,1,Radiation Dosage,70.2
1587,1,1,Metastasis,M0
1587,1,1,Tumor Site,larynx
1587,1,1,Research lab HPV,HPV unknown
1587,1,1,Initial Chemotherapy Agent,carbo/PTX
1587,1,1,Clinical lab p16,p16 unkown
1587,1,1,1st Failure Type,locoregional
1587,1,1,Research lab p16,p16 unknown
1587,1,1,2nd Failure Type,no known failure
1587,1,1,Overall Stage,IVa
1587,1,1,Tumor Stage,T4a
1588,1,1,1st Failure Type,no known failure
1588,1,1,Research lab p16,p16 unknown
1588,1,1,Radiation Dosage,63
1588,1,1,Treatment Modality,RT
1588,1,1,Metastasis,M0
1588,1,1,Occurrence #,1st primary
1588,1,1,2nd Failure Type,no known failure
1588,1,1,Tumor Stage,T1
1588,1,1,Nodal Stage,N0
1588,1,1,Research lab HPV,HPV unknown
1588,1,1,Clinical lab p16,p16 unkown
1588,1,1,Overall Stage,I
1588,1,1,Tumor Site,larynx
1589,1,1,Research lab p16,p16 unknown
1589,1,1,Overall Stage,Unknown
1589,1,1,Research lab HPV,HPV unknown
1589,1,1,Tumor Stage,Unknown
1589,1,1,Tumor Site,larynx
1589,1,1,2nd Failure Type,no known failure
1589,1,1,Treatment Modality,Unknown
1589,1,1,Metastasis,Unknown
1589,1,1,1st Failure Type,no known failure
1589,1,1,Occurrence #,1st primary
1589,1,1,Nodal Stage,Unknown
1589,1,1,Clinical lab p16,p16 unkown
1590,1,1,2nd Failure Type,no known failure
1590,1,1,Radiation Dosage,unknown
1590,1,1,Overall Stage,IVa
1590,1,1,Occurrence #,1st primary
1590,1,1,Metastasis,M0
1590,1,1,Research lab HPV,HPV unknown
1590,1,1,Research lab p16,p16 unknown
1590,1,1,Clinical lab p16,p16 unkown
1590,1,1,Treatment Modality,Sx & RT
1590,1,1,Tumor Stage,T4a
1590,1,1,Nodal Stage,N0
1590,1,1,1st Failure Type,no known failure
1590,1,1,Tumor Site,larynx
1591,1,1,Occurrence #,1st primary
1591,1,1,1st Failure Type,no known failure
1591,1,1,Tumor Stage,T1
1591,1,1,Overall Stage,I
1591,1,1,Research lab HPV,HPV unknown
1591,1,1,Treatment Modality,RT
1591,1,1,Tumor Site,larynx
1591,1,1,Clinical lab p16,p16 unkown
1591,1,1,Metastasis,M0
1591,1,1,Research lab p16,p16 unknown
1591,1,1,Radiation Dosage,63
1591,1,1,Nodal Stage,N0
1591,1,1,2nd Failure Type,no known failure
1592,1,1,Research lab HPV,HPV unknown
1592,1,1,Treatment Modality,Sx
1592,1,1,Nodal Stage,N0
1592,1,1,Tumor Stage,T1
1592,1,1,Tumor Site,larynx
1592,1,1,Research lab p16,p16 unknown
1592,1,1,Occurrence #,1st primary
1592,1,1,2nd Failure Type,no known failure
1592,1,1,1st Failure Type,no known failure
1592,1,1,Metastasis,M0
1592,1,1,Clinical lab p16,p16 unkown
1592,1,1,Overall Stage,I
1593,1,1,Metastasis,M0
1593,1,1,Treatment Modality,Sx
1593,1,1,Nodal Stage,N0
1593,1,1,Clinical lab p16,p16 unkown
1593,1,1,2nd Failure Type,no known failure
1593,1,1,1st Failure Type,no known failure
1593,1,1,Research lab p16,p16 unknown
1593,1,1,Tumor Site,larynx
1593,1,1,Overall Stage,I
1593,1,1,Occurrence #,1st primary
1593,1,1,Research lab HPV,HPV unknown
1593,1,1,Tumor Stage,T1
1594,1,1,Nodal Stage,N0
1594,1,1,2nd Failure Type,no known failure
1594,1,1,Overall Stage,III
1594,1,1,Treatment Modality,CTX-RT
1594,1,1,1st Failure Type,no known failure
1594,1,1,Radiation Dosage,70.2
1594,1,1,Research lab HPV,HPV unknown
1594,1,1,Clinical lab p16,p16 unkown
1594,1,1,Research lab p16,p16 unknown
1594,1,1,Initial Chemotherapy Agent,cis
1594,1,1,Occurrence #,1st primary
1594,1,1,Tumor Stage,T3
1594,1,1,Tumor Site,larynx
1594,1,1,Metastasis,M0
1595,1,1,Tumor Site,larynx
1595,1,1,Overall Stage,IVa
1595,1,1,Radiation Dosage,43.2
1595,1,1,Occurrence #,1st primary
1595,1,1,Tumor Stage,T4a
1595,1,1,1st Failure Type,no known failure
1595,1,1,Research lab p16,p16 unknown
1595,1,1,Research lab HPV,HPV unknown
1595,1,1,2nd Failure Type,no known failure
1595,1,1,Metastasis,M0
1595,1,1,Clinical lab p16,p16 unkown
1595,1,1,Treatment Modality,RT
1595,1,1,Nodal Stage,N0
1596,1,1,Initial Chemotherapy Agent,carbo/PTX/amifostine
1596,1,1,Clinical lab p16,p16 unkown
1596,1,1,Research lab HPV,HPV unknown
1596,1,1,2nd Failure Type,no known failure
1596,1,1,Tumor Stage,T4a
1596,1,1,Nodal Stage,N2
1596,1,1,1st Failure Type,distant
1596,1,1,Radiation Dosage,48.6
1596,1,1,Treatment Modality,Sx & CTX-RT
1596,1,1,Overall Stage,IVa
1596,1,1,Occurrence #,1st primary
1596,1,1,Research lab p16,p16 unknown
1596,1,1,Metastasis,M0
1596,1,1,Tumor Site,larynx
1597,1,1,Tumor Stage,T1
1597,1,1,2nd Failure Type,no known failure
1597,1,1,Metastasis,M0
1597,1,1,1st Failure Type,locoregional
1597,1,1,1st Failure Treatment Modality,Sx & RT
1597,1,1,Research lab HPV,HPV unknown
1597,1,1,Tumor Site,larynx
1597,1,1,1st Failure Site,larynx
1597,1,1,Clinical lab p16,p16 unkown
1597,1,1,1st Failure Radiation Dosage,69.6
1597,1,1,Overall Stage,I
1597,1,1,Nodal Stage,N0
1597,1,1,Occurrence #,1st primary
1597,1,1,Research lab p16,p16 unknown
1597,1,1,Treatment Modality,Sx
1598,1,1,Tumor Site,larynx
1598,1,1,Occurrence #,1st primary
1598,1,1,Nodal Stage,N0
1598,1,1,Metastasis,M0
1598,1,1,Research lab HPV,HPV unknown
1598,1,1,Clinical lab p16,p16 unkown
1598,1,1,Research lab p16,p16 unknown
1598,1,1,2nd Failure Type,no known failure
1598,1,1,Overall Stage,I
1598,1,1,Tumor Stage,T1
1598,1,1,1st Failure Type,no known failure
1598,1,1,Treatment Modality,Sx
1599,1,1,Treatment Modality,RT
1599,1,1,Clinical lab p16,p16 unkown
1599,1,1,Radiation Dosage,unknown
1599,1,1,Nodal Stage,N0
1599,1,1,Metastasis,M0
1599,1,1,Tumor Site,larynx
1599,1,1,Research lab p16,p16 unknown
1599,1,1,1st Failure Site,larynx
1599,1,1,Tumor Stage,T3
1599,1,1,Overall Stage,III
1599,1,1,1st Failure Treatment Modality,Sx
1599,1,1,2nd Failure Type,no known failure
1599,1,1,1st Failure Type,locoregional
1599,1,1,Occurrence #,1st primary
1599,1,1,Research lab HPV,HPV unknown
1600,1,1,1st Failure Type,no known failure
1600,1,1,Overall Stage,II
1600,1,1,Treatment Modality,RT
1600,1,1,Radiation Dosage,41.4
1600,1,1,2nd Failure Type,no known failure
1600,1,1,Clinical lab p16,p16 unkown
1600,1,1,Metastasis,M0
1600,1,1,Research lab HPV,HPV unknown
1600,1,1,Tumor Stage,T2
1600,1,1,Research lab p16,p16 unknown
1600,1,1,Occurrence #,1st primary
1600,1,1,Tumor Site,larynx
1600,1,1,Nodal Stage,N0
1601,1,1,Metastasis,M0
1601,1,1,2nd Failure Type,no known failure
1601,1,1,Research lab HPV,HPV unknown
1601,1,1,1st Failure Type,no known failure
1601,1,1,Research lab p16,p16 unknown
1601,1,1,Occurrence #,1st primary
1601,1,1,Clinical lab p16,p16 unkown
1601,1,1,Overall Stage,IVa
1601,1,1,Tumor Site,larynx
1601,1,1,Nodal Stage,N2
1601,1,1,Tumor Stage,T2
1601,1,1,Treatment Modality,Sx
1602,1,1,1st Failure Type,no known failure
1602,1,1,Overall Stage,IVa
1602,1,1,Metastasis,M0
1602,1,1,Treatment Modality,Sx
1602,1,1,Research lab p16,p16 unknown
1602,1,1,Research lab HPV,HPV unknown
1602,1,1,Occurrence #,1st primary
1602,1,1,Tumor Site,larynx
1602,1,1,Tumor Stage,T4a
1602,1,1,Nodal Stage,N0
1602,1,1,Clinical lab p16,p16 unkown
1602,1,1,2nd Failure Type,no known failure
1603,1,1,Treatment Modality,CTX-RT
1603,1,1,1st Failure Type,no known failure
1603,1,1,Clinical lab p16,p16 unkown
1603,1,1,Nodal Stage,N2
1603,1,1,Tumor Stage,T3
1603,1,1,2nd Failure Type,no known failure
1603,1,1,Tumor Site,larynx
1603,1,1,Research lab p16,p16 unknown
1603,1,1,Metastasis,M0
1603,1,1,Radiation Dosage,70.2
1603,1,1,Second Line Chemotherapy Agent,carbo/doce
1603,1,1,Overall Stage,IVa
1603,1,1,Occurrence #,1st primary
1603,1,1,Research lab HPV,HPV unknown
1603,1,1,Initial Chemotherapy Agent,cis
1604,1,1,Nodal Stage,N1
1604,1,1,Clinical lab p16,p16 unkown
1604,1,1,Initial Chemotherapy Agent,unknown
1604,1,1,Tumor Stage,T2
1604,1,1,Research lab p16,p16 unknown
1604,1,1,Research lab HPV,HPV unknown
1604,1,1,2nd Failure Type,no known failure
1604,1,1,Tumor Site,larynx
1604,1,1,Overall Stage,III
1604,1,1,Occurrence #,1st primary
1604,1,1,Treatment Modality,CTX-RT
1604,1,1,Radiation Dosage,unknown
1604,1,1,Metastasis,M0
1604,1,1,1st Failure Type,no known failure
1605,1,1,Metastasis,M0
1605,1,1,Tumor Stage,T3
1605,1,1,Nodal Stage,N0
1605,1,1,Treatment Modality,Sx
1605,1,1,Overall Stage,III
1605,1,1,Tumor Site,larynx
1605,1,1,1st Failure Type,no known failure
1605,1,1,Research lab p16,p16 unknown
1605,1,1,Research lab HPV,HPV unknown
1605,1,1,2nd Failure Type,no known failure
1605,1,1,Clinical lab p16,p16 unkown
1605,1,1,Occurrence #,recurrence
1606,1,1,Overall Stage,IVa
1606,1,1,Occurrence #,1st primary
1606,1,1,Tumor Site,larynx
1606,1,1,Research lab HPV,HPV unknown
1606,1,1,Nodal Stage,N2
1606,1,1,Metastasis,M0
1606,1,1,Initial Chemotherapy Agent,unknown
1606,1,1,Research lab p16,p16 unknown
1606,1,1,1st Failure Type,no known failure
1606,1,1,Treatment Modality,CTX-RT
1606,1,1,Radiation Dosage,70.2
1606,1,1,Clinical lab p16,p16 unkown
1606,1,1,Tumor Stage,T3
1606,1,1,2nd Failure Type,no known failure
1607,1,1,Occurrence #,1st primary
1607,1,1,Radiation Dosage,63
1607,1,1,2nd Failure Type,no known failure
1607,1,1,Nodal Stage,N2
1607,1,1,Clinical lab p16,p16 unkown
1607,1,1,Treatment Modality,Sx & RT
1607,1,1,Tumor Site,larynx
1607,1,1,Research lab HPV,HPV unknown
1607,1,1,Metastasis,M0
1607,1,1,Tumor Stage,T4a
1607,1,1,Overall Stage,IVa
1607,1,1,1st Failure Type,no known failure
1607,1,1,Research lab p16,p16 unknown
1608,1,1,2nd Failure Type,no known failure
1608,1,1,Treatment Modality,RT
1608,1,1,Research lab HPV,HPV unknown
1608,1,1,1st Failure Type,no known failure
1608,1,1,Tumor Stage,T1
1608,1,1,Metastasis,M0
1608,1,1,Nodal Stage,N0
1608,1,1,Radiation Dosage,63
1608,1,1,Occurrence #,1st primary
1608,1,1,Overall Stage,I
1608,1,1,Research lab p16,p16 unknown
1608,1,1,Clinical lab p16,p16 unkown
1608,1,1,Tumor Site,larynx
1609,1,1,1st Failure Type,no known failure
1609,1,1,2nd Failure Type,no known failure
1609,1,1,Research lab HPV,HPV unknown
1609,1,1,Nodal Stage,N0
1609,1,1,Metastasis,M0
1609,1,1,Clinical lab p16,p16 unkown
1609,1,1,Tumor Site,larynx
1609,1,1,Occurrence #,1st primary
1609,1,1,Overall Stage,IVa
1609,1,1,Research lab p16,p16 unknown
1609,1,1,Tumor Stage,T4a
1609,1,1,Treatment Modality,Sx
1610,1,1,Overall Stage,III
1610,1,1,Nodal Stage,N0
1610,1,1,Occurrence #,1st primary
1610,1,1,Clinical lab p16,p16 unkown
1610,1,1,1st Failure Type,no known failure
1610,1,1,Radiation Dosage,unknown
1610,1,1,Tumor Site,larynx
1610,1,1,Tumor Stage,T3
1610,1,1,2nd Failure Type,no known failure
1610,1,1,Research lab p16,p16 unknown
1610,1,1,Research lab HPV,HPV unknown
1610,1,1,Metastasis,M0
1610,1,1,Treatment Modality,RT
1611,1,1,Overall Stage,I
1611,1,1,Radiation Dosage,63
1611,1,1,Clinical lab p16,p16 unkown
1611,1,1,Tumor Site,larynx
1611,1,1,Research lab p16,p16 unknown
1611,1,1,Nodal Stage,N0
1611,1,1,Metastasis,M0
1611,1,1,Treatment Modality,RT
1611,1,1,1st Failure Type,no known failure
1611,1,1,Tumor Stage,T1
1611,1,1,Occurrence #,1st primary
1611,1,1,2nd Failure Type,no known failure
1611,1,1,Research lab HPV,HPV unknown
1612,1,1,Occurrence #,recurrence
1612,1,1,Tumor Stage,T1
1612,1,1,1st Failure Type,no known failure
1612,1,1,Metastasis,M0
1612,1,1,Nodal Stage,N0
1612,1,1,Overall Stage,I
1612,1,1,Clinical lab p16,p16 unkown
1612,1,1,Research lab p16,p16 unknown
1612,1,1,Treatment Modality,Sx
1612,1,1,Tumor Site,larynx
1612,1,1,2nd Failure Type,no known failure
1612,1,1,Research lab HPV,HPV unknown
1613,1,1,Tumor Site,larynx
1613,1,1,Tumor Stage,T4a
1613,1,1,Occurrence #,1st primary
1613,1,1,2nd Failure Type,no known failure
1613,1,1,Clinical lab p16,p16 unkown
1613,1,1,Research lab p16,p16 unknown
1613,1,1,Metastasis,M0
1613,1,1,1st Failure Type,no known failure
1613,1,1,Research lab HPV,HPV unknown
1613,1,1,Treatment Modality,Sx
1613,1,1,Overall Stage,IVa
1613,1,1,Nodal Stage,N1
1614,1,1,Overall Stage,IVa
1614,1,1,Tumor Site,larynx
1614,1,1,Research lab HPV,HPV unknown
1614,1,1,Treatment Modality,Sx & RT
1614,1,1,Clinical lab p16,p16 unkown
1614,1,1,Metastasis,M0
1614,1,1,Research lab p16,p16 unknown
1614,1,1,Occurrence #,1st primary
1614,1,1,2nd Failure Type,no known failure
1614,1,1,1st Failure Type,locoregional
1614,1,1,Radiation Dosage,52.4
1614,1,1,Tumor Stage,T2
1614,1,1,Nodal Stage,N2
1615,1,1,Nodal Stage,N0
1615,1,1,Treatment Modality,Unknown
1615,1,1,Tumor Site,larynx
1615,1,1,Metastasis,M0
1615,1,1,Tumor Stage,T3
1615,1,1,Clinical lab p16,p16 unkown
1615,1,1,Overall Stage,III
1615,1,1,1st Failure Type,no known failure
1615,1,1,Research lab HPV,HPV unknown
1615,1,1,2nd Failure Type,no known failure
1615,1,1,Research lab p16,p16 unknown
1615,1,1,Occurrence #,1st primary
1616,1,1,Research lab p16,p16 unknown
1616,1,1,Clinical lab p16,p16 unkown
1616,1,1,Tumor Site,larynx
1616,1,1,1st Failure Type,no known failure
1616,1,1,2nd Failure Type,no known failure
1616,1,1,Nodal Stage,N0
1616,1,1,Occurrence #,1st primary
1616,1,1,Treatment Modality,Unknown
1616,1,1,Research lab HPV,HPV unknown
1616,1,1,Overall Stage,III
1616,1,1,Metastasis,M0
1616,1,1,Tumor Stage,T3
1617,1,1,Research lab p16,p16 unknown
1617,1,1,Tumor Stage,T4a
1617,1,1,Occurrence #,recurrence
1617,1,1,2nd Failure Type,no known failure
1617,1,1,1st Failure Type,no known failure
1617,1,1,Nodal Stage,N0
1617,1,1,Tumor Site,larynx
1617,1,1,Overall Stage,IVa
1617,1,1,Metastasis,M0
1617,1,1,Research lab HPV,HPV unknown
1617,1,1,Treatment Modality,Sx
1617,1,1,Clinical lab p16,p16 unkown
1618,1,1,Nodal Stage,N0
1618,1,1,Research lab HPV,HPV unknown
1618,1,1,Occurrence #,1st primary
1618,1,1,Treatment Modality,Unknown
1618,1,1,Tumor Stage,T4a
1618,1,1,2nd Failure Type,no known failure
1618,1,1,Tumor Site,larynx
1618,1,1,Metastasis,M0
1618,1,1,Clinical lab p16,p16 unkown
1618,1,1,Overall Stage,IVa
1618,1,1,Research lab p16,p16 unknown
1618,1,1,1st Failure Type,no known failure
1619,1,1,Research lab p16,p16 unknown
1619,1,1,Research lab HPV,HPV unknown
1619,1,1,1st Failure Type,distant
1619,1,1,Treatment Modality,Sx & RT
1619,1,1,Tumor Site,larynx
1619,1,1,Overall Stage,IVa
1619,1,1,Clinical lab p16,p16 unkown
1619,1,1,Nodal Stage,N2
1619,1,1,Tumor Stage,T4a
1619,1,1,Radiation Dosage,unknown
1619,1,1,Occurrence #,1st primary
1619,1,1,2nd Failure Type,no known failure
1619,1,1,Metastasis,M0
1620,1,1,Occurrence #,1st primary
1620,1,1,2nd Failure Type,no known failure
1620,1,1,Nodal Stage,N0
1620,1,1,Overall Stage,I
1620,1,1,Metastasis,M0
1620,1,1,Tumor Stage,T1
1620,1,1,Research lab HPV,HPV unknown
1620,1,1,Tumor Site,larynx
1620,1,1,Radiation Dosage,66
1620,1,1,Treatment Modality,RT
1620,1,1,1st Failure Type,no known failure
1620,1,1,Clinical lab p16,p16 unkown
1620,1,1,Research lab p16,p16 unknown
1621,1,1,Research lab HPV,HPV unknown
1621,1,1,Nodal Stage,N0
1621,1,1,Tumor Site,larynx
1621,1,1,Tumor Stage,T3
1621,1,1,Radiation Dosage,70.2
1621,1,1,Treatment Modality,RT
1621,1,1,Metastasis,M0
1621,1,1,2nd Failure Type,no known failure
1621,1,1,Occurrence #,1st primary
1621,1,1,Research lab p16,p16 unknown
1621,1,1,Clinical lab p16,p16 unkown
1621,1,1,1st Failure Type,no known failure
1621,1,1,Overall Stage,III
1622,1,1,Research lab p16,p16 unknown
1622,1,1,Treatment Modality,Sx & RT
1622,1,1,Clinical lab p16,p16 unkown
1622,1,1,Radiation Dosage,59.4
1622,1,1,1st Failure Type,no known failure
1622,1,1,2nd Failure Type,no known failure
1622,1,1,Metastasis,M0
1622,1,1,Overall Stage,IVa
1622,1,1,Nodal Stage,N0
1622,1,1,Occurrence #,1st primary
1622,1,1,Tumor Stage,T4a
1622,1,1,Research lab HPV,HPV unknown
1622,1,1,Tumor Site,larynx
1623,1,1,1st Failure Type,locoregional
1623,1,1,Tumor Stage,T4a
1623,1,1,Research lab p16,p16 unknown
1623,1,1,2nd Failure Type,no known failure
1623,1,1,Overall Stage,IVa
1623,1,1,Nodal Stage,N1
1623,1,1,Occurrence #,1st primary
1623,1,1,Research lab HPV,HPV unknown
1623,1,1,Metastasis,M0
1623,1,1,Radiation Dosage,unknown
1623,1,1,Treatment Modality,Sx & RT
1623,1,1,Clinical lab p16,p16 unkown
1623,1,1,Tumor Site,larynx
1624,1,1,Tumor Stage,T2
1624,1,1,Clinical lab p16,p16 unkown
1624,1,1,1st Failure Type,no known failure
1624,1,1,Nodal Stage,N0
1624,1,1,Occurrence #,1st primary
1624,1,1,Overall Stage,II
1624,1,1,2nd Failure Type,no known failure
1624,1,1,Research lab HPV,HPV unknown
1624,1,1,Tumor Site,larynx
1624,1,1,Metastasis,M0
1624,1,1,Research lab p16,p16 unknown
1624,1,1,Treatment Modality,Sx
1625,1,1,Research lab p16,p16 unknown
1625,1,1,2nd Failure Type,no known failure
1625,1,1,Treatment Modality,Sx
1625,1,1,Clinical lab p16,p16 unkown
1625,1,1,Tumor Stage,T1
1625,1,1,Nodal Stage,N0
1625,1,1,Occurrence #,recurrence
1625,1,1,Research lab HPV,HPV unknown
1625,1,1,Metastasis,M0
1625,1,1,Overall Stage,I
1625,1,1,Tumor Site,larynx
1625,1,1,1st Failure Type,no known failure
1626,1,1,1st Failure Type,locoregional
1626,1,1,Nodal Stage,N1
1626,1,1,2nd Failure Type,no known failure
1626,1,1,Occurrence #,1st primary
1626,1,1,Tumor Site,larynx
1626,1,1,Initial Chemotherapy Agent,carbo/PTX
1626,1,1,Research lab HPV,HPV unknown
1626,1,1,Clinical lab p16,p16 unkown
1626,1,1,Overall Stage,IVa
1626,1,1,Radiation Dosage,70.2
1626,1,1,Tumor Stage,T4a
1626,1,1,Research lab p16,p16 unknown
1626,1,1,Metastasis,M0
1626,1,1,Treatment Modality,CTX-RT
1627,1,1,Research lab p16,p16 unknown
1627,1,1,Treatment Modality,Sx & CTX-RT
1627,1,1,Tumor Site,larynx
1627,1,1,1st Failure Type,no known failure
1627,1,1,Tumor Stage,T4a
1627,1,1,Clinical lab p16,p16 unkown
1627,1,1,Metastasis,M0
1627,1,1,Nodal Stage,N2
1627,1,1,Occurrence #,1st primary
1627,1,1,2nd Failure Type,no known failure
1627,1,1,Overall Stage,IVa
1627,1,1,Initial Chemotherapy Agent,cis
1627,1,1,Radiation Dosage,59.4
1627,1,1,Research lab HPV,HPV unknown
1628,1,1,Tumor Site,larynx
1628,1,1,1st Failure Type,locoregional
1628,1,1,Radiation Dosage,63
1628,1,1,Nodal Stage,N0
1628,1,1,1st Failure Site,larynx
1628,1,1,Clinical lab p16,p16 unkown
1628,1,1,Metastasis,M0
1628,1,1,Occurrence #,1st primary
1628,1,1,Research lab HPV,HPV unknown
1628,1,1,Research lab p16,p16 unknown
1628,1,1,2nd Failure Type,no known failure
1628,1,1,1st Failure Treatment Modality,Sx
1628,1,1,Treatment Modality,RT
1628,1,1,Overall Stage,I
1628,1,1,Tumor Stage,T1
1629,1,1,Overall Stage,II
1629,1,1,Clinical lab p16,p16 unkown
1629,1,1,Radiation Dosage,74.4
1629,1,1,Occurrence #,1st primary
1629,1,1,Research lab HPV,HPV unknown
1629,1,1,Tumor Site,larynx
1629,1,1,Nodal Stage,N0
1629,1,1,1st Failure Type,no known failure
1629,1,1,Metastasis,M0
1629,1,1,Research lab p16,p16 unknown
1629,1,1,Tumor Stage,T2
1629,1,1,2nd Failure Type,no known failure
1629,1,1,Treatment Modality,RT
1630,1,1,Research lab HPV,HPV unknown
1630,1,1,Treatment Modality,Sx & RT
1630,1,1,Metastasis,M0
1630,1,1,Radiation Dosage,59.4
1630,1,1,Tumor Stage,T3
1630,1,1,Clinical lab p16,p16 unkown
1630,1,1,Research lab p16,p16 unknown
1630,1,1,Tumor Site,larynx
1630,1,1,1st Failure Type,no known failure
1630,1,1,Occurrence #,1st primary
1630,1,1,2nd Failure Type,no known failure
1630,1,1,Nodal Stage,N0
1630,1,1,Overall Stage,III
1631,1,1,Treatment Modality,Sx
1631,1,1,Research lab p16,p16 unknown
1631,1,1,2nd Failure Type,no known failure
1631,1,1,Tumor Site,larynx
1631,1,1,Nodal Stage,N0
1631,1,1,Research lab HPV,HPV unknown
1631,1,1,Occurrence #,recurrence
1631,1,1,Tumor Stage,T4a
1631,1,1,Clinical lab p16,p16 unkown
1631,1,1,1st Failure Type,locoregional
1631,1,1,Overall Stage,IVa
1631,1,1,Metastasis,M0
1632,1,1,Treatment Modality,Sx & RT
1632,1,1,Tumor Stage,T3
1632,1,1,Metastasis,M0
1632,1,1,2nd Failure Type,no known failure
1632,1,1,Overall Stage,III
1632,1,1,Occurrence #,1st primary
1632,1,1,1st Failure Type,no known failure
1632,1,1,Radiation Dosage,66.6
1632,1,1,Research lab HPV,HPV unknown
1632,1,1,Clinical lab p16,p16 unkown
1632,1,1,Research lab p16,p16 unknown
1632,1,1,Tumor Site,larynx
1632,1,1,Nodal Stage,N0
1633,1,1,1st Failure Type,no known failure
1633,1,1,Occurrence #,1st primary
1633,1,1,Overall Stage,Unknown
1633,1,1,2nd Failure Type,no known failure
1633,1,1,Research lab p16,p16 unknown
1633,1,1,Tumor Site,larynx
1633,1,1,Clinical lab p16,p16 unkown
1633,1,1,Research lab HPV,HPV unknown
1633,1,1,Tumor Stage,Unknown
1633,1,1,Metastasis,Unknown
1633,1,1,Nodal Stage,Unknown
1633,1,1,Treatment Modality,Unknown
1634,1,1,Nodal Stage,N0
1634,1,1,Clinical lab p16,p16 unkown
1634,1,1,Overall Stage,III
1634,1,1,2nd Failure Type,no known failure
1634,1,1,Treatment Modality,CTX-RT
1634,1,1,Occurrence #,1st primary
1634,1,1,Research lab HPV,HPV unknown
1634,1,1,Tumor Stage,T3
1634,1,1,Tumor Site,larynx
1634,1,1,Radiation Dosage,70.2
1634,1,1,Initial Chemotherapy Agent,cis
1634,1,1,Research lab p16,p16 unknown
1634,1,1,1st Failure Type,no known failure
1634,1,1,Metastasis,M0
1635,1,1,Treatment Modality,Sx & RT
1635,1,1,1st Failure Site,larynx
1635,1,1,Occurrence #,1st primary
1635,1,1,1st Failure Treatment Modality,Sx & RT
1635,1,1,Nodal Stage,N0
1635,1,1,Research lab p16,p16 unknown
1635,1,1,Tumor Stage,T3
1635,1,1,1st Failure Type,locoregional
1635,1,1,Clinical lab p16,p16 unkown
1635,1,1,Overall Stage,III
1635,1,1,2nd Failure Type,no known failure
1635,1,1,Radiation Dosage,70.2
1635,1,1,Tumor Site,larynx
1635,1,1,Metastasis,M0
1635,1,1,Research lab HPV,HPV unknown
1635,1,1,1st Failure Radiation Dosage,unknown
1636,1,1,1st Failure Treatment Modality,CTX
1636,1,1,1st Failure Site,larynx
1636,1,1,Nodal Stage,N0
1636,1,1,Tumor Site,larynx
1636,1,1,Research lab HPV,HPV unknown
1636,1,1,1st Failure Type,locoregional
1636,1,1,Radiation Dosage,70.2
1636,1,1,Tumor Stage,T4a
1636,1,1,Treatment Modality,Sx & RT
1636,1,1,2nd Failure Type,no known failure
1636,1,1,Clinical lab p16,p16 unkown
1636,1,1,Research lab p16,p16 unknown
1636,1,1,Occurrence #,1st primary
1636,1,1,Overall Stage,IVa
1636,1,1,Metastasis,M0
1636,1,1,1st Failure Initial Chemotherapy Agent,gemcitabine/doce/cap
1637,1,1,Overall Stage,III
1637,1,1,Research lab HPV,HPV unknown
1637,1,1,Tumor Site,larynx
1637,1,1,1st Failure Type,no known failure
1637,1,1,2nd Failure Type,no known failure
1637,1,1,Clinical lab p16,p16 unkown
1637,1,1,Research lab p16,p16 unknown
1637,1,1,Metastasis,M0
1637,1,1,Treatment Modality,CTX
1637,1,1,Occurrence #,1st primary
1637,1,1,Tumor Stage,T3
1637,1,1,Initial Chemotherapy Agent,cis/PTX/5-FU
1637,1,1,Nodal Stage,N1
1638,1,1,1st Failure Type,distant
1638,1,1,Research lab p16,p16 unknown
1638,1,1,2nd Failure Type,no known failure
1638,1,1,Clinical lab p16,p16 unkown
1638,1,1,Radiation Dosage,70
1638,1,1,Tumor Stage,T2
1638,1,1,Metastasis,M0
1638,1,1,Nodal Stage,N0
1638,1,1,Tumor Site,larynx
1638,1,1,Occurrence #,1st primary
1638,1,1,Treatment Modality,RT
1638,1,1,Research lab HPV,HPV unknown
1638,1,1,Overall Stage,II
1639,1,1,Tumor Stage,T4b
1639,1,1,1st Failure Type,no known failure
1639,1,1,Clinical lab p16,p16 unkown
1639,1,1,Initial Chemotherapy Agent,carbo/PTX
1639,1,1,Treatment Modality,CTX-RT
1639,1,1,Radiation Dosage,60
1639,1,1,Tumor Site,larynx
1639,1,1,Research lab HPV,HPV unknown
1639,1,1,Nodal Stage,N0
1639,1,1,2nd Failure Type,no known failure
1639,1,1,Research lab p16,p16 unknown
1639,1,1,Overall Stage,IVb
1639,1,1,Metastasis,M0
1639,1,1,Occurrence #,recurrence
1640,1,1,Tumor Stage,T1
1640,1,1,Nodal Stage,N0
1640,1,1,Occurrence #,1st primary
1640,1,1,Treatment Modality,RT
1640,1,1,Research lab p16,p16 unknown
1640,1,1,Radiation Dosage,63
1640,1,1,Metastasis,M0
1640,1,1,2nd Failure Type,no known failure
1640,1,1,1st Failure Type,no known failure
1640,1,1,Research lab HPV,HPV unknown
1640,1,1,Tumor Site,larynx
1640,1,1,Overall Stage,I
1640,1,1,Clinical lab p16,p16 unkown
1641,1,1,Occurrence #,1st primary
1641,1,1,Overall Stage,IVc
1641,1,1,Nodal Stage,N2
1641,1,1,Research lab p16,p16 unknown
1641,1,1,Metastasis,M1
1641,1,1,Initial Chemotherapy Agent,carbo/PTX
1641,1,1,2nd Failure Type,no known failure
1641,1,1,Research lab HPV,HPV unknown
1641,1,1,Radiation Dosage,33
1641,1,1,Treatment Modality,Sx & CTX-RT
1641,1,1,Clinical lab p16,p16 unkown
1641,1,1,Tumor Site,larynx
1641,1,1,Tumor Stage,T4a
1641,1,1,1st Failure Type,no known failure
1642,1,1,Treatment Modality,RT
1642,1,1,Clinical lab p16,p16 unkown
1642,1,1,Metastasis,M0
1642,1,1,Tumor Stage,T1
1642,1,1,Research lab HPV,HPV unknown
1642,1,1,Tumor Site,larynx
1642,1,1,Nodal Stage,N0
1642,1,1,Occurrence #,1st primary
1642,1,1,Research lab p16,p16 unknown
1642,1,1,2nd Failure Type,no known failure
1642,1,1,Overall Stage,I
1642,1,1,Radiation Dosage,66
1642,1,1,1st Failure Type,no known failure
1643,1,1,Treatment Modality,Sx
1643,1,1,Research lab HPV,HPV unknown
1643,1,1,Occurrence #,1st primary
1643,1,1,1st Failure Type,no known failure
1643,1,1,Clinical lab p16,p16 unkown
1643,1,1,2nd Failure Type,no known failure
1643,1,1,Research lab p16,p16 unknown
1643,1,1,Metastasis,M0
1643,1,1,Tumor Site,larynx
1643,1,1,Tumor Stage,T4a
1643,1,1,Overall Stage,IVa
1643,1,1,Nodal Stage,N0
1644,1,1,Research lab HPV,HPV unknown
1644,1,1,Nodal Stage,N2
1644,1,1,Tumor Site,larynx
1644,1,1,Occurrence #,1st primary
1644,1,1,Research lab p16,p16 unknown
1644,1,1,Overall Stage,IVc
1644,1,1,1st Failure Type,distant
1644,1,1,2nd Failure Type,no known failure
1644,1,1,Tumor Stage,T4a
1644,1,1,Metastasis,M1
1644,1,1,Clinical lab p16,p16 unkown
1644,1,1,Treatment Modality,Sx
1645,1,1,Research lab HPV,HPV unknown
1645,1,1,1st Failure Type,no known failure
1645,1,1,Occurrence #,1st primary
1645,1,1,Treatment Modality,RT
1645,1,1,Metastasis,M0
1645,1,1,Overall Stage,I
1645,1,1,Tumor Stage,T1
1645,1,1,Clinical lab p16,p16 unkown
1645,1,1,2nd Failure Type,no known failure
1645,1,1,Radiation Dosage,66
1645,1,1,Tumor Site,larynx
1645,1,1,Nodal Stage,N0
1645,1,1,Research lab p16,p16 unknown
1646,1,1,2nd Failure Type,no known failure
1646,1,1,Occurrence #,recurrence
1646,1,1,Research lab HPV,HPV unknown
1646,1,1,Nodal Stage,N0
1646,1,1,Tumor Site,larynx
1646,1,1,Research lab p16,p16 unknown
1646,1,1,Treatment Modality,Sx
1646,1,1,Clinical lab p16,p16 unkown
1646,1,1,Overall Stage,III
1646,1,1,1st Failure Type,no known failure
1646,1,1,Metastasis,M0
1646,1,1,Tumor Stage,T3
1647,1,1,Tumor Stage,T4a
1647,1,1,Radiation Dosage,63
1647,1,1,1st Failure Treatment Modality,CTX-RT
1647,1,1,2nd Failure Type,no known failure
1647,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
1647,1,1,Nodal Stage,N1
1647,1,1,Tumor Site,larynx
1647,1,1,Occurrence #,1st primary
1647,1,1,Treatment Modality,Sx & RT
1647,1,1,Research lab HPV,HPV unknown
1647,1,1,1st Failure Site,larynx
1647,1,1,Overall Stage,IVa
1647,1,1,Metastasis,M0
1647,1,1,1st Failure Type,locoregional and distant
1647,1,1,Research lab p16,p16 unknown
1647,1,1,Clinical lab p16,p16 unkown
1647,1,1,1st Failure Radiation Dosage,9
1648,1,1,Occurrence #,1st primary
1648,1,1,Nodal Stage,N2
1648,1,1,Research lab HPV,HPV positive
1648,1,1,Tumor Site,larynx
1648,1,1,1st Failure Type,no known failure
1648,1,1,Metastasis,M0
1648,1,1,2nd Failure Type,no known failure
1648,1,1,Tumor Stage,T2
1648,1,1,Clinical lab p16,p16 positive
1648,1,1,Research lab p16,p16 unknown
1648,1,1,Overall Stage,IVa
1648,1,1,Treatment Modality,Unknown
1649,1,1,Nodal Stage,N2
1649,1,1,1st Failure Type,no known failure
1649,1,1,Research lab p16,p16 unknown
1649,1,1,Occurrence #,1st primary
1649,1,1,Tumor Site,larynx
1649,1,1,Tumor Stage,T4a
1649,1,1,Metastasis,M0
1649,1,1,Initial Chemotherapy Agent,cis/PTX
1649,1,1,2nd Failure Type,no known failure
1649,1,1,Treatment Modality,Sx & CTX
1649,1,1,Clinical lab p16,p16 unkown
1649,1,1,Overall Stage,IVa
1649,1,1,Research lab HPV,HPV unknown
1650,1,1,2nd Failure Type,no known failure
1650,1,1,Nodal Stage,N0
1650,1,1,Tumor Stage,T4a
1650,1,1,Initial Chemotherapy Agent,carbo/PTX
1650,1,1,Overall Stage,IVa
1650,1,1,Research lab p16,p16 unknown
1650,1,1,1st Failure Treatment Modality,Sx
1650,1,1,Metastasis,M0
1650,1,1,1st Failure Type,locoregional
1650,1,1,1st Failure Site,larynx
1650,1,1,Research lab HPV,HPV unknown
1650,1,1,Radiation Dosage,72
1650,1,1,Occurrence #,1st primary
1650,1,1,Clinical lab p16,p16 unkown
1650,1,1,Tumor Site,larynx
1650,1,1,Treatment Modality,CTX-RT
1651,1,1,1st Failure Type,no known failure
1651,1,1,Research lab HPV,HPV unknown
1651,1,1,Treatment Modality,CTX-RT
1651,1,1,Initial Chemotherapy Agent,cis
1651,1,1,Metastasis,M0
1651,1,1,Tumor Site,larynx
1651,1,1,Occurrence #,1st primary
1651,1,1,Clinical lab p16,p16 unkown
1651,1,1,Tumor Stage,T2
1651,1,1,2nd Failure Type,no known failure
1651,1,1,Research lab p16,p16 unknown
1651,1,1,Nodal Stage,N1
1651,1,1,Overall Stage,III
1651,1,1,Radiation Dosage,70.2
1652,1,1,Clinical lab p16,p16 unkown
1652,1,1,Tumor Stage,Unknown
1652,1,1,Tumor Site,larynx
1652,1,1,Treatment Modality,CTX-RT
1652,1,1,Research lab p16,p16 unknown
1652,1,1,Nodal Stage,Unknown
1652,1,1,Radiation Dosage,18
1652,1,1,Overall Stage,IVc
1652,1,1,Research lab HPV,HPV unknown
1652,1,1,1st Failure Type,no known failure
1652,1,1,Metastasis,M1
1652,1,1,Initial Chemotherapy Agent,unknown
1652,1,1,Occurrence #,recurrence
1652,1,1,2nd Failure Type,no known failure
1653,1,1,Clinical lab p16,p16 unkown
1653,1,1,1st Failure Type,no known failure
1653,1,1,2nd Failure Type,no known failure
1653,1,1,Metastasis,M0
1653,1,1,Nodal Stage,N0
1653,1,1,Research lab p16,p16 unknown
1653,1,1,Occurrence #,1st primary
1653,1,1,Tumor Site,larynx
1653,1,1,Tumor Stage,T2
1653,1,1,Research lab HPV,HPV unknown
1653,1,1,Treatment Modality,Sx
1653,1,1,Overall Stage,II
1654,1,1,Tumor Site,larynx
1654,1,1,Nodal Stage,N0
1654,1,1,Tumor Stage,T1
1654,1,1,Radiation Dosage,63
1654,1,1,Clinical lab p16,p16 unkown
1654,1,1,Research lab HPV,HPV unknown
1654,1,1,Overall Stage,I
1654,1,1,Occurrence #,1st primary
1654,1,1,Research lab p16,p16 unknown
1654,1,1,Treatment Modality,RT
1654,1,1,Metastasis,M0
1654,1,1,2nd Failure Type,no known failure
1654,1,1,1st Failure Type,no known failure
1655,1,1,Tumor Stage,T2
1655,1,1,Clinical lab p16,p16 unkown
1655,1,1,Occurrence #,recurrence
1655,1,1,Treatment Modality,Sx
1655,1,1,Tumor Site,larynx
1655,1,1,Metastasis,M0
1655,1,1,Overall Stage,II
1655,1,1,Research lab p16,p16 unknown
1655,1,1,Nodal Stage,N0
1655,1,1,1st Failure Type,no known failure
1655,1,1,Research lab HPV,HPV unknown
1655,1,1,2nd Failure Type,no known failure
1656,1,1,Research lab p16,p16 unknown
1656,1,1,Overall Stage,I
1656,1,1,Occurrence #,1st primary
1656,1,1,Tumor Stage,T1
1656,1,1,Treatment Modality,Sx
1656,1,1,Clinical lab p16,p16 unkown
1656,1,1,2nd Failure Type,no known failure
1656,1,1,Nodal Stage,N0
1656,1,1,Tumor Site,larynx
1656,1,1,Research lab HPV,HPV unknown
1656,1,1,1st Failure Type,no known failure
1656,1,1,Metastasis,M0
1657,1,1,Metastasis,M0
1657,1,1,Nodal Stage,N0
1657,1,1,2nd Failure Type,no known failure
1657,1,1,Overall Stage,I
1657,1,1,Tumor Site,larynx
1657,1,1,1st Failure Type,no known failure
1657,1,1,Tumor Stage,T1
1657,1,1,Clinical lab p16,p16 unkown
1657,1,1,Research lab HPV,HPV unknown
1657,1,1,Treatment Modality,Sx
1657,1,1,Occurrence #,recurrence
1657,1,1,Research lab p16,p16 unknown
1658,1,1,2nd Failure Type,no known failure
1658,1,1,Research lab p16,p16 unknown
1658,1,1,1st Failure Type,no known failure
1658,1,1,Overall Stage,III
1658,1,1,Research lab HPV,HPV unknown
1658,1,1,Tumor Stage,T3
1658,1,1,Clinical lab p16,p16 unkown
1658,1,1,Occurrence #,recurrence
1658,1,1,Treatment Modality,Sx
1658,1,1,Tumor Site,larynx
1658,1,1,Nodal Stage,N0
1658,1,1,Metastasis,M0
1659,1,1,Treatment Modality,Sx & RT
1659,1,1,Tumor Site,larynx
1659,1,1,Research lab HPV,HPV unknown
1659,1,1,2nd Failure Type,no known failure
1659,1,1,Tumor Stage,T1
1659,1,1,Nodal Stage,N0
1659,1,1,Clinical lab p16,p16 unkown
1659,1,1,Overall Stage,I
1659,1,1,Research lab p16,p16 unknown
1659,1,1,1st Failure Type,no known failure
1659,1,1,Metastasis,M0
1659,1,1,Occurrence #,1st primary
1659,1,1,Radiation Dosage,unknown
1660,1,1,Nodal Stage,N0
1660,1,1,Overall Stage,I
1660,1,1,Radiation Dosage,66
1660,1,1,2nd Failure Type,no known failure
1660,1,1,1st Failure Type,no known failure
1660,1,1,Metastasis,M0
1660,1,1,Occurrence #,1st primary
1660,1,1,Treatment Modality,RT
1660,1,1,Research lab HPV,HPV unknown
1660,1,1,Tumor Site,larynx
1660,1,1,Tumor Stage,T1
1660,1,1,Clinical lab p16,p16 unkown
1660,1,1,Research lab p16,p16 unknown
1661,1,1,Occurrence #,recurrence
1661,1,1,Metastasis,M0
1661,1,1,Research lab p16,p16 unknown
1661,1,1,1st Failure Type,no known failure
1661,1,1,Tumor Site,larynx
1661,1,1,2nd Failure Type,no known failure
1661,1,1,Research lab HPV,HPV unknown
1661,1,1,Nodal Stage,N1
1661,1,1,Clinical lab p16,p16 unkown
1661,1,1,Treatment Modality,Sx
1661,1,1,Tumor Stage,T4a
1661,1,1,Overall Stage,IVa
1662,1,1,Overall Stage,IVa
1662,1,1,Clinical lab p16,p16 unkown
1662,1,1,Occurrence #,1st primary
1662,1,1,2nd Failure Type,no known failure
1662,1,1,1st Failure Type,locoregional and distant
1662,1,1,Research lab HPV,HPV unknown
1662,1,1,Radiation Dosage,72
1662,1,1,Tumor Site,larynx
1662,1,1,Tumor Stage,T4a
1662,1,1,Nodal Stage,N0
1662,1,1,Research lab p16,p16 unknown
1662,1,1,Metastasis,M0
1662,1,1,Treatment Modality,RT
1663,1,1,Treatment Modality,CTX-RT
1663,1,1,Radiation Dosage,34
1663,1,1,Metastasis,M0
1663,1,1,Tumor Site,larynx
1663,1,1,Occurrence #,1st primary
1663,1,1,Tumor Stage,T3
1663,1,1,2nd Failure Type,no known failure
1663,1,1,1st Failure Type,no known failure
1663,1,1,Research lab HPV,HPV unknown
1663,1,1,Research lab p16,p16 unknown
1663,1,1,Overall Stage,IVa
1663,1,1,Nodal Stage,N2
1663,1,1,Initial Chemotherapy Agent,unknown
1663,1,1,Clinical lab p16,p16 unkown
1664,1,1,Research lab p16,p16 unknown
1664,1,1,Clinical lab p16,p16 unkown
1664,1,1,Occurrence #,1st primary
1664,1,1,Treatment Modality,RT
1664,1,1,Overall Stage,I
1664,1,1,Radiation Dosage,63
1664,1,1,Metastasis,M0
1664,1,1,Research lab HPV,HPV unknown
1664,1,1,Nodal Stage,N0
1664,1,1,2nd Failure Type,no known failure
1664,1,1,Tumor Stage,T1
1664,1,1,1st Failure Type,no known failure
1664,1,1,Tumor Site,larynx
1665,1,1,Research lab HPV,HPV unknown
1665,1,1,Treatment Modality,CTX-RT
1665,1,1,Initial Chemotherapy Agent,cis
1665,1,1,1st Failure Type,no known failure
1665,1,1,2nd Failure Type,no known failure
1665,1,1,Radiation Dosage,70.2
1665,1,1,Occurrence #,1st primary
1665,1,1,Clinical lab p16,p16 unkown
1665,1,1,Tumor Site,larynx
1665,1,1,Tumor Stage,T3
1665,1,1,Metastasis,M0
1665,1,1,Nodal Stage,N1
1665,1,1,Overall Stage,III
1665,1,1,Research lab p16,p16 unknown
1666,1,1,2nd Failure Type,no known failure
1666,1,1,Tumor Site,larynx
1666,1,1,Nodal Stage,N2
1666,1,1,Research lab p16,p16 unknown
1666,1,1,Research lab HPV,HPV unknown
1666,1,1,Occurrence #,1st primary
1666,1,1,1st Failure Type,locoregional
1666,1,1,Tumor Stage,T4a
1666,1,1,Overall Stage,IVa
1666,1,1,Treatment Modality,Sx
1666,1,1,Metastasis,M0
1666,1,1,Clinical lab p16,p16 unkown
1667,1,1,Tumor Site,larynx
1667,1,1,Overall Stage,II
1667,1,1,Research lab p16,p16 unknown
1667,1,1,1st Failure Type,no known failure
1667,1,1,2nd Failure Type,no known failure
1667,1,1,Metastasis,M0
1667,1,1,Research lab HPV,HPV unknown
1667,1,1,Clinical lab p16,p16 unkown
1667,1,1,Tumor Stage,T2
1667,1,1,Radiation Dosage,74.4
1667,1,1,Nodal Stage,N0
1667,1,1,Treatment Modality,RT
1667,1,1,Occurrence #,1st primary
1668,1,1,1st Failure Treatment Modality,CTX
1668,1,1,Research lab HPV,HPV unknown
1668,1,1,Tumor Stage,T4a
1668,1,1,Clinical lab p16,p16 unkown
1668,1,1,Nodal Stage,N0
1668,1,1,Occurrence #,recurrence
1668,1,1,1st Failure Initial Chemotherapy Agent,cetux
1668,1,1,Tumor Site,larynx
1668,1,1,2nd Failure Type,no known failure
1668,1,1,Metastasis,M0
1668,1,1,1st Failure Type,locoregional
1668,1,1,Research lab p16,p16 unknown
1668,1,1,Overall Stage,IVa
1668,1,1,Treatment Modality,Sx
1668,1,1,1st Failure Site,larynx
1669,1,1,Tumor Site,larynx
1669,1,1,Research lab HPV,HPV unknown
1669,1,1,1st Failure Type,distant
1669,1,1,Tumor Stage,T3
1669,1,1,Treatment Modality,Sx & RT
1669,1,1,1st Failure Radiation Dosage,19
1669,1,1,1st Failure Treatment Modality,RT
1669,1,1,1st Failure Site,larynx
1669,1,1,2nd Failure Type,no known failure
1669,1,1,Research lab p16,p16 unknown
1669,1,1,Overall Stage,IVa
1669,1,1,Nodal Stage,N2
1669,1,1,Clinical lab p16,p16 unkown
1669,1,1,Metastasis,M0
1669,1,1,Radiation Dosage,63
1669,1,1,Occurrence #,1st primary
1670,1,1,2nd Failure Type,no known failure
1670,1,1,Tumor Site,larynx
1670,1,1,Clinical lab p16,p16 unkown
1670,1,1,Research lab p16,p16 unknown
1670,1,1,Radiation Dosage,63
1670,1,1,1st Failure Type,no known failure
1670,1,1,Research lab HPV,HPV unknown
1670,1,1,Tumor Stage,T1
1670,1,1,Overall Stage,I
1670,1,1,Metastasis,M0
1670,1,1,Nodal Stage,N0
1670,1,1,Treatment Modality,RT
1670,1,1,Occurrence #,1st primary
1671,1,1,1st Failure Type,locoregional
1671,1,1,Treatment Modality,CTX
1671,1,1,Research lab p16,p16 unknown
1671,1,1,Occurrence #,1st primary
1671,1,1,Overall Stage,IVc
1671,1,1,Research lab HPV,HPV unknown
1671,1,1,Clinical lab p16,p16 unkown
1671,1,1,Metastasis,M1
1671,1,1,2nd Failure Type,no known failure
1671,1,1,Tumor Site,larynx
1671,1,1,Tumor Stage,T3
1671,1,1,Nodal Stage,N2
1671,1,1,Initial Chemotherapy Agent,cis/PTX
1672,1,1,Overall Stage,III
1672,1,1,Research lab HPV,HPV unknown
1672,1,1,Clinical lab p16,p16 unkown
1672,1,1,1st Failure Type,no known failure
1672,1,1,Nodal Stage,N0
1672,1,1,Tumor Stage,T3
1672,1,1,2nd Failure Type,no known failure
1672,1,1,Metastasis,M0
1672,1,1,Tumor Site,larynx
1672,1,1,Treatment Modality,Sx
1672,1,1,Research lab p16,p16 unknown
1672,1,1,Occurrence #,1st primary
1673,1,1,Tumor Site,larynx
1673,1,1,Metastasis,M1
1673,1,1,2nd Failure Type,no known failure
1673,1,1,Research lab p16,p16 unknown
1673,1,1,Overall Stage,IVc
1673,1,1,Occurrence #,1st primary
1673,1,1,Nodal Stage,N0
1673,1,1,Tumor Stage,T3
1673,1,1,Clinical lab p16,p16 unkown
1673,1,1,Treatment Modality,Unknown
1673,1,1,1st Failure Type,no known failure
1673,1,1,Research lab HPV,HPV unknown
1674,1,1,Metastasis,M0
1674,1,1,Clinical lab p16,p16 unkown
1674,1,1,Research lab p16,p16 unknown
1674,1,1,Treatment Modality,Unknown
1674,1,1,Occurrence #,1st primary
1674,1,1,1st Failure Type,no known failure
1674,1,1,2nd Failure Type,no known failure
1674,1,1,Tumor Site,larynx
1674,1,1,Tumor Stage,T4a
1674,1,1,Research lab HPV,HPV unknown
1674,1,1,Nodal Stage,N2
1674,1,1,Overall Stage,IVa
1675,1,1,Tumor Stage,T1
1675,1,1,Nodal Stage,N3
1675,1,1,Treatment Modality,CTX-RT
1675,1,1,2nd Failure Type,no known failure
1675,1,1,Metastasis,M0
1675,1,1,Research lab p16,p16 unknown
1675,1,1,Clinical lab p16,p16 unkown
1675,1,1,Initial Chemotherapy Agent,cis/PTX/5-FU
1675,1,1,Research lab HPV,HPV unknown
1675,1,1,Second Line Chemotherapy Agent,carbo/cetux
1675,1,1,1st Failure Type,distant
1675,1,1,Tumor Site,larynx
1675,1,1,Overall Stage,IVb
1675,1,1,Radiation Dosage,59.4
1675,1,1,Occurrence #,1st primary
1676,1,1,1st Failure Type,no known failure
1676,1,1,Overall Stage,II
1676,1,1,2nd Failure Type,no known failure
1676,1,1,Research lab p16,p16 unknown
1676,1,1,Nodal Stage,N0
1676,1,1,Clinical lab p16,p16 unkown
1676,1,1,Tumor Stage,T2
1676,1,1,Research lab HPV,HPV unknown
1676,1,1,Treatment Modality,Unknown
1676,1,1,Tumor Site,larynx
1676,1,1,Occurrence #,1st primary
1676,1,1,Metastasis,M0
1677,1,1,Radiation Dosage,70
1677,1,1,Research lab HPV,HPV unknown
1677,1,1,Overall Stage,III
1677,1,1,Clinical lab p16,p16 unkown
1677,1,1,Tumor Site,larynx
1677,1,1,Nodal Stage,N0
1677,1,1,Tumor Stage,T3
1677,1,1,Treatment Modality,CTX-RT
1677,1,1,Initial Chemotherapy Agent,carbo/PTX
1677,1,1,Metastasis,M0
1677,1,1,Occurrence #,1st primary
1677,1,1,Research lab p16,p16 unknown
1677,1,1,1st Failure Type,no known failure
1677,1,1,2nd Failure Type,no known failure
1678,1,1,1st Failure Type,no known failure
1678,1,1,Occurrence #,1st primary
1678,1,1,Overall Stage,II
1678,1,1,Research lab p16,p16 unknown
1678,1,1,Metastasis,M0
1678,1,1,Nodal Stage,N0
1678,1,1,Tumor Stage,T2
1678,1,1,Research lab HPV,HPV unknown
1678,1,1,Radiation Dosage,74.4
1678,1,1,Tumor Site,larynx
1678,1,1,Treatment Modality,RT
1678,1,1,Clinical lab p16,p16 unkown
1678,1,1,2nd Failure Type,no known failure
1679,1,1,Treatment Modality,Sx
1679,1,1,Metastasis,M0
1679,1,1,2nd Failure Type,no known failure
1679,1,1,Nodal Stage,N0
1679,1,1,Tumor Site,larynx
1679,1,1,Tumor Stage,T4a
1679,1,1,1st Failure Type,no known failure
1679,1,1,Research lab p16,p16 unknown
1679,1,1,Research lab HPV,HPV unknown
1679,1,1,Overall Stage,IVa
1679,1,1,Clinical lab p16,p16 unkown
1679,1,1,Occurrence #,recurrence
1680,1,1,Treatment Modality,Sx
1680,1,1,Tumor Stage,T1
1680,1,1,Metastasis,M0
1680,1,1,Research lab p16,p16 unknown
1680,1,1,Research lab HPV,HPV unknown
1680,1,1,2nd Failure Type,no known failure
1680,1,1,Nodal Stage,N0
1680,1,1,Tumor Site,larynx
1680,1,1,Overall Stage,I
1680,1,1,Occurrence #,1st primary
1680,1,1,Clinical lab p16,p16 unkown
1680,1,1,1st Failure Type,no known failure
1681,1,1,Research lab p16,p16 unknown
1681,1,1,Tumor Site,larynx
1681,1,1,Metastasis,M0
1681,1,1,1st Failure Type,locoregional
1681,1,1,1st Failure Site,larynx
1681,1,1,Occurrence #,1st primary
1681,1,1,Treatment Modality,Sx & RT
1681,1,1,Nodal Stage,N1
1681,1,1,1st Failure Initial Chemotherapy Agent,unknown
1681,1,1,1st Failure Treatment Modality,Sx & CTX
1681,1,1,2nd Failure Type,no known failure
1681,1,1,Clinical lab p16,p16 unkown
1681,1,1,Tumor Stage,T3
1681,1,1,Radiation Dosage,unknown
1681,1,1,Research lab HPV,HPV unknown
1681,1,1,Overall Stage,III
1682,1,1,Occurrence #,1st primary
1682,1,1,Clinical lab p16,p16 unkown
1682,1,1,Research lab p16,p16 unknown
1682,1,1,1st Failure Type,no known failure
1682,1,1,Research lab HPV,HPV unknown
1682,1,1,2nd Failure Type,no known failure
1682,1,1,Overall Stage,IVa
1682,1,1,Tumor Stage,T4a
1682,1,1,Metastasis,M0
1682,1,1,Treatment Modality,Sx
1682,1,1,Nodal Stage,N0
1682,1,1,Tumor Site,larynx
1683,1,1,Tumor Site,larynx
1683,1,1,Overall Stage,I
1683,1,1,2nd Failure Type,no known failure
1683,1,1,Research lab HPV,HPV unknown
1683,1,1,Clinical lab p16,p16 unkown
1683,1,1,Metastasis,M0
1683,1,1,Tumor Stage,T1
1683,1,1,Treatment Modality,RT
1683,1,1,Radiation Dosage,63
1683,1,1,Research lab p16,p16 unknown
1683,1,1,Nodal Stage,N0
1683,1,1,Occurrence #,1st primary
1683,1,1,1st Failure Type,no known failure
1684,1,1,Tumor Stage,T3
1684,1,1,Treatment Modality,CTX-RT
1684,1,1,2nd Failure Type,no known failure
1684,1,1,Research lab HPV,HPV unknown
1684,1,1,Research lab p16,p16 unknown
1684,1,1,Nodal Stage,N2
1684,1,1,Radiation Dosage,70.2
1684,1,1,Clinical lab p16,p16 unkown
1684,1,1,Occurrence #,1st primary
1684,1,1,Tumor Site,larynx
1684,1,1,1st Failure Type,distant
1684,1,1,Overall Stage,IVa
1684,1,1,Initial Chemotherapy Agent,cis
1684,1,1,Metastasis,M0
1685,1,1,Clinical lab p16,p16 unkown
1685,1,1,Research lab HPV,HPV unknown
1685,1,1,Nodal Stage,N0
1685,1,1,Tumor Stage,T1
1685,1,1,Radiation Dosage,63
1685,1,1,Tumor Site,larynx
1685,1,1,Metastasis,M0
1685,1,1,2nd Failure Type,no known failure
1685,1,1,1st Failure Type,no known failure
1685,1,1,Research lab p16,p16 unknown
1685,1,1,Occurrence #,1st primary
1685,1,1,Treatment Modality,RT
1685,1,1,Overall Stage,I
1686,1,1,Occurrence #,1st primary
1686,1,1,Metastasis,M1
1686,1,1,Research lab HPV,HPV unknown
1686,1,1,Treatment Modality,Sx & CTX-RT
1686,1,1,Tumor Stage,T2
1686,1,1,Initial Chemotherapy Agent,cis/5-FU
1686,1,1,Nodal Stage,N2
1686,1,1,Radiation Dosage,50
1686,1,1,Tumor Site,larynx
1686,1,1,Clinical lab p16,p16 unkown
1686,1,1,2nd Failure Type,no known failure
1686,1,1,Research lab p16,p16 unknown
1686,1,1,1st Failure Type,no known failure
1686,1,1,Overall Stage,IVc
1687,1,1,1st Failure Radiation Dosage,37.5
1687,1,1,1st Failure Treatment Modality,CTX-RT
1687,1,1,Occurrence #,1st primary
1687,1,1,2nd Failure Type,no known failure
1687,1,1,Radiation Dosage,63
1687,1,1,1st Failure Type,locoregional and distant
1687,1,1,Research lab HPV,HPV unknown
1687,1,1,Metastasis,M0
1687,1,1,Tumor Stage,T4a
1687,1,1,Nodal Stage,N2
1687,1,1,1st Failure Site,larynx
1687,1,1,Research lab p16,p16 unknown
1687,1,1,Initial Chemotherapy Agent,cis
1687,1,1,Clinical lab p16,p16 unkown
1687,1,1,Tumor Site,larynx
1687,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
1687,1,1,Overall Stage,IVa
1687,1,1,Treatment Modality,Sx & CTX-RT
1688,1,1,Overall Stage,II
1688,1,1,Metastasis,M0
1688,1,1,Nodal Stage,N0
1688,1,1,1st Failure Type,locoregional
1688,1,1,2nd Failure Type,no known failure
1688,1,1,Clinical lab p16,p16 unkown
1688,1,1,Treatment Modality,Sx
1688,1,1,Occurrence #,1st primary
1688,1,1,Tumor Stage,T2
1688,1,1,Research lab p16,p16 unknown
1688,1,1,Tumor Site,larynx
1688,1,1,Research lab HPV,HPV unknown
1689,1,1,Treatment Modality,CTX-RT
1689,1,1,Research lab HPV,HPV unknown
1689,1,1,1st Failure Initial Chemotherapy Agent,cis
1689,1,1,Metastasis,M0
1689,1,1,1st Failure Type,no known failure
1689,1,1,1st Failure Site,oral cavity
1689,1,1,Tumor Stage,T3
1689,1,1,Clinical lab p16,p16 unkown
1689,1,1,Research lab p16,p16 unknown
1689,1,1,Nodal Stage,N2
1689,1,1,2nd Failure Type,no known failure
1689,1,1,Radiation Dosage,70.2
1689,1,1,Initial Chemotherapy Agent,cis
1689,1,1,Tumor Site,larynx
1689,1,1,Occurrence #,1st primary
1689,1,1,1st Failure Radiation Dosage,67.2
1689,1,1,Overall Stage,IVa
1689,1,1,1st Failure Treatment Modality,Sx & CTX-RT
1690,1,1,Tumor Stage,T1
1690,1,1,Clinical lab p16,p16 unkown
1690,1,1,Occurrence #,1st primary
1690,1,1,Nodal Stage,N0
1690,1,1,Overall Stage,I
1690,1,1,Research lab HPV,HPV unknown
1690,1,1,Metastasis,M0
1690,1,1,1st Failure Type,no known failure
1690,1,1,Radiation Dosage,63
1690,1,1,Treatment Modality,RT
1690,1,1,Tumor Site,larynx
1690,1,1,2nd Failure Type,no known failure
1690,1,1,Research lab p16,p16 unknown
1691,1,1,Tumor Stage,T3
1691,1,1,Treatment Modality,Sx
1691,1,1,Research lab HPV,HPV unknown
1691,1,1,Metastasis,M0
1691,1,1,1st Failure Treatment Modality,Sx
1691,1,1,Occurrence #,recurrence
1691,1,1,1st Failure Type,locoregional
1691,1,1,2nd Failure Type,no known failure
1691,1,1,Research lab p16,p16 unknown
1691,1,1,Clinical lab p16,p16 unkown
1691,1,1,Tumor Site,larynx
1691,1,1,Nodal Stage,N0
1691,1,1,Overall Stage,III
1691,1,1,1st Failure Site,larynx
1692,1,1,2nd Failure Type,no known failure
1692,1,1,Overall Stage,I
1692,1,1,Tumor Site,larynx
1692,1,1,Radiation Dosage,63
1692,1,1,Occurrence #,1st primary
1692,1,1,Treatment Modality,RT
1692,1,1,1st Failure Type,locoregional
1692,1,1,Research lab p16,p16 unknown
1692,1,1,Metastasis,M0
1692,1,1,Tumor Stage,T1
1692,1,1,Clinical lab p16,p16 unkown
1692,1,1,Research lab HPV,HPV unknown
1692,1,1,Nodal Stage,N0
1693,1,1,Tumor Site,larynx
1693,1,1,Tumor Stage,T2
1693,1,1,Nodal Stage,N2
1693,1,1,Occurrence #,1st primary
1693,1,1,2nd Failure Type,no known failure
1693,1,1,Metastasis,M0
1693,1,1,Research lab HPV,HPV unknown
1693,1,1,Overall Stage,IVa
1693,1,1,Research lab p16,p16 unknown
1693,1,1,1st Failure Type,no known failure
1693,1,1,Treatment Modality,CTX-RT
1693,1,1,Initial Chemotherapy Agent,unknown
1693,1,1,Clinical lab p16,p16 unkown
1693,1,1,Radiation Dosage,unknown
1694,1,1,Tumor Site,larynx
1694,1,1,Overall Stage,IVa
1694,1,1,Nodal Stage,N2
1694,1,1,1st Failure Type,no known failure
1694,1,1,Clinical lab p16,p16 unkown
1694,1,1,Radiation Dosage,70.2
1694,1,1,Tumor Stage,T2
1694,1,1,Research lab HPV,HPV unknown
1694,1,1,Initial Chemotherapy Agent,cis/doce/ 5 FU
1694,1,1,Treatment Modality,CTX-RT
1694,1,1,Second Line Chemotherapy Agent,carbo
1694,1,1,Metastasis,M0
1694,1,1,Research lab p16,p16 unknown
1694,1,1,2nd Failure Type,no known failure
1694,1,1,Occurrence #,1st primary
1695,1,1,1st Failure Type,no known failure
1695,1,1,Overall Stage,I
1695,1,1,2nd Failure Type,no known failure
1695,1,1,Tumor Site,larynx
1695,1,1,Research lab p16,p16 unknown
1695,1,1,Treatment Modality,RT
1695,1,1,Metastasis,M0
1695,1,1,Research lab HPV,HPV unknown
1695,1,1,Radiation Dosage,63
1695,1,1,Occurrence #,1st primary
1695,1,1,Tumor Stage,T1
1695,1,1,Nodal Stage,N0
1695,1,1,Clinical lab p16,p16 unkown
1696,1,1,2nd Failure Type,no known failure
1696,1,1,Occurrence #,1st primary
1696,1,1,Metastasis,M0
1696,1,1,Tumor Site,larynx
1696,1,1,Treatment Modality,Sx
1696,1,1,Research lab p16,p16 unknown
1696,1,1,Research lab HPV,HPV unknown
1696,1,1,Nodal Stage,N2
1696,1,1,Overall Stage,IVa
1696,1,1,Tumor Stage,T4a
1696,1,1,1st Failure Type,no known failure
1696,1,1,Clinical lab p16,p16 unkown
1697,1,1,Clinical lab p16,p16 unkown
1697,1,1,Radiation Dosage,63
1697,1,1,Tumor Site,larynx
1697,1,1,Occurrence #,1st primary
1697,1,1,Tumor Stage,T4a
1697,1,1,Treatment Modality,Sx & RT
1697,1,1,Research lab HPV,HPV unknown
1697,1,1,Research lab p16,p16 unknown
1697,1,1,1st Failure Type,no known failure
1697,1,1,Overall Stage,IVa
1697,1,1,2nd Failure Type,no known failure
1697,1,1,Nodal Stage,N2
1697,1,1,Metastasis,M0
1698,1,1,Overall Stage,I
1698,1,1,2nd Failure Type,no known failure
1698,1,1,Occurrence #,1st primary
1698,1,1,Research lab p16,p16 unknown
1698,1,1,Metastasis,M0
1698,1,1,Treatment Modality,RT
1698,1,1,Research lab HPV,HPV unknown
1698,1,1,Tumor Stage,T1
1698,1,1,Tumor Site,larynx
1698,1,1,Nodal Stage,N0
1698,1,1,1st Failure Type,no known failure
1698,1,1,Radiation Dosage,63
1698,1,1,Clinical lab p16,p16 unkown
1699,1,1,1st Failure Type,distant
1699,1,1,Occurrence #,1st primary
1699,1,1,Clinical lab p16,p16 unkown
1699,1,1,Treatment Modality,Sx & CTX-RT
1699,1,1,Tumor Stage,T2
1699,1,1,1st Failure Site,hypopharynx
1699,1,1,Metastasis,M0
1699,1,1,Radiation Dosage,70.2
1699,1,1,Research lab p16,p16 unknown
1699,1,1,Nodal Stage,N2
1699,1,1,Research lab HPV,HPV unknown
1699,1,1,Overall Stage,IVa
1699,1,1,Tumor Site,hypopharynx
1699,1,1,Initial Chemotherapy Agent,cis
1699,1,1,1st Failure Treatment Modality,Sx
1699,1,1,2nd Failure Type,no known failure
1700,1,1,Tumor Site,hypopharynx
1700,1,1,Overall Stage,IVa
1700,1,1,Research lab HPV,HPV unknown
1700,1,1,Research lab p16,p16 unknown
1700,1,1,Treatment Modality,RT
1700,1,1,Clinical lab p16,p16 unkown
1700,1,1,Occurrence #,1st primary
1700,1,1,Radiation Dosage,30
1700,1,1,1st Failure Type,no known failure
1700,1,1,Tumor Stage,T4a
1700,1,1,2nd Failure Type,no known failure
1700,1,1,Nodal Stage,Unknown
1700,1,1,Metastasis,Unknown
1701,1,1,2nd Failure Type,no known failure
1701,1,1,Tumor Site,hypopharynx
1701,1,1,Metastasis,M0
1701,1,1,Clinical lab p16,p16 unkown
1701,1,1,Treatment Modality,Sx
1701,1,1,Nodal Stage,N2
1701,1,1,Tumor Stage,T3
1701,1,1,Research lab HPV,HPV unknown
1701,1,1,Research lab p16,p16 unknown
1701,1,1,Overall Stage,IVa
1701,1,1,1st Failure Type,no known failure
1701,1,1,Occurrence #,recurrence
1702,1,1,Treatment Modality,Sx
1702,1,1,Nodal Stage,N2
1702,1,1,Clinical lab p16,p16 unkown
1702,1,1,Occurrence #,1st primary
1702,1,1,Tumor Site,hypopharynx
1702,1,1,1st Failure Type,no known failure
1702,1,1,Metastasis,M0
1702,1,1,Tumor Stage,T3
1702,1,1,Overall Stage,IVa
1702,1,1,Research lab p16,p16 unknown
1702,1,1,2nd Failure Type,no known failure
1702,1,1,Research lab HPV,HPV unknown
1703,1,1,Metastasis,M0
1703,1,1,Research lab HPV,HPV unknown
1703,1,1,Tumor Stage,T3
1703,1,1,Nodal Stage,N0
1703,1,1,Initial Chemotherapy Agent,cis/doce
1703,1,1,Occurrence #,1st primary
1703,1,1,2nd Failure Type,no known failure
1703,1,1,Overall Stage,III
1703,1,1,Research lab p16,p16 unknown
1703,1,1,Clinical lab p16,p16 unkown
1703,1,1,Tumor Site,hypopharynx
1703,1,1,1st Failure Type,no known failure
1703,1,1,Radiation Dosage,70.2
1703,1,1,Treatment Modality,CTX-RT
1704,1,1,2nd Failure Type,no known failure
1704,1,1,1st Failure Treatment Modality,CTX
1704,1,1,Research lab p16,p16 unknown
1704,1,1,Overall Stage,IVa
1704,1,1,1st Failure Second Line Chemotherapy Agent,cis/doce
1704,1,1,Metastasis,M0
1704,1,1,Tumor Stage,T4a
1704,1,1,1st Failure Type,locoregional
1704,1,1,Occurrence #,recurrence
1704,1,1,Tumor Site,hypopharynx
1704,1,1,1st Failure Site,hypopharynx
1704,1,1,Nodal Stage,N2
1704,1,1,Clinical lab p16,p16 unkown
1704,1,1,Treatment Modality,Sx
1704,1,1,1st Failure Initial Chemotherapy Agent,MAGE-3 vaccine
1704,1,1,Research lab HPV,HPV unknown
1705,1,1,Treatment Modality,CTX-RT
1705,1,1,Occurrence #,1st primary
1705,1,1,Research lab HPV,HPV unknown
1705,1,1,Research lab p16,p16 unknown
1705,1,1,Overall Stage,IVa
1705,1,1,Metastasis,M0
1705,1,1,1st Failure Type,no known failure
1705,1,1,Clinical lab p16,p16 unkown
1705,1,1,Radiation Dosage,70.2
1705,1,1,Initial Chemotherapy Agent,carbo/PTX
1705,1,1,Tumor Site,hypopharynx
1705,1,1,2nd Failure Type,no known failure
1705,1,1,Tumor Stage,T3
1705,1,1,Nodal Stage,N2
1706,1,1,Tumor Site,hypopharynx
1706,1,1,2nd Failure Type,no known failure
1706,1,1,Metastasis,M0
1706,1,1,Overall Stage,III
1706,1,1,Occurrence #,other primary
1706,1,1,Research lab p16,p16 unknown
1706,1,1,Clinical lab p16,p16 unkown
1706,1,1,Nodal Stage,N0
1706,1,1,Treatment Modality,Sx
1706,1,1,Research lab HPV,HPV unknown
1706,1,1,Tumor Stage,T3
1706,1,1,1st Failure Type,no known failure
1707,1,1,Research lab HPV,HPV unknown
1707,1,1,Metastasis,M0
1707,1,1,1st Failure Type,no known failure
1707,1,1,Nodal Stage,N0
1707,1,1,Overall Stage,III
1707,1,1,2nd Failure Type,no known failure
1707,1,1,Treatment Modality,CTX-RT
1707,1,1,Initial Chemotherapy Agent,unknown
1707,1,1,Research lab p16,p16 unknown
1707,1,1,Clinical lab p16,p16 unkown
1707,1,1,Radiation Dosage,70.2
1707,1,1,Tumor Stage,T3
1707,1,1,Occurrence #,1st primary
1707,1,1,Tumor Site,hypopharynx
1708,1,1,Overall Stage,III
1708,1,1,Clinical lab p16,p16 unkown
1708,1,1,Radiation Dosage,70.2
1708,1,1,Research lab HPV,HPV unknown
1708,1,1,Tumor Site,hypopharynx
1708,1,1,Metastasis,M0
1708,1,1,Tumor Stage,T3
1708,1,1,Research lab p16,p16 unknown
1708,1,1,2nd Failure Type,no known failure
1708,1,1,Nodal Stage,N1
1708,1,1,Initial Chemotherapy Agent,carbo/PTX
1708,1,1,Treatment Modality,CTX-RT
1708,1,1,1st Failure Type,no known failure
1708,1,1,Occurrence #,1st primary
1709,1,1,Treatment Modality,Sx
1709,1,1,Research lab p16,p16 unknown
1709,1,1,Clinical lab p16,p16 unkown
1709,1,1,Occurrence #,other primary
1709,1,1,Research lab HPV,HPV unknown
1709,1,1,Overall Stage,II
1709,1,1,Tumor Stage,T2
1709,1,1,Metastasis,M0
1709,1,1,Tumor Site,hypopharynx
1709,1,1,2nd Failure Type,no known failure
1709,1,1,1st Failure Type,locoregional
1709,1,1,Nodal Stage,N0
1710,1,1,Overall Stage,IVa
1710,1,1,Nodal Stage,N2
1710,1,1,Tumor Stage,T3
1710,1,1,Research lab HPV,HPV unknown
1710,1,1,Occurrence #,1st primary
1710,1,1,Tumor Site,hypopharynx
1710,1,1,1st Failure Type,locoregional and distant
1710,1,1,Metastasis,M0
1710,1,1,Radiation Dosage,42
1710,1,1,2nd Failure Type,no known failure
1710,1,1,Clinical lab p16,p16 unkown
1710,1,1,Research lab p16,p16 unknown
1710,1,1,Treatment Modality,RT
1711,1,1,1st Failure Type,no known failure
1711,1,1,Initial Chemotherapy Agent,doce/PTX
1711,1,1,Research lab p16,p16 unknown
1711,1,1,Radiation Dosage,72
1711,1,1,Metastasis,M0
1711,1,1,Treatment Modality,CTX-RT
1711,1,1,Tumor Site,hypopharynx
1711,1,1,Tumor Stage,T3
1711,1,1,Research lab HPV,HPV unknown
1711,1,1,Overall Stage,III
1711,1,1,Clinical lab p16,p16 unkown
1711,1,1,Occurrence #,1st primary
1711,1,1,2nd Failure Type,no known failure
1711,1,1,Nodal Stage,N0
1712,1,1,1st Failure Type,locoregional
1712,1,1,Overall Stage,IVa
1712,1,1,Nodal Stage,N2
1712,1,1,Metastasis,M0
1712,1,1,2nd Failure Type,no known failure
1712,1,1,Tumor Stage,T4a
1712,1,1,Research lab p16,p16 unknown
1712,1,1,Radiation Dosage,60
1712,1,1,Tumor Site,hypopharynx
1712,1,1,Treatment Modality,CTX-RT
1712,1,1,Initial Chemotherapy Agent,carbo/PTX
1712,1,1,Clinical lab p16,p16 unkown
1712,1,1,Occurrence #,recurrence
1712,1,1,Research lab HPV,HPV unknown
1713,1,1,2nd Failure Type,no known failure
1713,1,1,Research lab HPV,HPV unknown
1713,1,1,Overall Stage,III
1713,1,1,Occurrence #,1st primary
1713,1,1,Tumor Stage,T3
1713,1,1,Tumor Site,hypopharynx
1713,1,1,Clinical lab p16,p16 unkown
1713,1,1,Nodal Stage,N0
1713,1,1,Metastasis,M0
1713,1,1,Treatment Modality,CTX-RT
1713,1,1,Radiation Dosage,70.2
1713,1,1,1st Failure Type,locoregional
1713,1,1,Initial Chemotherapy Agent,carbo/PTX
1713,1,1,Research lab p16,p16 unknown
1714,1,1,2nd Failure Type,no known failure
1714,1,1,Clinical lab p16,p16 unkown
1714,1,1,Overall Stage,IVa
1714,1,1,Occurrence #,1st primary
1714,1,1,1st Failure Type,no known failure
1714,1,1,Treatment Modality,CTX-RT
1714,1,1,Nodal Stage,N3
1714,1,1,Metastasis,M0
1714,1,1,Research lab p16,p16 unknown
1714,1,1,Tumor Site,hypopharynx
1714,1,1,Tumor Stage,T2
1714,1,1,Research lab HPV,HPV unknown
1714,1,1,Radiation Dosage,70.2
1714,1,1,Initial Chemotherapy Agent,carbo/PTX
1715,1,1,Tumor Site,hypopharynx
1715,1,1,1st Failure Type,locoregional
1715,1,1,Tumor Stage,T3
1715,1,1,Radiation Dosage,51.2
1715,1,1,Treatment Modality,Sx & RT
1715,1,1,Occurrence #,1st primary
1715,1,1,1st Failure Radiation Dosage,60
1715,1,1,Research lab HPV,HPV unknown
1715,1,1,Clinical lab p16,p16 unkown
1715,1,1,Metastasis,M0
1715,1,1,Research lab p16,p16 unknown
1715,1,1,2nd Failure Type,no known failure
1715,1,1,1st Failure Treatment Modality,CTX-RT
1715,1,1,Overall Stage,IVa
1715,1,1,Nodal Stage,N2
1715,1,1,1st Failure Site,hypopharynx
1715,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
1716,1,1,2nd Failure Type,no known failure
1716,1,1,Research lab HPV,HPV unknown
1716,1,1,Research lab p16,p16 unknown
1716,1,1,Occurrence #,recurrence
1716,1,1,Metastasis,M0
1716,1,1,Overall Stage,III
1716,1,1,Treatment Modality,Sx
1716,1,1,Clinical lab p16,p16 unkown
1716,1,1,Nodal Stage,N0
1716,1,1,Tumor Stage,T3
1716,1,1,Tumor Site,hypopharynx
1716,1,1,1st Failure Type,no known failure
1717,1,1,Clinical lab p16,p16 unkown
1717,1,1,2nd Failure Type,no known failure
1717,1,1,Tumor Stage,T4b
1717,1,1,Research lab p16,p16 unknown
1717,1,1,Nodal Stage,N2
1717,1,1,Metastasis,M0
1717,1,1,Radiation Dosage,70.2
1717,1,1,Treatment Modality,CTX-RT
1717,1,1,1st Failure Type,locoregional and distant
1717,1,1,Occurrence #,1st primary
1717,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1717,1,1,Research lab HPV,HPV unknown
1717,1,1,Overall Stage,IVb
1717,1,1,Tumor Site,hypopharynx
1718,1,1,Tumor Stage,T2
1718,1,1,Radiation Dosage,70.2
1718,1,1,Occurrence #,1st primary
1718,1,1,2nd Failure Type,no known failure
1718,1,1,Overall Stage,IVa
1718,1,1,Nodal Stage,N2
1718,1,1,Treatment Modality,CTX-RT
1718,1,1,Clinical lab p16,p16 unkown
1718,1,1,Metastasis,M0
1718,1,1,Research lab p16,p16 unknown
1718,1,1,Tumor Site,hypopharynx
1718,1,1,Research lab HPV,HPV unknown
1718,1,1,1st Failure Type,no known failure
1718,1,1,Initial Chemotherapy Agent,carbo/PTX
1719,1,1,Metastasis,M0
1719,1,1,2nd Failure Type,no known failure
1719,1,1,Clinical lab p16,p16 unkown
1719,1,1,Occurrence #,1st primary
1719,1,1,Treatment Modality,Sx
1719,1,1,Research lab p16,p16 unknown
1719,1,1,Tumor Stage,T3
1719,1,1,Overall Stage,III
1719,1,1,Nodal Stage,N0
1719,1,1,Research lab HPV,HPV unknown
1719,1,1,Tumor Site,hypopharynx
1719,1,1,1st Failure Type,no known failure
1720,1,1,Research lab p16,p16 unknown
1720,1,1,1st Failure Type,no known failure
1720,1,1,Radiation Dosage,70.2
1720,1,1,Research lab HPV,HPV unknown
1720,1,1,Tumor Stage,T2
1720,1,1,Initial Chemotherapy Agent,carbo/PTX
1720,1,1,Occurrence #,1st primary
1720,1,1,Tumor Site,hypopharynx
1720,1,1,Nodal Stage,N2
1720,1,1,Metastasis,M0
1720,1,1,Clinical lab p16,p16 unkown
1720,1,1,Overall Stage,IVa
1720,1,1,Treatment Modality,CTX-RT
1720,1,1,2nd Failure Type,no known failure
1721,1,1,Overall Stage,IVa
1721,1,1,Treatment Modality,Sx & CTX
1721,1,1,Research lab p16,p16 unknown
1721,1,1,Metastasis,M0
1721,1,1,Research lab HPV,HPV unknown
1721,1,1,Tumor Site,hypopharynx
1721,1,1,1st Failure Type,no known failure
1721,1,1,Initial Chemotherapy Agent,PTX/doce/gemcitabine
1721,1,1,2nd Failure Type,no known failure
1721,1,1,Nodal Stage,N2
1721,1,1,Tumor Stage,T4a
1721,1,1,Clinical lab p16,p16 unkown
1721,1,1,Occurrence #,recurrence
1722,1,1,Radiation Dosage,60
1722,1,1,Nodal Stage,N2
1722,1,1,Tumor Site,hypopharynx
1722,1,1,Research lab p16,p16 unknown
1722,1,1,Overall Stage,IVa
1722,1,1,Initial Chemotherapy Agent,cis
1722,1,1,Clinical lab p16,p16 unkown
1722,1,1,Treatment Modality,Sx & CTX-RT
1722,1,1,Tumor Stage,T4a
1722,1,1,1st Failure Type,no known failure
1722,1,1,Research lab HPV,HPV unknown
1722,1,1,Metastasis,M0
1722,1,1,Occurrence #,1st primary
1722,1,1,2nd Failure Type,no known failure
1723,1,1,Metastasis,M0
1723,1,1,Treatment Modality,Unknown
1723,1,1,Occurrence #,1st primary
1723,1,1,2nd Failure Type,no known failure
1723,1,1,Overall Stage,II
1723,1,1,Nodal Stage,N0
1723,1,1,Tumor Site,hypopharynx
1723,1,1,Tumor Stage,T2
1723,1,1,Research lab HPV,HPV unknown
1723,1,1,Clinical lab p16,p16 unkown
1723,1,1,1st Failure Type,no known failure
1723,1,1,Research lab p16,p16 unknown
1724,1,1,Radiation Dosage,59.4
1724,1,1,Occurrence #,other primary
1724,1,1,Clinical lab p16,p16 unkown
1724,1,1,Metastasis,M0
1724,1,1,Initial Chemotherapy Agent,carbo/PTX
1724,1,1,2nd Failure Type,no known failure
1724,1,1,Nodal Stage,N0
1724,1,1,Research lab HPV,HPV unknown
1724,1,1,Tumor Stage,T2
1724,1,1,1st Failure Type,no known failure
1724,1,1,Tumor Site,hypopharynx
1724,1,1,Overall Stage,II
1724,1,1,Treatment Modality,CTX-RT
1724,1,1,Research lab p16,p16 unknown
1725,1,1,Research lab p16,p16 unknown
1725,1,1,Tumor Site,hypopharynx
1725,1,1,Occurrence #,1st primary
1725,1,1,Treatment Modality,Sx
1725,1,1,Nodal Stage,N0
1725,1,1,Metastasis,M0
1725,1,1,Research lab HPV,HPV unknown
1725,1,1,Overall Stage,III
1725,1,1,1st Failure Type,no known failure
1725,1,1,Tumor Stage,T3
1725,1,1,2nd Failure Type,no known failure
1725,1,1,Clinical lab p16,p16 unkown
1726,1,1,Research lab HPV,HPV unknown
1726,1,1,Overall Stage,IVb
1726,1,1,Treatment Modality,Sx & CTX-RT
1726,1,1,Radiation Dosage,unknown
1726,1,1,Nodal Stage,N3
1726,1,1,1st Failure Type,no known failure
1726,1,1,Occurrence #,1st primary
1726,1,1,Tumor Stage,T3
1726,1,1,Metastasis,M0
1726,1,1,2nd Failure Type,no known failure
1726,1,1,Tumor Site,hypopharynx
1726,1,1,Initial Chemotherapy Agent,unknown
1726,1,1,Research lab p16,p16 unknown
1726,1,1,Clinical lab p16,p16 unkown
1727,1,1,Research lab HPV,HPV unknown
1727,1,1,Metastasis,M0
1727,1,1,Research lab p16,p16 unknown
1727,1,1,Initial Chemotherapy Agent,unknown
1727,1,1,Treatment Modality,Sx & CTX-RT
1727,1,1,2nd Failure Type,no known failure
1727,1,1,Nodal Stage,N2
1727,1,1,Radiation Dosage,unknown
1727,1,1,Tumor Site,hypopharynx
1727,1,1,Clinical lab p16,p16 unkown
1727,1,1,1st Failure Type,no known failure
1727,1,1,Tumor Stage,T2
1727,1,1,Occurrence #,1st primary
1727,1,1,Overall Stage,IVa
1728,1,1,Tumor Stage,T4a
1728,1,1,Initial Chemotherapy Agent,carbo/PTX
1728,1,1,2nd Failure Type,no known failure
1728,1,1,Research lab p16,p16 unknown
1728,1,1,Nodal Stage,N0
1728,1,1,1st Failure Type,no known failure
1728,1,1,Research lab HPV,HPV unknown
1728,1,1,Radiation Dosage,70.2
1728,1,1,Tumor Site,hypopharynx
1728,1,1,Metastasis,M0
1728,1,1,Overall Stage,IVa
1728,1,1,Clinical lab p16,p16 unkown
1728,1,1,Occurrence #,1st primary
1728,1,1,Treatment Modality,CTX-RT
1729,1,1,2nd Failure Type,no known failure
1729,1,1,Tumor Site,hypopharynx
1729,1,1,Overall Stage,IVa
1729,1,1,Research lab HPV,HPV unknown
1729,1,1,Radiation Dosage,70.2
1729,1,1,1st Failure Type,no known failure
1729,1,1,Metastasis,M0
1729,1,1,Clinical lab p16,p16 unkown
1729,1,1,Research lab p16,p16 unknown
1729,1,1,Occurrence #,1st primary
1729,1,1,Tumor Stage,T1
1729,1,1,Treatment Modality,RT
1729,1,1,Nodal Stage,N2
1730,1,1,Occurrence #,1st primary
1730,1,1,Research lab HPV,HPV unknown
1730,1,1,Treatment Modality,Sx
1730,1,1,Metastasis,M0
1730,1,1,Clinical lab p16,p16 unkown
1730,1,1,Nodal Stage,N0
1730,1,1,1st Failure Type,no known failure
1730,1,1,Research lab p16,p16 unknown
1730,1,1,2nd Failure Type,no known failure
1730,1,1,Tumor Site,hypopharynx
1730,1,1,Overall Stage,I
1730,1,1,Tumor Stage,T1
1731,1,1,1st Failure Type,no known failure
1731,1,1,Nodal Stage,Unknown
1731,1,1,2nd Failure Type,no known failure
1731,1,1,Clinical lab p16,p16 unkown
1731,1,1,Research lab HPV,HPV unknown
1731,1,1,Overall Stage,Unknown
1731,1,1,Metastasis,Unknown
1731,1,1,Treatment Modality,Unknown
1731,1,1,Occurrence #,1st primary
1731,1,1,Tumor Stage,Unknown
1731,1,1,Tumor Site,hypopharynx
1731,1,1,Research lab p16,p16 unknown
1732,1,1,Radiation Dosage,70.2
1732,1,1,Occurrence #,1st primary
1732,1,1,Tumor Site,hypopharynx
1732,1,1,Metastasis,M1
1732,1,1,Clinical lab p16,p16 unkown
1732,1,1,Second Line Chemotherapy Agent,cap
1732,1,1,2nd Failure Type,no known failure
1732,1,1,Overall Stage,IVc
1732,1,1,Initial Chemotherapy Agent,cis
1732,1,1,Tumor Stage,T3
1732,1,1,1st Failure Type,distant
1732,1,1,Nodal Stage,N2
1732,1,1,Treatment Modality,CTX-RT
1732,1,1,Research lab HPV,HPV unknown
1732,1,1,Research lab p16,p16 unknown
1733,1,1,Research lab p16,p16 unknown
1733,1,1,Nodal Stage,N0
1733,1,1,Radiation Dosage,unknown
1733,1,1,Metastasis,M0
1733,1,1,Initial Chemotherapy Agent,unknown
1733,1,1,1st Failure Type,no known failure
1733,1,1,Clinical lab p16,p16 unkown
1733,1,1,Tumor Site,hypopharynx
1733,1,1,Treatment Modality,CTX-RT
1733,1,1,Research lab HPV,HPV unknown
1733,1,1,Occurrence #,1st primary
1733,1,1,Overall Stage,II
1733,1,1,Tumor Stage,T2
1733,1,1,2nd Failure Type,no known failure
1734,1,1,Tumor Stage,T3
1734,1,1,Research lab p16,p16 unknown
1734,1,1,Treatment Modality,CTX-RT
1734,1,1,Clinical lab p16,p16 unkown
1734,1,1,Tumor Site,hypopharynx
1734,1,1,2nd Failure Type,no known failure
1734,1,1,Research lab HPV,HPV unknown
1734,1,1,Overall Stage,IVa
1734,1,1,Occurrence #,1st primary
1734,1,1,Initial Chemotherapy Agent,carbo/PTX
1734,1,1,Metastasis,M0
1734,1,1,1st Failure Type,no known failure
1734,1,1,Radiation Dosage,70.2
1734,1,1,Nodal Stage,N2
1735,1,1,Nodal Stage,N0
1735,1,1,Research lab HPV,HPV unknown
1735,1,1,Treatment Modality,RT
1735,1,1,Overall Stage,I
1735,1,1,Metastasis,M0
1735,1,1,Occurrence #,recurrence
1735,1,1,1st Failure Type,no known failure
1735,1,1,Radiation Dosage,66
1735,1,1,2nd Failure Type,no known failure
1735,1,1,Tumor Stage,T1
1735,1,1,Research lab p16,p16 unknown
1735,1,1,Clinical lab p16,p16 unkown
1735,1,1,Tumor Site,hypopharynx
1736,1,1,Occurrence #,1st primary
1736,1,1,Tumor Site,hypopharynx
1736,1,1,Treatment Modality,CTX
1736,1,1,Tumor Stage,T4a
1736,1,1,Initial Chemotherapy Agent,cis/doce
1736,1,1,Research lab HPV,HPV unknown
1736,1,1,1st Failure Type,no known failure
1736,1,1,Research lab p16,p16 unknown
1736,1,1,2nd Failure Type,no known failure
1736,1,1,Nodal Stage,N1
1736,1,1,Clinical lab p16,p16 unkown
1736,1,1,Metastasis,M0
1736,1,1,Overall Stage,IVa
1737,1,1,1st Failure Type,no known failure
1737,1,1,2nd Failure Type,no known failure
1737,1,1,Radiation Dosage,70
1737,1,1,Tumor Site,hypopharynx
1737,1,1,Treatment Modality,CTX-RT
1737,1,1,Initial Chemotherapy Agent,cis
1737,1,1,Research lab p16,p16 unknown
1737,1,1,Clinical lab p16,p16 unkown
1737,1,1,Metastasis,M0
1737,1,1,Tumor Stage,T3
1737,1,1,Research lab HPV,HPV unknown
1737,1,1,Overall Stage,III
1737,1,1,Nodal Stage,N0
1737,1,1,Occurrence #,1st primary
1738,1,1,Nodal Stage,N0
1738,1,1,Tumor Stage,T4a
1738,1,1,Research lab p16,p16 unknown
1738,1,1,Treatment Modality,CTX-RT
1738,1,1,Clinical lab p16,p16 unkown
1738,1,1,Tumor Site,hypopharynx
1738,1,1,Radiation Dosage,70.2
1738,1,1,Overall Stage,IVa
1738,1,1,Occurrence #,other primary
1738,1,1,Metastasis,M0
1738,1,1,Initial Chemotherapy Agent,carbo/PTX
1738,1,1,Research lab HPV,HPV unknown
1738,1,1,1st Failure Type,no known failure
1738,1,1,2nd Failure Type,no known failure
1739,1,1,Tumor Site,hypopharynx
1739,1,1,Initial Chemotherapy Agent,carbo/PTX
1739,1,1,Clinical lab p16,p16 unkown
1739,1,1,Nodal Stage,N1
1739,1,1,Research lab HPV,HPV unknown
1739,1,1,1st Failure Type,no known failure
1739,1,1,Metastasis,M0
1739,1,1,Occurrence #,recurrence
1739,1,1,Radiation Dosage,unknown
1739,1,1,2nd Failure Type,no known failure
1739,1,1,Overall Stage,IVa
1739,1,1,Treatment Modality,CTX-RT
1739,1,1,Tumor Stage,T4a
1739,1,1,Research lab p16,p16 unknown
1740,1,1,Research lab HPV,HPV unknown
1740,1,1,Metastasis,M0
1740,1,1,Treatment Modality,Sx & CTX-RT
1740,1,1,Occurrence #,1st primary
1740,1,1,Clinical lab p16,p16 unkown
1740,1,1,1st Failure Treatment Modality,Sx & CTX-RT
1740,1,1,Overall Stage,IVa
1740,1,1,Initial Chemotherapy Agent,cis/PTX
1740,1,1,1st Failure Type,locoregional
1740,1,1,Research lab p16,p16 unknown
1740,1,1,Tumor Stage,T2
1740,1,1,Nodal Stage,N2
1740,1,1,Radiation Dosage,70.2
1740,1,1,1st Failure Initial Chemotherapy Agent,cis/cetux
1740,1,1,Tumor Site,hypopharynx
1740,1,1,1st Failure Radiation Dosage,60
1740,1,1,1st Failure Site,hypopharynx
1740,1,1,2nd Failure Type,no known failure
1740,1,1,1st Failure Second Line Chemotherapy Agent,doce
1741,1,1,Occurrence #,1st primary
1741,1,1,Tumor Site,hypopharynx
1741,1,1,Metastasis,M1
1741,1,1,Clinical lab p16,p16 unkown
1741,1,1,Treatment Modality,Sx
1741,1,1,Tumor Stage,T2
1741,1,1,Nodal Stage,N3
1741,1,1,1st Failure Type,locoregional and distant
1741,1,1,Research lab HPV,HPV unknown
1741,1,1,2nd Failure Type,no known failure
1741,1,1,Overall Stage,IVc
1741,1,1,Research lab p16,p16 unknown
1742,1,1,Research lab p16,p16 unknown
1742,1,1,Tumor Stage,T3
1742,1,1,Overall Stage,IVb
1742,1,1,Research lab HPV,HPV unknown
1742,1,1,Nodal Stage,N3
1742,1,1,1st Failure Type,distant
1742,1,1,Metastasis,M0
1742,1,1,Tumor Site,hypopharynx
1742,1,1,Initial Chemotherapy Agent,carbo/PTX/amifistine
1742,1,1,Radiation Dosage,70.2
1742,1,1,2nd Failure Type,no known failure
1742,1,1,Clinical lab p16,p16 unkown
1742,1,1,Treatment Modality,CTX-RT
1742,1,1,Occurrence #,1st primary
1743,1,1,Clinical lab p16,p16 unkown
1743,1,1,Research lab HPV,HPV unknown
1743,1,1,2nd Failure Type,no known failure
1743,1,1,Nodal Stage,N0
1743,1,1,Research lab p16,p16 unknown
1743,1,1,Treatment Modality,Sx
1743,1,1,Tumor Stage,T4a
1743,1,1,Metastasis,M0
1743,1,1,1st Failure Type,no known failure
1743,1,1,Overall Stage,IVa
1743,1,1,Occurrence #,other primary
1743,1,1,Tumor Site,hypopharynx
1744,1,1,1st Failure Type,no known failure
1744,1,1,Clinical lab p16,p16 unkown
1744,1,1,Occurrence #,1st primary
1744,1,1,Tumor Stage,T4a
1744,1,1,2nd Failure Type,no known failure
1744,1,1,Research lab p16,p16 unknown
1744,1,1,Treatment Modality,Unknown
1744,1,1,Overall Stage,IVa
1744,1,1,Research lab HPV,HPV unknown
1744,1,1,Tumor Site,hypopharynx
1744,1,1,Nodal Stage,N1
1744,1,1,Metastasis,M0
1745,1,1,Research lab HPV,HPV unknown
1745,1,1,Tumor Stage,T4a
1745,1,1,Occurrence #,1st primary
1745,1,1,1st Failure Type,no known failure
1745,1,1,Radiation Dosage,72
1745,1,1,2nd Failure Type,no known failure
1745,1,1,Overall Stage,IVa
1745,1,1,Nodal Stage,N2
1745,1,1,Metastasis,M0
1745,1,1,Initial Chemotherapy Agent,PTX/cap
1745,1,1,Tumor Site,hypopharynx
1745,1,1,Research lab p16,p16 unknown
1745,1,1,Treatment Modality,CTX-RT
1745,1,1,Clinical lab p16,p16 unkown
1746,1,1,Treatment Modality,CTX-RT
1746,1,1,Research lab p16,p16 unknown
1746,1,1,Research lab HPV,HPV unknown
1746,1,1,2nd Failure Type,no known failure
1746,1,1,1st Failure Type,no known failure
1746,1,1,Clinical lab p16,p16 unkown
1746,1,1,Tumor Stage,T2
1746,1,1,Nodal Stage,N2
1746,1,1,Metastasis,M0
1746,1,1,Occurrence #,recurrence
1746,1,1,Radiation Dosage,60
1746,1,1,Initial Chemotherapy Agent,carbo/PTX
1746,1,1,Overall Stage,IVa
1746,1,1,Tumor Site,hypopharynx
1747,1,1,Metastasis,M0
1747,1,1,2nd Failure Type,no known failure
1747,1,1,Treatment Modality,Sx & CTX-RT
1747,1,1,Clinical lab p16,p16 unkown
1747,1,1,Overall Stage,IVb
1747,1,1,Initial Chemotherapy Agent,carbo/PTX
1747,1,1,Research lab p16,p16 unknown
1747,1,1,Tumor Site,hypopharynx
1747,1,1,1st Failure Type,distant
1747,1,1,Research lab HPV,HPV unknown
1747,1,1,Radiation Dosage,70.2
1747,1,1,Tumor Stage,T3
1747,1,1,Occurrence #,1st primary
1747,1,1,Nodal Stage,N3
1748,1,1,1st Failure Type,no known failure
1748,1,1,Initial Chemotherapy Agent,cis
1748,1,1,Tumor Stage,T4a
1748,1,1,Clinical lab p16,p16 unkown
1748,1,1,Nodal Stage,N2
1748,1,1,Research lab p16,p16 unknown
1748,1,1,Radiation Dosage,unknown
1748,1,1,Overall Stage,IVa
1748,1,1,Research lab HPV,HPV unknown
1748,1,1,Tumor Site,hypopharynx
1748,1,1,Occurrence #,1st primary
1748,1,1,2nd Failure Type,no known failure
1748,1,1,Treatment Modality,Sx & CTX-RT
1748,1,1,Metastasis,M0
1749,1,1,Overall Stage,IVa
1749,1,1,Tumor Stage,T3
1749,1,1,Radiation Dosage,70.2
1749,1,1,Treatment Modality,CTX-RT
1749,1,1,Research lab HPV,HPV unknown
1749,1,1,1st Failure Type,no known failure
1749,1,1,Research lab p16,p16 unknown
1749,1,1,Tumor Site,hypopharynx
1749,1,1,2nd Failure Type,no known failure
1749,1,1,Nodal Stage,N2
1749,1,1,Clinical lab p16,p16 unkown
1749,1,1,Occurrence #,1st primary
1749,1,1,Initial Chemotherapy Agent,cis
1749,1,1,Metastasis,M0
1750,1,1,Nodal Stage,N2
1750,1,1,Tumor Site,hypopharynx
1750,1,1,Research lab p16,p16 unknown
1750,1,1,Treatment Modality,RT
1750,1,1,1st Failure Type,no known failure
1750,1,1,2nd Failure Type,no known failure
1750,1,1,Clinical lab p16,p16 unkown
1750,1,1,Tumor Stage,T3
1750,1,1,Overall Stage,IVa
1750,1,1,Research lab HPV,HPV unknown
1750,1,1,Metastasis,M0
1750,1,1,Occurrence #,1st primary
1750,1,1,Radiation Dosage,70.2
1751,1,1,2nd Failure Type,no known failure
1751,1,1,1st Failure Site,hypopharynx
1751,1,1,Tumor Stage,T4a
1751,1,1,Treatment Modality,CTX-RT
1751,1,1,Initial Chemotherapy Agent,cis
1751,1,1,1st Failure Type,locoregional
1751,1,1,Nodal Stage,N1
1751,1,1,Research lab p16,p16 unknown
1751,1,1,Overall Stage,IVa
1751,1,1,Tumor Site,hypopharynx
1751,1,1,Occurrence #,1st primary
1751,1,1,Research lab HPV,HPV unknown
1751,1,1,Clinical lab p16,p16 unkown
1751,1,1,Radiation Dosage,70.2
1751,1,1,1st Failure Treatment Modality,Sx
1751,1,1,Metastasis,M0
1752,1,1,Clinical lab p16,p16 unkown
1752,1,1,Research lab HPV,HPV unknown
1752,1,1,1st Failure Type,locoregional
1752,1,1,Overall Stage,III
1752,1,1,Occurrence #,other primary
1752,1,1,Metastasis,M0
1752,1,1,Initial Chemotherapy Agent,carbo/5-FU
1752,1,1,Treatment Modality,Sx & CTX
1752,1,1,Tumor Stage,T3
1752,1,1,Nodal Stage,N0
1752,1,1,2nd Failure Type,no known failure
1752,1,1,Tumor Site,hypopharynx
1752,1,1,Research lab p16,p16 unknown
1753,1,1,Tumor Stage,T2
1753,1,1,1st Failure Site,hypopharynx
1753,1,1,Occurrence #,1st primary
1753,1,1,Research lab p16,p16 unknown
1753,1,1,Tumor Site,hypopharynx
1753,1,1,Overall Stage,II
1753,1,1,2nd Failure Type,no known failure
1753,1,1,Treatment Modality,RT
1753,1,1,1st Failure Type,locoregional
1753,1,1,Clinical lab p16,p16 unkown
1753,1,1,Research lab HPV,HPV unknown
1753,1,1,Metastasis,M0
1753,1,1,Nodal Stage,N0
1753,1,1,Radiation Dosage,74.4
1754,1,1,Overall Stage,IVa
1754,1,1,1st Failure Type,locoregional and distant
1754,1,1,Nodal Stage,N2
1754,1,1,Research lab p16,p16 unknown
1754,1,1,Occurrence #,1st primary
1754,1,1,Metastasis,M0
1754,1,1,Initial Chemotherapy Agent,cis
1754,1,1,Treatment Modality,CTX-RT
1754,1,1,Tumor Site,hypopharynx
1754,1,1,Radiation Dosage,70.2
1754,1,1,Tumor Stage,T2
1754,1,1,Clinical lab p16,p16 unkown
1754,1,1,Research lab HPV,HPV unknown
1754,1,1,2nd Failure Type,no known failure
1755,1,1,Research lab HPV,HPV unknown
1755,1,1,Overall Stage,I
1755,1,1,Clinical lab p16,p16 unkown
1755,1,1,1st Failure Site,hypopharynx
1755,1,1,Occurrence #,1st primary
1755,1,1,Research lab p16,p16 unknown
1755,1,1,Tumor Stage,T1
1755,1,1,1st Failure Treatment Modality,Sx
1755,1,1,Radiation Dosage,66
1755,1,1,Nodal Stage,N0
1755,1,1,2nd Failure Type,no known failure
1755,1,1,Metastasis,M0
1755,1,1,Tumor Site,hypopharynx
1755,1,1,Treatment Modality,RT
1755,1,1,1st Failure Type,locoregional
1756,1,1,Initial Chemotherapy Agent,carbo/PTX
1756,1,1,1st Failure Type,no known failure
1756,1,1,Clinical lab p16,p16 unkown
1756,1,1,Treatment Modality,CTX-RT
1756,1,1,Overall Stage,IVa
1756,1,1,Metastasis,M0
1756,1,1,Tumor Site,hypopharynx
1756,1,1,Nodal Stage,N2
1756,1,1,Research lab p16,p16 unknown
1756,1,1,Occurrence #,1st primary
1756,1,1,Radiation Dosage,70.2
1756,1,1,Research lab HPV,HPV unknown
1756,1,1,Tumor Stage,T1
1756,1,1,2nd Failure Type,no known failure
1757,1,1,1st Failure Type,no known failure
1757,1,1,Tumor Stage,T4a
1757,1,1,Treatment Modality,Unknown
1757,1,1,Occurrence #,1st primary
1757,1,1,Tumor Site,hypopharynx
1757,1,1,Nodal Stage,N1
1757,1,1,2nd Failure Type,no known failure
1757,1,1,Research lab HPV,HPV unknown
1757,1,1,Overall Stage,IVa
1757,1,1,Clinical lab p16,p16 unkown
1757,1,1,Research lab p16,p16 unknown
1757,1,1,Metastasis,M0
1758,1,1,1st Failure Type,locoregional and distant
1758,1,1,1st Failure Treatment Modality,Sx & CTX-RT
1758,1,1,1st Failure Initial Chemotherapy Agent,unknown
1758,1,1,Metastasis,M0
1758,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1758,1,1,Tumor Stage,T1
1758,1,1,Treatment Modality,CTX-RT
1758,1,1,1st Failure Site,hypopharynx
1758,1,1,1st Failure Radiation Dosage,60
1758,1,1,Tumor Site,hypopharynx
1758,1,1,Radiation Dosage,70.2
1758,1,1,Overall Stage,IVb
1758,1,1,Research lab HPV,HPV unknown
1758,1,1,2nd Failure Type,no known failure
1758,1,1,Research lab p16,p16 unknown
1758,1,1,Nodal Stage,N3
1758,1,1,Occurrence #,1st primary
1758,1,1,Clinical lab p16,p16 unkown
1759,1,1,Tumor Stage,T4b
1759,1,1,Nodal Stage,Unknown
1759,1,1,Treatment Modality,Unknown
1759,1,1,Tumor Site,hypopharynx
1759,1,1,Occurrence #,other primary
1759,1,1,1st Failure Type,no known failure
1759,1,1,Research lab p16,p16 unknown
1759,1,1,Overall Stage,IVb
1759,1,1,2nd Failure Type,no known failure
1759,1,1,Clinical lab p16,p16 unkown
1759,1,1,Research lab HPV,HPV unknown
1759,1,1,Metastasis,M0
1760,1,1,1st Failure Initial Chemotherapy Agent,cap
1760,1,1,Research lab p16,p16 unknown
1760,1,1,Nodal Stage,N2
1760,1,1,Metastasis,M0
1760,1,1,Tumor Site,hypopharynx
1760,1,1,Clinical lab p16,p16 unkown
1760,1,1,1st Failure Treatment Modality,CTX
1760,1,1,Occurrence #,1st primary
1760,1,1,Initial Chemotherapy Agent,cis/PTX
1760,1,1,Research lab HPV,HPV unknown
1760,1,1,Radiation Dosage,70.2
1760,1,1,2nd Failure Type,no known failure
1760,1,1,1st Failure Type,locoregional
1760,1,1,1st Failure Site,hypopharynx
1760,1,1,Overall Stage,IVb
1760,1,1,Second Line Chemotherapy Agent,carbo/doce
1760,1,1,Treatment Modality,CTX-RT
1760,1,1,Tumor Stage,T4b
1761,1,1,Research lab HPV,HPV unknown
1761,1,1,Radiation Dosage,72
1761,1,1,2nd Failure Type,no known failure
1761,1,1,Occurrence #,1st primary
1761,1,1,Clinical lab p16,p16 unkown
1761,1,1,Overall Stage,IVa
1761,1,1,1st Failure Type,no known failure
1761,1,1,Initial Chemotherapy Agent,carbo/PTX/cetux
1761,1,1,Treatment Modality,CTX-RT
1761,1,1,Tumor Stage,T2
1761,1,1,Research lab p16,p16 unknown
1761,1,1,Metastasis,M0
1761,1,1,Nodal Stage,N2
1761,1,1,Tumor Site,hypopharynx
1762,1,1,Nodal Stage,N0
1762,1,1,Treatment Modality,RT
1762,1,1,Occurrence #,other primary
1762,1,1,Clinical lab p16,p16 unkown
1762,1,1,Tumor Stage,T4a
1762,1,1,Metastasis,M0
1762,1,1,Tumor Site,hypopharynx
1762,1,1,1st Failure Type,locoregional
1762,1,1,Overall Stage,IVa
1762,1,1,Radiation Dosage,60
1762,1,1,Research lab HPV,HPV unknown
1762,1,1,2nd Failure Type,no known failure
1762,1,1,Research lab p16,p16 unknown
1763,1,1,Research lab HPV,HPV unknown
1763,1,1,Overall Stage,IVb
1763,1,1,Tumor Site,hypopharynx
1763,1,1,Research lab p16,p16 unknown
1763,1,1,1st Failure Type,no known failure
1763,1,1,Tumor Stage,T2
1763,1,1,Clinical lab p16,p16 unkown
1763,1,1,Occurrence #,1st primary
1763,1,1,Treatment Modality,Sx
1763,1,1,Nodal Stage,N3
1763,1,1,2nd Failure Type,no known failure
1763,1,1,Metastasis,M0
1764,1,1,Treatment Modality,RT
1764,1,1,Tumor Stage,T3
1764,1,1,Overall Stage,III
1764,1,1,Research lab p16,p16 unknown
1764,1,1,2nd Failure Type,no known failure
1764,1,1,Radiation Dosage,70.2
1764,1,1,Metastasis,M0
1764,1,1,Occurrence #,1st primary
1764,1,1,Research lab HPV,HPV unknown
1764,1,1,Clinical lab p16,p16 unkown
1764,1,1,Nodal Stage,N1
1764,1,1,1st Failure Type,locoregional and distant
1764,1,1,Tumor Site,hypopharynx
1765,1,1,Clinical lab p16,p16 unkown
1765,1,1,Research lab HPV,HPV unknown
1765,1,1,2nd Failure Type,no known failure
1765,1,1,Research lab p16,p16 unknown
1765,1,1,Nodal Stage,N3
1765,1,1,1st Failure Type,no known failure
1765,1,1,Occurrence #,1st primary
1765,1,1,Tumor Site,hypopharynx
1765,1,1,Treatment Modality,Unknown
1765,1,1,Metastasis,M0
1765,1,1,Overall Stage,IVb
1765,1,1,Tumor Stage,T2
1766,1,1,Research lab HPV,HPV unknown
1766,1,1,Metastasis,M0
1766,1,1,Treatment Modality,CTX-RT
1766,1,1,Clinical lab p16,p16 unkown
1766,1,1,Overall Stage,IVb
1766,1,1,Initial Chemotherapy Agent,carbo/PTX
1766,1,1,Occurrence #,1st primary
1766,1,1,Radiation Dosage,70.2
1766,1,1,Tumor Site,hypopharynx
1766,1,1,Tumor Stage,T3
1766,1,1,Research lab p16,p16 unknown
1766,1,1,2nd Failure Type,no known failure
1766,1,1,Nodal Stage,N3
1766,1,1,1st Failure Type,locoregional
1767,1,1,Occurrence #,recurrence
1767,1,1,Overall Stage,IVc
1767,1,1,1st Failure Type,no known failure
1767,1,1,Treatment Modality,Sx
1767,1,1,Research lab HPV,HPV unknown
1767,1,1,Metastasis,M1
1767,1,1,Nodal Stage,Unknown
1767,1,1,Tumor Stage,Unknown
1767,1,1,2nd Failure Type,no known failure
1767,1,1,Research lab p16,p16 unknown
1767,1,1,Tumor Site,hypopharynx
1767,1,1,Clinical lab p16,p16 unkown
1768,1,1,1st Failure Type,no known failure
1768,1,1,Occurrence #,1st primary
1768,1,1,Metastasis,M0
1768,1,1,2nd Failure Type,no known failure
1768,1,1,Radiation Dosage,70.2
1768,1,1,Nodal Stage,N2
1768,1,1,Tumor Stage,T4a
1768,1,1,Treatment Modality,CTX-RT
1768,1,1,Research lab p16,p16 unknown
1768,1,1,Tumor Site,hypopharynx
1768,1,1,Clinical lab p16,p16 unkown
1768,1,1,Overall Stage,IVa
1768,1,1,Research lab HPV,HPV unknown
1768,1,1,Initial Chemotherapy Agent,carbo/PTX
1769,1,1,Nodal Stage,N2
1769,1,1,Initial Chemotherapy Agent,cis
1769,1,1,Overall Stage,IVa
1769,1,1,Tumor Stage,T2
1769,1,1,2nd Failure Type,no known failure
1769,1,1,Research lab HPV,HPV unknown
1769,1,1,Tumor Site,hypopharynx
1769,1,1,Research lab p16,p16 unknown
1769,1,1,Metastasis,M0
1769,1,1,1st Failure Type,distant
1769,1,1,Treatment Modality,CTX-RT
1769,1,1,Occurrence #,1st primary
1769,1,1,Clinical lab p16,p16 unkown
1769,1,1,Radiation Dosage,70.2
1770,1,1,Treatment Modality,Sx
1770,1,1,1st Failure Treatment Modality,RT
1770,1,1,1st Failure Radiation Dosage,35
1770,1,1,Research lab HPV,HPV unknown
1770,1,1,Research lab p16,p16 unknown
1770,1,1,Tumor Stage,T1
1770,1,1,Overall Stage,III
1770,1,1,Occurrence #,other primary
1770,1,1,1st Failure Type,locoregional
1770,1,1,Clinical lab p16,p16 unkown
1770,1,1,Metastasis,M0
1770,1,1,Nodal Stage,N1
1770,1,1,Tumor Site,hypopharynx
1770,1,1,1st Failure Site,oropharynx
1770,1,1,2nd Failure Type,no known failure
1771,1,1,1st Failure Type,no known failure
1771,1,1,Clinical lab p16,p16 unkown
1771,1,1,Treatment Modality,Unknown
1771,1,1,Overall Stage,Unknown
1771,1,1,Tumor Stage,Unknown
1771,1,1,Metastasis,Unknown
1771,1,1,Nodal Stage,Unknown
1771,1,1,Tumor Site,hypopharynx
1771,1,1,Research lab HPV,HPV unknown
1771,1,1,Research lab p16,p16 unknown
1771,1,1,2nd Failure Type,no known failure
1771,1,1,Occurrence #,recurrence
1772,1,1,Tumor Stage,T4a
1772,1,1,Nodal Stage,N2
1772,1,1,Research lab p16,p16 unknown
1772,1,1,Occurrence #,other primary
1772,1,1,Treatment Modality,Sx
1772,1,1,Metastasis,M0
1772,1,1,2nd Failure Type,no known failure
1772,1,1,Clinical lab p16,p16 unkown
1772,1,1,1st Failure Type,no known failure
1772,1,1,Tumor Site,hypopharynx
1772,1,1,Research lab HPV,HPV unknown
1772,1,1,Overall Stage,IVa
1773,1,1,Occurrence #,1st primary
1773,1,1,Metastasis,M0
1773,1,1,Tumor Site,hypopharynx
1773,1,1,Research lab p16,p16 unknown
1773,1,1,2nd Failure Type,no known failure
1773,1,1,Treatment Modality,Sx & CTX-RT
1773,1,1,1st Failure Type,distant
1773,1,1,Nodal Stage,N1
1773,1,1,Overall Stage,III
1773,1,1,Radiation Dosage,70.2
1773,1,1,Clinical lab p16,p16 unkown
1773,1,1,Research lab HPV,HPV unknown
1773,1,1,Tumor Stage,T3
1773,1,1,Initial Chemotherapy Agent,cis
1774,1,1,Radiation Dosage,70.2
1774,1,1,2nd Failure Type,no known failure
1774,1,1,Overall Stage,IVa
1774,1,1,Initial Chemotherapy Agent,cetux
1774,1,1,Research lab p16,p16 unknown
1774,1,1,Nodal Stage,N2
1774,1,1,Clinical lab p16,p16 unkown
1774,1,1,Tumor Site,hypopharynx
1774,1,1,Treatment Modality,CTX-RT
1774,1,1,Research lab HPV,HPV unknown
1774,1,1,Metastasis,M0
1774,1,1,1st Failure Type,locoregional
1774,1,1,Tumor Stage,T3
1774,1,1,Occurrence #,other primary
1775,1,1,Treatment Modality,RT
1775,1,1,Nodal Stage,N2
1775,1,1,Tumor Stage,T4a
1775,1,1,2nd Failure Type,no known failure
1775,1,1,Overall Stage,IVa
1775,1,1,Clinical lab p16,p16 unkown
1775,1,1,Radiation Dosage,10
1775,1,1,Research lab HPV,HPV unknown
1775,1,1,Metastasis,M0
1775,1,1,Tumor Site,hypopharynx
1775,1,1,1st Failure Type,locoregional
1775,1,1,Research lab p16,p16 unknown
1775,1,1,Occurrence #,1st primary
1776,1,1,Research lab p16,p16 unknown
1776,1,1,Radiation Dosage,70.2
1776,1,1,Occurrence #,1st primary
1776,1,1,Research lab HPV,HPV unknown
1776,1,1,Clinical lab p16,p16 unkown
1776,1,1,Overall Stage,III
1776,1,1,Second Line Chemotherapy Agent,carbo/doce
1776,1,1,Treatment Modality,CTX-RT
1776,1,1,Nodal Stage,N1
1776,1,1,2nd Failure Type,no known failure
1776,1,1,Metastasis,M0
1776,1,1,1st Failure Type,no known failure
1776,1,1,Initial Chemotherapy Agent,cis
1776,1,1,Tumor Stage,T2
1776,1,1,Tumor Site,hypopharynx
1777,1,1,Overall Stage,IVb
1777,1,1,Tumor Stage,T4a
1777,1,1,Occurrence #,1st primary
1777,1,1,Metastasis,M0
1777,1,1,1st Failure Type,no known failure
1777,1,1,Clinical lab p16,p16 unkown
1777,1,1,2nd Failure Type,no known failure
1777,1,1,Treatment Modality,CTX-RT
1777,1,1,Research lab HPV,HPV unknown
1777,1,1,Initial Chemotherapy Agent,carbo/PTX
1777,1,1,Research lab p16,p16 unknown
1777,1,1,Tumor Site,hypopharynx
1777,1,1,Nodal Stage,N3
1777,1,1,Radiation Dosage,46.8
1778,1,1,Tumor Site,hypopharynx
1778,1,1,1st Failure Type,no known failure
1778,1,1,Radiation Dosage,70.2
1778,1,1,Tumor Stage,T4a
1778,1,1,Clinical lab p16,p16 unkown
1778,1,1,Research lab HPV,HPV unknown
1778,1,1,Occurrence #,1st primary
1778,1,1,Overall Stage,IVa
1778,1,1,2nd Failure Type,no known failure
1778,1,1,Research lab p16,p16 unknown
1778,1,1,Metastasis,M0
1778,1,1,Nodal Stage,N2
1778,1,1,Treatment Modality,RT
1779,1,1,Tumor Site,hypopharynx
1779,1,1,2nd Failure Type,no known failure
1779,1,1,Tumor Stage,T2
1779,1,1,Treatment Modality,Sx & CTX-RT
1779,1,1,Clinical lab p16,p16 unkown
1779,1,1,Research lab p16,p16 unknown
1779,1,1,Metastasis,M0
1779,1,1,1st Failure Type,locoregional
1779,1,1,Radiation Dosage,60
1779,1,1,Occurrence #,other primary
1779,1,1,Research lab HPV,HPV unknown
1779,1,1,Initial Chemotherapy Agent,carbo/PTX
1779,1,1,Nodal Stage,N0
1779,1,1,Overall Stage,II
1780,1,1,Treatment Modality,Sx
1780,1,1,Metastasis,M0
1780,1,1,Nodal Stage,N0
1780,1,1,Research lab p16,p16 unknown
1780,1,1,1st Failure Type,no known failure
1780,1,1,Tumor Stage,T3
1780,1,1,Overall Stage,III
1780,1,1,2nd Failure Type,no known failure
1780,1,1,Clinical lab p16,p16 unkown
1780,1,1,Occurrence #,recurrence
1780,1,1,Tumor Site,hypopharynx
1780,1,1,Research lab HPV,HPV unknown
1781,1,1,Nodal Stage,N3
1781,1,1,2nd Failure Type,no known failure
1781,1,1,1st Failure Type,distant
1781,1,1,Radiation Dosage,70
1781,1,1,Overall Stage,IVb
1781,1,1,Metastasis,M0
1781,1,1,Tumor Stage,T4a
1781,1,1,Initial Chemotherapy Agent,carbo/PTX
1781,1,1,Research lab p16,p16 unknown
1781,1,1,Occurrence #,1st primary
1781,1,1,Treatment Modality,Sx & CTX-RT
1781,1,1,Research lab HPV,HPV unknown
1781,1,1,Tumor Site,hypopharynx
1781,1,1,Clinical lab p16,p16 unkown
1782,1,1,Tumor Stage,T2
1782,1,1,Metastasis,M0
1782,1,1,Treatment Modality,Sx & CTX-RT
1782,1,1,Research lab HPV,HPV unknown
1782,1,1,Occurrence #,recurrence
1782,1,1,Nodal Stage,N0
1782,1,1,Tumor Site,hypopharynx
1782,1,1,1st Failure Type,no known failure
1782,1,1,2nd Failure Type,no known failure
1782,1,1,Initial Chemotherapy Agent,carbo/PTX
1782,1,1,Research lab p16,p16 unknown
1782,1,1,Overall Stage,II
1782,1,1,Clinical lab p16,p16 unkown
1782,1,1,Radiation Dosage,60
1783,1,1,Tumor Site,hypopharynx
1783,1,1,Clinical lab p16,p16 unkown
1783,1,1,2nd Failure Type,no known failure
1783,1,1,Initial Chemotherapy Agent,unknown
1783,1,1,Treatment Modality,CTX-RT
1783,1,1,1st Failure Type,no known failure
1783,1,1,Research lab p16,p16 unknown
1783,1,1,Metastasis,M0
1783,1,1,Tumor Stage,T4a
1783,1,1,Research lab HPV,HPV unknown
1783,1,1,Radiation Dosage,70.2
1783,1,1,Nodal Stage,N0
1783,1,1,Overall Stage,IVa
1783,1,1,Occurrence #,1st primary
1784,1,1,Research lab HPV,HPV unknown
1784,1,1,Tumor Site,hypopharynx
1784,1,1,Tumor Stage,T4a
1784,1,1,Clinical lab p16,p16 unkown
1784,1,1,Nodal Stage,N0
1784,1,1,2nd Failure Type,no known failure
1784,1,1,Overall Stage,IVa
1784,1,1,1st Failure Type,no known failure
1784,1,1,Metastasis,M0
1784,1,1,Research lab p16,p16 unknown
1784,1,1,Treatment Modality,Unknown
1784,1,1,Occurrence #,1st primary
1785,1,1,1st Failure Site,oral cavity
1785,1,1,Initial Chemotherapy Agent,cis
1785,1,1,1st Failure Type,locoregional
1785,1,1,Overall Stage,IVa
1785,1,1,Occurrence #,1st primary
1785,1,1,2nd Failure Type,no known failure
1785,1,1,Research lab p16,p16 unknown
1785,1,1,Radiation Dosage,unknown
1785,1,1,Clinical lab p16,p16 unkown
1785,1,1,Treatment Modality,Sx & CTX-RT
1785,1,1,Tumor Stage,T2
1785,1,1,Research lab HPV,HPV unknown
1785,1,1,Nodal Stage,N2
1785,1,1,Tumor Site,oral cavity
1785,1,1,Metastasis,M0
1786,1,1,1st Failure Type,no known failure
1786,1,1,Nodal Stage,N0
1786,1,1,Occurrence #,1st primary
1786,1,1,Research lab p16,p16 unknown
1786,1,1,Metastasis,M0
1786,1,1,Tumor Stage,T1
1786,1,1,Tumor Site,oral cavity
1786,1,1,Treatment Modality,Sx
1786,1,1,Overall Stage,I
1786,1,1,Research lab HPV,HPV unknown
1786,1,1,Clinical lab p16,p16 unkown
1786,1,1,2nd Failure Type,no known failure
1789,1,1,Nodal Stage,N3
1789,1,1,Initial Chemotherapy Agent,cis
1789,1,1,Radiation Dosage,70.2
1789,1,1,Occurrence #,1st primary
1789,1,1,Research lab HPV,HPV positive
1789,1,1,1st Failure Type,no known failure
1789,1,1,Research lab p16,p16 unknown
1789,1,1,Metastasis,M0
1789,1,1,Tumor Site,oropharynx
1789,1,1,Overall Stage,IVb
1789,1,1,Tumor Stage,T2
1789,1,1,Treatment Modality,CTX-RT
1789,1,1,2nd Failure Type,no known failure
1789,1,1,Clinical lab p16,p16 unkown
1790,1,1,1st Failure Type,locoregional and distant
1790,1,1,Research lab p16,p16 unknown
1790,1,1,Research lab HPV,HPV unknown
1790,1,1,Initial Chemotherapy Agent,Carbo/doce
1790,1,1,Metastasis,M0
1790,1,1,Overall Stage,IVa
1790,1,1,Nodal Stage,N2
1790,1,1,Clinical lab p16,p16 unkown
1790,1,1,Tumor Stage,T3
1790,1,1,Occurrence #,1st primary
1790,1,1,Treatment Modality,Sx & CTX-RT
1790,1,1,Tumor Site,oropharynx
1790,1,1,Radiation Dosage,70.2
1790,1,1,2nd Failure Type,no known failure
1791,1,1,Overall Stage,IVa
1791,1,1,1st Failure Type,no known failure
1791,1,1,Nodal Stage,N2
1791,1,1,Treatment Modality,CTX-RT
1791,1,1,2nd Failure Type,no known failure
1791,1,1,Research lab p16,p16 unknown
1791,1,1,Tumor Stage,T1
1791,1,1,Metastasis,M0
1791,1,1,Research lab HPV,HPV positive
1791,1,1,Tumor Site,oropharynx
1791,1,1,Clinical lab p16,p16 positive
1791,1,1,Initial Chemotherapy Agent,cis
1791,1,1,Occurrence #,1st primary
1791,1,1,Radiation Dosage,70.2
1792,1,1,Metastasis,M0
1792,1,1,1st Failure Type,no known failure
1792,1,1,Research lab p16,p16 unknown
1792,1,1,Treatment Modality,Unknown
1792,1,1,Overall Stage,IVb
1792,1,1,Occurrence #,1st primary
1792,1,1,Clinical lab p16,p16 unkown
1792,1,1,2nd Failure Type,no known failure
1792,1,1,Tumor Stage,T4b
1792,1,1,Research lab HPV,HPV unknown
1792,1,1,Tumor Site,oropharynx
1792,1,1,Nodal Stage,N1
1793,1,1,Radiation Dosage,70.2
1793,1,1,Tumor Site,oropharynx
1793,1,1,Overall Stage,IVa
1793,1,1,2nd Failure Type,no known failure
1793,1,1,Research lab p16,p16 unknown
1793,1,1,1st Failure Type,no known failure
1793,1,1,Clinical lab p16,p16 unkown
1793,1,1,Metastasis,M0
1793,1,1,Initial Chemotherapy Agent,carbo/doce
1793,1,1,Occurrence #,1st primary
1793,1,1,Tumor Stage,T4a
1793,1,1,Research lab HPV,HPV unknown
1793,1,1,Nodal Stage,N2
1793,1,1,Treatment Modality,CTX-RT
1794,1,1,Nodal Stage,N2
1794,1,1,Tumor Site,oropharynx
1794,1,1,Research lab HPV,HPV unknown
1794,1,1,Radiation Dosage,63
1794,1,1,Clinical lab p16,p16 unkown
1794,1,1,2nd Failure Type,no known failure
1794,1,1,Occurrence #,1st primary
1794,1,1,Treatment Modality,Sx & RT
1794,1,1,Metastasis,M0
1794,1,1,1st Failure Type,no known failure
1794,1,1,Overall Stage,IVa
1794,1,1,Tumor Stage,T1
1794,1,1,Research lab p16,p16 unknown
1795,1,1,Metastasis,M0
1795,1,1,1st Failure Type,no known failure
1795,1,1,Tumor Site,oropharynx
1795,1,1,Tumor Stage,T3
1795,1,1,2nd Failure Type,no known failure
1795,1,1,Treatment Modality,CTX-RT
1795,1,1,Research lab p16,p16 unknown
1795,1,1,Overall Stage,III
1795,1,1,Initial Chemotherapy Agent,cis
1795,1,1,Radiation Dosage,70.2
1795,1,1,Clinical lab p16,p16 unkown
1795,1,1,Research lab HPV,HPV unknown
1795,1,1,Occurrence #,1st primary
1795,1,1,Nodal Stage,N1
1796,1,1,Research lab HPV,HPV unknown
1796,1,1,Tumor Stage,T4a
1796,1,1,Metastasis,M0
1796,1,1,Research lab p16,p16 unknown
1796,1,1,Treatment Modality,Unknown
1796,1,1,Tumor Site,oropharynx
1796,1,1,Occurrence #,recurrence
1796,1,1,Clinical lab p16,p16 unkown
1796,1,1,1st Failure Type,no known failure
1796,1,1,Nodal Stage,N2
1796,1,1,Overall Stage,IVa
1796,1,1,2nd Failure Type,no known failure
1797,1,1,2nd Failure Type,no known failure
1797,1,1,Tumor Stage,T1
1797,1,1,Overall Stage,IVa
1797,1,1,Research lab p16,p16 unknown
1797,1,1,Metastasis,M0
1797,1,1,Nodal Stage,N2
1797,1,1,1st Failure Type,no known failure
1797,1,1,Clinical lab p16,p16 unkown
1797,1,1,Research lab HPV,HPV unknown
1797,1,1,Radiation Dosage,unknown
1797,1,1,Tumor Site,oropharynx
1797,1,1,Initial Chemotherapy Agent,unk
1797,1,1,Occurrence #,1st primary
1797,1,1,Treatment Modality,Sx & CTX-RT
1798,1,1,Clinical lab p16,p16 unkown
1798,1,1,1st Failure Type,no known failure
1798,1,1,Nodal Stage,N2
1798,1,1,Treatment Modality,Sx & CTX-RT
1798,1,1,Occurrence #,1st primary
1798,1,1,Tumor Site,oropharynx
1798,1,1,Radiation Dosage,63
1798,1,1,2nd Failure Type,no known failure
1798,1,1,Research lab p16,p16 unknown
1798,1,1,Tumor Stage,T1
1798,1,1,Metastasis,M0
1798,1,1,Overall Stage,IVa
1798,1,1,Initial Chemotherapy Agent,unknown
1798,1,1,Research lab HPV,HPV unknown
1799,1,1,2nd Failure Type,no known failure
1799,1,1,Metastasis,M0
1799,1,1,Tumor Site,oropharynx
1799,1,1,Tumor Stage,T3
1799,1,1,Initial Chemotherapy Agent,cis
1799,1,1,Overall Stage,IVa
1799,1,1,Occurrence #,1st primary
1799,1,1,Research lab HPV,HPV unknown
1799,1,1,Research lab p16,p16 unknown
1799,1,1,Treatment Modality,CTX-RT
1799,1,1,Clinical lab p16,p16 unkown
1799,1,1,1st Failure Type,no known failure
1799,1,1,Radiation Dosage,70.2
1799,1,1,Nodal Stage,N2
1800,1,1,Radiation Dosage,66
1800,1,1,Research lab HPV,HPV unknown
1800,1,1,Tumor Stage,T1
1800,1,1,Research lab p16,p16 unknown
1800,1,1,Tumor Site,oropharynx
1800,1,1,Treatment Modality,RT
1800,1,1,Overall Stage,I
1800,1,1,Clinical lab p16,p16 unkown
1800,1,1,Metastasis,M0
1800,1,1,Nodal Stage,N0
1800,1,1,1st Failure Type,no known failure
1800,1,1,Occurrence #,1st primary
1800,1,1,2nd Failure Type,no known failure
1801,1,1,Tumor Site,oropharynx
1801,1,1,Occurrence #,1st primary
1801,1,1,Research lab HPV,HPV unknown
1801,1,1,2nd Failure Type,no known failure
1801,1,1,Research lab p16,p16 unknown
1801,1,1,Nodal Stage,N0
1801,1,1,Metastasis,M0
1801,1,1,Overall Stage,II
1801,1,1,Tumor Stage,T2
1801,1,1,Clinical lab p16,p16 unkown
1801,1,1,Treatment Modality,Unknown
1801,1,1,1st Failure Type,no known failure
1802,1,1,Occurrence #,1st primary
1802,1,1,2nd Failure Type,no known failure
1802,1,1,Metastasis,M0
1802,1,1,Treatment Modality,CTX-RT
1802,1,1,Research lab HPV,HPV unknown
1802,1,1,Research lab p16,p16 unknown
1802,1,1,Overall Stage,IVa
1802,1,1,Tumor Site,oropharynx
1802,1,1,1st Failure Type,no known failure
1802,1,1,Nodal Stage,N2
1802,1,1,Tumor Stage,T2
1802,1,1,Clinical lab p16,p16 unkown
1803,1,1,Tumor Stage,T1
1803,1,1,Metastasis,M0
1803,1,1,Occurrence #,other primary
1803,1,1,2nd Failure Type,no known failure
1803,1,1,Research lab HPV,HPV unknown
1803,1,1,Treatment Modality,Sx & CTX-RT
1803,1,1,Radiation Dosage,60
1803,1,1,Clinical lab p16,p16 unkown
1803,1,1,1st Failure Type,no known failure
1803,1,1,Tumor Site,hypopharynx
1803,1,1,Research lab p16,p16 unknown
1803,1,1,Overall Stage,IVa
1803,1,1,Nodal Stage,N2
1803,1,1,Initial Chemotherapy Agent,unknown
1804,1,1,2nd Failure Type,no known failure
1804,1,1,Metastasis,M0
1804,1,1,Tumor Stage,T2
1804,1,1,Research lab HPV,HPV unknown
1804,1,1,Overall Stage,II
1804,1,1,Nodal Stage,N0
1804,1,1,1st Failure Type,no known failure
1804,1,1,Clinical lab p16,p16 unkown
1804,1,1,Treatment Modality,Sx
1804,1,1,Research lab p16,p16 unknown
1804,1,1,Tumor Site,hypopharynx
1804,1,1,Occurrence #,other primary
1805,1,1,Tumor Site,hypopharynx
1805,1,1,Treatment Modality,Sx
1805,1,1,1st Failure Type,no known failure
1805,1,1,2nd Failure Type,no known failure
1805,1,1,Overall Stage,III
1805,1,1,Research lab HPV,HPV unknown
1805,1,1,Occurrence #,other primary
1805,1,1,Clinical lab p16,p16 unkown
1805,1,1,Tumor Stage,Unknown
1805,1,1,Research lab p16,p16 unknown
1805,1,1,Metastasis,Unknown
1805,1,1,Nodal Stage,N1
1806,1,1,Nodal Stage,N0
1806,1,1,Clinical lab p16,p16 unkown
1806,1,1,1st Failure Type,locoregional
1806,1,1,1st Failure Site,oropharynx
1806,1,1,Occurrence #,other primary
1806,1,1,Tumor Site,oropharynx
1806,1,1,1st Failure Treatment Modality,Sx
1806,1,1,Overall Stage,II
1806,1,1,2nd Failure Type,no known failure
1806,1,1,Radiation Dosage,unknown
1806,1,1,Tumor Stage,T2
1806,1,1,Research lab p16,p16 unknown
1806,1,1,Research lab HPV,HPV unknown
1806,1,1,Metastasis,M0
1806,1,1,Treatment Modality,RT
1807,1,1,Nodal Stage,N1
1807,1,1,Radiation Dosage,unknown
1807,1,1,Clinical lab p16,p16 unkown
1807,1,1,Research lab p16,p16 negative
1807,1,1,1st Failure Type,no known failure
1807,1,1,Research lab HPV,HPV negative
1807,1,1,Occurrence #,other primary
1807,1,1,Metastasis,M0
1807,1,1,Overall Stage,IVb
1807,1,1,Treatment Modality,RT
1807,1,1,Tumor Site,oropharynx
1807,1,1,2nd Failure Type,no known failure
1807,1,1,Tumor Stage,T4b
1808,1,1,Treatment Modality,Sx & CTX
1808,1,1,Occurrence #,other primary
1808,1,1,Clinical lab p16,p16 unkown
1808,1,1,Research lab p16,p16 unknown
1808,1,1,Initial Chemotherapy Agent,cis/PTX
1808,1,1,Overall Stage,I
1808,1,1,Research lab HPV,HPV unknown
1808,1,1,1st Failure Type,locoregional
1808,1,1,2nd Failure Type,no known failure
1808,1,1,Metastasis,M0
1808,1,1,Nodal Stage,N0
1808,1,1,Tumor Stage,T1
1808,1,1,Tumor Site,oral cavity
1809,1,1,Treatment Modality,Unknown
1809,1,1,Research lab p16,p16 negative
1809,1,1,1st Failure Type,no known failure
1809,1,1,Research lab HPV,HPV negative
1809,1,1,Overall Stage,III
1809,1,1,Metastasis,M0
1809,1,1,2nd Failure Type,no known failure
1809,1,1,Clinical lab p16,p16 unkown
1809,1,1,Tumor Site,oropharynx
1809,1,1,Occurrence #,recurrence
1809,1,1,Tumor Stage,T3
1809,1,1,Nodal Stage,N0
1810,1,1,Overall Stage,IVa
1810,1,1,Radiation Dosage,70.2
1810,1,1,Occurrence #,1st primary
1810,1,1,Metastasis,M0
1810,1,1,1st Failure Type,no known failure
1810,1,1,Tumor Stage,T4a
1810,1,1,Nodal Stage,N0
1810,1,1,Initial Chemotherapy Agent,carbo/PTX
1810,1,1,Treatment Modality,CTX-RT
1810,1,1,Clinical lab p16,p16 unkown
1810,1,1,2nd Failure Type,no known failure
1810,1,1,Tumor Site,larynx
1810,1,1,Research lab HPV,HPV unknown
1810,1,1,Research lab p16,p16 unknown
1811,1,1,Research lab HPV,HPV unknown
1811,1,1,Overall Stage,IVa
1811,1,1,1st Failure Type,no known failure
1811,1,1,Clinical lab p16,p16 unkown
1811,1,1,Tumor Stage,T4a
1811,1,1,Nodal Stage,N1
1811,1,1,2nd Failure Type,no known failure
1811,1,1,Radiation Dosage,70.2
1811,1,1,Occurrence #,other primary
1811,1,1,Initial Chemotherapy Agent,carbo/PTX
1811,1,1,Tumor Site,larynx
1811,1,1,Treatment Modality,CTX-RT
1811,1,1,Metastasis,M0
1811,1,1,Research lab p16,p16 unknown
1812,1,1,Metastasis,M0
1812,1,1,Occurrence #,other primary
1812,1,1,Tumor Site,oral cavity
1812,1,1,Research lab p16,p16 unknown
1812,1,1,2nd Failure Type,no known failure
1812,1,1,Research lab HPV,HPV unknown
1812,1,1,Nodal Stage,N0
1812,1,1,Clinical lab p16,p16 unkown
1812,1,1,1st Failure Type,locoregional
1812,1,1,Tumor Stage,T2
1812,1,1,Overall Stage,II
1812,1,1,Treatment Modality,Sx
2222,1,1,Treatment Modality,Sx
2222,1,1,Clinical lab p16,p16 positive
2222,1,1,Research lab p16,p16 unknown
2222,1,1,Research lab HPV,HPV positive
2222,1,1,Overall Stage,III
2222,1,1,2nd Failure Type,no known failure
2222,1,1,Metastasis,M0
2222,1,1,Tumor Site,oral cavity
2222,1,1,Occurrence #,1st primary
2222,1,1,1st Failure Type,no known failure
2222,1,1,Tumor Stage,T3
2222,1,1,Nodal Stage,N0
2223,1,1,Tumor Site,oropharynx
2223,1,1,Metastasis,M0
2223,1,1,2nd Failure Type,no known failure
2223,1,1,Overall Stage,III
2223,1,1,Research lab p16,p16 unknown
2223,1,1,Occurrence #,recurrence
2223,1,1,Clinical lab p16,p16 positive
2223,1,1,1st Failure Type,locoregional
2223,1,1,Tumor Stage,T2
2223,1,1,Treatment Modality,Sx
2223,1,1,Research lab HPV,HPV positive
2223,1,1,Nodal Stage,N2
3000,1,1,Research lab p16,p16 unknown
3000,1,1,Tumor Site,oropharynx
3000,1,1,Initial Chemotherapy Agent,Carbo
3000,1,1,Treatment Modality,CTX-RT
3000,1,1,Occurrence #,1st primary
3000,1,1,Nodal Stage,N2
3000,1,1,Clinical lab p16,p16 positive
3000,1,1,2nd Failure Type,no known failure
3000,1,1,Radiation Dosage,70.2
3000,1,1,Research lab HPV,HPV positive
3000,1,1,Overall Stage,IVa
3000,1,1,Tumor Stage,T1
3000,1,1,Metastasis,M0
3000,1,1,1st Failure Type,no known failure
3001,1,1,Nodal Stage,N2
3001,1,1,Research lab HPV,HPV positive
3001,1,1,Treatment Modality,CTX-RT
3001,1,1,Tumor Site,oropharynx
3001,1,1,Radiation Dosage,70.2
3001,1,1,Research lab p16,p16 unknown
3001,1,1,Metastasis,M0
3001,1,1,1st Failure Type,no known failure
3001,1,1,Overall Stage,IVa
3001,1,1,Tumor Stage,T1
3001,1,1,Occurrence #,1st primary
3001,1,1,Clinical lab p16,p16 positive
3001,1,1,Initial Chemotherapy Agent,cis
3001,1,1,2nd Failure Type,no known failure
3002,1,1,Metastasis,M0
3002,1,1,1st Failure Type,no known failure
3002,1,1,Occurrence #,1st primary
3002,1,1,Nodal Stage,N2
3002,1,1,Tumor Stage,T1
3002,1,1,Tumor Site,oropharynx
3002,1,1,Treatment Modality,Sx
3002,1,1,Overall Stage,IVa
3002,1,1,2nd Failure Type,no known failure
3002,1,1,Clinical lab p16,p16 positive
3002,1,1,Research lab HPV,HPV positive
3002,1,1,Research lab p16,p16 unknown
3003,1,1,Metastasis,M0
3003,1,1,2nd Failure Type,no known failure
3003,1,1,Radiation Dosage,unknown
3003,1,1,Research lab HPV,HPV positive
3003,1,1,Nodal Stage,N0
3003,1,1,Tumor Stage,T1
3003,1,1,Clinical lab p16,p16 positive
3003,1,1,Overall Stage,I
3003,1,1,1st Failure Type,no known failure
3003,1,1,Research lab p16,p16 unknown
3003,1,1,Treatment Modality,Sx & RT
3003,1,1,Tumor Site,oropharynx
3003,1,1,Occurrence #,1st primary
3004,1,1,Initial Chemotherapy Agent,cis
3004,1,1,Metastasis,M0
3004,1,1,1st Failure Type,no known failure
3004,1,1,Radiation Dosage,70.2
3004,1,1,Overall Stage,IVa
3004,1,1,Treatment Modality,CTX-RT
3004,1,1,Tumor Stage,T1
3004,1,1,Research lab HPV,HPV positive
3004,1,1,Tumor Site,oropharynx
3004,1,1,Research lab p16,p16 unknown
3004,1,1,Clinical lab p16,p16 positive
3004,1,1,2nd Failure Type,no known failure
3004,1,1,Nodal Stage,N2
3004,1,1,Occurrence #,1st primary
3005,1,1,Occurrence #,1st primary
3005,1,1,Treatment Modality,Sx & CTX-RT
3005,1,1,Tumor Site,oropharynx
3005,1,1,Initial Chemotherapy Agent,Carbo
3005,1,1,Overall Stage,IVb
3005,1,1,Research lab HPV,HPV positive
3005,1,1,Radiation Dosage,70.2
3005,1,1,Clinical lab p16,p16 positive
3005,1,1,Tumor Stage,T2
3005,1,1,Nodal Stage,N3
3005,1,1,2nd Failure Type,no known failure
3005,1,1,Metastasis,M0
3005,1,1,Research lab p16,p16 unknown
3005,1,1,1st Failure Type,no known failure
3006,1,1,Occurrence #,1st primary
3006,1,1,Tumor Site,oropharynx
3006,1,1,Research lab HPV,HPV positive
3006,1,1,Research lab p16,p16 unknown
3006,1,1,Metastasis,M0
3006,1,1,Radiation Dosage,70.2
3006,1,1,Initial Chemotherapy Agent,cis
3006,1,1,Overall Stage,IVa
3006,1,1,Clinical lab p16,p16 positive
3006,1,1,2nd Failure Type,no known failure
3006,1,1,Treatment Modality,Sx & CTX-RT
3006,1,1,1st Failure Type,no known failure
3006,1,1,Nodal Stage,N2
3006,1,1,Tumor Stage,T1
3007,1,1,Nodal Stage,N0
3007,1,1,Tumor Stage,T2
3007,1,1,Occurrence #,1st primary
3007,1,1,Metastasis,M0
3007,1,1,Tumor Site,oropharynx
3007,1,1,Overall Stage,II
3007,1,1,2nd Failure Type,no known failure
3007,1,1,1st Failure Type,no known failure
3007,1,1,Research lab HPV,HPV positive
3007,1,1,Clinical lab p16,p16 positive
3007,1,1,Research lab p16,p16 unknown
3007,1,1,Treatment Modality,Sx
3008,1,1,1st Failure Radiation Dosage,palliative
3008,1,1,1st Failure Treatment Modality,Sx & CTX
3008,1,1,Occurrence #,1st primary
3008,1,1,Radiation Dosage,70.2
3008,1,1,2nd Failure Type,no known failure
3008,1,1,Overall Stage,IVa
3008,1,1,Tumor Stage,T2
3008,1,1,Treatment Modality,Sx & CTX-RT
3008,1,1,1st Failure Second Line Chemotherapy Agent,Treme.+MEDI
3008,1,1,1st Failure Type,distant
3008,1,1,Research lab p16,p16 unknown
3008,1,1,Clinical lab p16,p16 positive
3008,1,1,Metastasis,M0
3008,1,1,Initial Chemotherapy Agent,Carbo/cetux
3008,1,1,Tumor Site,oropharynx
3008,1,1,1st Failure Initial Chemotherapy Agent,Carbo/doce
3008,1,1,Research lab HPV,HPV positive
3008,1,1,Nodal Stage,N2
3009,1,1,Clinical lab p16,p16 positive
3009,1,1,Nodal Stage,N0
3009,1,1,Metastasis,M0
3009,1,1,Treatment Modality,CTX-RT
3009,1,1,1st Failure Type,no known failure
3009,1,1,Tumor Stage,T4a
3009,1,1,Research lab p16,p16 unknown
3009,1,1,Overall Stage,IVa
3009,1,1,Radiation Dosage,70.2
3009,1,1,2nd Failure Type,no known failure
3009,1,1,Research lab HPV,HPV positive
3009,1,1,Occurrence #,1st primary
3009,1,1,Tumor Site,oropharynx
3009,1,1,Initial Chemotherapy Agent,cis
3010,1,1,Metastasis,M0
3010,1,1,Clinical lab p16,p16 positive
3010,1,1,2nd Failure Type,no known failure
3010,1,1,Tumor Site,oropharynx
3010,1,1,Initial Chemotherapy Agent,cis
3010,1,1,Treatment Modality,CTX-RT
3010,1,1,1st Failure Type,no known failure
3010,1,1,Radiation Dosage,70.2
3010,1,1,Occurrence #,1st primary
3010,1,1,Research lab p16,p16 unknown
3010,1,1,Research lab HPV,HPV positive
3010,1,1,Overall Stage,IVa
3010,1,1,Nodal Stage,N2
3010,1,1,Tumor Stage,T1
3011,1,1,Nodal Stage,N0
3011,1,1,2nd Failure Type,no known failure
3011,1,1,1st Failure Type,no known failure
3011,1,1,Occurrence #,1st primary
3011,1,1,Clinical lab p16,p16 positive
3011,1,1,Overall Stage,I
3011,1,1,Research lab p16,p16 unknown
3011,1,1,Tumor Site,oral cavity
3011,1,1,Research lab HPV,HPV positive
3011,1,1,Treatment Modality,Sx
3011,1,1,Metastasis,M0
3011,1,1,Tumor Stage,T1
3012,1,1,Occurrence #,1st primary
3012,1,1,Overall Stage,IVa
3012,1,1,Research lab HPV,HPV positive
3012,1,1,Tumor Site,oropharynx
3012,1,1,Treatment Modality,CTX-RT
3012,1,1,Nodal Stage,N2
3012,1,1,Initial Chemotherapy Agent,cis
3012,1,1,Tumor Stage,T1
3012,1,1,1st Failure Type,no known failure
3012,1,1,Research lab p16,p16 unknown
3012,1,1,Clinical lab p16,p16 positive
3012,1,1,Radiation Dosage,68.4
3012,1,1,Metastasis,M0
3012,1,1,2nd Failure Type,no known failure
3013,1,1,Overall Stage,IVa
3013,1,1,Radiation Dosage,70.2
3013,1,1,1st Failure Type,no known failure
3013,1,1,Nodal Stage,N2
3013,1,1,Tumor Stage,T1
3013,1,1,Initial Chemotherapy Agent,cis
3013,1,1,Clinical lab p16,p16 positive
3013,1,1,Research lab p16,p16 unknown
3013,1,1,Tumor Site,oropharynx
3013,1,1,Research lab HPV,HPV positive
3013,1,1,Treatment Modality,CTX-RT
3013,1,1,Occurrence #,1st primary
3013,1,1,2nd Failure Type,no known failure
3013,1,1,Metastasis,M0
3014,1,1,Radiation Dosage,70.2
3014,1,1,Initial Chemotherapy Agent,carbo
3014,1,1,Research lab HPV,HPV positive
3014,1,1,Metastasis,M0
3014,1,1,Tumor Site,oropharynx
3014,1,1,1st Failure Treatment Modality,Sx
3014,1,1,Treatment Modality,CTX-RT
3014,1,1,Occurrence #,1st primary
3014,1,1,Tumor Stage,T2
3014,1,1,Overall Stage,III
3014,1,1,Research lab p16,p16 unknown
3014,1,1,1st Failure Site,oropharynx
3014,1,1,Clinical lab p16,p16 positive
3014,1,1,Nodal Stage,N1
3014,1,1,1st Failure Type,no known failure
3014,1,1,2nd Failure Type,no known failure
3015,1,1,Initial Chemotherapy Agent,cis
3015,1,1,2nd Failure Type,no known failure
3015,1,1,Metastasis,M0
3015,1,1,Radiation Dosage,70.2
3015,1,1,Research lab p16,p16 unknown
3015,1,1,1st Failure Type,no known failure
3015,1,1,Clinical lab p16,p16 positive
3015,1,1,Tumor Stage,T1
3015,1,1,Occurrence #,1st primary
3015,1,1,Treatment Modality,CTX-RT
3015,1,1,Nodal Stage,N2
3015,1,1,Research lab HPV,HPV positive
3015,1,1,Tumor Site,oropharynx
3015,1,1,Overall Stage,IVa
3016,1,1,Clinical lab p16,p16 positive
3016,1,1,Tumor Stage,T2
3016,1,1,2nd Failure Type,no known failure
3016,1,1,Nodal Stage,N1
3016,1,1,Initial Chemotherapy Agent,cis
3016,1,1,Occurrence #,1st primary
3016,1,1,Metastasis,M0
3016,1,1,Treatment Modality,Sx & CTX-RT
3016,1,1,Research lab p16,p16 unknown
3016,1,1,Research lab HPV,HPV positive
3016,1,1,1st Failure Type,no known failure
3016,1,1,Radiation Dosage,70.2
3016,1,1,Tumor Site,oropharynx
3016,1,1,Overall Stage,III
3017,1,1,Research lab HPV,HPV positive
3017,1,1,Treatment Modality,Sx & CTX-RT
3017,1,1,Nodal Stage,N0
3017,1,1,Occurrence #,1st primary
3017,1,1,Research lab p16,p16 unknown
3017,1,1,1st Failure Type,no known failure
3017,1,1,Clinical lab p16,p16 positive
3017,1,1,Tumor Stage,T1
3017,1,1,Radiation Dosage,66
3017,1,1,Tumor Site,oropharynx
3017,1,1,Metastasis,M0
3017,1,1,2nd Failure Type,no known failure
3017,1,1,Overall Stage,I
3017,1,1,Initial Chemotherapy Agent,Cis
3018,1,1,Treatment Modality,CTX-RT
3018,1,1,Nodal Stage,N2
3018,1,1,1st Failure Site,multiple
3018,1,1,Tumor Stage,T2
3018,1,1,Radiation Dosage,70.2
3018,1,1,Research lab HPV,HPV positive
3018,1,1,Overall Stage,IVc
3018,1,1,Occurrence #,other primary
3018,1,1,1st Failure Type,no known failure
3018,1,1,1st Failure Treatment Modality,Sx & CTX
3018,1,1,1st Failure Initial Chemotherapy Agent,cetux
3018,1,1,Metastasis,M1
3018,1,1,Tumor Site,oropharynx
3018,1,1,Initial Chemotherapy Agent,cis
3018,1,1,2nd Failure Type,no known failure
3018,1,1,Clinical lab p16,p16 positive
3018,1,1,Research lab p16,p16 unknown
3019,1,1,Occurrence #,1st primary
3019,1,1,Clinical lab p16,p16 positive
3019,1,1,Overall Stage,IVa
3019,1,1,Research lab p16,p16 unknown
3019,1,1,1st Failure Type,no known failure
3019,1,1,Tumor Site,oropharynx
3019,1,1,Initial Chemotherapy Agent,Carbo
3019,1,1,Research lab HPV,HPV positive
3019,1,1,Treatment Modality,CTX-RT
3019,1,1,Tumor Stage,T1
3019,1,1,Metastasis,M0
3019,1,1,Nodal Stage,N2
3019,1,1,Radiation Dosage,70.2
3019,1,1,2nd Failure Type,no known failure
3020,1,1,Metastasis,M0
3020,1,1,Nodal Stage,N2
3020,1,1,Tumor Stage,T2
3020,1,1,Clinical lab p16,p16 positive
3020,1,1,Radiation Dosage,70.2
3020,1,1,1st Failure Type,no known failure
3020,1,1,2nd Failure Type,no known failure
3020,1,1,Tumor Site,oropharynx
3020,1,1,Overall Stage,IVa
3020,1,1,Research lab HPV,HPV positive
3020,1,1,Treatment Modality,CTX-RT
3020,1,1,Occurrence #,1st primary
3020,1,1,Initial Chemotherapy Agent,cis
3020,1,1,Research lab p16,p16 unknown
3021,1,1,Research lab p16,p16 unknown
3021,1,1,Clinical lab p16,p16 positive
3021,1,1,Tumor Stage,T2
3021,1,1,Overall Stage,IVa
3021,1,1,Metastasis,M0
3021,1,1,Research lab HPV,HPV positive
3021,1,1,Initial Chemotherapy Agent,carbo
3021,1,1,1st Failure Type,no known failure
3021,1,1,Radiation Dosage,14
3021,1,1,Occurrence #,1st primary
3021,1,1,Treatment Modality,CTX-RT
3021,1,1,Nodal Stage,N2
3021,1,1,Tumor Site,oropharynx
3021,1,1,2nd Failure Type,no known failure
3022,1,1,Tumor Stage,T2
3022,1,1,2nd Failure Type,no known failure
3022,1,1,Overall Stage,IVa
3022,1,1,Second Line Chemotherapy Agent,Carbo
3022,1,1,Metastasis,M0
3022,1,1,Research lab p16,p16 unknown
3022,1,1,Research lab HPV,HPV positive
3022,1,1,Radiation Dosage,70.2
3022,1,1,Nodal Stage,N2
3022,1,1,1st Failure Type,no known failure
3022,1,1,Clinical lab p16,p16 positive
3022,1,1,Initial Chemotherapy Agent,cis
3022,1,1,Treatment Modality,Sx & CTX-RT
3022,1,1,Occurrence #,1st primary
3022,1,1,Tumor Site,oropharynx
3023,1,1,Tumor Stage,T2
3023,1,1,2nd Failure Type,no known failure
3023,1,1,Research lab p16,p16 unknown
3023,1,1,1st Failure Type,no known failure
3023,1,1,Overall Stage,III
3023,1,1,Clinical lab p16,p16 positive
3023,1,1,Metastasis,M0
3023,1,1,Radiation Dosage,70.2
3023,1,1,Initial Chemotherapy Agent,cis
3023,1,1,Treatment Modality,CTX-RT
3023,1,1,Nodal Stage,N1
3023,1,1,Tumor Site,oropharynx
3023,1,1,Occurrence #,1st primary
3023,1,1,Research lab HPV,HPV positive
3024,1,1,Clinical lab p16,p16 positive
3024,1,1,Occurrence #,1st primary
3024,1,1,Nodal Stage,N0
3024,1,1,Tumor Site,oral cavity
3024,1,1,Tumor Stage,T1
3024,1,1,2nd Failure Type,no known failure
3024,1,1,Treatment Modality,Sx
3024,1,1,Overall Stage,I
3024,1,1,Metastasis,M0
3024,1,1,Research lab HPV,HPV positive
3024,1,1,1st Failure Type,no known failure
3024,1,1,Research lab p16,p16 unknown
3025,1,1,Treatment Modality,Sx & RT
3025,1,1,1st Failure Type,no known failure
3025,1,1,Tumor Site,oral cavity
3025,1,1,Research lab HPV,HPV positive
3025,1,1,Radiation Dosage,59.4
3025,1,1,Occurrence #,1st primary
3025,1,1,Overall Stage,IVa
3025,1,1,Metastasis,M0
3025,1,1,Tumor Stage,T4a
3025,1,1,Nodal Stage,N0
3025,1,1,Clinical lab p16,p16 positive
3025,1,1,2nd Failure Type,no known failure
3025,1,1,Research lab p16,p16 unknown
3026,1,1,Second Line Chemotherapy Agent,carbo
3026,1,1,1st Failure Treatment Modality,Sx
3026,1,1,Radiation Dosage,63
3026,1,1,2nd Failure Type,no known failure
3026,1,1,Treatment Modality,Sx & CTX-RT
3026,1,1,Research lab HPV,HPV positive
3026,1,1,Tumor Site,oral cavity
3026,1,1,Research lab p16,p16 unknown
3026,1,1,Metastasis,M0
3026,1,1,Overall Stage,III
3026,1,1,Nodal Stage,N1
3026,1,1,1st Failure Site,oral cavity
3026,1,1,Tumor Stage,T1
3026,1,1,Initial Chemotherapy Agent,Cis
3026,1,1,1st Failure Type,no known failure
3026,1,1,Occurrence #,1st primary
3026,1,1,Clinical lab p16,p16 positive
3027,1,1,Clinical lab p16,p16 positive
3027,1,1,2nd Failure Type,no known failure
3027,1,1,Radiation Dosage,70.2
3027,1,1,Nodal Stage,N2
3027,1,1,Occurrence #,1st primary
3027,1,1,Treatment Modality,CTX-RT
3027,1,1,Overall Stage,IVa
3027,1,1,Tumor Stage,T3
3027,1,1,Metastasis,M0
3027,1,1,Tumor Site,oropharynx
3027,1,1,1st Failure Type,no known failure
3027,1,1,Research lab p16,p16 unknown
3027,1,1,Initial Chemotherapy Agent,cis
3027,1,1,Research lab HPV,HPV positive
3028,1,1,1st Failure Type,no known failure
3028,1,1,Research lab HPV,HPV positive
3028,1,1,Occurrence #,1st primary
3028,1,1,2nd Failure Type,no known failure
3028,1,1,Treatment Modality,Sx & CTX-RT
3028,1,1,Research lab p16,p16 unknown
3028,1,1,Radiation Dosage,70.2
3028,1,1,Metastasis,M0
3028,1,1,Overall Stage,IVa
3028,1,1,Nodal Stage,N2
3028,1,1,Clinical lab p16,p16 positive
3028,1,1,Tumor Site,oropharynx
3028,1,1,Initial Chemotherapy Agent,cis
3028,1,1,Tumor Stage,T3
3029,1,1,Overall Stage,II
3029,1,1,Tumor Stage,T2
3029,1,1,Tumor Site,oropharynx
3029,1,1,Research lab p16,p16 unknown
3029,1,1,1st Failure Type,no known failure
3029,1,1,Treatment Modality,Sx
3029,1,1,2nd Failure Type,no known failure
3029,1,1,Occurrence #,1st primary
3029,1,1,Metastasis,M0
3029,1,1,Research lab HPV,HPV positive
3029,1,1,Clinical lab p16,p16 positive
3029,1,1,Nodal Stage,N0
3030,1,1,Initial Chemotherapy Agent,carbo/doce
3030,1,1,Clinical lab p16,p16 positive
3030,1,1,Research lab p16,p16 unknown
3030,1,1,Overall Stage,IVb
3030,1,1,Second Line Chemotherapy Agent,Cis
3030,1,1,Nodal Stage,N3
3030,1,1,Tumor Stage,T2
3030,1,1,Metastasis,M0
3030,1,1,1st Failure Type,no known failure
3030,1,1,Research lab HPV,HPV positive
3030,1,1,Radiation Dosage,63
3030,1,1,Tumor Site,oropharynx
3030,1,1,2nd Failure Type,no known failure
3030,1,1,Occurrence #,1st primary
3030,1,1,Treatment Modality,Sx & CTX-RT
3031,1,1,Metastasis,M0
3031,1,1,Clinical lab p16,p16 positive
3031,1,1,1st Failure Type,no known failure
3031,1,1,2nd Failure Type,no known failure
3031,1,1,Tumor Stage,T4a
3031,1,1,Research lab HPV,HPV positive
3031,1,1,Occurrence #,1st primary
3031,1,1,Radiation Dosage,63
3031,1,1,Initial Chemotherapy Agent,cis
3031,1,1,Tumor Site,oropharynx
3031,1,1,Nodal Stage,N2
3031,1,1,Research lab p16,p16 unknown
3031,1,1,Treatment Modality,Sx & CTX-RT
3031,1,1,Overall Stage,IVa
3032,1,1,Initial Chemotherapy Agent,Cis
3032,1,1,Tumor Stage,T4a
3032,1,1,Tumor Site,oropharynx
3032,1,1,Research lab HPV,HPV positive
3032,1,1,Clinical lab p16,p16 positive
3032,1,1,Nodal Stage,N1
3032,1,1,Research lab p16,p16 unknown
3032,1,1,Radiation Dosage,72
3032,1,1,Overall Stage,IVa
3032,1,1,Metastasis,M0
3032,1,1,Occurrence #,1st primary
3032,1,1,1st Failure Type,no known failure
3032,1,1,Treatment Modality,Sx & CTX-RT
3032,1,1,2nd Failure Type,no known failure
3033,1,1,Research lab HPV,HPV positive
3033,1,1,Treatment Modality,Sx
3033,1,1,Nodal Stage,N0
3033,1,1,Research lab p16,p16 unknown
3033,1,1,Tumor Site,oral cavity
3033,1,1,1st Failure Type,no known failure
3033,1,1,Tumor Stage,T2
3033,1,1,2nd Failure Type,no known failure
3033,1,1,Occurrence #,1st primary
3033,1,1,Overall Stage,II
3033,1,1,Clinical lab p16,p16 positive
3033,1,1,Metastasis,M0
3034,1,1,Research lab p16,p16 unknown
3034,1,1,Tumor Stage,T1
3034,1,1,Treatment Modality,CTX-RT
3034,1,1,Initial Chemotherapy Agent,cis
3034,1,1,Metastasis,M0
3034,1,1,Clinical lab p16,p16 positive
3034,1,1,Overall Stage,IVa
3034,1,1,1st Failure Type,no known failure
3034,1,1,Research lab HPV,HPV positive
3034,1,1,Radiation Dosage,70.2
3034,1,1,Occurrence #,1st primary
3034,1,1,2nd Failure Type,no known failure
3034,1,1,Tumor Site,oropharynx
3034,1,1,Nodal Stage,N2
3035,1,1,2nd Failure Type,no known failure
3035,1,1,Metastasis,M0
3035,1,1,Overall Stage,I
3035,1,1,Nodal Stage,N0
3035,1,1,Tumor Site,oral cavity
3035,1,1,Research lab p16,p16 unknown
3035,1,1,Treatment Modality,Sx
3035,1,1,Research lab HPV,HPV positive
3035,1,1,Occurrence #,1st primary
3035,1,1,1st Failure Type,no known failure
3035,1,1,Tumor Stage,T1
3035,1,1,Clinical lab p16,p16 positive
3036,1,1,Metastasis,M0
3036,1,1,Research lab p16,p16 unknown
3036,1,1,1st Failure Type,no known failure
3036,1,1,Occurrence #,1st primary
3036,1,1,Initial Chemotherapy Agent,Cis/carbo
3036,1,1,Research lab HPV,HPV positive
3036,1,1,Treatment Modality,CTX-RT
3036,1,1,Tumor Stage,T1
3036,1,1,2nd Failure Type,no known failure
3036,1,1,Nodal Stage,N2
3036,1,1,Overall Stage,IVa
3036,1,1,Clinical lab p16,p16 positive
3036,1,1,Radiation Dosage,70.2
3036,1,1,Tumor Site,oropharynx
3037,1,1,Research lab HPV,HPV positive
3037,1,1,2nd Failure Type,no known failure
3037,1,1,Tumor Stage,T1
3037,1,1,Research lab p16,p16 unknown
3037,1,1,Treatment Modality,Sx
3037,1,1,Occurrence #,1st primary
3037,1,1,1st Failure Type,no known failure
3037,1,1,Clinical lab p16,p16 positive
3037,1,1,Overall Stage,I
3037,1,1,Nodal Stage,N0
3037,1,1,Metastasis,M0
3037,1,1,Tumor Site,oral cavity
3038,1,1,Occurrence #,1st primary
3038,1,1,Treatment Modality,CTX-RT
3038,1,1,Radiation Dosage,70.2
3038,1,1,Research lab p16,p16 unknown
3038,1,1,Nodal Stage,N1
3038,1,1,2nd Failure Type,no known failure
3038,1,1,1st Failure Type,no known failure
3038,1,1,Tumor Stage,T3
3038,1,1,Clinical lab p16,p16 positive
3038,1,1,Initial Chemotherapy Agent,cis
3038,1,1,Overall Stage,III
3038,1,1,Metastasis,M0
3038,1,1,Tumor Site,oropharynx
3038,1,1,Research lab HPV,HPV positive
3039,1,1,1st Failure Type,no known failure
3039,1,1,1st Failure Treatment Modality,Sx
3039,1,1,2nd Failure Type,no known failure
3039,1,1,Occurrence #,1st primary
3039,1,1,Tumor Stage,T1
3039,1,1,Clinical lab p16,p16 positive
3039,1,1,Research lab HPV,HPV positive
3039,1,1,Overall Stage,I
3039,1,1,Treatment Modality,Sx
3039,1,1,Nodal Stage,N0
3039,1,1,Tumor Site,oral cavity
3039,1,1,Metastasis,M0
3039,1,1,1st Failure Site,oral cavity
3039,1,1,Research lab p16,p16 unknown
3040,1,1,Nodal Stage,N2
3040,1,1,2nd Failure Type,no known failure
3040,1,1,Radiation Dosage,63
3040,1,1,Tumor Stage,T1
3040,1,1,Overall Stage,IVa
3040,1,1,Tumor Site,oropharynx
3040,1,1,Metastasis,M0
3040,1,1,Occurrence #,1st primary
3040,1,1,Clinical lab p16,p16 positive
3040,1,1,Treatment Modality,Sx & CTX-RT
3040,1,1,Research lab HPV,HPV positive
3040,1,1,1st Failure Type,no known failure
3040,1,1,Research lab p16,p16 unknown
3040,1,1,Initial Chemotherapy Agent,cis
3041,1,1,Initial Chemotherapy Agent,carbo
3041,1,1,Metastasis,M0
3041,1,1,Radiation Dosage,63
3041,1,1,Research lab HPV,HPV positive
3041,1,1,Treatment Modality,Sx & CTX-RT
3041,1,1,1st Failure Type,no known failure
3041,1,1,Research lab p16,p16 unknown
3041,1,1,2nd Failure Type,no known failure
3041,1,1,Tumor Site,oral cavity
3041,1,1,Tumor Stage,T2
3041,1,1,Overall Stage,IVa
3041,1,1,Nodal Stage,N2
3041,1,1,Clinical lab p16,p16 positive
3041,1,1,Occurrence #,1st primary
3042,1,1,Clinical lab p16,p16 positive
3042,1,1,Tumor Site,oral cavity
3042,1,1,Overall Stage,IVa
3042,1,1,Tumor Stage,T2
3042,1,1,Metastasis,M0
3042,1,1,2nd Failure Type,no known failure
3042,1,1,Treatment Modality,Sx
3042,1,1,Research lab HPV,HPV positive
3042,1,1,Nodal Stage,N2
3042,1,1,1st Failure Type,no known failure
3042,1,1,Research lab p16,p16 unknown
3042,1,1,Occurrence #,1st primary
3043,1,1,Clinical lab p16,p16 positive
3043,1,1,Research lab p16,p16 unknown
3043,1,1,1st Failure Treatment Modality,Sx & CTX-RT
3043,1,1,Radiation Dosage,64
3043,1,1,1st Failure Second Line Chemotherapy Agent,Nivo
3043,1,1,Occurrence #,1st primary
3043,1,1,Initial Chemotherapy Agent,cis
3043,1,1,1st Failure Type,no known failure
3043,1,1,1st Failure Radiation Dosage,60
3043,1,1,Tumor Site,oral cavity
3043,1,1,Research lab HPV,HPV positive
3043,1,1,Nodal Stage,N2
3043,1,1,2nd Failure Type,no known failure
3043,1,1,Overall Stage,IVa
3043,1,1,Treatment Modality,Sx & CTX-RT
3043,1,1,Metastasis,M0
3043,1,1,Tumor Stage,T3
3043,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
3044,1,1,Occurrence #,1st primary
3044,1,1,Radiation Dosage,70.2
3044,1,1,Tumor Site,oropharynx
3044,1,1,Research lab HPV,HPV positive
3044,1,1,Research lab p16,p16 unknown
3044,1,1,1st Failure Type,no known failure
3044,1,1,Overall Stage,IVa
3044,1,1,Tumor Stage,T4a
3044,1,1,Clinical lab p16,p16 positive
3044,1,1,2nd Failure Type,no known failure
3044,1,1,Treatment Modality,CTX-RT
3044,1,1,Nodal Stage,N2
3044,1,1,Initial Chemotherapy Agent,cis
3044,1,1,Metastasis,M0
3045,1,1,Treatment Modality,Sx
3045,1,1,Metastasis,M0
3045,1,1,Research lab HPV,HPV positive
3045,1,1,Tumor Site,oral cavity
3045,1,1,Research lab p16,p16 unknown
3045,1,1,Clinical lab p16,p16 positive
3045,1,1,1st Failure Type,no known failure
3045,1,1,Overall Stage,IVa
3045,1,1,Occurrence #,1st primary
3045,1,1,2nd Failure Type,no known failure
3045,1,1,Nodal Stage,N1
3045,1,1,Tumor Stage,T4a
3046,1,1,2nd Failure Type,no known failure
3046,1,1,Metastasis,M0
3046,1,1,1st Failure Site,oropharynx
3046,1,1,Tumor Stage,T1
3046,1,1,1st Failure Radiation Dosage,66
3046,1,1,Nodal Stage,N0
3046,1,1,Clinical lab p16,p16 positive
3046,1,1,1st Failure Type,no known failure
3046,1,1,Treatment Modality,Sx
3046,1,1,Occurrence #,1st primary
3046,1,1,Tumor Site,oropharynx
3046,1,1,Overall Stage,I
3046,1,1,1st Failure Treatment Modality,Sx & RT
3046,1,1,Research lab p16,p16 unknown
3046,1,1,Research lab HPV,HPV positive
3047,1,1,Metastasis,M0
3047,1,1,Tumor Site,oral cavity
3047,1,1,2nd Failure Type,no known failure
3047,1,1,Occurrence #,recurrence
3047,1,1,Research lab HPV,HPV positive
3047,1,1,Nodal Stage,N0
3047,1,1,Tumor Stage,T1
3047,1,1,1st Failure Site,larynx
3047,1,1,1st Failure Type,no known failure
3047,1,1,1st Failure Treatment Modality,Sx
3047,1,1,Treatment Modality,Sx & RT
3047,1,1,Clinical lab p16,p16 positive
3047,1,1,Overall Stage,I
3047,1,1,Research lab p16,p16 unknown
3048,1,1,1st Failure Type,no known failure
3048,1,1,Tumor Stage,T2
3048,1,1,Tumor Site,oropharynx
3048,1,1,Research lab p16,p16 unknown
3048,1,1,Metastasis,M0
3048,1,1,Overall Stage,II
3048,1,1,Treatment Modality,CTX-RT
3048,1,1,2nd Failure Type,no known failure
3048,1,1,Occurrence #,1st primary
3048,1,1,Initial Chemotherapy Agent,cis
3048,1,1,Nodal Stage,N0
3048,1,1,Clinical lab p16,p16 positive
3048,1,1,Research lab HPV,HPV positive
3048,1,1,Radiation Dosage,71.4
3049,1,1,Nodal Stage,N2
3049,1,1,1st Failure Type,no known failure
3049,1,1,Overall Stage,IVa
3049,1,1,2nd Failure Type,no known failure
3049,1,1,Occurrence #,1st primary
3049,1,1,Clinical lab p16,p16 positive
3049,1,1,Research lab HPV,HPV positive
3049,1,1,Treatment Modality,CTX-RT
3049,1,1,Initial Chemotherapy Agent,cis
3049,1,1,Metastasis,M0
3049,1,1,Tumor Site,oropharynx
3049,1,1,Tumor Stage,T2
3049,1,1,Research lab p16,p16 unknown
3049,1,1,1st Failure Treatment Modality,Sx
3049,1,1,Radiation Dosage,70.2
3050,1,1,Research lab p16,p16 unknown
3050,1,1,Research lab HPV,HPV positive
3050,1,1,1st Failure Type,no known failure
3050,1,1,Nodal Stage,N0
3050,1,1,Treatment Modality,Sx
3050,1,1,2nd Failure Type,no known failure
3050,1,1,Clinical lab p16,p16 positive
3050,1,1,Metastasis,M0
3050,1,1,Tumor Stage,T1
3050,1,1,Tumor Site,oral cavity
3050,1,1,Occurrence #,1st primary
3050,1,1,Overall Stage,I
3051,1,1,Treatment Modality,Sx
3051,1,1,2nd Failure Type,no known failure
3051,1,1,Occurrence #,1st primary
3051,1,1,Metastasis,M0
3051,1,1,Research lab p16,p16 unknown
3051,1,1,1st Failure Type,no known failure
3051,1,1,Nodal Stage,N2
3051,1,1,Tumor Site,oropharynx
3051,1,1,Research lab HPV,HPV positive
3051,1,1,Overall Stage,IVa
3051,1,1,Tumor Stage,T2
3051,1,1,Clinical lab p16,p16 positive
3052,1,1,Overall Stage,IVa
3052,1,1,Clinical lab p16,p16 positive
3052,1,1,Tumor Stage,T1
3052,1,1,Metastasis,M0
3052,1,1,Research lab HPV,HPV positive
3052,1,1,Tumor Site,oropharynx
3052,1,1,Treatment Modality,CTX-RT
3052,1,1,Second Line Chemotherapy Agent,Carbo
3052,1,1,Research lab p16,p16 unknown
3052,1,1,Radiation Dosage,70.2
3052,1,1,Initial Chemotherapy Agent,cis
3052,1,1,1st Failure Type,no known failure
3052,1,1,Occurrence #,1st primary
3052,1,1,2nd Failure Type,no known failure
3052,1,1,Nodal Stage,N2
3053,1,1,Initial Chemotherapy Agent,cis
3053,1,1,2nd Failure Type,no known failure
3053,1,1,Nodal Stage,N1
3053,1,1,Occurrence #,1st primary
3053,1,1,Treatment Modality,CTX-RT
3053,1,1,Tumor Stage,T2
3053,1,1,Research lab HPV,HPV positive
3053,1,1,Metastasis,M0
3053,1,1,Overall Stage,III
3053,1,1,1st Failure Type,no known failure
3053,1,1,Tumor Site,oropharynx
3053,1,1,Clinical lab p16,p16 positive
3053,1,1,Research lab p16,p16 unknown
3053,1,1,Radiation Dosage,68
3054,1,1,Tumor Site,oral cavity
3054,1,1,Nodal Stage,N0
3054,1,1,Metastasis,M0
3054,1,1,Clinical lab p16,p16 positive
3054,1,1,Overall Stage,I
3054,1,1,Research lab HPV,HPV positive
3054,1,1,2nd Failure Type,no known failure
3054,1,1,Treatment Modality,Sx
3054,1,1,Tumor Stage,T1
3054,1,1,Occurrence #,1st primary
3054,1,1,Research lab p16,p16 unknown
3054,1,1,1st Failure Type,no known failure
3055,1,1,Research lab HPV,HPV positive
3055,1,1,Occurrence #,other primary
3055,1,1,1st Failure Type,no known failure
3055,1,1,Treatment Modality,Sx
3055,1,1,Clinical lab p16,p16 positive
3055,1,1,2nd Failure Type,no known failure
3055,1,1,Metastasis,M0
3055,1,1,1st Failure Site,oral cavity
3055,1,1,Overall Stage,I
3055,1,1,1st Failure Treatment Modality,Sx
3055,1,1,Research lab p16,p16 unknown
3055,1,1,Nodal Stage,N0
3055,1,1,Tumor Site,oral cavity
3055,1,1,Tumor Stage,T1
3056,1,1,Initial Chemotherapy Agent,cis
3056,1,1,Second Line Chemotherapy Agent,Carbo
3056,1,1,Treatment Modality,CTX-RT
3056,1,1,Research lab p16,p16 unknown
3056,1,1,Metastasis,M0
3056,1,1,Clinical lab p16,p16 positive
3056,1,1,Nodal Stage,N2
3056,1,1,2nd Failure Type,no known failure
3056,1,1,Research lab HPV,HPV positive
3056,1,1,Radiation Dosage,70.2
3056,1,1,Tumor Stage,T1
3056,1,1,Overall Stage,IVa
3056,1,1,Tumor Site,oropharynx
3056,1,1,Occurrence #,1st primary
3056,1,1,1st Failure Type,no known failure
3057,1,1,Tumor Site,oropharynx
3057,1,1,Overall Stage,IVa
3057,1,1,Nodal Stage,N2
3057,1,1,2nd Failure Type,no known failure
3057,1,1,Research lab HPV,HPV positive
3057,1,1,Research lab p16,p16 unknown
3057,1,1,Metastasis,M0
3057,1,1,Tumor Stage,T4a
3057,1,1,1st Failure Type,no known failure
3057,1,1,Clinical lab p16,p16 positive
3057,1,1,Radiation Dosage,70.2
3057,1,1,Occurrence #,1st primary
3057,1,1,Initial Chemotherapy Agent,Carbo/doce
3057,1,1,Treatment Modality,CTX-RT
3058,1,1,Radiation Dosage,70.2
3058,1,1,1st Failure Type,no known failure
3058,1,1,Tumor Site,oropharynx
3058,1,1,Research lab HPV,HPV positive
3058,1,1,Treatment Modality,Sx & CTX-RT
3058,1,1,Metastasis,M0
3058,1,1,Research lab p16,p16 unknown
3058,1,1,Tumor Stage,T3
3058,1,1,Occurrence #,1st primary
3058,1,1,Initial Chemotherapy Agent,cis
3058,1,1,Overall Stage,III
3058,1,1,Nodal Stage,N0
3058,1,1,Clinical lab p16,p16 positive
3058,1,1,2nd Failure Type,no known failure
3059,1,1,Clinical lab p16,p16 positive
3059,1,1,Metastasis,M0
3059,1,1,2nd Failure Type,no known failure
3059,1,1,Tumor Stage,T1
3059,1,1,Research lab p16,p16 unknown
3059,1,1,Nodal Stage,N0
3059,1,1,Tumor Site,oropharynx
3059,1,1,Research lab HPV,HPV positive
3059,1,1,1st Failure Type,no known failure
3059,1,1,Treatment Modality,Sx
3059,1,1,Occurrence #,1st primary
3059,1,1,Overall Stage,I
3060,1,1,2nd Failure Type,no known failure
3060,1,1,Treatment Modality,Sx
3060,1,1,1st Failure Type,no known failure
3060,1,1,Research lab p16,p16 unknown
3060,1,1,Research lab HPV,HPV positive
3060,1,1,Nodal Stage,N2
3060,1,1,Tumor Site,oral cavity
3060,1,1,Overall Stage,IVa
3060,1,1,Occurrence #,1st primary
3060,1,1,Tumor Stage,T1
3060,1,1,Metastasis,M0
3060,1,1,Clinical lab p16,p16 positive
3061,1,1,2nd Failure Type,no known failure
3061,1,1,Research lab HPV,HPV positive
3061,1,1,Research lab p16,p16 unknown
3061,1,1,Metastasis,M0
3061,1,1,Nodal Stage,N2
3061,1,1,Tumor Site,oropharynx
3061,1,1,Clinical lab p16,p16 unkown
3061,1,1,Treatment Modality,CTX-RT
3061,1,1,Overall Stage,IVa
3061,1,1,1st Failure Type,no known failure
3061,1,1,Radiation Dosage,70.2
3061,1,1,Initial Chemotherapy Agent,carbo
3061,1,1,Occurrence #,1st primary
3061,1,1,Tumor Stage,T2
3062,1,1,Treatment Modality,CTX-RT
3062,1,1,Research lab HPV,HPV positive
3062,1,1,Tumor Site,oropharynx
3062,1,1,Research lab p16,p16 unknown
3062,1,1,Initial Chemotherapy Agent,Carbo/PTX
3062,1,1,2nd Failure Type,no known failure
3062,1,1,Nodal Stage,N2
3062,1,1,Metastasis,M0
3062,1,1,Clinical lab p16,p16 unkown
3062,1,1,Occurrence #,1st primary
3062,1,1,Radiation Dosage,70
3062,1,1,Tumor Stage,T3
3062,1,1,1st Failure Type,no known failure
3062,1,1,Overall Stage,IVa
3063,1,1,Nodal Stage,N2
3063,1,1,Occurrence #,1st primary
3063,1,1,Treatment Modality,CTX-RT
3063,1,1,2nd Failure Type,no known failure
3063,1,1,Initial Chemotherapy Agent,cis
3063,1,1,Research lab HPV,HPV positive
3063,1,1,Tumor Site,oropharynx
3063,1,1,Clinical lab p16,p16 unkown
3063,1,1,1st Failure Type,no known failure
3063,1,1,Radiation Dosage,70.2
3063,1,1,Research lab p16,p16 unknown
3063,1,1,Metastasis,M0
3063,1,1,Overall Stage,IVb
3063,1,1,Tumor Stage,T4a
3064,1,1,Clinical lab p16,p16 negative
3064,1,1,Treatment Modality,Sx & CTX-RT
3064,1,1,Research lab HPV,HPV negative
3064,1,1,1st Failure Radiation Dosage,30
3064,1,1,Tumor Stage,T2
3064,1,1,Radiation Dosage,70.2
3064,1,1,1st Failure Treatment Modality,Sx
3064,1,1,Metastasis,M0
3064,1,1,2nd Failure Type,no known failure
3064,1,1,Overall Stage,IVa
3064,1,1,Initial Chemotherapy Agent,Carbo
3064,1,1,1st Failure Type,no known failure
3064,1,1,Nodal Stage,N2
3064,1,1,Occurrence #,other primary
3064,1,1,Research lab p16,p16 unknown
3064,1,1,Tumor Site,oropharynx
3065,1,1,Research lab p16,p16 unknown
3065,1,1,Research lab HPV,HPV negative
3065,1,1,2nd Failure Type,no known failure
3065,1,1,Nodal Stage,Unknown
3065,1,1,Tumor Site,oral cavity
3065,1,1,1st Failure Type,no known failure
3065,1,1,Metastasis,Unknown
3065,1,1,Tumor Stage,Unknown
3065,1,1,Clinical lab p16,p16 negative
3065,1,1,Overall Stage,Unknown
3065,1,1,Treatment Modality,Sx
3065,1,1,Occurrence #,other primary
3066,1,1,Metastasis,Unknown
3066,1,1,Occurrence #,1st primary
3066,1,1,Tumor Stage,Unknown
3066,1,1,2nd Failure Type,no known failure
3066,1,1,Treatment Modality,Sx
3066,1,1,Nodal Stage,Unknown
3066,1,1,1st Failure Type,no known failure
3066,1,1,Clinical lab p16,p16 negative
3066,1,1,Overall Stage,Unknown
3066,1,1,Research lab p16,p16 unknown
3066,1,1,Tumor Site,oral cavity
3066,1,1,Research lab HPV,HPV negative
3067,1,1,Overall Stage,Unknown
3067,1,1,Occurrence #,1st primary
3067,1,1,Clinical lab p16,p16 negative
3067,1,1,Nodal Stage,Unknown
3067,1,1,Treatment Modality,Sx
3067,1,1,Research lab p16,p16 unknown
3067,1,1,1st Failure Type,no known failure
3067,1,1,Research lab HPV,HPV negative
3067,1,1,Metastasis,Unknown
3067,1,1,Tumor Stage,Unknown
3067,1,1,2nd Failure Type,no known failure
3067,1,1,Tumor Site,oral cavity
3068,1,1,Tumor Stage,Unknown
3068,1,1,Overall Stage,Unknown
3068,1,1,1st Failure Type,no known failure
3068,1,1,Clinical lab p16,p16 negative
3068,1,1,Occurrence #,1st primary
3068,1,1,Tumor Site,oral cavity
3068,1,1,Research lab p16,p16 unknown
3068,1,1,Metastasis,Unknown
3068,1,1,Research lab HPV,HPV negative
3068,1,1,2nd Failure Type,no known failure
3068,1,1,Nodal Stage,Unknown
3068,1,1,Treatment Modality,Sx
3069,1,1,1st Failure Type,locoregional
3069,1,1,Research lab p16,p16 unknown
3069,1,1,Nodal Stage,N0
3069,1,1,Overall Stage,I
3069,1,1,Occurrence #,recurrence
3069,1,1,Tumor Site,oral cavity
3069,1,1,Clinical lab p16,p16 negative
3069,1,1,2nd Failure Type,no known failure
3069,1,1,Research lab HPV,HPV negative
3069,1,1,Tumor Stage,T1
3069,1,1,Treatment Modality,Sx
3069,1,1,Metastasis,M0
3070,1,1,Occurrence #,1st primary
3070,1,1,Research lab p16,p16 unknown
3070,1,1,2nd Failure Type,no known failure
3070,1,1,Tumor Site,oral cavity
3070,1,1,Research lab HPV,HPV negative
3070,1,1,1st Failure Type,no known failure
3070,1,1,Metastasis,M0
3070,1,1,Treatment Modality,Sx
3070,1,1,Clinical lab p16,p16 negative
3070,1,1,Tumor Stage,T1
3070,1,1,Overall Stage,I
3070,1,1,Nodal Stage,N0
3071,1,1,2nd Failure Type,no known failure
3071,1,1,Tumor Stage,T1
3071,1,1,Clinical lab p16,p16 negative
3071,1,1,1st Failure Type,no known failure
3071,1,1,Metastasis,M0
3071,1,1,Research lab p16,p16 unknown
3071,1,1,Research lab HPV,HPV negative
3071,1,1,Occurrence #,1st primary
3071,1,1,Treatment Modality,Sx
3071,1,1,Overall Stage,I
3071,1,1,Nodal Stage,N0
3071,1,1,Tumor Site,oral cavity
3072,1,1,Occurrence #,1st primary
3072,1,1,Overall Stage,Unknown
3072,1,1,Metastasis,Unknown
3072,1,1,1st Failure Type,no known failure
3072,1,1,Treatment Modality,Sx
3072,1,1,Research lab p16,p16 unknown
3072,1,1,2nd Failure Type,no known failure
3072,1,1,Clinical lab p16,p16 negative
3072,1,1,Research lab HPV,HPV negative
3072,1,1,Tumor Site,oral cavity
3072,1,1,Nodal Stage,Unknown
3072,1,1,Tumor Stage,Unknown
3073,1,1,Research lab HPV,HPV negative
3073,1,1,Radiation Dosage,66
3073,1,1,Nodal Stage,N2
3073,1,1,Treatment Modality,Sx & CTX-RT
3073,1,1,Tumor Stage,T1
3073,1,1,2nd Failure Type,no known failure
3073,1,1,Tumor Site,oral cavity
3073,1,1,Initial Chemotherapy Agent,Cis
3073,1,1,Occurrence #,1st primary
3073,1,1,Metastasis,M0
3073,1,1,Research lab p16,p16 unknown
3073,1,1,1st Failure Type,no known failure
3073,1,1,Overall Stage,IVa
3073,1,1,Clinical lab p16,p16 negative
3074,1,1,Tumor Stage,T2
3074,1,1,1st Failure Site,oral cavity
3074,1,1,Metastasis,M0
3074,1,1,1st Failure Type,no known failure
3074,1,1,Overall Stage,II
3074,1,1,1st Failure Treatment Modality,Sx
3074,1,1,Treatment Modality,Sx
3074,1,1,Research lab p16,p16 unknown
3074,1,1,Clinical lab p16,p16 negative
3074,1,1,2nd Failure Type,no known failure
3074,1,1,Research lab HPV,HPV negative
3074,1,1,Tumor Site,oral cavity
3074,1,1,Occurrence #,1st primary
3074,1,1,Nodal Stage,N0
3075,1,1,Nodal Stage,Unknown
3075,1,1,Tumor Site,oral cavity
3075,1,1,Treatment Modality,Sx
3075,1,1,Overall Stage,Unknown
3075,1,1,Clinical lab p16,p16 negative
3075,1,1,Occurrence #,1st primary
3075,1,1,Research lab p16,p16 unknown
3075,1,1,1st Failure Type,no known failure
3075,1,1,Research lab HPV,HPV negative
3075,1,1,Tumor Stage,Unknown
3075,1,1,Metastasis,Unknown
3075,1,1,2nd Failure Type,no known failure
3076,1,1,Metastasis,Unknown
3076,1,1,Overall Stage,Unknown
3076,1,1,Clinical lab p16,p16 negative
3076,1,1,Tumor Stage,Unknown
3076,1,1,Research lab HPV,HPV negative
3076,1,1,Research lab p16,p16 unknown
3076,1,1,2nd Failure Type,no known failure
3076,1,1,Occurrence #,1st primary
3076,1,1,1st Failure Type,no known failure
3076,1,1,Tumor Site,oral cavity
3076,1,1,Nodal Stage,Unknown
3076,1,1,Treatment Modality,Sx
3077,1,1,2nd Failure Type,no known failure
3077,1,1,Tumor Stage,Unknown
3077,1,1,Research lab HPV,HPV negative
3077,1,1,Research lab p16,p16 unknown
3077,1,1,Clinical lab p16,p16 negative
3077,1,1,Tumor Site,oral cavity
3077,1,1,Overall Stage,Unknown
3077,1,1,Nodal Stage,Unknown
3077,1,1,Occurrence #,1st primary
3077,1,1,Metastasis,Unknown
3077,1,1,Treatment Modality,Sx
3077,1,1,1st Failure Type,no known failure
3078,1,1,Overall Stage,Unknown
3078,1,1,Metastasis,Unknown
3078,1,1,Occurrence #,1st primary
3078,1,1,Nodal Stage,Unknown
3078,1,1,Clinical lab p16,p16 negative
3078,1,1,Research lab p16,p16 unknown
3078,1,1,Tumor Site,oral cavity
3078,1,1,1st Failure Type,no known failure
3078,1,1,2nd Failure Type,no known failure
3078,1,1,Research lab HPV,HPV negative
3078,1,1,Tumor Stage,Unknown
3078,1,1,Treatment Modality,Sx
3079,1,1,Radiation Dosage,60
3079,1,1,Overall Stage,II
3079,1,1,1st Failure Type,no known failure
3079,1,1,Research lab p16,p16 unknown
3079,1,1,Tumor Stage,T2
3079,1,1,Treatment Modality,Sx & RT
3079,1,1,Nodal Stage,N0
3079,1,1,Clinical lab p16,p16 negative
3079,1,1,Tumor Site,oropharynx
3079,1,1,Occurrence #,1st primary
3079,1,1,Metastasis,M0
3079,1,1,2nd Failure Type,no known failure
3079,1,1,Research lab HPV,HPV negative
3080,1,1,Nodal Stage,N2
3080,1,1,Metastasis,M0
3080,1,1,Occurrence #,1st primary
3080,1,1,Tumor Stage,T4a
3080,1,1,1st Failure Type,no known failure
3080,1,1,Clinical lab p16,p16 negative
3080,1,1,Tumor Site,oral cavity
3080,1,1,Treatment Modality,CTX
3080,1,1,Overall Stage,IVa
3080,1,1,Research lab p16,p16 unknown
3080,1,1,Initial Chemotherapy Agent,PTX/Ifosfamide/carbo
3080,1,1,Research lab HPV,HPV negative
3080,1,1,2nd Failure Type,no known failure
3081,1,1,Occurrence #,1st primary
3081,1,1,2nd Failure Type,no known failure
3081,1,1,Research lab p16,p16 unknown
3081,1,1,1st Failure Type,locoregional and distant
3081,1,1,Second Line Chemotherapy Agent,Carbo
3081,1,1,Tumor Stage,T4a
3081,1,1,Nodal Stage,N2
3081,1,1,Initial Chemotherapy Agent,Cis/doce/5FU
3081,1,1,Overall Stage,IVa
3081,1,1,Treatment Modality,CTX-RT
3081,1,1,Research lab HPV,HPV negative
3081,1,1,Tumor Site,oral cavity
3081,1,1,Metastasis,M0
3081,1,1,Radiation Dosage,75.9
3081,1,1,Clinical lab p16,p16 negative
3082,1,1,Clinical lab p16,p16 negative
3082,1,1,Metastasis,M0
3082,1,1,Research lab p16,p16 unknown
3082,1,1,Treatment Modality,Sx
3082,1,1,Tumor Stage,T2
3082,1,1,Tumor Site,oral cavity
3082,1,1,Research lab HPV,HPV negative
3082,1,1,1st Failure Type,no known failure
3082,1,1,Occurrence #,1st primary
3082,1,1,2nd Failure Type,no known failure
3082,1,1,Nodal Stage,N0
3082,1,1,Overall Stage,II
3083,1,1,Tumor Stage,T4a
3083,1,1,Tumor Site,oropharynx
3083,1,1,2nd Failure Type,no known failure
3083,1,1,Clinical lab p16,p16 negative
3083,1,1,Research lab p16,p16 unknown
3083,1,1,Occurrence #,1st primary
3083,1,1,Overall Stage,IVb
3083,1,1,1st Failure Type,no known failure
3083,1,1,Research lab HPV,HPV negative
3083,1,1,Nodal Stage,N2
3083,1,1,Treatment Modality,Unknown
3083,1,1,Metastasis,M0
3084,1,1,1st Failure Type,no known failure
3084,1,1,Overall Stage,I
3084,1,1,2nd Failure Type,no known failure
3084,1,1,Nodal Stage,N0
3084,1,1,Clinical lab p16,p16 negative
3084,1,1,Occurrence #,1st primary
3084,1,1,Tumor Stage,T1
3084,1,1,Tumor Site,oral cavity
3084,1,1,Research lab HPV,HPV negative
3084,1,1,Research lab p16,p16 unknown
3084,1,1,Treatment Modality,Sx
3084,1,1,Metastasis,M0
3085,1,1,Research lab p16,p16 unknown
3085,1,1,Research lab HPV,HPV negative
3085,1,1,1st Failure Type,locoregional
3085,1,1,Clinical lab p16,p16 negative
3085,1,1,2nd Failure Type,no known failure
3085,1,1,Overall Stage,IVb
3085,1,1,Nodal Stage,N3
3085,1,1,Occurrence #,1st primary
3085,1,1,Tumor Site,oropharynx
3085,1,1,Second Line Chemotherapy Agent,Carbo
3085,1,1,Initial Chemotherapy Agent,TPF/5FU
3085,1,1,Treatment Modality,CTX
3085,1,1,Tumor Stage,T4a
3085,1,1,Metastasis,M0
3086,1,1,Initial Chemotherapy Agent,carbo
3086,1,1,Nodal Stage,N2
3086,1,1,Clinical lab p16,p16 negative
3086,1,1,2nd Failure Type,no known failure
3086,1,1,Overall Stage,IVa
3086,1,1,Occurrence #,1st primary
3086,1,1,Metastasis,M0
3086,1,1,Treatment Modality,CTX-RT
3086,1,1,Tumor Site,oropharynx
3086,1,1,Tumor Stage,T4a
3086,1,1,Research lab p16,p16 unknown
3086,1,1,1st Failure Type,no known failure
3086,1,1,Research lab HPV,HPV negative
3087,1,1,Clinical lab p16,p16 negative
3087,1,1,Treatment Modality,CTX-RT
3087,1,1,Tumor Stage,T2
3087,1,1,Radiation Dosage,60
3087,1,1,Research lab HPV,HPV negative
3087,1,1,Tumor Site,oropharynx
3087,1,1,1st Failure Type,distant
3087,1,1,Occurrence #,1st primary
3087,1,1,2nd Failure Type,no known failure
3087,1,1,Initial Chemotherapy Agent,Cis/doce/5FU
3087,1,1,Metastasis,M1
3087,1,1,Second Line Chemotherapy Agent,Cis/5FU
3087,1,1,Nodal Stage,N2
3087,1,1,Overall Stage,IVc
3087,1,1,Research lab p16,p16 unknown
3088,1,1,2nd Failure Type,no known failure
3088,1,1,Research lab HPV,HPV negative
3088,1,1,Tumor Site,oropharynx
3088,1,1,Occurrence #,other primary
3088,1,1,Metastasis,M0
3088,1,1,1st Failure Type,no known failure
3088,1,1,Treatment Modality,Sx
3088,1,1,Nodal Stage,N2
3088,1,1,Overall Stage,IVa
3088,1,1,Research lab p16,p16 unknown
3088,1,1,Tumor Stage,T4a
3088,1,1,Clinical lab p16,p16 negative
3089,1,1,Research lab HPV,HPV negative
3089,1,1,Research lab p16,p16 unknown
3089,1,1,2nd Failure Type,no known failure
3089,1,1,Metastasis,M0
3089,1,1,1st Failure Type,no known failure
3089,1,1,Overall Stage,IVa
3089,1,1,Clinical lab p16,p16 negative
3089,1,1,Tumor Stage,T4a
3089,1,1,Treatment Modality,CTX-RT
3089,1,1,Nodal Stage,N2
3089,1,1,Occurrence #,1st primary
3089,1,1,Tumor Site,oropharynx
3089,1,1,Radiation Dosage,70.2
3089,1,1,Initial Chemotherapy Agent,cis
3090,1,1,Metastasis,M0
3090,1,1,Tumor Stage,T4a
3090,1,1,Occurrence #,1st primary
3090,1,1,Tumor Site,oral cavity
3090,1,1,2nd Failure Type,no known failure
3090,1,1,Clinical lab p16,p16 negative
3090,1,1,1st Failure Site,oropharynx
3090,1,1,Nodal Stage,N0
3090,1,1,Treatment Modality,Sx
3090,1,1,Overall Stage,IVa
3090,1,1,Research lab HPV,HPV negative
3090,1,1,1st Failure Type,locoregional
3090,1,1,Research lab p16,p16 unknown
3091,1,1,Metastasis,M0
3091,1,1,Clinical lab p16,p16 negative
3091,1,1,2nd Failure Type,no known failure
3091,1,1,Occurrence #,1st primary
3091,1,1,Nodal Stage,N0
3091,1,1,Tumor Site,oral cavity
3091,1,1,Research lab HPV,HPV negative
3091,1,1,Treatment Modality,Sx
3091,1,1,1st Failure Type,no known failure
3091,1,1,Overall Stage,II
3091,1,1,Tumor Stage,T2
3091,1,1,Research lab p16,p16 unknown
3092,1,1,Radiation Dosage,60
3092,1,1,Clinical lab p16,p16 negative
3092,1,1,Initial Chemotherapy Agent,cis
3092,1,1,2nd Failure Type,no known failure
3092,1,1,Occurrence #,1st primary
3092,1,1,Treatment Modality,Sx & CTX-RT
3092,1,1,Metastasis,M0
3092,1,1,Overall Stage,IVa
3092,1,1,Research lab p16,p16 unknown
3092,1,1,Tumor Stage,T1
3092,1,1,Nodal Stage,N2
3092,1,1,Tumor Site,oral cavity
3092,1,1,Research lab HPV,HPV negative
3092,1,1,1st Failure Type,no known failure
3093,1,1,Tumor Site,oropharynx
3093,1,1,Clinical lab p16,p16 negative
3093,1,1,Initial Chemotherapy Agent,cis
3093,1,1,1st Failure Second Line Chemotherapy Agent,Carbo/AUC
3093,1,1,Nodal Stage,N2
3093,1,1,Occurrence #,1st primary
3093,1,1,Treatment Modality,Sx & CTX-RT
3093,1,1,2nd Failure Type,no known failure
3093,1,1,Overall Stage,IVa
3093,1,1,Tumor Stage,T4a
3093,1,1,Research lab HPV,HPV negative
3093,1,1,Radiation Dosage,70.2
3093,1,1,1st Failure Site,oropharynx
3093,1,1,Research lab p16,p16 unknown
3093,1,1,1st Failure Type,no known failure
3093,1,1,1st Failure Treatment Modality,Sx & RT
3093,1,1,Metastasis,M0
3093,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
3094,1,1,2nd Failure Type,no known failure
3094,1,1,Tumor Stage,T2
3094,1,1,Occurrence #,1st primary
3094,1,1,Metastasis,M0
3094,1,1,1st Failure Type,no known failure
3094,1,1,Tumor Site,oral cavity
3094,1,1,Research lab HPV,HPV negative
3094,1,1,Overall Stage,II
3094,1,1,Clinical lab p16,p16 negative
3094,1,1,Radiation Dosage,unknown
3094,1,1,Nodal Stage,N0
3094,1,1,Research lab p16,p16 unknown
3094,1,1,Treatment Modality,Sx & RT
3095,1,1,Radiation Dosage,70.2
3095,1,1,1st Failure Type,no known failure
3095,1,1,Nodal Stage,N3
3095,1,1,Clinical lab p16,p16 negative
3095,1,1,Tumor Site,oropharynx
3095,1,1,Treatment Modality,CTX-RT
3095,1,1,Metastasis,M0
3095,1,1,Research lab p16,p16 unknown
3095,1,1,Research lab HPV,HPV negative
3095,1,1,2nd Failure Type,no known failure
3095,1,1,Initial Chemotherapy Agent,cis
3095,1,1,Tumor Stage,T4a
3095,1,1,Overall Stage,IVb
3095,1,1,Occurrence #,1st primary
3096,1,1,1st Failure Type,no known failure
3096,1,1,Overall Stage,I
3096,1,1,Research lab HPV,HPV negative
3096,1,1,Treatment Modality,Sx
3096,1,1,Nodal Stage,N0
3096,1,1,Research lab p16,p16 unknown
3096,1,1,Occurrence #,1st primary
3096,1,1,Metastasis,M0
3096,1,1,Clinical lab p16,p16 negative
3096,1,1,2nd Failure Type,no known failure
3096,1,1,Tumor Stage,T1
3096,1,1,Tumor Site,oropharynx
3097,1,1,Radiation Dosage,70.2
3097,1,1,Treatment Modality,CTX-RT
3097,1,1,Clinical lab p16,p16 negative
3097,1,1,Overall Stage,IVa
3097,1,1,Metastasis,M0
3097,1,1,Nodal Stage,N2
3097,1,1,Research lab p16,p16 unknown
3097,1,1,1st Failure Type,no known failure
3097,1,1,Research lab HPV,HPV negative
3097,1,1,2nd Failure Type,no known failure
3097,1,1,Tumor Site,oropharynx
3097,1,1,Occurrence #,1st primary
3097,1,1,Tumor Stage,T3
3097,1,1,Initial Chemotherapy Agent,cis
3098,1,1,1st Failure Type,no known failure
3098,1,1,Tumor Stage,T2
3098,1,1,Research lab HPV,HPV negative
3098,1,1,Research lab p16,p16 unknown
3098,1,1,Overall Stage,II
3098,1,1,Occurrence #,1st primary
3098,1,1,Metastasis,M0
3098,1,1,Treatment Modality,Sx
3098,1,1,2nd Failure Type,no known failure
3098,1,1,Clinical lab p16,p16 negative
3098,1,1,Tumor Site,oral cavity
3098,1,1,Nodal Stage,N0
3099,1,1,1st Failure Treatment Modality,Sx & CTX-RT
3099,1,1,Tumor Site,oral cavity
3099,1,1,2nd Failure Type,no known failure
3099,1,1,1st Failure Initial Chemotherapy Agent,cis
3099,1,1,1st Failure Site,oral cavity
3099,1,1,Research lab p16,p16 unknown
3099,1,1,Tumor Stage,T4a
3099,1,1,Research lab HPV,HPV negative
3099,1,1,Occurrence #,1st primary
3099,1,1,Clinical lab p16,p16 negative
3099,1,1,Metastasis,M0
3099,1,1,1st Failure Type,no known failure
3099,1,1,Nodal Stage,N2
3099,1,1,Overall Stage,IVa
3099,1,1,Treatment Modality,Sx
3100,1,1,Clinical lab p16,p16 negative
3100,1,1,2nd Failure Type,no known failure
3100,1,1,Research lab p16,p16 unknown
3100,1,1,Tumor Site,oral cavity
3100,1,1,Tumor Stage,T2
3100,1,1,Metastasis,M0
3100,1,1,Treatment Modality,Sx
3100,1,1,Research lab HPV,HPV negative
3100,1,1,Overall Stage,IVa
3100,1,1,Occurrence #,1st primary
3100,1,1,1st Failure Type,no known failure
3100,1,1,Nodal Stage,N2
3101,1,1,Research lab HPV,HPV negative
3101,1,1,Nodal Stage,N2
3101,1,1,Clinical lab p16,p16 negative
3101,1,1,Radiation Dosage,60
3101,1,1,Metastasis,M0
3101,1,1,2nd Failure Type,no known failure
3101,1,1,Occurrence #,1st primary
3101,1,1,Treatment Modality,Sx & CTX-RT
3101,1,1,Tumor Stage,T2
3101,1,1,1st Failure Type,no known failure
3101,1,1,Research lab p16,p16 unknown
3101,1,1,Tumor Site,oral cavity
3101,1,1,Overall Stage,IVa
3101,1,1,Initial Chemotherapy Agent,Carbo
3102,1,1,1st Failure Type,no known failure
3102,1,1,Nodal Stage,N2
3102,1,1,Research lab HPV,HPV negative
3102,1,1,Overall Stage,IVa
3102,1,1,Tumor Site,oral cavity
3102,1,1,Occurrence #,1st primary
3102,1,1,Tumor Stage,T3
3102,1,1,Clinical lab p16,p16 negative
3102,1,1,Treatment Modality,Sx
3102,1,1,Research lab p16,p16 unknown
3102,1,1,Metastasis,M0
3102,1,1,2nd Failure Type,no known failure
3103,1,1,Initial Chemotherapy Agent,cis
3103,1,1,Treatment Modality,CTX-RT
3103,1,1,Nodal Stage,N2
3103,1,1,2nd Failure Type,no known failure
3103,1,1,Research lab p16,p16 unknown
3103,1,1,Clinical lab p16,p16 negative
3103,1,1,Tumor Stage,T4a
3103,1,1,Occurrence #,1st primary
3103,1,1,Tumor Site,oropharynx
3103,1,1,Radiation Dosage,70.2
3103,1,1,Overall Stage,IVa
3103,1,1,1st Failure Type,no known failure
3103,1,1,Research lab HPV,HPV negative
3103,1,1,Metastasis,M0
3104,1,1,Metastasis,M1
3104,1,1,Radiation Dosage,70
3104,1,1,Tumor Stage,T4a
3104,1,1,Clinical lab p16,p16 negative
3104,1,1,Research lab p16,p16 unknown
3104,1,1,Nodal Stage,N2
3104,1,1,Occurrence #,other primary
3104,1,1,Research lab HPV,HPV negative
3104,1,1,Tumor Site,oropharynx
3104,1,1,2nd Failure Type,no known failure
3104,1,1,Overall Stage,IVc
3104,1,1,Initial Chemotherapy Agent,cis
3104,1,1,1st Failure Type,no known failure
3104,1,1,Treatment Modality,CTX-RT
3105,1,1,1st Failure Type,distant
3105,1,1,Tumor Site,oropharynx
3105,1,1,Research lab p16,p16 unknown
3105,1,1,Tumor Stage,T3
3105,1,1,Occurrence #,1st primary
3105,1,1,Initial Chemotherapy Agent,Carbo/doce
3105,1,1,1st Failure Second Line Chemotherapy Agent,cetux
3105,1,1,Overall Stage,IVc
3105,1,1,Metastasis,M1
3105,1,1,Research lab HPV,HPV negative
3105,1,1,Clinical lab p16,p16 negative
3105,1,1,1st Failure Initial Chemotherapy Agent,carbo/pemetrexed
3105,1,1,2nd Failure Type,no known failure
3105,1,1,Nodal Stage,N2
3105,1,1,Treatment Modality,CTX
3106,1,1,Treatment Modality,Sx & CTX-RT
3106,1,1,1st Failure Treatment Modality,Sx & CTX
3106,1,1,Overall Stage,IVa
3106,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
3106,1,1,Initial Chemotherapy Agent,cis
3106,1,1,Metastasis,M0
3106,1,1,2nd Failure Type,no known failure
3106,1,1,Tumor Site,oral cavity
3106,1,1,Occurrence #,1st primary
3106,1,1,Tumor Stage,T1
3106,1,1,Nodal Stage,N2
3106,1,1,1st Failure Type,locoregional
3106,1,1,Radiation Dosage,63
3106,1,1,Research lab p16,p16 unknown
3106,1,1,Research lab HPV,HPV negative
3106,1,1,Clinical lab p16,p16 negative
3107,1,1,Overall Stage,II
3107,1,1,Nodal Stage,N0
3107,1,1,Occurrence #,recurrence
3107,1,1,1st Failure Treatment Modality,Sx
3107,1,1,1st Failure Initial Chemotherapy Agent,cis
3107,1,1,2nd Failure Type,no known failure
3107,1,1,Clinical lab p16,p16 negative
3107,1,1,Research lab p16,p16 unknown
3107,1,1,Treatment Modality,Sx
3107,1,1,1st Failure Radiation Dosage,60
3107,1,1,Metastasis,M0
3107,1,1,Tumor Site,oral cavity
3107,1,1,Tumor Stage,T2
3107,1,1,1st Failure Type,locoregional
3107,1,1,1st Failure Site,oral cavity
3107,1,1,Research lab HPV,HPV negative
3108,1,1,1st Failure Type,no known failure
3108,1,1,Research lab p16,p16 unknown
3108,1,1,Tumor Site,oropharynx
3108,1,1,Research lab HPV,HPV negative
3108,1,1,Nodal Stage,N0
3108,1,1,Occurrence #,recurrence
3108,1,1,Tumor Stage,T1
3108,1,1,Metastasis,M0
3108,1,1,Treatment Modality,Sx
3108,1,1,2nd Failure Type,no known failure
3108,1,1,Clinical lab p16,p16 negative
3108,1,1,Overall Stage,I
3109,1,1,Research lab p16,p16 unknown
3109,1,1,2nd Failure Type,no known failure
3109,1,1,Treatment Modality,Sx
3109,1,1,1st Failure Type,no known failure
3109,1,1,Nodal Stage,N0
3109,1,1,Clinical lab p16,p16 negative
3109,1,1,Research lab HPV,HPV negative
3109,1,1,Tumor Site,oral cavity
3109,1,1,Overall Stage,I
3109,1,1,Tumor Stage,T1
3109,1,1,Occurrence #,1st primary
3109,1,1,Metastasis,M0
3110,1,1,Nodal Stage,N0
3110,1,1,Radiation Dosage,66
3110,1,1,1st Failure Type,no known failure
3110,1,1,Tumor Site,oropharynx
3110,1,1,Overall Stage,II
3110,1,1,Treatment Modality,RT
3110,1,1,Clinical lab p16,p16 negative
3110,1,1,2nd Failure Type,no known failure
3110,1,1,Tumor Stage,T2
3110,1,1,Metastasis,M0
3110,1,1,Research lab HPV,HPV negative
3110,1,1,Occurrence #,Unknown
3110,1,1,Research lab p16,p16 unknown
3111,1,1,Research lab p16,p16 unknown
3111,1,1,Treatment Modality,Sx & CTX-RT
3111,1,1,Overall Stage,IVa
3111,1,1,Tumor Site,oral cavity
3111,1,1,Nodal Stage,N1
3111,1,1,Metastasis,M0
3111,1,1,Clinical lab p16,p16 negative
3111,1,1,2nd Failure Type,no known failure
3111,1,1,Tumor Stage,T4a
3111,1,1,Research lab HPV,HPV negative
3111,1,1,Occurrence #,other primary
3111,1,1,1st Failure Type,no known failure
3112,1,1,Initial Chemotherapy Agent,cis
3112,1,1,Tumor Stage,T4a
3112,1,1,Research lab HPV,HPV negative
3112,1,1,Occurrence #,1st primary
3112,1,1,Treatment Modality,Sx & CTX-RT
3112,1,1,Overall Stage,IVa
3112,1,1,Tumor Site,oral cavity
3112,1,1,Clinical lab p16,p16 negative
3112,1,1,Research lab p16,p16 unknown
3112,1,1,Nodal Stage,N2
3112,1,1,Radiation Dosage,71.4
3112,1,1,1st Failure Type,no known failure
3112,1,1,Second Line Chemotherapy Agent,Carbo
3112,1,1,Metastasis,M0
3112,1,1,2nd Failure Type,no known failure
3113,1,1,Nodal Stage,N0
3113,1,1,Tumor Site,oral cavity
3113,1,1,Metastasis,M0
3113,1,1,Overall Stage,II
3113,1,1,Tumor Stage,T2
3113,1,1,2nd Failure Type,no known failure
3113,1,1,Occurrence #,1st primary
3113,1,1,Research lab HPV,HPV negative
3113,1,1,1st Failure Type,no known failure
3113,1,1,Clinical lab p16,p16 negative
3113,1,1,Treatment Modality,Sx
3113,1,1,Research lab p16,p16 unknown
3114,1,1,Treatment Modality,Sx
3114,1,1,Research lab p16,p16 unknown
3114,1,1,1st Failure Type,no known failure
3114,1,1,Nodal Stage,N0
3114,1,1,Overall Stage,I
3114,1,1,Tumor Stage,T1
3114,1,1,Research lab HPV,HPV negative
3114,1,1,2nd Failure Type,no known failure
3114,1,1,Metastasis,M0
3114,1,1,Occurrence #,1st primary
3114,1,1,Clinical lab p16,p16 negative
3114,1,1,Tumor Site,oral cavity
3115,1,1,Research lab HPV,HPV negative
3115,1,1,Clinical lab p16,p16 negative
3115,1,1,Treatment Modality,Sx
3115,1,1,Overall Stage,I
3115,1,1,Tumor Stage,T1
3115,1,1,Metastasis,M0
3115,1,1,2nd Failure Type,no known failure
3115,1,1,Occurrence #,1st primary
3115,1,1,1st Failure Type,no known failure
3115,1,1,Research lab p16,p16 unknown
3115,1,1,Tumor Site,oral cavity
3115,1,1,Nodal Stage,N0
3116,1,1,Clinical lab p16,p16 negative
3116,1,1,Research lab HPV,HPV negative
3116,1,1,Research lab p16,p16 unknown
3116,1,1,Nodal Stage,N0
3116,1,1,Metastasis,M0
3116,1,1,Overall Stage,I
3116,1,1,Treatment Modality,Sx
3116,1,1,2nd Failure Type,no known failure
3116,1,1,Tumor Stage,T1
3116,1,1,1st Failure Type,no known failure
3116,1,1,Tumor Site,oral cavity
3116,1,1,Occurrence #,1st primary
3117,1,1,Research lab HPV,HPV negative
3117,1,1,1st Failure Type,no known failure
3117,1,1,Research lab p16,p16 unknown
3117,1,1,Metastasis,M0
3117,1,1,Overall Stage,IVa
3117,1,1,Tumor Stage,T3
3117,1,1,Occurrence #,1st primary
3117,1,1,Nodal Stage,N2
3117,1,1,2nd Failure Type,no known failure
3117,1,1,Clinical lab p16,p16 negative
3117,1,1,Treatment Modality,Sx
3117,1,1,Tumor Site,oral cavity
3118,1,1,Research lab p16,p16 unknown
3118,1,1,1st Failure Type,no known failure
3118,1,1,Occurrence #,1st primary
3118,1,1,Metastasis,M0
3118,1,1,Research lab HPV,HPV negative
3118,1,1,2nd Failure Type,no known failure
3118,1,1,Nodal Stage,N0
3118,1,1,Overall Stage,II
3118,1,1,Tumor Stage,T2
3118,1,1,Clinical lab p16,p16 negative
3118,1,1,Tumor Site,oral cavity
3118,1,1,Treatment Modality,Sx
3119,1,1,Tumor Site,oral cavity
3119,1,1,Tumor Stage,T1
3119,1,1,Research lab HPV,HPV negative
3119,1,1,Nodal Stage,N0
3119,1,1,1st Failure Type,no known failure
3119,1,1,Metastasis,M0
3119,1,1,Overall Stage,I
3119,1,1,Treatment Modality,Sx
3119,1,1,Research lab p16,p16 unknown
3119,1,1,Clinical lab p16,p16 negative
3119,1,1,2nd Failure Type,no known failure
3119,1,1,Occurrence #,1st primary
3120,1,1,Occurrence #,1st primary
3120,1,1,Treatment Modality,Sx
3120,1,1,Clinical lab p16,p16 negative
3120,1,1,Tumor Site,oral cavity
3120,1,1,1st Failure Type,no known failure
3120,1,1,Overall Stage,IVa
3120,1,1,2nd Failure Type,no known failure
3120,1,1,Research lab HPV,HPV negative
3120,1,1,Metastasis,M0
3120,1,1,Tumor Stage,T4a
3120,1,1,Research lab p16,p16 unknown
3120,1,1,Nodal Stage,N0
3121,1,1,Clinical lab p16,p16 negative
3121,1,1,Occurrence #,1st primary
3121,1,1,Tumor Site,oral cavity
3121,1,1,Nodal Stage,N0
3121,1,1,Overall Stage,IVa
3121,1,1,2nd Failure Type,no known failure
3121,1,1,Treatment Modality,Sx
3121,1,1,Research lab p16,p16 unknown
3121,1,1,1st Failure Type,no known failure
3121,1,1,Metastasis,M0
3121,1,1,Tumor Stage,T4a
3121,1,1,Research lab HPV,HPV negative
3122,1,1,Metastasis,M0
3122,1,1,Occurrence #,1st primary
3122,1,1,Tumor Site,oropharynx
3122,1,1,Tumor Stage,T1
3122,1,1,Overall Stage,I
3122,1,1,2nd Failure Type,no known failure
3122,1,1,1st Failure Site,oral cavity
3122,1,1,Clinical lab p16,p16 negative
3122,1,1,1st Failure Treatment Modality,Sx
3122,1,1,Treatment Modality,Sx
3122,1,1,Nodal Stage,N0
3122,1,1,Research lab HPV,HPV negative
3122,1,1,1st Failure Type,no known failure
3122,1,1,Research lab p16,p16 unknown
3123,1,1,Nodal Stage,N0
3123,1,1,1st Failure Type,no known failure
3123,1,1,Occurrence #,1st primary
3123,1,1,Treatment Modality,Sx & RT
3123,1,1,Overall Stage,II
3123,1,1,Tumor Site,oral cavity
3123,1,1,Research lab p16,p16 unknown
3123,1,1,Clinical lab p16,p16 negative
3123,1,1,Research lab HPV,HPV negative
3123,1,1,Radiation Dosage,59.4
3123,1,1,Metastasis,M0
3123,1,1,Tumor Stage,T2
3123,1,1,2nd Failure Type,no known failure
3124,1,1,Tumor Site,oral cavity
3124,1,1,1st Failure Type,no known failure
3124,1,1,Tumor Stage,T1
3124,1,1,Clinical lab p16,p16 negative
3124,1,1,Treatment Modality,Sx
3124,1,1,Research lab HPV,HPV negative
3124,1,1,Occurrence #,other primary
3124,1,1,Research lab p16,p16 unknown
3124,1,1,2nd Failure Type,no known failure
3124,1,1,Metastasis,M0
3124,1,1,Nodal Stage,N0
3124,1,1,Overall Stage,I
3125,1,1,Metastasis,M0
3125,1,1,Occurrence #,1st primary
3125,1,1,Radiation Dosage,63
3125,1,1,Research lab HPV,HPV negative
3125,1,1,Nodal Stage,N0
3125,1,1,Treatment Modality,Sx & RT
3125,1,1,2nd Failure Type,no known failure
3125,1,1,Overall Stage,II
3125,1,1,Research lab p16,p16 unknown
3125,1,1,1st Failure Type,no known failure
3125,1,1,Tumor Site,oral cavity
3125,1,1,Tumor Stage,T2
3125,1,1,Clinical lab p16,p16 negative
3126,1,1,Clinical lab p16,p16 negative
3126,1,1,Nodal Stage,N0
3126,1,1,Research lab p16,p16 unknown
3126,1,1,Radiation Dosage,Unknown
3126,1,1,Tumor Stage,T4a
3126,1,1,Occurrence #,1st primary
3126,1,1,Research lab HPV,HPV negative
3126,1,1,1st Failure Type,no known failure
3126,1,1,Treatment Modality,Sx & CTX-RT
3126,1,1,Metastasis,M0
3126,1,1,Initial Chemotherapy Agent,Unk
3126,1,1,Tumor Site,oral cavity
3126,1,1,Overall Stage,IVa
3126,1,1,2nd Failure Type,no known failure
3127,1,1,Overall Stage,I
3127,1,1,Research lab HPV,HPV negative
3127,1,1,2nd Failure Type,no known failure
3127,1,1,Clinical lab p16,p16 negative
3127,1,1,Treatment Modality,Sx
3127,1,1,1st Failure Treatment Modality,Sx
3127,1,1,Metastasis,M0
3127,1,1,1st Failure Type,locoregional
3127,1,1,1st Failure Site,oral cavity
3127,1,1,Tumor Stage,T1
3127,1,1,Tumor Site,oral cavity
3127,1,1,Occurrence #,other primary
3127,1,1,Research lab p16,p16 unknown
3127,1,1,Nodal Stage,N0
3128,1,1,1st Failure Type,no known failure
3128,1,1,Clinical lab p16,p16 negative
3128,1,1,Metastasis,M0
3128,1,1,Research lab p16,p16 unknown
3128,1,1,Research lab HPV,HPV negative
3128,1,1,1st Failure Treatment Modality,Sx
3128,1,1,Nodal Stage,N0
3128,1,1,1st Failure Site,oral cavity
3128,1,1,Treatment Modality,Sx
3128,1,1,Occurrence #,1st primary
3128,1,1,Overall Stage,I
3128,1,1,2nd Failure Type,no known failure
3128,1,1,Tumor Site,oral cavity
3128,1,1,Tumor Stage,T1
3129,1,1,Research lab p16,p16 unknown
3129,1,1,Tumor Stage,T2
3129,1,1,1st Failure Type,no known failure
3129,1,1,Overall Stage,II
3129,1,1,Metastasis,M0
3129,1,1,Clinical lab p16,p16 negative
3129,1,1,Tumor Site,oral cavity
3129,1,1,Research lab HPV,HPV negative
3129,1,1,Nodal Stage,N0
3129,1,1,Occurrence #,1st primary
3129,1,1,2nd Failure Type,no known failure
3129,1,1,Treatment Modality,Sx
3130,1,1,Treatment Modality,Sx & RT
3130,1,1,Research lab HPV,HPV negative
3130,1,1,Research lab p16,p16 unknown
3130,1,1,Nodal Stage,N0
3130,1,1,Tumor Site,oral cavity
3130,1,1,Clinical lab p16,p16 negative
3130,1,1,1st Failure Type,no known failure
3130,1,1,Metastasis,M0
3130,1,1,Tumor Stage,T1
3130,1,1,2nd Failure Type,no known failure
3130,1,1,Occurrence #,1st primary
3130,1,1,Radiation Dosage,66.6
3130,1,1,Overall Stage,I
3131,1,1,Research lab HPV,HPV negative
3131,1,1,Nodal Stage,N0
3131,1,1,1st Failure Type,no known failure
3131,1,1,Tumor Site,oral cavity
3131,1,1,Metastasis,M0
3131,1,1,Research lab p16,p16 unknown
3131,1,1,Clinical lab p16,p16 negative
3131,1,1,Tumor Stage,T1
3131,1,1,2nd Failure Type,no known failure
3131,1,1,Overall Stage,I
3131,1,1,Occurrence #,1st primary
3131,1,1,Treatment Modality,Sx
3132,1,1,Occurrence #,1st primary
3132,1,1,Treatment Modality,Sx
3132,1,1,Tumor Stage,T2
3132,1,1,Tumor Site,oral cavity
3132,1,1,Clinical lab p16,p16 negative
3132,1,1,1st Failure Type,no known failure
3132,1,1,Research lab HPV,HPV negative
3132,1,1,Overall Stage,II
3132,1,1,Metastasis,M0
3132,1,1,2nd Failure Type,no known failure
3132,1,1,Nodal Stage,N0
3132,1,1,Research lab p16,p16 unknown
3133,1,1,2nd Failure Type,no known failure
3133,1,1,Occurrence #,1st primary
3133,1,1,Treatment Modality,CTX-RT
3133,1,1,Tumor Site,oropharynx
3133,1,1,Clinical lab p16,p16 negative
3133,1,1,1st Failure Initial Chemotherapy Agent,carbo/doce
3133,1,1,1st Failure Type,distant
3133,1,1,Radiation Dosage,70.2
3133,1,1,Tumor Stage,T2
3133,1,1,Research lab HPV,HPV negative
3133,1,1,Research lab p16,p16 unknown
3133,1,1,Overall Stage,IVa
3133,1,1,Metastasis,M0
3133,1,1,Nodal Stage,N2
3133,1,1,1st Failure Treatment Modality,CTX
3133,1,1,Initial Chemotherapy Agent,Carbo
3134,1,1,Initial Chemotherapy Agent,cis
3134,1,1,Clinical lab p16,p16 negative
3134,1,1,Metastasis,M0
3134,1,1,Overall Stage,IVa
3134,1,1,Tumor Site,oral cavity
3134,1,1,Research lab p16,p16 unknown
3134,1,1,Occurrence #,1st primary
3134,1,1,Research lab HPV,HPV negative
3134,1,1,2nd Failure Type,no known failure
3134,1,1,Treatment Modality,Sx & CTX-RT
3134,1,1,1st Failure Type,no known failure
3134,1,1,Tumor Stage,T4a
3134,1,1,Nodal Stage,N2
3134,1,1,Radiation Dosage,63
3135,1,1,1st Failure Type,locoregional
3135,1,1,Overall Stage,IVa
3135,1,1,1st Failure Site,oral cavity
3135,1,1,1st Failure Treatment Modality,Sx
3135,1,1,Research lab p16,p16 unknown
3135,1,1,Nodal Stage,N2
3135,1,1,Tumor Stage,T4a
3135,1,1,Treatment Modality,Sx
3135,1,1,2nd Failure Type,no known failure
3135,1,1,Occurrence #,1st primary
3135,1,1,Tumor Site,oral cavity
3135,1,1,Clinical lab p16,p16 negative
3135,1,1,Metastasis,M0
3135,1,1,Research lab HPV,HPV negative
3136,1,1,Metastasis,M0
3136,1,1,Tumor Site,oral cavity
3136,1,1,Treatment Modality,Sx
3136,1,1,Tumor Stage,T1
3136,1,1,Nodal Stage,N0
3136,1,1,2nd Failure Type,no known failure
3136,1,1,Research lab HPV,HPV negative
3136,1,1,Clinical lab p16,p16 negative
3136,1,1,Occurrence #,1st primary
3136,1,1,Research lab p16,p16 unknown
3136,1,1,Overall Stage,I
3136,1,1,1st Failure Type,no known failure
3137,1,1,Overall Stage,IVa
3137,1,1,Tumor Stage,T4a
3137,1,1,Research lab HPV,HPV negative
3137,1,1,Tumor Site,oropharynx
3137,1,1,Occurrence #,1st primary
3137,1,1,Treatment Modality,Sx & CTX
3137,1,1,Clinical lab p16,p16 negative
3137,1,1,Nodal Stage,N2
3137,1,1,Metastasis,M0
3137,1,1,Initial Chemotherapy Agent,cis
3137,1,1,1st Failure Type,no known failure
3137,1,1,Research lab p16,p16 unknown
3137,1,1,2nd Failure Type,no known failure
3138,1,1,Nodal Stage,N0
3138,1,1,Overall Stage,IVa
3138,1,1,Research lab HPV,HPV negative
3138,1,1,Tumor Stage,T4a
3138,1,1,Research lab p16,p16 unknown
3138,1,1,Metastasis,M0
3138,1,1,Treatment Modality,Sx
3138,1,1,1st Failure Type,no known failure
3138,1,1,Clinical lab p16,p16 negative
3138,1,1,Occurrence #,1st primary
3138,1,1,2nd Failure Type,no known failure
3138,1,1,Tumor Site,oral cavity
3139,1,1,Overall Stage,I
3139,1,1,Occurrence #,1st primary
3139,1,1,Nodal Stage,N0
3139,1,1,2nd Failure Type,no known failure
3139,1,1,Treatment Modality,Sx
3139,1,1,1st Failure Type,no known failure
3139,1,1,Research lab p16,p16 unknown
3139,1,1,Tumor Stage,T1
3139,1,1,Clinical lab p16,p16 negative
3139,1,1,Research lab HPV,HPV negative
3139,1,1,Metastasis,M0
3139,1,1,Tumor Site,oral cavity
3140,1,1,Research lab HPV,HPV negative
3140,1,1,Nodal Stage,N2
3140,1,1,2nd Failure Type,no known failure
3140,1,1,Tumor Stage,T2
3140,1,1,Clinical lab p16,p16 negative
3140,1,1,Research lab p16,p16 unknown
3140,1,1,Tumor Site,oral cavity
3140,1,1,Treatment Modality,Sx & CTX-RT
3140,1,1,1st Failure Type,no known failure
3140,1,1,Occurrence #,1st primary
3140,1,1,Overall Stage,IVa
3140,1,1,Metastasis,M0
3141,1,1,Tumor Stage,T1
3141,1,1,2nd Failure Type,no known failure
3141,1,1,Overall Stage,I
3141,1,1,Treatment Modality,Sx & RT
3141,1,1,1st Failure Type,no known failure
3141,1,1,Tumor Site,oral cavity
3141,1,1,Metastasis,M0
3141,1,1,Research lab HPV,HPV negative
3141,1,1,Occurrence #,1st primary
3141,1,1,Nodal Stage,N0
3141,1,1,Radiation Dosage,66
3141,1,1,Research lab p16,p16 unknown
3141,1,1,Clinical lab p16,p16 negative
3142,1,1,1st Failure Site,larynx
3142,1,1,1st Failure Type,no known failure
3142,1,1,Tumor Site,oral cavity
3142,1,1,Clinical lab p16,p16 negative
3142,1,1,Occurrence #,1st primary
3142,1,1,Research lab p16,p16 unknown
3142,1,1,Metastasis,M0
3142,1,1,1st Failure Treatment Modality,Sx
3142,1,1,Treatment Modality,Sx
3142,1,1,Nodal Stage,N2
3142,1,1,Research lab HPV,HPV negative
3142,1,1,Tumor Stage,T4a
3142,1,1,Overall Stage,IVa
3142,1,1,2nd Failure Type,no known failure
3143,1,1,Nodal Stage,N2
3143,1,1,2nd Failure Type,no known failure
3143,1,1,Metastasis,M0
3143,1,1,Radiation Dosage,63
3143,1,1,Overall Stage,IVa
3143,1,1,Research lab HPV,HPV negative
3143,1,1,Occurrence #,recurrence
3143,1,1,Treatment Modality,Sx & CTX-RT
3143,1,1,Initial Chemotherapy Agent,Carbo
3143,1,1,Research lab p16,p16 unknown
3143,1,1,Tumor Site,oral cavity
3143,1,1,Clinical lab p16,p16 negative
3143,1,1,1st Failure Type,no known failure
3143,1,1,Tumor Stage,T4a
3144,1,1,Initial Chemotherapy Agent,Carbo
3144,1,1,Research lab p16,p16 unknown
3144,1,1,Overall Stage,IVa
3144,1,1,Treatment Modality,CTX-RT
3144,1,1,Metastasis,M0
3144,1,1,Second Line Chemotherapy Agent,Carbo/PTX
3144,1,1,Tumor Site,oropharynx
3144,1,1,Occurrence #,1st primary
3144,1,1,Nodal Stage,N2
3144,1,1,2nd Failure Type,no known failure
3144,1,1,Clinical lab p16,p16 negative
3144,1,1,1st Failure Type,locoregional
3144,1,1,Radiation Dosage,70.2
3144,1,1,Research lab HPV,HPV negative
3144,1,1,Tumor Stage,T2
3145,1,1,1st Failure Type,no known failure
3145,1,1,1st Failure Treatment Modality,Sx
3145,1,1,Tumor Stage,T1
3145,1,1,Research lab p16,p16 unknown
3145,1,1,Overall Stage,I
3145,1,1,Research lab HPV,HPV negative
3145,1,1,Metastasis,M0
3145,1,1,Nodal Stage,N0
3145,1,1,Treatment Modality,Sx
3145,1,1,Clinical lab p16,p16 negative
3145,1,1,Occurrence #,1st primary
3145,1,1,2nd Failure Type,no known failure
3145,1,1,Tumor Site,oral cavity
3146,1,1,Treatment Modality,Sx
3146,1,1,Clinical lab p16,p16 unkown
3146,1,1,Occurrence #,1st primary
3146,1,1,Overall Stage,I
3146,1,1,Metastasis,M0
3146,1,1,1st Failure Type,no known failure
3146,1,1,Research lab p16,p16 unknown
3146,1,1,2nd Failure Type,no known failure
3146,1,1,Tumor Site,oral cavity
3146,1,1,Tumor Stage,T1
3146,1,1,Nodal Stage,N0
3146,1,1,Research lab HPV,HPV unknown
3147,1,1,Overall Stage,III
3147,1,1,Radiation Dosage,63
3147,1,1,Nodal Stage,N1
3147,1,1,Tumor Site,oral cavity
3147,1,1,1st Failure Type,no known failure
3147,1,1,Research lab p16,p16 unknown
3147,1,1,Tumor Stage,T2
3147,1,1,Metastasis,M0
3147,1,1,2nd Failure Type,no known failure
3147,1,1,Research lab HPV,HPV unknown
3147,1,1,Occurrence #,1st primary
3147,1,1,Clinical lab p16,p16 unkown
3147,1,1,Treatment Modality,Sx & RT
3148,1,1,2nd Failure Type,no known failure
3148,1,1,1st Failure Type,no known failure
3148,1,1,Initial Chemotherapy Agent,cis
3148,1,1,Tumor Site,oral cavity
3148,1,1,Research lab p16,p16 unknown
3148,1,1,Research lab HPV,HPV unknown
3148,1,1,Tumor Stage,T4a
3148,1,1,Overall Stage,IVb
3148,1,1,Clinical lab p16,p16 negative
3148,1,1,Nodal Stage,N2
3148,1,1,Occurrence #,1st primary
3148,1,1,Treatment Modality,Sx & CTX-RT
3148,1,1,Radiation Dosage,52.2
3148,1,1,Metastasis,M0
3149,1,1,Nodal Stage,N0
3149,1,1,2nd Failure Type,no known failure
3149,1,1,Research lab p16,p16 unknown
3149,1,1,Metastasis,M0
3149,1,1,Research lab HPV,HPV unknown
3149,1,1,Treatment Modality,Sx
3149,1,1,Overall Stage,I
3149,1,1,Occurrence #,1st primary
3149,1,1,Tumor Site,oral cavity
3149,1,1,Clinical lab p16,p16 negative
3149,1,1,1st Failure Type,no known failure
3149,1,1,Tumor Stage,T1
3150,1,1,Metastasis,M0
3150,1,1,2nd Failure Type,no known failure
3150,1,1,Tumor Stage,T2
3150,1,1,Research lab p16,p16 unknown
3150,1,1,Research lab HPV,HPV unknown
3150,1,1,Clinical lab p16,p16 negative
3150,1,1,Occurrence #,1st primary
3150,1,1,Nodal Stage,N0
3150,1,1,Overall Stage,II
3150,1,1,Treatment Modality,Sx
3150,1,1,1st Failure Type,no known failure
3150,1,1,Tumor Site,oral cavity
3151,1,1,Tumor Stage,T4a
3151,1,1,Tumor Site,oral cavity
3151,1,1,Nodal Stage,N1
3151,1,1,Metastasis,M0
3151,1,1,Clinical lab p16,p16 negative
3151,1,1,Occurrence #,1st primary
3151,1,1,Research lab p16,p16 unknown
3151,1,1,Overall Stage,IVa
3151,1,1,Research lab HPV,HPV unknown
3151,1,1,Treatment Modality,Sx
3151,1,1,2nd Failure Type,no known failure
3151,1,1,1st Failure Type,no known failure
3152,1,1,Research lab HPV,HPV unknown
3152,1,1,2nd Failure Type,no known failure
3152,1,1,Metastasis,M0
3152,1,1,Overall Stage,I
3152,1,1,Research lab p16,p16 unknown
3152,1,1,Clinical lab p16,p16 negative
3152,1,1,Treatment Modality,Sx
3152,1,1,1st Failure Type,locoregional
3152,1,1,1st Failure Site,oral cavity
3152,1,1,Tumor Stage,T1
3152,1,1,Occurrence #,recurrence
3152,1,1,Tumor Site,oral cavity
3152,1,1,1st Failure Treatment Modality,Sx
3152,1,1,Nodal Stage,N0
3153,1,1,Treatment Modality,Sx
3153,1,1,Overall Stage,I
3153,1,1,1st Failure Treatment Modality,Sx
3153,1,1,Research lab p16,p16 unknown
3153,1,1,Occurrence #,1st primary
3153,1,1,Clinical lab p16,p16 unkown
3153,1,1,1st Failure Type,no known failure
3153,1,1,1st Failure Site,oral cavity
3153,1,1,Tumor Site,oral cavity
3153,1,1,Nodal Stage,N0
3153,1,1,2nd Failure Type,no known failure
3153,1,1,Tumor Stage,T1
3153,1,1,Metastasis,M0
3153,1,1,Research lab HPV,HPV unknown
3154,1,1,Occurrence #,other primary
3154,1,1,Overall Stage,IVc
3154,1,1,Research lab HPV,HPV unknown
3154,1,1,Clinical lab p16,p16 unkown
3154,1,1,Treatment Modality,Sx & CTX-RT
3154,1,1,Tumor Stage,T4a
3154,1,1,1st Failure Type,no known failure
3154,1,1,Nodal Stage,N2
3154,1,1,Research lab p16,p16 unknown
3154,1,1,Radiation Dosage,64
3154,1,1,Metastasis,M1
3154,1,1,Tumor Site,hypopharynx
3154,1,1,2nd Failure Type,no known failure
3154,1,1,Initial Chemotherapy Agent,cis
3154,1,1,Second Line Chemotherapy Agent,2/26/14
3155,1,1,Occurrence #,1st primary
3155,1,1,Research lab HPV,HPV unknown
3155,1,1,Clinical lab p16,p16 unkown
3155,1,1,Tumor Site,oral cavity
3155,1,1,2nd Failure Type,no known failure
3155,1,1,Metastasis,M0
3155,1,1,Research lab p16,p16 unknown
3155,1,1,Treatment Modality,Sx
3155,1,1,1st Failure Type,no known failure
3155,1,1,Nodal Stage,N0
3155,1,1,Overall Stage,I
3155,1,1,Tumor Stage,T1
3156,1,1,Occurrence #,1st primary
3156,1,1,Radiation Dosage,70.2
3156,1,1,Overall Stage,III
3156,1,1,Research lab HPV,HPV unknown
3156,1,1,Tumor Stage,T2
3156,1,1,Tumor Site,oropharynx
3156,1,1,Initial Chemotherapy Agent,cis
3156,1,1,2nd Failure Type,no known failure
3156,1,1,Nodal Stage,N1
3156,1,1,Research lab p16,p16 unknown
3156,1,1,Metastasis,M0
3156,1,1,1st Failure Type,no known failure
3156,1,1,Treatment Modality,CTX-RT
3156,1,1,Clinical lab p16,p16 unkown
3157,1,1,Tumor Site,oropharynx
3157,1,1,Occurrence #,1st primary
3157,1,1,Overall Stage,IVa
3157,1,1,2nd Failure Type,no known failure
3157,1,1,Tumor Stage,T4a
3157,1,1,Radiation Dosage,70.2
3157,1,1,Metastasis,M0
3157,1,1,1st Failure Type,no known failure
3157,1,1,Initial Chemotherapy Agent,cis
3157,1,1,Nodal Stage,N1
3157,1,1,Second Line Chemotherapy Agent,Carbo
3157,1,1,Treatment Modality,Sx & CTX-RT
3157,1,1,Clinical lab p16,p16 unkown
3157,1,1,Research lab HPV,HPV unknown
3157,1,1,Research lab p16,p16 unknown
3158,1,1,Overall Stage,I
3158,1,1,Research lab HPV,HPV unknown
3158,1,1,2nd Failure Type,no known failure
3158,1,1,Nodal Stage,N0
3158,1,1,Research lab p16,p16 unknown
3158,1,1,Clinical lab p16,p16 unkown
3158,1,1,Treatment Modality,Sx
3158,1,1,Tumor Stage,T1
3158,1,1,1st Failure Type,no known failure
3158,1,1,Occurrence #,1st primary
3158,1,1,Metastasis,M0
3158,1,1,Tumor Site,oral cavity
3159,1,1,Clinical lab p16,p16 unkown
3159,1,1,Occurrence #,1st primary
3159,1,1,Tumor Site,oropharynx
3159,1,1,Treatment Modality,CTX-RT
3159,1,1,Radiation Dosage,70.2
3159,1,1,Metastasis,M0
3159,1,1,Tumor Stage,T2
3159,1,1,Initial Chemotherapy Agent,carbo/PTX
3159,1,1,2nd Failure Type,no known failure
3159,1,1,Nodal Stage,N2
3159,1,1,Overall Stage,IVa
3159,1,1,Research lab p16,p16 unknown
3159,1,1,Research lab HPV,HPV unknown
3159,1,1,1st Failure Type,no known failure
3160,1,1,Treatment Modality,Sx & CTX-RT
3160,1,1,Tumor Stage,T4a
3160,1,1,Metastasis,M0
3160,1,1,Research lab p16,p16 unknown
3160,1,1,2nd Failure Type,no known failure
3160,1,1,Initial Chemotherapy Agent,unknown
3160,1,1,Research lab HPV,HPV unknown
3160,1,1,Overall Stage,IVb
3160,1,1,Tumor Site,oropharynx
3160,1,1,Occurrence #,1st primary
3160,1,1,Clinical lab p16,p16 unkown
3160,1,1,Radiation Dosage,unknown
3160,1,1,1st Failure Type,no known failure
3160,1,1,Nodal Stage,N3
3161,1,1,2nd Failure Type,no known failure
3161,1,1,Treatment Modality,Sx
3161,1,1,Research lab HPV,HPV unknown
3161,1,1,Occurrence #,1st primary
3161,1,1,Tumor Site,oral cavity
3161,1,1,Clinical lab p16,p16 unkown
3161,1,1,Metastasis,M0
3161,1,1,Tumor Stage,T2
3161,1,1,Nodal Stage,N2
3161,1,1,Research lab p16,p16 unknown
3161,1,1,Overall Stage,IVa
3161,1,1,1st Failure Type,no known failure
3162,1,1,Metastasis,M0
3162,1,1,Clinical lab p16,p16 unkown
3162,1,1,Tumor Site,oral cavity
3162,1,1,Tumor Stage,T1
3162,1,1,1st Failure Site,oral cavity
3162,1,1,1st Failure Type,locoregional
3162,1,1,1st Failure Initial Chemotherapy Agent,Cis
3162,1,1,Nodal Stage,N0
3162,1,1,2nd Failure Type,no known failure
3162,1,1,Occurrence #,1st primary
3162,1,1,Research lab p16,p16 unknown
3162,1,1,Overall Stage,I
3162,1,1,1st Failure Treatment Modality,Sx & CTX-RT
3162,1,1,Research lab HPV,HPV unknown
3162,1,1,Treatment Modality,Sx
3163,1,1,Clinical lab p16,p16 unkown
3163,1,1,Metastasis,M0
3163,1,1,Occurrence #,1st primary
3163,1,1,Research lab p16,p16 unknown
3163,1,1,Treatment Modality,Sx
3163,1,1,Tumor Site,oral cavity
3163,1,1,Overall Stage,I
3163,1,1,Nodal Stage,N0
3163,1,1,Tumor Stage,T1
3163,1,1,Research lab HPV,HPV unknown
3163,1,1,2nd Failure Type,no known failure
3163,1,1,1st Failure Type,no known failure
3164,1,1,Occurrence #,1st primary
3164,1,1,Treatment Modality,Sx
3164,1,1,Metastasis,M0
3164,1,1,Tumor Site,oral cavity
3164,1,1,2nd Failure Type,no known failure
3164,1,1,Tumor Stage,T4a
3164,1,1,Research lab p16,p16 unknown
3164,1,1,Nodal Stage,N0
3164,1,1,Clinical lab p16,p16 unkown
3164,1,1,Research lab HPV,HPV unknown
3164,1,1,Overall Stage,IVa
3164,1,1,1st Failure Type,no known failure
3165,1,1,Research lab p16,p16 unknown
3165,1,1,Overall Stage,IVa
3165,1,1,Treatment Modality,Sx
3165,1,1,Metastasis,M0
3165,1,1,Tumor Stage,T4a
3165,1,1,Tumor Site,oral cavity
3165,1,1,2nd Failure Type,no known failure
3165,1,1,Research lab HPV,HPV unknown
3165,1,1,1st Failure Type,no known failure
3165,1,1,Nodal Stage,N2
3165,1,1,Occurrence #,1st primary
3165,1,1,Clinical lab p16,p16 unkown
3166,1,1,Tumor Stage,T2
3166,1,1,Treatment Modality,CTX-RT
3166,1,1,Clinical lab p16,p16 unkown
3166,1,1,1st Failure Type,no known failure
3166,1,1,Metastasis,M0
3166,1,1,Research lab HPV,HPV unknown
3166,1,1,Nodal Stage,N2
3166,1,1,Radiation Dosage,70.2
3166,1,1,Occurrence #,1st primary
3166,1,1,Tumor Site,oropharynx
3166,1,1,Initial Chemotherapy Agent,Cis
3166,1,1,2nd Failure Type,no known failure
3166,1,1,Overall Stage,IVa
3166,1,1,Research lab p16,p16 unknown
3167,1,1,Clinical lab p16,p16 unkown
3167,1,1,Research lab HPV,HPV unknown
3167,1,1,Occurrence #,1st primary
3167,1,1,Tumor Site,oral cavity
3167,1,1,Treatment Modality,Sx
3167,1,1,Nodal Stage,N2
3167,1,1,1st Failure Type,no known failure
3167,1,1,Research lab p16,p16 unknown
3167,1,1,Metastasis,M0
3167,1,1,Tumor Stage,T3
3167,1,1,Overall Stage,IVa
3167,1,1,2nd Failure Type,no known failure
3168,1,1,Occurrence #,1st primary
3168,1,1,Clinical lab p16,p16 unkown
3168,1,1,1st Failure Site,oral cavity
3168,1,1,Overall Stage,IVa
3168,1,1,Treatment Modality,Sx
3168,1,1,2nd Failure Type,no known failure
3168,1,1,Nodal Stage,N2
3168,1,1,Metastasis,M0
3168,1,1,Tumor Stage,T4a
3168,1,1,1st Failure Type,no known failure
3168,1,1,Research lab HPV,HPV unknown
3168,1,1,Tumor Site,oral cavity
3168,1,1,1st Failure Treatment Modality,Sx
3168,1,1,Research lab p16,p16 unknown
3169,1,1,Treatment Modality,Sx
3169,1,1,Tumor Stage,T1
3169,1,1,2nd Failure Type,no known failure
3169,1,1,Nodal Stage,N2
3169,1,1,Research lab p16,p16 unknown
3169,1,1,Overall Stage,IVa
3169,1,1,Metastasis,M0
3169,1,1,Research lab HPV,HPV unknown
3169,1,1,Tumor Site,oral cavity
3169,1,1,Occurrence #,1st primary
3169,1,1,Clinical lab p16,p16 unkown
3169,1,1,1st Failure Type,no known failure
3170,1,1,1st Failure Type,no known failure
3170,1,1,Clinical lab p16,p16 unkown
3170,1,1,Nodal Stage,N3
3170,1,1,2nd Failure Type,no known failure
3170,1,1,Tumor Stage,T1
3170,1,1,Overall Stage,IVa
3170,1,1,Metastasis,M0
3170,1,1,Research lab HPV,HPV unknown
3170,1,1,Tumor Site,oral cavity
3170,1,1,Occurrence #,1st primary
3170,1,1,Treatment Modality,Sx
3170,1,1,Research lab p16,p16 unknown
3171,1,1,Occurrence #,1st primary
3171,1,1,Treatment Modality,Sx & CTX-RT
3171,1,1,1st Failure Treatment Modality,Sx
3171,1,1,Research lab HPV,HPV unknown
3171,1,1,Nodal Stage,N2
3171,1,1,Overall Stage,IVa
3171,1,1,Research lab p16,p16 unknown
3171,1,1,1st Failure Type,no known failure
3171,1,1,Tumor Stage,T4a
3171,1,1,Initial Chemotherapy Agent,doce/cap
3171,1,1,Tumor Site,oropharynx
3171,1,1,Radiation Dosage,72
3171,1,1,Clinical lab p16,p16 unkown
3171,1,1,Metastasis,M0
3171,1,1,1st Failure Site,oral cavity
3171,1,1,2nd Failure Type,no known failure
3172,1,1,Occurrence #,1st primary
3172,1,1,Initial Chemotherapy Agent,carbo/doce
3172,1,1,Research lab HPV,HPV unknown
3172,1,1,Treatment Modality,CTX
3172,1,1,2nd Failure Type,no known failure
3172,1,1,Tumor Site,oral cavity
3172,1,1,Overall Stage,III
3172,1,1,Tumor Stage,T2
3172,1,1,1st Failure Type,no known failure
3172,1,1,Research lab p16,p16 unknown
3172,1,1,Clinical lab p16,p16 unkown
3172,1,1,Nodal Stage,N1
3172,1,1,Metastasis,M0
3173,1,1,2nd Failure Type,no known failure
3173,1,1,Occurrence #,1st primary
3173,1,1,Clinical lab p16,p16 unkown
3173,1,1,Radiation Dosage,unknown
3173,1,1,Metastasis,M0
3173,1,1,1st Failure Type,no known failure
3173,1,1,Research lab HPV,HPV unknown
3173,1,1,Overall Stage,IVa
3173,1,1,Treatment Modality,Sx & RT
3173,1,1,Research lab p16,p16 unknown
3173,1,1,Tumor Site,oral cavity
3173,1,1,Nodal Stage,N1
3173,1,1,Tumor Stage,T4a
3174,1,1,Occurrence #,1st primary
3174,1,1,Tumor Site,oral cavity
3174,1,1,1st Failure Site,oral cavity
3174,1,1,Metastasis,M0
3174,1,1,2nd Failure Type,no known failure
3174,1,1,Overall Stage,IVa
3174,1,1,Clinical lab p16,p16 unkown
3174,1,1,1st Failure Type,locoregional
3174,1,1,Treatment Modality,Sx
3174,1,1,Nodal Stage,N2
3174,1,1,Research lab p16,p16 unknown
3174,1,1,1st Failure Treatment Modality,Sx
3174,1,1,Tumor Stage,T3
3174,1,1,Research lab HPV,HPV unknown
3175,1,1,Research lab HPV,HPV unknown
3175,1,1,Metastasis,M0
3175,1,1,2nd Failure Type,no known failure
3175,1,1,Clinical lab p16,p16 unkown
3175,1,1,1st Failure Type,no known failure
3175,1,1,Treatment Modality,Sx & CTX-RT
3175,1,1,Nodal Stage,N0
3175,1,1,Tumor Stage,T1
3175,1,1,Research lab p16,p16 unknown
3175,1,1,Initial Chemotherapy Agent,carbo
3175,1,1,Radiation Dosage,30
3175,1,1,Occurrence #,1st primary
3175,1,1,Tumor Site,oral cavity
3175,1,1,Overall Stage,I
3176,1,1,Overall Stage,IVa
3176,1,1,Research lab p16,p16 unknown
3176,1,1,Treatment Modality,RT
3176,1,1,Tumor Stage,T4a
3176,1,1,Clinical lab p16,p16 unkown
3176,1,1,2nd Failure Type,no known failure
3176,1,1,Radiation Dosage,70.2
3176,1,1,1st Failure Type,no known failure
3176,1,1,Tumor Site,oropharynx
3176,1,1,Nodal Stage,N2
3176,1,1,Metastasis,M0
3176,1,1,Occurrence #,1st primary
3176,1,1,Research lab HPV,HPV unknown
3177,1,1,Radiation Dosage,11
3177,1,1,Overall Stage,IVa
3177,1,1,Clinical lab p16,p16 unkown
3177,1,1,2nd Failure Type,no known failure
3177,1,1,1st Failure Type,no known failure
3177,1,1,Nodal Stage,N2
3177,1,1,Research lab HPV,HPV unknown
3177,1,1,Research lab p16,p16 unknown
3177,1,1,Metastasis,M0
3177,1,1,Occurrence #,1st primary
3177,1,1,Tumor Stage,T1
3177,1,1,Treatment Modality,Sx & RT
3177,1,1,Tumor Site,oral cavity
3178,1,1,Occurrence #,1st primary
3178,1,1,Treatment Modality,Sx
3178,1,1,Overall Stage,IVa
3178,1,1,Nodal Stage,N2
3178,1,1,Metastasis,M0
3178,1,1,Tumor Site,oral cavity
3178,1,1,1st Failure Type,no known failure
3178,1,1,Research lab HPV,HPV unknown
3178,1,1,Research lab p16,p16 unknown
3178,1,1,2nd Failure Type,no known failure
3178,1,1,Tumor Stage,T4a
3178,1,1,Clinical lab p16,p16 unkown
3179,1,1,Metastasis,M0
3179,1,1,Second Line Chemotherapy Agent,Carbo
3179,1,1,Clinical lab p16,p16 unkown
3179,1,1,Treatment Modality,Sx & CTX-RT
3179,1,1,Research lab p16,p16 unknown
3179,1,1,Research lab HPV,HPV unknown
3179,1,1,Overall Stage,IVa
3179,1,1,1st Failure Site,oral cavity
3179,1,1,Occurrence #,1st primary
3179,1,1,2nd Failure Type,no known failure
3179,1,1,Initial Chemotherapy Agent,cis
3179,1,1,1st Failure Type,no known failure
3179,1,1,Tumor Site,oral cavity
3179,1,1,1st Failure Treatment Modality,Sx
3179,1,1,Radiation Dosage,66.6
3179,1,1,Tumor Stage,T4a
3179,1,1,Nodal Stage,N2
3180,1,1,Clinical lab p16,p16 unkown
3180,1,1,1st Failure Type,no known failure
3180,1,1,2nd Failure Type,no known failure
3180,1,1,Research lab p16,p16 unknown
3180,1,1,Nodal Stage,N0
3180,1,1,Tumor Site,oral cavity
3180,1,1,Tumor Stage,T1
3180,1,1,Research lab HPV,HPV unknown
3180,1,1,Metastasis,M0
3180,1,1,Treatment Modality,Sx
3180,1,1,Overall Stage,I
3180,1,1,Occurrence #,1st primary
3181,1,1,Overall Stage,Unknown
3181,1,1,Clinical lab p16,p16 unkown
3181,1,1,1st Failure Type,no known failure
3181,1,1,2nd Failure Type,no known failure
3181,1,1,Occurrence #,Unknown
3181,1,1,Nodal Stage,Unknown
3181,1,1,Metastasis,Unknown
3181,1,1,Treatment Modality,Unknown
3181,1,1,Research lab HPV,HPV unknown
3181,1,1,Research lab p16,p16 unknown
3181,1,1,Tumor Site,Unknown
3181,1,1,Tumor Stage,Unknown
3182,1,1,Metastasis,M0
3182,1,1,Research lab p16,p16 unknown
3182,1,1,Treatment Modality,Sx
3182,1,1,Tumor Site,oral cavity
3182,1,1,Occurrence #,1st primary
3182,1,1,Tumor Stage,T3
3182,1,1,Research lab HPV,HPV unknown
3182,1,1,2nd Failure Type,no known failure
3182,1,1,Clinical lab p16,p16 unkown
3182,1,1,1st Failure Type,no known failure
3182,1,1,Nodal Stage,N0
3182,1,1,Overall Stage,III
3183,1,1,1st Failure Type,no known failure
3183,1,1,Tumor Stage,T1
3183,1,1,Research lab HPV,HPV unknown
3183,1,1,Clinical lab p16,p16 unkown
3183,1,1,Nodal Stage,N0
3183,1,1,Overall Stage,I
3183,1,1,Occurrence #,1st primary
3183,1,1,Tumor Site,oral cavity
3183,1,1,2nd Failure Type,no known failure
3183,1,1,Research lab p16,p16 unknown
3183,1,1,Treatment Modality,Sx
3183,1,1,Metastasis,M0
3184,1,1,Clinical lab p16,p16 unkown
3184,1,1,Tumor Site,oral cavity
3184,1,1,Occurrence #,1st primary
3184,1,1,Nodal Stage,N0
3184,1,1,Research lab p16,p16 unknown
3184,1,1,Treatment Modality,Sx
3184,1,1,1st Failure Type,no known failure
3184,1,1,Overall Stage,IVa
3184,1,1,2nd Failure Type,no known failure
3184,1,1,Tumor Stage,T4a
3184,1,1,Metastasis,M0
3184,1,1,Research lab HPV,HPV unknown
3185,1,1,Treatment Modality,Sx & RT
3185,1,1,Occurrence #,1st primary
3185,1,1,Tumor Site,oral cavity
3185,1,1,2nd Failure Type,no known failure
3185,1,1,Clinical lab p16,p16 unkown
3185,1,1,1st Failure Type,no known failure
3185,1,1,Research lab HPV,HPV unknown
3185,1,1,Nodal Stage,N1
3185,1,1,Tumor Stage,T1
3185,1,1,Research lab p16,p16 unknown
3185,1,1,Metastasis,M0
3185,1,1,Radiation Dosage,60
3185,1,1,Overall Stage,III
3186,1,1,Metastasis,M0
3186,1,1,Tumor Stage,T1
3186,1,1,Research lab HPV,HPV unknown
3186,1,1,Tumor Site,oral cavity
3186,1,1,Clinical lab p16,p16 unkown
3186,1,1,Occurrence #,1st primary
3186,1,1,2nd Failure Type,no known failure
3186,1,1,1st Failure Type,no known failure
3186,1,1,Overall Stage,I
3186,1,1,Research lab p16,p16 unknown
3186,1,1,Treatment Modality,Sx
3186,1,1,Nodal Stage,N0
3187,1,1,Nodal Stage,N0
3187,1,1,Research lab HPV,HPV unknown
3187,1,1,1st Failure Type,no known failure
3187,1,1,Research lab p16,p16 unknown
3187,1,1,Overall Stage,I
3187,1,1,Treatment Modality,Sx
3187,1,1,Metastasis,M0
3187,1,1,Occurrence #,other primary
3187,1,1,Clinical lab p16,p16 unkown
3187,1,1,Tumor Site,oral cavity
3187,1,1,2nd Failure Type,no known failure
3187,1,1,Tumor Stage,T1
3188,1,1,1st Failure Type,no known failure
3188,1,1,Overall Stage,Unknown
3188,1,1,Nodal Stage,Unknown
3188,1,1,Clinical lab p16,p16 unkown
3188,1,1,Research lab HPV,HPV unknown
3188,1,1,Metastasis,Unknown
3188,1,1,Research lab p16,p16 unknown
3188,1,1,Treatment Modality,Sx
3188,1,1,Tumor Site,oral cavity
3188,1,1,2nd Failure Type,no known failure
3188,1,1,Occurrence #,1st primary
3188,1,1,Tumor Stage,Unknown
3189,1,1,Tumor Stage,Unknown
3189,1,1,2nd Failure Type,no known failure
3189,1,1,Metastasis,Unknown
3189,1,1,Research lab HPV,HPV unknown
3189,1,1,Nodal Stage,Unknown
3189,1,1,Occurrence #,1st primary
3189,1,1,Research lab p16,p16 unknown
3189,1,1,Clinical lab p16,p16 unkown
3189,1,1,Tumor Site,oral cavity
3189,1,1,Treatment Modality,Sx
3189,1,1,1st Failure Type,no known failure
3189,1,1,Overall Stage,Unknown
3190,1,1,Overall Stage,I
3190,1,1,Tumor Site,oral cavity
3190,1,1,2nd Failure Type,no known failure
3190,1,1,Research lab HPV,HPV unknown
3190,1,1,Treatment Modality,Sx
3190,1,1,Tumor Stage,T1
3190,1,1,Metastasis,M0
3190,1,1,1st Failure Type,no known failure
3190,1,1,Nodal Stage,N0
3190,1,1,Occurrence #,1st primary
3190,1,1,Clinical lab p16,p16 unkown
3190,1,1,Research lab p16,p16 unknown
3191,1,1,Occurrence #,1st primary
3191,1,1,Treatment Modality,Sx
3191,1,1,Metastasis,M0
3191,1,1,Tumor Site,oral cavity
3191,1,1,Research lab HPV,HPV unknown
3191,1,1,Tumor Stage,T1
3191,1,1,Clinical lab p16,p16 unkown
3191,1,1,Research lab p16,p16 unknown
3191,1,1,Overall Stage,I
3191,1,1,1st Failure Type,no known failure
3191,1,1,2nd Failure Type,no known failure
3191,1,1,Nodal Stage,N0
3192,1,1,Research lab p16,p16 unknown
3192,1,1,Metastasis,M0
3192,1,1,1st Failure Type,no known failure
3192,1,1,Nodal Stage,N0
3192,1,1,Research lab HPV,HPV unknown
3192,1,1,Occurrence #,1st primary
3192,1,1,Tumor Stage,T1
3192,1,1,Tumor Site,oral cavity
3192,1,1,Overall Stage,I
3192,1,1,Treatment Modality,Sx
3192,1,1,2nd Failure Type,no known failure
3192,1,1,Clinical lab p16,p16 unkown
3193,1,1,Tumor Stage,T1
3193,1,1,Research lab p16,p16 unknown
3193,1,1,2nd Failure Type,no known failure
3193,1,1,Tumor Site,oral cavity
3193,1,1,Treatment Modality,Sx
3193,1,1,1st Failure Type,no known failure
3193,1,1,Research lab HPV,HPV unknown
3193,1,1,Metastasis,M0
3193,1,1,Clinical lab p16,p16 unkown
3193,1,1,Nodal Stage,N0
3193,1,1,Overall Stage,I
3193,1,1,Occurrence #,1st primary
3194,1,1,Tumor Stage,T1
3194,1,1,Tumor Site,oral cavity
3194,1,1,Research lab p16,p16 unknown
3194,1,1,Clinical lab p16,p16 unkown
3194,1,1,Metastasis,M0
3194,1,1,Research lab HPV,HPV unknown
3194,1,1,Nodal Stage,N0
3194,1,1,Occurrence #,1st primary
3194,1,1,Treatment Modality,Sx
3194,1,1,2nd Failure Type,no known failure
3194,1,1,1st Failure Type,no known failure
3194,1,1,Overall Stage,I
3195,1,1,Clinical lab p16,p16 unkown
3195,1,1,2nd Failure Type,no known failure
3195,1,1,1st Failure Type,no known failure
3195,1,1,Nodal Stage,N0
3195,1,1,Tumor Site,oral cavity
3195,1,1,Treatment Modality,Sx
3195,1,1,Overall Stage,I
3195,1,1,Research lab HPV,HPV unknown
3195,1,1,Research lab p16,p16 unknown
3195,1,1,Tumor Stage,T1
3195,1,1,Occurrence #,1st primary
3195,1,1,Metastasis,M0
3196,1,1,Occurrence #,1st primary
3196,1,1,Metastasis,M0
3196,1,1,Nodal Stage,N0
3196,1,1,Tumor Stage,T1
3196,1,1,Overall Stage,I
3196,1,1,Research lab p16,p16 unknown
3196,1,1,1st Failure Type,no known failure
3196,1,1,2nd Failure Type,no known failure
3196,1,1,Research lab HPV,HPV unknown
3196,1,1,Treatment Modality,Sx
3196,1,1,Clinical lab p16,p16 unkown
3196,1,1,Tumor Site,oral cavity
3197,1,1,Clinical lab p16,p16 unkown
3197,1,1,Occurrence #,recurrence
3197,1,1,Overall Stage,IVa
3197,1,1,Tumor Stage,T4a
3197,1,1,Radiation Dosage,66
3197,1,1,Nodal Stage,N1
3197,1,1,1st Failure Type,no known failure
3197,1,1,Treatment Modality,Sx & CTX-RT
3197,1,1,Research lab HPV,HPV unknown
3197,1,1,Research lab p16,p16 unknown
3197,1,1,2nd Failure Type,no known failure
3197,1,1,Tumor Site,oral cavity
3197,1,1,Metastasis,M0
3197,1,1,Initial Chemotherapy Agent,cis
3198,1,1,Research lab p16,p16 unknown
3198,1,1,Nodal Stage,N3
3198,1,1,2nd Failure Type,no known failure
3198,1,1,Tumor Site,oropharynx
3198,1,1,1st Failure Type,no known failure
3198,1,1,Metastasis,M0
3198,1,1,Tumor Stage,T1
3198,1,1,Research lab HPV,HPV unknown
3198,1,1,Overall Stage,IVb
3198,1,1,Clinical lab p16,p16 unkown
3198,1,1,Occurrence #,1st primary
3198,1,1,Treatment Modality,Sx & CTX-RT
3199,1,1,Clinical lab p16,p16 unkown
3199,1,1,Tumor Site,oral cavity
3199,1,1,1st Failure Type,no known failure
3199,1,1,2nd Failure Type,no known failure
3199,1,1,Tumor Stage,T1
3199,1,1,Metastasis,M0
3199,1,1,Nodal Stage,N0
3199,1,1,Treatment Modality,Sx
3199,1,1,Research lab p16,p16 unknown
3199,1,1,Occurrence #,1st primary
3199,1,1,Overall Stage,I
3199,1,1,Research lab HPV,HPV unknown
3200,1,1,Research lab p16,p16 unknown
3200,1,1,Clinical lab p16,p16 unkown
3200,1,1,Treatment Modality,Sx & RT
3200,1,1,2nd Failure Type,no known failure
3200,1,1,Tumor Stage,T1
3200,1,1,Tumor Site,oral cavity
3200,1,1,Metastasis,M0
3200,1,1,Overall Stage,Unknown
3200,1,1,Nodal Stage,Unknown
3200,1,1,Research lab HPV,HPV unknown
3200,1,1,Radiation Dosage,60
3200,1,1,1st Failure Type,no known failure
3200,1,1,Occurrence #,1st primary
3201,1,1,Tumor Stage,T2
3201,1,1,Treatment Modality,Sx
3201,1,1,Tumor Site,oral cavity
3201,1,1,Occurrence #,1st primary
3201,1,1,Clinical lab p16,p16 unkown
3201,1,1,Metastasis,M0
3201,1,1,Research lab HPV,HPV unknown
3201,1,1,Nodal Stage,N0
3201,1,1,Research lab p16,p16 unknown
3201,1,1,2nd Failure Type,no known failure
3201,1,1,1st Failure Type,no known failure
3201,1,1,Overall Stage,II
3202,1,1,Research lab p16,p16 unknown
3202,1,1,Occurrence #,1st primary
3202,1,1,Overall Stage,I
3202,1,1,Tumor Site,oral cavity
3202,1,1,Treatment Modality,Sx
3202,1,1,1st Failure Type,no known failure
3202,1,1,Clinical lab p16,p16 unkown
3202,1,1,Metastasis,M0
3202,1,1,Tumor Stage,T1
3202,1,1,2nd Failure Type,no known failure
3202,1,1,Research lab HPV,HPV unknown
3202,1,1,Nodal Stage,N0
3203,1,1,Tumor Stage,T1
3203,1,1,Nodal Stage,N0
3203,1,1,Overall Stage,I
3203,1,1,Clinical lab p16,p16 unkown
3203,1,1,Metastasis,M0
3203,1,1,Occurrence #,1st primary
3203,1,1,Research lab p16,p16 unknown
3203,1,1,Research lab HPV,HPV unknown
3203,1,1,Treatment Modality,Sx
3203,1,1,1st Failure Type,no known failure
3203,1,1,2nd Failure Type,no known failure
3203,1,1,Tumor Site,oral cavity
3204,1,1,Tumor Stage,Unknown
3204,1,1,Metastasis,Unknown
3204,1,1,Tumor Site,oropharynx
3204,1,1,Occurrence #,1st primary
3204,1,1,Clinical lab p16,p16 unkown
3204,1,1,2nd Failure Type,no known failure
3204,1,1,Research lab p16,p16 unknown
3204,1,1,Research lab HPV,HPV unknown
3204,1,1,Initial Chemotherapy Agent,Doce/cis/5Fu
3204,1,1,Treatment Modality,Unknown
3204,1,1,1st Failure Type,no known failure
3204,1,1,Overall Stage,Unknown
3204,1,1,Nodal Stage,Unknown
3205,1,1,Occurrence #,1st primary
3205,1,1,Research lab p16,p16 unknown
3205,1,1,Nodal Stage,N0
3205,1,1,Metastasis,M0
3205,1,1,Treatment Modality,Sx
3205,1,1,Research lab HPV,HPV unknown
3205,1,1,2nd Failure Type,no known failure
3205,1,1,Overall Stage,I
3205,1,1,Clinical lab p16,p16 unkown
3205,1,1,1st Failure Type,no known failure
3205,1,1,Tumor Stage,T1
3205,1,1,Tumor Site,oral cavity
3206,1,1,2nd Failure Type,no known failure
3206,1,1,Research lab HPV,HPV unknown
3206,1,1,Tumor Site,oral cavity
3206,1,1,Overall Stage,III
3206,1,1,Clinical lab p16,p16 unkown
3206,1,1,Metastasis,M0
3206,1,1,Tumor Stage,T3
3206,1,1,Nodal Stage,N0
3206,1,1,1st Failure Type,no known failure
3206,1,1,Occurrence #,1st primary
3206,1,1,Radiation Dosage,70.2
3206,1,1,Initial Chemotherapy Agent,cis
3206,1,1,Research lab p16,p16 unknown
3206,1,1,Treatment Modality,Sx & CTX-RT
3207,1,1,Clinical lab p16,p16 unkown
3207,1,1,Occurrence #,1st primary
3207,1,1,Tumor Stage,Unknown
3207,1,1,Research lab p16,p16 unknown
3207,1,1,Nodal Stage,Unknown
3207,1,1,Treatment Modality,Sx
3207,1,1,Tumor Site,oral cavity
3207,1,1,Metastasis,Unknown
3207,1,1,1st Failure Type,no known failure
3207,1,1,Overall Stage,Unknown
3207,1,1,2nd Failure Type,no known failure
3207,1,1,Research lab HPV,HPV unknown
3208,1,1,1st Failure Type,no known failure
3208,1,1,Nodal Stage,N2
3208,1,1,Research lab HPV,HPV unknown
3208,1,1,2nd Failure Type,no known failure
3208,1,1,Radiation Dosage,unknown
3208,1,1,Overall Stage,IVa
3208,1,1,Treatment Modality,Sx & RT
3208,1,1,Research lab p16,p16 unknown
3208,1,1,Occurrence #,1st primary
3208,1,1,Clinical lab p16,p16 unkown
3208,1,1,Tumor Site,oral cavity
3208,1,1,Metastasis,M0
3208,1,1,Tumor Stage,T4a
3209,1,1,Tumor Stage,T2
3209,1,1,Tumor Site,oral cavity
3209,1,1,1st Failure Site,oropharynx
3209,1,1,Overall Stage,II
3209,1,1,Treatment Modality,Sx
3209,1,1,Research lab HPV,HPV unknown
3209,1,1,Occurrence #,1st primary
3209,1,1,Clinical lab p16,p16 unkown
3209,1,1,Nodal Stage,N0
3209,1,1,1st Failure Treatment Modality,Sx
3209,1,1,Research lab p16,p16 unknown
3209,1,1,2nd Failure Type,no known failure
3209,1,1,Metastasis,M0
3209,1,1,1st Failure Type,no known failure
3210,1,1,Treatment Modality,Sx
3210,1,1,Metastasis,M0
3210,1,1,Tumor Site,oral cavity
3210,1,1,1st Failure Type,no known failure
3210,1,1,2nd Failure Type,no known failure
3210,1,1,Overall Stage,I
3210,1,1,Tumor Stage,T1
3210,1,1,Clinical lab p16,p16 unkown
3210,1,1,Research lab HPV,HPV unknown
3210,1,1,Research lab p16,p16 unknown
3210,1,1,Nodal Stage,N0
3210,1,1,Occurrence #,1st primary
3211,1,1,2nd Failure Type,no known failure
3211,1,1,Nodal Stage,N1
3211,1,1,1st Failure Type,no known failure
3211,1,1,Tumor Stage,T2
3211,1,1,Occurrence #,1st primary
3211,1,1,Research lab HPV,HPV unknown
3211,1,1,Clinical lab p16,p16 unkown
3211,1,1,Treatment Modality,Sx
3211,1,1,Tumor Site,oral cavity
3211,1,1,Research lab p16,p16 unknown
3211,1,1,Overall Stage,III
3211,1,1,Metastasis,M0
3212,1,1,Treatment Modality,Sx
3212,1,1,Occurrence #,1st primary
3212,1,1,1st Failure Type,no known failure
3212,1,1,Metastasis,M0
3212,1,1,Tumor Stage,T1
3212,1,1,Nodal Stage,N0
3212,1,1,Research lab HPV,HPV unknown
3212,1,1,Clinical lab p16,p16 unkown
3212,1,1,Research lab p16,p16 unknown
3212,1,1,Overall Stage,I
3212,1,1,2nd Failure Type,no known failure
3212,1,1,Tumor Site,oral cavity
3213,1,1,Tumor Stage,T1
3213,1,1,Occurrence #,1st primary
3213,1,1,Tumor Site,oral cavity
3213,1,1,Metastasis,M0
3213,1,1,Overall Stage,I
3213,1,1,Nodal Stage,N0
3213,1,1,1st Failure Type,no known failure
3213,1,1,Research lab HPV,HPV unknown
3213,1,1,Treatment Modality,Sx
3213,1,1,2nd Failure Type,no known failure
3213,1,1,Clinical lab p16,p16 unkown
3213,1,1,Research lab p16,p16 unknown
3214,1,1,Tumor Stage,T2
3214,1,1,2nd Failure Type,no known failure
3214,1,1,Treatment Modality,Sx
3214,1,1,1st Failure Type,no known failure
3214,1,1,Nodal Stage,N2
3214,1,1,Clinical lab p16,p16 unkown
3214,1,1,Metastasis,M0
3214,1,1,Overall Stage,IVa
3214,1,1,Tumor Site,oral cavity
3214,1,1,Research lab p16,p16 unknown
3214,1,1,Occurrence #,1st primary
3214,1,1,Research lab HPV,HPV unknown
3215,1,1,Treatment Modality,Sx
3215,1,1,1st Failure Type,no known failure
3215,1,1,Occurrence #,1st primary
3215,1,1,Nodal Stage,N0
3215,1,1,Clinical lab p16,p16 unkown
3215,1,1,Research lab HPV,HPV unknown
3215,1,1,1st Failure Treatment Modality,Sx
3215,1,1,Research lab p16,p16 unknown
3215,1,1,Overall Stage,I
3215,1,1,Metastasis,M0
3215,1,1,Tumor Site,oral cavity
3215,1,1,2nd Failure Type,no known failure
3215,1,1,Tumor Stage,T1
3216,1,1,Radiation Dosage,70.2
3216,1,1,Research lab HPV,HPV unknown
3216,1,1,Research lab p16,p16 unknown
3216,1,1,Tumor Site,oropharynx
3216,1,1,Tumor Stage,T1
3216,1,1,Initial Chemotherapy Agent,carbo/PTX
3216,1,1,Metastasis,M0
3216,1,1,1st Failure Type,no known failure
3216,1,1,Overall Stage,IVa
3216,1,1,Clinical lab p16,p16 unkown
3216,1,1,Nodal Stage,N2
3216,1,1,2nd Failure Type,no known failure
3216,1,1,Occurrence #,1st primary
3216,1,1,Treatment Modality,CTX-RT
3217,1,1,Research lab HPV,HPV unknown
3217,1,1,1st Failure Type,no known failure
3217,1,1,2nd Failure Type,no known failure
3217,1,1,Tumor Site,oropharynx
3217,1,1,Treatment Modality,CTX-RT
3217,1,1,Radiation Dosage,70.2
3217,1,1,Occurrence #,1st primary
3217,1,1,Initial Chemotherapy Agent,cis
3217,1,1,Tumor Stage,T2
3217,1,1,Metastasis,M0
3217,1,1,Nodal Stage,N2
3217,1,1,Clinical lab p16,p16 unkown
3217,1,1,Overall Stage,IVa
3217,1,1,Research lab p16,p16 unknown
3218,1,1,Tumor Site,oral cavity
3218,1,1,1st Failure Type,no known failure
3218,1,1,Tumor Stage,T1
3218,1,1,Metastasis,M0
3218,1,1,Treatment Modality,Sx
3218,1,1,2nd Failure Type,no known failure
3218,1,1,Clinical lab p16,p16 unkown
3218,1,1,Overall Stage,I
3218,1,1,Occurrence #,1st primary
3218,1,1,Research lab p16,p16 unknown
3218,1,1,Nodal Stage,N0
3218,1,1,Research lab HPV,HPV unknown
3219,1,1,Tumor Stage,Unknown
3219,1,1,Research lab HPV,HPV unknown
3219,1,1,2nd Failure Type,no known failure
3219,1,1,Research lab p16,p16 unknown
3219,1,1,Clinical lab p16,p16 unkown
3219,1,1,Occurrence #,1st primary
3219,1,1,Treatment Modality,Sx
3219,1,1,Tumor Site,oral cavity
3219,1,1,Metastasis,Unknown
3219,1,1,Overall Stage,Unknown
3219,1,1,1st Failure Type,no known failure
3219,1,1,Nodal Stage,Unknown
3220,1,1,2nd Failure Type,no known failure
3220,1,1,Research lab HPV,HPV unknown
3220,1,1,Clinical lab p16,p16 unkown
3220,1,1,Overall Stage,I
3220,1,1,Research lab p16,p16 unknown
3220,1,1,Occurrence #,1st primary
3220,1,1,Treatment Modality,Sx
3220,1,1,Nodal Stage,N0
3220,1,1,Metastasis,M0
3220,1,1,1st Failure Type,no known failure
3220,1,1,Tumor Stage,T1
3220,1,1,Tumor Site,oral cavity
3221,1,1,Overall Stage,IVa
3221,1,1,Tumor Site,oral cavity
3221,1,1,Research lab p16,p16 unknown
3221,1,1,Nodal Stage,N2
3221,1,1,Research lab HPV,HPV unknown
3221,1,1,1st Failure Type,no known failure
3221,1,1,Occurrence #,1st primary
3221,1,1,Treatment Modality,Sx & RT
3221,1,1,2nd Failure Type,no known failure
3221,1,1,Metastasis,M0
3221,1,1,Tumor Stage,T3
3221,1,1,Clinical lab p16,p16 unkown
3221,1,1,Radiation Dosage,60
3222,1,1,2nd Failure Type,no known failure
3222,1,1,Tumor Stage,Unknown
3222,1,1,Tumor Site,oral cavity
3222,1,1,Metastasis,Unknown
3222,1,1,Overall Stage,Unknown
3222,1,1,Clinical lab p16,p16 unkown
3222,1,1,Occurrence #,1st primary
3222,1,1,Research lab HPV,HPV unknown
3222,1,1,Treatment Modality,Sx
3222,1,1,Research lab p16,p16 unknown
3222,1,1,1st Failure Type,no known failure
3222,1,1,Nodal Stage,Unknown
3223,1,1,Clinical lab p16,p16 unkown
3223,1,1,Metastasis,M0
3223,1,1,Treatment Modality,Sx
3223,1,1,Research lab p16,p16 unknown
3223,1,1,Tumor Stage,T1
3223,1,1,Overall Stage,I
3223,1,1,Nodal Stage,N0
3223,1,1,Research lab HPV,HPV unknown
3223,1,1,Tumor Site,oral cavity
3223,1,1,2nd Failure Type,no known failure
3223,1,1,1st Failure Type,no known failure
3223,1,1,Occurrence #,1st primary
3224,1,1,Metastasis,M0
3224,1,1,Overall Stage,I
3224,1,1,Occurrence #,1st primary
3224,1,1,Clinical lab p16,p16 unkown
3224,1,1,Nodal Stage,N0
3224,1,1,Research lab HPV,HPV unknown
3224,1,1,1st Failure Site,multiple
3224,1,1,Tumor Site,oral cavity
3224,1,1,1st Failure Type,no known failure
3224,1,1,Research lab p16,p16 unknown
3224,1,1,2nd Failure Type,no known failure
3224,1,1,Treatment Modality,Sx
3224,1,1,Tumor Stage,T1
3225,1,1,Metastasis,M0
3225,1,1,Treatment Modality,Sx
3225,1,1,Clinical lab p16,p16 unkown
3225,1,1,1st Failure Type,no known failure
3225,1,1,Tumor Stage,T4a
3225,1,1,Nodal Stage,N0
3225,1,1,Overall Stage,IVa
3225,1,1,Research lab HPV,HPV unknown
3225,1,1,Research lab p16,p16 unknown
3225,1,1,2nd Failure Type,no known failure
3225,1,1,Occurrence #,1st primary
3225,1,1,Tumor Site,oral cavity
3226,1,1,Tumor Site,oral cavity
3226,1,1,Metastasis,M0
3226,1,1,Overall Stage,III
3226,1,1,Research lab HPV,HPV unknown
3226,1,1,1st Failure Type,no known failure
3226,1,1,2nd Failure Type,no known failure
3226,1,1,Treatment Modality,Sx & RT
3226,1,1,Tumor Stage,T3
3226,1,1,Research lab p16,p16 unknown
3226,1,1,Occurrence #,1st primary
3226,1,1,Clinical lab p16,p16 unkown
3226,1,1,Nodal Stage,N0
3227,1,1,1st Failure Type,no known failure
3227,1,1,Radiation Dosage,60
3227,1,1,2nd Failure Type,no known failure
3227,1,1,Nodal Stage,N1
3227,1,1,Treatment Modality,Sx & CTX-RT
3227,1,1,Tumor Site,oral cavity
3227,1,1,Clinical lab p16,p16 unkown
3227,1,1,Overall Stage,IVa
3227,1,1,Tumor Stage,T2
3227,1,1,Metastasis,M0
3227,1,1,Research lab p16,p16 unknown
3227,1,1,Research lab HPV,HPV unknown
3227,1,1,Occurrence #,recurrence
3227,1,1,Initial Chemotherapy Agent,Carbo
3228,1,1,Research lab p16,p16 unknown
3228,1,1,Nodal Stage,N1
3228,1,1,Tumor Stage,T2
3228,1,1,Metastasis,M0
3228,1,1,Treatment Modality,Sx
3228,1,1,Tumor Site,oral cavity
3228,1,1,Occurrence #,1st primary
3228,1,1,Clinical lab p16,p16 unkown
3228,1,1,1st Failure Type,no known failure
3228,1,1,Research lab HPV,HPV unknown
3228,1,1,Overall Stage,III
3228,1,1,2nd Failure Type,no known failure
3229,1,1,Nodal Stage,N0
3229,1,1,Tumor Site,oral cavity
3229,1,1,Treatment Modality,Sx
3229,1,1,Overall Stage,IVa
3229,1,1,Research lab p16,p16 unknown
3229,1,1,Research lab HPV,HPV unknown
3229,1,1,Metastasis,M0
3229,1,1,Occurrence #,1st primary
3229,1,1,Clinical lab p16,p16 unkown
3229,1,1,Tumor Stage,T4a
3229,1,1,2nd Failure Type,no known failure
3229,1,1,1st Failure Type,no known failure
3230,1,1,Research lab p16,p16 unknown
3230,1,1,Occurrence #,1st primary
3230,1,1,Metastasis,M0
3230,1,1,Overall Stage,I
3230,1,1,Treatment Modality,Sx
3230,1,1,Tumor Site,oral cavity
3230,1,1,Research lab HPV,HPV unknown
3230,1,1,Clinical lab p16,p16 unkown
3230,1,1,1st Failure Type,no known failure
3230,1,1,2nd Failure Type,no known failure
3230,1,1,Tumor Stage,T1
3230,1,1,Nodal Stage,N0
3231,1,1,Overall Stage,III
3231,1,1,2nd Failure Type,no known failure
3231,1,1,Treatment Modality,Sx
3231,1,1,Tumor Site,oral cavity
3231,1,1,Nodal Stage,N0
3231,1,1,Research lab HPV,HPV unknown
3231,1,1,Metastasis,M0
3231,1,1,Research lab p16,p16 unknown
3231,1,1,1st Failure Type,no known failure
3231,1,1,Clinical lab p16,p16 unkown
3231,1,1,Tumor Stage,T3
3231,1,1,Occurrence #,1st primary
3232,1,1,Tumor Stage,T1
3232,1,1,Nodal Stage,N0
3232,1,1,Clinical lab p16,p16 unkown
3232,1,1,1st Failure Type,locoregional
3232,1,1,1st Failure Site,oral cavity
3232,1,1,Tumor Site,oral cavity
3232,1,1,Treatment Modality,Sx
3232,1,1,Overall Stage,I
3232,1,1,2nd Failure Type,no known failure
3232,1,1,Research lab HPV,HPV unknown
3232,1,1,Research lab p16,p16 unknown
3232,1,1,1st Failure Treatment Modality,Sx
3232,1,1,Metastasis,M0
3232,1,1,Occurrence #,1st primary
3233,1,1,Tumor Site,oral cavity
3233,1,1,Clinical lab p16,p16 unkown
3233,1,1,Occurrence #,1st primary
3233,1,1,Tumor Stage,T4a
3233,1,1,Treatment Modality,Sx
3233,1,1,Overall Stage,IVa
3233,1,1,2nd Failure Type,no known failure
3233,1,1,Research lab HPV,HPV unknown
3233,1,1,Metastasis,M0
3233,1,1,1st Failure Type,no known failure
3233,1,1,Nodal Stage,N0
3233,1,1,Research lab p16,p16 unknown
3234,1,1,Overall Stage,Unknown
3234,1,1,Treatment Modality,Sx
3234,1,1,Clinical lab p16,p16 unkown
3234,1,1,2nd Failure Type,no known failure
3234,1,1,Tumor Stage,Unknown
3234,1,1,1st Failure Type,no known failure
3234,1,1,Nodal Stage,Unknown
3234,1,1,Research lab p16,p16 unknown
3234,1,1,Research lab HPV,HPV unknown
3234,1,1,Tumor Site,oral cavity
3234,1,1,Occurrence #,1st primary
3234,1,1,Metastasis,Unknown
3235,1,1,2nd Failure Type,no known failure
3235,1,1,Overall Stage,I
3235,1,1,Research lab p16,p16 unknown
3235,1,1,Clinical lab p16,p16 unkown
3235,1,1,Tumor Site,oral cavity
3235,1,1,Tumor Stage,T1
3235,1,1,1st Failure Type,no known failure
3235,1,1,Nodal Stage,N0
3235,1,1,Research lab HPV,HPV unknown
3235,1,1,Metastasis,M0
3235,1,1,Occurrence #,1st primary
3235,1,1,Treatment Modality,Sx
3236,1,1,Clinical lab p16,p16 unkown
3236,1,1,2nd Failure Type,no known failure
3236,1,1,Overall Stage,I
3236,1,1,Nodal Stage,N0
3236,1,1,Tumor Site,oral cavity
3236,1,1,1st Failure Type,no known failure
3236,1,1,Treatment Modality,Sx
3236,1,1,Metastasis,M0
3236,1,1,Research lab p16,p16 unknown
3236,1,1,Occurrence #,1st primary
3236,1,1,Research lab HPV,HPV unknown
3236,1,1,Tumor Stage,T1
3237,1,1,1st Failure Type,no known failure
3237,1,1,Tumor Site,oral cavity
3237,1,1,Treatment Modality,Sx
3237,1,1,Research lab p16,p16 unknown
3237,1,1,Overall Stage,II
3237,1,1,Tumor Stage,T2
3237,1,1,Metastasis,M0
3237,1,1,Research lab HPV,HPV unknown
3237,1,1,Occurrence #,1st primary
3237,1,1,Clinical lab p16,p16 unkown
3237,1,1,2nd Failure Type,no known failure
3237,1,1,Nodal Stage,N0
3238,1,1,Occurrence #,1st primary
3238,1,1,Tumor Stage,Unknown
3238,1,1,1st Failure Type,no known failure
3238,1,1,Research lab HPV,HPV unknown
3238,1,1,Tumor Site,oral cavity
3238,1,1,Clinical lab p16,p16 unkown
3238,1,1,2nd Failure Type,no known failure
3238,1,1,Research lab p16,p16 unknown
3238,1,1,Nodal Stage,Unknown
3238,1,1,Treatment Modality,Sx
3238,1,1,Metastasis,Unknown
3238,1,1,Overall Stage,Unknown
3239,1,1,Tumor Site,oral cavity
3239,1,1,Nodal Stage,N0
3239,1,1,Occurrence #,1st primary
3239,1,1,Research lab p16,p16 unknown
3239,1,1,Research lab HPV,HPV unknown
3239,1,1,Tumor Stage,T1
3239,1,1,1st Failure Type,no known failure
3239,1,1,Clinical lab p16,p16 unkown
3239,1,1,Overall Stage,I
3239,1,1,Metastasis,M0
3239,1,1,2nd Failure Type,no known failure
3239,1,1,Treatment Modality,Sx
3240,1,1,Occurrence #,1st primary
3240,1,1,Initial Chemotherapy Agent,cis
3240,1,1,Research lab p16,p16 unknown
3240,1,1,1st Failure Type,no known failure
3240,1,1,Research lab HPV,HPV unknown
3240,1,1,2nd Failure Type,no known failure
3240,1,1,Overall Stage,IVa
3240,1,1,Tumor Site,oral cavity
3240,1,1,Treatment Modality,Sx & CTX-RT
3240,1,1,Metastasis,M0
3240,1,1,Nodal Stage,N1
3240,1,1,Tumor Stage,T4a
3240,1,1,Clinical lab p16,p16 unkown
3241,1,1,Research lab p16,p16 unknown
3241,1,1,Nodal Stage,Unknown
3241,1,1,2nd Failure Type,no known failure
3241,1,1,Metastasis,Unknown
3241,1,1,Overall Stage,Unknown
3241,1,1,1st Failure Type,no known failure
3241,1,1,Tumor Stage,Unknown
3241,1,1,Clinical lab p16,p16 unkown
3241,1,1,Treatment Modality,Sx
3241,1,1,Tumor Site,Unknown
3241,1,1,Research lab HPV,HPV unknown
3241,1,1,Occurrence #,1st primary
3242,1,1,Metastasis,M0
3242,1,1,Clinical lab p16,p16 unkown
3242,1,1,Overall Stage,I
3242,1,1,Tumor Site,oral cavity
3242,1,1,Treatment Modality,Sx
3242,1,1,Research lab p16,p16 unknown
3242,1,1,Tumor Stage,T1
3242,1,1,2nd Failure Type,no known failure
3242,1,1,Research lab HPV,HPV unknown
3242,1,1,Nodal Stage,N0
3242,1,1,1st Failure Type,no known failure
3242,1,1,Occurrence #,1st primary
3243,1,1,2nd Failure Type,no known failure
3243,1,1,Research lab p16,p16 unknown
3243,1,1,Occurrence #,1st primary
3243,1,1,Nodal Stage,N0
3243,1,1,1st Failure Type,no known failure
3243,1,1,Clinical lab p16,p16 unkown
3243,1,1,Tumor Stage,T1
3243,1,1,Treatment Modality,Sx
3243,1,1,Metastasis,M0
3243,1,1,Research lab HPV,HPV unknown
3243,1,1,Tumor Site,oral cavity
3243,1,1,Overall Stage,I
3244,1,1,1st Failure Type,no known failure
3244,1,1,Research lab p16,p16 unknown
3244,1,1,Metastasis,M0
3244,1,1,Tumor Site,oral cavity
3244,1,1,Research lab HPV,HPV unknown
3244,1,1,Nodal Stage,N0
3244,1,1,Occurrence #,1st primary
3244,1,1,Tumor Stage,T1
3244,1,1,Treatment Modality,Sx
3244,1,1,2nd Failure Type,no known failure
3244,1,1,Clinical lab p16,p16 unkown
3244,1,1,Overall Stage,I
3245,1,1,Occurrence #,1st primary
3245,1,1,Research lab HPV,HPV unknown
3245,1,1,Treatment Modality,Sx
3245,1,1,Tumor Stage,T1
3245,1,1,Clinical lab p16,p16 unkown
3245,1,1,2nd Failure Type,no known failure
3245,1,1,Overall Stage,I
3245,1,1,1st Failure Type,no known failure
3245,1,1,Research lab p16,p16 unknown
3245,1,1,Metastasis,M0
3245,1,1,Nodal Stage,N0
3245,1,1,Tumor Site,oral cavity
3246,1,1,2nd Failure Type,no known failure
3246,1,1,1st Failure Type,no known failure
3246,1,1,Tumor Stage,T1
3246,1,1,Research lab HPV,HPV unknown
3246,1,1,Overall Stage,I
3246,1,1,Nodal Stage,N0
3246,1,1,Clinical lab p16,p16 unkown
3246,1,1,Tumor Site,oral cavity
3246,1,1,Treatment Modality,Sx
3246,1,1,Research lab p16,p16 unknown
3246,1,1,Metastasis,M0
3246,1,1,Occurrence #,1st primary
3247,1,1,Research lab p16,p16 unknown
3247,1,1,Research lab HPV,HPV unknown
3247,1,1,2nd Failure Type,no known failure
3247,1,1,Treatment Modality,Sx
3247,1,1,Overall Stage,III
3247,1,1,1st Failure Type,no known failure
3247,1,1,Tumor Site,oral cavity
3247,1,1,Tumor Stage,T2
3247,1,1,Metastasis,M0
3247,1,1,Nodal Stage,N1
3247,1,1,Clinical lab p16,p16 unkown
3247,1,1,Occurrence #,1st primary
3248,1,1,Nodal Stage,N0
3248,1,1,Clinical lab p16,p16 unkown
3248,1,1,2nd Failure Type,no known failure
3248,1,1,Tumor Site,oral cavity
3248,1,1,Overall Stage,II
3248,1,1,Occurrence #,1st primary
3248,1,1,Treatment Modality,Sx
3248,1,1,Research lab HPV,HPV unknown
3248,1,1,Metastasis,M0
3248,1,1,Research lab p16,p16 unknown
3248,1,1,1st Failure Type,no known failure
3248,1,1,Tumor Stage,T2
3249,1,1,Occurrence #,1st primary
3249,1,1,Radiation Dosage,66
3249,1,1,2nd Failure Type,no known failure
3249,1,1,Tumor Stage,T2
3249,1,1,Research lab p16,p16 unknown
3249,1,1,Tumor Site,oral cavity
3249,1,1,Clinical lab p16,p16 unkown
3249,1,1,Metastasis,M0
3249,1,1,Treatment Modality,Sx & RT
3249,1,1,Overall Stage,II
3249,1,1,Research lab HPV,HPV unknown
3249,1,1,1st Failure Type,no known failure
3249,1,1,Nodal Stage,N0
3250,1,1,2nd Failure Type,no known failure
3250,1,1,Research lab HPV,HPV unknown
3250,1,1,Treatment Modality,Sx
3250,1,1,Research lab p16,p16 unknown
3250,1,1,Metastasis,M0
3250,1,1,Tumor Site,oral cavity
3250,1,1,Nodal Stage,N0
3250,1,1,Occurrence #,1st primary
3250,1,1,Clinical lab p16,p16 unkown
3250,1,1,Overall Stage,I
3250,1,1,Tumor Stage,T1
3250,1,1,1st Failure Type,no known failure
3251,1,1,Research lab HPV,HPV unknown
3251,1,1,1st Failure Type,no known failure
3251,1,1,Overall Stage,I
3251,1,1,Research lab p16,p16 unknown
3251,1,1,Occurrence #,1st primary
3251,1,1,Treatment Modality,Sx
3251,1,1,Clinical lab p16,p16 unkown
3251,1,1,Tumor Site,oropharynx
3251,1,1,Tumor Stage,T1
3251,1,1,Metastasis,M0
3251,1,1,Nodal Stage,N0
3251,1,1,2nd Failure Type,no known failure
3252,1,1,Research lab p16,p16 unknown
3252,1,1,2nd Failure Type,no known failure
3252,1,1,1st Failure Type,no known failure
3252,1,1,Research lab HPV,HPV unknown
3252,1,1,Overall Stage,IVa
3252,1,1,Metastasis,M0
3252,1,1,Clinical lab p16,p16 unkown
3252,1,1,Tumor Site,oral cavity
3252,1,1,Nodal Stage,N2
3252,1,1,Treatment Modality,Sx
3252,1,1,Tumor Stage,T4a
3252,1,1,Occurrence #,recurrence
3253,1,1,Metastasis,M0
3253,1,1,Clinical lab p16,p16 unkown
3253,1,1,Nodal Stage,N2
3253,1,1,Occurrence #,1st primary
3253,1,1,Radiation Dosage,unknown
3253,1,1,Tumor Stage,T4a
3253,1,1,Treatment Modality,Sx & CTX-RT
3253,1,1,Research lab p16,p16 unknown
3253,1,1,Tumor Site,oral cavity
3253,1,1,2nd Failure Type,no known failure
3253,1,1,Initial Chemotherapy Agent,unk
3253,1,1,Overall Stage,IVa
3253,1,1,1st Failure Type,no known failure
3253,1,1,Research lab HPV,HPV unknown
3254,1,1,Research lab HPV,HPV unknown
3254,1,1,Clinical lab p16,p16 unkown
3254,1,1,Nodal Stage,Unknown
3254,1,1,Research lab p16,p16 unknown
3254,1,1,Treatment Modality,Sx
3254,1,1,Occurrence #,1st primary
3254,1,1,1st Failure Type,no known failure
3254,1,1,Tumor Site,oral cavity
3254,1,1,Metastasis,Unknown
3254,1,1,Tumor Stage,Unknown
3254,1,1,Overall Stage,Unknown
3254,1,1,2nd Failure Type,no known failure
3255,1,1,2nd Failure Type,no known failure
3255,1,1,Treatment Modality,Sx
3255,1,1,Occurrence #,1st primary
3255,1,1,1st Failure Type,no known failure
3255,1,1,Tumor Site,oral cavity
3255,1,1,Metastasis,M0
3255,1,1,Research lab HPV,HPV unknown
3255,1,1,Research lab p16,p16 unknown
3255,1,1,Clinical lab p16,p16 unkown
3255,1,1,Nodal Stage,N0
3255,1,1,Tumor Stage,T1
3255,1,1,Overall Stage,I
3256,1,1,Treatment Modality,Sx
3256,1,1,Nodal Stage,N0
3256,1,1,Tumor Stage,T4a
3256,1,1,1st Failure Type,no known failure
3256,1,1,Overall Stage,IVa
3256,1,1,2nd Failure Type,no known failure
3256,1,1,Research lab HPV,HPV unknown
3256,1,1,Clinical lab p16,p16 unkown
3256,1,1,Research lab p16,p16 unknown
3256,1,1,Tumor Site,oral cavity
3256,1,1,Metastasis,M0
3256,1,1,Occurrence #,1st primary
3257,1,1,Research lab p16,p16 unknown
3257,1,1,Overall Stage,I
3257,1,1,Metastasis,M0
3257,1,1,Treatment Modality,Sx
3257,1,1,Nodal Stage,N0
3257,1,1,Tumor Site,oral cavity
3257,1,1,2nd Failure Type,no known failure
3257,1,1,Tumor Stage,T1
3257,1,1,Occurrence #,1st primary
3257,1,1,1st Failure Type,no known failure
3257,1,1,Clinical lab p16,p16 unkown
3257,1,1,Research lab HPV,HPV unknown
3258,1,1,Overall Stage,II
3258,1,1,Nodal Stage,N0
3258,1,1,2nd Failure Type,no known failure
3258,1,1,Metastasis,M0
3258,1,1,Clinical lab p16,p16 unkown
3258,1,1,1st Failure Type,no known failure
3258,1,1,Occurrence #,1st primary
3258,1,1,Tumor Site,oral cavity
3258,1,1,Tumor Stage,T2
3258,1,1,Research lab HPV,HPV unknown
3258,1,1,Treatment Modality,Sx
3258,1,1,Research lab p16,p16 unknown
3259,1,1,Overall Stage,IVa
3259,1,1,2nd Failure Type,no known failure
3259,1,1,Tumor Site,oral cavity
3259,1,1,Initial Chemotherapy Agent,cis
3259,1,1,Research lab p16,p16 unknown
3259,1,1,Nodal Stage,N2
3259,1,1,Research lab HPV,HPV unknown
3259,1,1,Treatment Modality,Sx & CTX-RT
3259,1,1,Tumor Stage,T4a
3259,1,1,Occurrence #,1st primary
3259,1,1,Radiation Dosage,63
3259,1,1,1st Failure Type,no known failure
3259,1,1,Clinical lab p16,p16 unkown
3259,1,1,Second Line Chemotherapy Agent,Carbo
3259,1,1,Metastasis,M0
3260,1,1,Nodal Stage,N0
3260,1,1,Research lab HPV,HPV unknown
3260,1,1,2nd Failure Type,no known failure
3260,1,1,Clinical lab p16,p16 unkown
3260,1,1,1st Failure Type,no known failure
3260,1,1,Occurrence #,recurrence
3260,1,1,Tumor Stage,T1
3260,1,1,Research lab p16,p16 unknown
3260,1,1,Treatment Modality,Sx
3260,1,1,Metastasis,M0
3260,1,1,Overall Stage,I
3260,1,1,Tumor Site,oropharynx
3261,1,1,1st Failure Type,no known failure
3261,1,1,Metastasis,M0
3261,1,1,Research lab p16,p16 unknown
3261,1,1,Treatment Modality,Sx
3261,1,1,2nd Failure Type,no known failure
3261,1,1,Clinical lab p16,p16 unkown
3261,1,1,Overall Stage,II
3261,1,1,Tumor Site,oral cavity
3261,1,1,Research lab HPV,HPV unknown
3261,1,1,Tumor Stage,T2
3261,1,1,Occurrence #,1st primary
3261,1,1,Nodal Stage,N0
3262,1,1,Research lab HPV,HPV unknown
3262,1,1,Metastasis,Unknown
3262,1,1,Overall Stage,Unknown
3262,1,1,Nodal Stage,Unknown
3262,1,1,1st Failure Site,oropharynx
3262,1,1,1st Failure Type,no known failure
3262,1,1,Tumor Stage,Unknown
3262,1,1,Occurrence #,1st primary
3262,1,1,1st Failure Treatment Modality,Sx
3262,1,1,2nd Failure Type,no known failure
3262,1,1,Clinical lab p16,p16 unkown
3262,1,1,Treatment Modality,Sx
3262,1,1,Research lab p16,p16 unknown
3262,1,1,Tumor Site,oropharynx
3263,1,1,1st Failure Type,no known failure
3263,1,1,2nd Failure Type,no known failure
3263,1,1,Tumor Stage,T1
3263,1,1,Occurrence #,recurrence
3263,1,1,Clinical lab p16,p16 unkown
3263,1,1,Nodal Stage,N0
3263,1,1,Overall Stage,I
3263,1,1,Metastasis,M0
3263,1,1,Research lab p16,p16 unknown
3263,1,1,Research lab HPV,HPV unknown
3263,1,1,Treatment Modality,Sx
3263,1,1,Tumor Site,oral cavity
3264,1,1,Tumor Stage,T1
3264,1,1,Nodal Stage,N0
3264,1,1,Treatment Modality,Sx
3264,1,1,Occurrence #,1st primary
3264,1,1,Clinical lab p16,p16 unkown
3264,1,1,Research lab p16,p16 unknown
3264,1,1,Overall Stage,I
3264,1,1,Tumor Site,oral cavity
3264,1,1,2nd Failure Type,no known failure
3264,1,1,Metastasis,M0
3264,1,1,Research lab HPV,HPV unknown
3264,1,1,1st Failure Type,no known failure
3265,1,1,Overall Stage,III
3265,1,1,Tumor Site,oral cavity
3265,1,1,Metastasis,M0
3265,1,1,2nd Failure Type,no known failure
3265,1,1,Treatment Modality,Sx
3265,1,1,Nodal Stage,N1
3265,1,1,Research lab p16,p16 unknown
3265,1,1,Clinical lab p16,p16 unkown
3265,1,1,Research lab HPV,HPV unknown
3265,1,1,1st Failure Type,no known failure
3265,1,1,Tumor Stage,T1
3265,1,1,Occurrence #,1st primary
3266,1,1,Nodal Stage,Unknown
3266,1,1,Clinical lab p16,p16 unkown
3266,1,1,Metastasis,Unknown
3266,1,1,Occurrence #,1st primary
3266,1,1,Research lab HPV,HPV unknown
3266,1,1,2nd Failure Type,no known failure
3266,1,1,Tumor Site,oral cavity
3266,1,1,1st Failure Type,no known failure
3266,1,1,Overall Stage,Unknown
3266,1,1,Treatment Modality,Sx
3266,1,1,Research lab p16,p16 unknown
3266,1,1,Tumor Stage,Unknown
3267,1,1,Occurrence #,1st primary
3267,1,1,Clinical lab p16,p16 unkown
3267,1,1,Tumor Site,oropharynx
3267,1,1,Nodal Stage,N0
3267,1,1,Research lab p16,p16 unknown
3267,1,1,Overall Stage,I
3267,1,1,Treatment Modality,Sx
3267,1,1,2nd Failure Type,no known failure
3267,1,1,1st Failure Type,no known failure
3267,1,1,Research lab HPV,HPV unknown
3267,1,1,Metastasis,M0
3267,1,1,Tumor Stage,T1
3268,1,1,Tumor Stage,T1
3268,1,1,Treatment Modality,Sx
3268,1,1,Occurrence #,1st primary
3268,1,1,1st Failure Type,no known failure
3268,1,1,Overall Stage,I
3268,1,1,Metastasis,M0
3268,1,1,Tumor Site,oral cavity
3268,1,1,Research lab HPV,HPV unknown
3268,1,1,Nodal Stage,N0
3268,1,1,2nd Failure Type,no known failure
3268,1,1,Clinical lab p16,p16 unkown
3268,1,1,Research lab p16,p16 unknown
3269,1,1,Clinical lab p16,p16 unkown
3269,1,1,Nodal Stage,N1
3269,1,1,Treatment Modality,Sx
3269,1,1,Metastasis,M0
3269,1,1,2nd Failure Type,no known failure
3269,1,1,Tumor Stage,T3
3269,1,1,1st Failure Type,no known failure
3269,1,1,Research lab p16,p16 unknown
3269,1,1,Overall Stage,III
3269,1,1,Occurrence #,1st primary
3269,1,1,Research lab HPV,HPV unknown
3269,1,1,Tumor Site,oral cavity
3270,1,1,Tumor Site,oral cavity
3270,1,1,Nodal Stage,N0
3270,1,1,Treatment Modality,Sx
3270,1,1,Tumor Stage,T1
3270,1,1,Overall Stage,I
3270,1,1,1st Failure Type,no known failure
3270,1,1,Clinical lab p16,p16 unkown
3270,1,1,Occurrence #,1st primary
3270,1,1,2nd Failure Type,no known failure
3270,1,1,Research lab p16,p16 unknown
3270,1,1,Metastasis,M0
3270,1,1,Research lab HPV,HPV unknown
3271,1,1,Clinical lab p16,p16 unkown
3271,1,1,Research lab HPV,HPV unknown
3271,1,1,Tumor Stage,T4a
3271,1,1,2nd Failure Type,no known failure
3271,1,1,Occurrence #,1st primary
3271,1,1,Nodal Stage,N2
3271,1,1,Metastasis,M0
3271,1,1,Research lab p16,p16 unknown
3271,1,1,1st Failure Type,no known failure
3271,1,1,Overall Stage,IVa
3271,1,1,Treatment Modality,Sx
3271,1,1,Tumor Site,oral cavity
3272,1,1,Overall Stage,II
3272,1,1,Clinical lab p16,p16 unkown
3272,1,1,Tumor Site,oral cavity
3272,1,1,Metastasis,M0
3272,1,1,Research lab HPV,HPV unknown
3272,1,1,Research lab p16,p16 unknown
3272,1,1,Occurrence #,1st primary
3272,1,1,2nd Failure Type,no known failure
3272,1,1,Treatment Modality,Sx
3272,1,1,1st Failure Type,no known failure
3272,1,1,Nodal Stage,N0
3272,1,1,Tumor Stage,T2
3273,1,1,Overall Stage,I
3273,1,1,Research lab HPV,HPV unknown
3273,1,1,Research lab p16,p16 unknown
3273,1,1,Tumor Stage,T1
3273,1,1,1st Failure Site,oral cavity
3273,1,1,Occurrence #,1st primary
3273,1,1,Treatment Modality,Sx
3273,1,1,2nd Failure Type,no known failure
3273,1,1,Tumor Site,oral cavity
3273,1,1,Clinical lab p16,p16 unkown
3273,1,1,1st Failure Type,locoregional
3273,1,1,Metastasis,M0
3273,1,1,1st Failure Treatment Modality,Sx
3273,1,1,Nodal Stage,N0
3274,1,1,Tumor Stage,T1
3274,1,1,Treatment Modality,Sx
3274,1,1,Nodal Stage,N0
3274,1,1,Metastasis,M0
3274,1,1,Occurrence #,1st primary
3274,1,1,Research lab HPV,HPV unknown
3274,1,1,1st Failure Type,no known failure
3274,1,1,Tumor Site,oral cavity
3274,1,1,Research lab p16,p16 unknown
3274,1,1,2nd Failure Type,no known failure
3274,1,1,Clinical lab p16,p16 unkown
3274,1,1,Overall Stage,I
3275,1,1,Treatment Modality,Sx
3275,1,1,Research lab p16,p16 unknown
3275,1,1,1st Failure Type,no known failure
3275,1,1,Metastasis,M0
3275,1,1,Overall Stage,I
3275,1,1,Tumor Site,oral cavity
3275,1,1,2nd Failure Type,no known failure
3275,1,1,Clinical lab p16,p16 unkown
3275,1,1,Tumor Stage,T1
3275,1,1,Occurrence #,1st primary
3275,1,1,Nodal Stage,N0
3275,1,1,Research lab HPV,HPV unknown
3276,1,1,Clinical lab p16,p16 unkown
3276,1,1,1st Failure Type,no known failure
3276,1,1,Research lab HPV,HPV unknown
3276,1,1,2nd Failure Type,no known failure
3276,1,1,Tumor Stage,T1
3276,1,1,Treatment Modality,Sx
3276,1,1,Overall Stage,I
3276,1,1,Occurrence #,1st primary
3276,1,1,Tumor Site,oral cavity
3276,1,1,Nodal Stage,N0
3276,1,1,Research lab p16,p16 unknown
3276,1,1,Metastasis,M0
3277,1,1,2nd Failure Type,no known failure
3277,1,1,Clinical lab p16,p16 unkown
3277,1,1,Research lab p16,p16 unknown
3277,1,1,Occurrence #,1st primary
3277,1,1,Overall Stage,Unknown
3277,1,1,Treatment Modality,Sx
3277,1,1,Nodal Stage,Unknown
3277,1,1,Metastasis,Unknown
3277,1,1,Tumor Stage,Unknown
3277,1,1,Research lab HPV,HPV unknown
3277,1,1,1st Failure Type,no known failure
3277,1,1,Tumor Site,oral cavity
3278,1,1,Metastasis,M0
3278,1,1,Tumor Site,oral cavity
3278,1,1,Overall Stage,I
3278,1,1,Research lab p16,p16 unknown
3278,1,1,Clinical lab p16,p16 unkown
3278,1,1,Research lab HPV,HPV unknown
3278,1,1,Tumor Stage,T1
3278,1,1,Nodal Stage,N0
3278,1,1,Occurrence #,1st primary
3278,1,1,Treatment Modality,Sx
3278,1,1,1st Failure Type,no known failure
3278,1,1,2nd Failure Type,no known failure
3279,1,1,Metastasis,M0
3279,1,1,Research lab HPV,HPV unknown
3279,1,1,2nd Failure Type,no known failure
3279,1,1,Occurrence #,1st primary
3279,1,1,Clinical lab p16,p16 unkown
3279,1,1,Tumor Site,oral cavity
3279,1,1,Tumor Stage,T1
3279,1,1,1st Failure Type,no known failure
3279,1,1,Nodal Stage,N0
3279,1,1,Treatment Modality,Sx
3279,1,1,Overall Stage,I
3279,1,1,Research lab p16,p16 unknown
3280,1,1,Tumor Stage,T1
3280,1,1,Metastasis,M0
3280,1,1,1st Failure Type,no known failure
3280,1,1,Research lab p16,p16 unknown
3280,1,1,Occurrence #,other primary
3280,1,1,Treatment Modality,Sx & RT
3280,1,1,Research lab HPV,HPV unknown
3280,1,1,Nodal Stage,N0
3280,1,1,Tumor Site,oral cavity
3280,1,1,Overall Stage,I
3280,1,1,2nd Failure Type,no known failure
3280,1,1,Clinical lab p16,p16 unkown
3281,1,1,Nodal Stage,N0
3281,1,1,Overall Stage,I
3281,1,1,Metastasis,M0
3281,1,1,Tumor Stage,T1
3281,1,1,1st Failure Type,no known failure
3281,1,1,Tumor Site,oral cavity
3281,1,1,Treatment Modality,Sx
3281,1,1,Research lab p16,p16 unknown
3281,1,1,Research lab HPV,HPV unknown
3281,1,1,Occurrence #,1st primary
3281,1,1,Clinical lab p16,p16 unkown
3281,1,1,2nd Failure Type,no known failure
3282,1,1,Clinical lab p16,p16 unkown
3282,1,1,1st Failure Type,no known failure
3282,1,1,Overall Stage,IVa
3282,1,1,Treatment Modality,Sx
3282,1,1,Occurrence #,1st primary
3282,1,1,Nodal Stage,N2
3282,1,1,2nd Failure Type,no known failure
3282,1,1,Tumor Site,oral cavity
3282,1,1,Tumor Stage,T4a
3282,1,1,Research lab p16,p16 unknown
3282,1,1,Metastasis,M0
3282,1,1,Research lab HPV,HPV unknown
3283,1,1,Clinical lab p16,p16 unkown
3283,1,1,1st Failure Site,oral cavity
3283,1,1,Tumor Site,oral cavity
3283,1,1,Nodal Stage,N0
3283,1,1,Research lab HPV,HPV unknown
3283,1,1,1st Failure Type,no known failure
3283,1,1,Tumor Stage,T4a
3283,1,1,1st Failure Treatment Modality,Sx
3283,1,1,Occurrence #,1st primary
3283,1,1,Metastasis,M0
3283,1,1,Research lab p16,p16 unknown
3283,1,1,2nd Failure Type,no known failure
3283,1,1,Treatment Modality,Sx
3283,1,1,Overall Stage,IVa
3284,1,1,Metastasis,M0
3284,1,1,1st Failure Type,no known failure
3284,1,1,Tumor Site,oral cavity
3284,1,1,2nd Failure Type,no known failure
3284,1,1,Overall Stage,IVa
3284,1,1,Clinical lab p16,p16 unkown
3284,1,1,Nodal Stage,N0
3284,1,1,Occurrence #,1st primary
3284,1,1,Research lab HPV,HPV unknown
3284,1,1,Treatment Modality,Sx
3284,1,1,Tumor Stage,T4a
3284,1,1,Research lab p16,p16 unknown
3285,1,1,2nd Failure Type,no known failure
3285,1,1,Research lab HPV,HPV unknown
3285,1,1,Metastasis,M0
3285,1,1,Nodal Stage,N1
3285,1,1,Overall Stage,III
3285,1,1,Occurrence #,1st primary
3285,1,1,Treatment Modality,Sx
3285,1,1,Clinical lab p16,p16 unkown
3285,1,1,Research lab p16,p16 unknown
3285,1,1,1st Failure Type,no known failure
3285,1,1,Tumor Site,oral cavity
3285,1,1,Tumor Stage,T2
3286,1,1,Tumor Stage,T1
3286,1,1,Treatment Modality,Sx
3286,1,1,1st Failure Type,no known failure
3286,1,1,Research lab HPV,HPV unknown
3286,1,1,Occurrence #,other primary
3286,1,1,Tumor Site,oral cavity
3286,1,1,2nd Failure Type,no known failure
3286,1,1,Research lab p16,p16 unknown
3286,1,1,Nodal Stage,N0
3286,1,1,Overall Stage,I
3286,1,1,Clinical lab p16,p16 unkown
3286,1,1,Metastasis,M0
3287,1,1,Overall Stage,Unknown
3287,1,1,Treatment Modality,Unknown
3287,1,1,1st Failure Type,no known failure
3287,1,1,Metastasis,Unknown
3287,1,1,Nodal Stage,Unknown
3287,1,1,Tumor Site,oral cavity
3287,1,1,Research lab p16,p16 unknown
3287,1,1,Research lab HPV,HPV unknown
3287,1,1,Clinical lab p16,p16 unkown
3287,1,1,Occurrence #,1st primary
3287,1,1,Tumor Stage,Unknown
3287,1,1,2nd Failure Type,no known failure
3288,1,1,Research lab p16,p16 unknown
3288,1,1,Overall Stage,II
3288,1,1,Treatment Modality,Sx
3288,1,1,1st Failure Type,no known failure
3288,1,1,Tumor Stage,T2
3288,1,1,Research lab HPV,HPV unknown
3288,1,1,2nd Failure Type,no known failure
3288,1,1,Nodal Stage,N0
3288,1,1,Tumor Site,oral cavity
3288,1,1,Metastasis,M0
3288,1,1,Occurrence #,1st primary
3288,1,1,Clinical lab p16,p16 unkown
3289,1,1,Research lab p16,p16 unknown
3289,1,1,Tumor Site,oral cavity
3289,1,1,Occurrence #,1st primary
3289,1,1,Overall Stage,Unknown
3289,1,1,Treatment Modality,Sx
3289,1,1,Research lab HPV,HPV unknown
3289,1,1,Metastasis,Unknown
3289,1,1,Nodal Stage,Unknown
3289,1,1,1st Failure Type,no known failure
3289,1,1,Tumor Stage,Unknown
3289,1,1,Clinical lab p16,p16 unkown
3289,1,1,2nd Failure Type,no known failure
3290,1,1,Tumor Site,oral cavity
3290,1,1,Tumor Stage,T1
3290,1,1,Treatment Modality,Sx
3290,1,1,1st Failure Type,locoregional
3290,1,1,Research lab p16,p16 unknown
3290,1,1,Nodal Stage,N0
3290,1,1,1st Failure Site,oral cavity
3290,1,1,1st Failure Treatment Modality,Sx
3290,1,1,Metastasis,M0
3290,1,1,Clinical lab p16,p16 unkown
3290,1,1,Overall Stage,I
3290,1,1,Occurrence #,1st primary
3290,1,1,Research lab HPV,HPV unknown
3290,1,1,2nd Failure Type,no known failure
3291,1,1,Clinical lab p16,p16 unkown
3291,1,1,Nodal Stage,N0
3291,1,1,Tumor Stage,T2
3291,1,1,Occurrence #,1st primary
3291,1,1,1st Failure Type,no known failure
3291,1,1,Metastasis,M0
3291,1,1,Tumor Site,oral cavity
3291,1,1,2nd Failure Type,no known failure
3291,1,1,Research lab p16,p16 unknown
3291,1,1,Overall Stage,II
3291,1,1,Treatment Modality,Sx
3291,1,1,Research lab HPV,HPV unknown
3292,1,1,Tumor Site,oral cavity
3292,1,1,Nodal Stage,N0
3292,1,1,Research lab HPV,HPV unknown
3292,1,1,2nd Failure Type,no known failure
3292,1,1,Clinical lab p16,p16 unkown
3292,1,1,Research lab p16,p16 unknown
3292,1,1,Metastasis,M0
3292,1,1,Occurrence #,1st primary
3292,1,1,Overall Stage,I
3292,1,1,Treatment Modality,Sx
3292,1,1,Tumor Stage,T1
3292,1,1,1st Failure Type,no known failure
3293,1,1,Clinical lab p16,p16 unkown
3293,1,1,Metastasis,M0
3293,1,1,Research lab HPV,HPV unknown
3293,1,1,1st Failure Type,no known failure
3293,1,1,Occurrence #,1st primary
3293,1,1,Overall Stage,I
3293,1,1,2nd Failure Type,no known failure
3293,1,1,Nodal Stage,N0
3293,1,1,Tumor Stage,T1
3293,1,1,Tumor Site,oral cavity
3293,1,1,Research lab p16,p16 unknown
3293,1,1,Treatment Modality,Sx
3294,1,1,Clinical lab p16,p16 unkown
3294,1,1,Research lab HPV,HPV unknown
3294,1,1,Overall Stage,I
3294,1,1,Research lab p16,p16 unknown
3294,1,1,2nd Failure Type,no known failure
3294,1,1,1st Failure Type,no known failure
3294,1,1,Treatment Modality,Sx
3294,1,1,Tumor Stage,T1
3294,1,1,Nodal Stage,N0
3294,1,1,Tumor Site,oral cavity
3294,1,1,Occurrence #,1st primary
3294,1,1,Metastasis,M0
3295,1,1,Occurrence #,1st primary
3295,1,1,Research lab HPV,HPV unknown
3295,1,1,Metastasis,M0
3295,1,1,Overall Stage,I
3295,1,1,2nd Failure Type,no known failure
3295,1,1,Tumor Site,oral cavity
3295,1,1,Clinical lab p16,p16 unkown
3295,1,1,Treatment Modality,Sx
3295,1,1,Tumor Stage,T1
3295,1,1,Nodal Stage,N0
3295,1,1,Research lab p16,p16 unknown
3295,1,1,1st Failure Type,no known failure
3296,1,1,Tumor Stage,T3
3296,1,1,Nodal Stage,N2
3296,1,1,Tumor Site,oral cavity
3296,1,1,Treatment Modality,Sx
3296,1,1,Research lab p16,p16 unknown
3296,1,1,Overall Stage,IVa
3296,1,1,Occurrence #,1st primary
3296,1,1,1st Failure Type,no known failure
3296,1,1,Clinical lab p16,p16 unkown
3296,1,1,2nd Failure Type,no known failure
3296,1,1,Research lab HPV,HPV unknown
3296,1,1,Metastasis,M0
3297,1,1,Clinical lab p16,p16 unkown
3297,1,1,Tumor Stage,T1
3297,1,1,2nd Failure Type,no known failure
3297,1,1,Occurrence #,1st primary
3297,1,1,Tumor Site,oral cavity
3297,1,1,Nodal Stage,N0
3297,1,1,1st Failure Type,no known failure
3297,1,1,Metastasis,M0
3297,1,1,Research lab HPV,HPV unknown
3297,1,1,Treatment Modality,Sx
3297,1,1,Research lab p16,p16 unknown
3297,1,1,Overall Stage,I
3298,1,1,Nodal Stage,N0
3298,1,1,Tumor Site,oral cavity
3298,1,1,Treatment Modality,Sx
3298,1,1,Tumor Stage,T1
3298,1,1,Overall Stage,I
3298,1,1,Metastasis,M0
3298,1,1,Occurrence #,1st primary
3298,1,1,Clinical lab p16,p16 unkown
3298,1,1,1st Failure Type,no known failure
3298,1,1,Research lab p16,p16 unknown
3298,1,1,Research lab HPV,HPV unknown
3298,1,1,2nd Failure Type,no known failure
3299,1,1,1st Failure Type,no known failure
3299,1,1,Tumor Site,oral cavity
3299,1,1,Tumor Stage,T3
3299,1,1,Research lab HPV,HPV unknown
3299,1,1,2nd Failure Type,no known failure
3299,1,1,Research lab p16,p16 unknown
3299,1,1,Metastasis,M0
3299,1,1,Clinical lab p16,p16 unkown
3299,1,1,Occurrence #,recurrence
3299,1,1,Radiation Dosage,40
3299,1,1,Overall Stage,III
3299,1,1,Treatment Modality,Sx & RT
3299,1,1,Nodal Stage,N0
3300,1,1,Treatment Modality,Sx
3300,1,1,Research lab p16,p16 unknown
3300,1,1,Research lab HPV,HPV unknown
3300,1,1,Occurrence #,recurrence
3300,1,1,Clinical lab p16,p16 unkown
3300,1,1,Nodal Stage,N0
3300,1,1,Metastasis,M0
3300,1,1,Tumor Site,oral cavity
3300,1,1,2nd Failure Type,no known failure
3300,1,1,1st Failure Type,no known failure
3300,1,1,Tumor Stage,T1
3300,1,1,Overall Stage,II
3301,1,1,Occurrence #,1st primary
3301,1,1,Nodal Stage,N1
3301,1,1,Clinical lab p16,p16 unkown
3301,1,1,2nd Failure Type,no known failure
3301,1,1,1st Failure Type,no known failure
3301,1,1,Research lab p16,p16 unknown
3301,1,1,Overall Stage,III
3301,1,1,Tumor Stage,T2
3301,1,1,Tumor Site,oral cavity
3301,1,1,Research lab HPV,HPV unknown
3301,1,1,Metastasis,M0
3301,1,1,Treatment Modality,Sx
3302,1,1,Research lab HPV,HPV unknown
3302,1,1,2nd Failure Type,no known failure
3302,1,1,Treatment Modality,Sx
3302,1,1,Tumor Stage,T1
3302,1,1,1st Failure Treatment Modality,Sx
3302,1,1,Clinical lab p16,p16 unkown
3302,1,1,Metastasis,M0
3302,1,1,Nodal Stage,N0
3302,1,1,Tumor Site,oral cavity
3302,1,1,1st Failure Type,no known failure
3302,1,1,Overall Stage,I
3302,1,1,Occurrence #,1st primary
3302,1,1,Research lab p16,p16 unknown
3303,1,1,Research lab p16,p16 unknown
3303,1,1,Research lab HPV,HPV unknown
3303,1,1,Tumor Site,oral cavity
3303,1,1,Overall Stage,III
3303,1,1,Treatment Modality,Sx
3303,1,1,2nd Failure Type,no known failure
3303,1,1,Metastasis,M0
3303,1,1,Occurrence #,1st primary
3303,1,1,1st Failure Type,no known failure
3303,1,1,Nodal Stage,N0
3303,1,1,Clinical lab p16,p16 unkown
3303,1,1,Tumor Stage,T3
3304,1,1,Metastasis,M0
3304,1,1,Overall Stage,I
3304,1,1,Research lab p16,p16 unknown
3304,1,1,Nodal Stage,N0
3304,1,1,Treatment Modality,Sx
3304,1,1,2nd Failure Type,no known failure
3304,1,1,1st Failure Type,no known failure
3304,1,1,Research lab HPV,HPV unknown
3304,1,1,Clinical lab p16,p16 unkown
3304,1,1,Tumor Stage,T1
3304,1,1,Occurrence #,1st primary
3304,1,1,Tumor Site,oral cavity
3305,1,1,Research lab p16,p16 unknown
3305,1,1,Tumor Site,oral cavity
3305,1,1,Treatment Modality,Sx
3305,1,1,1st Failure Treatment Modality,Sx
3305,1,1,Tumor Stage,T1
3305,1,1,2nd Failure Type,no known failure
3305,1,1,Overall Stage,I
3305,1,1,Metastasis,M0
3305,1,1,Occurrence #,1st primary
3305,1,1,1st Failure Type,no known failure
3305,1,1,Nodal Stage,N0
3305,1,1,Clinical lab p16,p16 unkown
3305,1,1,Research lab HPV,HPV unknown
3305,1,1,1st Failure Site,oral cavity
3306,1,1,1st Failure Treatment Modality,Sx
3306,1,1,Clinical lab p16,p16 unkown
3306,1,1,1st Failure Site,oral cavity
3306,1,1,1st Failure Type,no known failure
3306,1,1,Tumor Stage,T3
3306,1,1,Occurrence #,1st primary
3306,1,1,Metastasis,M0
3306,1,1,Nodal Stage,N0
3306,1,1,2nd Failure Type,no known failure
3306,1,1,Treatment Modality,Sx
3306,1,1,Tumor Site,oral cavity
3306,1,1,Research lab HPV,HPV unknown
3306,1,1,Research lab p16,p16 unknown
3306,1,1,Overall Stage,III
3307,1,1,Research lab HPV,HPV unknown
3307,1,1,Occurrence #,1st primary
3307,1,1,Initial Chemotherapy Agent,Carbo
3307,1,1,2nd Failure Type,no known failure
3307,1,1,1st Failure Type,no known failure
3307,1,1,Overall Stage,IVa
3307,1,1,Nodal Stage,N2
3307,1,1,Metastasis,M0
3307,1,1,Research lab p16,p16 unknown
3307,1,1,Radiation Dosage,63
3307,1,1,Clinical lab p16,p16 unkown
3307,1,1,Tumor Site,oral cavity
3307,1,1,Treatment Modality,Sx & CTX-RT
3307,1,1,Tumor Stage,T3
3308,1,1,Tumor Stage,T1
3308,1,1,Overall Stage,I
3308,1,1,Occurrence #,1st primary
3308,1,1,Metastasis,M0
3308,1,1,Clinical lab p16,p16 unkown
3308,1,1,1st Failure Type,no known failure
3308,1,1,2nd Failure Type,no known failure
3308,1,1,Research lab HPV,HPV unknown
3308,1,1,Research lab p16,p16 unknown
3308,1,1,Tumor Site,oral cavity
3308,1,1,Nodal Stage,N0
3308,1,1,Treatment Modality,Sx
3309,1,1,Research lab p16,p16 unknown
3309,1,1,Overall Stage,II
3309,1,1,Tumor Site,oral cavity
3309,1,1,Clinical lab p16,p16 unkown
3309,1,1,2nd Failure Type,no known failure
3309,1,1,Nodal Stage,N0
3309,1,1,Tumor Stage,T2
3309,1,1,Research lab HPV,HPV unknown
3309,1,1,Treatment Modality,Sx
3309,1,1,1st Failure Type,no known failure
3309,1,1,Metastasis,M0
3309,1,1,Occurrence #,1st primary
3310,1,1,Occurrence #,1st primary
3310,1,1,Research lab p16,p16 unknown
3310,1,1,Research lab HPV,HPV unknown
3310,1,1,Tumor Site,oral cavity
3310,1,1,Clinical lab p16,p16 unkown
3310,1,1,Treatment Modality,Sx
3310,1,1,Tumor Stage,T1
3310,1,1,1st Failure Type,no known failure
3310,1,1,2nd Failure Type,no known failure
3310,1,1,Nodal Stage,N0
3310,1,1,Overall Stage,I
3310,1,1,Metastasis,M0
3311,1,1,Research lab p16,p16 unknown
3311,1,1,Tumor Stage,T2
3311,1,1,Overall Stage,III
3311,1,1,Research lab HPV,HPV unknown
3311,1,1,Treatment Modality,Sx
3311,1,1,2nd Failure Type,no known failure
3311,1,1,Metastasis,M0
3311,1,1,1st Failure Type,no known failure
3311,1,1,Clinical lab p16,p16 unkown
3311,1,1,Nodal Stage,N1
3311,1,1,Tumor Site,oral cavity
3311,1,1,Occurrence #,1st primary
3312,1,1,Occurrence #,1st primary
3312,1,1,Research lab p16,p16 unknown
3312,1,1,Nodal Stage,N0
3312,1,1,2nd Failure Type,no known failure
3312,1,1,1st Failure Type,no known failure
3312,1,1,Clinical lab p16,p16 unkown
3312,1,1,Tumor Site,oral cavity
3312,1,1,Metastasis,M0
3312,1,1,Research lab HPV,HPV unknown
3312,1,1,Tumor Stage,T1
3312,1,1,Overall Stage,I
3312,1,1,Treatment Modality,Sx
3313,1,1,Tumor Site,oral cavity
3313,1,1,Tumor Stage,T2
3313,1,1,1st Failure Site,oral cavity
3313,1,1,Occurrence #,1st primary
3313,1,1,1st Failure Treatment Modality,Sx
3313,1,1,Overall Stage,II
3313,1,1,Nodal Stage,N0
3313,1,1,1st Failure Type,locoregional
3313,1,1,Metastasis,M0
3313,1,1,Research lab p16,p16 unknown
3313,1,1,Research lab HPV,HPV unknown
3313,1,1,Treatment Modality,Sx
3313,1,1,Clinical lab p16,p16 unkown
3313,1,1,2nd Failure Type,no known failure
3314,1,1,Nodal Stage,N0
3314,1,1,2nd Failure Type,no known failure
3314,1,1,Occurrence #,1st primary
3314,1,1,1st Failure Type,no known failure
3314,1,1,Tumor Site,oral cavity
3314,1,1,Tumor Stage,T1
3314,1,1,Metastasis,M0
3314,1,1,Clinical lab p16,p16 unkown
3314,1,1,Research lab p16,p16 unknown
3314,1,1,Treatment Modality,Sx
3314,1,1,Research lab HPV,HPV unknown
3314,1,1,Overall Stage,I
3315,1,1,Tumor Site,oral cavity
3315,1,1,Clinical lab p16,p16 unkown
3315,1,1,Nodal Stage,N0
3315,1,1,Research lab HPV,HPV unknown
3315,1,1,1st Failure Type,no known failure
3315,1,1,Treatment Modality,Sx
3315,1,1,2nd Failure Type,no known failure
3315,1,1,Metastasis,M0
3315,1,1,Tumor Stage,T3
3315,1,1,Occurrence #,1st primary
3315,1,1,Overall Stage,III
3315,1,1,Research lab p16,p16 unknown
3316,1,1,Metastasis,Unknown
3316,1,1,Occurrence #,1st primary
3316,1,1,Tumor Stage,Unknown
3316,1,1,Treatment Modality,Sx
3316,1,1,Research lab HPV,HPV unknown
3316,1,1,Overall Stage,Unknown
3316,1,1,Clinical lab p16,p16 unkown
3316,1,1,Tumor Site,oral cavity
3316,1,1,Research lab p16,p16 unknown
3316,1,1,Nodal Stage,Unknown
3316,1,1,1st Failure Type,no known failure
3316,1,1,2nd Failure Type,no known failure
3317,1,1,Research lab HPV,HPV unknown
3317,1,1,Clinical lab p16,p16 unkown
3317,1,1,Occurrence #,1st primary
3317,1,1,Metastasis,M0
3317,1,1,Tumor Stage,T2
3317,1,1,Overall Stage,III
3317,1,1,1st Failure Type,no known failure
3317,1,1,2nd Failure Type,no known failure
3317,1,1,Nodal Stage,N1
3317,1,1,Treatment Modality,Sx
3317,1,1,Tumor Site,oral cavity
3317,1,1,Research lab p16,p16 unknown
3318,1,1,2nd Failure Type,no known failure
3318,1,1,Research lab HPV,HPV unknown
3318,1,1,Treatment Modality,Sx
3318,1,1,Tumor Site,oral cavity
3318,1,1,Research lab p16,p16 unknown
3318,1,1,Clinical lab p16,p16 unkown
3318,1,1,Metastasis,M0
3318,1,1,Tumor Stage,T2
3318,1,1,Occurrence #,1st primary
3318,1,1,Nodal Stage,N2
3318,1,1,1st Failure Type,no known failure
3318,1,1,Overall Stage,IVa
3319,1,1,Occurrence #,1st primary
3319,1,1,Nodal Stage,N1
3319,1,1,Treatment Modality,Sx
3319,1,1,Research lab HPV,HPV unknown
3319,1,1,Tumor Site,oral cavity
3319,1,1,Metastasis,M0
3319,1,1,1st Failure Type,no known failure
3319,1,1,Research lab p16,p16 unknown
3319,1,1,Clinical lab p16,p16 unkown
3319,1,1,Overall Stage,III
3319,1,1,2nd Failure Type,no known failure
3319,1,1,Tumor Stage,T2
3320,1,1,Metastasis,M0
3320,1,1,Occurrence #,1st primary
3320,1,1,1st Failure Treatment Modality,Sx
3320,1,1,Research lab p16,p16 unknown
3320,1,1,1st Failure Type,no known failure
3320,1,1,1st Failure Site,oral cavity
3320,1,1,Treatment Modality,Sx
3320,1,1,Research lab HPV,HPV unknown
3320,1,1,Clinical lab p16,p16 unkown
3320,1,1,Overall Stage,III
3320,1,1,Nodal Stage,N1
3320,1,1,Tumor Site,oral cavity
3320,1,1,2nd Failure Type,no known failure
3320,1,1,Tumor Stage,T2
3321,1,1,2nd Failure Type,no known failure
3321,1,1,Nodal Stage,N2
3321,1,1,Clinical lab p16,p16 unkown
3321,1,1,Overall Stage,IVa
3321,1,1,Treatment Modality,Sx
3321,1,1,Tumor Stage,T2
3321,1,1,Occurrence #,1st primary
3321,1,1,1st Failure Type,no known failure
3321,1,1,Tumor Site,oral cavity
3321,1,1,Research lab HPV,HPV unknown
3321,1,1,Metastasis,M0
3321,1,1,Research lab p16,p16 unknown
3322,1,1,Metastasis,M0
3322,1,1,Tumor Site,oral cavity
3322,1,1,Tumor Stage,T1
3322,1,1,Research lab p16,p16 unknown
3322,1,1,1st Failure Site,oral cavity
3322,1,1,1st Failure Type,no known failure
3322,1,1,1st Failure Treatment Modality,Sx
3322,1,1,2nd Failure Type,no known failure
3322,1,1,Clinical lab p16,p16 unkown
3322,1,1,Overall Stage,I
3322,1,1,Occurrence #,1st primary
3322,1,1,Radiation Dosage,63
3322,1,1,Nodal Stage,N0
3322,1,1,Treatment Modality,Sx & RT
3322,1,1,Research lab HPV,HPV unknown
3323,1,1,Treatment Modality,CTX-RT
3323,1,1,Research lab p16,p16 unknown
3323,1,1,Metastasis,M1
3323,1,1,Overall Stage,IVc
3323,1,1,Occurrence #,1st primary
3323,1,1,Research lab HPV,HPV unknown
3323,1,1,Second Line Chemotherapy Agent,Carbo
3323,1,1,Radiation Dosage,70.2
3323,1,1,Nodal Stage,N2
3323,1,1,1st Failure Type,no known failure
3323,1,1,Clinical lab p16,p16 unkown
3323,1,1,Initial Chemotherapy Agent,doce/cis/cdetux
3323,1,1,2nd Failure Type,no known failure
3323,1,1,Tumor Stage,T4a
3323,1,1,Tumor Site,oral cavity
3324,1,1,2nd Failure Type,no known failure
3324,1,1,Metastasis,M0
3324,1,1,Overall Stage,IVa
3324,1,1,Occurrence #,1st primary
3324,1,1,Clinical lab p16,p16 unkown
3324,1,1,1st Failure Type,no known failure
3324,1,1,Nodal Stage,N0
3324,1,1,Treatment Modality,Sx
3324,1,1,Tumor Site,oral cavity
3324,1,1,Tumor Stage,T4a
3324,1,1,Research lab HPV,HPV unknown
3324,1,1,Research lab p16,p16 unknown
3325,1,1,Clinical lab p16,p16 unkown
3325,1,1,Metastasis,M0
3325,1,1,Occurrence #,1st primary
3325,1,1,Research lab p16,p16 unknown
3325,1,1,Tumor Site,oral cavity
3325,1,1,Nodal Stage,N0
3325,1,1,Research lab HPV,HPV unknown
3325,1,1,Overall Stage,I
3325,1,1,Treatment Modality,Sx
3325,1,1,Tumor Stage,T1
3325,1,1,2nd Failure Type,no known failure
3325,1,1,1st Failure Type,no known failure
3326,1,1,Tumor Stage,T1
3326,1,1,Research lab p16,p16 unknown
3326,1,1,Overall Stage,I
3326,1,1,Treatment Modality,Sx
3326,1,1,Occurrence #,1st primary
3326,1,1,Metastasis,M0
3326,1,1,Nodal Stage,N0
3326,1,1,2nd Failure Type,no known failure
3326,1,1,Research lab HPV,HPV unknown
3326,1,1,Clinical lab p16,p16 unkown
3326,1,1,1st Failure Type,no known failure
3326,1,1,Tumor Site,oral cavity
3327,1,1,Research lab p16,p16 unknown
3327,1,1,Overall Stage,I
3327,1,1,Metastasis,M0
3327,1,1,Occurrence #,1st primary
3327,1,1,Tumor Stage,T1
3327,1,1,Clinical lab p16,p16 unkown
3327,1,1,Research lab HPV,HPV unknown
3327,1,1,2nd Failure Type,no known failure
3327,1,1,Treatment Modality,Sx
3327,1,1,1st Failure Type,no known failure
3327,1,1,Nodal Stage,N0
3327,1,1,Tumor Site,oral cavity
3328,1,1,Research lab HPV,HPV unknown
3328,1,1,Research lab p16,p16 unknown
3328,1,1,Tumor Stage,T2
3328,1,1,Tumor Site,oral cavity
3328,1,1,Occurrence #,1st primary
3328,1,1,2nd Failure Type,no known failure
3328,1,1,Metastasis,M0
3328,1,1,Overall Stage,II
3328,1,1,Nodal Stage,N0
3328,1,1,Treatment Modality,Sx
3328,1,1,1st Failure Type,no known failure
3328,1,1,Clinical lab p16,p16 unkown
3329,1,1,Clinical lab p16,p16 unkown
3329,1,1,Treatment Modality,Sx
3329,1,1,Occurrence #,1st primary
3329,1,1,Research lab p16,p16 unknown
3329,1,1,2nd Failure Type,no known failure
3329,1,1,Research lab HPV,HPV unknown
3329,1,1,Tumor Site,oral cavity
3329,1,1,Metastasis,M0
3329,1,1,Nodal Stage,N2
3329,1,1,1st Failure Type,no known failure
3329,1,1,Tumor Stage,T2
3329,1,1,Overall Stage,IVa
3330,1,1,2nd Failure Type,no known failure
3330,1,1,Research lab HPV,HPV unknown
3330,1,1,Treatment Modality,Sx & CTX-RT
3330,1,1,1st Failure Type,no known failure
3330,1,1,Clinical lab p16,p16 unkown
3330,1,1,Overall Stage,IVa
3330,1,1,Tumor Stage,T4a
3330,1,1,Metastasis,M0
3330,1,1,Nodal Stage,N2
3330,1,1,Initial Chemotherapy Agent,cis
3330,1,1,Radiation Dosage,64
3330,1,1,Research lab p16,p16 unknown
3330,1,1,Tumor Site,oral cavity
3330,1,1,Occurrence #,1st primary
3331,1,1,1st Failure Type,no known failure
3331,1,1,Occurrence #,1st primary
3331,1,1,Tumor Site,oral cavity
3331,1,1,Tumor Stage,T1
3331,1,1,Clinical lab p16,p16 unkown
3331,1,1,Research lab p16,p16 unknown
3331,1,1,Research lab HPV,HPV unknown
3331,1,1,2nd Failure Type,no known failure
3331,1,1,Overall Stage,I
3331,1,1,Treatment Modality,Sx
3331,1,1,Nodal Stage,N0
3331,1,1,Metastasis,M0
3332,1,1,Tumor Stage,T1
3332,1,1,Occurrence #,1st primary
3332,1,1,Tumor Site,oral cavity
3332,1,1,Clinical lab p16,p16 unkown
3332,1,1,Overall Stage,I
3332,1,1,Metastasis,M0
3332,1,1,Research lab p16,p16 unknown
3332,1,1,Nodal Stage,N0
3332,1,1,2nd Failure Type,no known failure
3332,1,1,1st Failure Type,no known failure
3332,1,1,Research lab HPV,HPV unknown
3332,1,1,Treatment Modality,Sx
3333,1,1,Tumor Site,oral cavity
3333,1,1,1st Failure Type,no known failure
3333,1,1,Treatment Modality,Sx
3333,1,1,Tumor Stage,T2
3333,1,1,Clinical lab p16,p16 unkown
3333,1,1,2nd Failure Type,no known failure
3333,1,1,Overall Stage,III
3333,1,1,Research lab p16,p16 unknown
3333,1,1,Research lab HPV,HPV unknown
3333,1,1,Metastasis,M0
3333,1,1,Nodal Stage,N1
3333,1,1,Occurrence #,1st primary
3334,1,1,Research lab HPV,HPV unknown
3334,1,1,Treatment Modality,Sx
3334,1,1,1st Failure Type,no known failure
3334,1,1,Metastasis,M0
3334,1,1,Tumor Stage,T1
3334,1,1,Occurrence #,1st primary
3334,1,1,Research lab p16,p16 unknown
3334,1,1,Nodal Stage,N0
3334,1,1,Overall Stage,I
3334,1,1,Clinical lab p16,p16 unkown
3334,1,1,2nd Failure Type,no known failure
3334,1,1,Tumor Site,oral cavity
3335,1,1,2nd Failure Type,no known failure
3335,1,1,Research lab HPV,HPV unknown
3335,1,1,Tumor Stage,T1
3335,1,1,Research lab p16,p16 unknown
3335,1,1,1st Failure Type,no known failure
3335,1,1,Nodal Stage,N0
3335,1,1,Occurrence #,1st primary
3335,1,1,Treatment Modality,Sx
3335,1,1,Clinical lab p16,p16 unkown
3335,1,1,Tumor Site,oropharynx
3335,1,1,Metastasis,M0
3335,1,1,Overall Stage,I
3336,1,1,Research lab p16,p16 unknown
3336,1,1,Tumor Stage,T2
3336,1,1,Initial Chemotherapy Agent,cis
3336,1,1,Research lab HPV,HPV unknown
3336,1,1,Metastasis,M0
3336,1,1,Radiation Dosage,70.2
3336,1,1,1st Failure Type,no known failure
3336,1,1,Clinical lab p16,p16 unkown
3336,1,1,Occurrence #,1st primary
3336,1,1,2nd Failure Type,no known failure
3336,1,1,Tumor Site,oropharynx
3336,1,1,Treatment Modality,CTX-RT
3336,1,1,Overall Stage,IVa
3336,1,1,Nodal Stage,N2
3337,1,1,2nd Failure Type,no known failure
3337,1,1,Metastasis,M0
3337,1,1,Research lab p16,p16 unknown
3337,1,1,Nodal Stage,N0
3337,1,1,Tumor Site,oral cavity
3337,1,1,Overall Stage,I
3337,1,1,Clinical lab p16,p16 unkown
3337,1,1,1st Failure Type,no known failure
3337,1,1,Tumor Stage,T1
3337,1,1,Treatment Modality,Sx
3337,1,1,Research lab HPV,HPV unknown
3337,1,1,Occurrence #,1st primary
3338,1,1,1st Failure Type,no known failure
3338,1,1,Nodal Stage,N0
3338,1,1,Occurrence #,1st primary
3338,1,1,Research lab HPV,HPV unknown
3338,1,1,Metastasis,M0
3338,1,1,Clinical lab p16,p16 unkown
3338,1,1,Tumor Site,oral cavity
3338,1,1,Tumor Stage,T2
3338,1,1,Overall Stage,II
3338,1,1,2nd Failure Type,no known failure
3338,1,1,Treatment Modality,Sx
3338,1,1,Research lab p16,p16 unknown
3339,1,1,Nodal Stage,N0
3339,1,1,Clinical lab p16,p16 unkown
3339,1,1,Overall Stage,I
3339,1,1,1st Failure Type,no known failure
3339,1,1,Research lab p16,p16 unknown
3339,1,1,Metastasis,M0
3339,1,1,Research lab HPV,HPV unknown
3339,1,1,Tumor Stage,T1
3339,1,1,2nd Failure Type,no known failure
3339,1,1,Tumor Site,oral cavity
3339,1,1,Occurrence #,1st primary
3339,1,1,Treatment Modality,Sx
3340,1,1,Treatment Modality,Sx
3340,1,1,Overall Stage,I
3340,1,1,Tumor Stage,T1
3340,1,1,Metastasis,M0
3340,1,1,2nd Failure Type,no known failure
3340,1,1,Clinical lab p16,p16 unkown
3340,1,1,Occurrence #,1st primary
3340,1,1,Tumor Site,oral cavity
3340,1,1,Research lab HPV,HPV unknown
3340,1,1,1st Failure Type,no known failure
3340,1,1,Research lab p16,p16 unknown
3340,1,1,Nodal Stage,N0
3341,1,1,Tumor Stage,T1
3341,1,1,Tumor Site,oral cavity
3341,1,1,Clinical lab p16,p16 unkown
3341,1,1,Overall Stage,IVa
3341,1,1,Occurrence #,1st primary
3341,1,1,Research lab HPV,HPV unknown
3341,1,1,1st Failure Type,no known failure
3341,1,1,Research lab p16,p16 unknown
3341,1,1,Nodal Stage,N2
3341,1,1,Metastasis,M0
3341,1,1,Treatment Modality,Sx
3341,1,1,2nd Failure Type,no known failure
3342,1,1,Clinical lab p16,p16 unkown
3342,1,1,1st Failure Type,no known failure
3342,1,1,Tumor Stage,Unknown
3342,1,1,Research lab p16,p16 unknown
3342,1,1,Occurrence #,1st primary
3342,1,1,Research lab HPV,HPV unknown
3342,1,1,Tumor Site,oral cavity
3342,1,1,2nd Failure Type,no known failure
3342,1,1,Metastasis,Unknown
3342,1,1,Nodal Stage,Unknown
3342,1,1,Overall Stage,Unknown
3342,1,1,Treatment Modality,Sx
3343,1,1,Radiation Dosage,70.2
3343,1,1,Occurrence #,1st primary
3343,1,1,Treatment Modality,CTX-RT
3343,1,1,Research lab p16,p16 unknown
3343,1,1,Tumor Site,oropharynx
3343,1,1,Research lab HPV,HPV unknown
3343,1,1,Overall Stage,IVa
3343,1,1,2nd Failure Type,no known failure
3343,1,1,Clinical lab p16,p16 unkown
3343,1,1,Initial Chemotherapy Agent,cetux
3343,1,1,Metastasis,M0
3343,1,1,1st Failure Type,no known failure
3343,1,1,Nodal Stage,N2
3343,1,1,Tumor Stage,T2
3344,1,1,1st Failure Type,no known failure
3344,1,1,Research lab p16,p16 unknown
3344,1,1,Overall Stage,I
3344,1,1,Tumor Stage,T1
3344,1,1,2nd Failure Type,no known failure
3344,1,1,Metastasis,M0
3344,1,1,Clinical lab p16,p16 unkown
3344,1,1,Tumor Site,oral cavity
3344,1,1,Occurrence #,1st primary
3344,1,1,Nodal Stage,N0
3344,1,1,Treatment Modality,Sx
3344,1,1,Research lab HPV,HPV unknown
3345,1,1,Metastasis,M0
3345,1,1,2nd Failure Type,no known failure
3345,1,1,Clinical lab p16,p16 unkown
3345,1,1,Nodal Stage,N0
3345,1,1,Treatment Modality,Sx
3345,1,1,Tumor Stage,T1
3345,1,1,1st Failure Type,no known failure
3345,1,1,Occurrence #,1st primary
3345,1,1,Overall Stage,I
3345,1,1,Tumor Site,oral cavity
3345,1,1,Research lab HPV,HPV unknown
3345,1,1,Research lab p16,p16 unknown
3346,1,1,Tumor Stage,T4a
3346,1,1,Tumor Site,oral cavity
3346,1,1,Research lab HPV,HPV unknown
3346,1,1,Nodal Stage,N0
3346,1,1,1st Failure Type,no known failure
3346,1,1,2nd Failure Type,no known failure
3346,1,1,Radiation Dosage,60
3346,1,1,Metastasis,M0
3346,1,1,Occurrence #,1st primary
3346,1,1,Clinical lab p16,p16 unkown
3346,1,1,Research lab p16,p16 unknown
3346,1,1,Treatment Modality,Sx & RT
3346,1,1,Overall Stage,IVa
3347,1,1,Treatment Modality,Sx
3347,1,1,Tumor Stage,T2
3347,1,1,Overall Stage,II
3347,1,1,1st Failure Type,no known failure
3347,1,1,2nd Failure Type,no known failure
3347,1,1,Occurrence #,1st primary
3347,1,1,Research lab HPV,HPV unknown
3347,1,1,Tumor Site,oral cavity
3347,1,1,Research lab p16,p16 unknown
3347,1,1,Nodal Stage,N0
3347,1,1,Metastasis,M0
3347,1,1,Clinical lab p16,p16 unkown
3348,1,1,2nd Failure Type,no known failure
3348,1,1,Occurrence #,1st primary
3348,1,1,Clinical lab p16,p16 unkown
3348,1,1,Research lab HPV,HPV unknown
3348,1,1,Research lab p16,p16 unknown
3348,1,1,Tumor Site,oral cavity
3348,1,1,Nodal Stage,N0
3348,1,1,1st Failure Type,no known failure
3348,1,1,Treatment Modality,Sx
3348,1,1,Overall Stage,I
3348,1,1,Tumor Stage,T1
3348,1,1,Metastasis,M0
3349,1,1,Research lab HPV,HPV unknown
3349,1,1,Research lab p16,p16 unknown
3349,1,1,Clinical lab p16,p16 unkown
3349,1,1,Treatment Modality,Sx
3349,1,1,Occurrence #,1st primary
3349,1,1,2nd Failure Type,no known failure
3349,1,1,1st Failure Type,no known failure
3349,1,1,Tumor Stage,T2
3349,1,1,Tumor Site,oral cavity
3349,1,1,Nodal Stage,N0
3349,1,1,Overall Stage,II
3349,1,1,Metastasis,M0
3350,1,1,Treatment Modality,Sx & RT
3350,1,1,Nodal Stage,N0
3350,1,1,Radiation Dosage,66
3350,1,1,1st Failure Type,no known failure
3350,1,1,Tumor Stage,T4a
3350,1,1,Research lab p16,p16 unknown
3350,1,1,Clinical lab p16,p16 unkown
3350,1,1,Metastasis,M0
3350,1,1,Research lab HPV,HPV unknown
3350,1,1,Tumor Site,oral cavity
3350,1,1,Overall Stage,IVa
3350,1,1,2nd Failure Type,no known failure
3350,1,1,Occurrence #,1st primary
3351,1,1,1st Failure Type,no known failure
3351,1,1,Research lab p16,p16 unknown
3351,1,1,Tumor Stage,T3
3351,1,1,Occurrence #,1st primary
3351,1,1,2nd Failure Type,no known failure
3351,1,1,Nodal Stage,N0
3351,1,1,Research lab HPV,HPV unknown
3351,1,1,Overall Stage,III
3351,1,1,Clinical lab p16,p16 unkown
3351,1,1,Tumor Site,oral cavity
3351,1,1,Metastasis,M0
3351,1,1,Treatment Modality,Sx
3352,1,1,Metastasis,M0
3352,1,1,2nd Failure Type,no known failure
3352,1,1,1st Failure Type,no known failure
3352,1,1,Research lab HPV,HPV unknown
3352,1,1,Clinical lab p16,p16 unkown
3352,1,1,Research lab p16,p16 unknown
3352,1,1,Overall Stage,I
3352,1,1,Occurrence #,1st primary
3352,1,1,Tumor Site,oral cavity
3352,1,1,Nodal Stage,N0
3352,1,1,Tumor Stage,T1
3352,1,1,Treatment Modality,Sx
3353,1,1,Overall Stage,IVa
3353,1,1,Research lab HPV,HPV unknown
3353,1,1,Metastasis,M0
3353,1,1,Nodal Stage,N2
3353,1,1,2nd Failure Type,no known failure
3353,1,1,Treatment Modality,Sx & RT
3353,1,1,Clinical lab p16,p16 unkown
3353,1,1,Tumor Site,oral cavity
3353,1,1,Occurrence #,1st primary
3353,1,1,Research lab p16,p16 unknown
3353,1,1,1st Failure Type,no known failure
3353,1,1,Radiation Dosage,59.4
3353,1,1,Tumor Stage,T4a
3354,1,1,Tumor Stage,T1
3354,1,1,Tumor Site,oral cavity
3354,1,1,Metastasis,M0
3354,1,1,Research lab p16,p16 unknown
3354,1,1,2nd Failure Type,no known failure
3354,1,1,Clinical lab p16,p16 unkown
3354,1,1,Overall Stage,I
3354,1,1,Occurrence #,1st primary
3354,1,1,Treatment Modality,Sx
3354,1,1,1st Failure Type,no known failure
3354,1,1,Research lab HPV,HPV unknown
3354,1,1,Nodal Stage,N0
3355,1,1,Metastasis,M0
3355,1,1,Nodal Stage,N0
3355,1,1,Treatment Modality,Sx
3355,1,1,Research lab p16,p16 unknown
3355,1,1,Overall Stage,I
3355,1,1,Occurrence #,1st primary
3355,1,1,Tumor Stage,T1
3355,1,1,Clinical lab p16,p16 unkown
3355,1,1,1st Failure Type,no known failure
3355,1,1,Tumor Site,oral cavity
3355,1,1,Research lab HPV,HPV unknown
3355,1,1,2nd Failure Type,no known failure
3356,1,1,1st Failure Type,no known failure
3356,1,1,2nd Failure Type,no known failure
3356,1,1,Occurrence #,1st primary
3356,1,1,Nodal Stage,N0
3356,1,1,Overall Stage,II
3356,1,1,Clinical lab p16,p16 unkown
3356,1,1,Metastasis,M0
3356,1,1,Tumor Site,oral cavity
3356,1,1,Research lab HPV,HPV unknown
3356,1,1,Research lab p16,p16 unknown
3356,1,1,Tumor Stage,T2
3356,1,1,Treatment Modality,Sx
3357,1,1,Nodal Stage,N0
3357,1,1,1st Failure Treatment Modality,Sx
3357,1,1,Research lab HPV,HPV unknown
3357,1,1,Clinical lab p16,p16 unkown
3357,1,1,2nd Failure Type,no known failure
3357,1,1,1st Failure Type,no known failure
3357,1,1,Tumor Site,oral cavity
3357,1,1,Treatment Modality,Sx
3357,1,1,Research lab p16,p16 unknown
3357,1,1,Tumor Stage,T1
3357,1,1,Metastasis,M0
3357,1,1,Overall Stage,I
3357,1,1,Occurrence #,1st primary
3358,1,1,Research lab p16,p16 unknown
3358,1,1,2nd Failure Type,no known failure
3358,1,1,1st Failure Type,no known failure
3358,1,1,Tumor Site,oral cavity
3358,1,1,Clinical lab p16,p16 unkown
3358,1,1,Treatment Modality,Sx
3358,1,1,Tumor Stage,T1
3358,1,1,Overall Stage,I
3358,1,1,Occurrence #,1st primary
3358,1,1,Metastasis,M0
3358,1,1,Nodal Stage,N0
3358,1,1,Research lab HPV,HPV unknown
3359,1,1,Occurrence #,1st primary
3359,1,1,Research lab p16,p16 unknown
3359,1,1,Overall Stage,IVa
3359,1,1,Treatment Modality,Sx & CTX-RT
3359,1,1,Initial Chemotherapy Agent,Carbo/ PTX
3359,1,1,Radiation Dosage,66.6
3359,1,1,2nd Failure Type,no known failure
3359,1,1,Nodal Stage,N2
3359,1,1,Tumor Site,oral cavity
3359,1,1,Metastasis,M0
3359,1,1,1st Failure Type,no known failure
3359,1,1,Research lab HPV,HPV unknown
3359,1,1,Tumor Stage,T2
3359,1,1,Clinical lab p16,p16 unkown
3360,1,1,Tumor Site,oral cavity
3360,1,1,Research lab HPV,HPV unknown
3360,1,1,Nodal Stage,N1
3360,1,1,Radiation Dosage,unknown
3360,1,1,Research lab p16,p16 unknown
3360,1,1,Tumor Stage,T4a
3360,1,1,Clinical lab p16,p16 unkown
3360,1,1,Metastasis,M0
3360,1,1,Overall Stage,IVa
3360,1,1,Initial Chemotherapy Agent,cis
3360,1,1,Treatment Modality,Sx & CTX-RT
3360,1,1,2nd Failure Type,no known failure
3360,1,1,Occurrence #,1st primary
3360,1,1,1st Failure Type,no known failure
3361,1,1,Metastasis,M0
3361,1,1,Nodal Stage,N0
3361,1,1,Treatment Modality,Sx
3361,1,1,Tumor Site,oral cavity
3361,1,1,Clinical lab p16,p16 unkown
3361,1,1,Research lab p16,p16 unknown
3361,1,1,Research lab HPV,HPV unknown
3361,1,1,Overall Stage,II
3361,1,1,2nd Failure Type,no known failure
3361,1,1,1st Failure Type,no known failure
3361,1,1,Occurrence #,1st primary
3361,1,1,Tumor Stage,T2
3362,1,1,Metastasis,M0
3362,1,1,Clinical lab p16,p16 unkown
3362,1,1,Tumor Site,oral cavity
3362,1,1,Nodal Stage,N0
3362,1,1,1st Failure Type,no known failure
3362,1,1,Research lab p16,p16 unknown
3362,1,1,2nd Failure Type,no known failure
3362,1,1,Research lab HPV,HPV unknown
3362,1,1,Occurrence #,1st primary
3362,1,1,Tumor Stage,T1
3362,1,1,Treatment Modality,Sx
3362,1,1,Overall Stage,I
3363,1,1,2nd Failure Type,no known failure
3363,1,1,Tumor Site,oropharynx
3363,1,1,Occurrence #,recurrence
3363,1,1,Nodal Stage,N2
3363,1,1,Clinical lab p16,p16 unkown
3363,1,1,Tumor Stage,T1
3363,1,1,Research lab p16,p16 unknown
3363,1,1,Research lab HPV,HPV unknown
3363,1,1,Overall Stage,IVa
3363,1,1,1st Failure Treatment Modality,Sx
3363,1,1,1st Failure Type,no known failure
3363,1,1,Metastasis,M0
3363,1,1,Treatment Modality,Sx & CTX-RT
3364,1,1,2nd Failure Type,no known failure
3364,1,1,Metastasis,M0
3364,1,1,Clinical lab p16,p16 unkown
3364,1,1,Tumor Site,oral cavity
3364,1,1,Tumor Stage,T1
3364,1,1,Nodal Stage,N0
3364,1,1,Research lab p16,p16 unknown
3364,1,1,1st Failure Type,no known failure
3364,1,1,Occurrence #,1st primary
3364,1,1,Research lab HPV,HPV unknown
3364,1,1,Treatment Modality,Sx
3364,1,1,Overall Stage,I
3365,1,1,2nd Failure Type,no known failure
3365,1,1,Occurrence #,1st primary
3365,1,1,Research lab HPV,HPV unknown
3365,1,1,Overall Stage,II
3365,1,1,1st Failure Type,no known failure
3365,1,1,1st Failure Site,oral cavity
3365,1,1,Nodal Stage,N0
3365,1,1,Tumor Stage,T2
3365,1,1,Research lab p16,p16 unknown
3365,1,1,Clinical lab p16,p16 unkown
3365,1,1,Metastasis,M0
3365,1,1,Tumor Site,oral cavity
3365,1,1,Treatment Modality,Sx
3365,1,1,1st Failure Treatment Modality,Sx
3366,1,1,1st Failure Type,no known failure
3366,1,1,Research lab HPV,HPV unknown
3366,1,1,Overall Stage,III
3366,1,1,Clinical lab p16,p16 unkown
3366,1,1,Treatment Modality,Sx
3366,1,1,Occurrence #,1st primary
3366,1,1,2nd Failure Type,no known failure
3366,1,1,Tumor Site,oral cavity
3366,1,1,Tumor Stage,T2
3366,1,1,Nodal Stage,N1
3366,1,1,Metastasis,M0
3366,1,1,Research lab p16,p16 unknown
3367,1,1,Overall Stage,I
3367,1,1,Research lab p16,p16 unknown
3367,1,1,2nd Failure Type,no known failure
3367,1,1,Research lab HPV,HPV unknown
3367,1,1,Treatment Modality,Sx
3367,1,1,1st Failure Type,no known failure
3367,1,1,Occurrence #,1st primary
3367,1,1,Clinical lab p16,p16 unkown
3367,1,1,Metastasis,M0
3367,1,1,Nodal Stage,N0
3367,1,1,Tumor Stage,T1
3367,1,1,Tumor Site,oral cavity
3368,1,1,Tumor Stage,T4a
3368,1,1,2nd Failure Type,no known failure
3368,1,1,Treatment Modality,Sx
3368,1,1,Research lab p16,p16 unknown
3368,1,1,Metastasis,M0
3368,1,1,Research lab HPV,HPV unknown
3368,1,1,Clinical lab p16,p16 unkown
3368,1,1,Tumor Site,oral cavity
3368,1,1,Nodal Stage,N0
3368,1,1,Overall Stage,IVa
3368,1,1,Occurrence #,1st primary
3368,1,1,1st Failure Type,no known failure
3369,1,1,Research lab HPV,HPV unknown
3369,1,1,1st Failure Type,no known failure
3369,1,1,Nodal Stage,N0
3369,1,1,Metastasis,M0
3369,1,1,Clinical lab p16,p16 unkown
3369,1,1,Tumor Site,oral cavity
3369,1,1,2nd Failure Type,no known failure
3369,1,1,Treatment Modality,Sx
3369,1,1,Overall Stage,I
3369,1,1,Research lab p16,p16 unknown
3369,1,1,Occurrence #,1st primary
3369,1,1,Tumor Stage,T1
3370,1,1,1st Failure Type,no known failure
3370,1,1,Tumor Site,oral cavity
3370,1,1,1st Failure Site,oral cavity
3370,1,1,1st Failure Treatment Modality,Sx
3370,1,1,Overall Stage,III
3370,1,1,2nd Failure Type,no known failure
3370,1,1,Radiation Dosage,64
3370,1,1,Metastasis,M0
3370,1,1,Occurrence #,other primary
3370,1,1,Nodal Stage,N1
3370,1,1,Research lab p16,p16 unknown
3370,1,1,Research lab HPV,HPV unknown
3370,1,1,Clinical lab p16,p16 unkown
3370,1,1,Treatment Modality,Sx
3370,1,1,Tumor Stage,T1
3371,1,1,Treatment Modality,Sx
3371,1,1,2nd Failure Type,no known failure
3371,1,1,Metastasis,M0
3371,1,1,Tumor Stage,T1
3371,1,1,Research lab p16,p16 unknown
3371,1,1,1st Failure Type,no known failure
3371,1,1,Clinical lab p16,p16 unkown
3371,1,1,Tumor Site,oral cavity
3371,1,1,Nodal Stage,N0
3371,1,1,Research lab HPV,HPV unknown
3371,1,1,Overall Stage,I
3371,1,1,Occurrence #,1st primary
3372,1,1,Clinical lab p16,p16 unkown
3372,1,1,2nd Failure Type,no known failure
3372,1,1,Occurrence #,other primary
3372,1,1,Research lab p16,p16 unknown
3372,1,1,Treatment Modality,Sx
3372,1,1,Research lab HPV,HPV unknown
3372,1,1,Nodal Stage,N2
3372,1,1,Overall Stage,IVa
3372,1,1,Tumor Site,oral cavity
3372,1,1,Metastasis,M0
3372,1,1,Tumor Stage,T2
3372,1,1,1st Failure Type,no known failure
3373,1,1,Metastasis,M0
3373,1,1,Occurrence #,other primary
3373,1,1,Research lab p16,p16 unknown
3373,1,1,Clinical lab p16,p16 unkown
3373,1,1,1st Failure Type,no known failure
3373,1,1,Tumor Site,oral cavity
3373,1,1,Nodal Stage,N0
3373,1,1,Tumor Stage,T1
3373,1,1,Treatment Modality,Sx
3373,1,1,Research lab HPV,HPV unknown
3373,1,1,2nd Failure Type,no known failure
3373,1,1,Overall Stage,I
3374,1,1,Nodal Stage,N0
3374,1,1,Overall Stage,IVa
3374,1,1,Metastasis,M0
3374,1,1,Tumor Site,oral cavity
3374,1,1,1st Failure Type,no known failure
3374,1,1,Research lab p16,p16 unknown
3374,1,1,Occurrence #,other primary
3374,1,1,Research lab HPV,HPV unknown
3374,1,1,2nd Failure Type,no known failure
3374,1,1,Clinical lab p16,p16 unkown
3374,1,1,Treatment Modality,Sx
3374,1,1,Tumor Stage,T4a
3375,1,1,Overall Stage,IVa
3375,1,1,Tumor Site,oral cavity
3375,1,1,Research lab HPV,HPV unknown
3375,1,1,Tumor Stage,T4a
3375,1,1,Research lab p16,p16 unknown
3375,1,1,Nodal Stage,N2
3375,1,1,1st Failure Type,no known failure
3375,1,1,Treatment Modality,Unknown
3375,1,1,Occurrence #,1st primary
3375,1,1,Clinical lab p16,p16 unkown
3375,1,1,2nd Failure Type,no known failure
3375,1,1,Metastasis,M0
3376,1,1,1st Failure Type,no known failure
3376,1,1,Research lab p16,p16 unknown
3376,1,1,Metastasis,M0
3376,1,1,Occurrence #,1st primary
3376,1,1,Research lab HPV,HPV unknown
3376,1,1,Initial Chemotherapy Agent,Carbo
3376,1,1,Overall Stage,IVa
3376,1,1,2nd Failure Type,no known failure
3376,1,1,Radiation Dosage,44
3376,1,1,Nodal Stage,N1
3376,1,1,Treatment Modality,Sx & CTX-RT
3376,1,1,Clinical lab p16,p16 unkown
3376,1,1,Tumor Site,oral cavity
3376,1,1,Tumor Stage,T4a
3377,1,1,1st Failure Initial Chemotherapy Agent,carbo
3377,1,1,2nd Failure Type,no known failure
3377,1,1,1st Failure Radiation Dosage,28
3377,1,1,Occurrence #,1st primary
3377,1,1,1st Failure Site,oral cavity
3377,1,1,Clinical lab p16,p16 unkown
3377,1,1,1st Failure Type,locoregional
3377,1,1,Metastasis,M0
3377,1,1,Treatment Modality,Sx
3377,1,1,Research lab HPV,HPV unknown
3377,1,1,Tumor Site,oral cavity
3377,1,1,Research lab p16,p16 unknown
3377,1,1,Nodal Stage,N0
3377,1,1,Overall Stage,III
3377,1,1,Tumor Stage,T3
3378,1,1,Overall Stage,I
3378,1,1,Treatment Modality,Sx
3378,1,1,Research lab p16,p16 unknown
3378,1,1,Clinical lab p16,p16 unkown
3378,1,1,Metastasis,M0
3378,1,1,Tumor Site,oral cavity
3378,1,1,2nd Failure Type,no known failure
3378,1,1,Tumor Stage,T1
3378,1,1,Occurrence #,other primary
3378,1,1,Nodal Stage,N0
3378,1,1,1st Failure Type,no known failure
3378,1,1,Research lab HPV,HPV unknown
3379,1,1,Metastasis,M0
3379,1,1,Clinical lab p16,p16 unkown
3379,1,1,1st Failure Type,no known failure
3379,1,1,Tumor Site,oral cavity
3379,1,1,Research lab p16,p16 unknown
3379,1,1,Nodal Stage,N1
3379,1,1,2nd Failure Type,no known failure
3379,1,1,Research lab HPV,HPV unknown
3379,1,1,Occurrence #,1st primary
3379,1,1,Overall Stage,IVa
3379,1,1,Treatment Modality,Sx
3379,1,1,Tumor Stage,T4a
3380,1,1,Nodal Stage,N1
3380,1,1,Occurrence #,1st primary
3380,1,1,Tumor Site,oral cavity
3380,1,1,Research lab HPV,HPV unknown
3380,1,1,Overall Stage,III
3380,1,1,Tumor Stage,T2
3380,1,1,Clinical lab p16,p16 unkown
3380,1,1,Treatment Modality,Sx
3380,1,1,1st Failure Treatment Modality,Sx
3380,1,1,Research lab p16,p16 unknown
3380,1,1,Metastasis,M0
3380,1,1,1st Failure Type,locoregional
3380,1,1,1st Failure Site,oral cavity
3380,1,1,2nd Failure Type,no known failure
3381,1,1,Treatment Modality,Sx
3381,1,1,Occurrence #,recurrence
3381,1,1,Nodal Stage,N0
3381,1,1,Clinical lab p16,p16 unkown
3381,1,1,2nd Failure Type,no known failure
3381,1,1,Tumor Site,oral cavity
3381,1,1,Tumor Stage,T4a
3381,1,1,Metastasis,M0
3381,1,1,1st Failure Type,no known failure
3381,1,1,Research lab p16,p16 unknown
3381,1,1,Overall Stage,IVa
3381,1,1,Research lab HPV,HPV unknown
3382,1,1,Metastasis,M0
3382,1,1,Research lab p16,p16 unknown
3382,1,1,Occurrence #,1st primary
3382,1,1,Overall Stage,IVb
3382,1,1,1st Failure Type,no known failure
3382,1,1,Tumor Stage,T4a
3382,1,1,Research lab HPV,HPV unknown
3382,1,1,2nd Failure Type,no known failure
3382,1,1,Tumor Site,oropharynx
3382,1,1,Treatment Modality,Sx
3382,1,1,Nodal Stage,N3
3382,1,1,Clinical lab p16,p16 unkown
3383,1,1,2nd Failure Type,no known failure
3383,1,1,Tumor Stage,T1
3383,1,1,Clinical lab p16,p16 unkown
3383,1,1,Research lab p16,p16 unknown
3383,1,1,1st Failure Type,no known failure
3383,1,1,Occurrence #,1st primary
3383,1,1,Overall Stage,I
3383,1,1,Tumor Site,oral cavity
3383,1,1,Treatment Modality,Sx
3383,1,1,Nodal Stage,N0
3383,1,1,Metastasis,M0
3383,1,1,Research lab HPV,HPV unknown
3384,1,1,Treatment Modality,CTX
3384,1,1,Overall Stage,IVa
3384,1,1,2nd Failure Type,no known failure
3384,1,1,Clinical lab p16,p16 unkown
3384,1,1,Occurrence #,1st primary
3384,1,1,Second Line Chemotherapy Agent,Cis/Doce
3384,1,1,Research lab HPV,HPV unknown
3384,1,1,1st Failure Type,distant
3384,1,1,Initial Chemotherapy Agent,Cis/5FU
3384,1,1,Tumor Stage,T2
3384,1,1,Nodal Stage,N2
3384,1,1,Metastasis,M0
3384,1,1,Research lab p16,p16 unknown
3384,1,1,Tumor Site,oral cavity
3385,1,1,Research lab p16,p16 unknown
3385,1,1,Nodal Stage,N3
3385,1,1,1st Failure Type,no known failure
3385,1,1,Treatment Modality,CTX-RT
3385,1,1,Overall Stage,IVb
3385,1,1,Tumor Site,oropharynx
3385,1,1,Research lab HPV,HPV unknown
3385,1,1,Initial Chemotherapy Agent,cis
3385,1,1,Clinical lab p16,p16 unkown
3385,1,1,2nd Failure Type,no known failure
3385,1,1,Tumor Stage,T4a
3385,1,1,Radiation Dosage,70.2
3385,1,1,Metastasis,M0
3385,1,1,Occurrence #,1st primary
3386,1,1,Treatment Modality,Sx
3386,1,1,Tumor Stage,T1
3386,1,1,Research lab HPV,HPV unknown
3386,1,1,2nd Failure Type,no known failure
3386,1,1,Occurrence #,1st primary
3386,1,1,Tumor Site,oral cavity
3386,1,1,Research lab p16,p16 unknown
3386,1,1,Clinical lab p16,p16 unkown
3386,1,1,1st Failure Type,no known failure
3386,1,1,Metastasis,M0
3386,1,1,Nodal Stage,N0
3386,1,1,Overall Stage,I
3387,1,1,Research lab p16,p16 unknown
3387,1,1,Tumor Site,oral cavity
3387,1,1,Initial Chemotherapy Agent,Carbo/PTX
3387,1,1,Research lab HPV,HPV unknown
3387,1,1,Metastasis,M0
3387,1,1,1st Failure Treatment Modality,CTX-RT
3387,1,1,1st Failure Initial Chemotherapy Agent,carbo/PTX
3387,1,1,Radiation Dosage,38
3387,1,1,Nodal Stage,N0
3387,1,1,Treatment Modality,CTX-RT
3387,1,1,Clinical lab p16,p16 unkown
3387,1,1,Overall Stage,II
3387,1,1,Tumor Stage,T2
3387,1,1,Occurrence #,1st primary
3387,1,1,1st Failure Type,no known failure
3387,1,1,2nd Failure Type,no known failure
3387,1,1,1st Failure Radiation Dosage,38
3388,1,1,Tumor Site,oral cavity
3388,1,1,Metastasis,M0
3388,1,1,Radiation Dosage,63
3388,1,1,Tumor Stage,T2
3388,1,1,Treatment Modality,Sx & RT
3388,1,1,Overall Stage,III
3388,1,1,Research lab HPV,HPV unknown
3388,1,1,Occurrence #,recurrence
3388,1,1,1st Failure Type,no known failure
3388,1,1,Clinical lab p16,p16 unkown
3388,1,1,2nd Failure Type,no known failure
3388,1,1,Nodal Stage,N1
3388,1,1,Research lab p16,p16 unknown
3389,1,1,Research lab HPV,HPV unknown
3389,1,1,Overall Stage,III
3389,1,1,Nodal Stage,N1
3389,1,1,Metastasis,M0
3389,1,1,Occurrence #,1st primary
3389,1,1,Clinical lab p16,p16 unkown
3389,1,1,Treatment Modality,Sx
3389,1,1,Research lab p16,p16 unknown
3389,1,1,2nd Failure Type,no known failure
3389,1,1,Tumor Stage,T3
3389,1,1,1st Failure Type,locoregional
3389,1,1,Tumor Site,oral cavity
3390,1,1,1st Failure Second Line Chemotherapy Agent,Nivo
3390,1,1,Research lab HPV,HPV unknown
3390,1,1,Metastasis,M0
3390,1,1,1st Failure Initial Chemotherapy Agent,carbo
3390,1,1,Tumor Site,oral cavity
3390,1,1,1st Failure Type,no known failure
3390,1,1,Nodal Stage,N2
3390,1,1,1st Failure Treatment Modality,CTX
3390,1,1,Radiation Dosage,66
3390,1,1,Treatment Modality,Sx & CTX-RT
3390,1,1,2nd Failure Type,no known failure
3390,1,1,Clinical lab p16,p16 unkown
3390,1,1,Initial Chemotherapy Agent,cis
3390,1,1,Overall Stage,IVa
3390,1,1,Tumor Stage,T1
3390,1,1,Occurrence #,1st primary
3390,1,1,Research lab p16,p16 unknown
3391,1,1,Tumor Stage,T4a
3391,1,1,2nd Failure Type,no known failure
3391,1,1,Nodal Stage,N0
3391,1,1,Clinical lab p16,p16 unkown
3391,1,1,Research lab p16,p16 unknown
3391,1,1,Treatment Modality,Sx
3391,1,1,1st Failure Type,no known failure
3391,1,1,Metastasis,M0
3391,1,1,Overall Stage,IVa
3391,1,1,Research lab HPV,HPV unknown
3391,1,1,Occurrence #,1st primary
3391,1,1,Tumor Site,oral cavity
3392,1,1,2nd Failure Type,no known failure
3392,1,1,1st Failure Type,no known failure
3392,1,1,Tumor Stage,T1
3392,1,1,Clinical lab p16,p16 unkown
3392,1,1,Tumor Site,oral cavity
3392,1,1,Occurrence #,1st primary
3392,1,1,Research lab p16,p16 unknown
3392,1,1,Metastasis,M0
3392,1,1,Treatment Modality,Sx
3392,1,1,Research lab HPV,HPV unknown
3392,1,1,Nodal Stage,N0
3392,1,1,Overall Stage,I
3393,1,1,Research lab HPV,HPV unknown
3393,1,1,Occurrence #,1st primary
3393,1,1,Tumor Stage,T4a
3393,1,1,Research lab p16,p16 unknown
3393,1,1,Tumor Site,oral cavity
3393,1,1,2nd Failure Type,no known failure
3393,1,1,Nodal Stage,N3
3393,1,1,Clinical lab p16,p16 unkown
3393,1,1,Radiation Dosage,33.8
3393,1,1,Metastasis,M0
3393,1,1,Initial Chemotherapy Agent,Carbo
3393,1,1,Treatment Modality,CTX-RT
3393,1,1,1st Failure Type,no known failure
3393,1,1,Overall Stage,IVb
3394,1,1,Overall Stage,IVa
3394,1,1,1st Failure Type,locoregional
3394,1,1,Tumor Site,oral cavity
3394,1,1,Research lab p16,p16 unknown
3394,1,1,Research lab HPV,HPV unknown
3394,1,1,Nodal Stage,N0
3394,1,1,Radiation Dosage,Unknown
3394,1,1,Occurrence #,other primary
3394,1,1,Tumor Stage,T4a
3394,1,1,Metastasis,M0
3394,1,1,Treatment Modality,Sx & RT
3394,1,1,2nd Failure Type,no known failure
3394,1,1,Clinical lab p16,p16 unkown
3395,1,1,Nodal Stage,N1
3395,1,1,Research lab HPV,HPV unknown
3395,1,1,1st Failure Type,no known failure
3395,1,1,2nd Failure Type,no known failure
3395,1,1,Clinical lab p16,p16 unkown
3395,1,1,Treatment Modality,Sx
3395,1,1,Metastasis,M0
3395,1,1,Occurrence #,other primary
3395,1,1,Tumor Stage,T2
3395,1,1,Overall Stage,III
3395,1,1,Tumor Site,oral cavity
3395,1,1,Research lab p16,p16 unknown
3396,1,1,Overall Stage,I
3396,1,1,Clinical lab p16,p16 unkown
3396,1,1,Treatment Modality,Sx
3396,1,1,1st Failure Type,locoregional
3396,1,1,Metastasis,M0
3396,1,1,Tumor Stage,T1
3396,1,1,Occurrence #,1st primary
3396,1,1,Research lab p16,p16 unknown
3396,1,1,Nodal Stage,N0
3396,1,1,Research lab HPV,HPV unknown
3396,1,1,Tumor Site,oral cavity
3396,1,1,2nd Failure Type,no known failure
3397,1,1,Overall Stage,IVa
3397,1,1,Clinical lab p16,p16 unkown
3397,1,1,Initial Chemotherapy Agent,5FU/Doce/cis
3397,1,1,Nodal Stage,N2
3397,1,1,Occurrence #,recurrence
3397,1,1,Metastasis,M0
3397,1,1,2nd Failure Type,no known failure
3397,1,1,Research lab p16,p16 unknown
3397,1,1,Tumor Site,oral cavity
3397,1,1,Treatment Modality,Sx & CTX
3397,1,1,1st Failure Type,no known failure
3397,1,1,Research lab HPV,HPV unknown
3397,1,1,Tumor Stage,T4a
3398,1,1,Tumor Stage,Unknown
3398,1,1,Occurrence #,1st primary
3398,1,1,Overall Stage,Unknown
3398,1,1,Research lab HPV,HPV unknown
3398,1,1,Research lab p16,p16 unknown
3398,1,1,Nodal Stage,Unknown
3398,1,1,Metastasis,Unknown
3398,1,1,Clinical lab p16,p16 unkown
3398,1,1,1st Failure Type,no known failure
3398,1,1,2nd Failure Type,no known failure
3398,1,1,Tumor Site,oral cavity
3398,1,1,Treatment Modality,Unknown
3399,1,1,Research lab p16,p16 unknown
3399,1,1,Clinical lab p16,p16 unkown
3399,1,1,1st Failure Type,no known failure
3399,1,1,Research lab HPV,HPV unknown
3399,1,1,Nodal Stage,N0
3399,1,1,Occurrence #,1st primary
3399,1,1,2nd Failure Type,no known failure
3399,1,1,Overall Stage,II
3399,1,1,Tumor Site,oral cavity
3399,1,1,Treatment Modality,Sx
3399,1,1,Tumor Stage,T2
3399,1,1,Metastasis,M0
3400,1,1,2nd Failure Type,no known failure
3400,1,1,Treatment Modality,Sx
3400,1,1,Research lab HPV,HPV unknown
3400,1,1,Tumor Stage,T4a
3400,1,1,Overall Stage,IVa
3400,1,1,Tumor Site,oral cavity
3400,1,1,1st Failure Type,no known failure
3400,1,1,Research lab p16,p16 unknown
3400,1,1,Clinical lab p16,p16 unkown
3400,1,1,Occurrence #,1st primary
3400,1,1,Nodal Stage,N0
3400,1,1,Metastasis,M0
3401,1,1,Nodal Stage,N0
3401,1,1,Research lab p16,p16 unknown
3401,1,1,Research lab HPV,HPV unknown
3401,1,1,Metastasis,M0
3401,1,1,Overall Stage,I
3401,1,1,Clinical lab p16,p16 unkown
3401,1,1,1st Failure Initial Chemotherapy Agent,Carbo/PTX
3401,1,1,Occurrence #,1st primary
3401,1,1,1st Failure Treatment Modality,Sx & CTX-RT
3401,1,1,Treatment Modality,Sx
3401,1,1,1st Failure Second Line Chemotherapy Agent,Cis/cap
3401,1,1,Tumor Stage,T1
3401,1,1,Tumor Site,oral cavity
3401,1,1,1st Failure Type,no known failure
3401,1,1,2nd Failure Type,no known failure
3401,1,1,1st Failure Radiation Dosage,50
3402,1,1,Research lab p16,p16 unknown
3402,1,1,Tumor Site,oral cavity
3402,1,1,Tumor Stage,T2
3402,1,1,Occurrence #,1st primary
3402,1,1,Overall Stage,II
3402,1,1,Research lab HPV,HPV unknown
3402,1,1,Nodal Stage,N0
3402,1,1,Treatment Modality,Sx
3402,1,1,2nd Failure Type,no known failure
3402,1,1,Clinical lab p16,p16 unkown
3402,1,1,Metastasis,M0
3402,1,1,1st Failure Type,no known failure
3403,1,1,Occurrence #,1st primary
3403,1,1,Tumor Stage,T1
3403,1,1,2nd Failure Type,no known failure
3403,1,1,Metastasis,M0
3403,1,1,Nodal Stage,N2
3403,1,1,1st Failure Type,no known failure
3403,1,1,Research lab HPV,HPV unknown
3403,1,1,Research lab p16,p16 unknown
3403,1,1,Clinical lab p16,p16 unkown
3403,1,1,Tumor Site,oropharynx
3403,1,1,Overall Stage,IVa
3403,1,1,Treatment Modality,Unknown
3404,1,1,Metastasis,M0
3404,1,1,1st Failure Site,oropharynx
3404,1,1,Occurrence #,1st primary
3404,1,1,Overall Stage,III
3404,1,1,Clinical lab p16,p16 unkown
3404,1,1,1st Failure Type,no known failure
3404,1,1,1st Failure Treatment Modality,Sx
3404,1,1,2nd Failure Type,no known failure
3404,1,1,Tumor Stage,T2
3404,1,1,Tumor Site,oral cavity
3404,1,1,Treatment Modality,Sx & RT
3404,1,1,Research lab p16,p16 unknown
3404,1,1,Research lab HPV,HPV unknown
3404,1,1,Nodal Stage,N1
3405,1,1,Treatment Modality,Sx
3405,1,1,1st Failure Type,no known failure
3405,1,1,Research lab p16,p16 unknown
3405,1,1,Metastasis,M0
3405,1,1,Occurrence #,1st primary
3405,1,1,Tumor Site,oral cavity
3405,1,1,Tumor Stage,T2
3405,1,1,2nd Failure Type,no known failure
3405,1,1,Clinical lab p16,p16 unkown
3405,1,1,Nodal Stage,N2
3405,1,1,Research lab HPV,HPV unknown
3405,1,1,Overall Stage,IVa
3406,1,1,Nodal Stage,N0
3406,1,1,Research lab HPV,HPV unknown
3406,1,1,2nd Failure Type,no known failure
3406,1,1,Tumor Stage,T4a
3406,1,1,1st Failure Type,no known failure
3406,1,1,Tumor Site,oral cavity
3406,1,1,Research lab p16,p16 unknown
3406,1,1,Metastasis,M0
3406,1,1,Treatment Modality,Sx
3406,1,1,Clinical lab p16,p16 unkown
3406,1,1,Overall Stage,IVa
3406,1,1,Occurrence #,1st primary
3407,1,1,Research lab p16,p16 unknown
3407,1,1,Nodal Stage,N0
3407,1,1,1st Failure Type,no known failure
3407,1,1,Overall Stage,I
3407,1,1,2nd Failure Type,no known failure
3407,1,1,Tumor Stage,T1
3407,1,1,Clinical lab p16,p16 unkown
3407,1,1,Tumor Site,oropharynx
3407,1,1,Occurrence #,recurrence
3407,1,1,Treatment Modality,Sx
3407,1,1,Metastasis,M0
3407,1,1,Research lab HPV,HPV unknown
3408,1,1,Tumor Site,oral cavity
3408,1,1,Occurrence #,1st primary
3408,1,1,Nodal Stage,N0
3408,1,1,Clinical lab p16,p16 unkown
3408,1,1,Overall Stage,II
3408,1,1,Treatment Modality,Sx
3408,1,1,Metastasis,M0
3408,1,1,Research lab p16,p16 unknown
3408,1,1,Research lab HPV,HPV unknown
3408,1,1,1st Failure Type,no known failure
3408,1,1,2nd Failure Type,no known failure
3408,1,1,Tumor Stage,T2
3409,1,1,1st Failure Type,no known failure
3409,1,1,Metastasis,M0
3409,1,1,Nodal Stage,N0
3409,1,1,Overall Stage,IVa
3409,1,1,Research lab HPV,HPV unknown
3409,1,1,Treatment Modality,Sx
3409,1,1,Clinical lab p16,p16 unkown
3409,1,1,Research lab p16,p16 unknown
3409,1,1,Tumor Site,oral cavity
3409,1,1,Occurrence #,1st primary
3409,1,1,Tumor Stage,T4a
3409,1,1,2nd Failure Type,no known failure
3410,1,1,Nodal Stage,N0
3410,1,1,Research lab HPV,HPV unknown
3410,1,1,Tumor Site,oropharynx
3410,1,1,Metastasis,M0
3410,1,1,Clinical lab p16,p16 unkown
3410,1,1,Overall Stage,I
3410,1,1,Treatment Modality,Sx
3410,1,1,Research lab p16,p16 unknown
3410,1,1,1st Failure Type,no known failure
3410,1,1,2nd Failure Type,no known failure
3410,1,1,Tumor Stage,T1
3410,1,1,Occurrence #,1st primary
3411,1,1,Occurrence #,1st primary
3411,1,1,Treatment Modality,Sx
3411,1,1,Tumor Site,oral cavity
3411,1,1,Metastasis,M0
3411,1,1,Clinical lab p16,p16 unkown
3411,1,1,Research lab p16,p16 unknown
3411,1,1,Research lab HPV,HPV unknown
3411,1,1,Tumor Stage,T1
3411,1,1,2nd Failure Type,no known failure
3411,1,1,1st Failure Type,no known failure
3411,1,1,Nodal Stage,N0
3411,1,1,Overall Stage,I
3412,1,1,Tumor Site,oral cavity
3412,1,1,Research lab p16,p16 unknown
3412,1,1,Overall Stage,I
3412,1,1,Treatment Modality,Sx
3412,1,1,Metastasis,M0
3412,1,1,Occurrence #,1st primary
3412,1,1,Tumor Stage,T1
3412,1,1,2nd Failure Type,no known failure
3412,1,1,1st Failure Type,no known failure
3412,1,1,Clinical lab p16,p16 unkown
3412,1,1,Nodal Stage,N0
3412,1,1,1st Failure Site,oral cavity
3412,1,1,Research lab HPV,HPV unknown
3412,1,1,1st Failure Initial Chemotherapy Agent,cis
3412,1,1,1st Failure Treatment Modality,Sx & CTX-RT
3413,1,1,Clinical lab p16,p16 unkown
3413,1,1,1st Failure Type,no known failure
3413,1,1,Treatment Modality,Sx & CTX-RT
3413,1,1,Metastasis,M1
3413,1,1,Research lab p16,p16 unknown
3413,1,1,2nd Failure Type,no known failure
3413,1,1,Overall Stage,IVc
3413,1,1,Occurrence #,1st primary
3413,1,1,Tumor Stage,T3
3413,1,1,Radiation Dosage,aborted during 2nd week
3413,1,1,Tumor Site,oral cavity
3413,1,1,Initial Chemotherapy Agent,cis
3413,1,1,Research lab HPV,HPV unknown
3413,1,1,Nodal Stage,N2
3414,1,1,Radiation Dosage,70.2
3414,1,1,Treatment Modality,CTX-RT
3414,1,1,Metastasis,M0
3414,1,1,Clinical lab p16,p16 unkown
3414,1,1,Nodal Stage,N1
3414,1,1,1st Failure Type,no known failure
3414,1,1,Research lab p16,p16 unknown
3414,1,1,Tumor Stage,T4a
3414,1,1,Initial Chemotherapy Agent,Cis
3414,1,1,Research lab HPV,HPV unknown
3414,1,1,Occurrence #,1st primary
3414,1,1,Tumor Site,oral cavity
3414,1,1,2nd Failure Type,no known failure
3414,1,1,Overall Stage,IVa
3415,1,1,Tumor Site,oropharynx
3415,1,1,Tumor Stage,T3
3415,1,1,Occurrence #,1st primary
3415,1,1,Clinical lab p16,p16 unkown
3415,1,1,Research lab p16,p16 unknown
3415,1,1,2nd Failure Type,no known failure
3415,1,1,1st Failure Type,locoregional
3415,1,1,Radiation Dosage,70.2
3415,1,1,Overall Stage,IVa
3415,1,1,Metastasis,M0
3415,1,1,Treatment Modality,CTX-RT
3415,1,1,Nodal Stage,N2
3415,1,1,Initial Chemotherapy Agent,carbo
3415,1,1,Research lab HPV,HPV unknown
3416,1,1,Tumor Stage,Unknown
3416,1,1,Tumor Site,oropharynx
3416,1,1,Treatment Modality,Sx
3416,1,1,Overall Stage,Unknown
3416,1,1,Research lab p16,p16 unknown
3416,1,1,2nd Failure Type,no known failure
3416,1,1,Clinical lab p16,p16 unkown
3416,1,1,Occurrence #,other primary
3416,1,1,Nodal Stage,Unknown
3416,1,1,Research lab HPV,HPV unknown
3416,1,1,Metastasis,Unknown
3416,1,1,1st Failure Type,no known failure
3417,1,1,Tumor Site,larynx
3417,1,1,Research lab HPV,HPV unknown
3417,1,1,Overall Stage,II
3417,1,1,1st Failure Treatment Modality,Sx & RT
3417,1,1,1st Failure Radiation Dosage,60
3417,1,1,Occurrence #,1st primary
3417,1,1,2nd Failure Type,no known failure
3417,1,1,Nodal Stage,N0
3417,1,1,1st Failure Type,no known failure
3417,1,1,Clinical lab p16,p16 unkown
3417,1,1,Tumor Stage,T2
3417,1,1,1st Failure Site,larynx
3417,1,1,Metastasis,M0
3417,1,1,Treatment Modality,RT
3417,1,1,Radiation Dosage,74.4
3417,1,1,Research lab p16,p16 unknown
3418,1,1,Tumor Site,oral cavity
3418,1,1,Nodal Stage,N1
3418,1,1,Occurrence #,1st primary
3418,1,1,Treatment Modality,Sx
3418,1,1,1st Failure Type,no known failure
3418,1,1,Metastasis,M0
3418,1,1,2nd Failure Type,no known failure
3418,1,1,Research lab HPV,HPV unknown
3418,1,1,Clinical lab p16,p16 unkown
3418,1,1,Tumor Stage,T1
3418,1,1,Overall Stage,III
3418,1,1,Research lab p16,p16 unknown
3419,1,1,Clinical lab p16,p16 unkown
3419,1,1,1st Failure Type,no known failure
3419,1,1,Metastasis,M0
3419,1,1,Research lab HPV,HPV unknown
3419,1,1,Treatment Modality,Sx & RT
3419,1,1,Research lab p16,p16 unknown
3419,1,1,Radiation Dosage,66.6
3419,1,1,Nodal Stage,N0
3419,1,1,Overall Stage,IVa
3419,1,1,2nd Failure Type,no known failure
3419,1,1,Tumor Stage,T4a
3419,1,1,Tumor Site,oral cavity
3419,1,1,Occurrence #,1st primary
3420,1,1,Clinical lab p16,p16 unkown
3420,1,1,Nodal Stage,N0
3420,1,1,Tumor Stage,T4a
3420,1,1,Overall Stage,IVa
3420,1,1,2nd Failure Type,no known failure
3420,1,1,Research lab HPV,HPV unknown
3420,1,1,Metastasis,M0
3420,1,1,Research lab p16,p16 unknown
3420,1,1,Treatment Modality,Sx
3420,1,1,Occurrence #,1st primary
3420,1,1,Tumor Site,oral cavity
3420,1,1,1st Failure Type,no known failure
3421,1,1,Research lab p16,p16 unknown
3421,1,1,Nodal Stage,N2
3421,1,1,Treatment Modality,Sx
3421,1,1,1st Failure Type,no known failure
3421,1,1,Metastasis,M0
3421,1,1,2nd Failure Type,no known failure
3421,1,1,Tumor Stage,T2
3421,1,1,Occurrence #,1st primary
3421,1,1,Research lab HPV,HPV unknown
3421,1,1,Clinical lab p16,p16 unkown
3421,1,1,Overall Stage,IVa
3421,1,1,Tumor Site,oral cavity
3422,1,1,2nd Failure Type,no known failure
3422,1,1,Overall Stage,IVa
3422,1,1,Clinical lab p16,p16 unkown
3422,1,1,1st Failure Type,no known failure
3422,1,1,Tumor Stage,T4a
3422,1,1,Treatment Modality,Sx
3422,1,1,Occurrence #,1st primary
3422,1,1,Tumor Site,oral cavity
3422,1,1,Research lab HPV,HPV unknown
3422,1,1,Nodal Stage,N0
3422,1,1,Research lab p16,p16 unknown
3422,1,1,Metastasis,M0
3423,1,1,Research lab HPV,HPV unknown
3423,1,1,Tumor Stage,T1
3423,1,1,Treatment Modality,Sx
3423,1,1,Clinical lab p16,p16 unkown
3423,1,1,2nd Failure Type,no known failure
3423,1,1,Occurrence #,1st primary
3423,1,1,Nodal Stage,N0
3423,1,1,Metastasis,M0
3423,1,1,Tumor Site,oral cavity
3423,1,1,Research lab p16,p16 unknown
3423,1,1,1st Failure Type,no known failure
3423,1,1,Overall Stage,I
3424,1,1,1st Failure Initial Chemotherapy Agent,Carbo
3424,1,1,1st Failure Site,oropharynx
3424,1,1,Tumor Stage,T2
3424,1,1,1st Failure Radiation Dosage,60
3424,1,1,Nodal Stage,N2
3424,1,1,1st Failure Type,locoregional
3424,1,1,Treatment Modality,Sx
3424,1,1,Overall Stage,IVa
3424,1,1,Occurrence #,other primary
3424,1,1,Metastasis,M0
3424,1,1,2nd Failure Type,no known failure
3424,1,1,Tumor Site,oropharynx
3424,1,1,Research lab p16,p16 unknown
3424,1,1,Clinical lab p16,p16 unkown
3424,1,1,1st Failure Treatment Modality,Sx & CTX-RT
3424,1,1,Research lab HPV,HPV unknown
3425,1,1,Research lab p16,p16 unknown
3425,1,1,Tumor Site,oral cavity
3425,1,1,1st Failure Type,no known failure
3425,1,1,Nodal Stage,N0
3425,1,1,Occurrence #,recurrence
3425,1,1,2nd Failure Type,no known failure
3425,1,1,Research lab HPV,HPV unknown
3425,1,1,Treatment Modality,Sx
3425,1,1,Metastasis,M0
3425,1,1,Tumor Stage,T2
3425,1,1,Overall Stage,II
3425,1,1,Clinical lab p16,p16 unkown
3426,1,1,1st Failure Treatment Modality,Sx
3426,1,1,Occurrence #,1st primary
3426,1,1,2nd Failure Type,no known failure
3426,1,1,Clinical lab p16,p16 unkown
3426,1,1,Tumor Stage,T2
3426,1,1,Research lab HPV,HPV unknown
3426,1,1,Metastasis,M0
3426,1,1,Overall Stage,IVa
3426,1,1,Tumor Site,oral cavity
3426,1,1,Treatment Modality,Sx
3426,1,1,1st Failure Type,no known failure
3426,1,1,1st Failure Site,oral cavity
3426,1,1,Research lab p16,p16 unknown
3426,1,1,Nodal Stage,N2
3427,1,1,Research lab p16,p16 unknown
3427,1,1,Occurrence #,1st primary
3427,1,1,Treatment Modality,Sx
3427,1,1,2nd Failure Type,no known failure
3427,1,1,Tumor Site,oral cavity
3427,1,1,Metastasis,M0
3427,1,1,Tumor Stage,T2
3427,1,1,Clinical lab p16,p16 unkown
3427,1,1,Nodal Stage,N2
3427,1,1,Overall Stage,IVa
3427,1,1,1st Failure Type,no known failure
3427,1,1,Research lab HPV,HPV unknown
3428,1,1,Radiation Dosage,63
3428,1,1,Research lab p16,p16 unknown
3428,1,1,Treatment Modality,Sx & CTX-RT
3428,1,1,Nodal Stage,N2
3428,1,1,Tumor Stage,T4a
3428,1,1,Research lab HPV,HPV unknown
3428,1,1,Tumor Site,oral cavity
3428,1,1,Occurrence #,1st primary
3428,1,1,2nd Failure Type,no known failure
3428,1,1,Initial Chemotherapy Agent,cis
3428,1,1,Clinical lab p16,p16 unkown
3428,1,1,Metastasis,M0
3428,1,1,Overall Stage,IVa
3428,1,1,1st Failure Type,no known failure
3429,1,1,2nd Failure Type,no known failure
3429,1,1,Tumor Stage,T1
3429,1,1,Nodal Stage,N0
3429,1,1,Metastasis,M0
3429,1,1,Overall Stage,I
3429,1,1,Tumor Site,oral cavity
3429,1,1,Research lab p16,p16 unknown
3429,1,1,Clinical lab p16,p16 unkown
3429,1,1,1st Failure Site,oral cavity
3429,1,1,Research lab HPV,HPV unknown
3429,1,1,Treatment Modality,Sx
3429,1,1,1st Failure Type,locoregional
3429,1,1,1st Failure Treatment Modality,Sx
3429,1,1,Occurrence #,1st primary
3430,1,1,Research lab p16,p16 unknown
3430,1,1,Tumor Stage,T4a
3430,1,1,Clinical lab p16,p16 unkown
3430,1,1,Overall Stage,IVa
3430,1,1,Research lab HPV,HPV unknown
3430,1,1,Treatment Modality,Sx
3430,1,1,1st Failure Type,no known failure
3430,1,1,Metastasis,M0
3430,1,1,Occurrence #,1st primary
3430,1,1,Tumor Site,oral cavity
3430,1,1,2nd Failure Type,no known failure
3430,1,1,Nodal Stage,N0
3431,1,1,Nodal Stage,N2
3431,1,1,Overall Stage,IVa
3431,1,1,Metastasis,M0
3431,1,1,Clinical lab p16,p16 unkown
3431,1,1,Research lab HPV,HPV unknown
3431,1,1,1st Failure Type,no known failure
3431,1,1,Occurrence #,1st primary
3431,1,1,Treatment Modality,Sx & CTX-RT
3431,1,1,Radiation Dosage,63
3431,1,1,Initial Chemotherapy Agent,Cis
3431,1,1,Research lab p16,p16 unknown
3431,1,1,2nd Failure Type,no known failure
3431,1,1,Tumor Stage,T3
3431,1,1,Tumor Site,oral cavity
3432,1,1,Clinical lab p16,p16 unkown
3432,1,1,Treatment Modality,Sx & CTX-RT
3432,1,1,Tumor Site,oral cavity
3432,1,1,2nd Failure Type,no known failure
3432,1,1,Overall Stage,IVa
3432,1,1,Metastasis,Unknown
3432,1,1,Radiation Dosage,Unknown
3432,1,1,Tumor Stage,T4a
3432,1,1,Research lab HPV,HPV unknown
3432,1,1,Nodal Stage,N2
3432,1,1,Initial Chemotherapy Agent,cis
3432,1,1,1st Failure Type,distant
3432,1,1,Occurrence #,1st primary
3432,1,1,Research lab p16,p16 unknown
3433,1,1,Research lab p16,p16 unknown
3433,1,1,Tumor Stage,T1
3433,1,1,Clinical lab p16,p16 unkown
3433,1,1,Metastasis,M0
3433,1,1,Tumor Site,oral cavity
3433,1,1,Research lab HPV,HPV unknown
3433,1,1,Overall Stage,I
3433,1,1,Occurrence #,1st primary
3433,1,1,Nodal Stage,N0
3433,1,1,2nd Failure Type,no known failure
3433,1,1,Treatment Modality,Sx
3433,1,1,1st Failure Type,no known failure
3434,1,1,1st Failure Treatment Modality,Sx
3434,1,1,Overall Stage,II
3434,1,1,Research lab p16,p16 unknown
3434,1,1,Metastasis,M0
3434,1,1,Tumor Site,oral cavity
3434,1,1,2nd Failure Type,no known failure
3434,1,1,Occurrence #,1st primary
3434,1,1,Treatment Modality,Sx & RT
3434,1,1,Nodal Stage,N0
3434,1,1,Tumor Stage,T2
3434,1,1,1st Failure Type,no known failure
3434,1,1,1st Failure Site,oral cavity
3434,1,1,Clinical lab p16,p16 unkown
3434,1,1,Research lab HPV,HPV unknown
3435,1,1,Research lab HPV,HPV unknown
3435,1,1,1st Failure Type,no known failure
3435,1,1,Treatment Modality,Sx
3435,1,1,Clinical lab p16,p16 unkown
3435,1,1,Occurrence #,1st primary
3435,1,1,Research lab p16,p16 unknown
3435,1,1,Tumor Site,oral cavity
3435,1,1,Tumor Stage,T1
3435,1,1,2nd Failure Type,no known failure
3435,1,1,Nodal Stage,N0
3435,1,1,Overall Stage,I
3435,1,1,Metastasis,M0
3436,1,1,Treatment Modality,Sx
3436,1,1,Metastasis,M0
3436,1,1,Occurrence #,other primary
3436,1,1,Clinical lab p16,p16 unkown
3436,1,1,Tumor Stage,T4a
3436,1,1,1st Failure Type,no known failure
3436,1,1,Tumor Site,oral cavity
3436,1,1,Nodal Stage,N2
3436,1,1,2nd Failure Type,no known failure
3436,1,1,Research lab p16,p16 unknown
3436,1,1,Research lab HPV,HPV unknown
3436,1,1,Overall Stage,IVa
3437,1,1,Tumor Site,oral cavity
3437,1,1,Clinical lab p16,p16 unkown
3437,1,1,Tumor Stage,T4a
3437,1,1,Nodal Stage,N0
3437,1,1,Research lab HPV,HPV unknown
3437,1,1,Research lab p16,p16 unknown
3437,1,1,Metastasis,M0
3437,1,1,Treatment Modality,Sx
3437,1,1,2nd Failure Type,no known failure
3437,1,1,Overall Stage,IVa
3437,1,1,1st Failure Type,no known failure
3437,1,1,Occurrence #,other primary
3438,1,1,Tumor Stage,T2
3438,1,1,Overall Stage,II
3438,1,1,Research lab HPV,HPV unknown
3438,1,1,Tumor Site,oral cavity
3438,1,1,Occurrence #,1st primary
3438,1,1,1st Failure Type,no known failure
3438,1,1,2nd Failure Type,no known failure
3438,1,1,Metastasis,M0
3438,1,1,Research lab p16,p16 unknown
3438,1,1,Treatment Modality,Sx
3438,1,1,Nodal Stage,N0
3438,1,1,Clinical lab p16,p16 unkown
3439,1,1,Treatment Modality,Sx
3439,1,1,Tumor Site,oropharynx
3439,1,1,Overall Stage,IVa
3439,1,1,Occurrence #,other primary
3439,1,1,Research lab p16,p16 unknown
3439,1,1,Metastasis,M0
3439,1,1,Clinical lab p16,p16 unkown
3439,1,1,Tumor Stage,T4a
3439,1,1,Nodal Stage,N0
3439,1,1,Research lab HPV,HPV unknown
3439,1,1,2nd Failure Type,no known failure
3439,1,1,1st Failure Type,no known failure
3440,1,1,Metastasis,M0
3440,1,1,Occurrence #,1st primary
3440,1,1,1st Failure Type,no known failure
3440,1,1,Overall Stage,III
3440,1,1,Treatment Modality,Sx
3440,1,1,Research lab p16,p16 unknown
3440,1,1,Clinical lab p16,p16 unkown
3440,1,1,Tumor Stage,T2
3440,1,1,2nd Failure Type,no known failure
3440,1,1,Research lab HPV,HPV unknown
3440,1,1,Tumor Site,oral cavity
3440,1,1,Nodal Stage,N2
3441,1,1,Tumor Stage,T2
3441,1,1,Tumor Site,oral cavity
3441,1,1,Nodal Stage,N0
3441,1,1,Metastasis,M0
3441,1,1,Occurrence #,1st primary
3441,1,1,Overall Stage,II
3441,1,1,Treatment Modality,Sx
3441,1,1,Clinical lab p16,p16 unkown
3441,1,1,Research lab HPV,HPV unknown
3441,1,1,Research lab p16,p16 unknown
3441,1,1,1st Failure Treatment Modality,Sx
3441,1,1,1st Failure Site,oral cavity
3441,1,1,1st Failure Type,no known failure
3441,1,1,2nd Failure Type,no known failure
3442,1,1,Research lab HPV,HPV unknown
3442,1,1,Metastasis,Unknown
3442,1,1,Occurrence #,1st primary
3442,1,1,Nodal Stage,Unknown
3442,1,1,Research lab p16,p16 unknown
3442,1,1,1st Failure Type,no known failure
3442,1,1,Clinical lab p16,p16 unkown
3442,1,1,Tumor Site,oropharynx
3442,1,1,Overall Stage,Unknown
3442,1,1,Tumor Stage,Unknown
3442,1,1,2nd Failure Type,no known failure
3442,1,1,Treatment Modality,Sx
3443,1,1,Research lab p16,p16 unknown
3443,1,1,Tumor Stage,T4a
3443,1,1,Tumor Site,oral cavity
3443,1,1,1st Failure Type,no known failure
3443,1,1,Overall Stage,IVa
3443,1,1,Research lab HPV,HPV unknown
3443,1,1,Clinical lab p16,p16 unkown
3443,1,1,Treatment Modality,Sx
3443,1,1,Nodal Stage,N0
3443,1,1,Occurrence #,1st primary
3443,1,1,2nd Failure Type,no known failure
3443,1,1,Metastasis,M0
3444,1,1,Overall Stage,IVa
3444,1,1,Research lab p16,p16 unknown
3444,1,1,Tumor Site,oropharynx
3444,1,1,2nd Failure Type,no known failure
3444,1,1,Metastasis,M0
3444,1,1,Clinical lab p16,p16 unkown
3444,1,1,Tumor Stage,T4a
3444,1,1,Initial Chemotherapy Agent,cis
3444,1,1,Radiation Dosage,70.2
3444,1,1,Treatment Modality,CTX-RT
3444,1,1,Nodal Stage,N2
3444,1,1,Occurrence #,1st primary
3444,1,1,1st Failure Type,no known failure
3444,1,1,Research lab HPV,HPV unknown
3445,1,1,Research lab p16,p16 unknown
3445,1,1,Metastasis,M0
3445,1,1,Treatment Modality,Sx
3445,1,1,2nd Failure Type,no known failure
3445,1,1,Tumor Stage,T4a
3445,1,1,Nodal Stage,N0
3445,1,1,Tumor Site,oral cavity
3445,1,1,1st Failure Type,no known failure
3445,1,1,Research lab HPV,HPV unknown
3445,1,1,Occurrence #,1st primary
3445,1,1,Clinical lab p16,p16 unkown
3445,1,1,Overall Stage,IVa
3446,1,1,Overall Stage,II
3446,1,1,Tumor Stage,T2
3446,1,1,2nd Failure Type,no known failure
3446,1,1,Research lab p16,p16 unknown
3446,1,1,Occurrence #,1st primary
3446,1,1,Nodal Stage,N0
3446,1,1,Tumor Site,oral cavity
3446,1,1,Research lab HPV,HPV unknown
3446,1,1,Metastasis,M0
3446,1,1,Clinical lab p16,p16 unkown
3446,1,1,1st Failure Type,no known failure
3446,1,1,Treatment Modality,Sx
3447,1,1,Tumor Stage,T2
3447,1,1,2nd Failure Type,no known failure
3447,1,1,Nodal Stage,N1
3447,1,1,Metastasis,M0
3447,1,1,Research lab p16,p16 unknown
3447,1,1,1st Failure Type,no known failure
3447,1,1,Treatment Modality,Sx
3447,1,1,Tumor Site,oral cavity
3447,1,1,Clinical lab p16,p16 unkown
3447,1,1,Overall Stage,III
3447,1,1,Research lab HPV,HPV unknown
3447,1,1,Occurrence #,1st primary
3448,1,1,Nodal Stage,N0
3448,1,1,Research lab HPV,HPV unknown
3448,1,1,Occurrence #,recurrence
3448,1,1,Treatment Modality,Sx
3448,1,1,Tumor Stage,T4a
3448,1,1,1st Failure Type,no known failure
3448,1,1,2nd Failure Type,no known failure
3448,1,1,Research lab p16,p16 unknown
3448,1,1,Metastasis,M0
3448,1,1,Tumor Site,oral cavity
3448,1,1,Overall Stage,IVa
3448,1,1,Clinical lab p16,p16 unkown
3449,1,1,Tumor Stage,T4a
3449,1,1,2nd Failure Type,no known failure
3449,1,1,Overall Stage,IVb
3449,1,1,Occurrence #,recurrence
3449,1,1,Tumor Site,oral cavity
3449,1,1,1st Failure Type,no known failure
3449,1,1,Clinical lab p16,p16 unkown
3449,1,1,Research lab HPV,HPV unknown
3449,1,1,Nodal Stage,N2
3449,1,1,Treatment Modality,Sx
3449,1,1,Research lab p16,p16 unknown
3449,1,1,Metastasis,M0
3450,1,1,2nd Failure Type,no known failure
3450,1,1,Tumor Site,oral cavity
3450,1,1,Occurrence #,1st primary
3450,1,1,Research lab HPV,HPV unknown
3450,1,1,Clinical lab p16,p16 unkown
3450,1,1,Tumor Stage,T1
3450,1,1,Research lab p16,p16 unknown
3450,1,1,Treatment Modality,Sx
3450,1,1,Overall Stage,III
3450,1,1,1st Failure Type,no known failure
3450,1,1,Metastasis,M0
3450,1,1,Nodal Stage,N2
3451,1,1,Treatment Modality,Sx
3451,1,1,Research lab HPV,HPV unknown
3451,1,1,2nd Failure Type,no known failure
3451,1,1,Tumor Stage,T4a
3451,1,1,Clinical lab p16,p16 unkown
3451,1,1,Research lab p16,p16 unknown
3451,1,1,Tumor Site,oral cavity
3451,1,1,Occurrence #,1st primary
3451,1,1,Metastasis,M0
3451,1,1,Nodal Stage,N2
3451,1,1,1st Failure Type,no known failure
3451,1,1,Overall Stage,IVa
3452,1,1,2nd Failure Type,no known failure
3452,1,1,Treatment Modality,Sx
3452,1,1,Research lab HPV,HPV unknown
3452,1,1,1st Failure Type,no known failure
3452,1,1,Clinical lab p16,p16 unkown
3452,1,1,Research lab p16,p16 unknown
3452,1,1,Overall Stage,IVa
3452,1,1,Metastasis,M0
3452,1,1,Nodal Stage,N2
3452,1,1,Tumor Stage,T4a
3452,1,1,Tumor Site,oral cavity
3452,1,1,Occurrence #,1st primary
3453,1,1,Occurrence #,1st primary
3453,1,1,Tumor Site,oral cavity
3453,1,1,Tumor Stage,T4a
3453,1,1,Nodal Stage,N0
3453,1,1,Metastasis,M0
3453,1,1,Overall Stage,IVa
3453,1,1,Research lab p16,p16 unknown
3453,1,1,Clinical lab p16,p16 unkown
3453,1,1,Research lab HPV,HPV unknown
3453,1,1,Treatment Modality,Sx
3453,1,1,1st Failure Type,no known failure
3453,1,1,2nd Failure Type,no known failure
